data_2jn3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jn3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.23 0.538 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 m -56.56 145.16 29.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.888 . . . . 0.0 110.182 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.6 -176.48 17.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.4 m -106.35 131.28 53.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -1.137 . . . . 0.0 110.251 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.468 ' CZ3' ' HG3' ' A' ' 107' ' ' MET . 93.0 m95 -119.62 142.84 48.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -124.22 122.12 36.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 110.257 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.15 127.21 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 121' ' ' ARG . 34.3 p90 -133.08 2.37 3.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.251 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.82 127.99 2.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -143.96 120.77 11.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.243 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 55.7 tt0 -99.82 144.65 28.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.941 . . . . 0.0 110.197 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 22.3 m120 58.32 16.33 3.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.277 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.693 ' CE2' ' CD1' ' A' ' 18' ' ' LEU . 90.4 t80 -52.98 -47.64 68.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 110.164 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.09 -47.51 76.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 37.0 mt-10 -56.47 -60.23 3.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.649 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 45.0 t80 -49.74 -54.99 15.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.693 ' CD1' ' CE2' ' A' ' 14' ' ' TYR . 22.2 mt -52.68 -49.51 65.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 63.1 mttt -42.47 -40.19 2.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.915 . . . . 0.0 110.156 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.451 ' HB3' ' HA3' ' A' ' 114' ' ' GLY . . . -68.84 -25.54 64.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.639 HD12 ' CE2' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -59.04 -19.09 40.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.181 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.605 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 76.36 25.43 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.903 . . . . 0.0 110.166 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.557 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 20.3 mt -75.17 168.24 29.35 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 23' ' ' LEU . 46.4 Cg_endo -73.05 138.06 27.52 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.01 1.531 . . . . 0.0 110.444 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -54.32 -44.44 72.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.925 . . . . 0.0 110.159 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -53.75 -25.3 18.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.665 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 44.9 tp -90.36 -23.95 20.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.901 . . . . 0.0 110.243 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.853 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 81.2 mt -74.81 -42.3 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.233 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -74.97 -20.6 59.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.9 mmm -93.0 -27.12 17.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.212 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -105.71 4.44 30.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 110.273 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.853 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 23.4 ptt180 -72.43 3.63 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 10.4 t0 -154.45 47.19 0.58 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.046 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 4.2 mt -121.12 117.29 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 110.168 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -91.3 82.48 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.186 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 1.046 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.09 132.89 18.77 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.034 1.544 . . . . 0.0 110.428 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 6' ' ' TRP . 8.2 mt -83.2 162.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.0 t -140.67 116.48 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -97.21 136.01 38.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.855 . . . . 0.0 110.224 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.5 mm -123.63 132.78 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.198 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.4 ' HB3' ' HB ' ' A' ' 48' ' ' VAL . 37.2 tt0 -132.56 63.21 1.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 110.2 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 51.6 tt0 -59.3 165.8 2.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 110.218 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 38.3 mtmt -163.77 37.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.28 -97.84 0.53 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 14.8 m-20 -112.4 -7.48 13.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -1.122 . . . . 0.0 110.166 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.574 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 12.0 m-20 -102.55 157.75 16.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.592 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 41.3 m-85 -138.55 139.5 38.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.218 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 58.6 t -117.19 104.19 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -104.16 128.32 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.423 HG22 ' HE3' ' A' ' 52' ' ' LYS . 94.0 m -130.51 100.27 5.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.1 m -83.68 140.15 32.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 110.224 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 50' ' ' THR . 55.3 mttt -132.17 107.38 8.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.868 . . . . 0.0 110.204 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.497 ' CG2' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -94.0 168.15 12.25 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 110.211 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.6 Cg_endo -72.96 -29.93 11.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.016 1.535 . . . . 0.0 110.477 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -95.35 -22.05 18.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.485 ' O ' ' OG1' ' A' ' 53' ' ' THR . 5.1 pt20 -162.45 169.58 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.2 p -134.6 124.88 26.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.227 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 73' ' ' MET . 54.0 t -123.24 125.86 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.482 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 64.3 m -112.94 148.16 35.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.213 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 59' ' ' THR . 27.2 m120 -143.87 147.52 34.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.279 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 t -138.92 140.12 38.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.549 ' CD1' HG22 ' A' ' 82' ' ' VAL . 34.5 p90 -151.89 166.19 32.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -0.904 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.401 ' CG2' ' OD1' ' A' ' 46' ' ' ASP . 88.7 m -116.26 152.26 34.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 3.9 tp -78.47 122.91 26.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.56 14.4 53.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -144.63 136.11 25.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -1.169 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.0 123.1 18.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.12 150.54 43.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.244 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -83.93 132.58 34.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 110.222 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.7 mm -121.85 146.31 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 m -123.62 136.97 54.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 0.0 110.21 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.659 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 57.9 p -90.92 162.68 14.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.291 -0.88 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.457 ' HG2' HG22 ' A' ' 58' ' ' VAL . 23.9 mtm -75.8 -10.62 59.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.501 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 4.5 p30 -88.76 -14.92 35.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.49 28.73 4.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.659 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 18.0 mttt -107.02 128.16 54.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -1.121 . . . . 0.0 110.233 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -107.06 139.36 41.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.208 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.29 154.37 5.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.208 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.0 mtmm -98.6 153.05 18.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.419 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -157.82 133.66 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 m -95.2 102.58 14.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.186 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 62' ' ' PHE . 47.5 t -73.81 142.99 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 6.5 p-80 -144.36 157.25 44.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.927 . . . . 0.0 110.246 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.0 mt -99.86 134.26 43.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.875 . . . . 0.0 110.233 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -140.73 117.22 10.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.246 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 17.9 m120 61.93 27.59 16.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.514 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.61 40.58 26.75 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.514 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 61.3 mttt -151.4 130.32 12.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -1.14 . . . . 0.0 110.225 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.49 HD23 ' CG1' ' A' ' 82' ' ' VAL . 7.4 tt -76.58 129.94 37.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.576 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 70.3 t -138.46 125.92 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.932 . . . . 0.0 110.188 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 51.9 m -117.92 90.57 3.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -85.24 164.55 17.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 110.211 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 34.9 t -155.07 -158.37 0.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.405 ' N ' ' OG ' ' A' ' 93' ' ' SER . 35.0 mt-10 -108.1 35.41 3.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 110.239 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -177.58 1.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.0 110.149 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.896 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER 179.21 148.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.198 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.479 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -121.76 160.62 24.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.155 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 52.1 t-80 -142.15 140.92 32.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.182 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 110' ' ' THR . 48.2 mt-10 -151.74 126.33 9.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.226 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.7 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 41.3 tt0 -125.95 156.32 39.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.161 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.7 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 7.8 mp0 -157.53 147.55 20.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.902 . . . . 0.0 110.261 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.0 p -116.12 139.26 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -130.33 99.48 5.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.925 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.37 -118.11 5.76 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -103.9 8.15 36.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.232 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -116.1 159.06 22.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.468 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -129.04 139.2 52.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.289 -0.882 . . . . 0.0 110.17 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 80.0 t -126.33 126.18 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.2 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 35.1 mt-10 -110.5 131.28 55.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 99' ' ' GLU . 12.2 p -122.17 117.62 26.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 97' ' ' SER . 53.8 mt -129.16 139.41 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.251 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 69.9 p -112.75 131.56 55.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.176 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.639 ' CE2' HD12 ' A' ' 21' ' ' LEU . 3.2 t80 -151.89 126.82 9.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.918 . . . . 0.0 110.231 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' A' ' 20' ' ' ALA . . . 65.42 36.51 92.72 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.89 11.42 66.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 17' ' ' PHE . 69.2 t -114.36 138.06 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -1.117 . . . . 0.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 43.9 m -112.18 135.67 52.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 110.195 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.649 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 59.2 tp -115.0 144.36 43.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 119' ' ' ILE . 94.1 mt -125.7 94.44 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.433 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 9.9 ttp180 -89.54 132.26 35.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 110.204 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.501 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 45.1 mtm180 -109.9 122.8 48.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' A' ' 6' ' ' TRP . 59.2 m -119.73 152.96 36.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -116.98 155.48 29.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.212 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 5' ' ' THR . 39.5 ttp85 -81.38 135.2 35.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.221 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.409 ' O ' HD11 ' A' ' 40' ' ' ILE . 88.6 m-85 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.244 0.545 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.1 p -56.87 146.26 27.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.299 -0.875 . . . . 0.0 110.172 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.15 -174.06 17.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 89.0 m -107.64 131.11 54.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -1.141 . . . . 0.0 110.241 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.501 ' CE3' ' HG3' ' A' ' 107' ' ' MET . 90.8 m95 -120.15 145.09 47.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -126.47 122.06 34.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.851 . . . . 0.0 110.177 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.5 126.02 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 39.1 p90 -126.81 -29.61 2.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.912 . . . . 0.0 110.19 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.78 129.57 40.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.86 . . . . 0.0 110.269 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.437 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.6 pt20 -143.11 119.61 11.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 110.203 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.429 ' O ' HD11 ' A' ' 118' ' ' LEU . 56.6 tt0 -98.66 144.45 27.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 110.247 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.718 ' OD1' ' OE1' ' A' ' 16' ' ' GLU . 1.9 t30 60.25 14.21 4.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.657 ' CZ ' HD12 ' A' ' 18' ' ' LEU . 74.0 t80 -51.59 -52.14 49.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -62.95 -48.5 78.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.718 ' OE1' ' OD1' ' A' ' 13' ' ' ASN . 65.3 mt-10 -55.73 -59.36 4.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.148 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 70.4 t80 -49.2 -55.49 12.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.657 HD12 ' CZ ' ' A' ' 14' ' ' TYR . 12.7 mt -58.15 -42.25 85.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 3.5 tttm -49.14 -41.23 35.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.57 -27.75 66.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.672 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.1 tp -58.75 -20.27 47.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.672 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 79.61 28.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 110.268 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 65.6 mt -74.73 165.86 50.2 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.134 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.547 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 45.6 Cg_endo -73.14 140.13 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.021 1.537 . . . . 0.0 110.382 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.7 -40.87 84.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.61 -26.58 56.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.229 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.73 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 43.3 tp -92.46 -19.41 22.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.736 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 94.0 mt -82.92 -40.93 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 0.0 110.172 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -75.36 -27.56 59.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.174 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 57.9 tpp -86.53 -27.64 23.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.237 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.73 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -103.03 4.92 37.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.736 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 6.3 ptt180 -71.57 2.07 5.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -152.33 48.66 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 110.24 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.079 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.9 mt -123.72 118.46 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.207 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.47 84.56 0.11 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.232 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 1.079 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.05 130.58 15.62 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.986 1.519 . . . . 0.0 110.433 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.481 HG21 ' N ' ' A' ' 38' ' ' VAL . 9.8 mt -84.39 157.86 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.481 ' N ' HG21 ' A' ' 37' ' ' ILE . 75.6 t -137.26 115.77 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -96.27 137.49 35.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.41 ' CD1' ' HE3' ' A' ' 107' ' ' MET . 79.3 mt -123.95 129.72 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.52 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 55.8 tt0 -130.33 67.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 0.0 110.23 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.716 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 9.3 tt0 -62.39 171.37 1.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.143 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.716 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 17.9 mtmt -171.74 38.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.153 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.16 -104.54 0.87 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -108.52 0.64 21.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -1.149 . . . . 0.0 110.222 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.1 t0 -108.89 145.04 36.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.614 ' CE1' ' HG3' ' A' ' 42' ' ' GLN . 7.6 m-85 -127.18 139.43 52.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 110.276 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 59.4 t -120.01 104.61 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.29 122.44 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 110.146 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.419 HG21 ' OG1' ' A' ' 59' ' ' THR . 91.3 m -122.72 106.08 10.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 110.261 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -92.61 134.58 34.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -127.11 119.6 26.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.961 . . . . 0.0 110.289 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.653 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -103.25 169.86 6.92 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.174 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.07 -17.82 24.5 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.093 1.575 . . . . 0.0 110.404 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -104.88 -24.71 12.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.956 . . . . 0.0 110.213 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.653 ' O ' ' OG1' ' A' ' 53' ' ' THR . 3.8 pt20 -163.58 169.08 19.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.186 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.0 p -129.79 127.85 41.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.231 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 73' ' ' MET . 19.4 m -124.96 127.02 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.177 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.419 ' OG1' HG21 ' A' ' 50' ' ' THR . 36.2 m -115.64 147.36 40.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -142.46 149.46 39.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.261 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.3 t -141.81 137.76 31.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.152 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.606 ' CD1' HG22 ' A' ' 82' ' ' VAL . 52.0 p90 -150.5 169.89 20.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 110.237 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.9 m -117.65 150.57 38.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.196 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.515 ' CD1' ' CE1' ' A' ' 47' ' ' PHE . 17.3 mt -79.53 123.81 27.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 110.212 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.48 9.66 52.56 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -145.72 143.7 29.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -1.131 . . . . 0.0 110.193 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -68.68 127.78 34.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.202 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.571 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.06 147.63 50.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -80.28 134.99 36.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.241 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 70' ' ' ILE . 23.8 mm -124.26 144.81 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.151 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.1 m -121.78 136.06 54.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.21 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.595 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 66.4 p -87.88 161.14 17.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.431 ' HA ' HG12 ' A' ' 58' ' ' VAL . 1.5 ttp -73.89 -11.91 60.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.198 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -89.13 -14.04 37.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 110.213 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.67 50.77 0.83 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.595 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 7.7 tttt -128.61 129.65 46.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -1.155 . . . . 0.0 110.146 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -105.79 137.59 43.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.203 -0.936 . . . . 0.0 110.192 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.1 155.08 11.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.232 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -101.45 145.47 28.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.535 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.3 m -153.08 133.78 13.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.307 -0.871 . . . . 0.0 110.156 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -94.97 100.04 11.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.606 HG22 ' CD1' ' A' ' 62' ' ' PHE . 49.4 t -70.36 142.26 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 8.5 p-80 -146.04 151.41 37.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.15 132.03 40.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 110.262 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -140.87 131.49 25.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 97.3 m-20 56.69 17.43 3.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.2 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.548 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 83.8 40.88 8.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.548 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 97.4 mttt -155.57 131.84 10.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -1.121 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.491 ' CD2' HG11 ' A' ' 82' ' ' VAL . 6.7 tt -72.64 130.89 41.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.244 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.555 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 92.8 t -139.25 125.31 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.179 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.535 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 99.5 m -115.65 90.16 3.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -84.59 169.5 14.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.214 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 29.5 t -160.72 -157.58 0.54 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 110.196 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 18.7 tt0 -109.74 32.93 4.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.231 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.711 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -175.74 6.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 1.073 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.3 OUTLIER 171.87 141.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 110.26 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.435 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -114.72 174.75 5.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.4 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 47.6 t-80 -156.31 137.84 14.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.148 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 110' ' ' THR . 69.5 tt0 -149.85 126.49 10.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.218 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 47.5 tt0 -125.54 161.16 27.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.923 . . . . 0.0 110.247 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.514 ' OE1' ' HG3' ' A' ' 103' ' ' LYS . 10.9 tm-20 -161.81 148.72 14.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.434 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 10.8 p -116.0 143.18 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 110.223 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.514 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 92.6 mttt -133.26 92.7 3.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.99 -109.81 2.98 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.665 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 24.5 p30 -112.1 11.23 20.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -1.152 . . . . 0.0 110.18 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.665 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 61.5 mt-10 -118.64 155.18 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.501 ' HG3' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -125.1 141.85 51.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.48 121.54 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.13 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 40.8 mt-10 -107.74 119.27 38.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 99' ' ' GLU . 38.0 p -108.48 119.61 40.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 97' ' ' SER . 53.0 mt -130.39 131.73 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.357 -0.84 . . . . 0.0 110.209 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 6.3 t -110.55 141.27 43.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.175 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.681 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 10.7 t80 -161.26 128.34 4.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.15 33.95 74.85 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.9 12.78 75.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 112' ' ' THR . 73.1 t -116.48 139.47 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -1.155 . . . . 0.0 110.191 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 47.3 m -112.92 134.0 54.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.608 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 43.1 tp -114.07 150.55 33.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.0 mt -130.6 94.74 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.444 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 9.4 ttp180 -88.93 131.42 35.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 25.7 mtt-85 -110.41 124.71 52.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.915 . . . . 0.0 110.174 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.1 m -122.07 149.44 43.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -115.38 153.15 31.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.19 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.7 ttp85 -78.19 134.75 37.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.192 -179.932 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 49.3 m-85 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.319 0.581 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 p -57.65 144.93 35.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.97 -178.7 17.33 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 91.0 m -106.13 134.73 48.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -1.148 . . . . 0.0 110.242 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.462 ' CE2' ' HE3' ' A' ' 107' ' ' MET . 92.9 m95 -121.15 136.33 55.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -118.88 118.15 30.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.201 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.94 126.03 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.238 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.593 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 11.8 p90 -128.5 -19.59 3.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.593 ' HB1' ' CE1' ' A' ' 9' ' ' TYR . . . -141.74 131.6 24.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.207 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -143.06 166.47 24.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.226 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 56.0 tt0 -141.03 146.44 37.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.932 . . . . 0.0 110.21 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 79.4 m-20 56.19 20.72 4.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -53.67 50.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.862 . . . . 0.0 110.215 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -59.36 -57.04 14.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -46.25 -52.93 11.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.581 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 69.6 t80 -52.56 -46.3 66.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.17 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 mt -59.3 -43.05 92.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.893 . . . . 0.0 110.172 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -54.58 -42.08 70.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.4 75.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.616 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 3.9 tp -64.42 -17.41 63.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.17 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.616 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 74.95 28.91 1.04 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.226 -0.922 . . . . 0.0 110.22 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 24' ' ' PRO . 20.2 mt -75.39 165.03 56.98 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.721 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.3 Cg_endo -73.11 139.89 30.3 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.036 1.545 . . . . 0.0 110.473 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.441 ' HG2' ' HG3' ' A' ' 29' ' ' LYS . 41.9 tt0 -58.56 -36.32 73.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.291 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -61.55 -28.89 69.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.893 . . . . 0.0 110.192 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.721 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 33.3 tp -92.11 -29.2 16.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.222 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.661 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 95.8 mt -74.48 -44.29 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 3.5 mmpt? -71.07 -23.96 62.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.207 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.0 ttp -89.68 -29.31 18.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.16 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -100.64 -0.29 37.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.236 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.661 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -65.97 -11.61 48.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.468 ' HB2' ' NE ' ' A' ' 32' ' ' ARG . 6.5 t0 -138.08 45.56 2.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 0.0 110.16 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.002 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 1.7 mt -115.81 122.1 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.895 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.54 82.42 0.12 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.236 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 1.002 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.7 Cg_endo -73.0 136.64 25.22 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.008 1.53 . . . . 0.0 110.451 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.419 HG21 ' N ' ' A' ' 38' ' ' VAL . 11.6 mt -89.24 154.67 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.218 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.419 ' N ' HG21 ' A' ' 37' ' ' ILE . 77.4 t -131.58 111.48 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 73.6 tt0 -94.81 132.47 39.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.77 128.51 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -133.63 74.81 1.57 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 110.181 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.519 ' OE1' ' CZ ' ' A' ' 47' ' ' PHE . 13.0 pt20 -78.41 162.72 26.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 110.208 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 86.3 mttt -156.47 49.12 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 0.0 110.19 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.04 -100.61 0.9 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 39.5 m-20 -110.48 -7.85 14.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -1.221 . . . . 0.0 110.198 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -98.58 152.96 19.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.211 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.519 ' CZ ' ' OE1' ' A' ' 42' ' ' GLN . 1.6 m-85 -136.42 136.42 39.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 110.155 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.01 110.82 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.196 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 4.6 m -113.75 135.32 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.1 m -122.07 98.16 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.91 . . . . 0.0 110.203 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.2 m -78.63 138.54 38.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.198 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -132.83 114.74 14.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.255 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.658 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -99.31 168.33 9.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 47.1 Cg_endo -73.07 -33.85 7.01 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.017 1.535 . . . . 0.0 110.529 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -93.07 -21.87 19.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.221 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.658 ' O ' ' OG1' ' A' ' 53' ' ' THR . 1.6 tt0 -161.4 162.12 30.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.448 ' N ' ' CG ' ' A' ' 56' ' ' GLN . 3.5 p -128.71 130.11 46.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 110.263 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.493 ' CG2' ' HG2' ' A' ' 73' ' ' MET . 87.9 t -129.19 124.28 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.186 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.41 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 14.5 t -109.64 143.08 39.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.285 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 59' ' ' THR . 23.7 m120 -138.72 148.98 44.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 110.211 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.4 t -140.59 134.94 31.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 110.245 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.646 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 27.5 p90 -148.03 166.91 26.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.7 m -115.46 146.38 41.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 0.0 110.185 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.499 HD13 ' CD1' ' A' ' 47' ' ' PHE . 14.5 mt -78.51 122.83 26.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.226 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.1 4.63 41.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -145.51 151.92 38.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -1.159 . . . . 0.0 110.16 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -72.4 131.13 42.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.646 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.11 151.46 49.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 12.9 p-10 -88.01 134.86 33.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 70' ' ' ILE . 8.3 mm -124.37 143.28 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.88 . . . . 0.0 110.208 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 m -117.76 134.09 55.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.579 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 1.4 p -88.86 158.96 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.493 ' HG2' ' CG2' ' A' ' 58' ' ' VAL . 72.7 mtm -74.27 -8.11 55.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.246 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.476 ' OD1' ' HB ' ' A' ' 72' ' ' THR . 46.0 p-10 -92.03 -15.47 27.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 74' ' ' ASP . . . 109.14 28.44 4.4 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.579 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 3.9 mttt -108.44 130.94 55.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -1.148 . . . . 0.0 110.201 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -111.2 136.55 50.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 110.187 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.55 161.82 32.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.154 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.19 157.56 18.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.3 p -169.17 140.39 2.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.227 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.0 m -98.14 102.67 14.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.433 HG12 ' CZ ' ' A' ' 62' ' ' PHE . 46.5 t -72.22 140.76 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.252 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.547 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 14.4 p-80 -145.23 153.78 41.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.2 mt -100.99 126.37 47.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 0.0 110.251 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.25 147.3 39.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 53.3 15.25 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.22 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.62 48.83 6.04 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.644 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 7.3 pttt -169.85 135.96 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.324 -1.104 . . . . 0.0 110.229 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.5 tt -68.88 144.62 54.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.855 . . . . 0.0 110.238 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.547 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 73.4 t -152.03 114.28 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.315 -0.866 . . . . 0.0 110.215 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 86.9 m -105.7 98.74 8.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.275 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -94.58 155.14 17.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 17.3 t -145.96 -165.92 2.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.45 ' N ' ' OG ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -100.52 31.88 3.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 110.199 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.5 ptpt -175.38 4.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.203 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.894 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -179.31 145.5 0.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -122.5 159.75 27.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 110.264 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 54.0 t-80 -144.72 141.42 29.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.303 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.677 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 10.1 pt-20 -157.17 125.18 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 110.207 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.551 ' OE1' ' CE ' ' A' ' 107' ' ' MET . 6.1 tt0 -128.36 162.62 26.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.893 . . . . 0.0 110.213 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.475 ' CG ' ' HB2' ' A' ' 88' ' ' LYS . 20.3 mt-10 -153.73 155.93 36.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.81 139.96 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 110.197 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -135.8 98.65 3.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.01 -110.47 3.04 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -115.67 12.17 15.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -1.192 . . . . 0.0 110.16 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -117.71 160.03 22.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.199 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.551 ' CE ' ' OE1' ' A' ' 100' ' ' GLN . 28.1 tpp -132.09 138.02 47.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.56 132.54 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.18 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 34.8 mt-10 -117.71 130.1 56.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.649 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 5.7 m -122.65 124.45 43.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 97' ' ' SER . 87.3 mt -130.78 136.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.248 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.8 p -113.36 127.11 56.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.257 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.492 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 27.3 t80 -149.29 129.79 13.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 110.172 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.41 39.58 97.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.44 6.58 49.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.72 141.94 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -1.127 . . . . 0.0 110.258 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.5 m -118.36 130.18 55.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.865 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.581 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 48.8 tp -108.76 145.92 34.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.922 . . . . 0.0 110.252 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 119' ' ' ILE . 97.1 mt -127.09 114.68 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 32.5 ttp180 -111.49 128.02 55.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.96 . . . . 0.0 110.169 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 67.9 mtt180 -104.72 127.05 52.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 110.173 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 66.3 m -123.51 154.45 39.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.845 . . . . 0.0 110.171 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -118.14 160.7 21.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.162 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 5' ' ' THR . 15.6 ttp180 -88.79 137.69 32.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.208 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.278 0.561 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 p -57.33 144.87 34.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.94 . . . . 0.0 110.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.73 -173.75 18.7 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.7 m -111.7 129.52 56.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -1.149 . . . . 0.0 110.229 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.481 ' CZ3' ' HG3' ' A' ' 107' ' ' MET . 70.1 m95 -118.01 138.61 52.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -118.31 118.13 30.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.3 t -64.95 126.22 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.546 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 18.0 p90 -127.08 -21.79 3.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.546 ' HB1' ' CE1' ' A' ' 9' ' ' TYR . . . -136.28 131.73 34.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.159 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 26.3 pt20 -146.98 118.27 7.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.204 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 118' ' ' LEU . 56.5 tt0 -94.03 152.89 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.885 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 m120 50.47 27.25 2.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.169 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -58.05 -52.2 66.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -64.62 -50.52 66.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 110.188 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 36.7 mm-40 -51.06 -61.49 2.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.178 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.68 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 63.5 t80 -49.22 -52.3 27.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.171 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -44.79 93.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 110.221 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 14.5 mttm -46.7 -38.31 9.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.29 -27.23 63.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.665 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.5 tp -61.87 -23.51 66.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.665 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 79.73 30.5 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.588 HD21 ' HD2' ' A' ' 24' ' ' PRO . 15.1 mt -77.53 166.77 41.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.588 ' HD2' HD21 ' A' ' 23' ' ' LEU . 46.1 Cg_endo -73.08 143.2 35.63 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.04 1.547 . . . . 0.0 110.43 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -65.16 -41.25 94.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.166 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -55.24 -28.14 51.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.397 -0.815 . . . . 0.0 110.175 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.549 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 41.5 tp -89.43 -22.07 22.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 24' ' ' PRO . 92.5 mt -86.99 -40.01 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 50.0 mmtt -72.58 -30.04 64.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 110.241 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.5 ttp -87.77 -24.03 23.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 27' ' ' LEU . . . -101.66 6.58 42.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 110.175 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.684 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 16.6 ptt180 -68.12 4.17 1.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.337 -0.852 . . . . 0.0 110.195 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.684 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.9 m-20 -151.73 50.21 0.81 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.049 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.3 mt -122.48 119.37 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.215 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -91.19 83.25 0.11 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 110.301 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 1.049 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.9 Cg_endo -73.02 136.52 24.97 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.023 1.538 . . . . 0.0 110.475 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.681 HG21 ' N ' ' A' ' 38' ' ' VAL . 55.1 mt -100.45 171.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.185 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.681 ' N ' HG21 ' A' ' 37' ' ' ILE . 11.2 p -147.41 132.9 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.217 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -110.3 111.55 22.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 110.206 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.3 mt -99.93 138.46 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.244 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.541 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 56.7 tt0 -137.76 70.0 1.39 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.154 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.582 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 52.5 tt0 -67.0 159.75 27.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.206 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 53.9 mmtt -156.17 42.76 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.59 -100.59 0.77 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -109.94 -5.62 15.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -1.185 . . . . 0.0 110.261 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.405 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 7.1 t0 -102.12 152.32 21.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.484 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 39.1 m-85 -133.96 140.88 47.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.198 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -126.55 104.9 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.211 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.75 135.8 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 110.231 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.438 ' OG1' HG21 ' A' ' 59' ' ' THR . 99.8 m -133.81 104.67 6.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 m -87.3 136.91 32.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.858 . . . . 0.0 110.247 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -129.65 123.53 31.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 110.188 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.648 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -107.15 169.03 7.18 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.05 -18.78 23.7 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.06 1.558 . . . . 0.0 110.448 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -103.41 -21.92 13.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.21 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.648 ' O ' ' OG1' ' A' ' 53' ' ' THR . 17.8 pt20 -164.13 165.11 22.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 110.142 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 p -129.41 130.47 46.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.151 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.36 127.88 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.438 HG21 ' OG1' ' A' ' 50' ' ' THR . 91.2 m -112.27 137.76 49.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 59' ' ' THR . 58.0 m-20 -133.51 151.86 51.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 t -147.12 128.75 15.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.6 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 37.1 p90 -141.87 169.19 18.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 110.184 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.6 m -114.78 142.45 46.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.178 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.508 HD12 ' CA ' ' A' ' 83' ' ' HIS . 3.0 tp -76.58 124.95 28.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.99 -2.75 41.05 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.59 149.96 45.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -1.13 . . . . 0.0 110.18 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.46 ' OE2' ' HD2' ' A' ' 79' ' ' LYS . 71.4 tt0 -70.76 123.81 22.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.6 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -122.83 148.0 45.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 110.271 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -80.23 135.01 36.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 110.146 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 70' ' ' ILE . 17.2 mm -128.22 145.14 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 110.25 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.488 ' O ' HG23 ' A' ' 71' ' ' THR . 5.1 t -119.23 135.43 54.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.27 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.436 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -84.15 156.28 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -17.18 64.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 76' ' ' LYS . 2.9 p30 -83.11 -10.3 58.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.16 28.36 5.86 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.436 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 10.3 mtpt -106.24 133.76 50.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -1.129 . . . . 0.0 110.246 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.03 138.49 44.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -169.48 150.82 4.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.141 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HD2' ' OE2' ' A' ' 67' ' ' GLU . 7.2 mtmm -95.15 155.95 16.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.916 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.28 131.76 5.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.195 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 m -93.37 99.39 11.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.226 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.657 HG11 ' CD2' ' A' ' 89' ' ' LEU . 40.7 t -73.99 143.86 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.662 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 2.9 p-80 -147.36 160.62 42.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 0.0 110.225 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.493 HD11 HD23 ' A' ' 64' ' ' LEU . 3.2 mp -101.06 133.87 44.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 0.0 110.186 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -139.03 115.52 10.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 53.2 t-20 62.79 24.19 14.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.656 ' O ' ' CG ' ' A' ' 88' ' ' LYS . . . 80.76 46.46 7.22 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.656 ' CG ' ' O ' ' A' ' 87' ' ' GLY . 28.7 mtmt -161.87 117.83 2.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -1.149 . . . . 0.0 110.219 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.657 ' CD2' HG11 ' A' ' 82' ' ' VAL . 1.7 tt -61.79 135.84 57.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 110.189 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.662 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 75.6 t -145.42 121.93 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.924 ' CG2' ' HB3' ' A' ' 98' ' ' HIS . 8.8 t -118.86 103.69 9.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.185 -0.947 . . . . 0.0 110.191 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -93.55 154.52 17.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 110.189 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 t -141.67 -158.24 0.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 36.8 mt-10 -109.52 31.82 5.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.22 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -176.88 6.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 110.198 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.835 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 178.28 147.5 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.516 ' O ' HG22 ' A' ' 111' ' ' ILE . 15.9 t -125.24 158.41 34.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 110.243 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.924 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 59.0 t-80 -141.61 146.02 35.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 110' ' ' THR . 24.5 mt-10 -157.68 126.04 5.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.266 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.444 ' HG3' ' CG ' ' A' ' 109' ' ' GLU . 61.1 tt0 -126.17 162.06 26.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.538 ' OE2' ' O ' ' A' ' 102' ' ' VAL . 11.0 tm-20 -160.4 150.91 18.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.538 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 8.4 p -116.72 142.75 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.206 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 50.6 mttt -134.56 91.2 2.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.07 -107.42 2.79 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -115.09 9.64 15.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -1.199 . . . . 0.0 110.243 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -117.97 161.13 20.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 110.19 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.481 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -131.85 140.68 49.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.216 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.5 t -126.92 125.02 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.224 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.444 ' CG ' ' HG3' ' A' ' 100' ' ' GLN . 28.0 mt-10 -110.73 126.99 55.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 99' ' ' GLU . 4.8 t -117.93 119.46 34.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.216 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 97' ' ' SER . 71.6 mt -126.12 132.16 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 31.8 m -109.74 132.93 53.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.593 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 11.8 t80 -156.3 127.39 6.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.929 . . . . 0.0 110.223 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.28 36.54 89.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.34 7.3 60.15 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.473 ' CG1' ' HA ' ' A' ' 17' ' ' PHE . 60.4 t -111.01 141.01 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -1.156 . . . . 0.0 110.223 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 78.5 m -117.48 130.44 56.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.226 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.68 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 54.7 tp -110.38 146.85 35.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.239 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.31 100.25 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.182 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -93.39 119.89 33.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.0 110.207 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 42.3 mtt180 -101.13 125.75 47.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 110.231 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.8 m -123.88 158.1 32.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.184 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -119.93 158.31 26.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 22.3 ttt180 -85.68 136.64 33.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 110.24 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.207 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 75.2 m-85 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.249 0.547 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.8 m -56.89 144.43 33.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.209 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.27 -175.95 18.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.2 p -107.04 131.59 53.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -1.126 . . . . 0.0 110.221 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.453 ' CD1' ' HE1' ' A' ' 107' ' ' MET . 93.2 m95 -119.6 137.02 54.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -119.28 113.7 21.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.239 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.04 135.99 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.165 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 9' ' ' TYR . 10.9 p90 -139.09 -15.82 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.206 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.495 ' HB1' ' CE1' ' A' ' 9' ' ' TYR . . . -138.7 130.97 28.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.43 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 15.7 mt-30 -144.87 160.64 40.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.902 . . . . 0.0 110.202 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.469 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 12.7 pt-20 -137.77 150.91 47.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.147 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.7 m120 54.35 33.79 19.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.83 -54.32 40.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.228 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -60.78 -53.72 53.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -50.0 -56.05 12.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.451 ' CD2' ' HB2' ' A' ' 118' ' ' LEU . 33.2 t80 -54.05 -47.0 72.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.488 ' N ' HD21 ' A' ' 18' ' ' LEU . 2.3 mm? -60.74 -42.1 96.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.163 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -54.45 -37.52 65.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 110.159 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.91 -33.2 71.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 110.24 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.636 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.5 tp -63.86 -21.19 66.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 0.0 110.252 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.636 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 77.98 31.77 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 110.216 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.625 HD21 ' HD2' ' A' ' 24' ' ' PRO . 14.2 mt -80.13 166.18 42.02 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.183 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.625 ' HD2' HD21 ' A' ' 23' ' ' LEU . 45.8 Cg_endo -73.09 142.35 34.19 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.103 1.581 . . . . 0.0 110.386 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.505 ' CD ' ' HE3' ' A' ' 29' ' ' LYS . 43.2 tt0 -64.79 -33.5 76.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -61.15 -26.88 68.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.457 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 40.0 tp -90.07 -27.81 19.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 110.158 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 28' ' ' ILE . 95.5 mt -76.19 -45.23 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.287 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HE3' ' CD ' ' A' ' 25' ' ' GLU . 21.0 mttt -69.4 -26.82 64.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.4 mtt -85.95 -27.66 24.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.189 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.47 7.38 42.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 110.205 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.579 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 16.0 ptt180 -66.7 -1.28 3.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.202 -0.936 . . . . 0.0 110.195 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.579 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.1 m-20 -148.0 47.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.259 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.943 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 5.1 mt -121.51 115.49 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 110.242 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -92.54 88.76 0.33 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.943 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.9 Cg_endo -73.03 139.26 29.6 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.042 1.548 . . . . 0.0 110.467 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.447 ' C ' HG21 ' A' ' 38' ' ' VAL . 17.2 mt -89.89 162.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.447 HG21 ' C ' ' A' ' 37' ' ' ILE . 79.5 t -139.11 114.05 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 110.217 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -98.12 136.6 38.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 110.168 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.8 mt -124.68 129.29 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.233 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 54.6 tt0 -129.92 75.1 1.63 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 0.0 110.19 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.694 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 2.0 tm0? -72.39 162.06 29.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 43.1 mtmt -160.51 49.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.18 -104.19 1.31 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 64.4 m-20 -109.85 -0.37 18.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -1.148 . . . . 0.0 110.152 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.0 t0 -104.03 146.54 28.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.0 110.194 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.694 ' CE1' ' HG3' ' A' ' 42' ' ' GLN . 4.1 m-85 -128.36 135.42 49.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.4 t -123.7 108.29 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.212 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.3 t -110.23 128.98 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.8 m -129.13 108.03 10.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -92.04 138.25 31.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.25 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 1.1 pttt -131.85 126.09 33.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 110.166 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.662 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.89 170.41 5.46 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.926 . . . . 0.0 110.184 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.476 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.5 Cg_endo -73.03 -20.03 22.35 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.039 1.547 . . . . 0.0 110.497 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -105.04 -22.03 13.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 0.0 110.218 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -161.83 159.6 27.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.241 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.4 p -130.51 131.0 44.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 110.239 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.2 t -128.53 129.36 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.223 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.4 t -111.19 137.49 48.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.257 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' HB3' ' CD1' ' A' ' 70' ' ' ILE . 63.0 m-20 -132.3 149.62 52.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 110.161 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 t -144.67 128.97 17.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.898 . . . . 0.0 110.186 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.442 ' CB ' ' CB ' ' A' ' 68' ' ' ALA . 39.6 p90 -142.81 170.44 15.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -119.01 153.41 34.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.222 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.606 HD13 ' CD1' ' A' ' 47' ' ' PHE . 22.2 mt -81.4 125.34 30.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.22 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.28 12.39 54.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -146.7 139.26 25.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.147 . . . . 0.0 110.218 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -66.04 127.22 31.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -127.94 149.06 50.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.57 138.53 33.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.177 -0.952 . . . . 0.0 110.254 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 70' ' ' ILE . 5.0 mm -130.57 144.43 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 71' ' ' THR . 4.1 t -118.22 135.01 54.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.656 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 34.7 p -87.1 160.38 18.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.189 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.9 ttm -72.22 -11.53 60.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 110.203 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -89.51 -13.36 37.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.155 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.0 51.11 0.96 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.656 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 11.0 mttt -128.53 133.11 48.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -1.126 . . . . 0.0 110.169 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -110.0 135.87 50.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -164.02 159.71 20.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.224 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -105.86 155.32 19.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.197 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.1 p -164.13 136.62 4.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.23 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.4 m -95.29 97.67 10.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 110.225 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.492 HG11 HD23 ' A' ' 89' ' ' LEU . 47.6 t -69.23 142.18 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 110.248 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.62 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 9.6 p-80 -147.54 150.09 33.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.5 mt -96.06 129.89 43.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.204 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.54 144.12 31.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 110.141 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.36 11.55 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.59 45.39 6.11 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 11.5 pttt -170.76 132.28 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -1.124 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.876 ' O ' HG21 ' A' ' 90' ' ' VAL . 3.6 tt -61.16 149.19 38.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.876 HG21 ' O ' ' A' ' 89' ' ' LEU . 87.3 t -155.51 109.3 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.608 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 87.2 m -103.01 103.78 13.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.183 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -99.4 157.47 16.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.224 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 14.3 t -151.21 -171.13 3.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.202 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 54.3 tt0 -98.14 30.73 2.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.188 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.522 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 1.6 pttt -169.8 -2.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 0.0 110.205 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.854 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -176.31 147.49 0.7 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.92 . . . . 0.0 110.212 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.8 159.05 28.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.847 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.608 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 64.6 t-80 -143.17 137.08 28.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.437 ' HG3' ' CG2' ' A' ' 90' ' ' VAL . 44.8 tt0 -151.19 126.91 10.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.163 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.569 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 9.1 tt0 -133.76 154.79 50.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 110.111 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.454 ' HA ' ' CE1' ' A' ' 2' ' ' PHE . 58.8 tt0 -149.37 159.86 43.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 110.269 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.41 138.06 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -0.897 . . . . 0.0 110.173 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -133.84 93.97 3.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.277 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.67 -106.75 2.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -118.78 12.61 13.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -1.135 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.04 155.27 31.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.159 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.453 ' HE1' ' CD1' ' A' ' 6' ' ' TRP . 25.8 tpp -128.41 140.31 51.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.1 t -125.97 126.69 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.183 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.569 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 29.5 mt-10 -114.58 136.13 53.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 p -124.73 123.93 41.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.233 -0.917 . . . . 0.0 110.22 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 72.7 mt -130.88 129.82 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 112' ' ' THR . 5.0 t -113.41 131.87 55.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 6.3 t80 -154.19 125.12 7.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.256 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.29 33.38 61.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.25 3.73 66.42 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 112' ' ' THR . 62.9 t -109.69 139.56 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -1.157 . . . . 0.0 110.199 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 55.3 m -113.98 135.22 54.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.224 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.451 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 41.6 tp -113.95 139.13 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.172 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.469 ' HB ' ' OE2' ' A' ' 12' ' ' GLU . 96.8 mt -120.43 110.45 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -105.96 120.94 43.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.94 . . . . 0.0 110.186 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 52.4 mtt180 -102.17 127.05 49.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 0.0 110.19 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.9 m -122.81 163.41 20.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.207 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -128.15 158.56 37.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.902 . . . . 0.0 110.19 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -85.11 136.56 33.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.177 -179.955 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.32 0.581 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.3 p -56.81 145.71 28.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.44 -177.02 17.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.3 p -105.75 134.24 49.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -1.182 . . . . 0.0 110.18 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.467 ' CE2' ' HE3' ' A' ' 107' ' ' MET . 95.3 m95 -121.27 142.62 49.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -124.07 118.2 26.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.209 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.2 t -65.8 126.78 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 110.167 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.521 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 22.6 p90 -128.16 -23.07 3.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.718 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -135.13 133.61 39.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 110.223 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.718 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 2.0 mp0 -146.7 112.24 5.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.892 . . . . 0.0 110.216 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.447 ' HG2' ' ND2' ' A' ' 13' ' ' ASN . 56.1 tt0 -89.65 147.32 23.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.447 ' ND2' ' HG2' ' A' ' 12' ' ' GLU . 75.6 m-20 55.02 24.07 5.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.504 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 27.5 t80 -56.57 -52.43 64.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 110.208 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -63.54 -48.61 76.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.23 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 66.8 mt-10 -53.79 -62.23 1.79 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 110.222 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.693 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 38.2 t80 -48.29 -57.83 5.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.504 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -57.12 -46.66 82.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 110.183 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -42.79 -41.86 3.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.192 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.19 -28.25 66.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.633 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -58.13 -20.13 38.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.219 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.633 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 77.94 31.37 0.42 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.549 HD21 ' HD2' ' A' ' 24' ' ' PRO . 15.5 mt -77.03 165.99 48.1 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.188 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.591 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.08 140.59 31.46 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.969 1.51 . . . . 0.0 110.409 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.404 ' HG2' ' HE2' ' A' ' 29' ' ' LYS . 42.4 tt0 -61.52 -39.48 91.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.29 -26.54 63.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.309 -0.87 . . . . 0.0 110.191 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 14.8 tp -90.42 -23.26 21.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.586 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 95.2 mt -81.09 -43.18 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.978 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HE2' ' HG2' ' A' ' 25' ' ' GLU . 37.3 mtmt -72.52 -24.41 61.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 37.4 mtt -87.9 -32.91 18.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.99 5.44 48.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.187 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.632 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 31.3 ptt85 -65.53 -1.11 2.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.632 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.6 m-20 -149.91 47.57 0.93 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.91 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.9 mt -118.7 121.03 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -95.8 83.02 0.22 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.337 -0.852 . . . . 0.0 110.234 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.91 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.5 Cg_endo -73.05 137.49 26.55 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.031 1.543 . . . . 0.0 110.47 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.5 mt -90.01 157.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.155 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.3 t -134.93 112.72 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -94.05 138.24 32.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.234 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.43 HD11 ' CD1' ' A' ' 6' ' ' TRP . 71.3 mt -126.73 127.78 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.214 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -133.03 75.27 1.61 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.246 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.547 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 6.7 pt20 -78.57 163.53 25.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.218 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 31.0 mmtp -154.79 49.93 0.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.75 -99.21 0.8 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -110.05 -9.11 14.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.271 -1.135 . . . . 0.0 110.216 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 34.4 t0 -98.0 157.23 16.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 110.196 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.591 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 2.1 m-85 -139.89 133.55 30.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.232 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.9 t -114.24 100.75 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 110.242 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.553 HG11 ' O ' ' A' ' 49' ' ' VAL . 4.2 p -100.85 135.49 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.187 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.461 ' CG2' HG21 ' A' ' 59' ' ' THR . 36.0 m -138.59 105.56 5.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.4 m -88.4 138.2 31.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.244 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -130.35 119.16 22.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 110.282 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.563 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -106.89 167.44 9.48 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 110.223 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD2' HG23 ' A' ' 53' ' ' THR . 46.8 Cg_endo -73.07 -20.68 21.47 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.057 1.556 . . . . 0.0 110.472 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -102.93 -20.6 14.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.524 ' O ' ' OG1' ' A' ' 53' ' ' THR . 5.0 pt20 -166.31 159.17 14.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.907 . . . . 0.0 110.191 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.3 p -129.05 131.29 47.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.224 -0.922 . . . . 0.0 110.205 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.26 128.26 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 110.19 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.461 HG21 ' CG2' ' A' ' 50' ' ' THR . 46.2 m -110.59 136.83 49.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 110.19 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 49' ' ' VAL . 81.6 m-20 -135.02 153.91 51.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.245 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.2 t -143.17 128.17 18.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.221 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.508 ' CD1' HG22 ' A' ' 82' ' ' VAL . 52.4 p90 -139.7 168.59 19.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.162 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.5 m -120.07 142.48 48.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.513 HD13 ' CD1' ' A' ' 47' ' ' PHE . 15.5 mt -74.21 126.03 29.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 110.258 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.89 58.23 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -137.47 142.23 41.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.263 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.459 ' HA ' HG23 ' A' ' 81' ' ' THR . 75.3 tt0 -68.01 126.25 28.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.436 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -127.28 150.1 49.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 0.0 110.237 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -81.57 136.56 35.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 110.227 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.459 HD11 HG22 ' A' ' 70' ' ' ILE . 3.8 mm -129.43 144.77 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -116.77 134.42 54.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.253 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.02 155.06 21.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.883 . . . . 0.0 110.128 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 ttm -67.13 -14.94 63.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.215 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.47 -13.07 47.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.54 29.72 4.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -104.99 135.39 46.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -1.156 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -112.02 132.59 54.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.227 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.14 162.95 31.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -107.86 158.69 17.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.194 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.483 ' HB2' ' CG2' ' A' ' 91' ' ' THR . 25.3 p -165.4 147.26 7.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.204 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.459 HG23 ' HA ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER -109.45 87.85 2.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.223 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.561 HG12 HD12 ' A' ' 89' ' ' LEU . 16.1 t -53.3 154.96 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 110.18 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.415 ' O ' HG21 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -152.17 147.46 26.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 0.0 110.224 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.9 mt -100.91 99.07 9.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 87' ' ' GLY . . . -114.37 152.59 31.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.178 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.472 ' HB3' ' CD ' ' A' ' 88' ' ' LYS . 3.3 t30 46.5 17.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 110.149 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 85' ' ' ALA . . . 77.97 48.96 7.31 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.746 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -167.21 127.69 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -1.159 . . . . 0.0 110.252 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.784 ' O ' HG11 ' A' ' 90' ' ' VAL . 4.2 tt -59.22 147.67 34.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 110.179 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.784 HG11 ' O ' ' A' ' 89' ' ' LEU . 22.2 m -154.67 109.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 97.5 m -103.55 100.11 9.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -98.11 161.0 13.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.463 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -152.33 -165.36 2.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 110.186 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.635 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 49.2 tt0 -101.16 31.29 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' CE2' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -173.3 4.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.933 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.67 141.69 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.303 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 111' ' ' ILE . 69.3 m -117.52 160.52 21.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.541 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.9 t-80 -144.12 140.66 29.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 110' ' ' THR . 14.0 tt0 -155.17 123.59 5.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.231 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 12.0 tt0 -129.04 157.17 42.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -153.84 154.67 34.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.209 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.43 141.52 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.226 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -136.61 90.69 2.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.24 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.8 -105.59 2.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -119.19 11.42 12.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -1.145 . . . . 0.0 110.169 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -117.52 154.31 31.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.229 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.467 ' HE3' ' CE2' ' A' ' 6' ' ' TRP . 26.8 tpp -125.38 138.57 54.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 110.293 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.2 t -126.4 124.73 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.33 -0.857 . . . . 0.0 110.228 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 33.2 mt-10 -112.32 121.61 45.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 99' ' ' GLU . 85.4 m -110.19 119.09 38.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.231 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 97' ' ' SER . 68.1 mt -126.52 129.72 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 74.7 m -109.31 138.06 46.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.547 ' CE2' ' O ' ' A' ' 95' ' ' LYS . 21.1 t80 -160.81 127.65 4.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 110.196 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.23 34.45 75.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.75 8.55 68.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.3 t -112.4 141.42 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -1.168 . . . . 0.0 110.207 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.9 m -116.9 130.94 57.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 110.259 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.693 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 41.8 tp -110.34 152.68 25.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 119' ' ' ILE . 97.5 mt -131.37 94.6 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -88.57 126.53 35.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.221 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.488 ' HB3' ' OH ' ' A' ' 9' ' ' TYR . 27.6 mtt180 -106.23 125.78 51.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 56.5 m -123.49 153.42 40.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.919 . . . . 0.0 110.218 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -119.81 159.01 25.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.87 . . . . 0.0 110.204 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -86.0 135.28 33.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.255 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.283 0.563 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -51.91 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.36 -162.69 33.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 p -114.2 128.07 56.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -1.145 . . . . 0.0 110.22 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.495 ' NE1' ' HE2' ' A' ' 107' ' ' MET . 92.0 m95 -117.11 137.82 52.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.254 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.37 123.19 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 110.257 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.52 133.03 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 34.2 p90 -133.75 -27.62 1.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.5 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -130.94 137.13 49.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.563 ' O ' ' HG2' ' A' ' 11' ' ' GLN . 3.7 pm0 -152.18 140.96 20.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.209 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.409 ' O ' HD13 ' A' ' 118' ' ' LEU . 30.9 tt0 -115.28 151.26 34.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 50.57 25.38 1.98 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -55.22 -47.13 75.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -0.92 . . . . 0.0 110.241 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.12 -51.82 54.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -49.03 -61.64 1.96 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.169 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.586 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 52.2 t80 -50.32 -44.94 54.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.142 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.5 mt -61.14 -46.72 89.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.245 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -50.98 -36.53 39.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.262 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.38 -32.21 72.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.608 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -61.14 -21.01 63.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.608 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 75.62 37.82 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.248 -0.907 . . . . 0.0 110.172 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.772 HD21 ' HD2' ' A' ' 24' ' ' PRO . 3.7 mt -79.19 165.32 49.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.772 ' HD2' HD21 ' A' ' 23' ' ' LEU . 46.2 Cg_endo -73.04 136.37 24.68 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.989 1.521 . . . . 0.0 110.508 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -54.09 -30.78 49.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.53 -41.55 96.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.902 . . . . 0.0 110.271 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.498 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 63.4 tp -80.09 -45.83 17.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.247 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 23' ' ' LEU . 72.8 mt -53.48 -54.1 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 110.215 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 6.6 mmtp -59.35 -29.73 67.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.733 ' O ' HD13 ' A' ' 34' ' ' ILE . 65.1 mtt -86.08 -20.53 28.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 0.0 110.168 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.67 4.56 35.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.245 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.747 ' HG3' ' OD2' ' A' ' 33' ' ' ASP . 20.3 ptt180 -75.21 -0.4 19.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.227 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.747 ' OD2' ' HG3' ' A' ' 32' ' ' ARG . 62.6 m-20 -152.36 42.03 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.932 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 27.5 mt -121.36 115.46 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.219 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -92.25 88.83 0.32 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.208 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.932 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.4 Cg_endo -73.12 138.6 28.25 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.026 1.54 . . . . 0.0 110.399 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.467 HG21 ' N ' ' A' ' 38' ' ' VAL . 21.6 mt -89.62 157.35 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.254 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.467 ' N ' HG21 ' A' ' 37' ' ' ILE . 89.4 t -136.84 119.09 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -100.64 134.5 43.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 110.185 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.435 HD11 ' CD1' ' A' ' 6' ' ' TRP . 83.0 mt -121.9 129.48 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -131.89 74.9 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.813 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 4.0 tt0 -73.87 164.45 26.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.6 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 47.3 mttt -156.97 42.29 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 110.221 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.8 -97.69 0.62 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -112.88 -0.24 14.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -1.185 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -104.84 147.95 27.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.967 . . . . 0.0 110.243 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.813 ' CE1' ' HB2' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -128.57 133.95 48.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 110.224 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.5 t -122.37 107.73 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.248 -0.908 . . . . 0.0 110.191 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.18 133.99 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.2 m -132.69 107.46 8.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 0.0 110.203 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -92.0 137.45 32.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 110.234 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 1.6 pttm -131.5 127.83 38.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.617 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -111.49 170.23 5.49 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 110.186 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.99 -16.54 25.64 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.054 1.555 . . . . 0.0 110.487 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.0 mtp-105 -106.32 -19.33 13.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.898 . . . . 0.0 110.191 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.617 ' O ' ' OG1' ' A' ' 53' ' ' THR . 19.5 pt20 -167.44 161.25 13.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 110.232 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.9 p -130.03 133.8 46.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.3 t -131.3 130.18 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.937 . . . . 0.0 110.176 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 t -112.04 134.8 53.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 110.143 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -129.69 151.91 49.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -0.88 . . . . 0.0 110.173 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -147.04 127.39 13.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.626 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 38.2 p90 -141.4 172.93 12.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 110.218 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.5 m -118.68 148.71 42.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.202 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.719 ' CD1' ' CD2' ' A' ' 47' ' ' PHE . 9.9 mt -79.57 123.34 27.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.269 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.93 5.41 47.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -143.94 145.3 32.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -1.139 . . . . 0.0 110.164 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.21 127.19 31.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.626 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -125.42 148.18 48.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -83.86 136.2 34.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.922 . . . . 0.0 110.224 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.447 HD11 HG22 ' A' ' 70' ' ' ILE . 6.0 mm -127.85 145.96 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.172 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 71' ' ' THR . 4.4 t -119.84 133.46 55.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.626 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -83.28 155.8 23.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -17.04 63.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 110.228 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -84.89 -12.24 53.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 110.222 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.34 30.58 4.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.626 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 23.5 mttt -107.28 131.98 53.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -1.136 . . . . 0.0 110.15 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -111.69 138.19 48.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.218 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -167.65 159.37 11.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 57.3 mttt -103.75 167.5 9.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 110.202 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 27.0 p -178.22 137.36 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 110.245 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.9 m -93.93 104.9 16.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.31 -0.869 . . . . 0.0 110.213 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.431 HG11 HD23 ' A' ' 89' ' ' LEU . 55.3 t -75.78 140.28 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.257 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.563 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 9.0 p-80 -144.11 155.25 43.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tp -100.14 134.41 43.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.188 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.92 117.55 14.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 10.0 t-20 61.55 30.23 18.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.401 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 75.94 40.99 29.01 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.401 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 83.5 mttt -152.96 125.0 7.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 110.181 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.431 HD23 HG11 ' A' ' 82' ' ' VAL . 7.8 tt -71.44 134.47 46.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.197 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.563 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 77.2 t -140.64 120.26 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 110.286 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 53.6 m -113.24 92.4 3.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.211 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -86.22 160.6 19.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.443 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -152.96 -169.77 3.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.145 -0.972 . . . . 0.0 110.211 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.586 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -99.29 36.93 1.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.19 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 94' ' ' GLU . 0.9 OUTLIER -179.15 -1.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.823 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -175.11 147.3 0.91 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.242 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.487 ' O ' HG22 ' A' ' 111' ' ' ILE . 39.1 m -124.53 152.49 43.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.472 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 62.3 t-80 -137.47 142.91 41.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 110.261 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 110' ' ' THR . 47.5 mt-10 -153.24 128.65 9.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 12.5 tt0 -132.51 152.7 51.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.131 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.57 155.38 39.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 110.259 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.422 HG21 ' CH2' ' A' ' 6' ' ' TRP . 12.9 p -119.71 135.49 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -128.6 96.07 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 110.177 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.94 -101.67 1.72 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -120.67 10.78 11.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -1.142 . . . . 0.0 110.177 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -119.6 158.34 26.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.225 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.495 ' HE2' ' NE1' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -129.27 140.39 51.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 110.165 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.4 t -123.35 123.16 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 29.5 mt-10 -109.48 121.07 44.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 99' ' ' GLU . 20.8 m -111.95 117.02 31.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 97' ' ' SER . 67.6 mt -123.31 128.21 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 45.6 m -107.99 135.59 49.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.508 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 13.8 t80 -158.39 127.36 5.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.89 37.48 93.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.99 8.22 60.87 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 17' ' ' PHE . 60.5 t -111.03 139.08 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -1.116 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 62.0 m -117.78 132.09 56.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.586 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 67.5 tp -110.9 149.14 31.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.3 mt -128.33 98.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.426 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 16.3 mtm180 -96.11 128.52 43.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 25.3 mtt180 -104.31 128.26 52.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.4 m -124.09 155.99 37.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.202 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -119.41 151.01 39.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 110.203 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 45.4 ttt180 -75.71 138.31 41.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.188 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.468 ' CG2' ' OXT' ' A' ' 125' ' ' VAL . 9.3 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.268 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.235 0.54 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 76.6 p -56.64 145.32 28.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.27 -174.06 18.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.1 m -109.85 130.25 55.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -1.136 . . . . 0.0 110.218 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.469 ' CE2' ' HE1' ' A' ' 107' ' ' MET . 90.5 m95 -118.61 145.66 45.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.853 . . . . 0.0 110.25 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -127.97 118.94 24.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.181 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.486 HG12 ' OE1' ' A' ' 11' ' ' GLN . 48.9 t -64.35 136.35 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.945 . . . . 0.0 110.23 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.534 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 11.1 p90 -137.61 -19.14 1.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 110.224 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.697 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -137.22 134.28 36.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -0.925 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.697 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 5.1 mt-30 -149.0 162.76 39.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 110.158 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' O ' HD11 ' A' ' 118' ' ' LEU . 59.4 tt0 -134.12 144.85 48.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.415 ' ND2' ' OE1' ' A' ' 16' ' ' GLU . 4.3 t30 54.98 35.7 25.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.266 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -65.08 -49.23 70.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 0.0 110.199 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -60.88 -48.08 83.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.166 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 55.2 mt-10 -55.32 -46.2 76.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.566 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 43.5 t80 -52.86 -60.31 3.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.887 . . . . 0.0 110.271 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -50.83 -39.94 54.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.199 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -58.77 -36.81 74.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.245 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.18 -38.2 60.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.755 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.9 tp -56.57 -25.24 51.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.925 . . . . 0.0 110.19 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.755 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 84.99 18.1 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.555 HD21 ' HD2' ' A' ' 24' ' ' PRO . 15.3 mt -66.1 166.86 14.11 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.555 ' HD2' HD21 ' A' ' 23' ' ' LEU . 47.2 Cg_endo -73.04 133.31 19.52 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.019 1.536 . . . . 0.0 110.446 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.484 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . 61.1 mm-40 -51.23 -46.41 62.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.197 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.09 -37.27 20.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.499 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 35.3 tp -80.1 -37.36 33.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.898 . . . . 0.0 110.288 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.541 ' HA ' HD11 ' A' ' 18' ' ' LEU . 45.6 mt -58.82 -54.75 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -56.9 -24.45 52.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.73 ' O ' HD13 ' A' ' 34' ' ' ILE . 56.6 mtt -93.62 -18.39 22.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.233 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.45 -10.59 16.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.224 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -1.71 3.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -150.83 47.03 0.86 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.152 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 13.1 mt -125.0 109.0 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -84.1 88.13 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 1.152 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.2 Cg_endo -73.11 138.42 27.98 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.04 1.548 . . . . 0.0 110.45 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.1 mt -89.78 164.56 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 110.178 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.9 t -141.79 119.98 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 110.287 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -101.83 135.91 42.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.205 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.468 ' CD1' ' HE2' ' A' ' 107' ' ' MET . 75.5 mt -121.32 129.78 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.15 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.598 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 43.7 tt0 -132.33 66.51 1.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.943 . . . . 0.0 110.228 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.913 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 37.6 tt0 -71.47 162.26 29.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.572 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 18.5 pttm -159.11 48.01 0.32 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.296 -0.878 . . . . 0.0 110.175 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.4 -103.16 0.78 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 60.2 m-20 -111.52 0.57 16.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -1.132 . . . . 0.0 110.167 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.41 ' OD1' ' CG2' ' A' ' 63' ' ' THR . 43.6 m-20 -104.18 150.35 24.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 110.267 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.913 ' CE1' ' HB2' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -130.88 135.46 47.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.42 105.75 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 110.219 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.6 t -109.07 135.18 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.257 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.47 ' OG1' HG23 ' A' ' 59' ' ' THR . 98.3 m -132.17 108.49 9.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.902 . . . . 0.0 110.163 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -90.1 132.77 35.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.9 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -127.94 122.72 33.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.264 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.79 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -106.16 170.19 6.08 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.178 -0.951 . . . . 0.0 110.225 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.12 -17.73 24.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.066 1.561 . . . . 0.0 110.382 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -104.11 -22.69 13.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 0.0 110.176 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.614 ' O ' ' OG1' ' A' ' 53' ' ' THR . 14.7 pt20 -162.82 164.69 26.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.7 p -130.29 130.41 44.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.915 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.448 ' CG2' ' HG3' ' A' ' 73' ' ' MET . 61.6 t -128.86 126.27 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.534 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 85.6 m -108.83 141.18 41.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.233 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.534 ' OD1' ' O ' ' A' ' 59' ' ' THR . 73.2 m-20 -137.11 151.61 49.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.4 m -146.58 132.07 18.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.581 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 41.2 p90 -145.24 170.13 16.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.918 . . . . 0.0 110.185 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.41 ' CG2' ' OD1' ' A' ' 46' ' ' ASP . 86.5 m -116.26 148.53 40.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.703 ' CD1' ' CD2' ' A' ' 47' ' ' PHE . 10.4 mt -80.17 124.25 28.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.72 6.67 49.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -145.82 148.76 33.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -1.082 . . . . 0.0 110.217 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -71.68 125.2 26.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.204 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.581 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -122.24 150.43 42.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 110.221 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -84.53 133.16 34.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 110.102 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.485 HD11 HG22 ' A' ' 70' ' ' ILE . 5.1 mm -126.38 146.71 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.221 -0.924 . . . . 0.0 110.175 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -121.44 135.03 55.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 110.232 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.509 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -84.81 154.77 22.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.448 ' HG3' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -67.63 -15.04 63.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.223 -0.923 . . . . 0.0 110.176 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.444 ' OD1' ' HB2' ' A' ' 76' ' ' LYS . 3.0 p30 -85.52 -10.37 56.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.938 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.2 31.97 4.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.509 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 26.4 mttt -108.77 132.63 53.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.13 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -108.38 136.69 47.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.872 . . . . 0.0 110.203 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -165.49 156.94 14.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -105.56 165.12 11.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 0.0 110.224 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -175.15 137.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.293 -0.88 . . . . 0.0 110.178 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 m -95.52 99.89 11.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -0.894 . . . . 0.0 110.195 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.585 HG12 HD13 ' A' ' 89' ' ' LEU . 53.1 t -72.99 141.24 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 5.3 p-80 -146.55 160.33 42.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.77 130.83 48.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 110.212 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.438 ' O ' ' HE2' ' A' ' 88' ' ' LYS . . . -137.46 133.37 34.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.1 t30 57.63 13.44 1.94 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.04 53.54 2.81 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.807 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 3.6 pttt -174.74 125.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -1.182 . . . . 0.0 110.214 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.585 HD13 HG12 ' A' ' 82' ' ' VAL . 4.1 tt -57.31 147.46 25.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.18 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.58 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 78.9 t -157.57 109.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.952 ' CG2' ' HB3' ' A' ' 98' ' ' HIS . 10.0 t -106.39 107.93 19.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 110.21 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -97.53 151.99 19.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.146 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 1.4 m -144.86 -174.1 4.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 110.162 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 61.1 tt0 -99.0 38.49 1.38 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 94' ' ' GLU . 2.6 pttt 179.22 2.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.206 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.825 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.82 143.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 0.0 110.197 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -125.06 157.31 36.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.952 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 46.5 t-80 -144.79 143.16 30.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.203 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.477 ' HG3' HG21 ' A' ' 90' ' ' VAL . 17.1 tt0 -153.9 125.05 7.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 42.6 tt0 -125.83 158.93 33.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.895 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -156.68 156.94 34.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 110.148 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.413 HG21 ' CH2' ' A' ' 6' ' ' TRP . 10.0 p -120.84 140.35 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -132.82 89.14 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.1 -104.67 2.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.595 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 44.2 p-10 -117.79 7.39 12.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -1.123 . . . . 0.0 110.274 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.595 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 43.4 mt-10 -115.16 167.75 10.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.247 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.469 ' HE1' ' CE2' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -138.98 139.88 38.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 110.226 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.1 t -125.78 129.36 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 24.0 mt-10 -116.67 135.61 53.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.6 m -124.79 120.93 33.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.203 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 97' ' ' SER . 81.4 mt -126.76 135.88 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.246 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.5 p -117.5 125.06 50.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.255 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.509 ' HD2' ' CB ' ' A' ' 96' ' ' PHE . 56.0 t80 -148.11 128.06 13.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -0.877 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.3 35.92 88.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.12 6.0 59.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.9 t -111.08 135.65 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -1.132 . . . . 0.0 110.199 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.4 m -113.37 135.89 53.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 18.9 tp -115.03 141.29 48.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.55 108.63 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -104.92 124.54 49.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.16 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 9.4 mtm180 -103.72 124.96 49.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 56.9 m -119.57 161.39 20.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.277 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -127.76 155.81 43.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 110.249 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -80.27 134.68 36.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.9 . . . . 0.0 110.217 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.204 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.429 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 87.6 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.212 0.53 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.4 p -54.99 143.34 26.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.915 . . . . 0.0 110.149 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.05 -173.61 17.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.7 m -107.94 131.71 54.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -1.191 . . . . 0.0 110.23 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.51 ' CD2' ' HG3' ' A' ' 107' ' ' MET . 89.9 m95 -119.72 134.82 55.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 110.223 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -117.45 118.79 33.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.915 . . . . 0.0 110.171 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.75 128.42 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.0 110.226 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 46.6 p90 -126.38 -24.19 3.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' C ' ' HG3' ' A' ' 11' ' ' GLN . . . -136.43 132.03 34.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.429 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 29.9 mt-30 -141.37 120.81 13.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 52.3 tt0 -98.96 144.33 28.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.222 -0.924 . . . . 0.0 110.19 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.478 HD21 ' CD ' ' A' ' 16' ' ' GLU . 6.9 m120 56.59 18.35 3.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.224 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -55.04 -44.46 74.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.853 . . . . 0.0 110.239 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -67.87 -45.08 75.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.478 ' CD ' HD21 ' A' ' 13' ' ' ASN . 44.0 mt-10 -57.47 -59.95 4.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.622 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 51.4 t80 -51.14 -56.54 12.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.197 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 18' ' ' LEU . 4.0 mm? -54.73 -42.82 72.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -54.7 -37.32 65.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -30.6 70.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.694 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -57.56 -20.83 34.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.208 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.694 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 82.1 28.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.267 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 65.2 mt -73.48 167.4 35.12 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.94 . . . . 0.0 110.24 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.57 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 46.1 Cg_endo -73.02 136.05 24.17 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.416 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -52.11 -44.93 64.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.183 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.82 -27.07 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.18 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.598 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 23.2 tp -88.54 -21.7 23.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.868 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 82.9 mt -78.6 -41.76 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -74.72 -21.53 59.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 110.225 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.6 mtt -90.54 -30.62 17.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.179 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -104.52 4.24 32.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 110.197 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.868 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.89 -6.71 23.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.217 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -147.36 49.78 1.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 0.0 110.22 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.04 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.5 mt -123.9 117.72 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 2.1 mptt -90.0 86.72 0.19 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 1.04 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.05 133.44 19.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.95 1.5 . . . . 0.0 110.432 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.448 HG21 ' N ' ' A' ' 38' ' ' VAL . 12.8 mt -86.2 158.45 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.448 ' N ' HG21 ' A' ' 37' ' ' ILE . 80.5 t -137.74 118.94 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.245 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -98.84 133.45 43.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.181 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.551 ' CD1' ' HE3' ' A' ' 107' ' ' MET . 67.5 mt -118.53 133.04 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.173 -0.954 . . . . 0.0 110.145 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -138.09 68.01 1.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.875 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.566 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 15.8 pt20 -71.69 167.7 19.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.213 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 43.0 mttt -160.43 47.26 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.197 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.74 -98.74 0.72 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 23.1 m-20 -111.5 -6.79 14.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 110.206 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.44 155.52 17.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.239 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.634 ' CD1' HD13 ' A' ' 64' ' ' LEU . 2.3 m-85 -138.98 135.98 34.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.39 109.71 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -111.1 134.05 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.905 . . . . 0.0 110.164 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.5 m -129.39 106.94 9.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.238 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.4 m -87.72 135.59 33.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.241 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -128.74 114.7 16.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.2 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.726 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -102.88 168.31 9.01 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.205 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD2' HG23 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.09 -22.01 19.88 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.946 1.498 . . . . 0.0 110.433 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.5 mtp-105 -99.66 -20.96 16.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.276 -0.89 . . . . 0.0 110.178 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.472 ' O ' ' OG1' ' A' ' 53' ' ' THR . 15.7 pt20 -168.24 160.25 11.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.7 p -128.98 134.76 48.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.21 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -132.45 130.04 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.204 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.443 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 88.4 m -110.26 138.26 46.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.457 ' OD1' ' CG2' ' A' ' 71' ' ' THR . 67.8 m-20 -134.57 156.0 49.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -151.17 126.29 9.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CE1' HG13 ' A' ' 82' ' ' VAL . 44.0 p90 -139.33 176.08 9.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.1 m -120.49 147.01 45.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 110.254 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.634 HD13 ' CD1' ' A' ' 47' ' ' PHE . 21.1 mt -81.04 123.59 28.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 110.271 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.54 2.59 40.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -145.6 148.79 33.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 110.238 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -70.91 131.03 43.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.248 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -132.36 144.06 50.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.185 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 14.1 p-10 -73.82 141.6 46.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.879 . . . . 0.0 110.225 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 70' ' ' ILE . 2.4 mm -136.28 141.61 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 110.244 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.457 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 4.0 t -113.86 132.79 55.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.242 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.447 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -83.97 160.0 21.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 110.256 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.461 ' SD ' ' CG2' ' A' ' 53' ' ' THR . 13.3 ttm -68.49 -19.27 64.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -83.29 -12.88 56.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.75 28.11 5.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.447 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 5.4 mttm -101.38 133.73 45.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -1.146 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -109.71 132.71 53.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.249 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.59 160.25 22.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -104.94 160.92 14.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.282 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -170.86 138.91 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.154 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 m -96.95 99.4 10.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.885 . . . . 0.0 110.276 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.539 HG13 HD13 ' A' ' 89' ' ' LEU . 47.4 t -69.0 140.74 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.599 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 6.8 p-80 -146.62 154.08 41.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.25 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.7 mt -98.13 129.6 44.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.185 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.37 143.71 34.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 110.166 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.74 13.18 0.98 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 110.186 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.22 48.04 5.25 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.743 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -172.17 134.15 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 110.22 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.75 ' O ' HG21 ' A' ' 90' ' ' VAL . 1.9 tt -61.31 145.77 50.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.75 HG21 ' O ' ' A' ' 89' ' ' LEU . 87.2 t -153.78 109.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 97.6 m -102.75 103.16 13.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 110.191 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -100.42 156.21 17.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.915 . . . . 0.0 110.208 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.586 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 2.9 t -147.36 -163.65 1.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.228 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.683 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 32.4 tt0 -101.85 33.85 2.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.328 -0.857 . . . . 0.0 110.113 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 8.6 ptmt -177.97 7.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.886 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -179.65 141.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.223 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.512 ' O ' HG22 ' A' ' 111' ' ' ILE . 47.9 m -118.99 156.96 28.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.527 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 54.2 t-80 -140.11 143.4 36.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 110.26 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 110' ' ' THR . 17.9 tt0 -158.28 119.16 3.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 110.271 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 9.5 tt0 -123.94 158.72 31.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 110.248 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.429 ' HA ' ' CE1' ' A' ' 2' ' ' PHE . 28.2 tt0 -157.95 152.69 25.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.24 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.488 HG11 ' O ' ' A' ' 102' ' ' VAL . 10.6 p -117.7 142.91 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -129.75 90.71 3.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.05 -113.34 3.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -105.73 3.83 29.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 110.191 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -112.22 160.55 17.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.551 ' HE3' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -130.02 140.09 50.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.21 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.2 t -127.58 122.31 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 110.178 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 19.8 mt-10 -104.23 128.1 51.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.186 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' GLU . 50.6 m -120.4 114.38 21.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.872 . . . . 0.0 110.23 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 97' ' ' SER . 60.9 mt -126.12 136.59 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.229 -0.919 . . . . 0.0 110.237 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.2 m -112.34 134.55 53.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.209 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.595 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 15.9 t80 -157.56 128.44 6.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 0.0 110.167 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.43 36.65 92.88 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.88 13.44 66.42 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.8 t -116.94 136.92 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -1.163 . . . . 0.0 110.18 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.3 m -114.09 131.76 56.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.622 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 61.5 tp -109.91 146.45 35.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 119' ' ' ILE . 96.0 mt -129.12 94.11 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 110.259 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.449 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 18.1 mtm180 -90.47 129.08 36.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 0.0 110.206 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 84.7 mtt180 -105.19 125.91 51.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.2 m -122.64 150.88 42.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -118.64 156.71 28.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 110.201 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -83.55 135.52 34.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.193 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.261 0.553 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.88 143.26 38.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.231 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.59 -172.71 19.36 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.7 m -110.65 131.77 54.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -1.093 . . . . 0.0 110.221 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.47 ' CZ3' ' HG3' ' A' ' 107' ' ' MET . 92.3 m95 -119.28 143.28 47.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -125.73 117.79 24.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.239 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.01 130.28 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.191 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.55 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 11.7 p90 -129.71 -18.98 3.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.55 ' HB1' ' CE1' ' A' ' 9' ' ' TYR . . . -139.37 134.87 33.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.481 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.8 pt20 -146.8 118.23 7.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -95.95 150.34 20.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 53.38 22.68 2.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.517 ' CE2' HD13 ' A' ' 18' ' ' LEU . 59.6 t80 -57.82 -45.07 86.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.201 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.28 -54.01 20.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -47.43 -64.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.567 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 45.5 t80 -48.06 -43.83 30.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.336 -0.852 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.517 HD13 ' CE2' ' A' ' 14' ' ' TYR . 17.0 mt -62.76 -45.15 94.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.945 . . . . 0.0 110.191 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -52.33 -33.31 42.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.69 -34.12 73.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.219 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -60.02 -21.16 60.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.264 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 73.06 45.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.774 HD23 ' HD2' ' A' ' 24' ' ' PRO . 5.7 mt -86.08 169.27 15.93 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.774 ' HD2' HD23 ' A' ' 23' ' ' LEU . 46.0 Cg_endo -73.11 135.4 22.86 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.031 1.542 . . . . 0.0 110.466 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -56.39 -26.55 53.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.92 . . . . 0.0 110.178 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.94 -38.07 82.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.93 . . . . 0.0 110.263 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.509 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 66.2 tp -83.87 -40.84 18.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 23' ' ' LEU . 63.1 mt -57.78 -51.36 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -61.67 -29.61 70.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 0.0 110.208 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.613 ' O ' HD13 ' A' ' 34' ' ' ILE . 60.1 ttm -84.75 -23.79 29.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 0.0 110.228 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -101.88 11.37 38.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.903 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -79.0 -2.58 40.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.208 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -151.66 44.91 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.886 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 21.1 mt -123.34 113.12 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 89.41 0.43 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.207 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.886 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.08 143.21 35.65 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.016 1.535 . . . . 0.0 110.403 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.403 HG21 ' O ' ' A' ' 6' ' ' TRP . 21.3 mt -89.24 162.9 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.206 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.3 t -141.28 119.44 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.159 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -100.05 138.94 36.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.9 . . . . 0.0 110.2 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.484 ' CD1' ' HE2' ' A' ' 107' ' ' MET . 60.2 mt -123.93 132.37 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 110.181 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -138.19 69.42 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.681 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 4.6 pt20 -75.03 173.63 10.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.681 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 71.4 mttt -165.53 48.64 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 110.189 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.23 -99.25 0.76 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 27.6 m-20 -111.69 -4.54 14.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 0.0 110.216 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -101.43 149.74 23.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.914 . . . . 0.0 110.232 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.543 ' CD1' HD13 ' A' ' 64' ' ' LEU . 2.1 m-85 -133.24 137.11 45.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.1 t -124.9 108.55 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.165 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.6 t -110.1 134.64 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.877 . . . . 0.0 110.212 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.422 HG21 ' CB ' ' A' ' 59' ' ' THR . 96.0 m -132.57 107.37 8.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.902 . . . . 0.0 110.186 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.4 m -87.16 135.5 33.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 110.215 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -128.78 120.83 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.209 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.644 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -107.14 168.48 7.96 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.222 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.516 ' HD2' HG23 ' A' ' 53' ' ' THR . 45.8 Cg_endo -73.03 -19.73 22.68 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.949 1.499 . . . . 0.0 110.407 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -106.26 -20.06 13.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.85 . . . . 0.0 110.203 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.557 ' NE2' ' HG2' ' A' ' 73' ' ' MET . 13.6 pt20 -163.38 158.96 21.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.169 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 p -132.33 131.53 42.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.32 131.35 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 110.195 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.422 ' CB ' HG21 ' A' ' 50' ' ' THR . 13.7 t -112.25 136.83 51.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 110.242 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -133.05 149.4 52.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -141.17 130.05 23.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.936 . . . . 0.0 110.248 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.471 ' CD1' HG22 ' A' ' 82' ' ' VAL . 37.6 p90 -143.93 169.46 17.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.7 m -118.34 146.76 44.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.543 HD13 ' CD1' ' A' ' 47' ' ' PHE . 17.8 mt -76.29 125.83 29.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 0.0 110.19 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.48 10.25 57.05 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -145.43 138.03 25.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -1.171 . . . . 0.0 110.218 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -67.39 122.81 18.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.166 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.09 142.04 51.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -0.919 . . . . 0.0 110.184 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -71.22 144.69 50.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.226 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.413 HG21 ' N ' ' A' ' 71' ' ' THR . 16.7 mm -134.88 142.79 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.225 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.413 ' N ' HG21 ' A' ' 70' ' ' ILE . 18.3 m -115.56 132.22 56.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.227 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.447 ' HB ' ' OD2' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -86.74 161.15 18.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.255 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.557 ' HG2' ' NE2' ' A' ' 56' ' ' GLN . 8.9 ttm -69.85 -20.84 63.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.447 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 2.9 p30 -79.34 -16.23 56.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.885 . . . . 0.0 110.186 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.87 23.01 6.98 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -96.58 138.47 34.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -1.136 . . . . 0.0 110.191 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -114.11 131.32 56.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.182 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.27 156.51 19.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.232 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -100.61 150.98 22.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 110.254 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.0 133.42 8.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.3 m -95.25 101.01 12.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.536 HG12 HD12 ' A' ' 89' ' ' LEU . 45.1 t -72.21 139.8 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.646 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 8.1 p-80 -139.21 156.04 47.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mp -100.19 131.44 46.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.96 116.65 13.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.887 . . . . 0.0 110.195 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 65.8 t30 60.1 28.06 17.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.649 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.15 48.01 10.29 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.876 ' HD2' ' OE2' ' A' ' 101' ' ' GLU . 3.4 mtpt -159.44 119.27 3.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -1.141 . . . . 0.0 110.221 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.536 HD12 HG12 ' A' ' 82' ' ' VAL . 5.2 tt -66.8 140.67 57.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 110.215 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.646 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 45.5 t -149.34 120.76 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 68.8 m -112.87 95.52 5.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -90.18 165.35 14.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.265 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 7.3 t -157.61 -162.54 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.543 ' N ' ' OG ' ' A' ' 93' ' ' SER . 41.6 tt0 -105.28 31.56 4.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 110.309 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 8.8 ptpt -172.6 1.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.906 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER 179.22 144.29 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 110.258 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.529 ' O ' HG22 ' A' ' 111' ' ' ILE . 46.2 m -119.27 159.99 23.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.261 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 56.1 t-80 -143.31 139.06 29.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.249 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 110' ' ' THR . 52.4 mt-10 -151.33 129.27 11.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.905 . . . . 0.0 110.161 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 28.4 tt0 -132.7 153.8 50.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.876 ' OE2' ' HD2' ' A' ' 88' ' ' LYS . 57.6 tt0 -153.49 156.86 38.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.274 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.467 HG22 ' CH2' ' A' ' 6' ' ' TRP . 12.4 p -121.09 137.72 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -127.93 92.74 3.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.4 -107.34 2.62 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -113.81 8.61 17.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -1.198 . . . . 0.0 110.227 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -117.24 158.7 23.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.484 ' HE2' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -129.94 142.21 50.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.253 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.1 t -128.19 125.7 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 0.0 110.223 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 31.4 mt-10 -108.4 126.96 53.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.211 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' GLU . 37.2 m -117.34 116.62 27.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 97' ' ' SER . 66.9 mt -125.71 129.58 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 50.7 m -106.52 139.68 40.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.169 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.583 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 11.7 t80 -161.48 126.36 3.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 66.63 38.2 93.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.2 8.46 58.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 17' ' ' PHE . 60.2 t -110.89 141.52 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -1.165 . . . . 0.0 110.217 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.2 m -117.73 130.75 56.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.893 . . . . 0.0 110.233 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.567 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 64.2 tp -110.01 148.33 31.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.208 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 119' ' ' ILE . 92.0 mt -128.91 98.91 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.201 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 13.7 mtm180 -93.41 124.48 37.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 46.7 mtm-85 -102.66 127.83 49.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.5 m -125.54 160.18 30.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.912 . . . . 0.0 110.223 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -123.97 157.06 35.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.157 -0.964 . . . . 0.0 110.223 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.4 ttt85 -81.75 133.37 35.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.224 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.205 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.406 ' CE2' ' HA ' ' A' ' 101' ' ' GLU . 90.3 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.278 0.561 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.1 m -56.5 145.59 27.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.22 -178.15 16.66 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.6 m -103.77 132.14 50.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -1.175 . . . . 0.0 110.195 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.49 ' CD1' ' CE ' ' A' ' 107' ' ' MET . 99.2 m95 -121.06 144.64 48.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -126.72 117.29 22.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.889 . . . . 0.0 110.116 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.437 HG13 ' CD ' ' A' ' 11' ' ' GLN . 48.8 t -64.6 126.06 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.555 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 13.3 p90 -125.98 -21.05 4.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.167 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.555 ' HB1' ' CE1' ' A' ' 9' ' ' TYR . . . -138.26 133.62 33.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.437 ' CD ' HG13 ' A' ' 8' ' ' VAL . 43.2 mt-30 -145.25 114.6 7.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.195 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 56.0 tt0 -92.04 144.01 25.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.937 . . . . 0.0 110.197 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 21.3 m120 57.44 17.51 3.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.922 . . . . 0.0 110.215 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.658 ' CZ ' HD12 ' A' ' 18' ' ' LEU . 81.9 t80 -53.59 -47.75 69.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.197 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -66.28 -47.84 72.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 36.2 mt-10 -55.78 -62.3 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.697 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 62.7 t80 -47.24 -57.89 4.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.268 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' CZ ' ' A' ' 14' ' ' TYR . 7.7 mt -57.14 -44.32 83.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.326 -0.859 . . . . 0.0 110.192 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 9.8 ttmm -46.93 -40.73 14.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.231 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.69 65.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.669 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.1 tp -56.81 -19.56 17.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.669 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 79.22 27.85 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.154 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 58.8 mt -74.21 166.67 42.7 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.221 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.555 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.13 138.87 28.68 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.026 1.54 . . . . 0.0 110.415 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -58.74 -41.02 85.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -56.19 -26.2 49.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.616 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 44.3 tp -93.12 -18.83 22.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 90.4 mt -82.68 -42.47 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.235 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.31 -32.67 66.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.56 -32.81 36.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.217 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -97.2 5.98 49.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.599 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.31 -5.3 13.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 110.204 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -149.23 52.61 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.226 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.12 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.7 mt -122.86 114.86 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.28 83.62 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.189 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 1.12 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.5 Cg_endo -73.03 131.59 17.01 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.109 1.584 . . . . 0.0 110.411 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.5 mt -86.11 155.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.5 t -135.25 118.54 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 110.238 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -97.43 137.61 36.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 40' ' ' ILE . 50.6 mm -124.75 129.02 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.224 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -129.28 74.18 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 110.184 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.668 ' OE1' ' CZ ' ' A' ' 47' ' ' PHE . 57.8 tt0 -69.86 166.3 19.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.193 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 36.8 mtmt -165.34 44.86 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.171 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.03 -105.25 1.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -107.63 -2.42 20.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -1.135 . . . . 0.0 110.224 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -102.28 148.72 25.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 110.189 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.668 ' CZ ' ' OE1' ' A' ' 42' ' ' GLN . 1.9 m-85 -131.03 135.06 47.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.292 -0.88 . . . . 0.0 110.152 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.8 t -120.19 108.99 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.5 t -110.04 129.95 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.7 m -129.56 105.38 8.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 110.268 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 m -89.55 137.52 32.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.88 . . . . 0.0 110.222 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -130.47 112.8 13.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.168 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.682 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -95.7 168.63 10.48 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.173 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.402 ' CD ' HG21 ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.12 -17.14 24.97 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.018 1.536 . . . . 0.0 110.434 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -106.55 -18.41 13.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.682 ' O ' ' OG1' ' A' ' 53' ' ' THR . 14.2 pt20 -167.84 161.63 13.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.1 p -128.53 135.82 49.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.99 126.9 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.209 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 t -109.92 139.56 44.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 110.147 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -136.2 147.93 47.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.254 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -139.49 130.54 26.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.242 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.604 ' CB ' ' CB ' ' A' ' 68' ' ' ALA . 34.2 p90 -144.42 173.15 12.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.228 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.0 m -120.19 143.35 48.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.298 -0.876 . . . . 0.0 110.126 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.571 ' CD2' HG13 ' A' ' 82' ' ' VAL . 30.8 mt -74.34 127.17 32.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.172 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.88 -1.4 57.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -136.34 145.11 45.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -1.135 . . . . 0.0 110.231 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -68.91 125.42 26.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.604 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -125.65 151.52 46.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -82.27 133.95 35.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.925 . . . . 0.0 110.187 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 70' ' ' ILE . 18.9 mm -125.94 145.65 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 110.252 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -121.04 135.13 55.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.925 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.594 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -85.28 157.46 20.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 0.0 110.238 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.87 -16.98 63.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 110.25 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -84.13 -11.49 56.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.09 30.3 4.84 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.594 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 27.7 mttt -104.03 132.07 50.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -1.138 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -107.18 135.02 49.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.285 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.01 158.9 15.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.163 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -104.88 147.16 28.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.2 m -151.04 139.19 20.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -103.25 88.64 3.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.182 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.668 HG12 HD12 ' A' ' 89' ' ' LEU . 16.9 t -52.73 157.03 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 110.271 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.68 144.51 19.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.252 -0.905 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.85 105.09 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.243 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.93 150.91 44.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.153 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 52.57 15.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.242 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.84 40.17 12.48 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 9.2 ptpt -163.54 133.0 4.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -1.127 . . . . 0.0 110.169 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.751 ' O ' HG21 ' A' ' 90' ' ' VAL . 5.5 tt -61.42 145.07 52.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.206 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.751 HG21 ' O ' ' A' ' 89' ' ' LEU . 41.4 t -150.48 111.42 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.531 ' HG1' ' HA ' ' A' ' 82' ' ' VAL . 87.4 m -106.96 97.95 7.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.232 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -95.45 162.78 13.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 110.193 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.5 t -152.42 -164.47 1.96 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -102.21 33.34 3.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 0.0 110.231 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.1 pttt -174.98 2.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.18 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.99 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER 178.56 143.14 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 111' ' ' ILE . 50.7 m -116.85 164.91 13.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 0.0 110.209 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.835 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 60.5 t-80 -146.84 141.24 26.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.835 ' HG3' ' O ' ' A' ' 98' ' ' HIS . 4.3 mp0 -153.58 128.29 9.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 0.0 110.213 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.461 ' NE2' ' HE2' ' A' ' 107' ' ' MET . 58.8 tt0 -131.89 157.4 44.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.406 ' HA ' ' CE2' ' A' ' 2' ' ' PHE . 36.7 tt0 -156.32 154.28 30.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.06 142.57 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.185 -0.947 . . . . 0.0 110.131 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -136.74 95.04 3.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 110.2 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.9 -110.76 3.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -114.62 12.62 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -1.149 . . . . 0.0 110.216 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -119.24 157.83 27.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.49 ' CE ' ' CD1' ' A' ' 6' ' ' TRP . 2.2 tpp -127.96 140.49 51.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.234 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.7 t -127.48 124.5 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 23.5 mt-10 -109.35 118.26 36.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.598 ' N ' ' O ' ' A' ' 99' ' ' GLU . 41.3 m -108.76 118.65 37.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 110.253 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 97' ' ' SER . 53.6 mt -127.76 132.64 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.164 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 76.6 m -108.52 139.54 43.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.649 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 10.9 t80 -161.19 127.06 3.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 65.48 38.59 94.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 67.92 12.31 62.21 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.444 HG13 ' HA ' ' A' ' 17' ' ' PHE . 63.4 t -114.57 138.27 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 110.168 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.6 m -115.02 131.49 56.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.263 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.697 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 63.8 tp -111.41 151.06 28.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 110.242 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.9 mt -129.39 94.1 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 64.8 mtp180 -87.27 124.09 32.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.192 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 65.3 mtt180 -104.72 125.15 50.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 74.3 m -124.29 152.93 42.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -115.39 156.12 26.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 110.215 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -82.61 136.04 34.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.196 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.246 0.546 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.89 144.38 44.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.16 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.59 176.19 14.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 42.3 p -103.48 134.05 47.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -1.108 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.464 ' CZ3' ' HG3' ' A' ' 107' ' ' MET . 86.0 m95 -122.46 142.96 50.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.226 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -123.31 118.51 27.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.0 t -64.61 127.74 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.285 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 47.6 p90 -128.41 -28.19 2.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.92 . . . . 0.0 110.25 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.84 133.76 43.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.175 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 14' ' ' TYR . 5.4 pt20 -146.62 118.61 8.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -97.11 148.99 22.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.148 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 m120 53.08 21.89 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 110.218 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.816 ' CZ ' HD12 ' A' ' 18' ' ' LEU . 86.6 t80 -60.12 -42.95 95.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 110.236 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.605 ' HG3' ' N ' ' A' ' 16' ' ' GLU . 14.2 pt-20 -69.55 -45.59 68.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 110.169 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.605 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 41.8 mt-10 -57.67 -60.37 3.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.69 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 52.2 t80 -51.65 -53.64 36.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.816 HD12 ' CZ ' ' A' ' 14' ' ' TYR . 8.9 mt -59.38 -47.23 86.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 110.19 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -48.46 -38.74 20.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.917 . . . . 0.0 110.175 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.22 -25.07 65.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.716 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.5 tp -60.37 -18.74 52.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.232 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.716 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 82.61 26.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.44 HD21 ' HD2' ' A' ' 24' ' ' PRO . 24.2 mt -72.91 163.14 70.61 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 110.231 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 45.9 Cg_endo -73.03 140.16 30.94 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.022 1.538 . . . . 0.0 110.442 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -56.02 -44.67 78.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -51.42 -36.53 44.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.16 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.476 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 20.8 tp -83.01 -23.34 33.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.679 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 35.0 mt -75.23 -40.98 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -76.43 -22.84 54.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.214 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.6 mtt -87.92 -27.24 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.948 . . . . 0.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -104.73 4.72 32.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.174 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.859 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 21.1 ptt180 -70.69 1.53 5.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -0.914 . . . . 0.0 110.206 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.859 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 1.5 m-20 -153.82 42.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.254 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.874 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 7.1 mt -121.38 117.06 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.557 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -94.06 89.25 0.42 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.251 -0.905 . . . . 0.0 110.221 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.874 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.09 138.07 27.44 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.0 1.526 . . . . 0.0 110.408 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.1 mt -87.51 161.42 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.922 . . . . 0.0 110.182 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.87 120.98 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.418 ' HG3' HG23 ' A' ' 5' ' ' THR . 42.1 tt0 -101.6 138.27 38.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.473 HD13 ' HE2' ' A' ' 107' ' ' MET . 75.5 mt -124.95 132.79 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.888 . . . . 0.0 110.23 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -137.14 72.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.594 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 6.5 pt20 -76.42 169.65 17.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.211 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 75.7 mttt -161.26 46.71 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 110.239 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.18 -97.88 0.64 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -112.03 -6.84 14.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.153 . . . . 0.0 110.207 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -99.8 152.71 19.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.917 . . . . 0.0 110.157 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.429 ' CE1' HD12 ' A' ' 64' ' ' LEU . 2.1 m-85 -136.34 137.96 41.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.62 109.6 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.21 -0.931 . . . . 0.0 110.229 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.1 t -111.19 134.41 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.186 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.491 ' OG1' HG23 ' A' ' 59' ' ' THR . 91.3 m -131.14 109.91 10.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -90.42 135.11 33.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -127.51 122.11 32.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.208 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.604 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.58 168.87 7.19 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.239 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.558 ' HD2' HG23 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.05 -17.54 24.8 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.059 1.557 . . . . 0.0 110.466 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.462 ' HD3' ' HB3' ' A' ' 56' ' ' GLN . 1.8 tmt_? -105.57 -24.09 12.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.186 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.462 ' HB3' ' HD3' ' A' ' 55' ' ' ARG . 2.5 pt20 -162.88 164.34 26.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.232 -0.918 . . . . 0.0 110.216 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.2 p -132.12 128.23 37.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 110.192 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.48 132.76 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.93 . . . . 0.0 110.222 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.491 HG23 ' OG1' ' A' ' 50' ' ' THR . 28.7 m -112.56 136.54 51.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 110.246 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.473 ' ND2' ' OG1' ' A' ' 71' ' ' THR . 14.5 m120 -133.03 150.58 52.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.174 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.4 m -143.08 137.51 29.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.202 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.684 ' CD1' ' CG2' ' A' ' 82' ' ' VAL . 32.5 p90 -150.04 162.01 41.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 90.7 m -112.2 143.54 43.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.429 HD12 ' CE1' ' A' ' 47' ' ' PHE . 14.1 mt -69.16 124.79 24.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.54 19.03 53.74 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.409 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 91.2 mttt -150.89 138.9 20.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -1.191 . . . . 0.0 110.152 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -72.05 135.51 46.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 0.0 110.188 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.46 146.75 42.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.233 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 13.9 p-10 -76.27 141.4 41.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.168 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 74.7 mt -140.31 145.93 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.473 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 1.6 p -111.83 147.34 35.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.194 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.641 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -98.6 158.6 15.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.213 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.514 ' SD ' ' CG2' ' A' ' 53' ' ' THR . 10.5 ttm -68.13 -17.16 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.554 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 3.1 p30 -87.5 -18.28 30.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.86 26.76 4.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.641 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 19.4 mttt -101.59 133.4 46.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -1.111 . . . . 0.0 110.226 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -110.67 134.99 51.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -165.44 161.38 18.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -104.55 151.51 23.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.2 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.497 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 0.9 OUTLIER -155.23 140.53 17.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.203 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.1 m -102.4 86.37 2.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.209 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.684 ' CG2' ' CD1' ' A' ' 62' ' ' PHE . 11.5 t -52.75 152.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.885 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.14 148.25 32.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 mt -102.19 105.02 15.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.67 132.27 55.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.211 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.7 t30 45.68 39.53 5.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.887 . . . . 0.0 110.217 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.36 42.62 95.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.674 ' HD3' ' CD ' ' A' ' 101' ' ' GLU . 25.3 mttt -150.04 119.38 6.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -1.104 . . . . 0.0 110.189 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.55 ' CD2' ' CG1' ' A' ' 82' ' ' VAL . 1.5 tt -68.87 133.2 47.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 89' ' ' LEU . 20.7 t -139.78 120.85 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.497 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 87.9 m -113.76 94.66 4.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.2 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 46.7 pttt -94.25 163.13 13.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.272 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 28.6 t -150.23 -154.66 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.206 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.49 ' N ' ' OG ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -107.04 22.55 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.17 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -165.41 6.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.201 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 1.018 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.86 139.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.501 ' O ' HG22 ' A' ' 111' ' ' ILE . 16.0 t -112.38 165.29 12.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -149.5 136.46 19.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.665 ' O ' ' N ' ' A' ' 110' ' ' THR . 33.3 tt0 -152.05 128.58 10.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.9 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.524 ' OE1' ' HG2' ' A' ' 109' ' ' GLU . 39.1 tt0 -132.43 160.52 36.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.179 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.674 ' CD ' ' HD3' ' A' ' 88' ' ' LYS . 82.3 tt0 -155.89 150.12 25.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.225 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.77 142.16 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 110.215 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -133.73 93.35 3.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 110.196 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.5 -108.39 2.78 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -114.26 8.73 16.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -1.119 . . . . 0.0 110.197 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -115.49 154.78 28.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.923 . . . . 0.0 110.164 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.503 ' SD ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -125.5 141.91 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.19 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.1 t -128.68 122.16 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.524 ' HG2' ' OE1' ' A' ' 100' ' ' GLN . 27.1 mt-10 -105.42 121.75 44.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.223 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.665 ' N ' ' O ' ' A' ' 99' ' ' GLU . 19.6 m -112.61 116.04 29.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 97' ' ' SER . 52.2 mt -126.47 132.1 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 77.0 m -108.95 137.26 47.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.92 . . . . 0.0 110.225 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.553 ' CD2' HD13 ' A' ' 21' ' ' LEU . 11.6 t80 -159.56 126.52 4.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.94 32.79 77.92 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.46 9.65 78.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.582 ' CG1' ' HA ' ' A' ' 17' ' ' PHE . 52.2 t -113.37 141.68 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -1.123 . . . . 0.0 110.246 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.3 m -115.85 134.26 55.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.192 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.69 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 16.9 tp -112.67 140.04 47.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 58.1 mt -122.48 98.38 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -93.59 124.96 37.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 110.244 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 32.9 mtm180 -103.07 122.82 45.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.6 m -120.44 150.42 40.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -114.91 151.63 33.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 110.19 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.1 ttt180 -74.87 133.31 41.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.189 179.977 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.231 0.539 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 p -57.79 144.47 38.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.8 -176.05 18.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.5 m -108.14 134.24 51.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -1.093 . . . . 0.0 110.215 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.475 ' CZ3' ' HB2' ' A' ' 107' ' ' MET . 98.8 m95 -121.12 139.2 53.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.179 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -121.89 125.6 46.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.239 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.449 HG13 ' HD3' ' A' ' 120' ' ' ARG . 19.4 m -62.34 123.35 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.212 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -134.27 2.77 3.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 110.223 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 121' ' ' ARG . . . -163.03 120.79 1.97 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -147.08 164.85 31.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 110.206 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -135.97 153.58 51.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.178 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 48.27 38.08 9.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -67.06 -49.31 65.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.188 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -61.8 -46.4 89.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 61.3 mt-10 -55.15 -42.93 73.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.195 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 55.2 t80 -55.41 -57.67 10.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 110.278 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.569 HD13 ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -50.78 -38.89 50.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 110.195 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 33.2 mttp -60.33 -38.8 84.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.262 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.63 -40.94 69.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.772 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 2.0 tp -54.68 -26.22 32.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.893 . . . . 0.0 110.23 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.772 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 86.64 18.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.526 HD21 ' HD2' ' A' ' 24' ' ' PRO . 16.5 mt -66.69 170.31 6.17 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.175 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.526 ' HD2' HD21 ' A' ' 23' ' ' LEU . 46.8 Cg_endo -73.09 132.96 18.86 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.123 1.591 . . . . 0.0 110.41 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.404 ' HA ' HD13 ' A' ' 28' ' ' ILE . 25.6 tp10 -51.94 -47.91 64.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.225 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -48.42 -35.62 13.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 110.241 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.526 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 41.6 tp -79.54 -33.4 41.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.17 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.569 ' HA ' HD13 ' A' ' 18' ' ' LEU . 85.6 mt -61.95 -52.22 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.193 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -59.08 -26.1 64.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -0.913 . . . . 0.0 110.179 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.674 ' O ' HD13 ' A' ' 34' ' ' ILE . 12.1 ttm -91.8 -23.12 19.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -101.29 -5.94 24.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -3.72 16.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -147.62 43.43 1.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.019 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 18.0 mt -120.49 109.93 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 110.206 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.48 86.59 0.2 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 0.0 110.198 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 1.019 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.6 Cg_endo -73.14 146.42 40.95 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.069 1.562 . . . . 0.0 110.443 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.2 mt -91.17 162.29 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.227 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.4 t -138.36 120.75 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -103.45 134.58 46.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.8 mt -120.67 131.7 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 37.0 tt0 -135.95 73.09 1.45 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 110.215 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -76.12 164.1 26.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.201 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 59.6 mttt -158.71 49.84 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.42 -101.85 1.01 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -110.91 1.11 17.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -1.131 . . . . 0.0 110.174 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 42.2 t0 -108.23 144.02 36.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 110.265 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.551 ' CD1' HD13 ' A' ' 64' ' ' LEU . 3.6 m-85 -127.29 143.51 51.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.897 . . . . 0.0 110.248 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.6 t -132.35 106.92 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.178 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.4 t -108.82 134.88 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.243 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.48 ' OG1' HG21 ' A' ' 59' ' ' THR . 87.1 m -131.91 109.51 10.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.217 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.0 m -92.1 132.72 36.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.257 -0.902 . . . . 0.0 110.093 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -126.17 128.32 47.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.28 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.759 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -111.11 169.76 5.97 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.0 110.273 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.13 -8.87 22.74 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.005 1.529 . . . . 0.0 110.403 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -117.39 -20.84 8.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.633 ' O ' ' OG1' ' A' ' 53' ' ' THR . 16.2 pt20 -162.43 160.5 26.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.883 . . . . 0.0 110.17 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 p -131.09 131.15 43.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.471 ' CG2' ' HG3' ' A' ' 73' ' ' MET . 57.4 t -127.7 129.35 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.194 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.48 HG21 ' OG1' ' A' ' 50' ' ' THR . 62.3 m -112.26 139.75 47.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -135.09 152.06 51.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.903 . . . . 0.0 110.19 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.4 t -148.38 131.15 16.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.225 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.573 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 50.5 p90 -143.51 171.55 13.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.929 . . . . 0.0 110.151 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.2 m -119.8 140.88 50.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.551 HD13 ' CD1' ' A' ' 47' ' ' PHE . 17.5 mt -74.41 127.67 33.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 110.202 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.42 4.4 56.18 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -145.05 145.07 31.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -1.154 . . . . 0.0 110.205 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.44 123.96 22.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.221 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.573 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.89 150.74 44.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 12.0 p-10 -86.39 140.65 29.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.464 HG21 ' N ' ' A' ' 71' ' ' THR . 12.1 mm -130.15 144.42 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.464 ' N ' HG21 ' A' ' 70' ' ' ILE . 4.0 m -116.56 131.77 56.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.194 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.651 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 73.0 p -86.04 158.16 19.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.471 ' HG3' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -70.01 -13.76 62.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.511 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 3.6 p30 -86.28 -16.92 36.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 110.22 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.53 27.7 4.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.651 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 22.1 mttt -105.06 131.36 52.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -107.84 135.83 48.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.26 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -164.22 159.38 20.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 83.4 mttt -105.93 171.01 7.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 110.256 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 27.6 p -179.88 136.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 m -95.34 103.43 15.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.197 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' A' ' 89' ' ' LEU . 43.2 t -76.77 140.54 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 110.244 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.647 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 35.0 p-80 -139.44 156.6 46.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.209 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 53.8 mt -101.41 132.15 47.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.164 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -135.77 117.97 15.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.22 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 57.84 31.39 20.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 110.231 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.611 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 72.24 49.78 19.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.705 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 51.1 mtpt -158.57 117.21 3.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.623 ' O ' HG21 ' A' ' 90' ' ' VAL . 4.5 tt -65.77 140.28 58.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.193 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.647 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 97.8 t -146.69 117.0 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.674 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 99.8 m -110.97 94.8 5.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 110.223 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -88.45 161.7 16.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.231 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 96' ' ' PHE . 30.2 t -157.47 -177.13 6.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.918 . . . . 0.0 110.237 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 84.1 tt0 -95.26 33.46 1.56 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.902 . . . . 0.0 110.184 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.539 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 10.8 ptpt -173.5 -2.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.837 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -176.96 146.62 0.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.2 m -123.13 156.87 34.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.154 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.674 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.5 t-80 -140.23 134.56 31.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.789 ' O ' HG22 ' A' ' 110' ' ' THR . 0.6 OUTLIER -149.07 125.14 10.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.857 . . . . 0.0 110.21 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.749 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 10.0 tt0 -131.94 156.47 46.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.705 ' OE1' ' HE3' ' A' ' 88' ' ' LYS . 76.8 tt0 -151.65 159.55 43.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.423 HG21 ' CH2' ' A' ' 6' ' ' TRP . 10.9 p -122.65 137.23 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -132.16 93.3 3.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.53 -106.77 2.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.405 ' ND2' ' HG3' ' A' ' 106' ' ' GLU . 3.4 p-10 -117.67 10.79 13.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -1.147 . . . . 0.0 110.165 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.405 ' HG3' ' ND2' ' A' ' 105' ' ' ASN . 70.0 mt-10 -118.43 160.79 21.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.195 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.536 ' SD ' ' OE1' ' A' ' 100' ' ' GLN . 28.5 ttm -134.58 142.08 46.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.221 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 74.2 t -125.62 128.65 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 110.24 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.749 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 15.7 mt-10 -115.87 136.17 53.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.211 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.789 HG22 ' O ' ' A' ' 99' ' ' GLU . 3.1 t -126.27 122.61 36.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.183 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.29 133.01 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 89.6 m -113.27 133.87 54.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.157 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.462 ' CE1' ' HA ' ' A' ' 21' ' ' LEU . 26.1 t80 -154.82 122.58 5.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 110.227 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.94 35.5 65.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.39 5.39 63.0 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.2 t -111.05 135.76 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -1.162 . . . . 0.0 110.23 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 59.2 m -112.93 135.43 53.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.553 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 23.5 tp -115.76 139.57 50.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.04 120.18 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.449 ' HD3' HG13 ' A' ' 8' ' ' VAL . 5.5 ttm105 -115.39 119.18 35.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 110.219 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 84.4 mtt180 -99.94 125.15 45.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.408 ' CB ' ' HB3' ' A' ' 6' ' ' TRP . 11.4 m -120.54 152.03 38.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.22 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -113.58 152.51 30.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 5' ' ' THR . 31.8 ttt180 -78.96 136.91 37.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.196 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.146 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.444 ' O ' HD11 ' A' ' 40' ' ' ILE . 64.4 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.269 0.557 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.4 p -58.78 145.26 41.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.275 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.06 -178.99 16.78 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 85.0 m -104.05 132.04 50.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -1.154 . . . . 0.0 110.193 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.449 ' CE3' ' HB2' ' A' ' 107' ' ' MET . 88.4 m95 -121.73 142.7 49.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.895 . . . . 0.0 110.164 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.01 122.32 38.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 110.212 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.55 124.16 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.204 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 38.1 p90 -124.94 -32.43 3.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.194 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' HB1' ' CD2' ' A' ' 9' ' ' TYR . . . -129.01 127.16 41.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.261 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 23.0 pt20 -141.48 117.72 10.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.467 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 41.4 tt0 -96.19 144.25 26.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.219 -0.926 . . . . 0.0 110.279 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 12' ' ' GLU . 6.8 t-20 60.79 14.63 5.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.583 ' CZ ' HD12 ' A' ' 18' ' ' LEU . 60.5 t80 -50.98 -53.75 30.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 110.315 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.8 -49.1 76.27 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 34.1 mt-10 -55.05 -58.98 5.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 110.236 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.643 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 63.9 t80 -50.56 -54.73 20.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.583 HD12 ' CZ ' ' A' ' 14' ' ' TYR . 4.4 mt -59.18 -41.18 87.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -50.09 -39.54 42.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.51 -27.53 65.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.676 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -59.71 -19.69 51.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.676 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 79.99 27.57 0.31 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.4 mt -74.32 164.2 62.92 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.335 -0.853 . . . . 0.0 110.186 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -73.13 140.8 31.63 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.066 1.561 . . . . 0.0 110.391 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.89 -41.11 90.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.156 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.6 -27.39 49.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.63 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 42.2 tp -91.74 -18.91 23.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.188 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.7 mt -85.01 -40.93 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -73.83 -30.87 62.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.181 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 51.6 ttm -82.57 -30.83 29.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.838 . . . . 0.0 110.234 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -99.17 3.97 46.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 110.206 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.701 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -64.5 -10.19 23.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.232 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.701 ' OD2' ' HD2' ' A' ' 32' ' ' ARG . 69.2 m-20 -143.93 55.96 1.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.183 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 1.8 mt -126.32 114.41 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -86.32 83.06 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 110.232 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 1.183 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.7 Cg_endo -73.07 131.52 16.85 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.029 1.542 . . . . 0.0 110.389 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -87.52 153.59 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 110.246 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.48 118.44 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.215 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -96.78 131.9 43.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.229 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.563 ' CD1' ' HE2' ' A' ' 107' ' ' MET . 74.0 mt -117.36 135.49 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.193 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -138.01 68.01 1.41 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -71.04 163.28 27.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 110.221 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 86.4 mttt -158.3 45.99 0.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.18 -97.85 0.67 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 52.3 m-20 -112.18 -3.7 14.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -1.181 . . . . 0.0 110.202 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.486 ' OD1' ' CG2' ' A' ' 63' ' ' THR . 38.3 m-20 -106.85 148.96 27.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 34.3 m-85 -131.88 148.79 52.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -127.27 99.74 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 110.164 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.13 132.65 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.865 . . . . 0.0 110.206 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 58.7 m -134.03 108.78 8.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.214 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 m -93.65 134.3 36.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 110.244 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -127.03 127.08 44.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.665 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 62.3 p -109.29 170.03 5.82 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.945 . . . . 0.0 110.204 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 46.7 Cg_endo -73.06 -5.57 17.43 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -120.7 -23.85 5.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.665 ' O ' ' OG1' ' A' ' 53' ' ' THR . 4.5 pt20 -161.43 165.89 28.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.175 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.2 p -132.6 130.8 40.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.161 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.9 t -127.37 126.21 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 14.7 t -111.06 146.39 36.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.643 ' OD1' HG22 ' A' ' 71' ' ' THR . 10.8 m-80 -139.63 142.91 37.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.85 . . . . 0.0 110.15 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -139.58 135.05 32.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.19 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.647 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 54.1 p90 -148.06 170.78 17.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.486 ' CG2' ' OD1' ' A' ' 46' ' ' ASP . 91.3 m -116.78 151.05 37.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.236 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.46 ' HG ' ' HA ' ' A' ' 83' ' ' HIS . 3.5 tp -82.66 120.07 25.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.244 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.85 9.61 34.44 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -148.53 147.08 28.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -1.154 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -68.76 126.72 30.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.647 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -126.14 148.01 49.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.313 -0.867 . . . . 0.0 110.173 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -84.3 138.36 32.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.497 HG22 HD11 ' A' ' 70' ' ' ILE . 11.4 mm -128.21 145.07 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 110.185 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.643 HG22 ' OD1' ' A' ' 60' ' ' ASN . 5.1 t -119.72 131.32 55.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.567 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 73.1 p -84.22 160.89 20.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.15 -12.52 60.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.117 -0.989 . . . . 0.0 110.226 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.503 ' OD1' ' HB ' ' A' ' 72' ' ' THR . 4.9 p-10 -89.35 -9.54 50.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.52 51.39 1.21 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.567 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 9.3 tttt -129.63 128.46 42.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -1.132 . . . . 0.0 110.197 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -104.53 141.04 37.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.72 156.32 7.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 13.7 mttm -105.41 165.86 10.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.217 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.9 p -178.05 139.95 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 p -94.46 107.95 19.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 0.0 110.22 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 62' ' ' PHE . 48.1 t -79.47 140.38 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.622 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 15.3 p-80 -145.03 161.54 39.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.5 mt -103.61 134.35 47.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 110.206 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -136.91 120.44 17.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 110.235 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 86.7 m-20 58.72 31.7 21.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.558 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 72.83 44.07 39.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.785 ' HD3' ' OE2' ' A' ' 101' ' ' GLU . 10.0 mtmt -156.39 121.66 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -1.164 . . . . 0.0 110.152 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.45 HD23 HG12 ' A' ' 82' ' ' VAL . 4.2 tt -66.73 136.04 54.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.897 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.622 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 69.2 t -142.34 117.27 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 75.0 m -109.99 95.3 5.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 110.244 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -91.55 154.43 19.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.215 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.4 t -145.84 -163.95 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.158 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -102.69 33.08 3.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.2 OUTLIER -175.52 2.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.919 . . . . 0.0 110.187 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.823 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -178.73 148.42 0.42 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 0.0 110.184 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.522 ' O ' HG22 ' A' ' 111' ' ' ILE . 41.8 m -123.75 159.89 28.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.8 t-80 -142.21 142.92 32.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.915 . . . . 0.0 110.251 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.567 ' O ' ' N ' ' A' ' 110' ' ' THR . 47.6 mt-10 -155.73 123.2 5.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.143 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 11.6 tt0 -129.23 159.07 37.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.202 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.785 ' OE2' ' HD3' ' A' ' 88' ' ' LYS . 57.6 tt0 -157.09 156.83 33.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 110.208 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.429 HG22 ' CD1' ' A' ' 2' ' ' PHE . 39.8 t -118.98 139.18 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -134.96 89.78 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.216 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.83 -102.59 2.48 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -123.09 10.72 9.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -1.122 . . . . 0.0 110.22 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -115.84 151.68 34.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.563 ' HE2' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -121.74 137.01 54.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.4 t -125.29 120.56 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 35.4 mt-10 -109.01 118.71 37.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.567 ' N ' ' O ' ' A' ' 99' ' ' GLU . 63.4 m -107.97 116.61 32.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.266 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.522 HG22 ' O ' ' A' ' 97' ' ' SER . 54.0 mt -125.4 131.46 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.226 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.7 m -109.69 134.47 51.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.569 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 12.8 t80 -157.42 128.16 6.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.21 33.83 74.32 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.08 11.73 70.77 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.0 t -116.26 138.36 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -1.135 . . . . 0.0 110.202 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 63.2 m -113.27 132.48 55.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.643 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 29.5 tp -113.02 152.09 29.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.89 . . . . 0.0 110.244 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.9 mt -129.65 94.98 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.172 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -87.76 126.61 35.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 91.0 mtt180 -106.88 124.96 50.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.214 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.2 m -122.66 149.4 44.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -115.55 150.76 36.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 110.177 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 5' ' ' THR . 23.2 ttt85 -74.99 132.95 41.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.191 -179.969 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.23 0.538 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.2 m -59.17 148.52 31.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 110.266 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.63 163.83 13.93 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.426 ' OG1' ' HB ' ' A' ' 125' ' ' VAL . 20.5 p -78.3 155.52 30.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -1.159 . . . . 0.0 110.16 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.539 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 96.7 m95 -141.93 127.64 19.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.948 ' HB3' ' HG2' ' A' ' 123' ' ' LYS . 6.1 tt0 -94.63 146.34 24.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.187 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.589 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 38.6 t -67.37 112.32 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.259 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 1.343 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 2.1 m-85 -72.86 -69.52 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.895 . . . . 0.0 110.252 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.895 ' H ' ' HG3' ' A' ' 121' ' ' ARG . . . -149.07 170.76 17.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.26 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.709 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 3.1 mp0 -148.43 112.25 5.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.238 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 54.6 tt0 -91.8 150.93 20.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.19 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 14' ' ' TYR . 23.6 m-20 52.49 19.12 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 7.4 t80 -42.85 -65.31 0.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.135 -0.978 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' GLU . 47.2 mt-10 -47.88 -57.33 5.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.212 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 5.7 mm-40 -41.83 -49.88 4.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.559 ' CD2' HD21 ' A' ' 118' ' ' LEU . 12.6 t80 -52.04 -63.3 1.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 18' ' ' LEU . 7.6 mt -44.49 -44.46 8.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.275 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 22.8 mttm -52.72 -37.93 59.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.03 -40.08 63.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.22 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.687 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -57.51 -25.22 59.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 110.231 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.687 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 79.6 23.22 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 110.162 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.581 HD21 ' HD2' ' A' ' 24' ' ' PRO . 15.5 mt -71.54 170.12 13.11 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.209 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.581 ' HD2' HD21 ' A' ' 23' ' ' LEU . 46.3 Cg_endo -73.11 139.32 29.46 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.067 1.562 . . . . 0.0 110.374 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 5.6 pt-20 -59.93 -46.74 88.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 110.238 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.536 ' OD2' ' HB2' ' A' ' 24' ' ' PRO . 2.6 p30 -47.34 -34.67 7.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.194 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.577 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 18.4 tp -88.97 -32.25 17.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.228 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.496 ' CG2' HD11 ' A' ' 18' ' ' LEU . 72.8 mt -70.61 -49.16 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 110.177 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -63.63 -32.07 73.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 110.164 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.1 ttp -84.33 -11.77 55.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 110.159 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -111.2 3.81 18.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.258 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.568 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 9.4 ptt180 -68.29 -3.21 10.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.182 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 81.0 m-20 -146.91 51.46 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.897 . . . . 0.0 110.178 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.786 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 11.6 mt -126.54 113.49 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.224 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -98.49 85.27 0.4 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.172 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.786 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.6 Cg_endo -73.05 154.69 52.72 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.983 1.517 . . . . 0.0 110.44 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.3 mt -95.32 169.31 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.193 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.1 t -145.64 118.24 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.248 -0.907 . . . . 0.0 110.225 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -98.31 147.19 24.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.483 HD11 HG22 ' A' ' 40' ' ' ILE . 65.4 mt -133.96 125.23 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -127.15 80.07 1.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.868 . . . . 0.0 110.177 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.755 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 41.1 tt0 -78.77 162.62 26.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.187 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 34.3 mmtt -159.22 46.28 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.248 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.15 -96.73 0.66 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -116.59 3.11 13.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -1.137 . . . . 0.0 110.157 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 40.5 t0 -107.98 139.28 42.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.93 . . . . 0.0 110.249 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.755 ' CE1' ' HB2' ' A' ' 42' ' ' GLN . 0.7 OUTLIER -120.61 135.61 55.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.38 103.16 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 110.154 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.08 129.03 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.157 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.486 HG21 HG21 ' A' ' 59' ' ' THR . 57.5 m -130.23 107.9 9.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.5 m -89.57 128.08 35.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.158 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -120.75 124.09 44.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.16 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.612 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -108.56 169.07 6.93 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.223 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.7 Cg_endo -73.04 -16.81 25.4 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.997 1.525 . . . . 0.0 110.483 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -111.95 -20.79 11.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.612 ' O ' ' OG1' ' A' ' 53' ' ' THR . 2.0 tt0 -160.95 155.32 23.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 p -131.46 137.54 48.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.167 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.8 t -133.65 132.04 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.908 . . . . 0.0 110.243 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.486 HG21 HG21 ' A' ' 50' ' ' THR . 17.1 m -111.79 137.31 49.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 110.205 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 59' ' ' THR . 7.5 m120 -132.38 155.77 47.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.932 . . . . 0.0 110.214 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 t -152.32 127.42 9.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.2 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.479 ' CB ' ' CB ' ' A' ' 68' ' ' ALA . 34.5 p90 -141.99 174.02 10.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.314 -0.867 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 27.7 m -118.38 150.71 39.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.52 HD12 ' CE2' ' A' ' 47' ' ' PHE . 5.6 mt -78.58 125.2 29.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.74 10.1 58.06 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -142.36 141.12 32.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -1.165 . . . . 0.0 110.173 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.8 124.87 25.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 0.0 110.22 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.479 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -125.35 149.29 48.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 0.0 110.27 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -82.15 139.08 34.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 110.138 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.458 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 4.4 mm -132.78 144.74 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 0.0 110.218 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 71' ' ' THR . 4.9 t -116.74 137.6 52.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.247 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.568 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -87.15 156.98 19.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.189 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.7 ttm -66.89 -16.36 64.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 110.256 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.56 -9.66 55.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.229 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.96 33.74 4.55 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.568 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 28.3 mttt -107.27 133.31 52.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -109.45 136.53 48.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -169.04 157.97 8.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.152 -0.968 . . . . 0.0 110.22 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 9.7 mtmt -102.29 172.06 7.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 110.227 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.3 p -178.65 137.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 110.154 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.0 m -97.04 99.75 11.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.408 ' CG1' HD23 ' A' ' 89' ' ' LEU . 46.1 t -72.84 139.03 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.235 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.64 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 11.4 p-80 -138.58 161.26 37.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.4 mt -105.63 132.12 52.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.262 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.62 115.61 13.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.218 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 59.8 t30 59.38 31.82 21.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 73.77 43.91 33.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.409 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 85.9 mttt -152.58 120.78 6.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -1.133 . . . . 0.0 110.177 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.495 ' O ' HG21 ' A' ' 90' ' ' VAL . 7.4 tt -72.54 133.11 44.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.64 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 99.0 t -141.55 122.83 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.918 . . . . 0.0 110.198 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 54.6 m -113.85 92.48 3.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -87.46 162.35 17.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 110.208 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 28.3 t -155.8 -164.44 1.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 110.181 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.404 ' N ' ' OG ' ' A' ' 93' ' ' SER . 40.7 tt0 -103.99 31.56 4.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.92 . . . . 0.0 110.183 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.515 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -172.65 -2.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.144 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.804 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -173.7 147.99 1.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.185 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.467 ' O ' HG22 ' A' ' 111' ' ' ILE . 70.9 m -124.82 154.33 41.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 64.1 t-80 -141.6 140.36 33.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.458 ' HG3' HG21 ' A' ' 90' ' ' VAL . 29.5 tt0 -152.15 127.52 9.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 110.186 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 13.8 tt0 -130.2 150.43 51.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.229 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -148.2 154.08 39.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 110.253 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 102' ' ' VAL . 13.2 p -119.69 131.86 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -126.76 93.09 3.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.882 . . . . 0.0 110.201 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.76 -95.74 1.26 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -126.52 15.74 7.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -1.162 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -123.73 150.75 44.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 110.206 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 121' ' ' ARG . 8.2 tpp -125.79 140.14 52.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.885 . . . . 0.0 110.172 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.02 124.46 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 110.256 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 33.6 mt-10 -115.25 123.7 49.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.9 m -111.99 123.16 49.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 97' ' ' SER . 73.7 mt -129.09 128.43 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.904 . . . . 0.0 110.197 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 90.1 m -111.93 133.49 54.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 110.223 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.556 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 5.8 t80 -156.0 122.38 5.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.245 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.07 32.54 58.42 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.41 1.43 65.03 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.1 t -108.5 141.31 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -1.131 . . . . 0.0 110.218 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 89.5 m -119.57 130.99 55.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.249 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.559 HD21 ' CD2' ' A' ' 17' ' ' PHE . 59.0 tp -110.43 140.84 44.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 85.4 mt -114.61 105.29 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -106.26 119.03 38.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -0.962 . . . . 0.0 110.196 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.895 ' HG3' ' H ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -102.49 136.87 41.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.792 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 1.4 m -123.71 140.1 53.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.278 -0.889 . . . . 0.0 110.205 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 1.343 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 15.4 ptmt -99.81 146.35 26.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 68.7 ttt180 -77.43 135.95 38.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.426 ' HB ' ' OG1' ' A' ' 5' ' ' THR . 64.7 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.21 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.4 ' HA ' ' CE ' ' A' ' 107' ' ' MET . 85.0 m-85 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.239 0.543 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -57.12 147.22 25.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.63 163.93 13.06 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 25.2 m -80.79 150.93 29.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 110.193 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.646 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 97.5 m95 -136.61 130.96 33.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.206 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.927 ' O ' ' HA ' ' A' ' 122' ' ' SER . 32.4 tt0 -95.73 144.59 26.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.201 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.622 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 21.7 t -66.61 119.96 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.905 . . . . 0.0 110.181 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 1.167 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.9 OUTLIER -80.94 -68.68 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 110.256 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.874 ' H ' ' HG3' ' A' ' 121' ' ' ARG . . . -150.33 169.6 21.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 110.236 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -146.44 110.59 5.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.487 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 9.5 mm-40 -88.55 155.07 19.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.686 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 68.3 m-20 47.38 21.35 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 110.165 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 4.4 t80 -46.19 -61.86 1.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' GLU . 67.0 mt-10 -51.27 -57.77 7.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.686 ' OE1' ' HA ' ' A' ' 13' ' ' ASN . 6.7 mp0 -41.7 -49.59 4.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.411 ' CD2' HD21 ' A' ' 118' ' ' LEU . 8.4 t80 -50.28 -62.8 1.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.247 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.476 HD21 ' HA ' ' A' ' 18' ' ' LEU . 9.2 mt -44.98 -47.35 11.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 90.4 mttt -49.4 -39.09 31.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.133 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.14 -38.4 63.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.174 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.671 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.3 tp -58.98 -24.81 63.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.239 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.671 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 80.25 22.49 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.683 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 6.6 mt -71.39 170.91 10.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 110.194 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.683 ' HD2' ' CD2' ' A' ' 23' ' ' LEU . 46.1 Cg_endo -72.99 138.07 27.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.004 1.528 . . . . 0.0 110.446 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -59.47 -40.76 87.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.212 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -53.24 -33.49 53.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.449 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 52.1 tp -85.65 -35.41 20.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 18' ' ' LEU . 96.2 mt -63.26 -52.09 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -59.52 -29.61 68.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.192 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.692 ' O ' HD13 ' A' ' 34' ' ' ILE . 96.2 mtp -86.37 -12.8 48.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -111.51 -3.62 15.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.888 . . . . 0.0 110.242 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -63.64 -6.61 5.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -147.2 55.21 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.791 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 16.5 mt -130.46 114.2 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -98.24 85.79 0.42 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.791 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.07 149.34 46.33 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.996 1.524 . . . . 0.0 110.426 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.697 HG21 ' N ' ' A' ' 38' ' ' VAL . 19.8 mt -89.51 175.25 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.235 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.697 ' N ' HG21 ' A' ' 37' ' ' ILE . 61.0 t -152.92 119.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -101.13 152.0 21.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 110.249 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 40' ' ' ILE . 58.2 mt -139.46 130.3 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.405 ' HB3' ' HB ' ' A' ' 48' ' ' VAL . 59.7 tt0 -130.1 72.36 1.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 110.207 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.676 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 56.4 tt0 -66.45 173.64 3.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.245 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.676 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 8.3 mtmt -171.49 35.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.234 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.1 -100.25 0.57 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -111.47 -0.86 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -1.151 . . . . 0.0 110.21 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 39.5 t0 -107.32 146.76 31.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.182 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.596 ' CD1' HD13 ' A' ' 64' ' ' LEU . 4.5 m-85 -127.53 139.52 52.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 65.7 t -120.91 101.99 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.208 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.8 t -103.93 130.75 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.193 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 85.5 m -133.31 105.42 6.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.89 . . . . 0.0 110.207 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -86.03 132.0 34.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -124.72 122.98 39.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.754 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -109.53 168.09 8.19 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.06 -5.99 18.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.966 1.508 . . . . 0.0 110.412 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -122.45 -18.41 6.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.19 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.529 ' O ' ' OG1' ' A' ' 53' ' ' THR . 5.8 pt20 -164.6 158.69 18.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.6 p -133.94 133.52 41.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.895 . . . . 0.0 110.21 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.53 132.84 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.214 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 13.5 t -115.28 138.71 50.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -0.912 . . . . 0.0 110.163 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -135.35 151.93 50.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 110.277 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.2 t -141.37 132.42 26.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.167 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.869 ' CD1' HG22 ' A' ' 82' ' ' VAL . 33.6 p90 -146.64 169.98 17.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.423 HG23 ' N ' ' A' ' 64' ' ' LEU . 58.1 m -117.81 153.85 32.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -0.929 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.596 HD13 ' CD1' ' A' ' 47' ' ' PHE . 8.0 mt -82.71 122.84 28.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.91 -3.16 55.7 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -132.98 148.63 52.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -1.148 . . . . 0.0 110.197 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.463 ' OE2' ' HB3' ' A' ' 79' ' ' LYS . 5.4 tm-20 -73.68 133.18 43.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.247 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -133.33 148.63 51.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.168 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 15.2 p-10 -78.14 135.1 37.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.898 . . . . 0.0 110.246 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 70' ' ' ILE . 17.1 mm -127.92 143.53 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.172 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p -118.47 139.86 50.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.206 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.718 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 29.3 p -93.54 158.0 15.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.233 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -11.44 59.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.2 -0.937 . . . . 0.0 110.226 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.459 ' OD2' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -87.54 -17.78 31.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 110.256 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.86 29.48 4.07 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.718 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 28.5 mttt -105.07 136.03 45.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 8.4 ptpp? -111.57 133.25 53.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.29 162.26 25.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 110.238 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.463 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 35.4 mttt -105.28 151.03 24.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.419 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.2 m -152.88 139.3 18.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.229 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -103.01 90.56 3.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.881 . . . . 0.0 110.157 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.869 HG22 ' CD1' ' A' ' 62' ' ' PHE . 39.3 t -58.71 152.23 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.276 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.59 152.25 38.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -105.58 102.31 11.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.87 132.44 54.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.1 t30 45.61 38.18 3.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.73 41.03 93.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -147.68 125.68 12.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -1.149 . . . . 0.0 110.212 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.515 HD12 HG12 ' A' ' 82' ' ' VAL . 6.2 tt -75.23 132.55 41.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.4 t -137.84 123.76 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.898 . . . . 0.0 110.241 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 55.3 m -119.7 88.69 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -85.65 171.52 11.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.183 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 15.1 t -160.03 -161.24 0.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.177 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.491 ' N ' ' OG ' ' A' ' 93' ' ' SER . 23.1 mt-10 -106.15 34.49 3.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 110.202 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.45 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 7.4 ptpt -177.49 -0.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.892 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -175.76 146.85 0.76 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.74 157.89 28.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.508 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 63.4 t-80 -142.58 138.51 30.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.285 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -149.59 128.2 12.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.917 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.621 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 53.6 tt0 -128.67 155.31 45.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 9.5 mp0 -154.82 148.91 25.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.1 p -116.18 137.04 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 110.299 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -131.65 95.54 3.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.22 -98.02 1.46 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -126.25 12.08 7.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.254 -1.145 . . . . 0.0 110.196 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -118.71 156.05 29.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -0.914 . . . . 0.0 110.151 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.42 ' HG3' ' CE3' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -129.02 140.84 51.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.201 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.3 t -127.66 125.66 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.22 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -114.84 132.64 56.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.0 m -121.37 122.75 40.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.216 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.75 133.92 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 75.1 p -113.93 136.47 52.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 0.0 110.203 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.523 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 4.6 t80 -157.36 122.75 4.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.875 . . . . 0.0 110.217 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.61 36.11 62.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.74 1.86 55.2 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 112' ' ' THR . 53.0 t -106.7 143.47 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -1.155 . . . . 0.0 110.174 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 85.8 m -121.46 129.39 52.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.487 ' CD1' ' O ' ' A' ' 12' ' ' GLU . 63.0 tp -108.37 145.02 35.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 119' ' ' ILE . 72.3 mt -119.03 103.31 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -102.61 114.18 28.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.874 ' HG3' ' H ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -102.09 137.94 39.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.927 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 5.9 m -125.5 161.88 26.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 110.223 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 1.167 ' HB2' ' CE2' ' A' ' 9' ' ' TYR . 51.8 tttt -128.57 157.55 40.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 110.225 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 5' ' ' THR . 45.2 ttt180 -89.95 135.52 33.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.209 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.55 HG12 ' OE1' ' A' ' 7' ' ' GLN . 33.8 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.155 0.503 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.1 p -57.82 148.5 25.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.68 164.79 13.03 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 21.6 m -82.58 145.95 29.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -1.151 . . . . 0.0 110.202 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.504 ' CE3' ' HB2' ' A' ' 107' ' ' MET . 98.1 m95 -129.88 130.36 45.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.819 ' HB2' ' HG2' ' A' ' 123' ' ' LYS . 65.1 mt-30 -103.26 117.72 35.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.897 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.504 ' C ' ' O ' ' A' ' 7' ' ' GLN . 16.9 t -35.95 134.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.236 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 1.472 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -99.46 -57.47 2.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 110.192 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.848 ' CB ' ' HE ' ' A' ' 121' ' ' ARG . . . -158.52 163.97 36.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 110.255 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.588 ' HB2' ' CG ' ' A' ' 14' ' ' TYR . 1.8 pt20 -137.26 106.17 5.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.76 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 39.4 tt0 -94.87 126.48 40.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.951 ' ND2' ' OE1' ' A' ' 16' ' ' GLU . 18.1 t-20 77.91 -4.02 2.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.867 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.588 ' CG ' ' HB2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -29.9 -72.72 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 110.222 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 14' ' ' TYR . 46.4 mt-10 -39.52 -61.15 0.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.951 ' OE1' ' ND2' ' A' ' 13' ' ' ASN . 28.6 mt-10 -42.93 -55.86 3.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.215 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.602 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 77.1 t80 -52.82 -46.6 67.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.85 -44.33 86.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.234 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -52.33 -42.18 63.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 110.154 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.99 -31.16 69.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 110.235 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.587 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 2.7 tp -65.3 -17.14 64.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 75.48 27.54 1.03 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.157 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.6 mt -76.57 163.66 64.54 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.172 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.527 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -73.09 138.62 28.37 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.999 1.526 . . . . 0.0 110.39 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -55.38 -38.3 68.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 110.25 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 30' ' ' MET . 44.5 t0 -59.24 -27.61 65.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.229 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.527 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 52.5 tp -90.7 -32.59 16.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 110.171 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.637 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.7 mt -69.74 -45.62 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 110.195 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -70.31 -19.9 63.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 26' ' ' ASP . 90.1 mmm -91.47 -29.17 17.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 110.154 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -102.31 -1.59 30.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.211 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.637 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 2.4 ppt_? -65.51 -10.55 35.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.175 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 10.3 t0 -141.65 47.7 1.65 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.093 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mt -121.22 113.13 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.78 81.28 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.25 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 1.093 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.9 Cg_endo -73.06 142.39 34.39 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.921 1.485 . . . . 0.0 110.371 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.447 HG21 ' O ' ' A' ' 6' ' ' TRP . 6.6 mt -88.64 164.62 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.261 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.5 t -141.52 109.93 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.236 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -89.25 137.66 32.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.276 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.423 HD11 ' CD1' ' A' ' 6' ' ' TRP . 82.1 mt -125.04 127.36 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.198 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -127.43 70.48 1.32 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.599 ' OE1' ' CZ ' ' A' ' 47' ' ' PHE . 57.0 tt0 -68.57 164.41 21.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.231 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 37.3 mttt -162.73 46.11 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.95 -101.06 0.89 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 29.3 m-20 -111.04 -3.86 15.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -1.146 . . . . 0.0 110.179 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -99.64 151.39 21.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.61 ' CD1' HD13 ' A' ' 64' ' ' LEU . 2.3 m-85 -133.42 131.03 39.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.225 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.3 109.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.186 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.5 t -111.81 129.27 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.169 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.4 m -123.81 103.31 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.17 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.3 m -83.63 137.94 33.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 0.0 110.164 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -131.74 117.05 18.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 110.16 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.589 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -103.68 168.17 9.06 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 110.239 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.512 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.3 Cg_endo -73.08 -27.81 13.54 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.016 1.535 . . . . 0.0 110.4 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.413 ' CD ' ' OE1' ' A' ' 56' ' ' GLN . 3.6 ttm180 -97.28 -23.83 15.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.249 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' OE1' ' CD ' ' A' ' 55' ' ' ARG . 1.1 pm0 -161.13 161.98 31.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.224 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 p -129.74 128.06 41.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 110.226 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.462 HG22 ' HG2' ' A' ' 73' ' ' MET . 59.4 t -126.77 127.83 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 110.16 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.4 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 14.1 t -111.65 140.85 45.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.195 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.452 ' ND2' ' OG1' ' A' ' 71' ' ' THR . 23.6 m120 -138.1 131.72 30.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.175 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -123.12 136.18 54.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.214 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.654 ' CD1' HG22 ' A' ' 82' ' ' VAL . 45.7 p90 -149.06 167.32 26.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.216 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.1 m -116.37 148.69 40.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 110.247 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.61 HD13 ' CD1' ' A' ' 47' ' ' PHE . 37.2 mt -76.49 126.37 30.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.56 13.23 58.57 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -144.22 138.67 28.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -1.136 . . . . 0.0 110.225 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -70.68 124.48 24.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.187 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.65 149.36 49.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.254 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -77.37 137.15 38.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 70' ' ' ILE . 25.5 mm -128.16 145.22 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -0.888 . . . . 0.0 110.226 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.452 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 2.0 p -121.73 134.78 54.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.92 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.677 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 36.5 p -86.96 156.51 19.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.91 . . . . 0.0 110.176 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.462 ' HG2' HG22 ' A' ' 58' ' ' VAL . 10.7 mtm -68.42 -15.6 63.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 110.181 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -82.32 -22.59 35.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.208 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.09 19.62 5.11 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.677 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 22.3 mttt -96.38 137.81 34.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -1.142 . . . . 0.0 110.236 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -113.96 133.22 55.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.55 162.07 30.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -106.01 143.99 33.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -0.894 . . . . 0.0 110.2 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.452 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -148.46 139.17 22.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.8 m -104.4 93.07 4.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 110.192 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.654 HG22 ' CD1' ' A' ' 62' ' ' PHE . 16.2 t -57.36 152.4 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.907 . . . . 0.0 110.217 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.54 147.28 30.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.253 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.0 mt -102.99 98.83 8.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.214 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 86' ' ' ASN . . . -110.11 138.03 47.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.159 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 85' ' ' ALA . 29.7 m120 42.98 39.35 1.75 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.47 52.09 53.56 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.755 ' HE2' ' OE1' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -161.61 112.98 1.72 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -1.18 . . . . 0.0 110.164 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.79 ' O ' HG21 ' A' ' 90' ' ' VAL . 3.9 tt -58.95 144.06 46.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.79 HG21 ' O ' ' A' ' 89' ' ' LEU . 48.1 t -151.01 114.62 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 85.5 m -109.73 94.2 4.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -91.43 165.14 13.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.859 . . . . 0.0 110.173 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.46 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 1.6 m -155.99 -158.44 0.81 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 53.1 tt0 -107.9 29.13 7.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 7.8 ptpt -171.1 1.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.247 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.863 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -178.65 148.04 0.41 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.181 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -122.72 157.83 31.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.611 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.2 t-80 -139.82 138.39 35.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 110.234 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 98' ' ' HIS . 78.1 mt-10 -152.66 126.15 8.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.489 ' NE2' ' SD ' ' A' ' 107' ' ' MET . 50.3 tt0 -133.92 155.65 49.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.755 ' OE1' ' HE2' ' A' ' 88' ' ' LYS . 47.5 tt0 -149.51 163.61 37.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.143 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 102' ' ' VAL . 12.0 p -127.2 129.49 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.182 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.6 pttt -126.94 96.9 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 110.202 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.57 -111.29 3.26 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.517 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 45.9 p-10 -115.2 14.42 16.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -1.132 . . . . 0.0 110.25 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.517 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 20.0 mt-10 -119.66 157.72 27.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.178 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.504 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 26.4 ttm -132.56 140.92 48.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 110.226 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 121' ' ' ARG . 65.1 t -127.42 133.65 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.206 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 70.9 mt-10 -117.5 123.99 47.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 110.227 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.2 m -114.02 123.13 48.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.18 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 97' ' ' SER . 82.2 mt -131.86 132.77 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 63.5 p -109.02 136.25 48.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 0.0 110.188 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.547 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 8.7 t80 -156.99 124.94 5.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.94 . . . . 0.0 110.19 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.68 38.45 89.96 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.53 2.67 44.46 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.9 t -105.66 147.1 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -1.165 . . . . 0.0 110.18 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.7 m -122.28 127.77 50.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.189 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.602 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 62.9 tp -105.98 153.07 22.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 91.4 mt -132.15 101.12 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 110.184 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 3.9 ttt180 -104.33 122.28 45.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.848 ' HE ' ' CB ' ' A' ' 10' ' ' ALA . 4.4 ptt180 -103.89 142.42 34.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.753 ' C ' ' CD2' ' A' ' 9' ' ' TYR . 0.7 OUTLIER -129.69 147.78 51.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.85 . . . . 0.0 110.248 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 1.472 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -106.57 149.15 27.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.185 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' THR . 76.1 ttt180 -82.18 139.89 34.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.171 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.248 0.547 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.1 p -57.22 146.79 27.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.202 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.81 -177.91 17.31 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.6 m -105.3 132.69 51.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -1.149 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.505 ' CE3' ' HB2' ' A' ' 107' ' ' MET . 98.5 m95 -121.13 147.08 46.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.862 . . . . 0.0 110.198 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -128.82 115.38 17.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 110.175 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.67 133.88 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.301 -0.874 . . . . 0.0 110.257 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.533 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 16.4 p90 -135.88 -19.4 1.56 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.533 ' HB1' ' CE1' ' A' ' 9' ' ' TYR . . . -139.05 133.81 32.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 110.277 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -146.1 116.77 7.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.237 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.484 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 63.5 mm-40 -88.44 142.12 27.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.9 . . . . 0.0 110.281 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.5 t30 55.66 26.31 9.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.23 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 35.1 t80 -54.8 -50.39 68.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -65.99 -45.94 79.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -0.934 . . . . 0.0 110.166 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.86 -60.35 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.194 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.638 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 41.8 t80 -48.56 -60.42 2.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.192 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.629 ' O ' ' N ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -53.92 -54.39 39.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.503 ' C ' ' O ' ' A' ' 18' ' ' LEU . 56.7 mttt -36.53 -44.99 0.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.14 -27.35 68.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.672 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -60.65 -19.58 58.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.263 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.672 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 80.15 30.79 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 110.186 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.575 HD21 ' HD2' ' A' ' 24' ' ' PRO . 15.0 mt -78.03 164.52 56.53 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.925 . . . . 0.0 110.197 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HD2' HD21 ' A' ' 23' ' ' LEU . 45.4 Cg_endo -73.13 141.19 32.21 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.019 1.536 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -62.25 -39.37 92.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.159 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -57.11 -29.36 63.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.211 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.603 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 44.7 tp -89.42 -23.14 22.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.206 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.607 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.9 mt -82.29 -40.22 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.199 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -73.49 -29.09 62.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.239 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.7 ttm -88.11 -25.95 22.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.208 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -101.74 2.72 38.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.607 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 18.0 ptt180 -67.33 -1.12 4.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.234 -0.916 . . . . 0.0 110.212 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.549 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.5 m-20 -146.74 49.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.915 . . . . 0.0 110.181 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.872 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.2 mt -122.41 123.07 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.75 83.0 0.23 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.211 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.872 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -72.98 138.94 29.21 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.061 1.558 . . . . 0.0 110.454 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.7 mt -93.16 153.93 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.886 . . . . 0.0 110.208 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.3 t -132.09 119.78 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 110.199 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -98.49 134.92 40.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 110.212 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.9 mt -121.52 131.13 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -135.72 74.53 1.51 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.248 -0.908 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.637 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 1.6 pt20 -76.64 164.88 25.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 57.0 mmtt -159.02 51.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 110.213 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.15 -103.66 1.26 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 33.3 m-20 -107.82 -3.38 19.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -1.187 . . . . 0.0 110.125 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.7 t0 -103.33 148.12 26.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.875 . . . . 0.0 110.185 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.571 ' CD1' HD13 ' A' ' 64' ' ' LEU . 2.9 m-85 -132.14 139.35 48.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.9 108.96 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.165 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.4 t -110.08 130.03 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.238 -0.914 . . . . 0.0 110.186 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.423 ' CG2' HG21 ' A' ' 59' ' ' THR . 94.2 m -130.07 110.59 11.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -92.93 132.91 36.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.162 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -125.46 121.55 34.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.191 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.603 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.4 168.64 7.54 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.193 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' A' ' 53' ' ' THR . 46.2 Cg_endo -73.12 -18.69 23.58 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.055 1.555 . . . . 0.0 110.395 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 19.9 mtp-105 -104.57 -20.83 13.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -166.81 160.75 14.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.194 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 p -129.78 133.47 47.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.195 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.17 128.79 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 110.265 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.454 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 25.1 m -111.86 138.4 48.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.256 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 59' ' ' THR . 67.0 m-20 -134.75 153.35 52.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 t -146.51 128.4 15.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.212 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.553 ' CB ' ' CB ' ' A' ' 68' ' ' ALA . 33.9 p90 -140.8 173.64 11.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -123.38 141.95 51.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.571 HD13 ' CD1' ' A' ' 47' ' ' PHE . 18.1 mt -74.28 126.21 30.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.02 -1.91 55.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.0 143.32 40.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -1.19 . . . . 0.0 110.17 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -66.61 122.4 17.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.286 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.553 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -123.54 146.87 47.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.176 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -81.94 137.28 35.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.517 HD11 HG22 ' A' ' 70' ' ' ILE . 4.9 mm -128.43 145.24 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -116.29 134.47 54.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.15 154.76 20.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.905 . . . . 0.0 110.186 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.5 ttm -65.91 -16.54 63.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.257 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -85.26 -11.35 55.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 110.186 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.25 33.2 4.65 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -107.32 133.24 52.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -1.191 . . . . 0.0 110.198 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -108.1 135.86 48.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.95 . . . . 0.0 110.199 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -167.43 156.18 9.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -103.49 166.85 10.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.23 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p -175.22 139.78 0.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.3 m -98.84 100.52 11.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.176 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.457 HG12 HD23 ' A' ' 89' ' ' LEU . 44.0 t -72.83 139.35 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 110.186 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 25.6 p-80 -136.55 161.08 36.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 110.207 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.5 mt -106.56 130.52 54.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -135.1 116.08 14.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 93.1 m-20 59.02 28.13 17.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.8 37.68 29.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -141.44 122.2 14.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -1.159 . . . . 0.0 110.248 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.457 HD23 HG12 ' A' ' 82' ' ' VAL . 7.8 tt -77.56 126.36 30.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.265 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.548 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 92.2 t -135.47 127.17 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.189 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 56.0 m -117.97 85.87 2.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.235 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -79.58 166.78 21.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.235 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.44 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -158.61 -167.2 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.204 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.753 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 43.4 mt-10 -100.84 43.82 1.04 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.181 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.753 ' HB3' ' O ' ' A' ' 94' ' ' GLU . 7.0 ptmt 170.1 3.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.239 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.843 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -176.95 144.65 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.417 ' O ' HG22 ' A' ' 111' ' ' ILE . 70.4 m -123.53 153.91 39.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.453 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 64.4 t-80 -138.56 145.89 41.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.484 ' HG3' ' CG2' ' A' ' 90' ' ' VAL . 2.4 tt0 -157.78 121.08 3.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.232 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.596 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 26.0 tt0 -122.8 159.81 27.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 27.5 mt-10 -157.61 144.76 18.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.3 p -111.07 140.84 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.23 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -137.11 96.22 3.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.877 . . . . 0.0 110.227 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.04 -108.98 2.77 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -116.39 10.83 14.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -1.163 . . . . 0.0 110.18 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.53 156.51 28.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.188 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.505 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 27.5 ttm -128.69 141.12 51.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.338 -0.851 . . . . 0.0 110.192 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.7 t -126.37 123.97 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.867 . . . . 0.0 110.194 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 23.3 mt-10 -110.66 115.28 29.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 99' ' ' GLU . 64.1 m -105.6 122.8 46.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 110.207 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 97' ' ' SER . 61.6 mt -129.82 129.73 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 45.8 m -109.6 135.73 50.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.165 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.572 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 15.9 t80 -159.17 127.05 4.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.07 32.88 65.53 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.48 5.47 67.88 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 17' ' ' PHE . 61.6 t -110.16 143.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.334 -1.097 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.0 m -118.6 130.18 55.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.9 . . . . 0.0 110.126 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.638 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 42.7 tp -111.24 147.36 35.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.196 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 87.0 mt -122.35 95.97 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 110.275 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.603 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 3.0 ttm180 -88.94 117.52 28.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 110.213 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.489 ' HB3' ' OH ' ' A' ' 9' ' ' TYR . 29.2 mtt180 -101.69 128.82 47.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.925 . . . . 0.0 110.17 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.2 m -126.8 151.81 47.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.197 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -112.09 156.22 22.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.194 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -83.31 135.53 34.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.202 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.439 ' O ' HD11 ' A' ' 40' ' ' ILE . 92.2 m-85 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.236 0.541 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.66 148.04 30.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -0.915 . . . . 0.0 110.218 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.6 163.77 13.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.8 m -80.38 152.23 28.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -1.173 . . . . 0.0 110.178 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.671 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 89.9 m95 -139.21 132.89 30.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.728 ' N ' ' O ' ' A' ' 123' ' ' LYS . 24.8 tt0 -98.71 124.66 43.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 t -44.33 126.2 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 1.289 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -88.51 -65.93 0.97 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.876 ' H ' ' HG3' ' A' ' 121' ' ' ARG . . . -155.07 163.13 40.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.568 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.6 pt20 -136.65 101.7 4.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.614 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 56.8 tt0 -87.05 137.46 32.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.133 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 32.2 m-20 65.36 -1.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 1.032 ' CZ ' HD12 ' A' ' 18' ' ' LEU . 77.8 t80 -32.22 -64.35 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.564 ' CG ' ' N ' ' A' ' 16' ' ' GLU . 13.6 pt-20 -48.26 -51.04 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.235 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.564 ' N ' ' CG ' ' A' ' 15' ' ' GLU . 68.0 mt-10 -54.74 -61.17 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.63 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 49.0 t80 -49.61 -56.27 10.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.032 HD12 ' CZ ' ' A' ' 14' ' ' TYR . 21.0 mt -54.58 -46.81 73.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 65.2 mttt -46.83 -41.29 15.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 -26.16 66.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 110.221 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.665 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -63.22 -20.16 65.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.665 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 78.86 30.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.246 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 37.3 mt -77.32 167.3 37.56 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.259 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.577 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.0 Cg_endo -73.1 140.32 30.98 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.065 1.56 . . . . 0.0 110.41 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -61.49 -36.57 80.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.168 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -59.22 -30.06 67.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.181 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.623 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 44.9 tp -89.46 -21.21 23.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 110.153 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.75 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 78.0 mt -78.71 -41.26 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 0.0 110.198 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 32' ' ' ARG . 18.0 mtmt -75.22 -24.1 57.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.27 -0.894 . . . . 0.0 110.251 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.5 tpp -87.87 -29.8 20.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.623 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -105.52 8.4 33.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 110.23 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.75 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.0 ptm85 -67.88 -7.67 30.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 110.176 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -146.74 59.86 1.2 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 1.16 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.5 mt -129.64 110.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -88.57 80.41 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.954 . . . . 0.0 110.274 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 1.16 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.05 140.78 31.83 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.005 1.529 . . . . 0.0 110.459 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.519 ' C ' HG21 ' A' ' 38' ' ' VAL . 5.2 mt -87.9 165.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.519 HG21 ' C ' ' A' ' 37' ' ' ILE . 69.0 t -142.67 116.59 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.239 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -92.17 140.74 29.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.439 HD11 ' O ' ' A' ' 2' ' ' PHE . 75.2 mt -126.92 129.25 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 110.18 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -129.67 66.37 1.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.597 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 52.6 tt0 -63.95 168.96 4.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 33.5 mtmt -167.78 44.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 0.0 110.22 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.97 -103.97 1.04 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 25.8 m-20 -108.23 -3.11 18.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -1.187 . . . . 0.0 110.172 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.36 150.3 23.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.653 ' CD1' HD13 ' A' ' 64' ' ' LEU . 2.9 m-85 -133.25 134.37 43.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.08 109.45 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 0.0 110.18 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.0 t -111.41 129.85 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.259 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.42 HG21 ' CG2' ' A' ' 59' ' ' THR . 84.7 m -126.04 106.86 9.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 110.195 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.8 m -88.64 136.55 32.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.202 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -129.69 117.52 20.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -102.39 168.11 9.42 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.1 Cg_endo -73.05 -28.01 13.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.028 1.541 . . . . 0.0 110.394 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.14 -19.43 17.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.245 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.588 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.4 OUTLIER -164.05 160.36 21.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.244 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 p -128.94 127.85 42.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.265 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.481 HG22 ' HG3' ' A' ' 73' ' ' MET . 58.2 t -125.78 124.42 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.149 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.42 ' CG2' HG21 ' A' ' 50' ' ' THR . 36.7 m -110.17 144.57 38.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -141.24 147.73 38.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.893 . . . . 0.0 110.25 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.7 m -139.07 135.08 33.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.923 . . . . 0.0 110.264 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.769 ' CD1' HG22 ' A' ' 82' ' ' VAL . 51.7 p90 -147.69 170.99 16.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 110.229 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.2 m -118.52 145.37 45.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 110.228 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.653 HD13 ' CD1' ' A' ' 47' ' ' PHE . 51.0 mt -77.1 124.44 27.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.27 -3.75 54.8 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -134.31 148.62 50.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 0.0 110.185 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.505 ' HA ' ' CG2' ' A' ' 81' ' ' THR . 75.7 tt0 -72.45 128.54 35.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.224 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.515 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.96 150.74 50.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -82.05 133.71 35.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.472 HD11 HG22 ' A' ' 70' ' ' ILE . 22.9 mm -123.45 145.06 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 96.3 m -122.8 135.07 54.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.686 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 43.1 p -89.78 157.92 17.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.481 ' HG3' HG22 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -68.3 -12.53 61.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.268 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -85.31 -21.5 28.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.06 23.23 4.99 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.686 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 27.1 mttt -98.62 135.32 40.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -1.118 . . . . 0.0 110.161 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -113.01 135.22 54.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 110.21 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -164.47 160.69 20.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.152 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.419 ' HD3' ' OE2' ' A' ' 67' ' ' GLU . 25.8 mttp -104.05 146.33 28.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.279 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.561 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -148.58 141.8 25.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.505 ' CG2' ' HA ' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -106.43 89.39 3.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.211 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.769 HG22 ' CD1' ' A' ' 62' ' ' PHE . 12.2 t -57.71 152.54 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.161 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.19 146.12 28.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.429 ' CD1' HD11 ' A' ' 64' ' ' LEU . 14.9 mt -98.41 101.02 12.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.843 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 86' ' ' ASN . . . -117.33 148.91 41.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.222 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' ALA . 3.4 t-20 44.53 27.51 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.159 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 70.45 40.17 68.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.805 ' HD3' ' CD ' ' A' ' 101' ' ' GLU . 11.1 mttt -152.95 132.09 12.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.208 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.569 HD12 HG12 ' A' ' 82' ' ' VAL . 8.3 tt -72.19 135.9 46.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.547 HG11 ' HG2' ' A' ' 99' ' ' GLU . 11.6 m -143.72 123.26 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.235 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.561 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 95.2 m -114.56 91.87 3.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -88.49 163.78 15.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.238 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 29.3 t -152.65 -158.03 0.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.196 -0.94 . . . . 0.0 110.197 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.459 ' N ' ' OG ' ' A' ' 93' ' ' SER . 44.6 mt-10 -106.59 26.15 10.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.489 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 7.8 ptpt -167.03 0.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.94 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -177.67 146.21 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 111' ' ' ILE . 29.3 t -117.72 160.03 22.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 58.6 t-80 -143.99 139.25 28.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.547 ' HG2' HG11 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -152.18 127.77 10.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.544 ' NE2' ' SD ' ' A' ' 107' ' ' MET . 46.0 tt0 -131.66 155.04 48.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.188 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.805 ' CD ' ' HD3' ' A' ' 88' ' ' LYS . 45.1 tt0 -151.64 155.09 37.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.52 HG11 ' O ' ' A' ' 102' ' ' VAL . 11.2 p -119.33 134.4 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.219 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.18 94.67 3.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.172 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.38 -111.84 3.37 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -116.23 18.31 15.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.17 . . . . 0.0 110.253 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -123.66 148.51 46.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.218 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.544 ' SD ' ' NE2' ' A' ' 100' ' ' GLN . 34.0 ttm -123.58 139.06 54.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 0.0 110.247 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.62 129.33 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 33.4 mt-10 -115.6 109.81 18.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 110.199 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 99' ' ' GLU . 25.8 m -99.01 123.21 43.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.133 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 97' ' ' SER . 52.7 mt -132.29 129.28 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.223 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.8 m -104.63 142.92 33.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.887 . . . . 0.0 110.267 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.609 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 5.6 t80 -163.16 124.83 2.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.9 37.44 83.67 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.34 9.38 60.91 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.2 t -112.32 140.2 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -1.13 . . . . 0.0 110.194 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.7 m -113.72 129.31 56.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 110.221 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.63 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 48.4 tp -108.66 153.65 23.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.259 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 119' ' ' ILE . 94.8 mt -130.97 94.55 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 0.9 OUTLIER -95.97 128.65 43.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 110.272 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.876 ' HG3' ' H ' ' A' ' 10' ' ' ALA . 1.3 ptp180 -109.85 136.9 48.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.226 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.59 ' C ' ' HD2' ' A' ' 9' ' ' TYR . 39.8 m -125.57 135.46 52.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 1.289 ' HB2' ' CE2' ' A' ' 9' ' ' TYR . 71.7 tttt -92.94 153.89 18.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.246 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 27.5 ttp85 -89.52 134.83 33.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.221 179.926 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.252 0.549 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.1 p -56.08 146.55 22.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 110.159 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.7 -172.49 19.47 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 p -110.69 128.04 55.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -1.133 . . . . 0.0 110.233 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.528 ' O ' HG21 ' A' ' 37' ' ' ILE . 94.3 m95 -115.92 143.51 45.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.171 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -128.71 116.67 19.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.179 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.08 144.88 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.253 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 9' ' ' TYR . 8.0 p90 -147.09 -14.23 0.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.251 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.494 ' HB1' ' CE1' ' A' ' 9' ' ' TYR . . . -139.61 141.86 37.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.14 164.7 37.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -140.33 158.8 43.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.19 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 46.51 38.03 5.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 110.233 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 7.8 t80 -69.84 -55.33 10.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -53.19 -57.88 8.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.271 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -48.38 -45.44 35.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.222 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -55.59 -57.25 12.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 110.228 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -51.07 -43.32 61.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.167 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -54.78 -35.49 63.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.39 -41.91 62.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -0.97 . . . . 0.0 110.162 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.658 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.7 tp -55.26 -25.58 34.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.658 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 80.56 24.13 0.35 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.588 HD21 ' HD2' ' A' ' 24' ' ' PRO . 14.5 mt -69.13 166.52 27.99 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.145 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.588 ' HD2' HD21 ' A' ' 23' ' ' LEU . 46.0 Cg_endo -73.14 132.13 17.61 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.058 1.557 . . . . 0.0 110.407 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -49.7 -46.04 49.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.972 . . . . 0.0 110.264 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -50.33 -35.81 29.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.191 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.58 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 41.7 tp -84.45 -33.61 23.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.434 HG12 ' CD1' ' A' ' 18' ' ' LEU . 96.9 mt -61.22 -56.09 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.149 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HG3' ' HG3' ' A' ' 30' ' ' MET . 13.4 pttp -56.01 -24.43 39.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.688 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 85.6 mtp -94.17 -9.74 35.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.245 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -113.34 -5.84 13.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.218 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.707 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -71.86 0.82 8.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 110.286 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.707 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.5 m-20 -150.18 41.69 0.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.688 ' CD1' ' O ' ' A' ' 30' ' ' MET . 23.8 mt -122.84 115.47 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.267 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -100.82 90.19 1.45 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.674 ' HB3' HG21 ' A' ' 53' ' ' THR . 46.5 Cg_endo -73.09 146.04 40.49 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.918 1.483 . . . . 0.0 110.4 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.528 HG21 ' O ' ' A' ' 6' ' ' TRP . 6.4 mt -86.45 173.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.439 ' N ' ' CG2' ' A' ' 37' ' ' ILE . 70.0 t -150.19 119.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.177 -0.952 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -103.45 148.04 26.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.225 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.8 mt -136.4 132.14 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 110.23 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 55.9 tt0 -132.28 73.82 1.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.793 ' OE1' ' N ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -68.73 170.53 9.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.244 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.626 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 14.2 mtmt -168.55 43.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.793 ' N ' ' OE1' ' A' ' 42' ' ' GLN . . . 120.04 -102.49 0.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 26.8 m-20 -110.36 -2.0 16.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -1.135 . . . . 0.0 110.154 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.1 t0 -104.2 150.39 24.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.672 ' CE1' ' HG3' ' A' ' 42' ' ' GLN . 3.0 m-85 -131.37 137.27 48.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.21 108.08 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.141 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' ASN . 62.8 t -108.37 130.92 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.415 ' OG1' HG23 ' A' ' 59' ' ' THR . 77.6 m -133.22 106.07 7.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.3 m -89.04 137.68 32.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.887 . . . . 0.0 110.223 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -130.97 124.11 30.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 110.258 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.674 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.08 169.25 6.81 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.485 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.4 Cg_endo -73.0 -20.53 21.82 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.992 1.522 . . . . 0.0 110.414 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -105.67 -22.46 12.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.497 ' O ' ' OG1' ' A' ' 53' ' ' THR . 4.5 pt20 -159.74 161.76 34.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 p -132.4 128.15 36.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 110.233 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.55 127.42 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.91 . . . . 0.0 110.233 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.415 HG23 ' OG1' ' A' ' 50' ' ' THR . 91.5 m -111.28 142.09 43.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 49' ' ' VAL . 28.1 m120 -139.41 151.05 45.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.162 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 m -141.58 135.14 29.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.191 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.541 ' CB ' ' CB ' ' A' ' 68' ' ' ALA . 35.0 p90 -148.26 166.65 27.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.8 m -116.02 150.4 37.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.611 HD13 ' CD1' ' A' ' 47' ' ' PHE . 31.4 mt -78.45 125.66 29.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.928 . . . . 0.0 110.198 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.47 5.93 60.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -139.95 139.46 36.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -1.135 . . . . 0.0 110.222 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -65.91 124.8 23.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.541 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -124.76 148.16 48.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.154 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 14.8 p-10 -81.18 136.89 35.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.161 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.416 HG21 ' N ' ' A' ' 71' ' ' THR . 23.7 mm -128.85 142.43 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 110.161 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.416 ' N ' HG21 ' A' ' 70' ' ' ILE . 5.0 m -113.55 139.88 48.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 110.233 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.672 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 68.3 p -93.97 158.39 15.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.8 ttm -70.67 -13.28 62.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.206 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.54 -12.87 47.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.02 25.42 7.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.672 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 12.0 mttt -102.89 136.89 41.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -1.114 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -110.67 135.37 51.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.162 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.21 153.67 9.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.277 -0.89 . . . . 0.0 110.208 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -99.23 155.98 17.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.3 m -157.92 134.26 9.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.167 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -96.55 96.38 8.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.196 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.625 HG11 ' CD2' ' A' ' 89' ' ' LEU . 48.4 t -69.92 142.53 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.669 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 13.9 p-80 -140.84 155.49 46.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.177 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.5 mt -100.12 132.34 45.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.237 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -138.75 111.51 7.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.22 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.675 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 86.2 m-20 64.35 27.59 13.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.214 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.515 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.34 43.5 20.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.634 ' HD2' ' OE2' ' A' ' 101' ' ' GLU . 49.4 mtpt -153.37 118.86 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -1.167 . . . . 0.0 110.203 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.625 ' CD2' HG11 ' A' ' 82' ' ' VAL . 4.8 tt -68.69 142.94 54.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.233 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.669 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 55.3 t -150.69 120.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -114.04 95.73 5.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.0 167.48 13.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.24 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 3.3 m -158.55 -168.08 2.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 110.236 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 27.0 tp10 -101.74 33.68 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 8.6 ptpt -174.75 0.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.226 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.895 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -179.01 144.71 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 0.0 110.184 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.9 m -119.4 158.37 26.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -143.42 136.52 27.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.207 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -148.32 131.38 16.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.219 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.483 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 40.5 tt0 -134.7 152.9 52.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.227 -0.921 . . . . 0.0 110.186 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.634 ' OE2' ' HD2' ' A' ' 88' ' ' LYS . 58.1 tt0 -150.72 159.11 44.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.457 HG21 ' CH2' ' A' ' 6' ' ' TRP . 12.7 p -123.52 136.89 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 110.18 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -130.65 96.97 4.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.246 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.53 -98.08 1.75 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.496 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 30.7 p-10 -126.87 11.6 7.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -1.137 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.496 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 48.4 mt-10 -118.38 164.99 14.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.213 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.519 ' CE ' ' NE1' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -137.27 143.04 41.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.17 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 76.4 t -127.21 127.31 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.375 -0.828 . . . . 0.0 110.238 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 33.9 mt-10 -114.42 134.74 54.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.0 m -124.09 122.38 37.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.179 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 74.8 mt -127.76 131.82 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 110.2 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 80.5 m -112.75 135.58 53.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 4.9 t80 -156.81 123.95 5.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.17 -0.956 . . . . 0.0 110.274 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.03 37.75 73.67 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.49 4.68 52.89 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 112' ' ' THR . 60.2 t -108.65 139.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -1.17 . . . . 0.0 110.178 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 63.6 m -115.13 130.86 57.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.9 tp -110.19 141.93 42.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.182 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.6 mt -120.34 121.36 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -117.75 117.57 29.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.156 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 12.2 mtt180 -98.24 129.01 44.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.169 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.5 p -125.74 166.33 16.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 110.263 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -129.62 158.83 38.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 110.155 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.408 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 73.8 ttt180 -81.35 134.58 35.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.22 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.247 0.546 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -76.48 -31.68 57.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.301 -0.874 . . . . 0.0 110.22 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 m -56.56 145.16 29.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.888 . . . . 0.0 110.182 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.6 -176.48 17.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.4 m -106.35 131.28 53.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -1.137 . . . . 0.0 110.251 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.468 ' CZ3' ' HG3' ' A' ' 107' ' ' MET . 93.0 m95 -119.62 142.84 48.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -124.22 122.12 36.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 110.257 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.15 127.21 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 121' ' ' ARG . 34.3 p90 -133.08 2.37 3.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.251 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.82 127.99 2.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -143.96 120.77 11.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.243 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 55.7 tt0 -99.82 144.65 28.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.941 . . . . 0.0 110.197 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 22.3 m120 58.32 16.33 3.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.277 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.693 ' CE2' ' CD1' ' A' ' 18' ' ' LEU . 90.4 t80 -52.98 -47.64 68.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 110.164 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.09 -47.51 76.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 37.0 mt-10 -56.47 -60.23 3.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.649 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 45.0 t80 -49.74 -54.99 15.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.796 ' CD2' H191 ' A' ' 130' ' ' JN3 . 22.2 mt -52.68 -49.51 65.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 63.1 mttt -42.47 -40.19 2.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.915 . . . . 0.0 110.156 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.451 ' HB3' ' HA3' ' A' ' 114' ' ' GLY . . . -68.84 -25.54 64.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.639 HD12 ' CE2' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -59.04 -19.09 40.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.181 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.605 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 76.36 25.43 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.903 . . . . 0.0 110.166 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.557 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 20.3 mt -75.17 168.24 29.35 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 23' ' ' LEU . 46.4 Cg_endo -73.05 138.06 27.52 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.01 1.531 . . . . 0.0 110.444 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -54.32 -44.44 72.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.925 . . . . 0.0 110.159 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -53.75 -25.3 18.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.665 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 44.9 tp -90.36 -23.95 20.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.901 . . . . 0.0 110.243 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.853 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 81.2 mt -74.81 -42.3 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.233 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -74.97 -20.6 59.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.9 mmm -93.0 -27.12 17.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.212 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -105.71 4.44 30.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 110.273 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.853 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 23.4 ptt180 -72.43 3.63 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 10.4 t0 -154.45 47.19 0.58 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.046 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 4.2 mt -121.12 117.29 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 110.168 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -91.3 82.48 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.186 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 1.046 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.09 132.89 18.77 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.034 1.544 . . . . 0.0 110.428 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 6' ' ' TRP . 8.2 mt -83.2 162.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.0 t -140.67 116.48 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -97.21 136.01 38.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.855 . . . . 0.0 110.224 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.5 mm -123.63 132.78 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.198 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.4 ' HB3' ' HB ' ' A' ' 48' ' ' VAL . 37.2 tt0 -132.56 63.21 1.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 110.2 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 51.6 tt0 -59.3 165.8 2.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 110.218 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 38.3 mtmt -163.77 37.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.28 -97.84 0.53 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 14.8 m-20 -112.4 -7.48 13.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -1.122 . . . . 0.0 110.166 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.574 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 12.0 m-20 -102.55 157.75 16.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.592 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 41.3 m-85 -138.55 139.5 38.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.218 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 58.6 t -117.19 104.19 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -104.16 128.32 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.423 HG22 ' HE3' ' A' ' 52' ' ' LYS . 94.0 m -130.51 100.27 5.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.1 m -83.68 140.15 32.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 110.224 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 50' ' ' THR . 55.3 mttt -132.17 107.38 8.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.868 . . . . 0.0 110.204 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.497 ' CG2' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -94.0 168.15 12.25 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 110.211 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.6 Cg_endo -72.96 -29.93 11.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.016 1.535 . . . . 0.0 110.477 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -95.35 -22.05 18.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.485 ' O ' ' OG1' ' A' ' 53' ' ' THR . 5.1 pt20 -162.45 169.58 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.2 p -134.6 124.88 26.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.227 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 73' ' ' MET . 54.0 t -123.24 125.86 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.482 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 64.3 m -112.94 148.16 35.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.213 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 59' ' ' THR . 27.2 m120 -143.87 147.52 34.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.279 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 t -138.92 140.12 38.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 34.5 p90 -151.89 166.19 32.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -0.904 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.401 ' CG2' ' OD1' ' A' ' 46' ' ' ASP . 88.7 m -116.26 152.26 34.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 3.9 tp -78.47 122.91 26.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.56 14.4 53.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -144.63 136.11 25.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -1.169 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.0 123.1 18.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.12 150.54 43.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.244 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -83.93 132.58 34.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 110.222 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.707 HG23 ' H8 ' ' A' ' 131' ' ' JN3 . 26.7 mm -121.85 146.31 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 m -123.62 136.97 54.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 0.0 110.21 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.659 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 57.9 p -90.92 162.68 14.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.291 -0.88 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.678 ' CE ' H122 ' A' ' 130' ' ' JN3 . 23.9 mtm -75.8 -10.62 59.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.501 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 4.5 p30 -88.76 -14.92 35.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.49 28.73 4.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.659 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 18.0 mttt -107.02 128.16 54.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -1.121 . . . . 0.0 110.233 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -107.06 139.36 41.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.208 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.29 154.37 5.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.208 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.0 mtmm -98.6 153.05 18.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.419 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -157.82 133.66 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 m -95.2 102.58 14.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.186 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 62' ' ' PHE . 47.5 t -73.81 142.99 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 6.5 p-80 -144.36 157.25 44.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.927 . . . . 0.0 110.246 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.0 mt -99.86 134.26 43.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.875 . . . . 0.0 110.233 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -140.73 117.22 10.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.246 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 17.9 m120 61.93 27.59 16.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.514 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.61 40.58 26.75 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.514 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 61.3 mttt -151.4 130.32 12.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -1.14 . . . . 0.0 110.225 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.553 HD21 ' H22' ' A' ' 131' ' ' JN3 . 7.4 tt -76.58 129.94 37.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.576 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 70.3 t -138.46 125.92 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.932 . . . . 0.0 110.188 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 51.9 m -117.92 90.57 3.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -85.24 164.55 17.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 110.211 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 34.9 t -155.07 -158.37 0.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.405 ' N ' ' OG ' ' A' ' 93' ' ' SER . 35.0 mt-10 -108.1 35.41 3.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 110.239 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -177.58 1.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.0 110.149 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.896 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER 179.21 148.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.198 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.479 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -121.76 160.62 24.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.155 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.674 ' CD2' H122 ' A' ' 131' ' ' JN3 . 52.1 t-80 -142.15 140.92 32.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.182 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 110' ' ' THR . 48.2 mt-10 -151.74 126.33 9.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.226 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.7 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 41.3 tt0 -125.95 156.32 39.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.161 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.7 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 7.8 mp0 -157.53 147.55 20.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.902 . . . . 0.0 110.261 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.0 p -116.12 139.26 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -130.33 99.48 5.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.925 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.37 -118.11 5.76 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -103.9 8.15 36.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.232 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -116.1 159.06 22.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.468 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -129.04 139.2 52.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.289 -0.882 . . . . 0.0 110.17 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 80.0 t -126.33 126.18 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.2 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 35.1 mt-10 -110.5 131.28 55.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 99' ' ' GLU . 12.2 p -122.17 117.62 26.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 97' ' ' SER . 53.8 mt -129.16 139.41 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.251 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 69.9 p -112.75 131.56 55.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.176 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.639 ' CE2' HD12 ' A' ' 21' ' ' LEU . 3.2 t80 -151.89 126.82 9.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.918 . . . . 0.0 110.231 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' A' ' 20' ' ' ALA . . . 65.42 36.51 92.72 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.89 11.42 66.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 17' ' ' PHE . 69.2 t -114.36 138.06 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -1.117 . . . . 0.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 43.9 m -112.18 135.67 52.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 110.195 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.649 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 59.2 tp -115.0 144.36 43.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 119' ' ' ILE . 94.1 mt -125.7 94.44 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.433 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 9.9 ttp180 -89.54 132.26 35.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 110.204 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.501 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 45.1 mtm180 -109.9 122.8 48.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' A' ' 6' ' ' TRP . 59.2 m -119.73 152.96 36.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -116.98 155.48 29.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.212 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 5' ' ' THR . 39.5 ttp85 -81.38 135.2 35.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.221 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.806 ' C4 ' ' HO7' ' A' ' 130' ' ' JN3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.707 ' H8 ' HG23 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.225 0.536 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.409 ' O ' HD11 ' A' ' 40' ' ' ILE . 88.6 m-85 -77.27 -33.09 55.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.1 p -56.87 146.26 27.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.299 -0.875 . . . . 0.0 110.172 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.15 -174.06 17.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 89.0 m -107.64 131.11 54.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -1.141 . . . . 0.0 110.241 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.501 ' CE3' ' HG3' ' A' ' 107' ' ' MET . 90.8 m95 -120.15 145.09 47.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -126.47 122.06 34.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.851 . . . . 0.0 110.177 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.5 126.02 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 39.1 p90 -126.81 -29.61 2.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.912 . . . . 0.0 110.19 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.78 129.57 40.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.86 . . . . 0.0 110.269 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.437 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.6 pt20 -143.11 119.61 11.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 110.203 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' O ' HD11 ' A' ' 118' ' ' LEU . 56.6 tt0 -98.66 144.45 27.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 110.247 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.718 ' OD1' ' OE1' ' A' ' 16' ' ' GLU . 1.9 t30 60.25 14.21 4.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.657 ' CZ ' HD12 ' A' ' 18' ' ' LEU . 74.0 t80 -51.59 -52.14 49.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -62.95 -48.5 78.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.718 ' OE1' ' OD1' ' A' ' 13' ' ' ASN . 65.3 mt-10 -55.73 -59.36 4.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.148 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 70.4 t80 -49.2 -55.49 12.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.746 HD23 H191 ' A' ' 130' ' ' JN3 . 12.7 mt -58.15 -42.25 85.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 3.5 tttm -49.14 -41.23 35.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.57 -27.75 66.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.672 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.1 tp -58.75 -20.27 47.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.672 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 79.61 28.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 110.268 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 65.6 mt -74.73 165.86 50.2 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.134 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.547 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 45.6 Cg_endo -73.14 140.13 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.021 1.537 . . . . 0.0 110.382 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.7 -40.87 84.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.61 -26.58 56.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.229 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.73 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 43.3 tp -92.46 -19.41 22.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.736 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 94.0 mt -82.92 -40.93 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 0.0 110.172 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -75.36 -27.56 59.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.174 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 57.9 tpp -86.53 -27.64 23.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.237 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.73 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -103.03 4.92 37.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.736 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 6.3 ptt180 -71.57 2.07 5.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -152.33 48.66 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 110.24 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.079 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.9 mt -123.72 118.46 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.207 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.47 84.56 0.11 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.232 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 1.079 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.05 130.58 15.62 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.986 1.519 . . . . 0.0 110.433 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.481 HG21 ' N ' ' A' ' 38' ' ' VAL . 9.8 mt -84.39 157.86 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.481 ' N ' HG21 ' A' ' 37' ' ' ILE . 75.6 t -137.26 115.77 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -96.27 137.49 35.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.41 ' CD1' ' HE3' ' A' ' 107' ' ' MET . 79.3 mt -123.95 129.72 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.52 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 55.8 tt0 -130.33 67.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 0.0 110.23 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.716 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 9.3 tt0 -62.39 171.37 1.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.143 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.716 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 17.9 mtmt -171.74 38.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.153 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.16 -104.54 0.87 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -108.52 0.64 21.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -1.149 . . . . 0.0 110.222 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.1 t0 -108.89 145.04 36.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.614 ' CE1' ' HG3' ' A' ' 42' ' ' GLN . 7.6 m-85 -127.18 139.43 52.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 110.276 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 59.4 t -120.01 104.61 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.29 122.44 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 110.146 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.419 HG21 ' OG1' ' A' ' 59' ' ' THR . 91.3 m -122.72 106.08 10.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 110.261 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -92.61 134.58 34.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -127.11 119.6 26.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.961 . . . . 0.0 110.289 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.653 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -103.25 169.86 6.92 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.174 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.07 -17.82 24.5 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.093 1.575 . . . . 0.0 110.404 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -104.88 -24.71 12.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.956 . . . . 0.0 110.213 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.653 ' O ' ' OG1' ' A' ' 53' ' ' THR . 3.8 pt20 -163.58 169.08 19.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.186 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.0 p -129.79 127.85 41.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.231 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 73' ' ' MET . 19.4 m -124.96 127.02 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.177 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.419 ' OG1' HG21 ' A' ' 50' ' ' THR . 36.2 m -115.64 147.36 40.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -142.46 149.46 39.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.261 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.3 t -141.81 137.76 31.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.152 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.713 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 52.0 p90 -150.5 169.89 20.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 110.237 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.9 m -117.65 150.57 38.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.196 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.515 ' CD1' ' CE1' ' A' ' 47' ' ' PHE . 17.3 mt -79.53 123.81 27.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 110.212 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.48 9.66 52.56 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -145.72 143.7 29.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -1.131 . . . . 0.0 110.193 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -68.68 127.78 34.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.202 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.571 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.06 147.63 50.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -80.28 134.99 36.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.241 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.767 HD11 ' H62' ' A' ' 131' ' ' JN3 . 23.8 mm -124.26 144.81 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.151 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.1 m -121.78 136.06 54.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.21 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.595 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 66.4 p -87.88 161.14 17.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.679 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 1.5 ttp -73.89 -11.91 60.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.198 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -89.13 -14.04 37.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 110.213 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.67 50.77 0.83 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.595 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 7.7 tttt -128.61 129.65 46.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -1.155 . . . . 0.0 110.146 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -105.79 137.59 43.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.203 -0.936 . . . . 0.0 110.192 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.1 155.08 11.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.232 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -101.45 145.47 28.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.535 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.3 m -153.08 133.78 13.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.307 -0.871 . . . . 0.0 110.156 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -94.97 100.04 11.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.606 HG22 ' CD1' ' A' ' 62' ' ' PHE . 49.4 t -70.36 142.26 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 8.5 p-80 -146.04 151.41 37.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.15 132.03 40.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 110.262 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -140.87 131.49 25.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 97.3 m-20 56.69 17.43 3.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.2 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.548 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 83.8 40.88 8.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.548 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 97.4 mttt -155.57 131.84 10.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -1.121 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.581 HD21 ' H22' ' A' ' 131' ' ' JN3 . 6.7 tt -72.64 130.89 41.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.244 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.555 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 92.8 t -139.25 125.31 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.179 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.535 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 99.5 m -115.65 90.16 3.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -84.59 169.5 14.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.214 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 29.5 t -160.72 -157.58 0.54 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 110.196 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 18.7 tt0 -109.74 32.93 4.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.231 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.711 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -175.74 6.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 1.073 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.3 OUTLIER 171.87 141.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 110.26 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.435 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -114.72 174.75 5.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.723 ' CD2' H122 ' A' ' 131' ' ' JN3 . 47.6 t-80 -156.31 137.84 14.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.148 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 110' ' ' THR . 69.5 tt0 -149.85 126.49 10.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.218 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 47.5 tt0 -125.54 161.16 27.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.923 . . . . 0.0 110.247 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.514 ' OE1' ' HG3' ' A' ' 103' ' ' LYS . 10.9 tm-20 -161.81 148.72 14.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.434 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 10.8 p -116.0 143.18 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 110.223 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.514 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 92.6 mttt -133.26 92.7 3.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.99 -109.81 2.98 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.665 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 24.5 p30 -112.1 11.23 20.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -1.152 . . . . 0.0 110.18 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.665 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 61.5 mt-10 -118.64 155.18 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.501 ' HG3' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -125.1 141.85 51.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.48 121.54 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.13 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 40.8 mt-10 -107.74 119.27 38.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 99' ' ' GLU . 38.0 p -108.48 119.61 40.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 97' ' ' SER . 53.0 mt -130.39 131.73 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.357 -0.84 . . . . 0.0 110.209 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 6.3 t -110.55 141.27 43.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.175 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.681 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 10.7 t80 -161.26 128.34 4.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.15 33.95 74.85 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.9 12.78 75.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 112' ' ' THR . 73.1 t -116.48 139.47 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -1.155 . . . . 0.0 110.191 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 47.3 m -112.92 134.0 54.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.608 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 43.1 tp -114.07 150.55 33.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.0 mt -130.6 94.74 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.444 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 9.4 ttp180 -88.93 131.42 35.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 25.7 mtt-85 -110.41 124.71 52.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.915 . . . . 0.0 110.174 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.1 m -122.07 149.44 43.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -115.38 153.15 31.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.19 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.7 ttp85 -78.19 134.75 37.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.192 -179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.746 H191 HD23 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.767 ' H62' HD11 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.232 0.539 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 49.3 m-85 -78.97 -29.43 43.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.251 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 p -57.65 144.93 35.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.97 -178.7 17.33 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 91.0 m -106.13 134.73 48.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -1.148 . . . . 0.0 110.242 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.462 ' CE2' ' HE3' ' A' ' 107' ' ' MET . 92.9 m95 -121.15 136.33 55.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -118.88 118.15 30.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.201 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.94 126.03 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.238 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.593 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 11.8 p90 -128.5 -19.59 3.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.593 ' HB1' ' CE1' ' A' ' 9' ' ' TYR . . . -141.74 131.6 24.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.207 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -143.06 166.47 24.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.226 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 56.0 tt0 -141.03 146.44 37.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.932 . . . . 0.0 110.21 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 79.4 m-20 56.19 20.72 4.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -53.67 50.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.862 . . . . 0.0 110.215 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -59.36 -57.04 14.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -46.25 -52.93 11.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.581 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 69.6 t80 -52.56 -46.3 66.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.17 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 mt -59.3 -43.05 92.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.893 . . . . 0.0 110.172 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -54.58 -42.08 70.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.4 75.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.616 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 3.9 tp -64.42 -17.41 63.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.17 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.616 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 74.95 28.91 1.04 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.226 -0.922 . . . . 0.0 110.22 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 24' ' ' PRO . 20.2 mt -75.39 165.03 56.98 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.721 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.3 Cg_endo -73.11 139.89 30.3 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.036 1.545 . . . . 0.0 110.473 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.441 ' HG2' ' HG3' ' A' ' 29' ' ' LYS . 41.9 tt0 -58.56 -36.32 73.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.291 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -61.55 -28.89 69.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.893 . . . . 0.0 110.192 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.721 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 33.3 tp -92.11 -29.2 16.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.222 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.661 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 95.8 mt -74.48 -44.29 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 3.5 mmpt? -71.07 -23.96 62.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.207 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.0 ttp -89.68 -29.31 18.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.16 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -100.64 -0.29 37.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.236 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.661 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -65.97 -11.61 48.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.468 ' HB2' ' NE ' ' A' ' 32' ' ' ARG . 6.5 t0 -138.08 45.56 2.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 0.0 110.16 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.002 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 1.7 mt -115.81 122.1 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.895 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.54 82.42 0.12 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.236 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 1.002 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.7 Cg_endo -73.0 136.64 25.22 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.008 1.53 . . . . 0.0 110.451 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.419 HG21 ' N ' ' A' ' 38' ' ' VAL . 11.6 mt -89.24 154.67 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.218 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.419 ' N ' HG21 ' A' ' 37' ' ' ILE . 77.4 t -131.58 111.48 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 73.6 tt0 -94.81 132.47 39.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.77 128.51 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -133.63 74.81 1.57 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 110.181 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.519 ' OE1' ' CZ ' ' A' ' 47' ' ' PHE . 13.0 pt20 -78.41 162.72 26.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 110.208 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 86.3 mttt -156.47 49.12 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 0.0 110.19 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.04 -100.61 0.9 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 39.5 m-20 -110.48 -7.85 14.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -1.221 . . . . 0.0 110.198 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -98.58 152.96 19.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.211 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.519 ' CZ ' ' OE1' ' A' ' 42' ' ' GLN . 1.6 m-85 -136.42 136.42 39.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 110.155 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.01 110.82 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.196 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 4.6 m -113.75 135.32 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.1 m -122.07 98.16 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.91 . . . . 0.0 110.203 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.2 m -78.63 138.54 38.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.198 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -132.83 114.74 14.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.255 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.658 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -99.31 168.33 9.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 47.1 Cg_endo -73.07 -33.85 7.01 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.017 1.535 . . . . 0.0 110.529 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -93.07 -21.87 19.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.221 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.658 ' O ' ' OG1' ' A' ' 53' ' ' THR . 1.6 tt0 -161.4 162.12 30.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.448 ' N ' ' CG ' ' A' ' 56' ' ' GLN . 3.5 p -128.71 130.11 46.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 110.263 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.493 ' CG2' ' HG2' ' A' ' 73' ' ' MET . 87.9 t -129.19 124.28 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.186 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.41 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 14.5 t -109.64 143.08 39.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.285 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 59' ' ' THR . 23.7 m120 -138.72 148.98 44.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 110.211 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.4 t -140.59 134.94 31.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 110.245 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.646 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 27.5 p90 -148.03 166.91 26.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.7 m -115.46 146.38 41.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 0.0 110.185 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.499 HD13 ' CD1' ' A' ' 47' ' ' PHE . 14.5 mt -78.51 122.83 26.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.226 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.1 4.63 41.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -145.51 151.92 38.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -1.159 . . . . 0.0 110.16 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -72.4 131.13 42.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.646 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.11 151.46 49.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 12.9 p-10 -88.01 134.86 33.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.786 HD13 ' H62' ' A' ' 131' ' ' JN3 . 8.3 mm -124.37 143.28 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.88 . . . . 0.0 110.208 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 m -117.76 134.09 55.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.579 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 1.4 p -88.86 158.96 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.73 ' CE ' H122 ' A' ' 130' ' ' JN3 . 72.7 mtm -74.27 -8.11 55.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.246 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.476 ' OD1' ' HB ' ' A' ' 72' ' ' THR . 46.0 p-10 -92.03 -15.47 27.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 74' ' ' ASP . . . 109.14 28.44 4.4 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.579 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 3.9 mttt -108.44 130.94 55.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -1.148 . . . . 0.0 110.201 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -111.2 136.55 50.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 110.187 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.55 161.82 32.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.154 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.19 157.56 18.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.3 p -169.17 140.39 2.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.227 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.0 m -98.14 102.67 14.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.433 HG12 ' CZ ' ' A' ' 62' ' ' PHE . 46.5 t -72.22 140.76 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.252 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.547 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 14.4 p-80 -145.23 153.78 41.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.2 mt -100.99 126.37 47.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 0.0 110.251 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.25 147.3 39.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 53.3 15.25 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.22 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.62 48.83 6.04 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.644 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 7.3 pttt -169.85 135.96 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.324 -1.104 . . . . 0.0 110.229 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.55 HD21 ' H22' ' A' ' 131' ' ' JN3 . 5.5 tt -68.88 144.62 54.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.855 . . . . 0.0 110.238 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.547 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 73.4 t -152.03 114.28 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.315 -0.866 . . . . 0.0 110.215 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.597 HG22 H111 ' A' ' 131' ' ' JN3 . 86.9 m -105.7 98.74 8.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.275 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -94.58 155.14 17.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 17.3 t -145.96 -165.92 2.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.45 ' N ' ' OG ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -100.52 31.88 3.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 110.199 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.5 ptpt -175.38 4.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.203 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.894 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -179.31 145.5 0.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -122.5 159.75 27.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 110.264 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 54.0 t-80 -144.72 141.42 29.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.303 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.677 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 10.1 pt-20 -157.17 125.18 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 110.207 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.551 ' OE1' ' CE ' ' A' ' 107' ' ' MET . 6.1 tt0 -128.36 162.62 26.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.893 . . . . 0.0 110.213 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.475 ' CG ' ' HB2' ' A' ' 88' ' ' LYS . 20.3 mt-10 -153.73 155.93 36.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.81 139.96 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 110.197 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -135.8 98.65 3.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.01 -110.47 3.04 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -115.67 12.17 15.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -1.192 . . . . 0.0 110.16 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -117.71 160.03 22.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.199 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.551 ' CE ' ' OE1' ' A' ' 100' ' ' GLN . 28.1 tpp -132.09 138.02 47.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.56 132.54 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.18 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 34.8 mt-10 -117.71 130.1 56.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.649 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 5.7 m -122.65 124.45 43.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.559 ' CD1' ' H3 ' ' A' ' 130' ' ' JN3 . 87.3 mt -130.78 136.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.248 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.8 p -113.36 127.11 56.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.257 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.492 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 27.3 t80 -149.29 129.79 13.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 110.172 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.41 39.58 97.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.44 6.58 49.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.72 141.94 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -1.127 . . . . 0.0 110.258 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.5 m -118.36 130.18 55.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.865 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.581 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 48.8 tp -108.76 145.92 34.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.922 . . . . 0.0 110.252 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 119' ' ' ILE . 97.1 mt -127.09 114.68 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 32.5 ttp180 -111.49 128.02 55.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.96 . . . . 0.0 110.169 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 67.9 mtt180 -104.72 127.05 52.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 110.173 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 66.3 m -123.51 154.45 39.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.845 . . . . 0.0 110.171 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -118.14 160.7 21.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.162 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 5' ' ' THR . 15.6 ttp180 -88.79 137.69 32.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.208 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.73 H122 ' CE ' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.786 ' H62' HD13 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.244 0.545 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -76.73 -33.83 58.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.223 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 p -57.33 144.87 34.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.94 . . . . 0.0 110.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.73 -173.75 18.7 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.7 m -111.7 129.52 56.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -1.149 . . . . 0.0 110.229 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.481 ' CZ3' ' HG3' ' A' ' 107' ' ' MET . 70.1 m95 -118.01 138.61 52.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -118.31 118.13 30.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.3 t -64.95 126.22 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.546 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 18.0 p90 -127.08 -21.79 3.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.546 ' HB1' ' CE1' ' A' ' 9' ' ' TYR . . . -136.28 131.73 34.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.159 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 26.3 pt20 -146.98 118.27 7.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.204 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 118' ' ' LEU . 56.5 tt0 -94.03 152.89 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.885 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 m120 50.47 27.25 2.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.169 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.561 ' HH ' H111 ' A' ' 130' ' ' JN3 . 10.5 t80 -58.05 -52.2 66.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -64.62 -50.52 66.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 110.188 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 36.7 mm-40 -51.06 -61.49 2.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.178 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.68 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 63.5 t80 -49.22 -52.3 27.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.171 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -44.79 93.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 110.221 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 14.5 mttm -46.7 -38.31 9.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.29 -27.23 63.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.665 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.5 tp -61.87 -23.51 66.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.665 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 79.73 30.5 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.588 HD21 ' HD2' ' A' ' 24' ' ' PRO . 15.1 mt -77.53 166.77 41.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.588 ' HD2' HD21 ' A' ' 23' ' ' LEU . 46.1 Cg_endo -73.08 143.2 35.63 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.04 1.547 . . . . 0.0 110.43 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -65.16 -41.25 94.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.166 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -55.24 -28.14 51.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.397 -0.815 . . . . 0.0 110.175 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.549 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 41.5 tp -89.43 -22.07 22.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 24' ' ' PRO . 92.5 mt -86.99 -40.01 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 50.0 mmtt -72.58 -30.04 64.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 110.241 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.5 ttp -87.77 -24.03 23.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 27' ' ' LEU . . . -101.66 6.58 42.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 110.175 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.684 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 16.6 ptt180 -68.12 4.17 1.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.337 -0.852 . . . . 0.0 110.195 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.684 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.9 m-20 -151.73 50.21 0.81 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.049 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.3 mt -122.48 119.37 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.215 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -91.19 83.25 0.11 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 110.301 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 1.049 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.9 Cg_endo -73.02 136.52 24.97 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.023 1.538 . . . . 0.0 110.475 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.681 HG21 ' N ' ' A' ' 38' ' ' VAL . 55.1 mt -100.45 171.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.185 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.681 ' N ' HG21 ' A' ' 37' ' ' ILE . 11.2 p -147.41 132.9 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.217 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -110.3 111.55 22.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 110.206 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.3 mt -99.93 138.46 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.244 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.541 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 56.7 tt0 -137.76 70.0 1.39 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.154 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.582 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 52.5 tt0 -67.0 159.75 27.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.206 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 53.9 mmtt -156.17 42.76 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.59 -100.59 0.77 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -109.94 -5.62 15.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -1.185 . . . . 0.0 110.261 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.405 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 7.1 t0 -102.12 152.32 21.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.484 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 39.1 m-85 -133.96 140.88 47.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.198 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -126.55 104.9 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.211 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.405 ' CG1' ' H42' ' A' ' 131' ' ' JN3 . 58.6 t -106.75 135.8 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 110.231 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.438 ' OG1' HG21 ' A' ' 59' ' ' THR . 99.8 m -133.81 104.67 6.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 m -87.3 136.91 32.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.858 . . . . 0.0 110.247 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -129.65 123.53 31.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 110.188 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.648 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -107.15 169.03 7.18 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.05 -18.78 23.7 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.06 1.558 . . . . 0.0 110.448 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -103.41 -21.92 13.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.21 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.648 ' O ' ' OG1' ' A' ' 53' ' ' THR . 17.8 pt20 -164.13 165.11 22.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 110.142 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 p -129.41 130.47 46.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.151 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.36 127.88 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.438 HG21 ' OG1' ' A' ' 50' ' ' THR . 91.2 m -112.27 137.76 49.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 59' ' ' THR . 58.0 m-20 -133.51 151.86 51.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 t -147.12 128.75 15.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.724 ' CE1' ' H5 ' ' A' ' 131' ' ' JN3 . 37.1 p90 -141.87 169.19 18.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 110.184 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.6 m -114.78 142.45 46.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.178 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.508 HD12 ' CA ' ' A' ' 83' ' ' HIS . 3.0 tp -76.58 124.95 28.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.99 -2.75 41.05 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.59 149.96 45.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -1.13 . . . . 0.0 110.18 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.46 ' OE2' ' HD2' ' A' ' 79' ' ' LYS . 71.4 tt0 -70.76 123.81 22.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.6 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -122.83 148.0 45.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 110.271 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -80.23 135.01 36.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 110.146 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.78 HD13 ' H62' ' A' ' 131' ' ' JN3 . 17.2 mm -128.22 145.14 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 110.25 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.488 ' O ' HG23 ' A' ' 71' ' ' THR . 5.1 t -119.23 135.43 54.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.27 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.741 HG22 ' HO7' ' A' ' 130' ' ' JN3 . 0.2 OUTLIER -84.15 156.28 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.683 ' HE1' H122 ' A' ' 130' ' ' JN3 . 0.2 OUTLIER -67.95 -17.18 64.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.711 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -83.11 -10.3 58.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.16 28.36 5.86 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.436 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 10.3 mtpt -106.24 133.76 50.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -1.129 . . . . 0.0 110.246 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.03 138.49 44.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -169.48 150.82 4.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.141 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HD2' ' OE2' ' A' ' 67' ' ' GLU . 7.2 mtmm -95.15 155.95 16.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.916 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.28 131.76 5.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.195 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 m -93.37 99.39 11.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.226 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.657 HG11 ' CD2' ' A' ' 89' ' ' LEU . 40.7 t -73.99 143.86 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.662 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 2.9 p-80 -147.36 160.62 42.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 0.0 110.225 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.493 HD11 HD23 ' A' ' 64' ' ' LEU . 3.2 mp -101.06 133.87 44.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 0.0 110.186 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -139.03 115.52 10.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 53.2 t-20 62.79 24.19 14.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.656 ' O ' ' CG ' ' A' ' 88' ' ' LYS . . . 80.76 46.46 7.22 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.656 ' CG ' ' O ' ' A' ' 87' ' ' GLY . 28.7 mtmt -161.87 117.83 2.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -1.149 . . . . 0.0 110.219 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.657 ' CD2' HG11 ' A' ' 82' ' ' VAL . 1.7 tt -61.79 135.84 57.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 110.189 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.662 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 75.6 t -145.42 121.93 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.924 ' CG2' ' HB3' ' A' ' 98' ' ' HIS . 8.8 t -118.86 103.69 9.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.185 -0.947 . . . . 0.0 110.191 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -93.55 154.52 17.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 110.189 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 t -141.67 -158.24 0.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 36.8 mt-10 -109.52 31.82 5.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.22 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -176.88 6.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 110.198 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.835 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 178.28 147.5 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.516 ' O ' HG22 ' A' ' 111' ' ' ILE . 15.9 t -125.24 158.41 34.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 110.243 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.924 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 59.0 t-80 -141.61 146.02 35.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 110' ' ' THR . 24.5 mt-10 -157.68 126.04 5.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.266 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.444 ' HG3' ' CG ' ' A' ' 109' ' ' GLU . 61.1 tt0 -126.17 162.06 26.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.538 ' OE2' ' O ' ' A' ' 102' ' ' VAL . 11.0 tm-20 -160.4 150.91 18.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.538 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 8.4 p -116.72 142.75 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.206 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 50.6 mttt -134.56 91.2 2.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.07 -107.42 2.79 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -115.09 9.64 15.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -1.199 . . . . 0.0 110.243 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -117.97 161.13 20.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 110.19 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.481 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -131.85 140.68 49.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.216 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.5 t -126.92 125.02 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.224 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.444 ' CG ' ' HG3' ' A' ' 100' ' ' GLN . 28.0 mt-10 -110.73 126.99 55.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 99' ' ' GLU . 4.8 t -117.93 119.46 34.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.216 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 97' ' ' SER . 71.6 mt -126.12 132.16 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 31.8 m -109.74 132.93 53.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.593 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 11.8 t80 -156.3 127.39 6.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.929 . . . . 0.0 110.223 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.28 36.54 89.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.34 7.3 60.15 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.473 ' CG1' ' HA ' ' A' ' 17' ' ' PHE . 60.4 t -111.01 141.01 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -1.156 . . . . 0.0 110.223 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 78.5 m -117.48 130.44 56.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.226 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.68 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 54.7 tp -110.38 146.85 35.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.239 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.31 100.25 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.182 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -93.39 119.89 33.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.0 110.207 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 42.3 mtt180 -101.13 125.75 47.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 110.231 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.8 m -123.88 158.1 32.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.184 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -119.93 158.31 26.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 22.3 ttt180 -85.68 136.64 33.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 110.24 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.207 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.741 ' HO7' HG22 ' A' ' 72' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.78 ' H62' HD13 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.282 0.563 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 75.2 m-85 -74.63 -31.03 61.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 110.224 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.8 m -56.89 144.43 33.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.209 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.27 -175.95 18.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.2 p -107.04 131.59 53.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -1.126 . . . . 0.0 110.221 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.453 ' CD1' ' HE1' ' A' ' 107' ' ' MET . 93.2 m95 -119.6 137.02 54.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -119.28 113.7 21.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.239 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.04 135.99 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.165 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 9' ' ' TYR . 10.9 p90 -139.09 -15.82 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.206 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.495 ' HB1' ' CE1' ' A' ' 9' ' ' TYR . . . -138.7 130.97 28.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.43 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 15.7 mt-30 -144.87 160.64 40.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.902 . . . . 0.0 110.202 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.469 ' OE2' ' HB ' ' A' ' 119' ' ' ILE . 12.7 pt-20 -137.77 150.91 47.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.147 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.7 m120 54.35 33.79 19.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.83 -54.32 40.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.228 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -60.78 -53.72 53.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -50.0 -56.05 12.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.451 ' CD2' ' HB2' ' A' ' 118' ' ' LEU . 33.2 t80 -54.05 -47.0 72.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.488 ' N ' HD21 ' A' ' 18' ' ' LEU . 2.3 mm? -60.74 -42.1 96.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.163 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -54.45 -37.52 65.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 110.159 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.91 -33.2 71.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 110.24 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.636 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.5 tp -63.86 -21.19 66.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 0.0 110.252 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.636 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 77.98 31.77 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 110.216 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.625 HD21 ' HD2' ' A' ' 24' ' ' PRO . 14.2 mt -80.13 166.18 42.02 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.183 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.625 ' HD2' HD21 ' A' ' 23' ' ' LEU . 45.8 Cg_endo -73.09 142.35 34.19 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.103 1.581 . . . . 0.0 110.386 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.505 ' CD ' ' HE3' ' A' ' 29' ' ' LYS . 43.2 tt0 -64.79 -33.5 76.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -61.15 -26.88 68.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.457 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 40.0 tp -90.07 -27.81 19.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 110.158 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 28' ' ' ILE . 95.5 mt -76.19 -45.23 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.287 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HE3' ' CD ' ' A' ' 25' ' ' GLU . 21.0 mttt -69.4 -26.82 64.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.4 mtt -85.95 -27.66 24.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.189 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.47 7.38 42.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 110.205 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.579 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 16.0 ptt180 -66.7 -1.28 3.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.202 -0.936 . . . . 0.0 110.195 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.579 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.1 m-20 -148.0 47.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.259 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.943 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 5.1 mt -121.51 115.49 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 110.242 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -92.54 88.76 0.33 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.943 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.9 Cg_endo -73.03 139.26 29.6 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.042 1.548 . . . . 0.0 110.467 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.447 ' C ' HG21 ' A' ' 38' ' ' VAL . 17.2 mt -89.89 162.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.447 HG21 ' C ' ' A' ' 37' ' ' ILE . 79.5 t -139.11 114.05 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 110.217 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -98.12 136.6 38.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 110.168 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.8 mt -124.68 129.29 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.233 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 54.6 tt0 -129.92 75.1 1.63 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 0.0 110.19 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.694 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 2.0 tm0? -72.39 162.06 29.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 43.1 mtmt -160.51 49.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.18 -104.19 1.31 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 64.4 m-20 -109.85 -0.37 18.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -1.148 . . . . 0.0 110.152 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.0 t0 -104.03 146.54 28.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.0 110.194 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.694 ' CE1' ' HG3' ' A' ' 42' ' ' GLN . 4.1 m-85 -128.36 135.42 49.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.4 t -123.7 108.29 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.212 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.435 ' CG1' ' H42' ' A' ' 131' ' ' JN3 . 85.3 t -110.23 128.98 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.8 m -129.13 108.03 10.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -92.04 138.25 31.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.25 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 1.1 pttt -131.85 126.09 33.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 110.166 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.662 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.89 170.41 5.46 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.926 . . . . 0.0 110.184 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.476 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.5 Cg_endo -73.03 -20.03 22.35 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.039 1.547 . . . . 0.0 110.497 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -105.04 -22.03 13.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 0.0 110.218 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' OE1' ' O25' ' A' ' 130' ' ' JN3 . 7.7 pt20 -161.83 159.6 27.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.4 p -130.51 131.0 44.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 110.239 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.2 t -128.53 129.36 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.223 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.4 t -111.19 137.49 48.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.257 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' HB3' ' CD1' ' A' ' 70' ' ' ILE . 63.0 m-20 -132.3 149.62 52.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 110.161 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 t -144.67 128.97 17.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.898 . . . . 0.0 110.186 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.774 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 39.6 p90 -142.81 170.44 15.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -119.01 153.41 34.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.222 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.606 HD13 ' CD1' ' A' ' 47' ' ' PHE . 22.2 mt -81.4 125.34 30.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.22 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.28 12.39 54.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -146.7 139.26 25.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.147 . . . . 0.0 110.218 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -66.04 127.22 31.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -127.94 149.06 50.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.57 138.53 33.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.177 -0.952 . . . . 0.0 110.254 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.765 HD13 ' H62' ' A' ' 131' ' ' JN3 . 5.0 mm -130.57 144.43 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 71' ' ' THR . 4.1 t -118.22 135.01 54.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.656 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 34.7 p -87.1 160.38 18.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.189 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.653 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 11.9 ttm -72.22 -11.53 60.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.942 ' HB3' H151 ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -89.51 -13.36 37.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.155 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.0 51.11 0.96 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.656 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 11.0 mttt -128.53 133.11 48.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -1.126 . . . . 0.0 110.169 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -110.0 135.87 50.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -164.02 159.71 20.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.224 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -105.86 155.32 19.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.197 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.1 p -164.13 136.62 4.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.23 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.4 m -95.29 97.67 10.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 110.225 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.492 HG11 HD23 ' A' ' 89' ' ' LEU . 47.6 t -69.23 142.18 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 110.248 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.62 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 9.6 p-80 -147.54 150.09 33.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.5 mt -96.06 129.89 43.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.204 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.54 144.12 31.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 110.141 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.36 11.55 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.59 45.39 6.11 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 11.5 pttt -170.76 132.28 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -1.124 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.876 ' O ' HG21 ' A' ' 90' ' ' VAL . 3.6 tt -61.16 149.19 38.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.876 HG21 ' O ' ' A' ' 89' ' ' LEU . 87.3 t -155.51 109.3 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.608 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 87.2 m -103.01 103.78 13.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.183 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -99.4 157.47 16.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.224 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 14.3 t -151.21 -171.13 3.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.202 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 54.3 tt0 -98.14 30.73 2.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.188 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.522 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 1.6 pttt -169.8 -2.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 0.0 110.205 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.854 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -176.31 147.49 0.7 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.92 . . . . 0.0 110.212 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.8 159.05 28.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.847 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.608 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 64.6 t-80 -143.17 137.08 28.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.437 ' HG3' ' CG2' ' A' ' 90' ' ' VAL . 44.8 tt0 -151.19 126.91 10.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.163 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.569 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 9.1 tt0 -133.76 154.79 50.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 110.111 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.454 ' HA ' ' CE1' ' A' ' 2' ' ' PHE . 58.8 tt0 -149.37 159.86 43.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 110.269 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.41 138.06 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -0.897 . . . . 0.0 110.173 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -133.84 93.97 3.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.277 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.67 -106.75 2.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -118.78 12.61 13.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -1.135 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.04 155.27 31.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.159 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.453 ' HE1' ' CD1' ' A' ' 6' ' ' TRP . 25.8 tpp -128.41 140.31 51.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.1 t -125.97 126.69 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.183 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.569 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 29.5 mt-10 -114.58 136.13 53.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 p -124.73 123.93 41.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.233 -0.917 . . . . 0.0 110.22 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 72.7 mt -130.88 129.82 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 112' ' ' THR . 5.0 t -113.41 131.87 55.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 6.3 t80 -154.19 125.12 7.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.256 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.29 33.38 61.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.25 3.73 66.42 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 112' ' ' THR . 62.9 t -109.69 139.56 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -1.157 . . . . 0.0 110.199 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 55.3 m -113.98 135.22 54.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.224 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.451 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 41.6 tp -113.95 139.13 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.172 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.469 ' HB ' ' OE2' ' A' ' 12' ' ' GLU . 96.8 mt -120.43 110.45 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -105.96 120.94 43.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.94 . . . . 0.0 110.186 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 52.4 mtt180 -102.17 127.05 49.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 0.0 110.19 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.9 m -122.81 163.41 20.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.207 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -128.15 158.56 37.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.902 . . . . 0.0 110.19 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -85.11 136.56 33.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.177 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.942 H151 ' HB3' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.774 ' H5 ' ' CE2' ' A' ' 62' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.491 ' HB3' HG13 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.26 0.552 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.04 -33.74 59.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.208 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.3 p -56.81 145.71 28.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.44 -177.02 17.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.3 p -105.75 134.24 49.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -1.182 . . . . 0.0 110.18 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.467 ' CE2' ' HE3' ' A' ' 107' ' ' MET . 95.3 m95 -121.27 142.62 49.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -124.07 118.2 26.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.209 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.2 t -65.8 126.78 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 110.167 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.521 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 22.6 p90 -128.16 -23.07 3.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.718 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -135.13 133.61 39.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 110.223 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.718 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 2.0 mp0 -146.7 112.24 5.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.892 . . . . 0.0 110.216 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.447 ' HG2' ' ND2' ' A' ' 13' ' ' ASN . 56.1 tt0 -89.65 147.32 23.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.447 ' ND2' ' HG2' ' A' ' 12' ' ' GLU . 75.6 m-20 55.02 24.07 5.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.504 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 27.5 t80 -56.57 -52.43 64.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 110.208 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -63.54 -48.61 76.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.23 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 66.8 mt-10 -53.79 -62.23 1.79 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 110.222 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.693 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 38.2 t80 -48.29 -57.83 5.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.504 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -57.12 -46.66 82.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 110.183 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -42.79 -41.86 3.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.192 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.19 -28.25 66.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.633 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -58.13 -20.13 38.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.219 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.633 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 77.94 31.37 0.42 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.549 HD21 ' HD2' ' A' ' 24' ' ' PRO . 15.5 mt -77.03 165.99 48.1 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.188 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.591 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.08 140.59 31.46 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.969 1.51 . . . . 0.0 110.409 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.404 ' HG2' ' HE2' ' A' ' 29' ' ' LYS . 42.4 tt0 -61.52 -39.48 91.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.29 -26.54 63.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.309 -0.87 . . . . 0.0 110.191 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 14.8 tp -90.42 -23.26 21.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.586 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 95.2 mt -81.09 -43.18 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.978 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HE2' ' HG2' ' A' ' 25' ' ' GLU . 37.3 mtmt -72.52 -24.41 61.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 37.4 mtt -87.9 -32.91 18.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.99 5.44 48.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.187 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.632 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 31.3 ptt85 -65.53 -1.11 2.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.632 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.6 m-20 -149.91 47.57 0.93 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.91 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.9 mt -118.7 121.03 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -95.8 83.02 0.22 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.337 -0.852 . . . . 0.0 110.234 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.91 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.5 Cg_endo -73.05 137.49 26.55 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.031 1.543 . . . . 0.0 110.47 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.5 mt -90.01 157.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.155 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.3 t -134.93 112.72 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -94.05 138.24 32.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.234 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.43 HD11 ' CD1' ' A' ' 6' ' ' TRP . 71.3 mt -126.73 127.78 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.214 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -133.03 75.27 1.61 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.246 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.547 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 6.7 pt20 -78.57 163.53 25.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.218 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 31.0 mmtp -154.79 49.93 0.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.75 -99.21 0.8 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -110.05 -9.11 14.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.271 -1.135 . . . . 0.0 110.216 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 34.4 t0 -98.0 157.23 16.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 110.196 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.591 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 2.1 m-85 -139.89 133.55 30.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.232 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.9 t -114.24 100.75 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 110.242 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.553 HG11 ' O ' ' A' ' 49' ' ' VAL . 4.2 p -100.85 135.49 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.187 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.461 ' CG2' HG21 ' A' ' 59' ' ' THR . 36.0 m -138.59 105.56 5.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.4 m -88.4 138.2 31.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.244 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -130.35 119.16 22.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 110.282 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.563 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -106.89 167.44 9.48 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 110.223 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD2' HG23 ' A' ' 53' ' ' THR . 46.8 Cg_endo -73.07 -20.68 21.47 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.057 1.556 . . . . 0.0 110.472 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -102.93 -20.6 14.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.524 ' O ' ' OG1' ' A' ' 53' ' ' THR . 5.0 pt20 -166.31 159.17 14.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.907 . . . . 0.0 110.191 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.3 p -129.05 131.29 47.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.224 -0.922 . . . . 0.0 110.205 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.26 128.26 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 110.19 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.461 HG21 ' CG2' ' A' ' 50' ' ' THR . 46.2 m -110.59 136.83 49.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 110.19 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 49' ' ' VAL . 81.6 m-20 -135.02 153.91 51.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.245 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.2 t -143.17 128.17 18.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.221 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.587 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 52.4 p90 -139.7 168.59 19.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.162 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.5 m -120.07 142.48 48.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.513 HD13 ' CD1' ' A' ' 47' ' ' PHE . 15.5 mt -74.21 126.03 29.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 110.258 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.89 58.23 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -137.47 142.23 41.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.263 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.459 ' HA ' HG23 ' A' ' 81' ' ' THR . 75.3 tt0 -68.01 126.25 28.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.436 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -127.28 150.1 49.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 0.0 110.237 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -81.57 136.56 35.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 110.227 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.798 ' CD1' ' H62' ' A' ' 131' ' ' JN3 . 3.8 mm -129.43 144.77 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -116.77 134.42 54.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.253 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.458 HG22 ' HO7' ' A' ' 130' ' ' JN3 . 0.3 OUTLIER -86.02 155.06 21.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.883 . . . . 0.0 110.128 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.787 ' SD ' H212 ' A' ' 130' ' ' JN3 . 16.4 ttm -67.13 -14.94 63.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.215 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.645 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -86.47 -13.07 47.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.54 29.72 4.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -104.99 135.39 46.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -1.156 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -112.02 132.59 54.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.227 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.14 162.95 31.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -107.86 158.69 17.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.194 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.483 ' HB2' ' CG2' ' A' ' 91' ' ' THR . 25.3 p -165.4 147.26 7.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.204 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.459 HG23 ' HA ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER -109.45 87.85 2.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.223 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.561 HG12 HD12 ' A' ' 89' ' ' LEU . 16.1 t -53.3 154.96 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 110.18 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.415 ' O ' HG21 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -152.17 147.46 26.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 0.0 110.224 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.9 mt -100.91 99.07 9.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 87' ' ' GLY . . . -114.37 152.59 31.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.178 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.472 ' HB3' ' CD ' ' A' ' 88' ' ' LYS . 3.3 t30 46.5 17.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 110.149 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 85' ' ' ALA . . . 77.97 48.96 7.31 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.746 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -167.21 127.69 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -1.159 . . . . 0.0 110.252 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.784 ' O ' HG11 ' A' ' 90' ' ' VAL . 4.2 tt -59.22 147.67 34.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 110.179 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.784 HG11 ' O ' ' A' ' 89' ' ' LEU . 22.2 m -154.67 109.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 97.5 m -103.55 100.11 9.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -98.11 161.0 13.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.463 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -152.33 -165.36 2.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 110.186 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.635 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 49.2 tt0 -101.16 31.29 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' CE2' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -173.3 4.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.933 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.67 141.69 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.303 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 111' ' ' ILE . 69.3 m -117.52 160.52 21.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.541 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.9 t-80 -144.12 140.66 29.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 110' ' ' THR . 14.0 tt0 -155.17 123.59 5.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.231 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 12.0 tt0 -129.04 157.17 42.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -153.84 154.67 34.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.209 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.491 HG13 ' HB3' ' A' ' 1' ' ' ALA . 10.0 p -116.43 141.52 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -136.61 90.69 2.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.24 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.8 -105.59 2.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -119.19 11.42 12.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -1.145 . . . . 0.0 110.169 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -117.52 154.31 31.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.229 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.467 ' HE3' ' CE2' ' A' ' 6' ' ' TRP . 26.8 tpp -125.38 138.57 54.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 110.293 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.2 t -126.4 124.73 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.33 -0.857 . . . . 0.0 110.228 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 33.2 mt-10 -112.32 121.61 45.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 99' ' ' GLU . 85.4 m -110.19 119.09 38.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.231 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 97' ' ' SER . 68.1 mt -126.52 129.72 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 74.7 m -109.31 138.06 46.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.547 ' CE2' ' O ' ' A' ' 95' ' ' LYS . 21.1 t80 -160.81 127.65 4.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 110.196 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.23 34.45 75.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.75 8.55 68.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.3 t -112.4 141.42 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -1.168 . . . . 0.0 110.207 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.9 m -116.9 130.94 57.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 110.259 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.693 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 41.8 tp -110.34 152.68 25.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 119' ' ' ILE . 97.5 mt -131.37 94.6 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -88.57 126.53 35.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.221 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.488 ' HB3' ' OH ' ' A' ' 9' ' ' TYR . 27.6 mtt180 -106.23 125.78 51.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 56.5 m -123.49 153.42 40.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.919 . . . . 0.0 110.218 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -119.81 159.01 25.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.87 . . . . 0.0 110.204 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -86.0 135.28 33.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.255 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.787 H212 ' SD ' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.798 ' H62' ' CD1' ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.793 ' O ' ' HB2' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.264 0.554 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.793 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 29.7 m-85 68.93 -59.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 110.266 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 1' ' ' ALA . 2.9 p -51.91 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.36 -162.69 33.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 p -114.2 128.07 56.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -1.145 . . . . 0.0 110.22 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.495 ' NE1' ' HE2' ' A' ' 107' ' ' MET . 92.0 m95 -117.11 137.82 52.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.254 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.37 123.19 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 110.257 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.52 133.03 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 34.2 p90 -133.75 -27.62 1.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.5 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -130.94 137.13 49.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.563 ' O ' ' HG2' ' A' ' 11' ' ' GLN . 3.7 pm0 -152.18 140.96 20.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.209 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.409 ' O ' HD13 ' A' ' 118' ' ' LEU . 30.9 tt0 -115.28 151.26 34.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 50.57 25.38 1.98 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -55.22 -47.13 75.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -0.92 . . . . 0.0 110.241 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.12 -51.82 54.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -49.03 -61.64 1.96 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.169 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.586 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 52.2 t80 -50.32 -44.94 54.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.142 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.632 HD22 H191 ' A' ' 130' ' ' JN3 . 49.5 mt -61.14 -46.72 89.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.245 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -50.98 -36.53 39.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.262 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.38 -32.21 72.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.608 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -61.14 -21.01 63.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.608 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 75.62 37.82 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.248 -0.907 . . . . 0.0 110.172 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.772 HD21 ' HD2' ' A' ' 24' ' ' PRO . 3.7 mt -79.19 165.32 49.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.772 ' HD2' HD21 ' A' ' 23' ' ' LEU . 46.2 Cg_endo -73.04 136.37 24.68 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.989 1.521 . . . . 0.0 110.508 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -54.09 -30.78 49.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.53 -41.55 96.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.902 . . . . 0.0 110.271 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.498 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 63.4 tp -80.09 -45.83 17.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.247 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 23' ' ' LEU . 72.8 mt -53.48 -54.1 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 110.215 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 6.6 mmtp -59.35 -29.73 67.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.733 ' O ' HD13 ' A' ' 34' ' ' ILE . 65.1 mtt -86.08 -20.53 28.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 0.0 110.168 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.67 4.56 35.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.245 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.747 ' HG3' ' OD2' ' A' ' 33' ' ' ASP . 20.3 ptt180 -75.21 -0.4 19.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.227 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.747 ' OD2' ' HG3' ' A' ' 32' ' ' ARG . 62.6 m-20 -152.36 42.03 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.932 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 27.5 mt -121.36 115.46 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.219 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -92.25 88.83 0.32 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.208 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.932 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.4 Cg_endo -73.12 138.6 28.25 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.026 1.54 . . . . 0.0 110.399 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.467 HG21 ' N ' ' A' ' 38' ' ' VAL . 21.6 mt -89.62 157.35 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.254 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.467 ' N ' HG21 ' A' ' 37' ' ' ILE . 89.4 t -136.84 119.09 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -100.64 134.5 43.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 110.185 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.435 HD11 ' CD1' ' A' ' 6' ' ' TRP . 83.0 mt -121.9 129.48 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -131.89 74.9 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.813 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 4.0 tt0 -73.87 164.45 26.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.6 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 47.3 mttt -156.97 42.29 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 110.221 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.8 -97.69 0.62 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -112.88 -0.24 14.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -1.185 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -104.84 147.95 27.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.967 . . . . 0.0 110.243 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.813 ' CE1' ' HB2' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -128.57 133.95 48.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 110.224 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.5 t -122.37 107.73 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.248 -0.908 . . . . 0.0 110.191 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.52 ' CG1' ' H42' ' A' ' 131' ' ' JN3 . 82.3 t -110.18 133.99 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.2 m -132.69 107.46 8.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 0.0 110.203 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -92.0 137.45 32.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 110.234 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 1.6 pttm -131.5 127.83 38.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.989 HG21 H212 ' A' ' 130' ' ' JN3 . 0.1 OUTLIER -111.49 170.23 5.49 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 110.186 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.99 -16.54 25.64 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.054 1.555 . . . . 0.0 110.487 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.0 mtp-105 -106.32 -19.33 13.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.898 . . . . 0.0 110.191 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.617 ' O ' ' OG1' ' A' ' 53' ' ' THR . 19.5 pt20 -167.44 161.25 13.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 110.232 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.9 p -130.03 133.8 46.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.3 t -131.3 130.18 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.937 . . . . 0.0 110.176 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 t -112.04 134.8 53.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 110.143 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -129.69 151.91 49.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -0.88 . . . . 0.0 110.173 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -147.04 127.39 13.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.721 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 38.2 p90 -141.4 172.93 12.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 110.218 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.5 m -118.68 148.71 42.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.202 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.719 ' CD1' ' CD2' ' A' ' 47' ' ' PHE . 9.9 mt -79.57 123.34 27.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.269 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.93 5.41 47.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -143.94 145.3 32.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -1.139 . . . . 0.0 110.164 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.21 127.19 31.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.626 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -125.42 148.18 48.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -83.86 136.2 34.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.922 . . . . 0.0 110.224 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.78 ' CD1' ' H62' ' A' ' 131' ' ' JN3 . 6.0 mm -127.85 145.96 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.172 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 71' ' ' THR . 4.4 t -119.84 133.46 55.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.626 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -83.28 155.8 23.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.676 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -69.05 -17.04 63.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 110.228 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.495 ' HB2' H151 ' A' ' 130' ' ' JN3 . 8.1 t0 -84.89 -12.24 53.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.34 30.58 4.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.626 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 23.5 mttt -107.28 131.98 53.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -1.136 . . . . 0.0 110.15 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -111.69 138.19 48.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.218 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -167.65 159.37 11.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 57.3 mttt -103.75 167.5 9.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 110.202 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 27.0 p -178.22 137.36 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 110.245 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.9 m -93.93 104.9 16.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.31 -0.869 . . . . 0.0 110.213 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.431 HG11 HD23 ' A' ' 89' ' ' LEU . 55.3 t -75.78 140.28 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.257 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.563 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 9.0 p-80 -144.11 155.25 43.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tp -100.14 134.41 43.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.188 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.92 117.55 14.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 10.0 t-20 61.55 30.23 18.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.401 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 75.94 40.99 29.01 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.401 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 83.5 mttt -152.96 125.0 7.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 110.181 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.556 HD21 ' H22' ' A' ' 131' ' ' JN3 . 7.8 tt -71.44 134.47 46.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.197 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.563 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 77.2 t -140.64 120.26 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 110.286 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 53.6 m -113.24 92.4 3.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.211 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -86.22 160.6 19.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.443 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -152.96 -169.77 3.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.145 -0.972 . . . . 0.0 110.211 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.586 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -99.29 36.93 1.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.19 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 94' ' ' GLU . 0.9 OUTLIER -179.15 -1.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.823 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -175.11 147.3 0.91 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.242 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.487 ' O ' HG22 ' A' ' 111' ' ' ILE . 39.1 m -124.53 152.49 43.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.472 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 62.3 t-80 -137.47 142.91 41.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 110.261 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 110' ' ' THR . 47.5 mt-10 -153.24 128.65 9.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 12.5 tt0 -132.51 152.7 51.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.131 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.57 155.38 39.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 110.259 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.422 HG21 ' CH2' ' A' ' 6' ' ' TRP . 12.9 p -119.71 135.49 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -128.6 96.07 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 110.177 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.94 -101.67 1.72 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -120.67 10.78 11.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -1.142 . . . . 0.0 110.177 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -119.6 158.34 26.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.225 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.495 ' HE2' ' NE1' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -129.27 140.39 51.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 110.165 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.4 t -123.35 123.16 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 29.5 mt-10 -109.48 121.07 44.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 99' ' ' GLU . 20.8 m -111.95 117.02 31.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 97' ' ' SER . 67.6 mt -123.31 128.21 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 45.6 m -107.99 135.59 49.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.508 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 13.8 t80 -158.39 127.36 5.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.89 37.48 93.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.99 8.22 60.87 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 17' ' ' PHE . 60.5 t -111.03 139.08 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -1.116 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 62.0 m -117.78 132.09 56.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.586 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 67.5 tp -110.9 149.14 31.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.3 mt -128.33 98.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.426 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 16.3 mtm180 -96.11 128.52 43.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 25.3 mtt180 -104.31 128.26 52.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.4 m -124.09 155.99 37.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.202 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -119.41 151.01 39.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 110.203 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 45.4 ttt180 -75.71 138.31 41.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.188 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.468 ' CG2' ' OXT' ' A' ' 125' ' ' VAL . 9.3 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.268 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.989 H212 HG21 ' A' ' 53' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.78 ' H62' ' CD1' ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.229 0.538 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -78.4 -32.24 48.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 110.18 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 76.6 p -56.64 145.32 28.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.27 -174.06 18.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.1 m -109.85 130.25 55.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -1.136 . . . . 0.0 110.218 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.469 ' CE2' ' HE1' ' A' ' 107' ' ' MET . 90.5 m95 -118.61 145.66 45.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.853 . . . . 0.0 110.25 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -127.97 118.94 24.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.181 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.486 HG12 ' OE1' ' A' ' 11' ' ' GLN . 48.9 t -64.35 136.35 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.945 . . . . 0.0 110.23 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.534 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 11.1 p90 -137.61 -19.14 1.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 110.224 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.697 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -137.22 134.28 36.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -0.925 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.697 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 5.1 mt-30 -149.0 162.76 39.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 110.158 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' O ' HD11 ' A' ' 118' ' ' LEU . 59.4 tt0 -134.12 144.85 48.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.415 ' ND2' ' OE1' ' A' ' 16' ' ' GLU . 4.3 t30 54.98 35.7 25.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.266 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -65.08 -49.23 70.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 0.0 110.199 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -60.88 -48.08 83.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.166 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 55.2 mt-10 -55.32 -46.2 76.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.566 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 43.5 t80 -52.86 -60.31 3.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.887 . . . . 0.0 110.271 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -50.83 -39.94 54.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.199 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -58.77 -36.81 74.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.245 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.18 -38.2 60.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.755 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.9 tp -56.57 -25.24 51.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.925 . . . . 0.0 110.19 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.755 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 84.99 18.1 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.555 HD21 ' HD2' ' A' ' 24' ' ' PRO . 15.3 mt -66.1 166.86 14.11 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.555 ' HD2' HD21 ' A' ' 23' ' ' LEU . 47.2 Cg_endo -73.04 133.31 19.52 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.019 1.536 . . . . 0.0 110.446 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.484 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . 61.1 mm-40 -51.23 -46.41 62.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.197 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.09 -37.27 20.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.499 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 35.3 tp -80.1 -37.36 33.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.898 . . . . 0.0 110.288 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.541 ' HA ' HD11 ' A' ' 18' ' ' LEU . 45.6 mt -58.82 -54.75 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -56.9 -24.45 52.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.73 ' O ' HD13 ' A' ' 34' ' ' ILE . 56.6 mtt -93.62 -18.39 22.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.233 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.45 -10.59 16.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.224 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -1.71 3.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -150.83 47.03 0.86 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.152 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 13.1 mt -125.0 109.0 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -84.1 88.13 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 1.152 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.2 Cg_endo -73.11 138.42 27.98 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.04 1.548 . . . . 0.0 110.45 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.1 mt -89.78 164.56 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 110.178 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.9 t -141.79 119.98 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 110.287 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -101.83 135.91 42.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.205 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.468 ' CD1' ' HE2' ' A' ' 107' ' ' MET . 75.5 mt -121.32 129.78 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.15 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.598 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 43.7 tt0 -132.33 66.51 1.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.943 . . . . 0.0 110.228 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.913 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 37.6 tt0 -71.47 162.26 29.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.572 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 18.5 pttm -159.11 48.01 0.32 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.296 -0.878 . . . . 0.0 110.175 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.4 -103.16 0.78 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 60.2 m-20 -111.52 0.57 16.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -1.132 . . . . 0.0 110.167 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.41 ' OD1' ' CG2' ' A' ' 63' ' ' THR . 43.6 m-20 -104.18 150.35 24.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 110.267 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.913 ' CE1' ' HB2' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -130.88 135.46 47.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.42 105.75 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 110.219 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.438 ' CG1' ' H42' ' A' ' 131' ' ' JN3 . 62.6 t -109.07 135.18 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.257 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.47 ' OG1' HG23 ' A' ' 59' ' ' THR . 98.3 m -132.17 108.49 9.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.902 . . . . 0.0 110.163 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -90.1 132.77 35.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.9 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -127.94 122.72 33.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.264 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.79 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -106.16 170.19 6.08 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.178 -0.951 . . . . 0.0 110.225 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.12 -17.73 24.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.066 1.561 . . . . 0.0 110.382 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -104.11 -22.69 13.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 0.0 110.176 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.614 ' O ' ' OG1' ' A' ' 53' ' ' THR . 14.7 pt20 -162.82 164.69 26.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.7 p -130.29 130.41 44.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.915 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.448 ' CG2' ' HG3' ' A' ' 73' ' ' MET . 61.6 t -128.86 126.27 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.534 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 85.6 m -108.83 141.18 41.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.233 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.534 ' OD1' ' O ' ' A' ' 59' ' ' THR . 73.2 m-20 -137.11 151.61 49.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.4 m -146.58 132.07 18.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.67 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 41.2 p90 -145.24 170.13 16.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.918 . . . . 0.0 110.185 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.41 ' CG2' ' OD1' ' A' ' 46' ' ' ASP . 86.5 m -116.26 148.53 40.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.703 ' CD1' ' CD2' ' A' ' 47' ' ' PHE . 10.4 mt -80.17 124.25 28.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.72 6.67 49.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -145.82 148.76 33.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -1.082 . . . . 0.0 110.217 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -71.68 125.2 26.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.204 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.581 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -122.24 150.43 42.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 110.221 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -84.53 133.16 34.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 110.102 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.716 ' CD1' ' H62' ' A' ' 131' ' ' JN3 . 5.1 mm -126.38 146.71 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.221 -0.924 . . . . 0.0 110.175 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -121.44 135.03 55.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 110.232 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.727 ' CG2' ' HO7' ' A' ' 130' ' ' JN3 . 0.2 OUTLIER -84.81 154.77 22.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.865 ' HE3' H122 ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -67.63 -15.04 63.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.223 -0.923 . . . . 0.0 110.176 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.448 ' HB3' H151 ' A' ' 130' ' ' JN3 . 3.0 p30 -85.52 -10.37 56.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.938 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.2 31.97 4.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.509 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 26.4 mttt -108.77 132.63 53.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.13 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -108.38 136.69 47.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.872 . . . . 0.0 110.203 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -165.49 156.94 14.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -105.56 165.12 11.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 0.0 110.224 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -175.15 137.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.293 -0.88 . . . . 0.0 110.178 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 m -95.52 99.89 11.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -0.894 . . . . 0.0 110.195 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.585 HG12 HD13 ' A' ' 89' ' ' LEU . 53.1 t -72.99 141.24 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 5.3 p-80 -146.55 160.33 42.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.77 130.83 48.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 110.212 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.438 ' O ' ' HE2' ' A' ' 88' ' ' LYS . . . -137.46 133.37 34.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.1 t30 57.63 13.44 1.94 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.04 53.54 2.81 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.807 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 3.6 pttt -174.74 125.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -1.182 . . . . 0.0 110.214 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.585 HD13 HG12 ' A' ' 82' ' ' VAL . 4.1 tt -57.31 147.46 25.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.18 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.58 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 78.9 t -157.57 109.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.952 ' CG2' ' HB3' ' A' ' 98' ' ' HIS . 10.0 t -106.39 107.93 19.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 110.21 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -97.53 151.99 19.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.146 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 1.4 m -144.86 -174.1 4.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 110.162 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 61.1 tt0 -99.0 38.49 1.38 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 94' ' ' GLU . 2.6 pttt 179.22 2.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.206 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.825 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.82 143.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 0.0 110.197 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -125.06 157.31 36.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.952 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 46.5 t-80 -144.79 143.16 30.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.203 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.477 ' HG3' HG21 ' A' ' 90' ' ' VAL . 17.1 tt0 -153.9 125.05 7.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 42.6 tt0 -125.83 158.93 33.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.895 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -156.68 156.94 34.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 110.148 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.413 HG21 ' CH2' ' A' ' 6' ' ' TRP . 10.0 p -120.84 140.35 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -132.82 89.14 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.1 -104.67 2.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.595 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 44.2 p-10 -117.79 7.39 12.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -1.123 . . . . 0.0 110.274 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.595 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 43.4 mt-10 -115.16 167.75 10.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.247 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.469 ' HE1' ' CE2' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -138.98 139.88 38.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 110.226 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.1 t -125.78 129.36 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 24.0 mt-10 -116.67 135.61 53.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.6 m -124.79 120.93 33.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.203 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 97' ' ' SER . 81.4 mt -126.76 135.88 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.246 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.5 p -117.5 125.06 50.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.255 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.509 ' HD2' ' CB ' ' A' ' 96' ' ' PHE . 56.0 t80 -148.11 128.06 13.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -0.877 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.3 35.92 88.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.12 6.0 59.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.9 t -111.08 135.65 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -1.132 . . . . 0.0 110.199 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.4 m -113.37 135.89 53.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 18.9 tp -115.03 141.29 48.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.55 108.63 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -104.92 124.54 49.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.16 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 9.4 mtm180 -103.72 124.96 49.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 56.9 m -119.57 161.39 20.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.277 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -127.76 155.81 43.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 110.249 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -80.27 134.68 36.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.9 . . . . 0.0 110.217 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.204 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.865 H122 ' HE3' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.716 ' H62' ' CD1' ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.235 0.54 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.429 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 87.6 m-85 -76.92 -31.31 56.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 110.185 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.4 p -54.99 143.34 26.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.915 . . . . 0.0 110.149 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.05 -173.61 17.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.7 m -107.94 131.71 54.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -1.191 . . . . 0.0 110.23 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.51 ' CD2' ' HG3' ' A' ' 107' ' ' MET . 89.9 m95 -119.72 134.82 55.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 110.223 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -117.45 118.79 33.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.915 . . . . 0.0 110.171 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.75 128.42 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.0 110.226 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 46.6 p90 -126.38 -24.19 3.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' C ' ' HG3' ' A' ' 11' ' ' GLN . . . -136.43 132.03 34.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.429 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 29.9 mt-30 -141.37 120.81 13.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 52.3 tt0 -98.96 144.33 28.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.222 -0.924 . . . . 0.0 110.19 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.478 HD21 ' CD ' ' A' ' 16' ' ' GLU . 6.9 m120 56.59 18.35 3.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.224 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -55.04 -44.46 74.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.853 . . . . 0.0 110.239 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -67.87 -45.08 75.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.478 ' CD ' HD21 ' A' ' 13' ' ' ASN . 44.0 mt-10 -57.47 -59.95 4.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.622 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 51.4 t80 -51.14 -56.54 12.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.197 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 18' ' ' LEU . 4.0 mm? -54.73 -42.82 72.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -54.7 -37.32 65.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -30.6 70.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.694 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -57.56 -20.83 34.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.208 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.694 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 82.1 28.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.267 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 65.2 mt -73.48 167.4 35.12 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.94 . . . . 0.0 110.24 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.57 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 46.1 Cg_endo -73.02 136.05 24.17 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.416 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -52.11 -44.93 64.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.183 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.82 -27.07 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.18 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.598 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 23.2 tp -88.54 -21.7 23.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.868 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 82.9 mt -78.6 -41.76 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -74.72 -21.53 59.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 110.225 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.6 mtt -90.54 -30.62 17.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.179 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -104.52 4.24 32.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 110.197 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.868 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.89 -6.71 23.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.217 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -147.36 49.78 1.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 0.0 110.22 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.04 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.5 mt -123.9 117.72 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 2.1 mptt -90.0 86.72 0.19 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 1.04 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.05 133.44 19.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.95 1.5 . . . . 0.0 110.432 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.448 HG21 ' N ' ' A' ' 38' ' ' VAL . 12.8 mt -86.2 158.45 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.448 ' N ' HG21 ' A' ' 37' ' ' ILE . 80.5 t -137.74 118.94 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.245 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -98.84 133.45 43.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.181 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.551 ' CD1' ' HE3' ' A' ' 107' ' ' MET . 67.5 mt -118.53 133.04 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.173 -0.954 . . . . 0.0 110.145 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -138.09 68.01 1.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.875 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.566 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 15.8 pt20 -71.69 167.7 19.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.213 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 43.0 mttt -160.43 47.26 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.197 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.74 -98.74 0.72 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 23.1 m-20 -111.5 -6.79 14.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 110.206 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.44 155.52 17.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.239 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.634 ' CD1' HD13 ' A' ' 64' ' ' LEU . 2.3 m-85 -138.98 135.98 34.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.39 109.71 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.544 HG12 ' HO3' ' A' ' 131' ' ' JN3 . 76.6 t -111.1 134.05 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.905 . . . . 0.0 110.164 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.5 m -129.39 106.94 9.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.238 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.4 m -87.72 135.59 33.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.241 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -128.74 114.7 16.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.2 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.726 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -102.88 168.31 9.01 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.205 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD2' HG23 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.09 -22.01 19.88 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.946 1.498 . . . . 0.0 110.433 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.5 mtp-105 -99.66 -20.96 16.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.276 -0.89 . . . . 0.0 110.178 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.472 ' O ' ' OG1' ' A' ' 53' ' ' THR . 15.7 pt20 -168.24 160.25 11.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.7 p -128.98 134.76 48.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.21 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -132.45 130.04 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.204 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.443 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 88.4 m -110.26 138.26 46.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.457 ' OD1' ' CG2' ' A' ' 71' ' ' THR . 67.8 m-20 -134.57 156.0 49.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -151.17 126.29 9.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.757 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 44.0 p90 -139.33 176.08 9.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.1 m -120.49 147.01 45.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 110.254 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.634 HD13 ' CD1' ' A' ' 47' ' ' PHE . 21.1 mt -81.04 123.59 28.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 110.271 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.54 2.59 40.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -145.6 148.79 33.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 110.238 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -70.91 131.03 43.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.248 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -132.36 144.06 50.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.185 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 14.1 p-10 -73.82 141.6 46.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.879 . . . . 0.0 110.225 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.754 ' CD1' ' H62' ' A' ' 131' ' ' JN3 . 2.4 mm -136.28 141.61 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 110.244 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.457 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 4.0 t -113.86 132.79 55.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.242 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.623 HG23 H161 ' A' ' 131' ' ' JN3 . 0.2 OUTLIER -83.97 160.0 21.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 110.256 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.722 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 13.3 ttm -68.49 -19.27 64.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -83.29 -12.88 56.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.75 28.11 5.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.447 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 5.4 mttm -101.38 133.73 45.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -1.146 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -109.71 132.71 53.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.249 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.59 160.25 22.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -104.94 160.92 14.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.282 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -170.86 138.91 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.154 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 m -96.95 99.4 10.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.885 . . . . 0.0 110.276 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.539 HG13 HD13 ' A' ' 89' ' ' LEU . 47.4 t -69.0 140.74 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.599 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 6.8 p-80 -146.62 154.08 41.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.25 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.7 mt -98.13 129.6 44.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.185 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.37 143.71 34.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 110.166 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.74 13.18 0.98 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 110.186 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.22 48.04 5.25 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.743 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -172.17 134.15 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 110.22 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.75 ' O ' HG21 ' A' ' 90' ' ' VAL . 1.9 tt -61.31 145.77 50.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.75 HG21 ' O ' ' A' ' 89' ' ' LEU . 87.2 t -153.78 109.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.568 HG22 H111 ' A' ' 131' ' ' JN3 . 97.6 m -102.75 103.16 13.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 110.191 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -100.42 156.21 17.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.915 . . . . 0.0 110.208 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.586 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 2.9 t -147.36 -163.65 1.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.228 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.683 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 32.4 tt0 -101.85 33.85 2.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.328 -0.857 . . . . 0.0 110.113 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 8.6 ptmt -177.97 7.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.886 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -179.65 141.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.223 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.512 ' O ' HG22 ' A' ' 111' ' ' ILE . 47.9 m -118.99 156.96 28.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.598 ' CD2' H122 ' A' ' 131' ' ' JN3 . 54.2 t-80 -140.11 143.4 36.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 110.26 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 110' ' ' THR . 17.9 tt0 -158.28 119.16 3.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 110.271 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 9.5 tt0 -123.94 158.72 31.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 110.248 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.429 ' HA ' ' CE1' ' A' ' 2' ' ' PHE . 28.2 tt0 -157.95 152.69 25.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.24 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.488 HG11 ' O ' ' A' ' 102' ' ' VAL . 10.6 p -117.7 142.91 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -129.75 90.71 3.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.05 -113.34 3.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -105.73 3.83 29.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 110.191 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -112.22 160.55 17.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.551 ' HE3' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -130.02 140.09 50.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.21 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.2 t -127.58 122.31 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 110.178 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 19.8 mt-10 -104.23 128.1 51.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.186 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' GLU . 50.6 m -120.4 114.38 21.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.872 . . . . 0.0 110.23 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 97' ' ' SER . 60.9 mt -126.12 136.59 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.229 -0.919 . . . . 0.0 110.237 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.2 m -112.34 134.55 53.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.209 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.595 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 15.9 t80 -157.56 128.44 6.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 0.0 110.167 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.43 36.65 92.88 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.88 13.44 66.42 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.8 t -116.94 136.92 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -1.163 . . . . 0.0 110.18 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.3 m -114.09 131.76 56.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.622 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 61.5 tp -109.91 146.45 35.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 119' ' ' ILE . 96.0 mt -129.12 94.11 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 110.259 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.653 ' NH1' ' H12' ' A' ' 130' ' ' JN3 . 18.1 mtm180 -90.47 129.08 36.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 0.0 110.206 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 84.7 mtt180 -105.19 125.91 51.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.2 m -122.64 150.88 42.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -118.64 156.71 28.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 110.201 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -83.55 135.52 34.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.193 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.722 ' H17' ' HB3' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.757 ' H5 ' ' CE2' ' A' ' 62' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.245 0.545 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -75.82 -29.78 58.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.198 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.88 143.26 38.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.231 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.59 -172.71 19.36 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.7 m -110.65 131.77 54.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -1.093 . . . . 0.0 110.221 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.47 ' CZ3' ' HG3' ' A' ' 107' ' ' MET . 92.3 m95 -119.28 143.28 47.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -125.73 117.79 24.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.239 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.01 130.28 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.191 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.55 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 11.7 p90 -129.71 -18.98 3.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.55 ' HB1' ' CE1' ' A' ' 9' ' ' TYR . . . -139.37 134.87 33.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.481 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.8 pt20 -146.8 118.23 7.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -95.95 150.34 20.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 53.38 22.68 2.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.517 ' CE2' HD13 ' A' ' 18' ' ' LEU . 59.6 t80 -57.82 -45.07 86.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.201 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.28 -54.01 20.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -47.43 -64.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.567 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 45.5 t80 -48.06 -43.83 30.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.336 -0.852 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.517 HD13 ' CE2' ' A' ' 14' ' ' TYR . 17.0 mt -62.76 -45.15 94.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.945 . . . . 0.0 110.191 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -52.33 -33.31 42.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.69 -34.12 73.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.219 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -60.02 -21.16 60.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.264 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 73.06 45.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.774 HD23 ' HD2' ' A' ' 24' ' ' PRO . 5.7 mt -86.08 169.27 15.93 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.774 ' HD2' HD23 ' A' ' 23' ' ' LEU . 46.0 Cg_endo -73.11 135.4 22.86 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.031 1.542 . . . . 0.0 110.466 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -56.39 -26.55 53.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.92 . . . . 0.0 110.178 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.94 -38.07 82.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.93 . . . . 0.0 110.263 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.509 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 66.2 tp -83.87 -40.84 18.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 23' ' ' LEU . 63.1 mt -57.78 -51.36 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -61.67 -29.61 70.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 0.0 110.208 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.613 ' O ' HD13 ' A' ' 34' ' ' ILE . 60.1 ttm -84.75 -23.79 29.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 0.0 110.228 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -101.88 11.37 38.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.903 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -79.0 -2.58 40.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.208 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -151.66 44.91 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.886 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 21.1 mt -123.34 113.12 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 89.41 0.43 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.207 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.886 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.08 143.21 35.65 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.016 1.535 . . . . 0.0 110.403 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.403 HG21 ' O ' ' A' ' 6' ' ' TRP . 21.3 mt -89.24 162.9 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.206 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.3 t -141.28 119.44 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.159 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -100.05 138.94 36.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.9 . . . . 0.0 110.2 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.484 ' CD1' ' HE2' ' A' ' 107' ' ' MET . 60.2 mt -123.93 132.37 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 110.181 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -138.19 69.42 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.681 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 4.6 pt20 -75.03 173.63 10.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.681 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 71.4 mttt -165.53 48.64 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 110.189 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.23 -99.25 0.76 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 27.6 m-20 -111.69 -4.54 14.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 0.0 110.216 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -101.43 149.74 23.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.914 . . . . 0.0 110.232 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.543 ' CD1' HD13 ' A' ' 64' ' ' LEU . 2.1 m-85 -133.24 137.11 45.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.1 t -124.9 108.55 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.165 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.449 ' CG1' ' H42' ' A' ' 131' ' ' JN3 . 81.6 t -110.1 134.64 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.877 . . . . 0.0 110.212 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.422 HG21 ' CB ' ' A' ' 59' ' ' THR . 96.0 m -132.57 107.37 8.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.902 . . . . 0.0 110.186 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.4 m -87.16 135.5 33.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 110.215 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -128.78 120.83 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.209 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.644 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -107.14 168.48 7.96 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.222 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.516 ' HD2' HG23 ' A' ' 53' ' ' THR . 45.8 Cg_endo -73.03 -19.73 22.68 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.949 1.499 . . . . 0.0 110.407 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -106.26 -20.06 13.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.85 . . . . 0.0 110.203 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.557 ' NE2' ' HG2' ' A' ' 73' ' ' MET . 13.6 pt20 -163.38 158.96 21.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.169 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 p -132.33 131.53 42.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.32 131.35 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 110.195 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.422 ' CB ' HG21 ' A' ' 50' ' ' THR . 13.7 t -112.25 136.83 51.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 110.242 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -133.05 149.4 52.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -141.17 130.05 23.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.936 . . . . 0.0 110.248 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.718 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 37.6 p90 -143.93 169.46 17.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.7 m -118.34 146.76 44.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.543 HD13 ' CD1' ' A' ' 47' ' ' PHE . 17.8 mt -76.29 125.83 29.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 0.0 110.19 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.48 10.25 57.05 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -145.43 138.03 25.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -1.171 . . . . 0.0 110.218 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -67.39 122.81 18.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.166 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.09 142.04 51.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -0.919 . . . . 0.0 110.184 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -71.22 144.69 50.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.226 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.871 HD13 ' H62' ' A' ' 131' ' ' JN3 . 16.7 mm -134.88 142.79 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.225 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.413 ' N ' HG21 ' A' ' 70' ' ' ILE . 18.3 m -115.56 132.22 56.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.227 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.579 HG23 H161 ' A' ' 131' ' ' JN3 . 0.2 OUTLIER -86.74 161.15 18.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.255 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.648 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 8.9 ttm -69.85 -20.84 63.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.711 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -79.34 -16.23 56.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.885 . . . . 0.0 110.186 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.87 23.01 6.98 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -96.58 138.47 34.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -1.136 . . . . 0.0 110.191 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -114.11 131.32 56.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.182 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.27 156.51 19.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.232 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -100.61 150.98 22.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 110.254 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.0 133.42 8.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.3 m -95.25 101.01 12.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.536 HG12 HD12 ' A' ' 89' ' ' LEU . 45.1 t -72.21 139.8 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.646 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 8.1 p-80 -139.21 156.04 47.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mp -100.19 131.44 46.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.96 116.65 13.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.887 . . . . 0.0 110.195 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 65.8 t30 60.1 28.06 17.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.649 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.15 48.01 10.29 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.876 ' HD2' ' OE2' ' A' ' 101' ' ' GLU . 3.4 mtpt -159.44 119.27 3.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -1.141 . . . . 0.0 110.221 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.554 HD21 ' H22' ' A' ' 131' ' ' JN3 . 5.2 tt -66.8 140.67 57.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 110.215 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.646 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 45.5 t -149.34 120.76 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 68.8 m -112.87 95.52 5.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -90.18 165.35 14.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.265 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 7.3 t -157.61 -162.54 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.543 ' N ' ' OG ' ' A' ' 93' ' ' SER . 41.6 tt0 -105.28 31.56 4.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 110.309 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 8.8 ptpt -172.6 1.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.906 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER 179.22 144.29 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 110.258 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.529 ' O ' HG22 ' A' ' 111' ' ' ILE . 46.2 m -119.27 159.99 23.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.261 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.537 ' CD2' H122 ' A' ' 131' ' ' JN3 . 56.1 t-80 -143.31 139.06 29.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.249 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 110' ' ' THR . 52.4 mt-10 -151.33 129.27 11.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.905 . . . . 0.0 110.161 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 28.4 tt0 -132.7 153.8 50.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.876 ' OE2' ' HD2' ' A' ' 88' ' ' LYS . 57.6 tt0 -153.49 156.86 38.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.274 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.467 HG22 ' CH2' ' A' ' 6' ' ' TRP . 12.4 p -121.09 137.72 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -127.93 92.74 3.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.4 -107.34 2.62 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -113.81 8.61 17.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -1.198 . . . . 0.0 110.227 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -117.24 158.7 23.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.484 ' HE2' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -129.94 142.21 50.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.253 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.1 t -128.19 125.7 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 0.0 110.223 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 31.4 mt-10 -108.4 126.96 53.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.211 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' GLU . 37.2 m -117.34 116.62 27.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 97' ' ' SER . 66.9 mt -125.71 129.58 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 50.7 m -106.52 139.68 40.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.169 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.583 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 11.7 t80 -161.48 126.36 3.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 66.63 38.2 93.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.2 8.46 58.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 17' ' ' PHE . 60.2 t -110.89 141.52 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -1.165 . . . . 0.0 110.217 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.2 m -117.73 130.75 56.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.893 . . . . 0.0 110.233 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.567 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 64.2 tp -110.01 148.33 31.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.208 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 119' ' ' ILE . 92.0 mt -128.91 98.91 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.201 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.683 ' NH1' ' H12' ' A' ' 130' ' ' JN3 . 13.7 mtm180 -93.41 124.48 37.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 46.7 mtm-85 -102.66 127.83 49.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.5 m -125.54 160.18 30.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.912 . . . . 0.0 110.223 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -123.97 157.06 35.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.157 -0.964 . . . . 0.0 110.223 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.4 ttt85 -81.75 133.37 35.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.224 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.205 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.783 ' C4 ' ' HO7' ' A' ' 130' ' ' JN3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.871 ' H62' HD13 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.312 0.577 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.406 ' CE2' ' HA ' ' A' ' 101' ' ' GLU . 90.3 m-85 -75.23 -30.96 60.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.1 m -56.5 145.59 27.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.22 -178.15 16.66 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.6 m -103.77 132.14 50.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -1.175 . . . . 0.0 110.195 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.49 ' CD1' ' CE ' ' A' ' 107' ' ' MET . 99.2 m95 -121.06 144.64 48.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -126.72 117.29 22.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.889 . . . . 0.0 110.116 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.437 HG13 ' CD ' ' A' ' 11' ' ' GLN . 48.8 t -64.6 126.06 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.555 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 13.3 p90 -125.98 -21.05 4.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.167 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.555 ' HB1' ' CE1' ' A' ' 9' ' ' TYR . . . -138.26 133.62 33.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.437 ' CD ' HG13 ' A' ' 8' ' ' VAL . 43.2 mt-30 -145.25 114.6 7.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.195 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 56.0 tt0 -92.04 144.01 25.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.937 . . . . 0.0 110.197 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 21.3 m120 57.44 17.51 3.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.922 . . . . 0.0 110.215 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.658 ' CZ ' HD12 ' A' ' 18' ' ' LEU . 81.9 t80 -53.59 -47.75 69.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.197 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -66.28 -47.84 72.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 36.2 mt-10 -55.78 -62.3 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.697 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 62.7 t80 -47.24 -57.89 4.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.268 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.835 ' CD2' H191 ' A' ' 130' ' ' JN3 . 7.7 mt -57.14 -44.32 83.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.326 -0.859 . . . . 0.0 110.192 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 9.8 ttmm -46.93 -40.73 14.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.231 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.69 65.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.669 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.1 tp -56.81 -19.56 17.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.669 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 79.22 27.85 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.154 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 58.8 mt -74.21 166.67 42.7 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.221 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.555 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.13 138.87 28.68 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.026 1.54 . . . . 0.0 110.415 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -58.74 -41.02 85.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -56.19 -26.2 49.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.616 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 44.3 tp -93.12 -18.83 22.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 90.4 mt -82.68 -42.47 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.235 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.31 -32.67 66.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.56 -32.81 36.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.217 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -97.2 5.98 49.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.599 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.31 -5.3 13.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 110.204 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -149.23 52.61 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.226 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.12 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.7 mt -122.86 114.86 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.28 83.62 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.189 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 1.12 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.5 Cg_endo -73.03 131.59 17.01 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.109 1.584 . . . . 0.0 110.411 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.5 mt -86.11 155.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.5 t -135.25 118.54 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 110.238 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -97.43 137.61 36.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 40' ' ' ILE . 50.6 mm -124.75 129.02 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.224 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -129.28 74.18 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 110.184 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.668 ' OE1' ' CZ ' ' A' ' 47' ' ' PHE . 57.8 tt0 -69.86 166.3 19.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.193 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 36.8 mtmt -165.34 44.86 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.171 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.03 -105.25 1.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -107.63 -2.42 20.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -1.135 . . . . 0.0 110.224 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -102.28 148.72 25.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 110.189 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.668 ' CZ ' ' OE1' ' A' ' 42' ' ' GLN . 1.9 m-85 -131.03 135.06 47.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.292 -0.88 . . . . 0.0 110.152 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.8 t -120.19 108.99 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.568 ' CG1' ' H42' ' A' ' 131' ' ' JN3 . 73.5 t -110.04 129.95 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.7 m -129.56 105.38 8.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 110.268 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 m -89.55 137.52 32.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.88 . . . . 0.0 110.222 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -130.47 112.8 13.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.168 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.682 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -95.7 168.63 10.48 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.173 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.402 ' CD ' HG21 ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.12 -17.14 24.97 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.018 1.536 . . . . 0.0 110.434 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -106.55 -18.41 13.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.682 ' O ' ' OG1' ' A' ' 53' ' ' THR . 14.2 pt20 -167.84 161.63 13.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.1 p -128.53 135.82 49.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.99 126.9 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.209 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 t -109.92 139.56 44.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 110.147 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -136.2 147.93 47.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.254 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -139.49 130.54 26.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.242 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.747 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 34.2 p90 -144.42 173.15 12.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.228 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.0 m -120.19 143.35 48.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.298 -0.876 . . . . 0.0 110.126 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.571 ' CD2' HG13 ' A' ' 82' ' ' VAL . 30.8 mt -74.34 127.17 32.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.172 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.88 -1.4 57.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -136.34 145.11 45.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -1.135 . . . . 0.0 110.231 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -68.91 125.42 26.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.604 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -125.65 151.52 46.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -82.27 133.95 35.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.925 . . . . 0.0 110.187 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.824 HD13 ' H62' ' A' ' 131' ' ' JN3 . 18.9 mm -125.94 145.65 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 110.252 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -121.04 135.13 55.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.925 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.594 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -85.28 157.46 20.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 0.0 110.238 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.757 ' HG2' H222 ' A' ' 130' ' ' JN3 . 0.2 OUTLIER -68.87 -16.98 63.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 110.25 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -84.13 -11.49 56.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.09 30.3 4.84 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.594 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 27.7 mttt -104.03 132.07 50.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -1.138 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -107.18 135.02 49.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.285 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.01 158.9 15.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.163 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -104.88 147.16 28.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.2 m -151.04 139.19 20.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -103.25 88.64 3.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.182 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.668 HG12 HD12 ' A' ' 89' ' ' LEU . 16.9 t -52.73 157.03 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 110.271 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.68 144.51 19.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.252 -0.905 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.85 105.09 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.243 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.93 150.91 44.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.153 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 52.57 15.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.242 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.84 40.17 12.48 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 9.2 ptpt -163.54 133.0 4.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -1.127 . . . . 0.0 110.169 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.751 ' O ' HG21 ' A' ' 90' ' ' VAL . 5.5 tt -61.42 145.07 52.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.206 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.751 HG21 ' O ' ' A' ' 89' ' ' LEU . 41.4 t -150.48 111.42 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.531 ' HG1' ' HA ' ' A' ' 82' ' ' VAL . 87.4 m -106.96 97.95 7.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.232 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -95.45 162.78 13.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 110.193 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.5 t -152.42 -164.47 1.96 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -102.21 33.34 3.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 0.0 110.231 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.1 pttt -174.98 2.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.18 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.99 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER 178.56 143.14 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 111' ' ' ILE . 50.7 m -116.85 164.91 13.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 0.0 110.209 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.835 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 60.5 t-80 -146.84 141.24 26.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.835 ' HG3' ' O ' ' A' ' 98' ' ' HIS . 4.3 mp0 -153.58 128.29 9.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 0.0 110.213 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.461 ' NE2' ' HE2' ' A' ' 107' ' ' MET . 58.8 tt0 -131.89 157.4 44.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.406 ' HA ' ' CE2' ' A' ' 2' ' ' PHE . 36.7 tt0 -156.32 154.28 30.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.06 142.57 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.185 -0.947 . . . . 0.0 110.131 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -136.74 95.04 3.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 110.2 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.9 -110.76 3.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -114.62 12.62 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -1.149 . . . . 0.0 110.216 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -119.24 157.83 27.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.49 ' CE ' ' CD1' ' A' ' 6' ' ' TRP . 2.2 tpp -127.96 140.49 51.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.234 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.7 t -127.48 124.5 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 23.5 mt-10 -109.35 118.26 36.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.598 ' N ' ' O ' ' A' ' 99' ' ' GLU . 41.3 m -108.76 118.65 37.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 110.253 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 97' ' ' SER . 53.6 mt -127.76 132.64 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.164 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 76.6 m -108.52 139.54 43.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.649 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 10.9 t80 -161.19 127.06 3.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 65.48 38.59 94.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 67.92 12.31 62.21 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.444 HG13 ' HA ' ' A' ' 17' ' ' PHE . 63.4 t -114.57 138.27 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 110.168 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.6 m -115.02 131.49 56.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.263 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.697 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 63.8 tp -111.41 151.06 28.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 110.242 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.9 mt -129.39 94.1 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.457 ' NH1' ' H12' ' A' ' 130' ' ' JN3 . 64.8 mtp180 -87.27 124.09 32.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.192 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 65.3 mtt180 -104.72 125.15 50.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 74.3 m -124.29 152.93 42.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -115.39 156.12 26.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 110.215 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -82.61 136.04 34.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.196 -179.981 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.835 H191 ' CD2' ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.824 ' H62' HD13 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.589 ' H3 ' HG13 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.194 0.521 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -77.28 -35.07 55.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 110.248 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.89 144.38 44.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.16 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.59 176.19 14.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 42.3 p -103.48 134.05 47.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -1.108 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.464 ' CZ3' ' HG3' ' A' ' 107' ' ' MET . 86.0 m95 -122.46 142.96 50.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.226 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -123.31 118.51 27.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.0 t -64.61 127.74 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.285 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 47.6 p90 -128.41 -28.19 2.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.92 . . . . 0.0 110.25 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.84 133.76 43.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.175 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 14' ' ' TYR . 5.4 pt20 -146.62 118.61 8.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -97.11 148.99 22.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.148 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 m120 53.08 21.89 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 110.218 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.816 ' CZ ' HD12 ' A' ' 18' ' ' LEU . 86.6 t80 -60.12 -42.95 95.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 110.236 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.605 ' HG3' ' N ' ' A' ' 16' ' ' GLU . 14.2 pt-20 -69.55 -45.59 68.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 110.169 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.605 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 41.8 mt-10 -57.67 -60.37 3.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.69 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 52.2 t80 -51.65 -53.64 36.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.82 ' CD2' H191 ' A' ' 130' ' ' JN3 . 8.9 mt -59.38 -47.23 86.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 110.19 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -48.46 -38.74 20.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.917 . . . . 0.0 110.175 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.22 -25.07 65.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.716 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.5 tp -60.37 -18.74 52.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.232 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.716 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 82.61 26.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.44 HD21 ' HD2' ' A' ' 24' ' ' PRO . 24.2 mt -72.91 163.14 70.61 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 110.231 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 45.9 Cg_endo -73.03 140.16 30.94 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.022 1.538 . . . . 0.0 110.442 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -56.02 -44.67 78.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -51.42 -36.53 44.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.16 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.476 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 20.8 tp -83.01 -23.34 33.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.679 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 35.0 mt -75.23 -40.98 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -76.43 -22.84 54.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.214 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.6 mtt -87.92 -27.24 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.948 . . . . 0.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HB2' H182 ' A' ' 130' ' ' JN3 . . . -104.73 4.72 32.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.174 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.859 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 21.1 ptt180 -70.69 1.53 5.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -0.914 . . . . 0.0 110.206 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.859 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 1.5 m-20 -153.82 42.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.254 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.874 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 7.1 mt -121.38 117.06 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.557 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -94.06 89.25 0.42 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.251 -0.905 . . . . 0.0 110.221 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.874 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.09 138.07 27.44 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.0 1.526 . . . . 0.0 110.408 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.1 mt -87.51 161.42 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.922 . . . . 0.0 110.182 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.87 120.98 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.418 ' HG3' HG23 ' A' ' 5' ' ' THR . 42.1 tt0 -101.6 138.27 38.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.473 HD13 ' HE2' ' A' ' 107' ' ' MET . 75.5 mt -124.95 132.79 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.888 . . . . 0.0 110.23 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -137.14 72.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.594 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 6.5 pt20 -76.42 169.65 17.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.211 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 75.7 mttt -161.26 46.71 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 110.239 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.18 -97.88 0.64 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -112.03 -6.84 14.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.153 . . . . 0.0 110.207 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -99.8 152.71 19.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.917 . . . . 0.0 110.157 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.429 ' CE1' HD12 ' A' ' 64' ' ' LEU . 2.1 m-85 -136.34 137.96 41.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.62 109.6 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.21 -0.931 . . . . 0.0 110.229 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.1 t -111.19 134.41 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.186 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.491 ' OG1' HG23 ' A' ' 59' ' ' THR . 91.3 m -131.14 109.91 10.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -90.42 135.11 33.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -127.51 122.11 32.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.208 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.604 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.58 168.87 7.19 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.239 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.558 ' HD2' HG23 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.05 -17.54 24.8 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.059 1.557 . . . . 0.0 110.466 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.462 ' HD3' ' HB3' ' A' ' 56' ' ' GLN . 1.8 tmt_? -105.57 -24.09 12.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.186 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.462 ' HB3' ' HD3' ' A' ' 55' ' ' ARG . 2.5 pt20 -162.88 164.34 26.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.232 -0.918 . . . . 0.0 110.216 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.2 p -132.12 128.23 37.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 110.192 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.48 132.76 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.93 . . . . 0.0 110.222 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.491 HG23 ' OG1' ' A' ' 50' ' ' THR . 28.7 m -112.56 136.54 51.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 110.246 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.473 ' ND2' ' OG1' ' A' ' 71' ' ' THR . 14.5 m120 -133.03 150.58 52.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.174 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.4 m -143.08 137.51 29.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.202 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.684 ' CD1' ' CG2' ' A' ' 82' ' ' VAL . 32.5 p90 -150.04 162.01 41.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 90.7 m -112.2 143.54 43.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.429 HD12 ' CE1' ' A' ' 47' ' ' PHE . 14.1 mt -69.16 124.79 24.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.54 19.03 53.74 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.409 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 91.2 mttt -150.89 138.9 20.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -1.191 . . . . 0.0 110.152 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -72.05 135.51 46.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 0.0 110.188 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.46 146.75 42.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.233 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 13.9 p-10 -76.27 141.4 41.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.168 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.936 HD12 H191 ' A' ' 131' ' ' JN3 . 74.7 mt -140.31 145.93 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.473 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 1.6 p -111.83 147.34 35.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.194 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.641 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -98.6 158.6 15.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.213 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.682 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 10.5 ttm -68.13 -17.16 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.554 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 3.1 p30 -87.5 -18.28 30.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.86 26.76 4.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.641 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 19.4 mttt -101.59 133.4 46.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -1.111 . . . . 0.0 110.226 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -110.67 134.99 51.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -165.44 161.38 18.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -104.55 151.51 23.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.2 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.497 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 0.9 OUTLIER -155.23 140.53 17.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.203 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.1 m -102.4 86.37 2.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.209 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.684 ' CG2' ' CD1' ' A' ' 62' ' ' PHE . 11.5 t -52.75 152.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.885 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.14 148.25 32.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 mt -102.19 105.02 15.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.67 132.27 55.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.211 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.7 t30 45.68 39.53 5.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.887 . . . . 0.0 110.217 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.36 42.62 95.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.674 ' HD3' ' CD ' ' A' ' 101' ' ' GLU . 25.3 mttt -150.04 119.38 6.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -1.104 . . . . 0.0 110.189 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.55 ' CD2' ' CG1' ' A' ' 82' ' ' VAL . 1.5 tt -68.87 133.2 47.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 89' ' ' LEU . 20.7 t -139.78 120.85 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.497 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 87.9 m -113.76 94.66 4.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.2 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 46.7 pttt -94.25 163.13 13.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.272 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 28.6 t -150.23 -154.66 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.206 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.49 ' N ' ' OG ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -107.04 22.55 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.17 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -165.41 6.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.201 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 1.018 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.86 139.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.501 ' O ' HG22 ' A' ' 111' ' ' ILE . 16.0 t -112.38 165.29 12.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.588 ' CD2' H122 ' A' ' 131' ' ' JN3 . 42.5 t-80 -149.5 136.46 19.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.665 ' O ' ' N ' ' A' ' 110' ' ' THR . 33.3 tt0 -152.05 128.58 10.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.9 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.524 ' OE1' ' HG2' ' A' ' 109' ' ' GLU . 39.1 tt0 -132.43 160.52 36.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.179 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.674 ' CD ' ' HD3' ' A' ' 88' ' ' LYS . 82.3 tt0 -155.89 150.12 25.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.225 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.589 HG13 ' H3 ' ' A' ' 1' ' ' ALA . 11.2 p -113.77 142.16 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 110.215 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -133.73 93.35 3.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 110.196 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.5 -108.39 2.78 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -114.26 8.73 16.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -1.119 . . . . 0.0 110.197 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -115.49 154.78 28.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.923 . . . . 0.0 110.164 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.503 ' SD ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -125.5 141.91 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.19 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.1 t -128.68 122.16 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.524 ' HG2' ' OE1' ' A' ' 100' ' ' GLN . 27.1 mt-10 -105.42 121.75 44.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.223 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.665 ' N ' ' O ' ' A' ' 99' ' ' GLU . 19.6 m -112.61 116.04 29.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 97' ' ' SER . 52.2 mt -126.47 132.1 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 77.0 m -108.95 137.26 47.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.92 . . . . 0.0 110.225 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.553 ' CD2' HD13 ' A' ' 21' ' ' LEU . 11.6 t80 -159.56 126.52 4.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.94 32.79 77.92 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.46 9.65 78.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.582 ' CG1' ' HA ' ' A' ' 17' ' ' PHE . 52.2 t -113.37 141.68 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -1.123 . . . . 0.0 110.246 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.3 m -115.85 134.26 55.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.192 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.69 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 16.9 tp -112.67 140.04 47.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 58.1 mt -122.48 98.38 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.447 HH11 ' H12' ' A' ' 130' ' ' JN3 . 6.1 ttp180 -93.59 124.96 37.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 110.244 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 32.9 mtm180 -103.07 122.82 45.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.6 m -120.44 150.42 40.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -114.91 151.63 33.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 110.19 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.1 ttt180 -74.87 133.31 41.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.189 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.82 H191 ' CD2' ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.936 H191 HD12 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.227 0.537 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -76.03 -28.01 57.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.207 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 p -57.79 144.47 38.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.8 -176.05 18.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.5 m -108.14 134.24 51.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -1.093 . . . . 0.0 110.215 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.475 ' CZ3' ' HB2' ' A' ' 107' ' ' MET . 98.8 m95 -121.12 139.2 53.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.179 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -121.89 125.6 46.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.239 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.449 HG13 ' HD3' ' A' ' 120' ' ' ARG . 19.4 m -62.34 123.35 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.212 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -134.27 2.77 3.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 110.223 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 121' ' ' ARG . . . -163.03 120.79 1.97 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -147.08 164.85 31.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 110.206 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -135.97 153.58 51.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.178 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 48.27 38.08 9.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -67.06 -49.31 65.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.188 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -61.8 -46.4 89.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 61.3 mt-10 -55.15 -42.93 73.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.195 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 55.2 t80 -55.41 -57.67 10.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 110.278 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.569 HD13 ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -50.78 -38.89 50.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 110.195 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 33.2 mttp -60.33 -38.8 84.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.262 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.63 -40.94 69.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.772 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 2.0 tp -54.68 -26.22 32.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.893 . . . . 0.0 110.23 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.772 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 86.64 18.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.526 HD21 ' HD2' ' A' ' 24' ' ' PRO . 16.5 mt -66.69 170.31 6.17 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.175 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.526 ' HD2' HD21 ' A' ' 23' ' ' LEU . 46.8 Cg_endo -73.09 132.96 18.86 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.123 1.591 . . . . 0.0 110.41 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.404 ' HA ' HD13 ' A' ' 28' ' ' ILE . 25.6 tp10 -51.94 -47.91 64.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.225 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -48.42 -35.62 13.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 110.241 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.526 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 41.6 tp -79.54 -33.4 41.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.17 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.569 ' HA ' HD13 ' A' ' 18' ' ' LEU . 85.6 mt -61.95 -52.22 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.193 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -59.08 -26.1 64.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -0.913 . . . . 0.0 110.179 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.674 ' O ' HD13 ' A' ' 34' ' ' ILE . 12.1 ttm -91.8 -23.12 19.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -101.29 -5.94 24.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -3.72 16.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -147.62 43.43 1.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.019 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 18.0 mt -120.49 109.93 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 110.206 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.48 86.59 0.2 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 0.0 110.198 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 1.019 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.6 Cg_endo -73.14 146.42 40.95 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.069 1.562 . . . . 0.0 110.443 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.2 mt -91.17 162.29 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.227 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.4 t -138.36 120.75 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -103.45 134.58 46.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.8 mt -120.67 131.7 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 37.0 tt0 -135.95 73.09 1.45 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 110.215 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.508 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -76.12 164.1 26.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.201 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 59.6 mttt -158.71 49.84 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.42 -101.85 1.01 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -110.91 1.11 17.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -1.131 . . . . 0.0 110.174 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 42.2 t0 -108.23 144.02 36.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 110.265 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.551 ' CD1' HD13 ' A' ' 64' ' ' LEU . 3.6 m-85 -127.29 143.51 51.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.897 . . . . 0.0 110.248 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.6 t -132.35 106.92 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.178 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.4 t -108.82 134.88 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.243 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.48 ' OG1' HG21 ' A' ' 59' ' ' THR . 87.1 m -131.91 109.51 10.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.217 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.0 m -92.1 132.72 36.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.257 -0.902 . . . . 0.0 110.093 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -126.17 128.32 47.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.28 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.759 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -111.11 169.76 5.97 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.0 110.273 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.13 -8.87 22.74 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.005 1.529 . . . . 0.0 110.403 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -117.39 -20.84 8.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.633 ' O ' ' OG1' ' A' ' 53' ' ' THR . 16.2 pt20 -162.43 160.5 26.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.883 . . . . 0.0 110.17 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 p -131.09 131.15 43.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.471 ' CG2' ' HG3' ' A' ' 73' ' ' MET . 57.4 t -127.7 129.35 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.194 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.48 HG21 ' OG1' ' A' ' 50' ' ' THR . 62.3 m -112.26 139.75 47.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -135.09 152.06 51.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.903 . . . . 0.0 110.19 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.4 t -148.38 131.15 16.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.225 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.784 ' CE1' ' H5 ' ' A' ' 131' ' ' JN3 . 50.5 p90 -143.51 171.55 13.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.929 . . . . 0.0 110.151 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.2 m -119.8 140.88 50.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.551 HD13 ' CD1' ' A' ' 47' ' ' PHE . 17.5 mt -74.41 127.67 33.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 110.202 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.42 4.4 56.18 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -145.05 145.07 31.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -1.154 . . . . 0.0 110.205 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.44 123.96 22.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.221 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.573 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.89 150.74 44.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 12.0 p-10 -86.39 140.65 29.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.784 HG23 H152 ' A' ' 131' ' ' JN3 . 12.1 mm -130.15 144.42 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.464 ' N ' HG21 ' A' ' 70' ' ' ILE . 4.0 m -116.56 131.77 56.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.194 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.651 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 73.0 p -86.04 158.16 19.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.773 ' HE3' H122 ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -70.01 -13.76 62.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.715 ' HB3' H151 ' A' ' 130' ' ' JN3 . 3.6 p30 -86.28 -16.92 36.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 110.22 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.53 27.7 4.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.651 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 22.1 mttt -105.06 131.36 52.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -107.84 135.83 48.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.26 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -164.22 159.38 20.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 83.4 mttt -105.93 171.01 7.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 110.256 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 27.6 p -179.88 136.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 m -95.34 103.43 15.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.197 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' A' ' 89' ' ' LEU . 43.2 t -76.77 140.54 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 110.244 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.647 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 35.0 p-80 -139.44 156.6 46.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.209 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 53.8 mt -101.41 132.15 47.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.164 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -135.77 117.97 15.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.22 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 57.84 31.39 20.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 110.231 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.611 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 72.24 49.78 19.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.705 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 51.1 mtpt -158.57 117.21 3.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.623 ' O ' HG21 ' A' ' 90' ' ' VAL . 4.5 tt -65.77 140.28 58.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.193 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.647 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 97.8 t -146.69 117.0 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.674 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 99.8 m -110.97 94.8 5.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 110.223 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -88.45 161.7 16.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.231 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 96' ' ' PHE . 30.2 t -157.47 -177.13 6.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.918 . . . . 0.0 110.237 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 84.1 tt0 -95.26 33.46 1.56 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.902 . . . . 0.0 110.184 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.539 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 10.8 ptpt -173.5 -2.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.837 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -176.96 146.62 0.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.2 m -123.13 156.87 34.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.154 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.674 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.5 t-80 -140.23 134.56 31.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.789 ' O ' HG22 ' A' ' 110' ' ' THR . 0.6 OUTLIER -149.07 125.14 10.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.857 . . . . 0.0 110.21 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.749 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 10.0 tt0 -131.94 156.47 46.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.705 ' OE1' ' HE3' ' A' ' 88' ' ' LYS . 76.8 tt0 -151.65 159.55 43.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.423 HG21 ' CH2' ' A' ' 6' ' ' TRP . 10.9 p -122.65 137.23 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -132.16 93.3 3.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.53 -106.77 2.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.405 ' ND2' ' HG3' ' A' ' 106' ' ' GLU . 3.4 p-10 -117.67 10.79 13.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -1.147 . . . . 0.0 110.165 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.405 ' HG3' ' ND2' ' A' ' 105' ' ' ASN . 70.0 mt-10 -118.43 160.79 21.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.195 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.536 ' SD ' ' OE1' ' A' ' 100' ' ' GLN . 28.5 ttm -134.58 142.08 46.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.221 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 74.2 t -125.62 128.65 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 110.24 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.749 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 15.7 mt-10 -115.87 136.17 53.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.211 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.789 HG22 ' O ' ' A' ' 99' ' ' GLU . 3.1 t -126.27 122.61 36.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.183 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.29 133.01 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 89.6 m -113.27 133.87 54.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.157 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.462 ' CE1' ' HA ' ' A' ' 21' ' ' LEU . 26.1 t80 -154.82 122.58 5.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 110.227 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.94 35.5 65.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.39 5.39 63.0 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.2 t -111.05 135.76 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -1.162 . . . . 0.0 110.23 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 59.2 m -112.93 135.43 53.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.553 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 23.5 tp -115.76 139.57 50.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.04 120.18 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.449 ' HD3' HG13 ' A' ' 8' ' ' VAL . 5.5 ttm105 -115.39 119.18 35.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 110.219 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 84.4 mtt180 -99.94 125.15 45.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.408 ' CB ' ' HB3' ' A' ' 6' ' ' TRP . 11.4 m -120.54 152.03 38.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.22 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -113.58 152.51 30.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 5' ' ' THR . 31.8 ttt180 -78.96 136.91 37.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.196 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.146 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.773 H122 ' HE3' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.784 H152 HG23 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.211 0.529 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.444 ' O ' HD11 ' A' ' 40' ' ' ILE . 64.4 m-85 -84.02 -38.47 20.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 110.251 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.4 p -58.78 145.26 41.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.275 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.06 -178.99 16.78 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 85.0 m -104.05 132.04 50.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -1.154 . . . . 0.0 110.193 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.449 ' CE3' ' HB2' ' A' ' 107' ' ' MET . 88.4 m95 -121.73 142.7 49.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.895 . . . . 0.0 110.164 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.01 122.32 38.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 110.212 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.55 124.16 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.204 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 38.1 p90 -124.94 -32.43 3.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.194 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' HB1' ' CD2' ' A' ' 9' ' ' TYR . . . -129.01 127.16 41.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.261 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 23.0 pt20 -141.48 117.72 10.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.467 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 41.4 tt0 -96.19 144.25 26.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.219 -0.926 . . . . 0.0 110.279 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 12' ' ' GLU . 6.8 t-20 60.79 14.63 5.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.583 ' CZ ' HD12 ' A' ' 18' ' ' LEU . 60.5 t80 -50.98 -53.75 30.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 110.315 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.8 -49.1 76.27 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 34.1 mt-10 -55.05 -58.98 5.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 110.236 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.643 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 63.9 t80 -50.56 -54.73 20.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.669 HD23 H191 ' A' ' 130' ' ' JN3 . 4.4 mt -59.18 -41.18 87.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -50.09 -39.54 42.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.51 -27.53 65.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.676 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -59.71 -19.69 51.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.676 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 79.99 27.57 0.31 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.4 mt -74.32 164.2 62.92 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.335 -0.853 . . . . 0.0 110.186 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -73.13 140.8 31.63 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.066 1.561 . . . . 0.0 110.391 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.89 -41.11 90.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.156 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.6 -27.39 49.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.63 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 42.2 tp -91.74 -18.91 23.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.188 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.7 mt -85.01 -40.93 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -73.83 -30.87 62.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.181 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 51.6 ttm -82.57 -30.83 29.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.838 . . . . 0.0 110.234 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -99.17 3.97 46.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 110.206 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.701 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -64.5 -10.19 23.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.232 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.701 ' OD2' ' HD2' ' A' ' 32' ' ' ARG . 69.2 m-20 -143.93 55.96 1.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.183 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 1.8 mt -126.32 114.41 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -86.32 83.06 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 110.232 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 1.183 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.7 Cg_endo -73.07 131.52 16.85 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.029 1.542 . . . . 0.0 110.389 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -87.52 153.59 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 110.246 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.48 118.44 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.215 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -96.78 131.9 43.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.229 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.563 ' CD1' ' HE2' ' A' ' 107' ' ' MET . 74.0 mt -117.36 135.49 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.193 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -138.01 68.01 1.41 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -71.04 163.28 27.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 110.221 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 86.4 mttt -158.3 45.99 0.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.18 -97.85 0.67 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 52.3 m-20 -112.18 -3.7 14.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -1.181 . . . . 0.0 110.202 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.486 ' OD1' ' CG2' ' A' ' 63' ' ' THR . 38.3 m-20 -106.85 148.96 27.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 34.3 m-85 -131.88 148.79 52.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -127.27 99.74 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 110.164 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.411 ' CG1' ' H42' ' A' ' 131' ' ' JN3 . 59.7 t -102.13 132.65 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.865 . . . . 0.0 110.206 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 58.7 m -134.03 108.78 8.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.214 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 m -93.65 134.3 36.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 110.244 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -127.03 127.08 44.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.665 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 62.3 p -109.29 170.03 5.82 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.945 . . . . 0.0 110.204 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 46.7 Cg_endo -73.06 -5.57 17.43 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -120.7 -23.85 5.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.665 ' O ' ' OG1' ' A' ' 53' ' ' THR . 4.5 pt20 -161.43 165.89 28.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.175 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.2 p -132.6 130.8 40.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.161 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.9 t -127.37 126.21 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 14.7 t -111.06 146.39 36.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.643 ' OD1' HG22 ' A' ' 71' ' ' THR . 10.8 m-80 -139.63 142.91 37.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.85 . . . . 0.0 110.15 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -139.58 135.05 32.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.19 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.733 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 54.1 p90 -148.06 170.78 17.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.486 ' CG2' ' OD1' ' A' ' 46' ' ' ASP . 91.3 m -116.78 151.05 37.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.236 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.46 ' HG ' ' HA ' ' A' ' 83' ' ' HIS . 3.5 tp -82.66 120.07 25.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.244 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.85 9.61 34.44 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -148.53 147.08 28.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -1.154 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -68.76 126.72 30.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.647 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -126.14 148.01 49.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.313 -0.867 . . . . 0.0 110.173 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -84.3 138.36 32.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.692 HG23 ' H8 ' ' A' ' 131' ' ' JN3 . 11.4 mm -128.21 145.07 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 110.185 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.643 HG22 ' OD1' ' A' ' 60' ' ' ASN . 5.1 t -119.72 131.32 55.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.567 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 73.1 p -84.22 160.89 20.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.597 ' CE ' H122 ' A' ' 130' ' ' JN3 . 0.3 OUTLIER -74.15 -12.52 60.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.117 -0.989 . . . . 0.0 110.226 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.662 ' HB3' H151 ' A' ' 130' ' ' JN3 . 4.9 p-10 -89.35 -9.54 50.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.52 51.39 1.21 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.567 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 9.3 tttt -129.63 128.46 42.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -1.132 . . . . 0.0 110.197 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -104.53 141.04 37.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.72 156.32 7.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 13.7 mttm -105.41 165.86 10.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.217 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.9 p -178.05 139.95 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 p -94.46 107.95 19.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 0.0 110.22 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 62' ' ' PHE . 48.1 t -79.47 140.38 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.622 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 15.3 p-80 -145.03 161.54 39.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.5 mt -103.61 134.35 47.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 110.206 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -136.91 120.44 17.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 110.235 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 86.7 m-20 58.72 31.7 21.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.558 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 72.83 44.07 39.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.785 ' HD3' ' OE2' ' A' ' 101' ' ' GLU . 10.0 mtmt -156.39 121.66 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -1.164 . . . . 0.0 110.152 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.533 HD21 ' H22' ' A' ' 131' ' ' JN3 . 4.2 tt -66.73 136.04 54.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.897 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.622 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 69.2 t -142.34 117.27 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 75.0 m -109.99 95.3 5.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 110.244 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -91.55 154.43 19.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.215 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.4 t -145.84 -163.95 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.158 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -102.69 33.08 3.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.2 OUTLIER -175.52 2.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.919 . . . . 0.0 110.187 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.823 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -178.73 148.42 0.42 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 0.0 110.184 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.522 ' O ' HG22 ' A' ' 111' ' ' ILE . 41.8 m -123.75 159.89 28.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.601 ' CD2' H122 ' A' ' 131' ' ' JN3 . 65.8 t-80 -142.21 142.92 32.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.915 . . . . 0.0 110.251 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.567 ' O ' ' N ' ' A' ' 110' ' ' THR . 47.6 mt-10 -155.73 123.2 5.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.143 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 11.6 tt0 -129.23 159.07 37.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.202 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.785 ' OE2' ' HD3' ' A' ' 88' ' ' LYS . 57.6 tt0 -157.09 156.83 33.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 110.208 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 1' ' ' ALA . 39.8 t -118.98 139.18 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -134.96 89.78 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.216 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.83 -102.59 2.48 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -123.09 10.72 9.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -1.122 . . . . 0.0 110.22 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -115.84 151.68 34.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.563 ' HE2' ' CD1' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -121.74 137.01 54.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.4 t -125.29 120.56 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 35.4 mt-10 -109.01 118.71 37.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.567 ' N ' ' O ' ' A' ' 99' ' ' GLU . 63.4 m -107.97 116.61 32.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.266 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.522 HG22 ' O ' ' A' ' 97' ' ' SER . 54.0 mt -125.4 131.46 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.226 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.7 m -109.69 134.47 51.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.569 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 12.8 t80 -157.42 128.16 6.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.21 33.83 74.32 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.08 11.73 70.77 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.0 t -116.26 138.36 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -1.135 . . . . 0.0 110.202 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 63.2 m -113.27 132.48 55.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.643 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 29.5 tp -113.02 152.09 29.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.89 . . . . 0.0 110.244 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.9 mt -129.65 94.98 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.172 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -87.76 126.61 35.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 91.0 mtt180 -106.88 124.96 50.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.214 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.2 m -122.66 149.4 44.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -115.55 150.76 36.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 110.177 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 5' ' ' THR . 23.2 ttt85 -74.99 132.95 41.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.191 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.669 H191 HD23 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.733 ' H5 ' ' CE2' ' A' ' 62' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.188 0.518 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -77.06 -27.85 54.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.2 m -59.17 148.52 31.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 110.266 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.63 163.83 13.93 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.426 ' OG1' ' HB ' ' A' ' 125' ' ' VAL . 20.5 p -78.3 155.52 30.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -1.159 . . . . 0.0 110.16 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.539 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 96.7 m95 -141.93 127.64 19.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.948 ' HB3' ' HG2' ' A' ' 123' ' ' LYS . 6.1 tt0 -94.63 146.34 24.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.187 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.589 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 38.6 t -67.37 112.32 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.259 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 1.343 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 2.1 m-85 -72.86 -69.52 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.895 . . . . 0.0 110.252 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.895 ' H ' ' HG3' ' A' ' 121' ' ' ARG . . . -149.07 170.76 17.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.26 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.709 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 3.1 mp0 -148.43 112.25 5.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.238 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 54.6 tt0 -91.8 150.93 20.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.19 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 14' ' ' TYR . 23.6 m-20 52.49 19.12 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 7.4 t80 -42.85 -65.31 0.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.135 -0.978 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' GLU . 47.2 mt-10 -47.88 -57.33 5.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.212 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 5.7 mm-40 -41.83 -49.88 4.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.559 ' CD2' HD21 ' A' ' 118' ' ' LEU . 12.6 t80 -52.04 -63.3 1.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 18' ' ' LEU . 7.6 mt -44.49 -44.46 8.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.275 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 22.8 mttm -52.72 -37.93 59.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.03 -40.08 63.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.22 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.687 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -57.51 -25.22 59.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 110.231 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.687 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 79.6 23.22 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 110.162 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.581 HD21 ' HD2' ' A' ' 24' ' ' PRO . 15.5 mt -71.54 170.12 13.11 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.209 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.581 ' HD2' HD21 ' A' ' 23' ' ' LEU . 46.3 Cg_endo -73.11 139.32 29.46 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.067 1.562 . . . . 0.0 110.374 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 5.6 pt-20 -59.93 -46.74 88.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 110.238 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.536 ' OD2' ' HB2' ' A' ' 24' ' ' PRO . 2.6 p30 -47.34 -34.67 7.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.194 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.577 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 18.4 tp -88.97 -32.25 17.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.228 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.496 ' CG2' HD11 ' A' ' 18' ' ' LEU . 72.8 mt -70.61 -49.16 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 110.177 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -63.63 -32.07 73.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 110.164 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.1 ttp -84.33 -11.77 55.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 110.159 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -111.2 3.81 18.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.258 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.568 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 9.4 ptt180 -68.29 -3.21 10.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.182 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 81.0 m-20 -146.91 51.46 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.897 . . . . 0.0 110.178 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.786 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 11.6 mt -126.54 113.49 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.224 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -98.49 85.27 0.4 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.172 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.786 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.6 Cg_endo -73.05 154.69 52.72 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.983 1.517 . . . . 0.0 110.44 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.3 mt -95.32 169.31 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.193 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.1 t -145.64 118.24 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.248 -0.907 . . . . 0.0 110.225 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -98.31 147.19 24.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.483 HD11 HG22 ' A' ' 40' ' ' ILE . 65.4 mt -133.96 125.23 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -127.15 80.07 1.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.868 . . . . 0.0 110.177 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.755 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 41.1 tt0 -78.77 162.62 26.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.187 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 34.3 mmtt -159.22 46.28 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.248 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.15 -96.73 0.66 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -116.59 3.11 13.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -1.137 . . . . 0.0 110.157 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 40.5 t0 -107.98 139.28 42.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.93 . . . . 0.0 110.249 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.755 ' CE1' ' HB2' ' A' ' 42' ' ' GLN . 0.7 OUTLIER -120.61 135.61 55.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.38 103.16 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 110.154 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.503 ' CG1' ' H42' ' A' ' 131' ' ' JN3 . 60.0 t -106.08 129.03 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.157 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.486 HG21 HG21 ' A' ' 59' ' ' THR . 57.5 m -130.23 107.9 9.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.5 m -89.57 128.08 35.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.158 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -120.75 124.09 44.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.16 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.612 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -108.56 169.07 6.93 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.223 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.7 Cg_endo -73.04 -16.81 25.4 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.997 1.525 . . . . 0.0 110.483 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -111.95 -20.79 11.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.612 ' O ' ' OG1' ' A' ' 53' ' ' THR . 2.0 tt0 -160.95 155.32 23.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 p -131.46 137.54 48.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.167 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.8 t -133.65 132.04 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.908 . . . . 0.0 110.243 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.486 HG21 HG21 ' A' ' 50' ' ' THR . 17.1 m -111.79 137.31 49.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 110.205 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 59' ' ' THR . 7.5 m120 -132.38 155.77 47.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.932 . . . . 0.0 110.214 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 t -152.32 127.42 9.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.2 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.761 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 34.5 p90 -141.99 174.02 10.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.314 -0.867 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 27.7 m -118.38 150.71 39.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.52 HD12 ' CE2' ' A' ' 47' ' ' PHE . 5.6 mt -78.58 125.2 29.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.74 10.1 58.06 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -142.36 141.12 32.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -1.165 . . . . 0.0 110.173 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.8 124.87 25.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 0.0 110.22 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.479 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -125.35 149.29 48.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 0.0 110.27 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -82.15 139.08 34.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 110.138 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.683 ' CD1' ' H62' ' A' ' 131' ' ' JN3 . 4.4 mm -132.78 144.74 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 0.0 110.218 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 71' ' ' THR . 4.9 t -116.74 137.6 52.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.247 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.606 HG22 ' HO7' ' A' ' 130' ' ' JN3 . 0.2 OUTLIER -87.15 156.98 19.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.189 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.758 ' HE2' H122 ' A' ' 130' ' ' JN3 . 13.7 ttm -66.89 -16.36 64.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 110.256 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.664 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -86.56 -9.66 55.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.229 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.96 33.74 4.55 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.568 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 28.3 mttt -107.27 133.31 52.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -109.45 136.53 48.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -169.04 157.97 8.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.152 -0.968 . . . . 0.0 110.22 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 9.7 mtmt -102.29 172.06 7.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 110.227 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.3 p -178.65 137.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 110.154 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.0 m -97.04 99.75 11.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.408 ' CG1' HD23 ' A' ' 89' ' ' LEU . 46.1 t -72.84 139.03 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.235 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.64 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 11.4 p-80 -138.58 161.26 37.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.4 mt -105.63 132.12 52.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.262 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.62 115.61 13.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.218 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 59.8 t30 59.38 31.82 21.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 73.77 43.91 33.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.409 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 85.9 mttt -152.58 120.78 6.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -1.133 . . . . 0.0 110.177 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.561 HD21 ' H22' ' A' ' 131' ' ' JN3 . 7.4 tt -72.54 133.11 44.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.64 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 99.0 t -141.55 122.83 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.918 . . . . 0.0 110.198 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 54.6 m -113.85 92.48 3.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -87.46 162.35 17.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 110.208 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 28.3 t -155.8 -164.44 1.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 110.181 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.404 ' N ' ' OG ' ' A' ' 93' ' ' SER . 40.7 tt0 -103.99 31.56 4.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.92 . . . . 0.0 110.183 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.515 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -172.65 -2.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.144 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.804 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -173.7 147.99 1.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.185 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.467 ' O ' HG22 ' A' ' 111' ' ' ILE . 70.9 m -124.82 154.33 41.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 64.1 t-80 -141.6 140.36 33.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.458 ' HG3' HG21 ' A' ' 90' ' ' VAL . 29.5 tt0 -152.15 127.52 9.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 110.186 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 13.8 tt0 -130.2 150.43 51.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.229 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -148.2 154.08 39.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 110.253 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 102' ' ' VAL . 13.2 p -119.69 131.86 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -126.76 93.09 3.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.882 . . . . 0.0 110.201 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.76 -95.74 1.26 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -126.52 15.74 7.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -1.162 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -123.73 150.75 44.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 110.206 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 121' ' ' ARG . 8.2 tpp -125.79 140.14 52.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.885 . . . . 0.0 110.172 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.02 124.46 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 110.256 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 33.6 mt-10 -115.25 123.7 49.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.9 m -111.99 123.16 49.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 97' ' ' SER . 73.7 mt -129.09 128.43 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.904 . . . . 0.0 110.197 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 90.1 m -111.93 133.49 54.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 110.223 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.556 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 5.8 t80 -156.0 122.38 5.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.245 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.07 32.54 58.42 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.41 1.43 65.03 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.1 t -108.5 141.31 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -1.131 . . . . 0.0 110.218 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 89.5 m -119.57 130.99 55.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.249 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.559 HD21 ' CD2' ' A' ' 17' ' ' PHE . 59.0 tp -110.43 140.84 44.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 85.4 mt -114.61 105.29 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -106.26 119.03 38.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -0.962 . . . . 0.0 110.196 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.895 ' HG3' ' H ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -102.49 136.87 41.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.792 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 1.4 m -123.71 140.1 53.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.278 -0.889 . . . . 0.0 110.205 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 1.343 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 15.4 ptmt -99.81 146.35 26.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 68.7 ttt180 -77.43 135.95 38.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.426 ' HB ' ' OG1' ' A' ' 5' ' ' THR . 64.7 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.21 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.758 H122 ' HE2' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.761 ' H5 ' ' CE2' ' A' ' 62' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.25 0.547 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.4 ' HA ' ' CE ' ' A' ' 107' ' ' MET . 85.0 m-85 -77.67 -31.19 52.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -57.12 147.22 25.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.63 163.93 13.06 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 25.2 m -80.79 150.93 29.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 110.193 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.646 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 97.5 m95 -136.61 130.96 33.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.206 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.927 ' O ' ' HA ' ' A' ' 122' ' ' SER . 32.4 tt0 -95.73 144.59 26.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.201 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.622 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 21.7 t -66.61 119.96 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.905 . . . . 0.0 110.181 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 1.167 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.9 OUTLIER -80.94 -68.68 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 110.256 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.874 ' H ' ' HG3' ' A' ' 121' ' ' ARG . . . -150.33 169.6 21.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 110.236 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -146.44 110.59 5.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.487 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 9.5 mm-40 -88.55 155.07 19.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.686 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 68.3 m-20 47.38 21.35 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 110.165 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 4.4 t80 -46.19 -61.86 1.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' GLU . 67.0 mt-10 -51.27 -57.77 7.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.686 ' OE1' ' HA ' ' A' ' 13' ' ' ASN . 6.7 mp0 -41.7 -49.59 4.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.411 ' CD2' HD21 ' A' ' 118' ' ' LEU . 8.4 t80 -50.28 -62.8 1.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.247 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.476 HD21 ' HA ' ' A' ' 18' ' ' LEU . 9.2 mt -44.98 -47.35 11.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 90.4 mttt -49.4 -39.09 31.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.133 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.14 -38.4 63.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.174 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.671 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.3 tp -58.98 -24.81 63.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.239 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.671 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 80.25 22.49 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.683 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 6.6 mt -71.39 170.91 10.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 110.194 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.683 ' HD2' ' CD2' ' A' ' 23' ' ' LEU . 46.1 Cg_endo -72.99 138.07 27.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.004 1.528 . . . . 0.0 110.446 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -59.47 -40.76 87.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.212 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -53.24 -33.49 53.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.449 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 52.1 tp -85.65 -35.41 20.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 18' ' ' LEU . 96.2 mt -63.26 -52.09 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -59.52 -29.61 68.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.192 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.692 ' O ' HD13 ' A' ' 34' ' ' ILE . 96.2 mtp -86.37 -12.8 48.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -111.51 -3.62 15.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.888 . . . . 0.0 110.242 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -63.64 -6.61 5.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -147.2 55.21 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.791 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 16.5 mt -130.46 114.2 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -98.24 85.79 0.42 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.791 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.07 149.34 46.33 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.996 1.524 . . . . 0.0 110.426 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.697 HG21 ' N ' ' A' ' 38' ' ' VAL . 19.8 mt -89.51 175.25 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.235 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.697 ' N ' HG21 ' A' ' 37' ' ' ILE . 61.0 t -152.92 119.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -101.13 152.0 21.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 110.249 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 40' ' ' ILE . 58.2 mt -139.46 130.3 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.405 ' HB3' ' HB ' ' A' ' 48' ' ' VAL . 59.7 tt0 -130.1 72.36 1.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 110.207 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.676 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 56.4 tt0 -66.45 173.64 3.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.245 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.676 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 8.3 mtmt -171.49 35.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.234 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.1 -100.25 0.57 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -111.47 -0.86 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -1.151 . . . . 0.0 110.21 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 39.5 t0 -107.32 146.76 31.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.182 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.596 ' CD1' HD13 ' A' ' 64' ' ' LEU . 4.5 m-85 -127.53 139.52 52.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 65.7 t -120.91 101.99 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.208 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.52 ' CG1' ' H42' ' A' ' 131' ' ' JN3 . 68.8 t -103.93 130.75 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.193 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 85.5 m -133.31 105.42 6.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.89 . . . . 0.0 110.207 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -86.03 132.0 34.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -124.72 122.98 39.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.754 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -109.53 168.09 8.19 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.06 -5.99 18.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.966 1.508 . . . . 0.0 110.412 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -122.45 -18.41 6.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.19 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.529 ' O ' ' OG1' ' A' ' 53' ' ' THR . 5.8 pt20 -164.6 158.69 18.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.6 p -133.94 133.52 41.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.895 . . . . 0.0 110.21 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.53 132.84 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.214 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 13.5 t -115.28 138.71 50.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -0.912 . . . . 0.0 110.163 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -135.35 151.93 50.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 110.277 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.2 t -141.37 132.42 26.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.167 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.869 ' CD1' HG22 ' A' ' 82' ' ' VAL . 33.6 p90 -146.64 169.98 17.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.423 HG23 ' N ' ' A' ' 64' ' ' LEU . 58.1 m -117.81 153.85 32.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -0.929 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.596 HD13 ' CD1' ' A' ' 47' ' ' PHE . 8.0 mt -82.71 122.84 28.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.91 -3.16 55.7 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -132.98 148.63 52.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -1.148 . . . . 0.0 110.197 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.463 ' OE2' ' HB3' ' A' ' 79' ' ' LYS . 5.4 tm-20 -73.68 133.18 43.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.247 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -133.33 148.63 51.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.168 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 15.2 p-10 -78.14 135.1 37.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.898 . . . . 0.0 110.246 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.741 HD13 ' H62' ' A' ' 131' ' ' JN3 . 17.1 mm -127.92 143.53 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.172 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p -118.47 139.86 50.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.206 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.718 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 29.3 p -93.54 158.0 15.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.233 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.63 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 0.7 OUTLIER -68.54 -11.44 59.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.2 -0.937 . . . . 0.0 110.226 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.798 ' HB3' H151 ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -87.54 -17.78 31.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 110.256 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.86 29.48 4.07 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.718 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 28.5 mttt -105.07 136.03 45.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 8.4 ptpp? -111.57 133.25 53.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.29 162.26 25.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 110.238 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.463 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 35.4 mttt -105.28 151.03 24.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.419 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.2 m -152.88 139.3 18.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.229 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -103.01 90.56 3.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.881 . . . . 0.0 110.157 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.869 HG22 ' CD1' ' A' ' 62' ' ' PHE . 39.3 t -58.71 152.23 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.276 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.59 152.25 38.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -105.58 102.31 11.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.87 132.44 54.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.1 t30 45.61 38.18 3.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.73 41.03 93.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -147.68 125.68 12.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -1.149 . . . . 0.0 110.212 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.614 HD21 ' H22' ' A' ' 131' ' ' JN3 . 6.2 tt -75.23 132.55 41.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.4 t -137.84 123.76 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.898 . . . . 0.0 110.241 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 55.3 m -119.7 88.69 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -85.65 171.52 11.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.183 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 15.1 t -160.03 -161.24 0.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.177 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.491 ' N ' ' OG ' ' A' ' 93' ' ' SER . 23.1 mt-10 -106.15 34.49 3.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 110.202 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.45 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 7.4 ptpt -177.49 -0.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.892 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -175.76 146.85 0.76 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.74 157.89 28.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.619 ' CE1' ' H21' ' A' ' 131' ' ' JN3 . 63.4 t-80 -142.58 138.51 30.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.285 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -149.59 128.2 12.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.917 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.621 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 53.6 tt0 -128.67 155.31 45.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 9.5 mp0 -154.82 148.91 25.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.1 p -116.18 137.04 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 110.299 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -131.65 95.54 3.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.22 -98.02 1.46 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -126.25 12.08 7.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.254 -1.145 . . . . 0.0 110.196 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -118.71 156.05 29.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -0.914 . . . . 0.0 110.151 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.42 ' HG3' ' CE3' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -129.02 140.84 51.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.201 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.3 t -127.66 125.66 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.22 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -114.84 132.64 56.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.0 m -121.37 122.75 40.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.216 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.75 133.92 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 75.1 p -113.93 136.47 52.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 0.0 110.203 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.523 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 4.6 t80 -157.36 122.75 4.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.875 . . . . 0.0 110.217 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.61 36.11 62.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.74 1.86 55.2 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 112' ' ' THR . 53.0 t -106.7 143.47 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -1.155 . . . . 0.0 110.174 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 85.8 m -121.46 129.39 52.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.487 ' CD1' ' O ' ' A' ' 12' ' ' GLU . 63.0 tp -108.37 145.02 35.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 119' ' ' ILE . 72.3 mt -119.03 103.31 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -102.61 114.18 28.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.874 ' HG3' ' H ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -102.09 137.94 39.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.927 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 5.9 m -125.5 161.88 26.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 110.223 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 1.167 ' HB2' ' CE2' ' A' ' 9' ' ' TYR . 51.8 tttt -128.57 157.55 40.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 110.225 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 5' ' ' THR . 45.2 ttt180 -89.95 135.52 33.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.209 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.55 HG12 ' OE1' ' A' ' 7' ' ' GLN . 33.8 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.798 H151 ' HB3' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.746 ' H5 ' ' CE2' ' A' ' 62' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.258 0.551 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -81.09 -30.89 34.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.179 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.1 p -57.82 148.5 25.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.68 164.79 13.03 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 21.6 m -82.58 145.95 29.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -1.151 . . . . 0.0 110.202 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.504 ' CE3' ' HB2' ' A' ' 107' ' ' MET . 98.1 m95 -129.88 130.36 45.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.819 ' HB2' ' HG2' ' A' ' 123' ' ' LYS . 65.1 mt-30 -103.26 117.72 35.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.897 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.504 ' C ' ' O ' ' A' ' 7' ' ' GLN . 16.9 t -35.95 134.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.236 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 1.472 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -99.46 -57.47 2.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 110.192 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.848 ' CB ' ' HE ' ' A' ' 121' ' ' ARG . . . -158.52 163.97 36.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 110.255 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.588 ' HB2' ' CG ' ' A' ' 14' ' ' TYR . 1.8 pt20 -137.26 106.17 5.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.76 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 39.4 tt0 -94.87 126.48 40.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.951 ' ND2' ' OE1' ' A' ' 16' ' ' GLU . 18.1 t-20 77.91 -4.02 2.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.867 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.588 ' CG ' ' HB2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -29.9 -72.72 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 110.222 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 14' ' ' TYR . 46.4 mt-10 -39.52 -61.15 0.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.951 ' OE1' ' ND2' ' A' ' 13' ' ' ASN . 28.6 mt-10 -42.93 -55.86 3.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.215 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.602 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 77.1 t80 -52.82 -46.6 67.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.85 -44.33 86.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.234 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -52.33 -42.18 63.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 110.154 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.99 -31.16 69.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 110.235 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.587 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 2.7 tp -65.3 -17.14 64.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 75.48 27.54 1.03 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.157 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.6 mt -76.57 163.66 64.54 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.172 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.527 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -73.09 138.62 28.37 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.999 1.526 . . . . 0.0 110.39 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -55.38 -38.3 68.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 110.25 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 30' ' ' MET . 44.5 t0 -59.24 -27.61 65.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.229 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.568 ' CD1' H232 ' A' ' 130' ' ' JN3 . 52.5 tp -90.7 -32.59 16.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 110.171 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.637 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.7 mt -69.74 -45.62 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 110.195 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -70.31 -19.9 63.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 26' ' ' ASP . 90.1 mmm -91.47 -29.17 17.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 110.154 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.6 ' HB2' H182 ' A' ' 130' ' ' JN3 . . . -102.31 -1.59 30.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.211 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.637 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 2.4 ppt_? -65.51 -10.55 35.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.175 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 10.3 t0 -141.65 47.7 1.65 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.093 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mt -121.22 113.13 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.78 81.28 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.25 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 1.093 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.9 Cg_endo -73.06 142.39 34.39 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.921 1.485 . . . . 0.0 110.371 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.447 HG21 ' O ' ' A' ' 6' ' ' TRP . 6.6 mt -88.64 164.62 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.261 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.5 t -141.52 109.93 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.236 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -89.25 137.66 32.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.276 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.423 HD11 ' CD1' ' A' ' 6' ' ' TRP . 82.1 mt -125.04 127.36 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.198 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -127.43 70.48 1.32 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.599 ' OE1' ' CZ ' ' A' ' 47' ' ' PHE . 57.0 tt0 -68.57 164.41 21.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.231 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 37.3 mttt -162.73 46.11 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.95 -101.06 0.89 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 29.3 m-20 -111.04 -3.86 15.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -1.146 . . . . 0.0 110.179 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -99.64 151.39 21.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.61 ' CD1' HD13 ' A' ' 64' ' ' LEU . 2.3 m-85 -133.42 131.03 39.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.225 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.3 109.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.186 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.5 t -111.81 129.27 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.169 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.4 m -123.81 103.31 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.17 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.3 m -83.63 137.94 33.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 0.0 110.164 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -131.74 117.05 18.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 110.16 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.589 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -103.68 168.17 9.06 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 110.239 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.512 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.3 Cg_endo -73.08 -27.81 13.54 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.016 1.535 . . . . 0.0 110.4 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.413 ' CD ' ' OE1' ' A' ' 56' ' ' GLN . 3.6 ttm180 -97.28 -23.83 15.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.249 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.549 ' NE2' H221 ' A' ' 130' ' ' JN3 . 1.1 pm0 -161.13 161.98 31.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.224 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 p -129.74 128.06 41.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 110.226 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.462 HG22 ' HG2' ' A' ' 73' ' ' MET . 59.4 t -126.77 127.83 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 110.16 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.4 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 14.1 t -111.65 140.85 45.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.195 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.452 ' ND2' ' OG1' ' A' ' 71' ' ' THR . 23.6 m120 -138.1 131.72 30.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.175 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -123.12 136.18 54.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.214 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.737 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 45.7 p90 -149.06 167.32 26.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.216 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.1 m -116.37 148.69 40.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 110.247 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.61 HD13 ' CD1' ' A' ' 47' ' ' PHE . 37.2 mt -76.49 126.37 30.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.56 13.23 58.57 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -144.22 138.67 28.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -1.136 . . . . 0.0 110.225 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -70.68 124.48 24.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.187 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.65 149.36 49.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.254 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -77.37 137.15 38.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.731 HG23 ' H8 ' ' A' ' 131' ' ' JN3 . 25.5 mm -128.16 145.22 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -0.888 . . . . 0.0 110.226 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.452 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 2.0 p -121.73 134.78 54.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.92 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.677 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 36.5 p -86.96 156.51 19.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.91 . . . . 0.0 110.176 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.785 ' HB3' H222 ' A' ' 130' ' ' JN3 . 10.7 mtm -68.42 -15.6 63.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 110.181 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -82.32 -22.59 35.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.208 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.09 19.62 5.11 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.677 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 22.3 mttt -96.38 137.81 34.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -1.142 . . . . 0.0 110.236 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -113.96 133.22 55.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.55 162.07 30.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -106.01 143.99 33.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -0.894 . . . . 0.0 110.2 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.452 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -148.46 139.17 22.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.8 m -104.4 93.07 4.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 110.192 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.654 HG22 ' CD1' ' A' ' 62' ' ' PHE . 16.2 t -57.36 152.4 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.907 . . . . 0.0 110.217 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.54 147.28 30.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.253 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.0 mt -102.99 98.83 8.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.214 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 86' ' ' ASN . . . -110.11 138.03 47.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.159 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 85' ' ' ALA . 29.7 m120 42.98 39.35 1.75 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.47 52.09 53.56 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.755 ' HE2' ' OE1' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -161.61 112.98 1.72 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -1.18 . . . . 0.0 110.164 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.79 ' O ' HG21 ' A' ' 90' ' ' VAL . 3.9 tt -58.95 144.06 46.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.79 HG21 ' O ' ' A' ' 89' ' ' LEU . 48.1 t -151.01 114.62 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 85.5 m -109.73 94.2 4.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -91.43 165.14 13.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.859 . . . . 0.0 110.173 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.46 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 1.6 m -155.99 -158.44 0.81 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 53.1 tt0 -107.9 29.13 7.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 7.8 ptpt -171.1 1.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.247 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.863 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -178.65 148.04 0.41 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.181 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -122.72 157.83 31.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.611 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.2 t-80 -139.82 138.39 35.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 110.234 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 98' ' ' HIS . 78.1 mt-10 -152.66 126.15 8.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.489 ' NE2' ' SD ' ' A' ' 107' ' ' MET . 50.3 tt0 -133.92 155.65 49.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.755 ' OE1' ' HE2' ' A' ' 88' ' ' LYS . 47.5 tt0 -149.51 163.61 37.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.143 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 102' ' ' VAL . 12.0 p -127.2 129.49 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.182 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.6 pttt -126.94 96.9 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 110.202 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.57 -111.29 3.26 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.517 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 45.9 p-10 -115.2 14.42 16.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -1.132 . . . . 0.0 110.25 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.517 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 20.0 mt-10 -119.66 157.72 27.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.178 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.504 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 26.4 ttm -132.56 140.92 48.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 110.226 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 121' ' ' ARG . 65.1 t -127.42 133.65 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.206 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 70.9 mt-10 -117.5 123.99 47.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 110.227 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.2 m -114.02 123.13 48.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.18 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 97' ' ' SER . 82.2 mt -131.86 132.77 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 63.5 p -109.02 136.25 48.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 0.0 110.188 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.547 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 8.7 t80 -156.99 124.94 5.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.94 . . . . 0.0 110.19 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.68 38.45 89.96 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.53 2.67 44.46 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.9 t -105.66 147.1 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -1.165 . . . . 0.0 110.18 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.7 m -122.28 127.77 50.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.189 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.602 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 62.9 tp -105.98 153.07 22.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 91.4 mt -132.15 101.12 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 110.184 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 3.9 ttt180 -104.33 122.28 45.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.848 ' HE ' ' CB ' ' A' ' 10' ' ' ALA . 4.4 ptt180 -103.89 142.42 34.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.753 ' C ' ' CD2' ' A' ' 9' ' ' TYR . 0.7 OUTLIER -129.69 147.78 51.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.85 . . . . 0.0 110.248 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 1.472 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -106.57 149.15 27.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.185 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' THR . 76.1 ttt180 -82.18 139.89 34.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.171 179.943 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.785 H222 ' HB3' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.737 ' H5 ' ' CE2' ' A' ' 62' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' H3 ' HG13 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.312 0.577 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -77.29 -33.75 55.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.223 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.1 p -57.22 146.79 27.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.202 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.81 -177.91 17.31 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.6 m -105.3 132.69 51.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -1.149 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.505 ' CE3' ' HB2' ' A' ' 107' ' ' MET . 98.5 m95 -121.13 147.08 46.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.862 . . . . 0.0 110.198 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -128.82 115.38 17.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 110.175 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.67 133.88 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.301 -0.874 . . . . 0.0 110.257 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.533 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 16.4 p90 -135.88 -19.4 1.56 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.533 ' HB1' ' CE1' ' A' ' 9' ' ' TYR . . . -139.05 133.81 32.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 110.277 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -146.1 116.77 7.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.237 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.484 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 63.5 mm-40 -88.44 142.12 27.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.9 . . . . 0.0 110.281 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.5 t30 55.66 26.31 9.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.23 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 35.1 t80 -54.8 -50.39 68.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -65.99 -45.94 79.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -0.934 . . . . 0.0 110.166 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.86 -60.35 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.194 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.638 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 41.8 t80 -48.56 -60.42 2.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.192 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.629 ' O ' ' N ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -53.92 -54.39 39.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.503 ' C ' ' O ' ' A' ' 18' ' ' LEU . 56.7 mttt -36.53 -44.99 0.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.14 -27.35 68.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.672 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -60.65 -19.58 58.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.263 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.672 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 80.15 30.79 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 110.186 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.575 HD21 ' HD2' ' A' ' 24' ' ' PRO . 15.0 mt -78.03 164.52 56.53 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.925 . . . . 0.0 110.197 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HD2' HD21 ' A' ' 23' ' ' LEU . 45.4 Cg_endo -73.13 141.19 32.21 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.019 1.536 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -62.25 -39.37 92.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.159 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -57.11 -29.36 63.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.211 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.603 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 44.7 tp -89.42 -23.14 22.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.206 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.607 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.9 mt -82.29 -40.22 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.199 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -73.49 -29.09 62.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.239 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.7 ttm -88.11 -25.95 22.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.208 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -101.74 2.72 38.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.607 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 18.0 ptt180 -67.33 -1.12 4.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.234 -0.916 . . . . 0.0 110.212 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.549 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.5 m-20 -146.74 49.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.915 . . . . 0.0 110.181 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.872 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.2 mt -122.41 123.07 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.75 83.0 0.23 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.211 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.872 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -72.98 138.94 29.21 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.061 1.558 . . . . 0.0 110.454 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.7 mt -93.16 153.93 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.886 . . . . 0.0 110.208 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.3 t -132.09 119.78 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 110.199 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -98.49 134.92 40.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 110.212 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.9 mt -121.52 131.13 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -135.72 74.53 1.51 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.248 -0.908 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.637 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 1.6 pt20 -76.64 164.88 25.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 57.0 mmtt -159.02 51.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 110.213 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.15 -103.66 1.26 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 33.3 m-20 -107.82 -3.38 19.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -1.187 . . . . 0.0 110.125 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.7 t0 -103.33 148.12 26.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.875 . . . . 0.0 110.185 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.571 ' CD1' HD13 ' A' ' 64' ' ' LEU . 2.9 m-85 -132.14 139.35 48.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.9 108.96 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.165 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.477 ' CG1' ' H42' ' A' ' 131' ' ' JN3 . 92.4 t -110.08 130.03 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.238 -0.914 . . . . 0.0 110.186 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.423 ' CG2' HG21 ' A' ' 59' ' ' THR . 94.2 m -130.07 110.59 11.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -92.93 132.91 36.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.162 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -125.46 121.55 34.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.191 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.603 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.4 168.64 7.54 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.193 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' A' ' 53' ' ' THR . 46.2 Cg_endo -73.12 -18.69 23.58 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.055 1.555 . . . . 0.0 110.395 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 19.9 mtp-105 -104.57 -20.83 13.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -166.81 160.75 14.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.194 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 p -129.78 133.47 47.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.195 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.17 128.79 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 110.265 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.454 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 25.1 m -111.86 138.4 48.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.256 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 59' ' ' THR . 67.0 m-20 -134.75 153.35 52.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 t -146.51 128.4 15.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.212 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.77 ' CE1' ' H5 ' ' A' ' 131' ' ' JN3 . 33.9 p90 -140.8 173.64 11.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -123.38 141.95 51.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.571 HD13 ' CD1' ' A' ' 47' ' ' PHE . 18.1 mt -74.28 126.21 30.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.02 -1.91 55.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.0 143.32 40.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -1.19 . . . . 0.0 110.17 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -66.61 122.4 17.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.286 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.553 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -123.54 146.87 47.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.176 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -81.94 137.28 35.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.711 ' CD1' ' H62' ' A' ' 131' ' ' JN3 . 4.9 mm -128.43 145.24 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -116.29 134.47 54.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.462 HG23 H161 ' A' ' 131' ' ' JN3 . 0.3 OUTLIER -87.15 154.76 20.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.905 . . . . 0.0 110.186 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.665 ' HE1' H122 ' A' ' 130' ' ' JN3 . 12.5 ttm -65.91 -16.54 63.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.257 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.738 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -85.26 -11.35 55.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 110.186 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.25 33.2 4.65 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -107.32 133.24 52.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -1.191 . . . . 0.0 110.198 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -108.1 135.86 48.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.95 . . . . 0.0 110.199 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -167.43 156.18 9.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -103.49 166.85 10.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.23 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p -175.22 139.78 0.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.3 m -98.84 100.52 11.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.176 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.457 HG12 HD23 ' A' ' 89' ' ' LEU . 44.0 t -72.83 139.35 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 110.186 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 25.6 p-80 -136.55 161.08 36.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 110.207 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.5 mt -106.56 130.52 54.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -135.1 116.08 14.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 93.1 m-20 59.02 28.13 17.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.8 37.68 29.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -141.44 122.2 14.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -1.159 . . . . 0.0 110.248 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.552 HD21 ' H22' ' A' ' 131' ' ' JN3 . 7.8 tt -77.56 126.36 30.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.265 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.548 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 92.2 t -135.47 127.17 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.189 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.548 HG22 H111 ' A' ' 131' ' ' JN3 . 56.0 m -117.97 85.87 2.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.235 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -79.58 166.78 21.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.235 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.44 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -158.61 -167.2 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.204 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.753 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 43.4 mt-10 -100.84 43.82 1.04 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.181 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.753 ' HB3' ' O ' ' A' ' 94' ' ' GLU . 7.0 ptmt 170.1 3.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.239 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.843 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -176.95 144.65 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.417 ' O ' HG22 ' A' ' 111' ' ' ILE . 70.4 m -123.53 153.91 39.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.498 ' CD2' H122 ' A' ' 131' ' ' JN3 . 64.4 t-80 -138.56 145.89 41.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.484 ' HG3' ' CG2' ' A' ' 90' ' ' VAL . 2.4 tt0 -157.78 121.08 3.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.232 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.596 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 26.0 tt0 -122.8 159.81 27.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 27.5 mt-10 -157.61 144.76 18.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.471 HG13 ' H3 ' ' A' ' 1' ' ' ALA . 11.3 p -111.07 140.84 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.23 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -137.11 96.22 3.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.877 . . . . 0.0 110.227 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.04 -108.98 2.77 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -116.39 10.83 14.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -1.163 . . . . 0.0 110.18 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.53 156.51 28.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.188 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.505 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 27.5 ttm -128.69 141.12 51.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.338 -0.851 . . . . 0.0 110.192 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.7 t -126.37 123.97 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.867 . . . . 0.0 110.194 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 23.3 mt-10 -110.66 115.28 29.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 99' ' ' GLU . 64.1 m -105.6 122.8 46.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 110.207 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 97' ' ' SER . 61.6 mt -129.82 129.73 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 45.8 m -109.6 135.73 50.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.165 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.572 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 15.9 t80 -159.17 127.05 4.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.07 32.88 65.53 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.48 5.47 67.88 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 17' ' ' PHE . 61.6 t -110.16 143.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.334 -1.097 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.0 m -118.6 130.18 55.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.9 . . . . 0.0 110.126 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.638 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 42.7 tp -111.24 147.36 35.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.196 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 87.0 mt -122.35 95.97 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 110.275 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.603 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 3.0 ttm180 -88.94 117.52 28.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 110.213 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.489 ' HB3' ' OH ' ' A' ' 9' ' ' TYR . 29.2 mtt180 -101.69 128.82 47.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.925 . . . . 0.0 110.17 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.2 m -126.8 151.81 47.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.197 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -112.09 156.22 22.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.194 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -83.31 135.53 34.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.202 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.738 H151 ' HB3' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.77 ' H5 ' ' CE1' ' A' ' 62' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.251 0.548 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.439 ' O ' HD11 ' A' ' 40' ' ' ILE . 92.2 m-85 -78.34 -29.62 47.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.66 148.04 30.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -0.915 . . . . 0.0 110.218 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.6 163.77 13.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.8 m -80.38 152.23 28.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -1.173 . . . . 0.0 110.178 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.671 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 89.9 m95 -139.21 132.89 30.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.728 ' N ' ' O ' ' A' ' 123' ' ' LYS . 24.8 tt0 -98.71 124.66 43.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 t -44.33 126.2 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 1.289 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -88.51 -65.93 0.97 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.876 ' H ' ' HG3' ' A' ' 121' ' ' ARG . . . -155.07 163.13 40.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 11' ' ' GLN . 13.6 pt20 -136.65 101.7 4.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.614 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 56.8 tt0 -87.05 137.46 32.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.133 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 32.2 m-20 65.36 -1.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 1.032 ' CZ ' HD12 ' A' ' 18' ' ' LEU . 77.8 t80 -32.22 -64.35 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.564 ' CG ' ' N ' ' A' ' 16' ' ' GLU . 13.6 pt-20 -48.26 -51.04 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.235 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.564 ' N ' ' CG ' ' A' ' 15' ' ' GLU . 68.0 mt-10 -54.74 -61.17 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.63 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 49.0 t80 -49.61 -56.27 10.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.032 HD12 ' CZ ' ' A' ' 14' ' ' TYR . 21.0 mt -54.58 -46.81 73.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 65.2 mttt -46.83 -41.29 15.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 -26.16 66.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 110.221 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.665 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -63.22 -20.16 65.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.665 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 78.86 30.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.246 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 37.3 mt -77.32 167.3 37.56 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.259 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.577 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.0 Cg_endo -73.1 140.32 30.98 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.065 1.56 . . . . 0.0 110.41 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -61.49 -36.57 80.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.168 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -59.22 -30.06 67.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.181 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.623 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 44.9 tp -89.46 -21.21 23.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 110.153 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.75 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 78.0 mt -78.71 -41.26 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 0.0 110.198 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 32' ' ' ARG . 18.0 mtmt -75.22 -24.1 57.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.27 -0.894 . . . . 0.0 110.251 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.5 tpp -87.87 -29.8 20.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.623 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -105.52 8.4 33.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 110.23 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.75 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.0 ptm85 -67.88 -7.67 30.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 110.176 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -146.74 59.86 1.2 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 1.16 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.5 mt -129.64 110.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -88.57 80.41 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.954 . . . . 0.0 110.274 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 1.16 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.05 140.78 31.83 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.005 1.529 . . . . 0.0 110.459 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.519 ' C ' HG21 ' A' ' 38' ' ' VAL . 5.2 mt -87.9 165.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.519 HG21 ' C ' ' A' ' 37' ' ' ILE . 69.0 t -142.67 116.59 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.239 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -92.17 140.74 29.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.439 HD11 ' O ' ' A' ' 2' ' ' PHE . 75.2 mt -126.92 129.25 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 110.18 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -129.67 66.37 1.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.597 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 52.6 tt0 -63.95 168.96 4.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 33.5 mtmt -167.78 44.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 0.0 110.22 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.97 -103.97 1.04 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 25.8 m-20 -108.23 -3.11 18.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -1.187 . . . . 0.0 110.172 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.36 150.3 23.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.653 ' CD1' HD13 ' A' ' 64' ' ' LEU . 2.9 m-85 -133.25 134.37 43.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.08 109.45 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 0.0 110.18 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.0 t -111.41 129.85 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.259 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.42 HG21 ' CG2' ' A' ' 59' ' ' THR . 84.7 m -126.04 106.86 9.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 110.195 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.8 m -88.64 136.55 32.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.202 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -129.69 117.52 20.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.688 HG21 H212 ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -102.39 168.11 9.42 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.1 Cg_endo -73.05 -28.01 13.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.028 1.541 . . . . 0.0 110.394 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.14 -19.43 17.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.245 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.588 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.4 OUTLIER -164.05 160.36 21.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.244 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 p -128.94 127.85 42.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.265 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.481 HG22 ' HG3' ' A' ' 73' ' ' MET . 58.2 t -125.78 124.42 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.149 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.42 ' CG2' HG21 ' A' ' 50' ' ' THR . 36.7 m -110.17 144.57 38.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -141.24 147.73 38.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.893 . . . . 0.0 110.25 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.7 m -139.07 135.08 33.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.923 . . . . 0.0 110.264 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.769 ' CD1' HG22 ' A' ' 82' ' ' VAL . 51.7 p90 -147.69 170.99 16.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 110.229 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.2 m -118.52 145.37 45.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 110.228 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.653 HD13 ' CD1' ' A' ' 47' ' ' PHE . 51.0 mt -77.1 124.44 27.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.27 -3.75 54.8 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -134.31 148.62 50.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 0.0 110.185 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.505 ' HA ' ' CG2' ' A' ' 81' ' ' THR . 75.7 tt0 -72.45 128.54 35.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.224 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.515 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.96 150.74 50.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -82.05 133.71 35.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.706 HG23 ' H8 ' ' A' ' 131' ' ' JN3 . 22.9 mm -123.45 145.06 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 96.3 m -122.8 135.07 54.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.686 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 43.1 p -89.78 157.92 17.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.672 ' HE3' H122 ' A' ' 130' ' ' JN3 . 0.9 OUTLIER -68.3 -12.53 61.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.268 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -85.31 -21.5 28.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.06 23.23 4.99 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.686 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 27.1 mttt -98.62 135.32 40.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -1.118 . . . . 0.0 110.161 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -113.01 135.22 54.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 110.21 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -164.47 160.69 20.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.152 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.419 ' HD3' ' OE2' ' A' ' 67' ' ' GLU . 25.8 mttp -104.05 146.33 28.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.279 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.561 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -148.58 141.8 25.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.505 ' CG2' ' HA ' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -106.43 89.39 3.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.211 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.769 HG22 ' CD1' ' A' ' 62' ' ' PHE . 12.2 t -57.71 152.54 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.161 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.19 146.12 28.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.429 ' CD1' HD11 ' A' ' 64' ' ' LEU . 14.9 mt -98.41 101.02 12.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.843 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 86' ' ' ASN . . . -117.33 148.91 41.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.222 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' ALA . 3.4 t-20 44.53 27.51 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.159 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 70.45 40.17 68.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.805 ' HD3' ' CD ' ' A' ' 101' ' ' GLU . 11.1 mttt -152.95 132.09 12.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.208 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.569 HD12 HG12 ' A' ' 82' ' ' VAL . 8.3 tt -72.19 135.9 46.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.547 HG11 ' HG2' ' A' ' 99' ' ' GLU . 11.6 m -143.72 123.26 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.235 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.561 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 95.2 m -114.56 91.87 3.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -88.49 163.78 15.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.238 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 29.3 t -152.65 -158.03 0.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.196 -0.94 . . . . 0.0 110.197 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.459 ' N ' ' OG ' ' A' ' 93' ' ' SER . 44.6 mt-10 -106.59 26.15 10.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.489 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 7.8 ptpt -167.03 0.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.94 ' CD1' ' O ' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -177.67 146.21 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 111' ' ' ILE . 29.3 t -117.72 160.03 22.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.554 ' CD2' H122 ' A' ' 131' ' ' JN3 . 58.6 t-80 -143.99 139.25 28.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.547 ' HG2' HG11 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -152.18 127.77 10.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.544 ' NE2' ' SD ' ' A' ' 107' ' ' MET . 46.0 tt0 -131.66 155.04 48.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.188 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.805 ' CD ' ' HD3' ' A' ' 88' ' ' LYS . 45.1 tt0 -151.64 155.09 37.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.52 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.2 p -119.33 134.4 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.219 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.18 94.67 3.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.172 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.38 -111.84 3.37 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -116.23 18.31 15.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.17 . . . . 0.0 110.253 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -123.66 148.51 46.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.218 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.544 ' SD ' ' NE2' ' A' ' 100' ' ' GLN . 34.0 ttm -123.58 139.06 54.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 0.0 110.247 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.62 129.33 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 33.4 mt-10 -115.6 109.81 18.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 110.199 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 99' ' ' GLU . 25.8 m -99.01 123.21 43.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.133 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 97' ' ' SER . 52.7 mt -132.29 129.28 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.223 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.8 m -104.63 142.92 33.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.887 . . . . 0.0 110.267 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.609 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 5.6 t80 -163.16 124.83 2.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.9 37.44 83.67 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.34 9.38 60.91 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.2 t -112.32 140.2 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -1.13 . . . . 0.0 110.194 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.7 m -113.72 129.31 56.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 110.221 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.63 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 48.4 tp -108.66 153.65 23.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.259 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 119' ' ' ILE . 94.8 mt -130.97 94.55 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 0.9 OUTLIER -95.97 128.65 43.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 110.272 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.876 ' HG3' ' H ' ' A' ' 10' ' ' ALA . 1.3 ptp180 -109.85 136.9 48.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.226 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.59 ' C ' ' HD2' ' A' ' 9' ' ' TYR . 39.8 m -125.57 135.46 52.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 1.289 ' HB2' ' CE2' ' A' ' 9' ' ' TYR . 71.7 tttt -92.94 153.89 18.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.246 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 27.5 ttp85 -89.52 134.83 33.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.221 179.926 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.802 H192 ' HE1' ' A' ' 14' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.765 ' H5 ' ' CE2' ' A' ' 62' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.281 0.563 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -76.33 -33.16 58.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 110.224 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.1 p -56.08 146.55 22.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 110.159 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.7 -172.49 19.47 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 p -110.69 128.04 55.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -1.133 . . . . 0.0 110.233 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.528 ' O ' HG21 ' A' ' 37' ' ' ILE . 94.3 m95 -115.92 143.51 45.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.171 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -128.71 116.67 19.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.179 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.08 144.88 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.253 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 9' ' ' TYR . 8.0 p90 -147.09 -14.23 0.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.251 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.494 ' HB1' ' CE1' ' A' ' 9' ' ' TYR . . . -139.61 141.86 37.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.14 164.7 37.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -140.33 158.8 43.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.19 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 46.51 38.03 5.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 110.233 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 7.8 t80 -69.84 -55.33 10.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -53.19 -57.88 8.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.271 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -48.38 -45.44 35.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.222 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -55.59 -57.25 12.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 110.228 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -51.07 -43.32 61.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.167 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -54.78 -35.49 63.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.39 -41.91 62.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -0.97 . . . . 0.0 110.162 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.658 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 1.7 tp -55.26 -25.58 34.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.658 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . 80.56 24.13 0.35 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.588 HD21 ' HD2' ' A' ' 24' ' ' PRO . 14.5 mt -69.13 166.52 27.99 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.145 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.588 ' HD2' HD21 ' A' ' 23' ' ' LEU . 46.0 Cg_endo -73.14 132.13 17.61 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.058 1.557 . . . . 0.0 110.407 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -49.7 -46.04 49.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.972 . . . . 0.0 110.264 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -50.33 -35.81 29.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.191 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.58 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 41.7 tp -84.45 -33.61 23.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.434 HG12 ' CD1' ' A' ' 18' ' ' LEU . 96.9 mt -61.22 -56.09 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.149 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HG3' ' HG3' ' A' ' 30' ' ' MET . 13.4 pttp -56.01 -24.43 39.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.688 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 85.6 mtp -94.17 -9.74 35.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.245 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -113.34 -5.84 13.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.218 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.707 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -71.86 0.82 8.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 110.286 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.707 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.5 m-20 -150.18 41.69 0.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.688 ' CD1' ' O ' ' A' ' 30' ' ' MET . 23.8 mt -122.84 115.47 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.267 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -100.82 90.19 1.45 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.674 ' HB3' HG21 ' A' ' 53' ' ' THR . 46.5 Cg_endo -73.09 146.04 40.49 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.918 1.483 . . . . 0.0 110.4 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.528 HG21 ' O ' ' A' ' 6' ' ' TRP . 6.4 mt -86.45 173.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.439 ' N ' ' CG2' ' A' ' 37' ' ' ILE . 70.0 t -150.19 119.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.177 -0.952 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -103.45 148.04 26.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.225 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.8 mt -136.4 132.14 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 110.23 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 55.9 tt0 -132.28 73.82 1.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.793 ' OE1' ' N ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -68.73 170.53 9.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.244 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.626 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 14.2 mtmt -168.55 43.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.793 ' N ' ' OE1' ' A' ' 42' ' ' GLN . . . 120.04 -102.49 0.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 26.8 m-20 -110.36 -2.0 16.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -1.135 . . . . 0.0 110.154 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.1 t0 -104.2 150.39 24.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.672 ' CE1' ' HG3' ' A' ' 42' ' ' GLN . 3.0 m-85 -131.37 137.27 48.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.21 108.08 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.141 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.534 ' CG1' ' H42' ' A' ' 131' ' ' JN3 . 62.8 t -108.37 130.92 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.415 ' OG1' HG23 ' A' ' 59' ' ' THR . 77.6 m -133.22 106.07 7.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.3 m -89.04 137.68 32.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.887 . . . . 0.0 110.223 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -130.97 124.11 30.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 110.258 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.674 HG21 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.08 169.25 6.81 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.485 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.4 Cg_endo -73.0 -20.53 21.82 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.992 1.522 . . . . 0.0 110.414 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -105.67 -22.46 12.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.497 ' O ' ' OG1' ' A' ' 53' ' ' THR . 4.5 pt20 -159.74 161.76 34.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 p -132.4 128.15 36.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 110.233 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.55 127.42 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.91 . . . . 0.0 110.233 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.415 HG23 ' OG1' ' A' ' 50' ' ' THR . 91.5 m -111.28 142.09 43.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 49' ' ' VAL . 28.1 m120 -139.41 151.05 45.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.162 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 m -141.58 135.14 29.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.191 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.619 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 35.0 p90 -148.26 166.65 27.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.8 m -116.02 150.4 37.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.611 HD13 ' CD1' ' A' ' 47' ' ' PHE . 31.4 mt -78.45 125.66 29.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.928 . . . . 0.0 110.198 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.47 5.93 60.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -139.95 139.46 36.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -1.135 . . . . 0.0 110.222 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -65.91 124.8 23.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.541 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -124.76 148.16 48.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.154 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 14.8 p-10 -81.18 136.89 35.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.161 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.85 HD13 ' H62' ' A' ' 131' ' ' JN3 . 23.7 mm -128.85 142.43 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 110.161 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.416 ' N ' HG21 ' A' ' 70' ' ' ILE . 5.0 m -113.55 139.88 48.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 110.233 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.672 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 68.3 p -93.97 158.39 15.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.759 ' HE2' H122 ' A' ' 130' ' ' JN3 . 15.8 ttm -70.67 -13.28 62.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.206 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.915 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.3 p30 -86.54 -12.87 47.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.02 25.42 7.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.672 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 12.0 mttt -102.89 136.89 41.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -1.114 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -110.67 135.37 51.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.162 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.21 153.67 9.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.277 -0.89 . . . . 0.0 110.208 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -99.23 155.98 17.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.3 m -157.92 134.26 9.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.167 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -96.55 96.38 8.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.196 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.625 HG11 ' CD2' ' A' ' 89' ' ' LEU . 48.4 t -69.92 142.53 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.669 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 13.9 p-80 -140.84 155.49 46.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.177 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.5 mt -100.12 132.34 45.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.237 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -138.75 111.51 7.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.22 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.675 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 86.2 m-20 64.35 27.59 13.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.214 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.515 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.34 43.5 20.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.634 ' HD2' ' OE2' ' A' ' 101' ' ' GLU . 49.4 mtpt -153.37 118.86 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -1.167 . . . . 0.0 110.203 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.625 ' CD2' HG11 ' A' ' 82' ' ' VAL . 4.8 tt -68.69 142.94 54.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.233 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.669 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 55.3 t -150.69 120.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.41 ' HB ' H112 ' A' ' 131' ' ' JN3 . 5.4 m -114.04 95.73 5.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.0 167.48 13.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.24 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 3.3 m -158.55 -168.08 2.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 110.236 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 27.0 tp10 -101.74 33.68 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 8.6 ptpt -174.75 0.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.226 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.895 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -179.01 144.71 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 0.0 110.184 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.9 m -119.4 158.37 26.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.581 ' CD2' H122 ' A' ' 131' ' ' JN3 . 56.8 t-80 -143.42 136.52 27.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.207 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -148.32 131.38 16.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.219 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.483 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 40.5 tt0 -134.7 152.9 52.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.227 -0.921 . . . . 0.0 110.186 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.634 ' OE2' ' HD2' ' A' ' 88' ' ' LYS . 58.1 tt0 -150.72 159.11 44.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.457 HG21 ' CH2' ' A' ' 6' ' ' TRP . 12.7 p -123.52 136.89 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 110.18 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -130.65 96.97 4.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.246 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.53 -98.08 1.75 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.496 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 30.7 p-10 -126.87 11.6 7.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -1.137 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.496 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 48.4 mt-10 -118.38 164.99 14.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.213 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.519 ' CE ' ' NE1' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -137.27 143.04 41.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.17 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 76.4 t -127.21 127.31 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.375 -0.828 . . . . 0.0 110.238 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 33.9 mt-10 -114.42 134.74 54.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.0 m -124.09 122.38 37.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.179 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 74.8 mt -127.76 131.82 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 110.2 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 80.5 m -112.75 135.58 53.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 4.9 t80 -156.81 123.95 5.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.17 -0.956 . . . . 0.0 110.274 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.03 37.75 73.67 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.49 4.68 52.89 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 112' ' ' THR . 60.2 t -108.65 139.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -1.17 . . . . 0.0 110.178 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 63.6 m -115.13 130.86 57.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.9 tp -110.19 141.93 42.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.182 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.6 mt -120.34 121.36 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.453 ' NH1' ' H12' ' A' ' 130' ' ' JN3 . 22.3 mtm180 -117.75 117.57 29.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.156 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 12.2 mtt180 -98.24 129.01 44.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.169 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.5 p -125.74 166.33 16.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 110.263 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -129.62 158.83 38.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 110.155 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.408 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 73.8 ttt180 -81.35 134.58 35.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.22 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' JN3 . . . . . 0.915 H151 ' HB3' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' JN3 . . . . . 0.85 ' H62' HD13 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.23 0.538 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 m -56.56 145.16 29.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.888 . . . . 0.0 110.182 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.6 -176.48 17.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.4 m -106.35 131.28 53.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -1.137 . . . . 0.0 110.251 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.467 ' CZ3' ' HG3' ' A' ' 107' ' ' MET . 93.0 m95 -119.62 142.84 48.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -124.22 122.12 36.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 110.257 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.15 127.21 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 121' ' ' ARG . 34.3 p90 -133.08 2.37 3.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.251 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.82 127.99 2.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -143.96 120.77 11.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.243 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 55.7 tt0 -99.82 144.65 28.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.941 . . . . 0.0 110.197 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 22.3 m120 58.32 16.33 3.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.277 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.961 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 90.4 t80 -52.98 -47.64 68.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 110.164 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.09 -47.51 76.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 37.0 mt-10 -56.47 -60.23 3.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.67 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 45.0 t80 -49.74 -54.99 15.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.961 HD11 ' CZ ' ' A' ' 14' ' ' TYR . 22.2 mt -52.68 -49.51 65.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 63.1 mttt -42.47 -40.19 2.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.915 . . . . 0.0 110.156 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.451 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -68.84 -25.54 64.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.864 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -59.04 -19.09 40.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.181 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.864 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 76.36 25.43 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.903 . . . . 0.0 110.166 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 20.3 mt -75.17 168.24 29.35 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 23' ' ' LEU . 46.4 Cg_endo -73.05 138.06 27.52 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.01 1.531 . . . . 0.0 110.444 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 28' ' ' ILE . 69.4 mm-40 -54.32 -44.44 72.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.925 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -53.75 -25.3 18.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.524 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 44.9 tp -90.36 -23.95 20.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.901 . . . . 0.0 110.243 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.854 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 81.2 mt -74.81 -42.3 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.233 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -74.97 -20.6 59.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.9 mmm -93.0 -27.12 17.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.212 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.513 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -105.71 4.44 30.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 110.273 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.854 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 23.4 ptt180 -72.43 3.63 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 10.4 t0 -154.45 47.19 0.58 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.081 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 4.2 mt -121.12 117.29 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 110.168 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -91.3 82.48 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.186 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.081 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.09 132.89 18.77 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.034 1.544 . . . . 0.0 110.428 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 38' ' ' VAL . 8.2 mt -83.2 162.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.414 ' N ' HG22 ' A' ' 37' ' ' ILE . 73.0 t -140.67 116.48 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 40' ' ' ILE . 36.0 tt0 -97.21 136.01 38.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.855 . . . . 0.0 110.224 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 39' ' ' GLU . 51.5 mm -123.63 132.78 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.198 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 48' ' ' VAL . 37.2 tt0 -132.56 63.21 1.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 110.2 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.646 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 51.6 tt0 -59.3 165.8 2.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 110.218 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 38.3 mtmt -163.77 37.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.28 -97.84 0.53 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 14.8 m-20 -112.4 -7.48 13.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -1.122 . . . . 0.0 110.166 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.621 ' OD1' HG23 ' A' ' 63' ' ' THR . 12.0 m-20 -102.55 157.75 16.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.592 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 41.3 m-85 -138.55 139.5 38.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.218 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 58.6 t -117.19 104.19 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.439 HG22 ' CD1' ' A' ' 40' ' ' ILE . 57.6 t -104.16 128.32 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.685 HG23 ' OG1' ' A' ' 59' ' ' THR . 94.0 m -130.51 100.27 5.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.1 m -83.68 140.15 32.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 110.224 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 57' ' ' THR . 55.3 mttt -132.17 107.38 8.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.868 . . . . 0.0 110.204 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.97 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -94.0 168.15 12.25 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 110.211 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.781 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.6 Cg_endo -72.96 -29.93 11.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.016 1.535 . . . . 0.0 110.477 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -95.35 -22.05 18.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -162.45 169.58 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.211 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 52' ' ' LYS . 9.2 p -134.6 124.88 26.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.227 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 73' ' ' MET . 54.0 t -123.24 125.86 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.685 ' OG1' HG23 ' A' ' 50' ' ' THR . 64.3 m -112.94 148.16 35.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.213 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -143.87 147.52 34.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.279 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 t -138.92 140.12 38.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.621 ' CE1' HG11 ' A' ' 82' ' ' VAL . 34.5 p90 -151.89 166.19 32.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -0.904 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.621 HG23 ' OD1' ' A' ' 46' ' ' ASP . 88.7 m -116.26 152.26 34.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 3.9 tp -78.47 122.91 26.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.56 14.4 53.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -144.63 136.11 25.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -1.169 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.0 123.1 18.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.461 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.12 150.54 43.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.244 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -83.93 132.58 34.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 110.222 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 70' ' ' ILE . 26.7 mm -121.85 146.31 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 m -123.62 136.97 54.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 0.0 110.21 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.674 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 57.9 p -90.92 162.68 14.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.291 -0.88 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.487 ' HA ' HG21 ' A' ' 58' ' ' VAL . 23.9 mtm -75.8 -10.62 59.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.506 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 4.5 p30 -88.76 -14.92 35.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.49 28.73 4.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.674 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 18.0 mttt -107.02 128.16 54.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -1.121 . . . . 0.0 110.233 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -107.06 139.36 41.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.208 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.29 154.37 5.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.208 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.0 mtmm -98.6 153.05 18.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.419 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -157.82 133.66 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 m -95.2 102.58 14.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.186 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.838 HG13 HD21 ' A' ' 89' ' ' LEU . 47.5 t -73.81 142.99 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 6.5 p-80 -144.36 157.25 44.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.927 . . . . 0.0 110.246 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 84' ' ' LEU . 12.0 mt -99.86 134.26 43.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.875 . . . . 0.0 110.233 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -140.73 117.22 10.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.246 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.603 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 17.9 m120 61.93 27.59 16.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.53 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.61 40.58 26.75 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.53 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 61.3 mttt -151.4 130.32 12.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -1.14 . . . . 0.0 110.225 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.838 HD21 HG13 ' A' ' 82' ' ' VAL . 7.4 tt -76.58 129.94 37.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.742 HG13 ' HG2' ' A' ' 99' ' ' GLU . 70.3 t -138.46 125.92 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.932 . . . . 0.0 110.188 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.532 ' OG1' HG22 ' A' ' 82' ' ' VAL . 51.9 m -117.92 90.57 3.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 12.1 pttp -85.24 164.55 17.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 110.211 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 34.9 t -155.07 -158.37 0.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.405 ' N ' ' OG ' ' A' ' 93' ' ' SER . 35.0 mt-10 -108.1 35.41 3.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 110.239 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -177.58 1.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.0 110.149 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.896 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER 179.21 148.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.198 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -121.76 160.62 24.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.155 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 52.1 t-80 -142.15 140.92 32.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.182 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.742 ' HG2' HG13 ' A' ' 90' ' ' VAL . 48.2 mt-10 -151.74 126.33 9.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.226 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.689 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 41.3 tt0 -125.95 156.32 39.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.161 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.689 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 7.8 mp0 -157.53 147.55 20.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.902 . . . . 0.0 110.261 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.0 p -116.12 139.26 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -130.33 99.48 5.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.925 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.37 -118.11 5.76 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -103.9 8.15 36.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.232 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -116.1 159.06 22.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.467 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -129.04 139.2 52.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.289 -0.882 . . . . 0.0 110.17 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 80.0 t -126.33 126.18 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.2 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 35.1 mt-10 -110.5 131.28 55.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 99' ' ' GLU . 12.2 p -122.17 117.62 26.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 97' ' ' SER . 53.8 mt -129.16 139.41 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.251 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 69.9 p -112.75 131.56 55.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.176 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 3.2 t80 -151.89 126.82 9.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.918 . . . . 0.0 110.231 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.451 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.42 36.51 92.72 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.89 11.42 66.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.497 HG11 ' HA ' ' A' ' 17' ' ' PHE . 69.2 t -114.36 138.06 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -1.117 . . . . 0.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 43.9 m -112.18 135.67 52.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 110.195 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.67 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 59.2 tp -115.0 144.36 43.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.1 mt -125.7 94.44 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 9.9 ttp180 -89.54 132.26 35.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 110.204 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.501 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 45.1 mtm180 -109.9 122.8 48.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 6' ' ' TRP . 59.2 m -119.73 152.96 36.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -116.98 155.48 29.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.212 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' THR . 39.5 ttp85 -81.38 135.2 35.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.221 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.244 0.545 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.1 p -56.87 146.26 27.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.299 -0.875 . . . . 0.0 110.172 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.15 -174.06 17.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 89.0 m -107.64 131.11 54.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -1.141 . . . . 0.0 110.241 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.556 ' CD1' HD12 ' A' ' 40' ' ' ILE . 90.8 m95 -120.15 145.09 47.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -126.47 122.06 34.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.851 . . . . 0.0 110.177 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.5 126.02 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 39.1 p90 -126.81 -29.61 2.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.912 . . . . 0.0 110.19 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.78 129.57 40.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.86 . . . . 0.0 110.269 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.6 pt20 -143.11 119.61 11.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 110.203 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.535 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.6 tt0 -98.66 144.45 27.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 110.247 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.868 ' ND2' ' OE1' ' A' ' 16' ' ' GLU . 1.0 OUTLIER 60.25 14.21 4.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.154 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.861 ' CE1' HD11 ' A' ' 18' ' ' LEU . 74.0 t80 -51.59 -52.14 49.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -62.95 -48.5 78.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.868 ' OE1' ' ND2' ' A' ' 13' ' ' ASN . 65.3 mt-10 -55.73 -59.36 4.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.148 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.713 ' CD2' HD22 ' A' ' 118' ' ' LEU . 70.4 t80 -49.2 -55.49 12.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.861 HD11 ' CE1' ' A' ' 14' ' ' TYR . 12.7 mt -58.15 -42.25 85.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 3.5 tttm -49.14 -41.23 35.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.57 -27.75 66.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.902 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.1 tp -58.75 -20.27 47.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.61 28.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 110.268 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 21' ' ' LEU . 65.6 mt -74.73 165.86 50.2 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.134 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.554 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 45.6 Cg_endo -73.14 140.13 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.021 1.537 . . . . 0.0 110.382 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.7 -40.87 84.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.61 -26.58 56.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.229 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.674 HD22 ' OD1' ' A' ' 74' ' ' ASP . 43.3 tp -92.46 -19.41 22.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.747 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 94.0 mt -82.92 -40.93 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 0.0 110.172 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -75.36 -27.56 59.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.174 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 57.9 tpp -86.53 -27.64 23.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.237 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -103.03 4.92 37.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.747 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 6.3 ptt180 -71.57 2.07 5.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -152.33 48.66 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 110.24 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.1 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.9 mt -123.72 118.46 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.207 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.47 84.56 0.11 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.232 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.1 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.05 130.58 15.62 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.986 1.519 . . . . 0.0 110.433 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.8 mt -84.39 157.86 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.6 t -137.26 115.77 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -96.27 137.49 35.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.556 HD12 ' CD1' ' A' ' 6' ' ' TRP . 79.3 mt -123.95 129.72 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 55.8 tt0 -130.33 67.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 0.0 110.23 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.733 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 48.8 tt0 -62.39 171.37 1.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.143 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.733 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 17.9 mtmt -171.74 38.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.153 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.16 -104.54 0.87 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -108.52 0.64 21.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -1.149 . . . . 0.0 110.222 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.1 t0 -108.89 145.04 36.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.696 ' CE1' HD11 ' A' ' 64' ' ' LEU . 7.6 m-85 -127.18 139.43 52.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 110.276 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 59.4 t -120.01 104.61 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.29 122.44 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 110.146 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.674 HG23 ' OG1' ' A' ' 59' ' ' THR . 91.3 m -122.72 106.08 10.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 110.261 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 58' ' ' VAL . 51.1 m -92.61 134.58 34.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -127.11 119.6 26.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.961 . . . . 0.0 110.289 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.653 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -103.25 169.86 6.92 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.174 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.07 -17.82 24.5 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.093 1.575 . . . . 0.0 110.404 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -104.88 -24.71 12.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.956 . . . . 0.0 110.213 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.653 ' O ' ' OG1' ' A' ' 53' ' ' THR . 3.8 pt20 -163.58 169.08 19.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.186 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.0 p -129.79 127.85 41.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.231 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' A' ' 73' ' ' MET . 19.4 m -124.96 127.02 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.177 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.674 ' OG1' HG23 ' A' ' 50' ' ' THR . 36.2 m -115.64 147.36 40.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -142.46 149.46 39.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.261 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.3 t -141.81 137.76 31.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.152 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.62 ' CE1' HG21 ' A' ' 82' ' ' VAL . 52.0 p90 -150.5 169.89 20.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 110.237 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.9 m -117.65 150.57 38.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.196 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.696 HD11 ' CE1' ' A' ' 47' ' ' PHE . 17.3 mt -79.53 123.81 27.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 110.212 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.48 9.66 52.56 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -145.72 143.7 29.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -1.131 . . . . 0.0 110.193 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -68.68 127.78 34.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.202 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.592 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.06 147.63 50.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -80.28 134.99 36.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.241 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 70' ' ' ILE . 23.8 mm -124.26 144.81 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.151 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.1 m -121.78 136.06 54.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.21 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.613 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 66.4 p -87.88 161.14 17.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.605 ' HA ' HG11 ' A' ' 58' ' ' VAL . 1.5 ttp -73.89 -11.91 60.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.198 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.674 ' OD1' HD22 ' A' ' 27' ' ' LEU . 7.3 t0 -89.13 -14.04 37.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 110.213 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.67 50.77 0.83 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.613 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 7.7 tttt -128.61 129.65 46.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -1.155 . . . . 0.0 110.146 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -105.79 137.59 43.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.203 -0.936 . . . . 0.0 110.192 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.1 155.08 11.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.232 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -101.45 145.47 28.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.537 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.3 m -153.08 133.78 13.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.307 -0.871 . . . . 0.0 110.156 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -94.97 100.04 11.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.788 HG13 HD21 ' A' ' 89' ' ' LEU . 49.4 t -70.36 142.26 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.66 ' CE1' ' HB ' ' A' ' 90' ' ' VAL . 24.5 p80 -146.04 151.41 37.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.15 132.03 40.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 110.262 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -140.87 131.49 25.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 97.3 m-20 56.69 17.43 3.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.2 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.56 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 83.8 40.88 8.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.56 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 97.4 mttt -155.57 131.84 10.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -1.121 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.788 HD21 HG13 ' A' ' 82' ' ' VAL . 6.7 tt -72.64 130.89 41.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.244 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.753 HG22 ' HG3' ' A' ' 99' ' ' GLU . 92.8 t -139.25 125.31 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.179 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.537 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 99.5 m -115.65 90.16 3.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -84.59 169.5 14.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.214 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 29.5 t -160.72 -157.58 0.54 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 110.196 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.445 ' N ' ' OG ' ' A' ' 93' ' ' SER . 18.7 tt0 -109.74 32.93 4.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.231 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.709 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -175.74 6.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 1.073 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.3 OUTLIER 171.87 141.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 110.26 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -114.72 174.75 5.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.423 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 47.6 t-80 -156.31 137.84 14.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.148 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.753 ' HG3' HG22 ' A' ' 90' ' ' VAL . 69.5 tt0 -149.85 126.49 10.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.218 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 47.5 tt0 -125.54 161.16 27.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.923 . . . . 0.0 110.247 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.532 ' OE1' ' HG3' ' A' ' 103' ' ' LYS . 10.9 tm-20 -161.81 148.72 14.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.434 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 10.8 p -116.0 143.18 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 110.223 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.532 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 92.6 mttt -133.26 92.7 3.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.99 -109.81 2.98 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.678 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 24.5 p30 -112.1 11.23 20.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -1.152 . . . . 0.0 110.18 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.678 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 61.5 mt-10 -118.64 155.18 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.491 ' HG3' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -125.1 141.85 51.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.48 121.54 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.13 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 40.8 mt-10 -107.74 119.27 38.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.556 ' N ' ' O ' ' A' ' 99' ' ' GLU . 38.0 p -108.48 119.61 40.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 97' ' ' SER . 53.0 mt -130.39 131.73 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.357 -0.84 . . . . 0.0 110.209 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 6.3 t -110.55 141.27 43.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.175 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.704 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 10.7 t80 -161.26 128.34 4.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.15 33.95 74.85 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.9 12.78 75.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 112' ' ' THR . 73.1 t -116.48 139.47 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -1.155 . . . . 0.0 110.191 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 47.3 m -112.92 134.0 54.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.713 HD22 ' CD2' ' A' ' 17' ' ' PHE . 43.1 tp -114.07 150.55 33.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.0 mt -130.6 94.74 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 9.4 ttp180 -88.93 131.42 35.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 25.7 mtt-85 -110.41 124.71 52.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.915 . . . . 0.0 110.174 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.1 m -122.07 149.44 43.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -115.38 153.15 31.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.19 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.7 ttp85 -78.19 134.75 37.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 125' ' ' VAL . 62.4 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.192 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.45 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 49.3 m-85 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.319 0.581 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 p -57.65 144.93 35.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.97 -178.7 17.33 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 91.0 m -106.13 134.73 48.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -1.148 . . . . 0.0 110.242 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.476 ' CE3' ' HB2' ' A' ' 107' ' ' MET . 92.9 m95 -121.15 136.33 55.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -118.88 118.15 30.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.201 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.448 HG21 ' HD2' ' A' ' 120' ' ' ARG . 59.5 t -63.94 126.03 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.238 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 11.8 p90 -128.5 -19.59 3.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -141.74 131.6 24.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.207 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -143.06 166.47 24.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.226 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 56.0 tt0 -141.03 146.44 37.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.932 . . . . 0.0 110.21 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 79.4 m-20 56.19 20.72 4.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.499 ' CE1' HD21 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -54.18 -53.67 50.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.862 . . . . 0.0 110.215 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -59.36 -57.04 14.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -46.25 -52.93 11.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.603 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 69.6 t80 -52.56 -46.3 66.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.17 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 mt -59.3 -43.05 92.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.893 . . . . 0.0 110.172 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -54.58 -42.08 70.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.4 75.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.83 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 3.9 tp -64.42 -17.41 63.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.17 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.83 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 74.95 28.91 1.04 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.226 -0.922 . . . . 0.0 110.22 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.559 HD11 HD23 ' A' ' 21' ' ' LEU . 20.2 mt -75.39 165.03 56.98 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.75 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.3 Cg_endo -73.11 139.89 30.3 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.036 1.545 . . . . 0.0 110.473 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HG2' ' HG3' ' A' ' 29' ' ' LYS . 41.9 tt0 -58.56 -36.32 73.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.291 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -61.55 -28.89 69.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.893 . . . . 0.0 110.192 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.75 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 33.3 tp -92.11 -29.2 16.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.222 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.654 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 95.8 mt -74.48 -44.29 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 3.5 mmpt? -71.07 -23.96 62.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.207 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.0 ttp -89.68 -29.31 18.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.16 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -100.64 -0.29 37.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.236 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.654 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -65.97 -11.61 48.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HB2' ' NE ' ' A' ' 32' ' ' ARG . 6.5 t0 -138.08 45.56 2.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 0.0 110.16 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.034 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 1.7 mt -115.81 122.1 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.895 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.54 82.42 0.12 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.236 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.034 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.7 Cg_endo -73.0 136.64 25.22 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.008 1.53 . . . . 0.0 110.451 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.6 mt -89.24 154.67 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.218 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.4 t -131.58 111.48 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 73.6 tt0 -94.81 132.47 39.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.451 HD12 ' CD1' ' A' ' 6' ' ' TRP . 67.4 mt -118.77 128.51 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -133.63 74.81 1.57 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 110.181 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.519 ' OE1' ' CZ ' ' A' ' 47' ' ' PHE . 13.0 pt20 -78.41 162.72 26.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 110.208 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 86.3 mttt -156.47 49.12 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 0.0 110.19 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.04 -100.61 0.9 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 39.5 m-20 -110.48 -7.85 14.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -1.221 . . . . 0.0 110.198 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -98.58 152.96 19.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.211 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.688 ' CD1' HD11 ' A' ' 64' ' ' LEU . 1.6 m-85 -136.42 136.42 39.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 110.155 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.01 110.82 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.196 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 4.6 m -113.75 135.32 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 91.1 m -122.07 98.16 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.91 . . . . 0.0 110.203 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.2 m -78.63 138.54 38.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.198 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -132.83 114.74 14.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.255 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.933 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -99.31 168.33 9.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.772 ' HD2' HG22 ' A' ' 53' ' ' THR . 47.1 Cg_endo -73.07 -33.85 7.01 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.017 1.535 . . . . 0.0 110.529 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -93.07 -21.87 19.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.221 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.658 ' O ' ' OG1' ' A' ' 53' ' ' THR . 1.6 tt0 -161.4 162.12 30.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.448 ' N ' ' CG ' ' A' ' 56' ' ' GLN . 3.5 p -128.71 130.11 46.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 110.263 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 73' ' ' MET . 87.9 t -129.19 124.28 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.186 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 14.5 t -109.64 143.08 39.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.285 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -138.72 148.98 44.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 110.211 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.4 t -140.59 134.94 31.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 110.245 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.666 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 27.5 p90 -148.03 166.91 26.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.7 m -115.46 146.38 41.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 0.0 110.185 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.688 HD11 ' CD1' ' A' ' 47' ' ' PHE . 14.5 mt -78.51 122.83 26.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.226 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.1 4.63 41.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -145.51 151.92 38.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -1.159 . . . . 0.0 110.16 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -72.4 131.13 42.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.11 151.46 49.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 12.9 p-10 -88.01 134.86 33.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 70' ' ' ILE . 8.3 mm -124.37 143.28 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.88 . . . . 0.0 110.208 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 m -117.76 134.09 55.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.579 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 1.4 p -88.86 158.96 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.601 ' HA ' HG21 ' A' ' 58' ' ' VAL . 72.7 mtm -74.27 -8.11 55.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.246 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.481 ' OD1' ' HB ' ' A' ' 72' ' ' THR . 46.0 p-10 -92.03 -15.47 27.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 74' ' ' ASP . . . 109.14 28.44 4.4 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.579 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 3.9 mttt -108.44 130.94 55.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -1.148 . . . . 0.0 110.201 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -111.2 136.55 50.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 110.187 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.526 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -160.55 161.82 32.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.154 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.19 157.56 18.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.3 p -169.17 140.39 2.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.227 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.0 m -98.14 102.67 14.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.626 HG13 HD21 ' A' ' 89' ' ' LEU . 46.5 t -72.22 140.76 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.252 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.437 ' CE1' ' HB ' ' A' ' 90' ' ' VAL . 31.6 p80 -145.23 153.78 41.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.511 HD12 HD13 ' A' ' 64' ' ' LEU . 14.2 mt -100.99 126.37 47.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 0.0 110.251 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.25 147.3 39.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 53.3 15.25 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.22 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.62 48.83 6.04 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 7.3 pttt -169.85 135.96 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.324 -1.104 . . . . 0.0 110.229 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.626 HD21 HG13 ' A' ' 82' ' ' VAL . 5.5 tt -68.88 144.62 54.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.855 . . . . 0.0 110.238 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.495 HG23 ' C ' ' A' ' 89' ' ' LEU . 73.4 t -152.03 114.28 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.315 -0.866 . . . . 0.0 110.215 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 86.9 m -105.7 98.74 8.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.275 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 17.2 pttt -94.58 155.14 17.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 17.3 t -145.96 -165.92 2.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.45 ' N ' ' OG ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -100.52 31.88 3.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 110.199 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.5 ptpt -175.38 4.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.203 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.894 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -179.31 145.5 0.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -122.5 159.75 27.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 110.264 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.515 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 54.0 t-80 -144.72 141.42 29.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.303 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.69 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 10.1 pt-20 -157.17 125.18 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 110.207 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.551 ' OE1' ' CE ' ' A' ' 107' ' ' MET . 6.1 tt0 -128.36 162.62 26.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.893 . . . . 0.0 110.213 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.496 ' CG ' ' HB2' ' A' ' 88' ' ' LYS . 20.3 mt-10 -153.73 155.93 36.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.81 139.96 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 110.197 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -135.8 98.65 3.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.01 -110.47 3.04 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -115.67 12.17 15.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -1.192 . . . . 0.0 110.16 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -117.71 160.03 22.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.199 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.551 ' CE ' ' OE1' ' A' ' 100' ' ' GLN . 28.1 tpp -132.09 138.02 47.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.56 132.54 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.18 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 34.8 mt-10 -117.71 130.1 56.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.672 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 5.7 m -122.65 124.45 43.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 97' ' ' SER . 87.3 mt -130.78 136.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.248 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.445 HG22 ' OG1' ' A' ' 117' ' ' THR . 15.8 p -113.36 127.11 56.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.257 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.515 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 27.3 t80 -149.29 129.79 13.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 110.172 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 62.41 39.58 97.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.44 6.58 49.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 114' ' ' GLY . 58.2 t -109.72 141.94 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -1.127 . . . . 0.0 110.258 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.445 ' OG1' HG22 ' A' ' 112' ' ' THR . 58.5 m -118.36 130.18 55.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.865 . . . . 0.0 110.211 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.603 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 48.8 tp -108.76 145.92 34.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.922 . . . . 0.0 110.252 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.09 114.68 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 32.5 ttp180 -111.49 128.02 55.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.96 . . . . 0.0 110.169 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 67.9 mtt180 -104.72 127.05 52.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 110.173 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 66.3 m -123.51 154.45 39.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.845 . . . . 0.0 110.171 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -118.14 160.7 21.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.162 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 5' ' ' THR . 15.6 ttp180 -88.79 137.69 32.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 125' ' ' VAL . 35.2 m . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.208 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.278 0.561 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 p -57.33 144.87 34.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.94 . . . . 0.0 110.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.73 -173.75 18.7 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.7 m -111.7 129.52 56.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -1.149 . . . . 0.0 110.229 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.523 ' CD1' HD12 ' A' ' 40' ' ' ILE . 70.1 m95 -118.01 138.61 52.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -118.31 118.13 30.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.3 t -64.95 126.22 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 18.0 p90 -127.08 -21.79 3.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.502 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -136.28 131.73 34.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.159 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.482 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 26.3 pt20 -146.98 118.27 7.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.204 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.442 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.5 tt0 -94.03 152.89 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.885 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 m120 50.47 27.25 2.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.169 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -58.05 -52.2 66.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -64.62 -50.52 66.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 110.188 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 36.7 mm-40 -51.06 -61.49 2.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.178 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.7 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 63.5 t80 -49.22 -52.3 27.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.171 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.581 HD23 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -59.5 -44.79 93.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 110.221 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 14.5 mttm -46.7 -38.31 9.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.29 -27.23 63.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.9 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.5 tp -61.87 -23.51 66.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.73 30.5 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.581 HD12 HD23 ' A' ' 18' ' ' LEU . 15.1 mt -77.53 166.77 41.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.1 Cg_endo -73.08 143.2 35.63 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.04 1.547 . . . . 0.0 110.43 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -65.16 -41.25 94.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.166 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -55.24 -28.14 51.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.397 -0.815 . . . . 0.0 110.175 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.575 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 41.5 tp -89.43 -22.07 22.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 24' ' ' PRO . 92.5 mt -86.99 -40.01 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -72.58 -30.04 64.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 110.241 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.405 ' CE ' ' HD2' ' A' ' 55' ' ' ARG . 9.5 ttp -87.77 -24.03 23.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -101.66 6.58 42.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 110.175 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.684 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 16.6 ptt180 -68.12 4.17 1.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.337 -0.852 . . . . 0.0 110.195 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.684 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.9 m-20 -151.73 50.21 0.81 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.087 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.3 mt -122.48 119.37 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.215 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -91.19 83.25 0.11 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 110.301 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.087 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.9 Cg_endo -73.02 136.52 24.97 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.023 1.538 . . . . 0.0 110.475 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 38' ' ' VAL . 55.1 mt -100.45 171.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.185 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.55 ' N ' HG22 ' A' ' 37' ' ' ILE . 11.2 p -147.41 132.9 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.217 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -110.3 111.55 22.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 110.206 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' A' ' 6' ' ' TRP . 64.3 mt -99.93 138.46 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.244 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.541 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 56.7 tt0 -137.76 70.0 1.39 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.154 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.569 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 52.5 tt0 -67.0 159.75 27.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.206 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 53.9 mmtt -156.17 42.76 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.59 -100.59 0.77 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -109.94 -5.62 15.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -1.185 . . . . 0.0 110.261 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.405 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 7.1 t0 -102.12 152.32 21.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.484 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 39.1 m-85 -133.96 140.88 47.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.198 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -126.55 104.9 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.211 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.75 135.8 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 110.231 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.737 ' OG1' HG23 ' A' ' 59' ' ' THR . 99.8 m -133.81 104.67 6.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 m -87.3 136.91 32.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.858 . . . . 0.0 110.247 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -129.65 123.53 31.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 110.188 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.644 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -107.15 169.03 7.18 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.05 -18.78 23.7 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.06 1.558 . . . . 0.0 110.448 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.405 ' HD2' ' CE ' ' A' ' 30' ' ' MET . 26.8 ttt180 -103.41 -21.92 13.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.21 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.644 ' O ' ' OG1' ' A' ' 53' ' ' THR . 17.8 pt20 -164.13 165.11 22.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 110.142 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 p -129.41 130.47 46.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.151 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.36 127.88 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.737 HG23 ' OG1' ' A' ' 50' ' ' THR . 91.2 m -112.27 137.76 49.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 59' ' ' THR . 58.0 m-20 -133.51 151.86 51.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 t -147.12 128.75 15.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.62 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 37.1 p90 -141.87 169.19 18.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 110.184 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.6 m -114.78 142.45 46.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.178 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.574 HD11 ' CA ' ' A' ' 83' ' ' HIS . 3.0 tp -76.58 124.95 28.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.99 -2.75 41.05 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.59 149.96 45.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -1.13 . . . . 0.0 110.18 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' OE2' ' HD2' ' A' ' 79' ' ' LYS . 71.4 tt0 -70.76 123.81 22.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.62 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -122.83 148.0 45.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 110.271 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -80.23 135.01 36.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 110.146 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.462 HD13 ' HA ' ' A' ' 70' ' ' ILE . 17.2 mm -128.22 145.14 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 110.25 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 t -119.23 135.43 54.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.27 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.436 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -84.15 156.28 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -17.18 64.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.407 ' OD1' ' HB2' ' A' ' 76' ' ' LYS . 2.9 p30 -83.11 -10.3 58.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.16 28.36 5.86 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.436 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 10.3 mtpt -106.24 133.76 50.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -1.129 . . . . 0.0 110.246 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.03 138.49 44.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.473 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -169.48 150.82 4.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.141 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.453 ' HD2' ' OE2' ' A' ' 67' ' ' GLU . 7.2 mtmm -95.15 155.95 16.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.916 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.28 131.76 5.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.195 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 m -93.37 99.39 11.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.226 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.898 ' CG1' HD21 ' A' ' 89' ' ' LEU . 40.7 t -73.99 143.86 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.662 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 2.9 p-80 -147.36 160.62 42.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 0.0 110.225 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 mp -101.06 133.87 44.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 0.0 110.186 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -139.03 115.52 10.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 53.2 t-20 62.79 24.19 14.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.656 ' O ' ' CG ' ' A' ' 88' ' ' LYS . . . 80.76 46.46 7.22 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.656 ' CG ' ' O ' ' A' ' 87' ' ' GLY . 28.7 mtmt -161.87 117.83 2.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -1.149 . . . . 0.0 110.219 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.898 HD21 ' CG1' ' A' ' 82' ' ' VAL . 1.7 tt -61.79 135.84 57.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 110.189 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.662 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 75.6 t -145.42 121.93 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.939 ' CG2' ' HB3' ' A' ' 98' ' ' HIS . 8.8 t -118.86 103.69 9.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.185 -0.947 . . . . 0.0 110.191 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 51.1 pttt -93.55 154.52 17.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 110.189 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 t -141.67 -158.24 0.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 36.8 mt-10 -109.52 31.82 5.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.22 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.57 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -176.88 6.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 110.198 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.835 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 178.28 147.5 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 111' ' ' ILE . 15.9 t -125.24 158.41 34.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 110.243 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.939 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 59.0 t-80 -141.61 146.02 35.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.849 ' HB2' HG23 ' A' ' 110' ' ' THR . 24.5 mt-10 -157.68 126.04 5.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.266 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 10.3 tt0 -126.17 162.06 26.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.538 ' OE2' ' O ' ' A' ' 102' ' ' VAL . 11.0 tm-20 -160.4 150.91 18.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.538 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 8.4 p -116.72 142.75 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.206 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 50.6 mttt -134.56 91.2 2.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.07 -107.42 2.79 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -115.09 9.64 15.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -1.199 . . . . 0.0 110.243 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -117.97 161.13 20.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 110.19 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.48 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -131.85 140.68 49.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.216 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.5 t -126.92 125.02 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.224 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 28.0 mt-10 -110.73 126.99 55.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.849 HG23 ' HB2' ' A' ' 99' ' ' GLU . 4.8 t -117.93 119.46 34.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.216 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 97' ' ' SER . 71.6 mt -126.12 132.16 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 31.8 m -109.74 132.93 53.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.616 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 11.8 t80 -156.3 127.39 6.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.929 . . . . 0.0 110.223 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 67.28 36.54 89.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.34 7.3 60.15 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 17' ' ' PHE . 60.4 t -111.01 141.01 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -1.156 . . . . 0.0 110.223 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 78.5 m -117.48 130.44 56.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.226 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.7 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 54.7 tp -110.38 146.85 35.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.239 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.31 100.25 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.182 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.44 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 9.1 mtm180 -93.39 119.89 33.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.0 110.207 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 42.3 mtt180 -101.13 125.75 47.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 110.231 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.8 m -123.88 158.1 32.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.184 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 10.4 tttm -119.93 158.31 26.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.415 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 22.3 ttt180 -85.68 136.64 33.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 110.24 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.207 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 75.2 m-85 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.249 0.547 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.8 m -56.89 144.43 33.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.209 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.27 -175.95 18.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.732 HG22 ' HG3' ' A' ' 39' ' ' GLU . 19.2 p -107.04 131.59 53.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -1.126 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.544 ' CD1' ' HE2' ' A' ' 107' ' ' MET . 93.2 m95 -119.6 137.02 54.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -119.28 113.7 21.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.239 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.424 HG11 ' OE1' ' A' ' 11' ' ' GLN . 39.9 t -61.04 135.99 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.165 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 10' ' ' ALA . 10.9 p90 -139.09 -15.82 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.206 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.532 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -138.7 130.97 28.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.435 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 15.7 mt-30 -144.87 160.64 40.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.902 . . . . 0.0 110.202 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.782 ' CD ' HD12 ' A' ' 119' ' ' ILE . 12.7 pt-20 -137.77 150.91 47.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.147 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.7 m120 54.35 33.79 19.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.44 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.6 t80 -62.83 -54.32 40.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -60.78 -53.72 53.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -50.0 -56.05 12.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.494 ' HD1' HD22 ' A' ' 18' ' ' LEU . 33.2 t80 -54.05 -47.0 72.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.895 ' CD1' HD12 ' A' ' 23' ' ' LEU . 2.3 mm? -60.74 -42.1 96.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.163 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -54.45 -37.52 65.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 110.159 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.91 -33.2 71.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 110.24 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.869 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.5 tp -63.86 -21.19 66.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 0.0 110.252 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.869 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 77.98 31.77 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 110.216 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.895 HD12 ' CD1' ' A' ' 18' ' ' LEU . 14.2 mt -80.13 166.18 42.02 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.183 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.484 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.09 142.35 34.19 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.103 1.581 . . . . 0.0 110.386 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.538 ' CD ' ' HE3' ' A' ' 29' ' ' LYS . 43.2 tt0 -64.79 -33.5 76.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -61.15 -26.88 68.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.484 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 40.0 tp -90.07 -27.81 19.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 110.158 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.5 mt -76.19 -45.23 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.287 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HE3' ' CD ' ' A' ' 25' ' ' GLU . 21.0 mttt -69.4 -26.82 64.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.4 mtt -85.95 -27.66 24.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.189 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -101.47 7.38 42.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.579 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 16.0 ptt180 -66.7 -1.28 3.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.202 -0.936 . . . . 0.0 110.195 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.579 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.1 m-20 -148.0 47.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.259 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.974 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 5.1 mt -121.51 115.49 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 110.242 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -92.54 88.76 0.33 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.974 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.9 Cg_endo -73.03 139.26 29.6 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.042 1.548 . . . . 0.0 110.467 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 38' ' ' VAL . 17.2 mt -89.89 162.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' N ' HG22 ' A' ' 37' ' ' ILE . 79.5 t -139.11 114.05 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 110.217 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.732 ' HG3' HG22 ' A' ' 5' ' ' THR . 13.4 tt0 -98.12 136.6 38.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 110.168 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.518 HD12 ' CD1' ' A' ' 6' ' ' TRP . 74.8 mt -124.68 129.29 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 54.6 tt0 -129.92 75.1 1.63 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 0.0 110.19 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.72 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 2.0 tm0? -72.39 162.06 29.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 43.1 mtmt -160.51 49.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.18 -104.19 1.31 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 64.4 m-20 -109.85 -0.37 18.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -1.148 . . . . 0.0 110.152 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.0 t0 -104.03 146.54 28.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.0 110.194 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.787 ' CE1' HD11 ' A' ' 64' ' ' LEU . 4.1 m-85 -128.36 135.42 49.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.4 t -123.7 108.29 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.212 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.3 t -110.23 128.98 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.8 m -129.13 108.03 10.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -92.04 138.25 31.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.25 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 1.1 pttt -131.85 126.09 33.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 110.166 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.865 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.89 170.41 5.46 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.926 . . . . 0.0 110.184 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.752 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.5 Cg_endo -73.03 -20.03 22.35 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.039 1.547 . . . . 0.0 110.497 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -105.04 -22.03 13.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 0.0 110.218 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -161.83 159.6 27.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.241 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.4 p -130.51 131.0 44.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 110.239 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.402 ' CG1' HG23 ' A' ' 71' ' ' THR . 56.2 t -128.53 129.36 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.223 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.4 t -111.19 137.49 48.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.257 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.417 ' HB3' ' CD1' ' A' ' 70' ' ' ILE . 63.0 m-20 -132.3 149.62 52.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 110.161 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 t -144.67 128.97 17.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.898 . . . . 0.0 110.186 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.442 ' CB ' ' CB ' ' A' ' 68' ' ' ALA . 39.6 p90 -142.81 170.44 15.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.521 HG21 ' HE2' ' A' ' 66' ' ' LYS . 17.6 m -119.01 153.41 34.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.222 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.787 HD11 ' CE1' ' A' ' 47' ' ' PHE . 22.2 mt -81.4 125.34 30.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.22 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.28 12.39 54.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HE2' HG21 ' A' ' 63' ' ' THR . 46.7 mtmt -146.7 139.26 25.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.147 . . . . 0.0 110.218 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -66.04 127.22 31.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -127.94 149.06 50.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.57 138.53 33.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.177 -0.952 . . . . 0.0 110.254 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 70' ' ' ILE . 5.0 mm -130.57 144.43 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.415 HG22 ' OD1' ' A' ' 60' ' ' ASN . 4.1 t -118.22 135.01 54.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.671 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 34.7 p -87.1 160.38 18.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.189 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.517 ' SD ' HG21 ' A' ' 53' ' ' THR . 11.9 ttm -72.22 -11.53 60.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -89.51 -13.36 37.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.155 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.0 51.11 0.96 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 11.0 mttt -128.53 133.11 48.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -1.126 . . . . 0.0 110.169 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -110.0 135.87 50.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.499 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -164.02 159.71 20.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.224 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -105.86 155.32 19.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.197 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.1 p -164.13 136.62 4.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.23 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.4 m -95.29 97.67 10.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 110.225 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.827 HG13 HD21 ' A' ' 89' ' ' LEU . 47.6 t -69.23 142.18 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 110.248 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.471 ' CE1' ' HB ' ' A' ' 90' ' ' VAL . 26.7 p80 -147.54 150.09 33.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.43 HD12 HD13 ' A' ' 64' ' ' LEU . 18.5 mt -96.06 129.89 43.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.54 144.12 31.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 110.141 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.36 11.55 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.59 45.39 6.11 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 11.5 pttt -170.76 132.28 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -1.124 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.827 HD21 HG13 ' A' ' 82' ' ' VAL . 3.6 tt -61.16 149.19 38.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.896 HG22 ' HG3' ' A' ' 99' ' ' GLU . 87.3 t -155.51 109.3 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 87.2 m -103.01 103.78 13.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.183 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.433 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 5.6 ptmt -99.4 157.47 16.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.224 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 14.3 t -151.21 -171.13 3.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.202 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.54 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 54.3 tt0 -98.14 30.73 2.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.188 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.525 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 1.6 pttt -169.8 -2.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 0.0 110.205 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.854 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -176.31 147.49 0.7 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.92 . . . . 0.0 110.212 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.8 159.05 28.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.847 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.637 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 64.6 t-80 -143.17 137.08 28.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.896 ' HG3' HG22 ' A' ' 90' ' ' VAL . 44.8 tt0 -151.19 126.91 10.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.163 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.576 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 9.1 tt0 -133.76 154.79 50.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 110.111 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.487 ' HA ' ' CE1' ' A' ' 2' ' ' PHE . 58.8 tt0 -149.37 159.86 43.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 110.269 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.41 138.06 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -0.897 . . . . 0.0 110.173 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -133.84 93.97 3.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.277 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.67 -106.75 2.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -118.78 12.61 13.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -1.135 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.04 155.27 31.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.159 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.544 ' HE2' ' CD1' ' A' ' 6' ' ' TRP . 25.8 tpp -128.41 140.31 51.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.1 t -125.97 126.69 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.183 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.576 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 29.5 mt-10 -114.58 136.13 53.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 p -124.73 123.93 41.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.233 -0.917 . . . . 0.0 110.22 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 72.7 mt -130.88 129.82 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 5.0 t -113.41 131.87 55.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 6.3 t80 -154.19 125.12 7.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.256 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.29 33.38 61.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.25 3.73 66.42 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 112' ' ' THR . 62.9 t -109.69 139.56 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -1.157 . . . . 0.0 110.199 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 55.3 m -113.98 135.22 54.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.224 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 12' ' ' GLU . 41.6 tp -113.95 139.13 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.172 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.782 HD12 ' CD ' ' A' ' 12' ' ' GLU . 96.8 mt -120.43 110.45 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -105.96 120.94 43.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.94 . . . . 0.0 110.186 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 52.4 mtt180 -102.17 127.05 49.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 0.0 110.19 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.9 m -122.81 163.41 20.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.207 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -128.15 158.56 37.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.902 . . . . 0.0 110.19 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -85.11 136.56 33.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.177 -179.955 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.32 0.581 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.3 p -56.81 145.71 28.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.44 -177.02 17.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.763 HG22 ' HG3' ' A' ' 39' ' ' GLU . 42.3 p -105.75 134.24 49.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -1.182 . . . . 0.0 110.18 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.497 ' CD1' ' HE2' ' A' ' 107' ' ' MET . 95.3 m95 -121.27 142.62 49.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -124.07 118.2 26.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.209 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.4 HG12 ' CD ' ' A' ' 11' ' ' GLN . 49.2 t -65.8 126.78 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 110.167 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 22.6 p90 -128.16 -23.07 3.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.719 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -135.13 133.61 39.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 110.223 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.719 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 2.0 mp0 -146.7 112.24 5.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.892 . . . . 0.0 110.216 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.484 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.1 tt0 -89.65 147.32 23.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.0 m120 55.02 24.07 5.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.655 ' CE1' HD11 ' A' ' 18' ' ' LEU . 27.5 t80 -56.57 -52.43 64.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 110.208 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -63.54 -48.61 76.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.23 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 66.8 mt-10 -53.79 -62.23 1.79 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 110.222 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.71 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 38.2 t80 -48.29 -57.83 5.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.66 HD23 HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -57.12 -46.66 82.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 110.183 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -42.79 -41.86 3.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.192 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.19 -28.25 66.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.866 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -58.13 -20.13 38.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.219 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 77.94 31.37 0.42 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.66 HD12 HD23 ' A' ' 18' ' ' LEU . 15.5 mt -77.03 165.99 48.1 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.188 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.615 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.08 140.59 31.46 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.969 1.51 . . . . 0.0 110.409 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.411 ' HG2' ' HE2' ' A' ' 29' ' ' LYS . 42.4 tt0 -61.52 -39.48 91.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.29 -26.54 63.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.309 -0.87 . . . . 0.0 110.191 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.615 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 14.8 tp -90.42 -23.26 21.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 95.2 mt -81.09 -43.18 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.978 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HE2' ' HG2' ' A' ' 25' ' ' GLU . 37.3 mtmt -72.52 -24.41 61.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 37.4 mtt -87.9 -32.91 18.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -97.99 5.44 48.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.632 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 31.3 ptt85 -65.53 -1.11 2.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.632 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.6 m-20 -149.91 47.57 0.93 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.942 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.9 mt -118.7 121.03 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -95.8 83.02 0.22 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.337 -0.852 . . . . 0.0 110.234 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.942 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.5 Cg_endo -73.05 137.49 26.55 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.031 1.543 . . . . 0.0 110.47 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.5 mt -90.01 157.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.155 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.3 t -134.93 112.72 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.763 ' HG3' HG22 ' A' ' 5' ' ' THR . 21.0 tt0 -94.05 138.24 32.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.234 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.469 HD12 ' CD1' ' A' ' 6' ' ' TRP . 71.3 mt -126.73 127.78 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.214 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -133.03 75.27 1.61 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.246 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.533 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 6.7 pt20 -78.57 163.53 25.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.218 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 31.0 mmtp -154.79 49.93 0.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.75 -99.21 0.8 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -110.05 -9.11 14.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.271 -1.135 . . . . 0.0 110.216 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 34.4 t0 -98.0 157.23 16.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 110.196 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.605 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.1 m-85 -139.89 133.55 30.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.232 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.9 t -114.24 100.75 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 110.242 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 60' ' ' ASN . 4.2 p -100.85 135.49 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.187 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 59' ' ' THR . 36.0 m -138.59 105.56 5.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.4 m -88.4 138.2 31.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.244 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -130.35 119.16 22.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 110.282 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.854 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -106.89 167.44 9.48 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 110.223 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.767 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.8 Cg_endo -73.07 -20.68 21.47 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.057 1.556 . . . . 0.0 110.472 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -102.93 -20.6 14.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -166.31 159.17 14.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.907 . . . . 0.0 110.191 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.3 p -129.05 131.29 47.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.224 -0.922 . . . . 0.0 110.205 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.26 128.26 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 110.19 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 50' ' ' THR . 46.2 m -110.59 136.83 49.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 110.19 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 49' ' ' VAL . 81.6 m-20 -135.02 153.91 51.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.245 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.2 t -143.17 128.17 18.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.221 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.706 ' CE1' HG21 ' A' ' 82' ' ' VAL . 52.4 p90 -139.7 168.59 19.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.162 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.5 m -120.07 142.48 48.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 84' ' ' LEU . 15.5 mt -74.21 126.03 29.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 110.258 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.89 58.23 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -137.47 142.23 41.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.263 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -68.01 126.25 28.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.207 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . . . -127.28 150.1 49.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 0.0 110.237 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -81.57 136.56 35.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 110.227 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.47 HD13 ' HA ' ' A' ' 70' ' ' ILE . 3.8 mm -129.43 144.77 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -116.77 134.42 54.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.253 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.02 155.06 21.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.883 . . . . 0.0 110.128 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 53' ' ' THR . 16.4 ttm -67.13 -14.94 63.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.215 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.47 -13.07 47.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.54 29.72 4.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -104.99 135.39 46.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -1.156 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -112.02 132.59 54.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.227 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -161.14 162.95 31.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -107.86 158.69 17.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.194 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.498 ' HB2' HG23 ' A' ' 91' ' ' THR . 25.3 p -165.4 147.26 7.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.204 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.45 87.85 2.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.223 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 89' ' ' LEU . 16.1 t -53.3 154.96 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 110.18 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.537 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -152.17 147.46 26.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 0.0 110.224 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.633 HD12 HD13 ' A' ' 64' ' ' LEU . 13.9 mt -100.91 99.07 9.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 87' ' ' GLY . . . -114.37 152.59 31.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.178 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.496 ' HB3' ' CD ' ' A' ' 88' ' ' LYS . 3.3 t30 46.5 17.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 110.149 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 85' ' ' ALA . . . 77.97 48.96 7.31 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.754 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -167.21 127.69 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -1.159 . . . . 0.0 110.252 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.859 HD11 HG11 ' A' ' 82' ' ' VAL . 4.2 tt -59.22 147.67 34.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 110.179 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.824 HG12 ' HG3' ' A' ' 99' ' ' GLU . 22.2 m -154.67 109.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 97.5 m -103.55 100.11 9.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -98.11 161.0 13.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.47 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -152.33 -165.36 2.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 110.186 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 49.2 tt0 -101.16 31.29 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' CE2' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -173.3 4.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.933 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.67 141.69 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.303 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.617 ' O ' HG23 ' A' ' 111' ' ' ILE . 69.3 m -117.52 160.52 21.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.566 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.9 t-80 -144.12 140.66 29.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.824 ' HG3' HG12 ' A' ' 90' ' ' VAL . 14.0 tt0 -155.17 123.59 5.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.231 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 12.0 tt0 -129.04 157.17 42.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -153.84 154.67 34.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.209 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.43 141.52 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.226 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -136.61 90.69 2.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.24 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.8 -105.59 2.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -119.19 11.42 12.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -1.145 . . . . 0.0 110.169 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -117.52 154.31 31.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.229 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.497 ' HE2' ' CD1' ' A' ' 6' ' ' TRP . 26.8 tpp -125.38 138.57 54.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 110.293 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.2 t -126.4 124.73 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.33 -0.857 . . . . 0.0 110.228 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 33.2 mt-10 -112.32 121.61 45.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 99' ' ' GLU . 85.4 m -110.19 119.09 38.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.231 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 97' ' ' SER . 68.1 mt -126.52 129.72 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 74.7 m -109.31 138.06 46.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.547 ' CE2' ' O ' ' A' ' 95' ' ' LYS . 21.1 t80 -160.81 127.65 4.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 110.196 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.23 34.45 75.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.75 8.55 68.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.3 t -112.4 141.42 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -1.168 . . . . 0.0 110.207 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.9 m -116.9 130.94 57.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 110.259 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.71 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 41.8 tp -110.34 152.68 25.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.5 mt -131.37 94.6 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -88.57 126.53 35.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.221 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 27.6 mtt180 -106.23 125.78 51.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 56.5 m -123.49 153.42 40.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.919 . . . . 0.0 110.218 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -119.81 159.01 25.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.87 . . . . 0.0 110.204 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -86.0 135.28 33.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.255 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.434 ' CE2' HG12 ' A' ' 102' ' ' VAL . 29.7 m-85 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.283 0.563 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -51.91 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.36 -162.69 33.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.655 HG22 ' HG3' ' A' ' 39' ' ' GLU . 9.8 p -114.2 128.07 56.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -1.145 . . . . 0.0 110.22 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.532 ' CD1' HD12 ' A' ' 40' ' ' ILE . 92.0 m95 -117.11 137.82 52.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.254 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.37 123.19 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 110.257 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.52 133.03 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.544 ' CD1' ' HB2' ' A' ' 10' ' ' ALA . 34.2 p90 -133.75 -27.62 1.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.544 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -130.94 137.13 49.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.56 ' O ' ' HG2' ' A' ' 11' ' ' GLN . 3.7 pm0 -152.18 140.96 20.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.209 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.402 ' O ' HD12 ' A' ' 118' ' ' LEU . 30.9 tt0 -115.28 151.26 34.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 50.57 25.38 1.98 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -55.22 -47.13 75.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -0.92 . . . . 0.0 110.241 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.12 -51.82 54.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -49.03 -61.64 1.96 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.169 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.605 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 52.2 t80 -50.32 -44.94 54.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.142 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 18' ' ' LEU . 49.5 mt -61.14 -46.72 89.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.245 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -50.98 -36.53 39.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.262 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.38 -32.21 72.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.849 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -61.14 -21.01 63.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.849 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 75.62 37.82 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.248 -0.907 . . . . 0.0 110.172 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.734 HD22 ' HD2' ' A' ' 24' ' ' PRO . 3.7 mt -79.19 165.32 49.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.734 ' HD2' HD22 ' A' ' 23' ' ' LEU . 46.2 Cg_endo -73.04 136.37 24.68 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.989 1.521 . . . . 0.0 110.508 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -54.09 -30.78 49.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.53 -41.55 96.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.902 . . . . 0.0 110.271 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.605 HD22 ' OD1' ' A' ' 74' ' ' ASP . 63.4 tp -80.09 -45.83 17.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.247 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.8 mt -53.48 -54.1 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 110.215 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 6.6 mmtp -59.35 -29.73 67.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.438 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 65.1 mtt -86.08 -20.53 28.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 0.0 110.168 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.555 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -103.67 4.56 35.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.245 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.767 ' HG3' ' OD2' ' A' ' 33' ' ' ASP . 20.3 ptt180 -75.21 -0.4 19.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.227 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.767 ' OD2' ' HG3' ' A' ' 32' ' ' ARG . 62.6 m-20 -152.36 42.03 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.964 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 27.5 mt -121.36 115.46 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.219 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.55 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -92.25 88.83 0.32 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.208 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.964 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.4 Cg_endo -73.12 138.6 28.25 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.026 1.54 . . . . 0.0 110.399 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -89.62 157.35 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.254 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -136.84 119.09 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.655 ' HG3' HG22 ' A' ' 5' ' ' THR . 28.5 tt0 -100.64 134.5 43.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 110.185 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.532 HD12 ' CD1' ' A' ' 6' ' ' TRP . 83.0 mt -121.9 129.48 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -131.89 74.9 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.807 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 24.3 tt0 -73.87 164.45 26.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.6 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 47.3 mttt -156.97 42.29 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 110.221 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.8 -97.69 0.62 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -112.88 -0.24 14.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -1.185 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -104.84 147.95 27.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.967 . . . . 0.0 110.243 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 1.178 ' CD2' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -128.57 133.95 48.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 110.224 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.5 t -122.37 107.73 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.248 -0.908 . . . . 0.0 110.191 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.18 133.99 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.2 m -132.69 107.46 8.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 0.0 110.203 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -92.0 137.45 32.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 110.234 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 1.6 pttm -131.5 127.83 38.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.58 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -111.49 170.23 5.49 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 110.186 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.99 -16.54 25.64 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.054 1.555 . . . . 0.0 110.487 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.0 mtp-105 -106.32 -19.33 13.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.898 . . . . 0.0 110.191 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.58 ' O ' ' OG1' ' A' ' 53' ' ' THR . 19.5 pt20 -167.44 161.25 13.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 110.232 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.9 p -130.03 133.8 46.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.3 t -131.3 130.18 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.937 . . . . 0.0 110.176 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 59' ' ' THR . 13.9 t -112.04 134.8 53.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 110.143 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -129.69 151.91 49.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -0.88 . . . . 0.0 110.173 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -147.04 127.39 13.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.649 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 38.2 p90 -141.4 172.93 12.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 110.218 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.5 m -118.68 148.71 42.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.202 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.178 HD11 ' CD2' ' A' ' 47' ' ' PHE . 9.9 mt -79.57 123.34 27.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.269 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.93 5.41 47.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -143.94 145.3 32.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -1.139 . . . . 0.0 110.164 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.21 127.19 31.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -125.42 148.18 48.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -83.86 136.2 34.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.922 . . . . 0.0 110.224 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 70' ' ' ILE . 6.0 mm -127.85 145.96 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.172 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 t -119.84 133.46 55.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.626 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -83.28 155.8 23.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -17.04 63.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 110.228 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.605 ' OD1' HD22 ' A' ' 27' ' ' LEU . 8.1 t0 -84.89 -12.24 53.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.34 30.58 4.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.626 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 23.5 mttt -107.28 131.98 53.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -1.136 . . . . 0.0 110.15 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -111.69 138.19 48.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.218 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.55 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -167.65 159.37 11.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 57.3 mttt -103.75 167.5 9.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 110.202 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 27.0 p -178.22 137.36 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 110.245 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.9 m -93.93 104.9 16.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.31 -0.869 . . . . 0.0 110.213 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.695 HG13 HD21 ' A' ' 89' ' ' LEU . 55.3 t -75.78 140.28 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.257 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.563 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 9.0 p-80 -144.11 155.25 43.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 89' ' ' LEU . 4.3 tp -100.14 134.41 43.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.92 117.55 14.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 10.0 t-20 61.55 30.23 18.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 75.94 40.99 29.01 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 83.5 mttt -152.96 125.0 7.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 110.181 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.695 HD21 HG13 ' A' ' 82' ' ' VAL . 7.8 tt -71.44 134.47 46.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.197 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.757 HG13 ' HG2' ' A' ' 99' ' ' GLU . 77.2 t -140.64 120.26 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 110.286 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 53.6 m -113.24 92.4 3.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.211 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 14.3 ptmt -86.22 160.6 19.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.446 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -152.96 -169.77 3.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.145 -0.972 . . . . 0.0 110.211 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -99.29 36.93 1.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.19 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.489 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -179.15 -1.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.823 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -175.11 147.3 0.91 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.242 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 111' ' ' ILE . 39.1 m -124.53 152.49 43.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.497 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 62.3 t-80 -137.47 142.91 41.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 110.261 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.757 ' HG2' HG13 ' A' ' 90' ' ' VAL . 47.5 mt-10 -153.24 128.65 9.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 12.5 tt0 -132.51 152.7 51.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.131 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.57 155.38 39.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 110.259 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.515 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.9 p -119.71 135.49 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -128.6 96.07 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 110.177 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.94 -101.67 1.72 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -120.67 10.78 11.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -1.142 . . . . 0.0 110.177 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -119.6 158.34 26.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.225 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.459 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -129.27 140.39 51.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 110.165 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.4 t -123.35 123.16 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 29.5 mt-10 -109.48 121.07 44.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 99' ' ' GLU . 20.8 m -111.95 117.02 31.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 97' ' ' SER . 67.6 mt -123.31 128.21 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 45.6 m -107.99 135.59 49.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.528 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 13.8 t80 -158.39 127.36 5.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 65.89 37.48 93.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.99 8.22 60.87 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 17' ' ' PHE . 60.5 t -111.03 139.08 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -1.116 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 62.0 m -117.78 132.09 56.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.605 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 67.5 tp -110.9 149.14 31.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.3 mt -128.33 98.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 16.3 mtm180 -96.11 128.52 43.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 25.3 mtt180 -104.31 128.26 52.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 107' ' ' MET . 75.4 m -124.09 155.99 37.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.202 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -119.41 151.01 39.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 110.203 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 5' ' ' THR . 45.4 ttt180 -75.71 138.31 41.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.188 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.7 ' OXT' HG22 ' A' ' 125' ' ' VAL . 9.3 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.268 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.235 0.54 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 76.6 p -56.64 145.32 28.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.27 -174.06 18.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.1 m -109.85 130.25 55.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -1.136 . . . . 0.0 110.218 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.479 ' CD1' HD12 ' A' ' 40' ' ' ILE . 90.5 m95 -118.61 145.66 45.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.853 . . . . 0.0 110.25 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -127.97 118.94 24.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.181 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.554 HG21 ' HD2' ' A' ' 120' ' ' ARG . 48.9 t -64.35 136.35 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.945 . . . . 0.0 110.23 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 11.1 p90 -137.61 -19.14 1.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 110.224 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.705 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -137.22 134.28 36.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -0.925 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.705 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 5.1 mt-30 -149.0 162.76 39.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 110.158 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.502 ' O ' HD12 ' A' ' 118' ' ' LEU . 59.4 tt0 -134.12 144.85 48.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.415 ' ND2' ' OE1' ' A' ' 16' ' ' GLU . 4.3 t30 54.98 35.7 25.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.266 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -65.08 -49.23 70.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 0.0 110.199 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -60.88 -48.08 83.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.166 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 55.2 mt-10 -55.32 -46.2 76.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.591 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 43.5 t80 -52.86 -60.31 3.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.887 . . . . 0.0 110.271 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.764 HD22 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -50.83 -39.94 54.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.199 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -58.77 -36.81 74.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.245 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.18 -38.2 60.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.973 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.9 tp -56.57 -25.24 51.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.925 . . . . 0.0 110.19 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.973 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 84.99 18.1 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.764 HD12 HD22 ' A' ' 18' ' ' LEU . 15.3 mt -66.1 166.86 14.11 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 47.2 Cg_endo -73.04 133.31 19.52 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.019 1.536 . . . . 0.0 110.446 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.986 ' HA ' HD12 ' A' ' 28' ' ' ILE . 61.1 mm-40 -51.23 -46.41 62.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.197 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.09 -37.27 20.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.516 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 35.3 tp -80.1 -37.36 33.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.898 . . . . 0.0 110.288 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.986 HD12 ' HA ' ' A' ' 25' ' ' GLU . 45.6 mt -58.82 -54.75 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -56.9 -24.45 52.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.575 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 56.6 mtt -93.62 -18.39 22.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.233 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -105.45 -10.59 16.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.224 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -1.71 3.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -150.83 47.03 0.86 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.169 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 13.1 mt -125.0 109.0 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -84.1 88.13 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.169 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.2 Cg_endo -73.11 138.42 27.98 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.04 1.548 . . . . 0.0 110.45 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 38' ' ' VAL . 46.1 mt -89.78 164.56 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 110.178 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.552 HG21 HH22 ' A' ' 120' ' ' ARG . 75.9 t -141.79 119.98 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 110.287 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -101.83 135.91 42.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.205 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.487 ' CD1' ' HE1' ' A' ' 107' ' ' MET . 75.5 mt -121.32 129.78 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.15 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 43.7 tt0 -132.33 66.51 1.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.943 . . . . 0.0 110.228 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.919 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 37.6 tt0 -71.47 162.26 29.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.573 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 18.5 pttm -159.11 48.01 0.32 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.296 -0.878 . . . . 0.0 110.175 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.4 -103.16 0.78 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 60.2 m-20 -111.52 0.57 16.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -1.132 . . . . 0.0 110.167 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.728 ' OD1' HG23 ' A' ' 63' ' ' THR . 43.6 m-20 -104.18 150.35 24.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 110.267 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 1.168 ' CD2' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -130.88 135.46 47.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.42 105.75 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 110.219 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.6 t -109.07 135.18 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.257 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.766 ' OG1' HG23 ' A' ' 59' ' ' THR . 98.3 m -132.17 108.49 9.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.902 . . . . 0.0 110.163 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -90.1 132.77 35.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.9 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -127.94 122.72 33.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.264 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.631 ' CG2' ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -106.16 170.19 6.08 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.178 -0.951 . . . . 0.0 110.225 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.12 -17.73 24.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.066 1.561 . . . . 0.0 110.382 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -104.11 -22.69 13.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 0.0 110.176 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.592 ' O ' ' OG1' ' A' ' 53' ' ' THR . 14.7 pt20 -162.82 164.69 26.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.7 p -130.29 130.41 44.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.915 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.47 HG21 ' HG3' ' A' ' 73' ' ' MET . 61.6 t -128.86 126.27 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.766 HG23 ' OG1' ' A' ' 50' ' ' THR . 85.6 m -108.83 141.18 41.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.233 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.534 ' OD1' ' O ' ' A' ' 59' ' ' THR . 73.2 m-20 -137.11 151.61 49.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.4 m -146.58 132.07 18.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.602 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 41.2 p90 -145.24 170.13 16.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.918 . . . . 0.0 110.185 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.728 HG23 ' OD1' ' A' ' 46' ' ' ASP . 86.5 m -116.26 148.53 40.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.168 HD11 ' CD2' ' A' ' 47' ' ' PHE . 10.4 mt -80.17 124.25 28.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.72 6.67 49.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -145.82 148.76 33.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -1.082 . . . . 0.0 110.217 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -71.68 125.2 26.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.204 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.602 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -122.24 150.43 42.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 110.221 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -84.53 133.16 34.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 110.102 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 70' ' ' ILE . 5.1 mm -126.38 146.71 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.221 -0.924 . . . . 0.0 110.175 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -121.44 135.03 55.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 110.232 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.509 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -84.81 154.77 22.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.47 ' HG3' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -67.63 -15.04 63.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.223 -0.923 . . . . 0.0 110.176 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 76' ' ' LYS . 3.0 p30 -85.52 -10.37 56.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.938 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.2 31.97 4.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.509 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 26.4 mttt -108.77 132.63 53.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.13 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -108.38 136.69 47.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.872 . . . . 0.0 110.203 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.447 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -165.49 156.94 14.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -105.56 165.12 11.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 0.0 110.224 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -175.15 137.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.293 -0.88 . . . . 0.0 110.178 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 m -95.52 99.89 11.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -0.894 . . . . 0.0 110.195 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.781 HG11 HD11 ' A' ' 89' ' ' LEU . 53.1 t -72.99 141.24 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 14.6 p80 -146.55 160.33 42.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.77 130.83 48.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 110.212 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.426 ' O ' ' HE2' ' A' ' 88' ' ' LYS . . . -137.46 133.37 34.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.1 t30 57.63 13.44 1.94 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.04 53.54 2.81 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.818 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 3.6 pttt -174.74 125.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -1.182 . . . . 0.0 110.214 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.781 HD11 HG11 ' A' ' 82' ' ' VAL . 4.1 tt -57.31 147.46 25.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.18 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 89' ' ' LEU . 78.9 t -157.57 109.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.971 ' CG2' ' HB3' ' A' ' 98' ' ' HIS . 10.0 t -106.39 107.93 19.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 110.21 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -97.53 151.99 19.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.146 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 1.4 m -144.86 -174.1 4.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 110.162 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 61.1 tt0 -99.0 38.49 1.38 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 94' ' ' GLU . 2.6 pttt 179.22 2.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.206 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.825 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.82 143.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 0.0 110.197 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -125.06 157.31 36.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.971 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 46.5 t-80 -144.79 143.16 30.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.203 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.473 ' CG ' HG22 ' A' ' 90' ' ' VAL . 17.1 tt0 -153.9 125.05 7.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.509 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 42.6 tt0 -125.83 158.93 33.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.895 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -156.68 156.94 34.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 110.148 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.437 HG23 ' CH2' ' A' ' 6' ' ' TRP . 10.0 p -120.84 140.35 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -132.82 89.14 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.1 -104.67 2.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.606 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 44.2 p-10 -117.79 7.39 12.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -1.123 . . . . 0.0 110.274 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.606 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 43.4 mt-10 -115.16 167.75 10.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.247 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.487 ' HE1' ' CD1' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -138.98 139.88 38.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 110.226 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.1 t -125.78 129.36 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 24.0 mt-10 -116.67 135.61 53.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.6 m -124.79 120.93 33.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.203 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 97' ' ' SER . 81.4 mt -126.76 135.88 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.246 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.498 HG22 HG23 ' A' ' 117' ' ' THR . 73.5 p -117.5 125.06 50.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.255 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.51 ' HD2' ' CB ' ' A' ' 96' ' ' PHE . 56.0 t80 -148.11 128.06 13.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -0.877 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.3 35.92 88.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.12 6.0 59.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 112' ' ' THR . 76.9 t -111.08 135.65 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -1.132 . . . . 0.0 110.199 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.498 HG23 HG22 ' A' ' 112' ' ' THR . 57.4 m -113.37 135.89 53.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.591 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 18.9 tp -115.03 141.29 48.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.55 108.63 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.554 ' HD2' HG21 ' A' ' 8' ' ' VAL . 26.8 ttp180 -104.92 124.54 49.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.16 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 9.4 mtm180 -103.72 124.96 49.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.423 ' OG ' HG22 ' A' ' 8' ' ' VAL . 56.9 m -119.57 161.39 20.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.277 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 34.7 tttm -127.76 155.81 43.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 110.249 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.4 ttt180 -80.27 134.68 36.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.9 . . . . 0.0 110.217 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.204 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 87.6 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.212 0.53 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.4 p -54.99 143.34 26.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.915 . . . . 0.0 110.149 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.05 -173.61 17.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.7 m -107.94 131.71 54.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -1.191 . . . . 0.0 110.23 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.513 ' NE1' ' HE3' ' A' ' 107' ' ' MET . 89.9 m95 -119.72 134.82 55.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 110.223 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -117.45 118.79 33.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.915 . . . . 0.0 110.171 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.422 HG11 ' CD ' ' A' ' 11' ' ' GLN . 60.2 t -66.75 128.42 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.0 110.226 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 46.6 p90 -126.38 -24.19 3.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.433 ' C ' ' HG3' ' A' ' 11' ' ' GLN . . . -136.43 132.03 34.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.433 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 29.9 mt-30 -141.37 120.81 13.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.442 ' HG2' HD21 ' A' ' 13' ' ' ASN . 52.3 tt0 -98.96 144.33 28.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.222 -0.924 . . . . 0.0 110.19 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.442 HD21 ' HG2' ' A' ' 12' ' ' GLU . 23.4 m-80 56.59 18.35 3.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.224 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.462 ' O ' HD23 ' A' ' 18' ' ' LEU . 61.9 t80 -55.04 -44.46 74.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.853 . . . . 0.0 110.239 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -67.87 -45.08 75.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 44.0 mt-10 -57.47 -59.95 4.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.809 ' HD1' HD22 ' A' ' 18' ' ' LEU . 51.4 t80 -51.14 -56.54 12.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.197 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.809 HD22 ' HD1' ' A' ' 17' ' ' PHE . 4.0 mm? -54.73 -42.82 72.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 1.1 tmtm? -54.7 -37.32 65.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -30.6 70.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.919 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -57.56 -20.83 34.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.208 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.919 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 82.1 28.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.267 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.521 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 65.2 mt -73.48 167.4 35.12 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.94 . . . . 0.0 110.24 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 46.1 Cg_endo -73.02 136.05 24.17 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.416 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.423 ' HA ' HD12 ' A' ' 28' ' ' ILE . 43.4 mt-10 -52.11 -44.93 64.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.183 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.82 -27.07 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.18 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 23.2 tp -88.54 -21.7 23.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.871 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 82.9 mt -78.6 -41.76 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -74.72 -21.53 59.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 110.225 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.6 mtt -90.54 -30.62 17.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.179 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -104.52 4.24 32.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 110.197 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.871 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.89 -6.71 23.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.217 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -147.36 49.78 1.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 0.0 110.22 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.072 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.5 mt -123.9 117.72 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.566 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 2.1 mptt -90.0 86.72 0.19 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.072 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.05 133.44 19.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.95 1.5 . . . . 0.0 110.432 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.8 mt -86.2 158.45 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 80.5 t -137.74 118.94 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.245 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -98.84 133.45 43.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.181 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.47 HD12 ' CD1' ' A' ' 6' ' ' TRP . 67.5 mt -118.53 133.04 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.173 -0.954 . . . . 0.0 110.145 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -138.09 68.01 1.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.875 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.587 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 15.8 pt20 -71.69 167.7 19.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.213 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 43.0 mttt -160.43 47.26 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.197 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.74 -98.74 0.72 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 23.1 m-20 -111.5 -6.79 14.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 110.206 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.44 155.52 17.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.239 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.804 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.3 m-85 -138.98 135.98 34.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.39 109.71 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -111.1 134.05 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.905 . . . . 0.0 110.164 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.623 HG23 ' OG1' ' A' ' 59' ' ' THR . 49.5 m -129.39 106.94 9.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.238 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.4 m -87.72 135.59 33.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.241 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -128.74 114.7 16.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.2 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.931 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -102.88 168.31 9.01 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.205 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.714 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.09 -22.01 19.88 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.946 1.498 . . . . 0.0 110.433 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.619 ' HD2' HD11 ' A' ' 34' ' ' ILE . 15.5 mtp-105 -99.66 -20.96 16.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.276 -0.89 . . . . 0.0 110.178 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.472 ' O ' ' OG1' ' A' ' 53' ' ' THR . 15.7 pt20 -168.24 160.25 11.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.7 p -128.98 134.76 48.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.21 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -132.45 130.04 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.204 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.623 ' OG1' HG23 ' A' ' 50' ' ' THR . 88.4 m -110.26 138.26 46.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.457 ' OD1' ' CG2' ' A' ' 71' ' ' THR . 67.8 m-20 -134.57 156.0 49.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -151.17 126.29 9.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.529 ' CE1' HG21 ' A' ' 82' ' ' VAL . 44.0 p90 -139.33 176.08 9.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.1 m -120.49 147.01 45.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 110.254 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.804 HD11 ' CD1' ' A' ' 47' ' ' PHE . 21.1 mt -81.04 123.59 28.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 110.271 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.54 2.59 40.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -145.6 148.79 33.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 110.238 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -70.91 131.03 43.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.248 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -132.36 144.06 50.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.185 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 14.1 p-10 -73.82 141.6 46.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.879 . . . . 0.0 110.225 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 70' ' ' ILE . 2.4 mm -136.28 141.61 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 110.244 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.457 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 4.0 t -113.86 132.79 55.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.242 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.447 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -83.97 160.0 21.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 110.256 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.511 ' SD ' HG21 ' A' ' 53' ' ' THR . 13.3 ttm -68.49 -19.27 64.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -83.29 -12.88 56.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.75 28.11 5.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.447 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 5.4 mttm -101.38 133.73 45.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -1.146 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -109.71 132.71 53.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.249 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.59 160.25 22.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -104.94 160.92 14.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.282 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -170.86 138.91 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.154 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 m -96.95 99.4 10.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.885 . . . . 0.0 110.276 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.658 HG13 HD21 ' A' ' 89' ' ' LEU . 47.4 t -69.0 140.74 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.523 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 19.5 p80 -146.62 154.08 41.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.25 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.7 mt -98.13 129.6 44.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.185 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.37 143.71 34.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 110.166 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.74 13.18 0.98 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 110.186 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.22 48.04 5.25 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.752 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -172.17 134.15 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 110.22 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.658 HD21 HG13 ' A' ' 82' ' ' VAL . 1.9 tt -61.31 145.77 50.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.879 HG22 ' HG3' ' A' ' 99' ' ' GLU . 87.2 t -153.78 109.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 97.6 m -102.75 103.16 13.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 110.191 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -100.42 156.21 17.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.915 . . . . 0.0 110.208 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.587 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 2.9 t -147.36 -163.65 1.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.228 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.682 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 32.4 tt0 -101.85 33.85 2.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.328 -0.857 . . . . 0.0 110.113 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 8.6 ptmt -177.97 7.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.886 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -179.65 141.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.223 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 111' ' ' ILE . 47.9 m -118.99 156.96 28.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.556 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 54.2 t-80 -140.11 143.4 36.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 110.26 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.879 ' HG3' HG22 ' A' ' 90' ' ' VAL . 17.9 tt0 -158.28 119.16 3.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 110.271 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 9.5 tt0 -123.94 158.72 31.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 110.248 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.458 ' HA ' ' CE1' ' A' ' 2' ' ' PHE . 28.2 tt0 -157.95 152.69 25.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.24 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.439 ' HB ' ' HE2' ' A' ' 107' ' ' MET . 10.6 p -117.7 142.91 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -129.75 90.71 3.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.05 -113.34 3.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -105.73 3.83 29.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 110.191 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -112.22 160.55 17.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.513 ' HE3' ' NE1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -130.02 140.09 50.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.21 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.2 t -127.58 122.31 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 110.178 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 19.8 mt-10 -104.23 128.1 51.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.186 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' GLU . 50.6 m -120.4 114.38 21.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.872 . . . . 0.0 110.23 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' SER . 60.9 mt -126.12 136.59 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.229 -0.919 . . . . 0.0 110.237 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 88.2 m -112.34 134.55 53.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.209 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.613 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 15.9 t80 -157.56 128.44 6.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 0.0 110.167 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 65.43 36.65 92.88 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.88 13.44 66.42 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 112' ' ' THR . 72.8 t -116.94 136.92 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -1.163 . . . . 0.0 110.18 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.3 m -114.09 131.76 56.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.641 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 61.5 tp -109.91 146.45 35.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.0 mt -129.12 94.11 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 110.259 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 18.1 mtm180 -90.47 129.08 36.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 0.0 110.206 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 84.7 mtt180 -105.19 125.91 51.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.2 m -122.64 150.88 42.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -118.64 156.71 28.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 110.201 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -83.55 135.52 34.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.193 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.261 0.553 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.88 143.26 38.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.231 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.59 -172.71 19.36 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.7 m -110.65 131.77 54.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -1.093 . . . . 0.0 110.221 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.48 ' CE2' ' HE3' ' A' ' 107' ' ' MET . 92.3 m95 -119.28 143.28 47.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -125.73 117.79 24.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.239 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.432 HG22 ' OG ' ' A' ' 122' ' ' SER . 47.8 t -66.01 130.28 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.191 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 11.7 p90 -129.71 -18.98 3.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.494 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -139.37 134.87 33.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.498 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.8 pt20 -146.8 118.23 7.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -95.95 150.34 20.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 53.38 22.68 2.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.423 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 59.6 t80 -57.82 -45.07 86.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.201 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.28 -54.01 20.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -47.43 -64.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.586 ' HA ' HG11 ' A' ' 116' ' ' VAL . 45.5 t80 -48.06 -43.83 30.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.336 -0.852 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.423 HD11 ' CZ ' ' A' ' 14' ' ' TYR . 17.0 mt -62.76 -45.15 94.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.945 . . . . 0.0 110.191 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -52.33 -33.31 42.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.69 -34.12 73.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.219 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.781 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -60.02 -21.16 60.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.264 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.781 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 73.06 45.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.014 HD22 ' HD2' ' A' ' 24' ' ' PRO . 5.7 mt -86.08 169.27 15.93 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.014 ' HD2' HD22 ' A' ' 23' ' ' LEU . 46.0 Cg_endo -73.11 135.4 22.86 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.031 1.542 . . . . 0.0 110.466 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -56.39 -26.55 53.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.92 . . . . 0.0 110.178 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.94 -38.07 82.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.93 . . . . 0.0 110.263 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.535 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 66.2 tp -83.87 -40.84 18.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 24' ' ' PRO . 63.1 mt -57.78 -51.36 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 33.1 mmtt -61.67 -29.61 70.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 60.1 ttm -84.75 -23.79 29.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 0.0 110.228 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.509 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -101.88 11.37 38.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.903 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 29' ' ' LYS . 30.1 ptt180 -79.0 -2.58 40.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.208 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -151.66 44.91 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.915 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 21.1 mt -123.34 113.12 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 89.41 0.43 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.207 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.915 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.08 143.21 35.65 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.016 1.535 . . . . 0.0 110.403 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 38' ' ' VAL . 21.3 mt -89.24 162.9 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.206 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.418 ' N ' HG22 ' A' ' 37' ' ' ILE . 98.3 t -141.28 119.44 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.159 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -100.05 138.94 36.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.9 . . . . 0.0 110.2 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.463 ' CD1' ' HE1' ' A' ' 107' ' ' MET . 60.2 mt -123.93 132.37 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 110.181 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -138.19 69.42 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.699 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 4.6 pt20 -75.03 173.63 10.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.699 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 71.4 mttt -165.53 48.64 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 110.189 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.23 -99.25 0.76 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 27.6 m-20 -111.69 -4.54 14.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 0.0 110.216 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -101.43 149.74 23.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.914 . . . . 0.0 110.232 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.748 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.1 m-85 -133.24 137.11 45.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.1 t -124.9 108.55 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.165 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.6 t -110.1 134.64 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.877 . . . . 0.0 110.212 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.0 m -132.57 107.37 8.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.902 . . . . 0.0 110.186 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.4 m -87.16 135.5 33.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 110.215 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -128.78 120.83 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.209 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.881 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -107.14 168.48 7.96 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.222 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.79 ' HD2' HG22 ' A' ' 53' ' ' THR . 45.8 Cg_endo -73.03 -19.73 22.68 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.949 1.499 . . . . 0.0 110.407 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -106.26 -20.06 13.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.85 . . . . 0.0 110.203 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.573 ' NE2' ' HG2' ' A' ' 73' ' ' MET . 13.6 pt20 -163.38 158.96 21.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.169 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 p -132.33 131.53 42.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.32 131.35 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 110.195 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 59' ' ' THR . 13.7 t -112.25 136.83 51.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 110.242 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -133.05 149.4 52.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -141.17 130.05 23.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.936 . . . . 0.0 110.248 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.451 ' CE1' HG21 ' A' ' 82' ' ' VAL . 37.6 p90 -143.93 169.46 17.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.7 m -118.34 146.76 44.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.748 HD11 ' CD1' ' A' ' 47' ' ' PHE . 17.8 mt -76.29 125.83 29.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 0.0 110.19 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.48 10.25 57.05 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -145.43 138.03 25.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -1.171 . . . . 0.0 110.218 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -67.39 122.81 18.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.166 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . . . -127.09 142.04 51.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -0.919 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -71.22 144.69 50.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.226 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.7 mm -134.88 142.79 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.225 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.3 m -115.56 132.22 56.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.227 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.452 ' HB ' ' OD2' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -86.74 161.15 18.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.255 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.573 ' HG2' ' NE2' ' A' ' 56' ' ' GLN . 8.9 ttm -69.85 -20.84 63.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.452 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 2.9 p30 -79.34 -16.23 56.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.885 . . . . 0.0 110.186 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.87 23.01 6.98 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -96.58 138.47 34.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -1.136 . . . . 0.0 110.191 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -114.11 131.32 56.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.182 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.27 156.51 19.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.232 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -100.61 150.98 22.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 110.254 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.0 133.42 8.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.3 m -95.25 101.01 12.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.801 HG13 HD21 ' A' ' 89' ' ' LEU . 45.1 t -72.21 139.8 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.646 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 8.1 p-80 -139.21 156.04 47.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mp -100.19 131.44 46.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.96 116.65 13.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.887 . . . . 0.0 110.195 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 65.8 t30 60.1 28.06 17.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.671 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.15 48.01 10.29 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.872 ' HD2' ' OE2' ' A' ' 101' ' ' GLU . 3.4 mtpt -159.44 119.27 3.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -1.141 . . . . 0.0 110.221 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.801 HD21 HG13 ' A' ' 82' ' ' VAL . 5.2 tt -66.8 140.67 57.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 110.215 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.746 HG13 ' HG2' ' A' ' 99' ' ' GLU . 45.5 t -149.34 120.76 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 68.8 m -112.87 95.52 5.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -90.18 165.35 14.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.265 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 7.3 t -157.61 -162.54 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.543 ' N ' ' OG ' ' A' ' 93' ' ' SER . 41.6 tt0 -105.28 31.56 4.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 110.309 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 8.8 ptpt -172.6 1.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.906 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER 179.22 144.29 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 110.258 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 111' ' ' ILE . 46.2 m -119.27 159.99 23.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.261 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.538 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 56.1 t-80 -143.31 139.06 29.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.249 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.746 ' HG2' HG13 ' A' ' 90' ' ' VAL . 52.4 mt-10 -151.33 129.27 11.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.905 . . . . 0.0 110.161 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 28.4 tt0 -132.7 153.8 50.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.872 ' OE2' ' HD2' ' A' ' 88' ' ' LYS . 57.6 tt0 -153.49 156.86 38.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.274 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.418 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.4 p -121.09 137.72 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -127.93 92.74 3.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.4 -107.34 2.62 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -113.81 8.61 17.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -1.198 . . . . 0.0 110.227 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -117.24 158.7 23.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.48 ' HE3' ' CE2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -129.94 142.21 50.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.253 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 121' ' ' ARG . 91.1 t -128.19 125.7 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 0.0 110.223 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 31.4 mt-10 -108.4 126.96 53.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.211 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' GLU . 37.2 m -117.34 116.62 27.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' SER . 66.9 mt -125.71 129.58 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 50.7 m -106.52 139.68 40.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.169 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.606 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 11.7 t80 -161.48 126.36 3.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 66.63 38.2 93.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.2 8.46 58.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 17' ' ' PHE . 60.2 t -110.89 141.52 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -1.165 . . . . 0.0 110.217 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.2 m -117.73 130.75 56.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.893 . . . . 0.0 110.233 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.586 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 64.2 tp -110.01 148.33 31.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.208 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 92.0 mt -128.91 98.91 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.201 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.474 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 13.7 mtm180 -93.41 124.48 37.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 46.7 mtm-85 -102.66 127.83 49.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.432 ' OG ' HG22 ' A' ' 8' ' ' VAL . 75.5 m -125.54 160.18 30.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.912 . . . . 0.0 110.223 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -123.97 157.06 35.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.157 -0.964 . . . . 0.0 110.223 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' THR . 15.4 ttt85 -81.75 133.37 35.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.224 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.205 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 101' ' ' GLU . 90.3 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.278 0.561 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.1 m -56.5 145.59 27.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.22 -178.15 16.66 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 63.6 m -103.77 132.14 50.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -1.175 . . . . 0.0 110.195 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.584 ' NE1' ' HE1' ' A' ' 107' ' ' MET . 99.2 m95 -121.06 144.64 48.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -126.72 117.29 22.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.889 . . . . 0.0 110.116 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.427 HG11 ' CD ' ' A' ' 11' ' ' GLN . 48.8 t -64.6 126.06 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 13.3 p90 -125.98 -21.05 4.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.167 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.52 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -138.26 133.62 33.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.427 ' CD ' HG11 ' A' ' 8' ' ' VAL . 43.2 mt-30 -145.25 114.6 7.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.195 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.44 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.0 tt0 -92.04 144.01 25.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.937 . . . . 0.0 110.197 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 21.3 m120 57.44 17.51 3.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.922 . . . . 0.0 110.215 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.866 ' CE1' HD11 ' A' ' 18' ' ' LEU . 81.9 t80 -53.59 -47.75 69.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.197 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -66.28 -47.84 72.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 36.2 mt-10 -55.78 -62.3 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.717 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 62.7 t80 -47.24 -57.89 4.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.268 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.866 HD11 ' CE1' ' A' ' 14' ' ' TYR . 7.7 mt -57.14 -44.32 83.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.326 -0.859 . . . . 0.0 110.192 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 9.8 ttmm -46.93 -40.73 14.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.231 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.69 65.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.889 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.1 tp -56.81 -19.56 17.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.889 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.22 27.85 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.154 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.477 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 58.8 mt -74.21 166.67 42.7 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.221 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.13 138.87 28.68 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.026 1.54 . . . . 0.0 110.415 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -58.74 -41.02 85.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -56.19 -26.2 49.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.596 HD22 ' OD1' ' A' ' 74' ' ' ASP . 44.3 tp -93.12 -18.83 22.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.606 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 90.4 mt -82.68 -42.47 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.235 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.31 -32.67 66.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.56 -32.81 36.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.217 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -97.2 5.98 49.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.606 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.31 -5.3 13.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 110.204 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.403 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 7.4 p-10 -149.23 52.61 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.226 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.139 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.7 mt -122.86 114.86 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.28 83.62 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.189 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.139 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.5 Cg_endo -73.03 131.59 17.01 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.109 1.584 . . . . 0.0 110.411 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.5 mt -86.11 155.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.5 t -135.25 118.54 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 110.238 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.477 ' O ' HD13 ' A' ' 40' ' ' ILE . 22.5 tt0 -97.43 137.61 36.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.591 HD12 HG22 ' A' ' 49' ' ' VAL . 50.6 mm -124.75 129.02 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.224 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -129.28 74.18 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 110.184 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.668 ' OE1' ' CZ ' ' A' ' 47' ' ' PHE . 57.8 tt0 -69.86 166.3 19.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.193 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 36.8 mtmt -165.34 44.86 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.171 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.03 -105.25 1.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -107.63 -2.42 20.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -1.135 . . . . 0.0 110.224 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -102.28 148.72 25.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 110.189 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.775 ' CD1' HD11 ' A' ' 64' ' ' LEU . 1.9 m-85 -131.03 135.06 47.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.292 -0.88 . . . . 0.0 110.152 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.8 t -120.19 108.99 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.591 HG22 HD12 ' A' ' 40' ' ' ILE . 73.5 t -110.04 129.95 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.433 HG22 ' HE3' ' A' ' 52' ' ' LYS . 92.7 m -129.56 105.38 8.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 110.268 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 m -89.55 137.52 32.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.88 . . . . 0.0 110.222 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.433 ' HE3' HG22 ' A' ' 50' ' ' THR . 44.2 mttt -130.47 112.8 13.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.168 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.682 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -95.7 168.63 10.48 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.173 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.417 ' CD ' HG23 ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.12 -17.14 24.97 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.018 1.536 . . . . 0.0 110.434 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -106.55 -18.41 13.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.682 ' O ' ' OG1' ' A' ' 53' ' ' THR . 14.2 pt20 -167.84 161.63 13.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.1 p -128.53 135.82 49.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.99 126.9 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.209 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 t -109.92 139.56 44.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 110.147 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -136.2 147.93 47.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.254 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -139.49 130.54 26.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.242 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.912 ' CE1' HG21 ' A' ' 82' ' ' VAL . 34.2 p90 -144.42 173.15 12.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.228 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.0 m -120.19 143.35 48.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.298 -0.876 . . . . 0.0 110.126 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.775 HD11 ' CD1' ' A' ' 47' ' ' PHE . 30.8 mt -74.34 127.17 32.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.172 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.88 -1.4 57.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -136.34 145.11 45.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -1.135 . . . . 0.0 110.231 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -68.91 125.42 26.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.609 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -125.65 151.52 46.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -82.27 133.95 35.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.925 . . . . 0.0 110.187 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.415 HG23 HD12 ' A' ' 70' ' ' ILE . 18.9 mm -125.94 145.65 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 110.252 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -121.04 135.13 55.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.925 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.594 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -85.28 157.46 20.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 0.0 110.238 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.87 -16.98 63.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 110.25 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.596 ' OD1' HD22 ' A' ' 27' ' ' LEU . 15.9 t0 -84.13 -11.49 56.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.09 30.3 4.84 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.594 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 27.7 mttt -104.03 132.07 50.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -1.138 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -107.18 135.02 49.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.285 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.01 158.9 15.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.163 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -104.88 147.16 28.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.467 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.2 m -151.04 139.19 20.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -103.25 88.64 3.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.182 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.042 HG11 HD11 ' A' ' 89' ' ' LEU . 16.9 t -52.73 157.03 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 110.271 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.68 144.51 19.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.252 -0.905 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.649 HD13 HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -99.85 105.09 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.243 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.93 150.91 44.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.153 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 52.57 15.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.242 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.84 40.17 12.48 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.673 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 9.2 ptpt -163.54 133.0 4.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -1.127 . . . . 0.0 110.169 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.042 HD11 HG11 ' A' ' 82' ' ' VAL . 5.5 tt -61.42 145.07 52.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.206 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.657 HG13 ' HG3' ' A' ' 99' ' ' GLU . 41.4 t -150.48 111.42 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 87.4 m -106.96 97.95 7.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.232 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.43 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 14.9 ptpt -95.45 162.78 13.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 110.193 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.5 t -152.42 -164.47 1.96 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -102.21 33.34 3.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 0.0 110.231 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.1 pttt -174.98 2.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.18 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.99 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER 178.56 143.14 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.643 ' O ' HG23 ' A' ' 111' ' ' ILE . 50.7 m -116.85 164.91 13.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 0.0 110.209 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.825 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 60.5 t-80 -146.84 141.24 26.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.825 ' HG3' ' O ' ' A' ' 98' ' ' HIS . 4.3 mp0 -153.58 128.29 9.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 0.0 110.213 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 9.8 tt0 -131.89 157.4 44.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.443 ' HA ' ' CE2' ' A' ' 2' ' ' PHE . 36.7 tt0 -156.32 154.28 30.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.06 142.57 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.185 -0.947 . . . . 0.0 110.131 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -136.74 95.04 3.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 110.2 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.9 -110.76 3.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -114.62 12.62 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -1.149 . . . . 0.0 110.216 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -119.24 157.83 27.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.584 ' HE1' ' NE1' ' A' ' 6' ' ' TRP . 2.2 tpp -127.96 140.49 51.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.234 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.7 t -127.48 124.5 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 120' ' ' ARG . 23.5 mt-10 -109.35 118.26 36.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.567 ' N ' ' O ' ' A' ' 99' ' ' GLU . 41.3 m -108.76 118.65 37.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 110.253 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 97' ' ' SER . 53.6 mt -127.76 132.64 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.164 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 76.6 m -108.52 139.54 43.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.672 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 10.9 t80 -161.19 127.06 3.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 65.48 38.59 94.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 67.92 12.31 62.21 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 17' ' ' PHE . 63.4 t -114.57 138.27 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 110.168 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.6 m -115.02 131.49 56.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.263 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.717 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 63.8 tp -111.41 151.06 28.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 110.242 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.9 mt -129.39 94.1 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.484 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 64.8 mtp180 -87.27 124.09 32.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.192 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 65.3 mtt180 -104.72 125.15 50.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 74.3 m -124.29 152.93 42.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -115.39 156.12 26.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 110.215 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 5' ' ' THR . 32.3 ttt180 -82.61 136.04 34.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.196 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.246 0.546 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.89 144.38 44.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.16 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.59 176.19 14.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 42.3 p -103.48 134.05 47.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -1.108 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.467 ' CZ3' ' HG3' ' A' ' 107' ' ' MET . 86.0 m95 -122.46 142.96 50.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.226 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -123.31 118.51 27.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.488 HG13 ' HG2' ' A' ' 120' ' ' ARG . 51.0 t -64.61 127.74 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.285 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 47.6 p90 -128.41 -28.19 2.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.92 . . . . 0.0 110.25 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.415 ' HB2' ' CD2' ' A' ' 9' ' ' TYR . . . -132.84 133.76 43.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.175 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.593 ' NE2' ' CG ' ' A' ' 14' ' ' TYR . 15.4 pt20 -146.62 118.61 8.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -97.11 148.99 22.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.148 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 m120 53.08 21.89 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 110.218 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.943 ' CE1' HD11 ' A' ' 18' ' ' LEU . 86.6 t80 -60.12 -42.95 95.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 110.236 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.625 ' HG3' ' N ' ' A' ' 16' ' ' GLU . 14.2 pt-20 -69.55 -45.59 68.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 110.169 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.625 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 41.8 mt-10 -57.67 -60.37 3.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.713 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 52.2 t80 -51.65 -53.64 36.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.943 HD11 ' CE1' ' A' ' 14' ' ' TYR . 8.9 mt -59.38 -47.23 86.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 110.19 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -48.46 -38.74 20.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.917 . . . . 0.0 110.175 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.22 -25.07 65.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.946 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.5 tp -60.37 -18.74 52.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.232 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.946 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 82.61 26.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 23' ' ' LEU . 24.2 mt -72.91 163.14 70.61 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 110.231 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.493 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.9 Cg_endo -73.03 140.16 30.94 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.022 1.538 . . . . 0.0 110.442 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -56.02 -44.67 78.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -51.42 -36.53 44.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.16 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.493 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 20.8 tp -83.01 -23.34 33.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.685 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 35.0 mt -75.23 -40.98 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 9.3 mtmt -76.43 -22.84 54.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.214 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.6 mtt -87.92 -27.24 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.948 . . . . 0.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -104.73 4.72 32.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.174 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.859 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 21.1 ptt180 -70.69 1.53 5.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -0.914 . . . . 0.0 110.206 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.859 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 1.5 m-20 -153.82 42.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.254 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.907 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 7.1 mt -121.38 117.06 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -94.06 89.25 0.42 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.251 -0.905 . . . . 0.0 110.221 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.907 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.09 138.07 27.44 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.0 1.526 . . . . 0.0 110.408 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.1 mt -87.51 161.42 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.922 . . . . 0.0 110.182 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.87 120.98 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -101.6 138.27 38.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.507 HD12 ' HE3' ' A' ' 107' ' ' MET . 75.5 mt -124.95 132.79 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.888 . . . . 0.0 110.23 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -137.14 72.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.614 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 1.1 pt20 -76.42 169.65 17.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.211 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 75.7 mttt -161.26 46.71 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 110.239 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.18 -97.88 0.64 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -112.03 -6.84 14.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.153 . . . . 0.0 110.207 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.561 ' OD1' HG23 ' A' ' 63' ' ' THR . 49.4 m-20 -99.8 152.71 19.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.917 . . . . 0.0 110.157 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.652 ' CE1' HD11 ' A' ' 64' ' ' LEU . 2.1 m-85 -136.34 137.96 41.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.62 109.6 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.21 -0.931 . . . . 0.0 110.229 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.1 t -111.19 134.41 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.186 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.672 ' OG1' HG23 ' A' ' 59' ' ' THR . 91.3 m -131.14 109.91 10.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -90.42 135.11 33.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -127.51 122.11 32.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.208 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.815 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.58 168.87 7.19 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.239 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.757 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.05 -17.54 24.8 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.059 1.557 . . . . 0.0 110.466 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.464 ' HD3' ' HB3' ' A' ' 56' ' ' GLN . 1.8 tmt_? -105.57 -24.09 12.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.186 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.485 ' OE1' ' HG2' ' A' ' 73' ' ' MET . 2.5 pt20 -162.88 164.34 26.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.232 -0.918 . . . . 0.0 110.216 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.2 p -132.12 128.23 37.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 110.192 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.48 132.76 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.93 . . . . 0.0 110.222 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.672 HG23 ' OG1' ' A' ' 50' ' ' THR . 28.7 m -112.56 136.54 51.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 110.246 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -133.03 150.58 52.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.174 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.4 m -143.08 137.51 29.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.202 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.889 ' CD1' HG21 ' A' ' 82' ' ' VAL . 32.5 p90 -150.04 162.01 41.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.561 HG23 ' OD1' ' A' ' 46' ' ' ASP . 90.7 m -112.2 143.54 43.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.652 HD11 ' CE1' ' A' ' 47' ' ' PHE . 14.1 mt -69.16 124.79 24.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.54 19.03 53.74 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.441 ' C ' HG23 ' A' ' 81' ' ' THR . 91.2 mttt -150.89 138.9 20.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -1.191 . . . . 0.0 110.152 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -72.05 135.51 46.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 0.0 110.188 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.46 146.75 42.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.233 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 13.9 p-10 -76.27 141.4 41.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.168 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 74.7 mt -140.31 145.93 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 p -111.83 147.34 35.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.194 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.641 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -98.6 158.6 15.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.213 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.626 ' SD ' HG21 ' A' ' 53' ' ' THR . 10.5 ttm -68.13 -17.16 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.564 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 3.1 p30 -87.5 -18.28 30.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.86 26.76 4.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.641 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 19.4 mttt -101.59 133.4 46.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -1.111 . . . . 0.0 110.226 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -110.67 134.99 51.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -165.44 161.38 18.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -104.55 151.51 23.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.2 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.495 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 0.9 OUTLIER -155.23 140.53 17.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.203 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.441 HG23 ' C ' ' A' ' 66' ' ' LYS . 6.1 m -102.4 86.37 2.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.209 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.889 HG21 ' CD1' ' A' ' 62' ' ' PHE . 11.5 t -52.75 152.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.885 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.14 148.25 32.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.512 HD12 HD13 ' A' ' 64' ' ' LEU . 1.6 mt -102.19 105.02 15.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.67 132.27 55.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.211 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.7 t30 45.68 39.53 5.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.887 . . . . 0.0 110.217 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.36 42.62 95.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.661 ' HD3' ' CD ' ' A' ' 101' ' ' GLU . 25.3 mttt -150.04 119.38 6.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -1.104 . . . . 0.0 110.189 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.801 HD21 HG13 ' A' ' 82' ' ' VAL . 1.5 tt -68.87 133.2 47.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.815 HG22 ' HG3' ' A' ' 99' ' ' GLU . 20.7 t -139.78 120.85 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.495 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 87.9 m -113.76 94.66 4.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.2 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 46.7 pttt -94.25 163.13 13.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.272 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 28.6 t -150.23 -154.66 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.206 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.49 ' N ' ' OG ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -107.04 22.55 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.17 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -165.41 6.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.201 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 1.018 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.86 139.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 111' ' ' ILE . 16.0 t -112.38 165.29 12.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.412 ' O ' HG13 ' A' ' 90' ' ' VAL . 42.5 t-80 -149.5 136.46 19.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.815 ' HG3' HG22 ' A' ' 90' ' ' VAL . 33.3 tt0 -152.05 128.58 10.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.9 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.702 HE21 ' HG2' ' A' ' 109' ' ' GLU . 11.9 tt0 -132.43 160.52 36.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.179 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.661 ' CD ' ' HD3' ' A' ' 88' ' ' LYS . 82.3 tt0 -155.89 150.12 25.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.225 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.77 142.16 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 110.215 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -133.73 93.35 3.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 110.196 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.5 -108.39 2.78 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -114.26 8.73 16.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -1.119 . . . . 0.0 110.197 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -115.49 154.78 28.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.923 . . . . 0.0 110.164 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.507 ' HE3' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -125.5 141.91 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.19 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.1 t -128.68 122.16 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.702 ' HG2' HE21 ' A' ' 100' ' ' GLN . 27.1 mt-10 -105.42 121.75 44.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.223 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.665 ' N ' ' O ' ' A' ' 99' ' ' GLU . 19.6 m -112.61 116.04 29.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 97' ' ' SER . 52.2 mt -126.47 132.1 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 77.0 m -108.95 137.26 47.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.92 . . . . 0.0 110.225 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 11.6 t80 -159.56 126.52 4.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.94 32.79 77.92 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.46 9.65 78.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 17' ' ' PHE . 52.2 t -113.37 141.68 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -1.123 . . . . 0.0 110.246 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.3 m -115.85 134.26 55.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.192 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.713 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 16.9 tp -112.67 140.04 47.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 118' ' ' LEU . 58.1 mt -122.48 98.38 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.488 ' HG2' HG13 ' A' ' 8' ' ' VAL . 6.1 ttp180 -93.59 124.96 37.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 110.244 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 32.9 mtm180 -103.07 122.82 45.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 6' ' ' TRP . 73.6 m -120.44 150.42 40.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -114.91 151.63 33.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 110.19 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.1 ttt180 -74.87 133.31 41.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.189 179.977 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.231 0.539 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 p -57.79 144.47 38.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.8 -176.05 18.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.5 m -108.14 134.24 51.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -1.093 . . . . 0.0 110.215 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.549 ' CH2' HG23 ' A' ' 102' ' ' VAL . 98.8 m95 -121.12 139.2 53.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.179 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -121.89 125.6 46.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.239 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.651 HG12 ' HD3' ' A' ' 120' ' ' ARG . 19.4 m -62.34 123.35 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.212 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -134.27 2.77 3.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 110.223 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 121' ' ' ARG . . . -163.03 120.79 1.97 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -147.08 164.85 31.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 110.206 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.454 ' O ' HD12 ' A' ' 118' ' ' LEU . 39.8 tt0 -135.97 153.58 51.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 48.27 38.08 9.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -67.06 -49.31 65.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.188 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -61.8 -46.4 89.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 61.3 mt-10 -55.15 -42.93 73.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.195 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 55.2 t80 -55.41 -57.67 10.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 110.278 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.725 HD22 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -50.78 -38.89 50.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 110.195 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 33.2 mttp -60.33 -38.8 84.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.262 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.63 -40.94 69.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.981 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.0 tp -54.68 -26.22 32.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.893 . . . . 0.0 110.23 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.981 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 86.64 18.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.725 HD12 HD22 ' A' ' 18' ' ' LEU . 16.5 mt -66.69 170.31 6.17 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.175 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 46.8 Cg_endo -73.09 132.96 18.86 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.123 1.591 . . . . 0.0 110.41 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.675 ' HA ' HD12 ' A' ' 28' ' ' ILE . 25.6 tp10 -51.94 -47.91 64.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.225 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -48.42 -35.62 13.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 110.241 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.529 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 41.6 tp -79.54 -33.4 41.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.17 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.675 HD12 ' HA ' ' A' ' 25' ' ' GLU . 85.6 mt -61.95 -52.22 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.193 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.408 ' HE2' ' HG3' ' A' ' 25' ' ' GLU . 17.5 mttm -59.08 -26.1 64.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -0.913 . . . . 0.0 110.179 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.462 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 12.1 ttm -91.8 -23.12 19.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.629 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -101.29 -5.94 24.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -3.72 16.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -147.62 43.43 1.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.049 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 18.0 mt -120.49 109.93 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 110.206 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HA ' HG21 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -90.48 86.59 0.2 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 0.0 110.198 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.049 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.6 Cg_endo -73.14 146.42 40.95 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.069 1.562 . . . . 0.0 110.443 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 38' ' ' VAL . 12.2 mt -91.17 162.29 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.227 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' N ' HG22 ' A' ' 37' ' ' ILE . 79.4 t -138.36 120.75 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -103.45 134.58 46.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.533 HD12 ' CD1' ' A' ' 6' ' ' TRP . 68.8 mt -120.67 131.7 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 37.0 tt0 -135.95 73.09 1.45 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 110.215 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.532 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -76.12 164.1 26.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.201 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 59.6 mttt -158.71 49.84 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.42 -101.85 1.01 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -110.91 1.11 17.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -1.131 . . . . 0.0 110.174 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 42.2 t0 -108.23 144.02 36.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 110.265 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.692 ' CD1' HD11 ' A' ' 64' ' ' LEU . 3.6 m-85 -127.29 143.51 51.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.897 . . . . 0.0 110.248 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.6 t -132.35 106.92 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.178 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.4 t -108.82 134.88 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.243 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.765 ' OG1' HG23 ' A' ' 59' ' ' THR . 87.1 m -131.91 109.51 10.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.217 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.0 m -92.1 132.72 36.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.257 -0.902 . . . . 0.0 110.093 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -126.17 128.32 47.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.28 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.806 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -111.11 169.76 5.97 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.0 110.273 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.13 -8.87 22.74 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.005 1.529 . . . . 0.0 110.403 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -117.39 -20.84 8.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.607 ' O ' ' OG1' ' A' ' 53' ' ' THR . 16.2 pt20 -162.43 160.5 26.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.883 . . . . 0.0 110.17 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 p -131.09 131.15 43.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 73' ' ' MET . 57.4 t -127.7 129.35 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.194 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.765 HG23 ' OG1' ' A' ' 50' ' ' THR . 62.3 m -112.26 139.75 47.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -135.09 152.06 51.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.903 . . . . 0.0 110.19 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.4 t -148.38 131.15 16.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.225 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.591 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 50.5 p90 -143.51 171.55 13.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.929 . . . . 0.0 110.151 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.2 m -119.8 140.88 50.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.692 HD11 ' CD1' ' A' ' 47' ' ' PHE . 17.5 mt -74.41 127.67 33.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 110.202 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.42 4.4 56.18 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -145.05 145.07 31.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -1.154 . . . . 0.0 110.205 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.44 123.96 22.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.221 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.591 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.89 150.74 44.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 12.0 p-10 -86.39 140.65 29.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 70' ' ' ILE . 12.1 mm -130.15 144.42 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -116.56 131.77 56.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.194 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.663 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 73.0 p -86.04 158.16 19.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.484 ' HG3' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -70.01 -13.76 62.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.515 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 3.6 p30 -86.28 -16.92 36.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 110.22 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.53 27.7 4.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.663 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 22.1 mttt -105.06 131.36 52.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -107.84 135.83 48.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.26 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.541 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -164.22 159.38 20.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 110.195 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 83.4 mttt -105.93 171.01 7.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 110.256 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 27.6 p -179.88 136.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 m -95.34 103.43 15.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.197 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.707 HG13 HD21 ' A' ' 89' ' ' LEU . 43.2 t -76.77 140.54 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 110.244 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.647 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 35.0 p-80 -139.44 156.6 46.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.209 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 84' ' ' LEU . 53.8 mt -101.41 132.15 47.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.164 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -135.77 117.97 15.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.22 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 57.84 31.39 20.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 110.231 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.634 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 72.24 49.78 19.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.675 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 51.1 mtpt -158.57 117.21 3.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.707 HD21 HG13 ' A' ' 82' ' ' VAL . 4.5 tt -65.77 140.28 58.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.193 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.906 HG22 ' CG ' ' A' ' 99' ' ' GLU . 97.8 t -146.69 117.0 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 99.8 m -110.97 94.8 5.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 110.223 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -88.45 161.7 16.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.231 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 96' ' ' PHE . 30.2 t -157.47 -177.13 6.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.918 . . . . 0.0 110.237 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 84.1 tt0 -95.26 33.46 1.56 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.902 . . . . 0.0 110.184 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.541 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 10.8 ptpt -173.5 -2.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.837 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -176.96 146.62 0.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.2 m -123.13 156.87 34.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.154 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.696 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.5 t-80 -140.23 134.56 31.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.906 ' CG ' HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -149.07 125.14 10.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.857 . . . . 0.0 110.21 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.745 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 10.0 tt0 -131.94 156.47 46.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.675 ' OE1' ' HE3' ' A' ' 88' ' ' LYS . 76.8 tt0 -151.65 159.55 43.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.549 HG23 ' CH2' ' A' ' 6' ' ' TRP . 10.9 p -122.65 137.23 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -132.16 93.3 3.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.53 -106.77 2.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -117.67 10.79 13.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -1.147 . . . . 0.0 110.165 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -118.43 160.79 21.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.195 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.536 ' SD ' ' OE1' ' A' ' 100' ' ' GLN . 28.5 ttm -134.58 142.08 46.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.221 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 74.2 t -125.62 128.65 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 110.24 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.745 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 15.7 mt-10 -115.87 136.17 53.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.211 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 99' ' ' GLU . 3.1 t -126.27 122.61 36.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.183 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.29 133.01 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 89.6 m -113.27 133.87 54.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.157 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 21' ' ' LEU . 26.1 t80 -154.82 122.58 5.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 110.227 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.94 35.5 65.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.39 5.39 63.0 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 112' ' ' THR . 70.2 t -111.05 135.76 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -1.162 . . . . 0.0 110.23 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.2 m -112.93 135.43 53.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.577 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 23.5 tp -115.76 139.57 50.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.04 120.18 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.651 ' HD3' HG12 ' A' ' 8' ' ' VAL . 5.5 ttm105 -115.39 119.18 35.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 110.219 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 84.4 mtt180 -99.94 125.15 45.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.428 ' HB3' ' HB3' ' A' ' 6' ' ' TRP . 11.4 m -120.54 152.03 38.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.22 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -113.58 152.51 30.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 5' ' ' THR . 31.8 ttt180 -78.96 136.91 37.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.196 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.146 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.56 ' HA ' HG21 ' A' ' 102' ' ' VAL . 64.4 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.269 0.557 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.4 p -58.78 145.26 41.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.275 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.06 -178.99 16.78 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 85.0 m -104.05 132.04 50.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -1.154 . . . . 0.0 110.193 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.691 ' CD1' HD12 ' A' ' 40' ' ' ILE . 88.4 m95 -121.73 142.7 49.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.895 . . . . 0.0 110.164 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.01 122.32 38.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 110.212 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.55 124.16 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.204 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 38.1 p90 -124.94 -32.43 3.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.194 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.01 127.16 41.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.261 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 23.0 pt20 -141.48 117.72 10.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.589 ' O ' HD12 ' A' ' 118' ' ' LEU . 41.4 tt0 -96.19 144.25 26.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.219 -0.926 . . . . 0.0 110.279 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' GLU . 12.9 t30 60.79 14.63 5.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.841 ' CE1' HD11 ' A' ' 18' ' ' LEU . 60.5 t80 -50.98 -53.75 30.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 110.315 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.8 -49.1 76.27 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 34.1 mt-10 -55.05 -58.98 5.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 110.236 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.73 ' CD2' HD22 ' A' ' 118' ' ' LEU . 63.9 t80 -50.56 -54.73 20.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.841 HD11 ' CE1' ' A' ' 14' ' ' TYR . 4.4 mt -59.18 -41.18 87.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -50.09 -39.54 42.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.51 -27.53 65.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.909 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -59.71 -19.69 51.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.99 27.57 0.31 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 23' ' ' LEU . 37.4 mt -74.32 164.2 62.92 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.335 -0.853 . . . . 0.0 110.186 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.554 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -73.13 140.8 31.63 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.066 1.561 . . . . 0.0 110.391 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.89 -41.11 90.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.156 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.6 -27.39 49.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.554 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 42.2 tp -91.74 -18.91 23.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.188 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.7 mt -85.01 -40.93 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -73.83 -30.87 62.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.181 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 51.6 ttm -82.57 -30.83 29.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.838 . . . . 0.0 110.234 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -99.17 3.97 46.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 110.206 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.679 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -64.5 -10.19 23.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.232 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.679 ' OD2' ' HD2' ' A' ' 32' ' ' ARG . 69.2 m-20 -143.93 55.96 1.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.21 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 1.8 mt -126.32 114.41 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -86.32 83.06 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 110.232 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.21 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.7 Cg_endo -73.07 131.52 16.85 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.029 1.542 . . . . 0.0 110.389 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -87.52 153.59 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 110.246 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.48 118.44 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.215 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -96.78 131.9 43.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.229 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.691 HD12 ' CD1' ' A' ' 6' ' ' TRP . 74.0 mt -117.36 135.49 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.193 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -138.01 68.01 1.41 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.503 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -71.04 163.28 27.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 110.221 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 86.4 mttt -158.3 45.99 0.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.18 -97.85 0.67 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 52.3 m-20 -112.18 -3.7 14.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -1.181 . . . . 0.0 110.202 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.809 ' OD1' HG23 ' A' ' 63' ' ' THR . 38.3 m-20 -106.85 148.96 27.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 34.3 m-85 -131.88 148.79 52.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -127.27 99.74 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 110.164 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.13 132.65 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.865 . . . . 0.0 110.206 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 58.7 m -134.03 108.78 8.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.214 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 m -93.65 134.3 36.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 110.244 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -127.03 127.08 44.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.663 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 62.3 p -109.29 170.03 5.82 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.945 . . . . 0.0 110.204 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.652 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 46.7 Cg_endo -73.06 -5.57 17.43 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -120.7 -23.85 5.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.663 ' O ' ' OG1' ' A' ' 53' ' ' THR . 4.5 pt20 -161.43 165.89 28.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.175 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.2 p -132.6 130.8 40.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.161 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.652 HG21 ' HA ' ' A' ' 73' ' ' MET . 48.9 t -127.37 126.21 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 14.7 t -111.06 146.39 36.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.894 ' OD1' HG22 ' A' ' 71' ' ' THR . 10.8 m-80 -139.63 142.91 37.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.85 . . . . 0.0 110.15 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -139.58 135.05 32.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.19 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.742 ' CE1' HG11 ' A' ' 82' ' ' VAL . 54.1 p90 -148.06 170.78 17.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.809 HG23 ' OD1' ' A' ' 46' ' ' ASP . 91.3 m -116.78 151.05 37.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.236 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.504 HD11 ' CA ' ' A' ' 83' ' ' HIS . 3.5 tp -82.66 120.07 25.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.244 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.85 9.61 34.44 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -148.53 147.08 28.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -1.154 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -68.76 126.72 30.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -126.14 148.01 49.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.313 -0.867 . . . . 0.0 110.173 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -84.3 138.36 32.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 70' ' ' ILE . 11.4 mm -128.21 145.07 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 110.185 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.894 HG22 ' OD1' ' A' ' 60' ' ' ASN . 5.1 t -119.72 131.32 55.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 73.1 p -84.22 160.89 20.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.652 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -74.15 -12.52 60.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.117 -0.989 . . . . 0.0 110.226 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.507 ' OD1' ' HB ' ' A' ' 72' ' ' THR . 4.9 p-10 -89.35 -9.54 50.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.52 51.39 1.21 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.584 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 9.3 tttt -129.63 128.46 42.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -1.132 . . . . 0.0 110.197 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -104.53 141.04 37.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.656 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -168.72 156.32 7.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 110.248 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 13.7 mttm -105.41 165.86 10.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.217 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.9 p -178.05 139.95 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 p -94.46 107.95 19.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 0.0 110.22 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.809 HG13 HD21 ' A' ' 89' ' ' LEU . 48.1 t -79.47 140.38 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.568 ' CE1' ' HB ' ' A' ' 90' ' ' VAL . 30.9 p80 -145.03 161.54 39.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.426 HD11 ' HZ ' ' A' ' 47' ' ' PHE . 16.5 mt -103.61 134.35 47.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -136.91 120.44 17.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 110.235 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 86.7 m-20 58.72 31.7 21.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.578 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 72.83 44.07 39.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.788 ' HD3' ' OE2' ' A' ' 101' ' ' GLU . 10.0 mtmt -156.39 121.66 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -1.164 . . . . 0.0 110.152 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.809 HD21 HG13 ' A' ' 82' ' ' VAL . 4.2 tt -66.73 136.04 54.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.897 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.683 HG13 ' HG2' ' A' ' 99' ' ' GLU . 69.2 t -142.34 117.27 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 75.0 m -109.99 95.3 5.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 110.244 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -91.55 154.43 19.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.215 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.4 t -145.84 -163.95 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.158 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -102.69 33.08 3.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.2 OUTLIER -175.52 2.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.919 . . . . 0.0 110.187 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.823 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -178.73 148.42 0.42 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 0.0 110.184 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.605 ' O ' HG23 ' A' ' 111' ' ' ILE . 41.8 m -123.75 159.89 28.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.8 t-80 -142.21 142.92 32.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.915 . . . . 0.0 110.251 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.683 ' HG2' HG13 ' A' ' 90' ' ' VAL . 47.6 mt-10 -155.73 123.2 5.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.143 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.425 ' CG ' ' HG2' ' A' ' 109' ' ' GLU . 11.6 tt0 -129.23 159.07 37.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.202 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.788 ' OE2' ' HD3' ' A' ' 88' ' ' LYS . 57.6 tt0 -157.09 156.83 33.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 110.208 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.56 HG21 ' HA ' ' A' ' 2' ' ' PHE . 39.8 t -118.98 139.18 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -134.96 89.78 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.216 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.83 -102.59 2.48 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -123.09 10.72 9.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -1.122 . . . . 0.0 110.22 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -115.84 151.68 34.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.543 ' HG2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -121.74 137.01 54.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.4 t -125.29 120.56 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.425 ' HG2' ' CG ' ' A' ' 100' ' ' GLN . 35.4 mt-10 -109.01 118.71 37.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.567 ' N ' ' O ' ' A' ' 99' ' ' GLU . 63.4 m -107.97 116.61 32.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.266 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 97' ' ' SER . 54.0 mt -125.4 131.46 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.226 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 32.7 m -109.69 134.47 51.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.59 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 12.8 t80 -157.42 128.16 6.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.21 33.83 74.32 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.08 11.73 70.77 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 112' ' ' THR . 78.0 t -116.26 138.36 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -1.135 . . . . 0.0 110.202 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 63.2 m -113.27 132.48 55.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.73 HD22 ' CD2' ' A' ' 17' ' ' PHE . 29.5 tp -113.02 152.09 29.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.89 . . . . 0.0 110.244 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.9 mt -129.65 94.98 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.172 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -87.76 126.61 35.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 91.0 mtt180 -106.88 124.96 50.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.214 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.2 m -122.66 149.4 44.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -115.55 150.76 36.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 110.177 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' THR . 23.2 ttt85 -74.99 132.95 41.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.445 HG13 ' OXT' ' A' ' 125' ' ' VAL . 7.9 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.191 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.23 0.538 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 57.2 m -59.17 148.52 31.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 110.266 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.63 163.83 13.93 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.434 ' OG1' ' HB ' ' A' ' 125' ' ' VAL . 20.5 p -78.3 155.52 30.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -1.159 . . . . 0.0 110.16 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.598 ' CH2' HG23 ' A' ' 102' ' ' VAL . 96.7 m95 -141.93 127.64 19.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.983 ' HB3' ' HG2' ' A' ' 123' ' ' LYS . 6.1 tt0 -94.63 146.34 24.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.187 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 36' ' ' PRO . 38.6 t -67.37 112.32 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.259 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 1.355 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 2.1 m-85 -72.86 -69.52 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.895 . . . . 0.0 110.252 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.961 ' H ' ' HG3' ' A' ' 121' ' ' ARG . . . -149.07 170.76 17.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.26 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.703 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 3.1 mp0 -148.43 112.25 5.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.238 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 54.6 tt0 -91.8 150.93 20.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.19 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 14' ' ' TYR . 23.6 m-20 52.49 19.12 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 7.4 t80 -42.85 -65.31 0.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.135 -0.978 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' GLU . 47.2 mt-10 -47.88 -57.33 5.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.212 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 5.7 mm-40 -41.83 -49.88 4.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.469 ' CD2' HD22 ' A' ' 118' ' ' LEU . 12.6 t80 -52.04 -63.3 1.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.791 ' CD2' HD12 ' A' ' 23' ' ' LEU . 7.6 mt -44.49 -44.46 8.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.275 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 22.8 mttm -52.72 -37.93 59.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.03 -40.08 63.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.22 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.883 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -57.51 -25.22 59.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 110.231 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.883 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.6 23.22 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 110.162 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.791 HD12 ' CD2' ' A' ' 18' ' ' LEU . 15.5 mt -71.54 170.12 13.11 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.209 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.3 Cg_endo -73.11 139.32 29.46 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.067 1.562 . . . . 0.0 110.374 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 5.6 pt-20 -59.93 -46.74 88.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 110.238 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' A' ' 24' ' ' PRO . 2.6 p30 -47.34 -34.67 7.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.194 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 18.4 tp -88.97 -32.25 17.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.228 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.669 HG12 HD13 ' A' ' 18' ' ' LEU . 72.8 mt -70.61 -49.16 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 110.177 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -63.63 -32.07 73.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 110.164 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.1 ttp -84.33 -11.77 55.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 110.159 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -111.2 3.81 18.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.258 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.568 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 9.4 ptt180 -68.29 -3.21 10.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.182 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 81.0 m-20 -146.91 51.46 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.897 . . . . 0.0 110.178 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.817 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 11.6 mt -126.54 113.49 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.224 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -98.49 85.27 0.4 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.172 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.0 ' HB3' HG23 ' A' ' 53' ' ' THR . 46.6 Cg_endo -73.05 154.69 52.72 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.983 1.517 . . . . 0.0 110.44 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.536 HG22 ' N ' ' A' ' 38' ' ' VAL . 6.3 mt -95.32 169.31 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.193 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.536 ' N ' HG22 ' A' ' 37' ' ' ILE . 75.1 t -145.64 118.24 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.248 -0.907 . . . . 0.0 110.225 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -98.31 147.19 24.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 3' ' ' SER . 65.4 mt -133.96 125.23 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -127.15 80.07 1.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.868 . . . . 0.0 110.177 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.752 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 41.1 tt0 -78.77 162.62 26.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.187 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 34.3 mmtt -159.22 46.28 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.248 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.15 -96.73 0.66 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -116.59 3.11 13.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -1.137 . . . . 0.0 110.157 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 40.5 t0 -107.98 139.28 42.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.93 . . . . 0.0 110.249 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.929 ' CE2' HD11 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -120.61 135.61 55.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.38 103.16 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 110.154 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.08 129.03 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.157 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.922 ' OG1' HG23 ' A' ' 59' ' ' THR . 57.5 m -130.23 107.9 9.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.5 m -89.57 128.08 35.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.158 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.459 ' CA ' HG22 ' A' ' 57' ' ' THR . 52.2 mtmt -120.75 124.09 44.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.16 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.0 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.56 169.07 6.93 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.223 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.881 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.7 Cg_endo -73.04 -16.81 25.4 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.997 1.525 . . . . 0.0 110.483 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -111.95 -20.79 11.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.58 ' O ' ' OG1' ' A' ' 53' ' ' THR . 2.0 tt0 -160.95 155.32 23.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.459 HG22 ' CA ' ' A' ' 52' ' ' LYS . 4.3 p -131.46 137.54 48.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.167 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.8 t -133.65 132.04 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.908 . . . . 0.0 110.243 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.922 HG23 ' OG1' ' A' ' 50' ' ' THR . 17.1 m -111.79 137.31 49.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 110.205 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.473 ' HB3' ' CD1' ' A' ' 70' ' ' ILE . 31.2 m-20 -132.38 155.77 47.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.932 . . . . 0.0 110.214 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 t -152.32 127.42 9.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.2 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.479 ' CB ' ' CB ' ' A' ' 68' ' ' ALA . 34.5 p90 -141.99 174.02 10.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.314 -0.867 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 27.7 m -118.38 150.71 39.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.929 HD11 ' CE2' ' A' ' 47' ' ' PHE . 5.6 mt -78.58 125.2 29.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.74 10.1 58.06 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -142.36 141.12 32.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -1.165 . . . . 0.0 110.173 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.8 124.87 25.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 0.0 110.22 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.479 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -125.35 149.29 48.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 0.0 110.27 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -82.15 139.08 34.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 110.138 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 4.4 mm -132.78 144.74 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 0.0 110.218 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -116.74 137.6 52.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.247 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.568 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -87.15 156.98 19.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.189 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.7 ttm -66.89 -16.36 64.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 110.256 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.56 -9.66 55.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.229 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.96 33.74 4.55 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.568 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 28.3 mttt -107.27 133.31 52.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -109.45 136.53 48.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.422 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -169.04 157.97 8.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.152 -0.968 . . . . 0.0 110.22 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 9.7 mtmt -102.29 172.06 7.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 110.227 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.3 p -178.65 137.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 110.154 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.0 m -97.04 99.75 11.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.683 HG13 HD21 ' A' ' 89' ' ' LEU . 46.1 t -72.84 139.03 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.235 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.64 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 11.4 p-80 -138.58 161.26 37.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 84' ' ' LEU . 26.4 mt -105.63 132.12 52.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.262 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.62 115.61 13.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.218 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 59.8 t30 59.38 31.82 21.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.426 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 73.77 43.91 33.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.426 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 85.9 mttt -152.58 120.78 6.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -1.133 . . . . 0.0 110.177 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.683 HD21 HG13 ' A' ' 82' ' ' VAL . 7.4 tt -72.54 133.11 44.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.698 HG22 ' HG3' ' A' ' 99' ' ' GLU . 99.0 t -141.55 122.83 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.918 . . . . 0.0 110.198 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 54.6 m -113.85 92.48 3.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 62.1 pttt -87.46 162.35 17.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 110.208 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 28.3 t -155.8 -164.44 1.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 110.181 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.423 ' N ' ' OG ' ' A' ' 93' ' ' SER . 40.7 tt0 -103.99 31.56 4.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.92 . . . . 0.0 110.183 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -172.65 -2.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.144 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.804 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -173.7 147.99 1.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.185 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 111' ' ' ILE . 70.9 m -124.82 154.33 41.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.515 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 64.1 t-80 -141.6 140.36 33.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.698 ' HG3' HG22 ' A' ' 90' ' ' VAL . 29.5 tt0 -152.15 127.52 9.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 110.186 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 13.8 tt0 -130.2 150.43 51.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.229 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -148.2 154.08 39.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 110.253 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.598 HG23 ' CH2' ' A' ' 6' ' ' TRP . 13.2 p -119.69 131.86 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -126.76 93.09 3.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.882 . . . . 0.0 110.201 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.76 -95.74 1.26 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -126.52 15.74 7.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -1.162 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -123.73 150.75 44.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 110.206 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 121' ' ' ARG . 8.2 tpp -125.79 140.14 52.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.885 . . . . 0.0 110.172 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.02 124.46 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 110.256 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 33.6 mt-10 -115.25 123.7 49.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.9 m -111.99 123.16 49.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 97' ' ' SER . 73.7 mt -129.09 128.43 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.904 . . . . 0.0 110.197 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 90.1 m -111.93 133.49 54.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 110.223 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 5.8 t80 -156.0 122.38 5.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.245 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.07 32.54 58.42 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.41 1.43 65.03 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.1 t -108.5 141.31 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -1.131 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.5 m -119.57 130.99 55.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.249 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.469 HD22 ' CD2' ' A' ' 17' ' ' PHE . 59.0 tp -110.43 140.84 44.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 85.4 mt -114.61 105.29 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -106.26 119.03 38.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -0.962 . . . . 0.0 110.196 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.961 ' HG3' ' H ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -102.49 136.87 41.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 1.4 m -123.71 140.1 53.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.278 -0.889 . . . . 0.0 110.205 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 1.355 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 15.4 ptmt -99.81 146.35 26.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.511 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 68.7 ttt180 -77.43 135.95 38.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.434 ' HB ' ' OG1' ' A' ' 5' ' ' THR . 64.7 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.21 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.433 ' HA ' ' CE ' ' A' ' 107' ' ' MET . 85.0 m-85 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.239 0.543 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -57.12 147.22 25.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.63 163.93 13.06 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 25.2 m -80.79 150.93 29.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 110.193 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.701 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 97.5 m95 -136.61 130.96 33.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.206 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.967 ' O ' ' HA ' ' A' ' 122' ' ' SER . 32.4 tt0 -95.73 144.59 26.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.201 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 36' ' ' PRO . 21.7 t -66.61 119.96 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.905 . . . . 0.0 110.181 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 1.154 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.9 OUTLIER -80.94 -68.68 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 110.256 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.921 ' H ' ' HG3' ' A' ' 121' ' ' ARG . . . -150.33 169.6 21.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 110.236 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -146.44 110.59 5.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.487 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 9.5 mm-40 -88.55 155.07 19.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.716 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 68.3 m-20 47.38 21.35 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 110.165 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 4.4 t80 -46.19 -61.86 1.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' GLU . 67.0 mt-10 -51.27 -57.77 7.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.716 ' OE1' ' HA ' ' A' ' 13' ' ' ASN . 6.7 mp0 -41.7 -49.59 4.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -50.28 -62.8 1.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.247 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.619 HD13 HG12 ' A' ' 28' ' ' ILE . 9.2 mt -44.98 -47.35 11.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 90.4 mttt -49.4 -39.09 31.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.133 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.14 -38.4 63.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.174 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.917 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.3 tp -58.98 -24.81 63.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.239 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.917 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 80.25 22.49 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.713 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 6.6 mt -71.39 170.91 10.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 110.194 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.713 ' HD2' ' CD2' ' A' ' 23' ' ' LEU . 46.1 Cg_endo -72.99 138.07 27.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.004 1.528 . . . . 0.0 110.446 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -59.47 -40.76 87.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.212 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -53.24 -33.49 53.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.635 HD23 HD22 ' A' ' 23' ' ' LEU . 52.1 tp -85.65 -35.41 20.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.619 HG12 HD13 ' A' ' 18' ' ' LEU . 96.2 mt -63.26 -52.09 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -59.52 -29.61 68.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.192 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 96.2 mtp -86.37 -12.8 48.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.235 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.602 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -111.51 -3.62 15.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.888 . . . . 0.0 110.242 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -63.64 -6.61 5.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -147.2 55.21 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.82 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 16.5 mt -130.46 114.2 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -98.24 85.79 0.42 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.984 ' HB3' HG23 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.07 149.34 46.33 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.996 1.524 . . . . 0.0 110.426 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.621 HG22 ' N ' ' A' ' 38' ' ' VAL . 19.8 mt -89.51 175.25 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.235 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.621 ' N ' HG22 ' A' ' 37' ' ' ILE . 61.0 t -152.92 119.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -101.13 152.0 21.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 110.249 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.488 HD12 ' HE3' ' A' ' 107' ' ' MET . 58.2 mt -139.46 130.3 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.42 ' HB3' ' HB ' ' A' ' 48' ' ' VAL . 59.7 tt0 -130.1 72.36 1.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 110.207 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.697 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 56.4 tt0 -66.45 173.64 3.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.245 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.697 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 8.3 mtmt -171.49 35.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.234 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.1 -100.25 0.57 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -111.47 -0.86 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -1.151 . . . . 0.0 110.21 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 39.5 t0 -107.32 146.76 31.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.182 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.767 ' CE1' HD11 ' A' ' 64' ' ' LEU . 4.5 m-85 -127.53 139.52 52.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 65.7 t -120.91 101.99 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.208 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.8 t -103.93 130.75 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.193 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 85.5 m -133.31 105.42 6.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.89 . . . . 0.0 110.207 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -86.03 132.0 34.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HA ' HG22 ' A' ' 57' ' ' THR . 57.4 mttt -124.72 122.98 39.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.984 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -109.53 168.09 8.19 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.735 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.06 -5.99 18.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.966 1.508 . . . . 0.0 110.412 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -122.45 -18.41 6.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.19 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.445 ' O ' ' OG1' ' A' ' 53' ' ' THR . 5.8 pt20 -164.6 158.69 18.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 52' ' ' LYS . 11.6 p -133.94 133.52 41.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.895 . . . . 0.0 110.21 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.53 132.84 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.214 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 13.5 t -115.28 138.71 50.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -0.912 . . . . 0.0 110.163 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -135.35 151.93 50.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 110.277 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.2 t -141.37 132.42 26.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.167 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.796 ' CE1' HG21 ' A' ' 82' ' ' VAL . 33.6 p90 -146.64 169.98 17.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 58.1 m -117.81 153.85 32.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -0.929 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.767 HD11 ' CE1' ' A' ' 47' ' ' PHE . 8.0 mt -82.71 122.84 28.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.91 -3.16 55.7 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -132.98 148.63 52.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -1.148 . . . . 0.0 110.197 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.46 ' OE2' ' HB3' ' A' ' 79' ' ' LYS . 5.4 tm-20 -73.68 133.18 43.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.247 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -133.33 148.63 51.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.168 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 15.2 p-10 -78.14 135.1 37.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.898 . . . . 0.0 110.246 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 70' ' ' ILE . 17.1 mm -127.92 143.53 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.172 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p -118.47 139.86 50.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.206 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.724 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 29.3 p -93.54 158.0 15.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.233 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -11.44 59.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.2 -0.937 . . . . 0.0 110.226 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.454 ' OD2' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -87.54 -17.78 31.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 110.256 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.86 29.48 4.07 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.724 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 28.5 mttt -105.07 136.03 45.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 8.4 ptpp? -111.57 133.25 53.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.29 162.26 25.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 110.238 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 35.4 mttt -105.28 151.03 24.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.42 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.2 m -152.88 139.3 18.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.229 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.01 90.56 3.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.881 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.847 HG13 HD21 ' A' ' 89' ' ' LEU . 39.3 t -58.71 152.23 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.276 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -146.59 152.25 38.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.546 HD12 HD13 ' A' ' 64' ' ' LEU . 1.3 mt -105.58 102.31 11.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.87 132.44 54.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.1 t30 45.61 38.18 3.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.411 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 66.73 41.03 93.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.411 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 89.8 mttt -147.68 125.68 12.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -1.149 . . . . 0.0 110.212 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.847 HD21 HG13 ' A' ' 82' ' ' VAL . 6.2 tt -75.23 132.55 41.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.782 HG13 ' HG2' ' A' ' 99' ' ' GLU . 43.4 t -137.84 123.76 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.898 . . . . 0.0 110.241 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 55.3 m -119.7 88.69 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.448 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 16.1 ptmt -85.65 171.52 11.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.183 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 15.1 t -160.03 -161.24 0.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.177 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.491 ' N ' ' OG ' ' A' ' 93' ' ' SER . 23.1 mt-10 -106.15 34.49 3.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 110.202 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.449 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 7.4 ptpt -177.49 -0.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.892 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -175.76 146.85 0.76 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -120.74 157.89 28.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 63.4 t-80 -142.58 138.51 30.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.285 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.782 ' HG2' HG13 ' A' ' 90' ' ' VAL . 44.2 mt-10 -149.59 128.2 12.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.917 . . . . 0.0 110.208 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.609 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 53.6 tt0 -128.67 155.31 45.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 9.5 mp0 -154.82 148.91 25.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 102' ' ' VAL . 12.1 p -116.18 137.04 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 110.299 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -131.65 95.54 3.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.22 -98.02 1.46 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -126.25 12.08 7.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.254 -1.145 . . . . 0.0 110.196 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -118.71 156.05 29.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -0.914 . . . . 0.0 110.151 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.488 ' HE3' HD12 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -129.02 140.84 51.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.201 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.3 t -127.66 125.66 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.22 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.406 ' HG3' ' HG3' ' A' ' 100' ' ' GLN . 27.9 mt-10 -114.84 132.64 56.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.0 m -121.37 122.75 40.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.216 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 97' ' ' SER . 56.8 mt -129.75 133.92 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 75.1 p -113.93 136.47 52.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 0.0 110.203 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 4.6 t80 -157.36 122.75 4.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.875 . . . . 0.0 110.217 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.61 36.11 62.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.74 1.86 55.2 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 112' ' ' THR . 53.0 t -106.7 143.47 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -1.155 . . . . 0.0 110.174 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.447 HG23 HG22 ' A' ' 112' ' ' THR . 85.8 m -121.46 129.39 52.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.487 ' CD1' ' O ' ' A' ' 12' ' ' GLU . 63.0 tp -108.37 145.02 35.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.3 mt -119.03 103.31 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.214 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -102.61 114.18 28.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.921 ' HG3' ' H ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -102.09 137.94 39.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.967 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 5.9 m -125.5 161.88 26.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 110.223 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 1.154 ' HB2' ' CE2' ' A' ' 9' ' ' TYR . 51.8 tttt -128.57 157.55 40.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 110.225 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 5' ' ' THR . 45.2 ttt180 -89.95 135.52 33.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.209 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.565 HG11 ' OE1' ' A' ' 7' ' ' GLN . 33.8 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.432 ' CE2' ' HA ' ' A' ' 101' ' ' GLU . 80.5 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.155 0.503 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.1 p -57.82 148.5 25.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.68 164.79 13.03 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 21.6 m -82.58 145.95 29.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -1.151 . . . . 0.0 110.202 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.645 ' CH2' HG23 ' A' ' 102' ' ' VAL . 98.1 m95 -129.88 130.36 45.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.851 ' HB2' ' HG2' ' A' ' 123' ' ' LYS . 65.1 mt-30 -103.26 117.72 35.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.897 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 36' ' ' PRO . 16.9 t -35.95 134.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.236 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 1.476 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -99.46 -57.47 2.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 110.192 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 1.324 ' HB3' ' NE ' ' A' ' 121' ' ' ARG . . . -158.52 163.97 36.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 110.255 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.599 ' HB2' ' CG ' ' A' ' 14' ' ' TYR . 1.8 pt20 -137.26 106.17 5.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.77 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 39.4 tt0 -94.87 126.48 40.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.801 ' OD1' ' OE1' ' A' ' 16' ' ' GLU . 12.1 t30 77.91 -4.02 2.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.867 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.75 ' CE1' HD21 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -29.9 -72.72 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 110.222 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 14' ' ' TYR . 46.4 mt-10 -39.52 -61.15 0.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.801 ' OE1' ' OD1' ' A' ' 13' ' ' ASN . 28.6 mt-10 -42.93 -55.86 3.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.215 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.625 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 77.1 t80 -52.82 -46.6 67.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.85 -44.33 86.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.234 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -52.33 -42.18 63.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 110.154 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.99 -31.16 69.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 110.235 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.844 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.7 tp -65.3 -17.14 64.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 75.48 27.54 1.03 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.157 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.725 HD11 HD23 ' A' ' 21' ' ' LEU . 41.6 mt -76.57 163.66 64.54 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.172 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -73.09 138.62 28.37 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.999 1.526 . . . . 0.0 110.39 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -55.38 -38.3 68.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 110.25 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 30' ' ' MET . 44.5 t0 -59.24 -27.61 65.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.229 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.654 HD22 ' OD1' ' A' ' 74' ' ' ASP . 52.5 tp -90.7 -32.59 16.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 110.171 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.629 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.7 mt -69.74 -45.62 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 110.195 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -70.31 -19.9 63.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.416 ' HE2' ' NH2' ' A' ' 55' ' ' ARG . 90.1 mmm -91.47 -29.17 17.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 110.154 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.503 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -102.31 -1.59 30.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.211 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.629 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 2.4 ppt_? -65.51 -10.55 35.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.175 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 10.3 t0 -141.65 47.7 1.65 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.12 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mt -121.22 113.13 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.78 81.28 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.25 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.12 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.9 Cg_endo -73.06 142.39 34.39 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.921 1.485 . . . . 0.0 110.371 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 38' ' ' VAL . 6.6 mt -88.64 164.62 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.261 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.445 ' N ' HG22 ' A' ' 37' ' ' ILE . 55.5 t -141.52 109.93 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.236 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -89.25 137.66 32.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.276 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.442 HD12 ' CD1' ' A' ' 6' ' ' TRP . 82.1 mt -125.04 127.36 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.198 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -127.43 70.48 1.32 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.6 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 57.0 tt0 -68.57 164.41 21.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.231 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 37.3 mttt -162.73 46.11 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.95 -101.06 0.89 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 29.3 m-20 -111.04 -3.86 15.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -1.146 . . . . 0.0 110.179 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -99.64 151.39 21.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.768 ' CE1' HD11 ' A' ' 64' ' ' LEU . 2.3 m-85 -133.42 131.03 39.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.225 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.3 109.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.186 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.5 t -111.81 129.27 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.169 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 88.4 m -123.81 103.31 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.17 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.3 m -83.63 137.94 33.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 0.0 110.164 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -131.74 117.05 18.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 110.16 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.973 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -103.68 168.17 9.06 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 110.239 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.84 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.3 Cg_endo -73.08 -27.81 13.54 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.016 1.535 . . . . 0.0 110.4 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.416 ' NH2' ' HE2' ' A' ' 30' ' ' MET . 3.6 ttm180 -97.28 -23.83 15.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.249 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.486 ' O ' ' OG1' ' A' ' 53' ' ' THR . 1.1 pm0 -161.13 161.98 31.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.224 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 p -129.74 128.06 41.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 110.226 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 73' ' ' MET . 59.4 t -126.77 127.83 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 110.16 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 14.1 t -111.65 140.85 45.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.195 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -138.1 131.72 30.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.175 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -123.12 136.18 54.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.214 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.908 ' CE1' HG21 ' A' ' 82' ' ' VAL . 45.7 p90 -149.06 167.32 26.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.216 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.1 m -116.37 148.69 40.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 110.247 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.772 HD13 HD12 ' A' ' 84' ' ' LEU . 37.2 mt -76.49 126.37 30.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.56 13.23 58.57 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' C ' HG23 ' A' ' 81' ' ' THR . 56.7 mttm -144.22 138.67 28.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -1.136 . . . . 0.0 110.225 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -70.68 124.48 24.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.187 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.65 149.36 49.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.254 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -77.37 137.15 38.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 70' ' ' ILE . 25.5 mm -128.16 145.22 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -0.888 . . . . 0.0 110.226 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.0 p -121.73 134.78 54.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.92 . . . . 0.0 110.213 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.684 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 36.5 p -86.96 156.51 19.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.91 . . . . 0.0 110.176 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.444 ' HA ' HG21 ' A' ' 58' ' ' VAL . 10.7 mtm -68.42 -15.6 63.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 110.181 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.654 ' OD1' HD22 ' A' ' 27' ' ' LEU . 11.2 t0 -82.32 -22.59 35.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.208 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.09 19.62 5.11 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.684 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 22.3 mttt -96.38 137.81 34.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -1.142 . . . . 0.0 110.236 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -113.96 133.22 55.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.55 162.07 30.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -106.01 143.99 33.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -0.894 . . . . 0.0 110.2 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.453 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -148.46 139.17 22.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.44 HG23 ' C ' ' A' ' 66' ' ' LYS . 17.8 m -104.4 93.07 4.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 110.192 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.957 HG11 HD11 ' A' ' 89' ' ' LEU . 16.2 t -57.36 152.4 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.907 . . . . 0.0 110.217 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.54 147.28 30.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.253 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.772 HD12 HD13 ' A' ' 64' ' ' LEU . 6.0 mt -102.99 98.83 8.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.214 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 86' ' ' ASN . . . -110.11 138.03 47.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.159 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 85' ' ' ALA . 29.7 m120 42.98 39.35 1.75 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.47 52.09 53.56 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.782 ' HE2' ' OE1' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -161.61 112.98 1.72 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -1.18 . . . . 0.0 110.164 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.957 HD11 HG11 ' A' ' 82' ' ' VAL . 3.9 tt -58.95 144.06 46.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.775 HG13 ' CG ' ' A' ' 99' ' ' GLU . 48.1 t -151.01 114.62 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 85.5 m -109.73 94.2 4.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -91.43 165.14 13.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.859 . . . . 0.0 110.173 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.461 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 1.6 m -155.99 -158.44 0.81 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.572 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 53.1 tt0 -107.9 29.13 7.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.529 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 7.8 ptpt -171.1 1.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.247 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.863 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -178.65 148.04 0.41 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.181 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.737 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -122.72 157.83 31.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.64 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.2 t-80 -139.82 138.39 35.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 110.234 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.775 ' CG ' HG13 ' A' ' 90' ' ' VAL . 78.1 mt-10 -152.66 126.15 8.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.455 ' CG ' ' HG2' ' A' ' 109' ' ' GLU . 9.3 tt0 -133.92 155.65 49.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.782 ' OE1' ' HE2' ' A' ' 88' ' ' LYS . 47.5 tt0 -149.51 163.61 37.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.143 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.645 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.0 p -127.2 129.49 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.182 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.6 pttt -126.94 96.9 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 110.202 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.57 -111.29 3.26 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.542 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 45.9 p-10 -115.2 14.42 16.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -1.132 . . . . 0.0 110.25 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.542 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 20.0 mt-10 -119.66 157.72 27.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.178 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.529 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 26.4 ttm -132.56 140.92 48.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 110.226 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 121' ' ' ARG . 65.1 t -127.42 133.65 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.206 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 70.9 mt-10 -117.5 123.99 47.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 110.227 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.2 m -114.02 123.13 48.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.18 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 97' ' ' SER . 82.2 mt -131.86 132.77 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 63.5 p -109.02 136.25 48.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 0.0 110.188 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 8.7 t80 -156.99 124.94 5.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.94 . . . . 0.0 110.19 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 67.68 38.45 89.96 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.53 2.67 44.46 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.9 t -105.66 147.1 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -1.165 . . . . 0.0 110.18 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.7 m -122.28 127.77 50.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.189 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.75 HD21 ' CE1' ' A' ' 14' ' ' TYR . 62.9 tp -105.98 153.07 22.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 91.4 mt -132.15 101.12 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 110.184 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 3.9 ttt180 -104.33 122.28 45.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 1.324 ' NE ' ' HB3' ' A' ' 10' ' ' ALA . 4.4 ptt180 -103.89 142.42 34.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.753 ' C ' ' CD2' ' A' ' 9' ' ' TYR . 0.7 OUTLIER -129.69 147.78 51.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.85 . . . . 0.0 110.248 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 1.476 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -106.57 149.15 27.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.185 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 5' ' ' THR . 76.1 ttt180 -82.18 139.89 34.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.171 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.248 0.547 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.1 p -57.22 146.79 27.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.202 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.81 -177.91 17.31 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.6 m -105.3 132.69 51.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -1.149 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.53 ' CE3' ' HB2' ' A' ' 107' ' ' MET . 98.5 m95 -121.13 147.08 46.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.862 . . . . 0.0 110.198 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -128.82 115.38 17.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 110.175 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.629 HG22 ' HD3' ' A' ' 120' ' ' ARG . 40.1 t -61.67 133.88 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.301 -0.874 . . . . 0.0 110.257 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.503 ' OH ' ' HB3' ' A' ' 121' ' ' ARG . 16.4 p90 -135.88 -19.4 1.56 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -139.05 133.81 32.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 110.277 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -146.1 116.77 7.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.237 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.594 ' O ' HD12 ' A' ' 118' ' ' LEU . 63.5 mm-40 -88.44 142.12 27.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.9 . . . . 0.0 110.281 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.5 t30 55.66 26.31 9.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.23 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.618 ' CE1' HD11 ' A' ' 18' ' ' LEU . 35.1 t80 -54.8 -50.39 68.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -65.99 -45.94 79.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -0.934 . . . . 0.0 110.166 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.86 -60.35 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.194 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.66 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 41.8 t80 -48.56 -60.42 2.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.192 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.723 HD23 HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -53.92 -54.39 39.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.503 ' C ' ' O ' ' A' ' 18' ' ' LEU . 56.7 mttt -36.53 -44.99 0.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.14 -27.35 68.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.907 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -60.65 -19.58 58.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.263 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.907 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 80.15 30.79 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 110.186 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.723 HD12 HD23 ' A' ' 18' ' ' LEU . 15.0 mt -78.03 164.52 56.53 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.925 . . . . 0.0 110.197 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.598 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.4 Cg_endo -73.13 141.19 32.21 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.019 1.536 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -62.25 -39.37 92.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.159 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -57.11 -29.36 63.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.211 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.598 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 44.7 tp -89.42 -23.14 22.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.206 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.9 mt -82.29 -40.22 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.199 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -73.49 -29.09 62.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.239 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.7 ttm -88.11 -25.95 22.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.208 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -101.74 2.72 38.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.621 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 18.0 ptt180 -67.33 -1.12 4.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.234 -0.916 . . . . 0.0 110.212 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.549 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.5 m-20 -146.74 49.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.915 . . . . 0.0 110.181 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.906 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.2 mt -122.41 123.07 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.75 83.0 0.23 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.211 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.906 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -72.98 138.94 29.21 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.061 1.558 . . . . 0.0 110.454 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.7 mt -93.16 153.93 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.886 . . . . 0.0 110.208 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.3 t -132.09 119.78 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 110.199 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -98.49 134.92 40.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 110.212 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.509 HD12 ' CD1' ' A' ' 6' ' ' TRP . 67.9 mt -121.52 131.13 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -135.72 74.53 1.51 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.248 -0.908 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.624 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 1.6 pt20 -76.64 164.88 25.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 57.0 mmtt -159.02 51.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 110.213 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.15 -103.66 1.26 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -107.82 -3.38 19.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -1.187 . . . . 0.0 110.125 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.7 t0 -103.33 148.12 26.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.875 . . . . 0.0 110.185 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.694 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.9 m-85 -132.14 139.35 48.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.9 108.96 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.165 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.4 t -110.08 130.03 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.238 -0.914 . . . . 0.0 110.186 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.759 ' OG1' HG23 ' A' ' 59' ' ' THR . 94.2 m -130.07 110.59 11.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -92.93 132.91 36.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.162 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -125.46 121.55 34.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.191 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.797 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.4 168.64 7.54 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.193 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.685 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.2 Cg_endo -73.12 -18.69 23.58 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.055 1.555 . . . . 0.0 110.395 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 19.9 mtp-105 -104.57 -20.83 13.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.414 ' O ' ' OG1' ' A' ' 53' ' ' THR . 19.0 pt20 -166.81 160.75 14.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.194 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 p -129.78 133.47 47.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.195 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.17 128.79 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 110.265 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.759 HG23 ' OG1' ' A' ' 50' ' ' THR . 25.1 m -111.86 138.4 48.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.256 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 59' ' ' THR . 67.0 m-20 -134.75 153.35 52.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 t -146.51 128.4 15.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.212 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.57 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 33.9 p90 -140.8 173.64 11.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -123.38 141.95 51.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.694 HD11 ' CD1' ' A' ' 47' ' ' PHE . 18.1 mt -74.28 126.21 30.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.02 -1.91 55.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.0 143.32 40.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -1.19 . . . . 0.0 110.17 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -66.61 122.4 17.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.286 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.57 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.54 146.87 47.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.176 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -81.94 137.28 35.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 70' ' ' ILE . 4.9 mm -128.43 145.24 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -116.29 134.47 54.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.15 154.76 20.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.905 . . . . 0.0 110.186 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.44 ' SD ' HG21 ' A' ' 53' ' ' THR . 12.5 ttm -65.91 -16.54 63.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.257 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -85.26 -11.35 55.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 110.186 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.25 33.2 4.65 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -107.32 133.24 52.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -1.191 . . . . 0.0 110.198 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -108.1 135.86 48.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.95 . . . . 0.0 110.199 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.544 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -167.43 156.18 9.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -103.49 166.85 10.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.23 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p -175.22 139.78 0.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.3 m -98.84 100.52 11.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.176 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.62 ' O ' HD23 ' A' ' 64' ' ' LEU . 44.0 t -72.83 139.35 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 110.186 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 25.6 p-80 -136.55 161.08 36.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 110.207 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.5 mt -106.56 130.52 54.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -135.1 116.08 14.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 93.1 m-20 59.02 28.13 17.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.8 37.68 29.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -141.44 122.2 14.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -1.159 . . . . 0.0 110.248 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.498 HD21 HG13 ' A' ' 82' ' ' VAL . 7.8 tt -77.56 126.36 30.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.265 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.841 HG22 ' HG3' ' A' ' 99' ' ' GLU . 92.2 t -135.47 127.17 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.189 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.614 ' OG1' HG22 ' A' ' 82' ' ' VAL . 56.0 m -117.97 85.87 2.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.235 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -79.58 166.78 21.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.235 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.448 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -158.61 -167.2 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.204 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.748 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 43.4 mt-10 -100.84 43.82 1.04 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.181 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.748 ' HB3' ' O ' ' A' ' 94' ' ' GLU . 7.0 ptmt 170.1 3.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.239 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.843 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -176.95 144.65 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 111' ' ' ILE . 70.4 m -123.53 153.91 39.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.482 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 64.4 t-80 -138.56 145.89 41.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.841 ' HG3' HG22 ' A' ' 90' ' ' VAL . 2.4 tt0 -157.78 121.08 3.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.232 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.615 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 26.0 tt0 -122.8 159.81 27.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 27.5 mt-10 -157.61 144.76 18.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.442 HG23 ' CH2' ' A' ' 6' ' ' TRP . 11.3 p -111.07 140.84 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.23 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -137.11 96.22 3.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.877 . . . . 0.0 110.227 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.04 -108.98 2.77 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -116.39 10.83 14.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -1.163 . . . . 0.0 110.18 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.53 156.51 28.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.188 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.53 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 27.5 ttm -128.69 141.12 51.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.338 -0.851 . . . . 0.0 110.192 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 121' ' ' ARG . 94.7 t -126.37 123.97 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.867 . . . . 0.0 110.194 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 23.3 mt-10 -110.66 115.28 29.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.1 m -105.6 122.8 46.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 110.207 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 97' ' ' SER . 61.6 mt -129.82 129.73 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 45.8 m -109.6 135.73 50.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.165 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.591 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 15.9 t80 -159.17 127.05 4.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.07 32.88 65.53 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.48 5.47 67.88 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 112' ' ' THR . 61.6 t -110.16 143.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.334 -1.097 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.0 m -118.6 130.18 55.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.9 . . . . 0.0 110.126 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.66 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 42.7 tp -111.24 147.36 35.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.196 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 87.0 mt -122.35 95.97 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 110.275 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.629 ' HD3' HG22 ' A' ' 8' ' ' VAL . 3.0 ttm180 -88.94 117.52 28.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 110.213 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.503 ' HB3' ' OH ' ' A' ' 9' ' ' TYR . 29.2 mtt180 -101.69 128.82 47.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.925 . . . . 0.0 110.17 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.2 m -126.8 151.81 47.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.197 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -112.09 156.22 22.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.194 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -83.31 135.53 34.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.202 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.236 0.541 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.66 148.04 30.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -0.915 . . . . 0.0 110.218 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.6 163.77 13.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.8 m -80.38 152.23 28.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -1.173 . . . . 0.0 110.178 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.719 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 89.9 m95 -139.21 132.89 30.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.728 ' N ' ' O ' ' A' ' 123' ' ' LYS . 24.8 tt0 -98.71 124.66 43.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 36' ' ' PRO . 10.9 t -44.33 126.2 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 1.267 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -88.51 -65.93 0.97 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 1.014 ' HB3' ' HD2' ' A' ' 121' ' ' ARG . . . -155.07 163.13 40.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.6 pt20 -136.65 101.7 4.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.6 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 56.8 tt0 -87.05 137.46 32.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.133 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.6 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 32.2 m-20 65.36 -1.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 1.183 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 77.8 t80 -32.22 -64.35 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.577 ' HG3' ' N ' ' A' ' 16' ' ' GLU . 13.6 pt-20 -48.26 -51.04 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.235 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.577 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 68.0 mt-10 -54.74 -61.17 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.648 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 49.0 t80 -49.61 -56.27 10.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.183 HD11 ' CZ ' ' A' ' 14' ' ' TYR . 21.0 mt -54.58 -46.81 73.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 65.2 mttt -46.83 -41.29 15.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 -26.16 66.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 110.221 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.861 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -63.22 -20.16 65.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.861 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 78.86 30.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.246 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 37.3 mt -77.32 167.3 37.56 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.259 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.0 Cg_endo -73.1 140.32 30.98 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.065 1.56 . . . . 0.0 110.41 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -61.49 -36.57 80.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.168 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -59.22 -30.06 67.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.181 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.658 HD22 ' OD1' ' A' ' 74' ' ' ASP . 44.9 tp -89.46 -21.21 23.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 110.153 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.747 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 78.0 mt -78.71 -41.26 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 0.0 110.198 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HA ' ' HD2' ' A' ' 32' ' ' ARG . 18.0 mtmt -75.22 -24.1 57.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.27 -0.894 . . . . 0.0 110.251 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.5 tpp -87.87 -29.8 20.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.454 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -105.52 8.4 33.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 110.23 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.747 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.0 ptm85 -67.88 -7.67 30.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 110.176 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -146.74 59.86 1.2 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.192 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.5 mt -129.64 110.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.583 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -88.57 80.41 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.954 . . . . 0.0 110.274 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.192 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.05 140.78 31.83 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.005 1.529 . . . . 0.0 110.459 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 38' ' ' VAL . 5.2 mt -87.9 165.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.459 ' N ' HG22 ' A' ' 37' ' ' ILE . 69.0 t -142.67 116.59 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.239 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -92.17 140.74 29.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.2 mt -126.92 129.25 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 110.18 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -129.67 66.37 1.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.619 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 52.6 tt0 -63.95 168.96 4.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.619 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 33.5 mtmt -167.78 44.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 0.0 110.22 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.97 -103.97 1.04 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 25.8 m-20 -108.23 -3.11 18.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -1.187 . . . . 0.0 110.172 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.36 150.3 23.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.684 ' CE1' HD11 ' A' ' 64' ' ' LEU . 2.9 m-85 -133.25 134.37 43.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.08 109.45 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 0.0 110.18 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.0 t -111.41 129.85 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.259 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.7 ' OG1' HG23 ' A' ' 59' ' ' THR . 84.7 m -126.04 106.86 9.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 110.195 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.8 m -88.64 136.55 32.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.202 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -129.69 117.52 20.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.884 HG22 ' HD2' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -102.39 168.11 9.42 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.884 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.1 Cg_endo -73.05 -28.01 13.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.028 1.541 . . . . 0.0 110.394 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.14 -19.43 17.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.245 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.508 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.4 OUTLIER -164.05 160.36 21.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.244 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 p -128.94 127.85 42.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.265 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' A' ' 73' ' ' MET . 58.2 t -125.78 124.42 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.149 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.7 HG23 ' OG1' ' A' ' 50' ' ' THR . 36.7 m -110.17 144.57 38.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -141.24 147.73 38.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.893 . . . . 0.0 110.25 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.7 m -139.07 135.08 33.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.923 . . . . 0.0 110.264 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 1.035 ' CE1' HG21 ' A' ' 82' ' ' VAL . 51.7 p90 -147.69 170.99 16.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 110.229 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.2 m -118.52 145.37 45.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 110.228 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.684 HD11 ' CE1' ' A' ' 47' ' ' PHE . 51.0 mt -77.1 124.44 27.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.27 -3.75 54.8 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -134.31 148.62 50.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 0.0 110.185 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.463 ' HA ' ' CG2' ' A' ' 81' ' ' THR . 75.7 tt0 -72.45 128.54 35.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.224 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.96 150.74 50.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -82.05 133.71 35.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 70' ' ' ILE . 22.9 mm -123.45 145.06 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 96.3 m -122.8 135.07 54.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.697 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 43.1 p -89.78 157.92 17.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.722 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -68.3 -12.53 61.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.268 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.658 ' OD1' HD22 ' A' ' 27' ' ' LEU . 5.3 t0 -85.31 -21.5 28.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.06 23.23 4.99 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.697 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 27.1 mttt -98.62 135.32 40.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -1.118 . . . . 0.0 110.161 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -113.01 135.22 54.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 110.21 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -164.47 160.69 20.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.152 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' HD3' ' OE2' ' A' ' 67' ' ' GLU . 25.8 mttp -104.05 146.33 28.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.279 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.56 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -148.58 141.8 25.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.463 ' CG2' ' HA ' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -106.43 89.39 3.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.211 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.035 HG21 ' CE1' ' A' ' 62' ' ' PHE . 12.2 t -57.71 152.54 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.161 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.19 146.12 28.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.564 ' CD1' HD13 ' A' ' 64' ' ' LEU . 14.9 mt -98.41 101.02 12.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.843 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 86' ' ' ASN . . . -117.33 148.91 41.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.222 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' ALA . 3.4 t-20 44.53 27.51 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.159 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.424 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 70.45 40.17 68.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.792 ' HD3' ' CD ' ' A' ' 101' ' ' GLU . 11.1 mttt -152.95 132.09 12.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.208 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.872 HD11 HG11 ' A' ' 82' ' ' VAL . 8.3 tt -72.19 135.9 46.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.664 HG12 ' CG ' ' A' ' 99' ' ' GLU . 11.6 m -143.72 123.26 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.235 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.56 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 95.2 m -114.56 91.87 3.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 5.9 ptmt -88.49 163.78 15.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.238 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 29.3 t -152.65 -158.03 0.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.196 -0.94 . . . . 0.0 110.197 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.459 ' N ' ' OG ' ' A' ' 93' ' ' SER . 44.6 mt-10 -106.59 26.15 10.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.505 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 7.8 ptpt -167.03 0.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.94 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -177.67 146.21 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 111' ' ' ILE . 29.3 t -117.72 160.03 22.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 58.6 t-80 -143.99 139.25 28.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.664 ' CG ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -152.18 127.77 10.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.544 ' NE2' ' SD ' ' A' ' 107' ' ' MET . 46.0 tt0 -131.66 155.04 48.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.188 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.792 ' CD ' ' HD3' ' A' ' 88' ' ' LYS . 45.1 tt0 -151.64 155.09 37.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.461 HG23 ' CH2' ' A' ' 6' ' ' TRP . 11.2 p -119.33 134.4 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.219 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.18 94.67 3.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.172 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.38 -111.84 3.37 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -116.23 18.31 15.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.17 . . . . 0.0 110.253 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -123.66 148.51 46.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.218 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.548 ' HB3' ' HB2' ' A' ' 122' ' ' SER . 34.0 ttm -123.58 139.06 54.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 0.0 110.247 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.62 129.33 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 33.4 mt-10 -115.6 109.81 18.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 110.199 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 99' ' ' GLU . 25.8 m -99.01 123.21 43.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.133 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 97' ' ' SER . 52.7 mt -132.29 129.28 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.223 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 21.8 m -104.63 142.92 33.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.887 . . . . 0.0 110.267 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.633 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 5.6 t80 -163.16 124.83 2.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 68.9 37.44 83.67 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.34 9.38 60.91 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 112' ' ' THR . 65.2 t -112.32 140.2 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -1.13 . . . . 0.0 110.194 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.7 m -113.72 129.31 56.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 110.221 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.648 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 48.4 tp -108.66 153.65 23.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.259 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.8 mt -130.97 94.55 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 0.9 OUTLIER -95.97 128.65 43.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 110.272 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 1.014 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 1.3 ptp180 -109.85 136.9 48.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.226 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.588 ' C ' ' HD2' ' A' ' 9' ' ' TYR . 39.8 m -125.57 135.46 52.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 1.267 ' HB2' ' CE2' ' A' ' 9' ' ' TYR . 71.7 tttt -92.94 153.89 18.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.246 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 27.5 ttp85 -89.52 134.83 33.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.456 HG21 ' OE1' ' A' ' 7' ' ' GLN . 53.0 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.221 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.252 0.549 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.1 p -56.08 146.55 22.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 110.159 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.7 -172.49 19.47 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.726 HG22 ' HG3' ' A' ' 39' ' ' GLU . 5.8 p -110.69 128.04 55.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -1.133 . . . . 0.0 110.233 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.536 ' CH2' HG23 ' A' ' 102' ' ' VAL . 94.3 m95 -115.92 143.51 45.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.171 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -128.71 116.67 19.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.179 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.08 144.88 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.253 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 9' ' ' TYR . 8.0 p90 -147.09 -14.23 0.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.251 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -139.61 141.86 37.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.14 164.7 37.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -140.33 158.8 43.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.19 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 46.51 38.03 5.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 110.233 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 7.8 t80 -69.84 -55.33 10.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -53.19 -57.88 8.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.271 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -48.38 -45.44 35.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.222 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.651 ' CD2' HD22 ' A' ' 118' ' ' LEU . 10.0 t80 -55.59 -57.25 12.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 110.228 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.721 HD13 HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -51.07 -43.32 61.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.167 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -54.78 -35.49 63.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.39 -41.91 62.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -0.97 . . . . 0.0 110.162 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.9 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.7 tp -55.26 -25.58 34.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 80.56 24.13 0.35 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.708 HD12 HD22 ' A' ' 18' ' ' LEU . 14.5 mt -69.13 166.52 27.99 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.145 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.0 Cg_endo -73.14 132.13 17.61 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.058 1.557 . . . . 0.0 110.407 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.66 ' HA ' HD12 ' A' ' 28' ' ' ILE . 44.8 mt-10 -49.7 -46.04 49.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.972 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -50.33 -35.81 29.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.191 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 41.7 tp -84.45 -33.61 23.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.721 HG12 HD13 ' A' ' 18' ' ' LEU . 96.9 mt -61.22 -56.09 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.149 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' A' ' 30' ' ' MET . 13.4 pttp -56.01 -24.43 39.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.688 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 85.6 mtp -94.17 -9.74 35.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.245 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -113.34 -5.84 13.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.218 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.707 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -71.86 0.82 8.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 110.286 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.707 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.5 m-20 -150.18 41.69 0.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.688 ' CD1' ' O ' ' A' ' 30' ' ' MET . 23.8 mt -122.84 115.47 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.267 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -100.82 90.19 1.45 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.978 ' HB3' HG23 ' A' ' 53' ' ' THR . 46.5 Cg_endo -73.09 146.04 40.49 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.918 1.483 . . . . 0.0 110.4 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 38' ' ' VAL . 6.4 mt -86.45 173.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.61 ' N ' HG22 ' A' ' 37' ' ' ILE . 70.0 t -150.19 119.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.177 -0.952 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.726 ' HG3' HG22 ' A' ' 5' ' ' THR . 20.1 tt0 -103.45 148.04 26.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.225 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.56 HD11 HE22 ' A' ' 100' ' ' GLN . 55.8 mt -136.4 132.14 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 110.23 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 55.9 tt0 -132.28 73.82 1.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.793 ' OE1' ' N ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -68.73 170.53 9.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.244 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 14.2 mtmt -168.55 43.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.793 ' N ' ' OE1' ' A' ' 42' ' ' GLN . . . 120.04 -102.49 0.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 26.8 m-20 -110.36 -2.0 16.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -1.135 . . . . 0.0 110.154 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.1 t0 -104.2 150.39 24.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.789 ' CE1' HD11 ' A' ' 64' ' ' LEU . 3.0 m-85 -131.37 137.27 48.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.21 108.08 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.141 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' ASN . 62.8 t -108.37 130.92 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.65 HG23 ' OG1' ' A' ' 59' ' ' THR . 77.6 m -133.22 106.07 7.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.3 m -89.04 137.68 32.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.887 . . . . 0.0 110.223 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -130.97 124.11 30.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 110.258 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.978 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.08 169.25 6.81 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.78 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.4 Cg_endo -73.0 -20.53 21.82 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.992 1.522 . . . . 0.0 110.414 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -105.67 -22.46 12.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.417 ' HG3' ' HG1' ' A' ' 53' ' ' THR . 4.5 pt20 -159.74 161.76 34.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 p -132.4 128.15 36.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 110.233 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.55 127.42 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.91 . . . . 0.0 110.233 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.65 ' OG1' HG23 ' A' ' 50' ' ' THR . 91.5 m -111.28 142.09 43.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 49' ' ' VAL . 83.6 m-20 -139.41 151.05 45.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.162 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 m -141.58 135.14 29.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.191 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.541 ' CB ' ' CB ' ' A' ' 68' ' ' ALA . 35.0 p90 -148.26 166.65 27.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.8 m -116.02 150.4 37.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.789 HD11 ' CE1' ' A' ' 47' ' ' PHE . 31.4 mt -78.45 125.66 29.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.928 . . . . 0.0 110.198 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.47 5.93 60.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -139.95 139.46 36.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -1.135 . . . . 0.0 110.222 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -65.91 124.8 23.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.541 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -124.76 148.16 48.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.154 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 14.8 p-10 -81.18 136.89 35.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.161 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 70' ' ' ILE . 23.7 mm -128.85 142.43 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 110.161 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 m -113.55 139.88 48.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 110.233 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.685 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 68.3 p -93.97 158.39 15.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.8 ttm -70.67 -13.28 62.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.206 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.54 -12.87 47.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.02 25.42 7.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.685 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 12.0 mttt -102.89 136.89 41.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -1.114 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -110.67 135.37 51.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.162 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.404 HD21 HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -166.21 153.67 9.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.277 -0.89 . . . . 0.0 110.208 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -99.23 155.98 17.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.3 m -157.92 134.26 9.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.167 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -96.55 96.38 8.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.196 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.907 HG13 HD21 ' A' ' 89' ' ' LEU . 48.4 t -69.92 142.53 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.669 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 13.9 p-80 -140.84 155.49 46.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.177 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.409 ' CD1' HD13 ' A' ' 64' ' ' LEU . 51.5 mt -100.12 132.34 45.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -138.75 111.51 7.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.22 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.676 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 86.2 m-20 64.35 27.59 13.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.214 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.532 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.34 43.5 20.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.623 ' HD2' ' OE2' ' A' ' 101' ' ' GLU . 49.4 mtpt -153.37 118.86 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -1.167 . . . . 0.0 110.203 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.907 HD21 HG13 ' A' ' 82' ' ' VAL . 4.8 tt -68.69 142.94 54.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.233 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.772 HG13 ' HG2' ' A' ' 99' ' ' GLU . 55.3 t -150.69 120.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.787 ' OG1' HG22 ' A' ' 82' ' ' VAL . 5.4 m -114.04 95.73 5.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.434 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -89.0 167.48 13.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.24 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 3.3 m -158.55 -168.08 2.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 110.236 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 27.0 tp10 -101.74 33.68 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.502 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 8.6 ptpt -174.75 0.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.226 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.895 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -179.01 144.71 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 0.0 110.184 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.9 m -119.4 158.37 26.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.4 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 56.8 t-80 -143.42 136.52 27.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.207 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.772 ' HG2' HG13 ' A' ' 90' ' ' VAL . 92.2 mt-10 -148.32 131.38 16.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.219 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.56 HE22 HD11 ' A' ' 40' ' ' ILE . 40.5 tt0 -134.7 152.9 52.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.227 -0.921 . . . . 0.0 110.186 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.623 ' OE2' ' HD2' ' A' ' 88' ' ' LYS . 58.1 tt0 -150.72 159.11 44.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.536 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.7 p -123.52 136.89 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 110.18 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -130.65 96.97 4.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.246 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.53 -98.08 1.75 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.502 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 30.7 p-10 -126.87 11.6 7.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -1.137 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.502 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 48.4 mt-10 -118.38 164.99 14.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.213 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.519 ' CE ' ' NE1' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -137.27 143.04 41.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.17 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 121' ' ' ARG . 76.4 t -127.21 127.31 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.375 -0.828 . . . . 0.0 110.238 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 33.9 mt-10 -114.42 134.74 54.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.0 m -124.09 122.38 37.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.179 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 74.8 mt -127.76 131.82 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 110.2 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 80.5 m -112.75 135.58 53.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.512 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 4.9 t80 -156.81 123.95 5.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.17 -0.956 . . . . 0.0 110.274 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 70.03 37.75 73.67 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.49 4.68 52.89 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 112' ' ' THR . 60.2 t -108.65 139.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -1.17 . . . . 0.0 110.178 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 63.6 m -115.13 130.86 57.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.651 HD22 ' CD2' ' A' ' 17' ' ' PHE . 36.9 tp -110.19 141.93 42.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.182 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.6 mt -120.34 121.36 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -117.75 117.57 29.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.156 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 12.2 mtt180 -98.24 129.01 44.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.169 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.5 p -125.74 166.33 16.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 110.263 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 35.4 tttm -129.62 158.83 38.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 110.155 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.405 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 73.8 ttt180 -81.35 134.58 35.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.22 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.247 0.546 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -76.48 -31.68 57.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.301 -0.874 . . . . 0.0 110.22 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 m -56.56 145.16 29.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.888 . . . . 0.0 110.182 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.6 -176.48 17.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.4 m -106.35 131.28 53.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -1.137 . . . . 0.0 110.251 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.467 ' CZ3' ' HG3' ' A' ' 107' ' ' MET . 93.0 m95 -119.62 142.84 48.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -124.22 122.12 36.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 110.257 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.15 127.21 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 121' ' ' ARG . 34.3 p90 -133.08 2.37 3.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.251 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.82 127.99 2.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -143.96 120.77 11.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.243 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 55.7 tt0 -99.82 144.65 28.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.941 . . . . 0.0 110.197 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 22.3 m120 58.32 16.33 3.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.277 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.961 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 90.4 t80 -52.98 -47.64 68.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 110.164 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.09 -47.51 76.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 37.0 mt-10 -56.47 -60.23 3.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.67 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 45.0 t80 -49.74 -54.99 15.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.09 HD21 H191 ' A' ' 130' ' ' JN3 . 22.2 mt -52.68 -49.51 65.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 63.1 mttt -42.47 -40.19 2.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.915 . . . . 0.0 110.156 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.451 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -68.84 -25.54 64.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.864 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -59.04 -19.09 40.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.181 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.864 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 76.36 25.43 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.903 . . . . 0.0 110.166 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 20.3 mt -75.17 168.24 29.35 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 23' ' ' LEU . 46.4 Cg_endo -73.05 138.06 27.52 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.01 1.531 . . . . 0.0 110.444 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 28' ' ' ILE . 69.4 mm-40 -54.32 -44.44 72.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.925 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -53.75 -25.3 18.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.524 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 44.9 tp -90.36 -23.95 20.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.901 . . . . 0.0 110.243 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.854 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 81.2 mt -74.81 -42.3 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.233 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -74.97 -20.6 59.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.9 mmm -93.0 -27.12 17.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.212 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.513 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -105.71 4.44 30.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 110.273 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.854 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 23.4 ptt180 -72.43 3.63 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 10.4 t0 -154.45 47.19 0.58 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.081 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 4.2 mt -121.12 117.29 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 110.168 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -91.3 82.48 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.186 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.081 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.09 132.89 18.77 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.034 1.544 . . . . 0.0 110.428 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 38' ' ' VAL . 8.2 mt -83.2 162.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.414 ' N ' HG22 ' A' ' 37' ' ' ILE . 73.0 t -140.67 116.48 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 40' ' ' ILE . 36.0 tt0 -97.21 136.01 38.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.855 . . . . 0.0 110.224 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 39' ' ' GLU . 51.5 mm -123.63 132.78 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.198 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 48' ' ' VAL . 37.2 tt0 -132.56 63.21 1.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 110.2 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.646 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 51.6 tt0 -59.3 165.8 2.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 110.218 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 38.3 mtmt -163.77 37.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.28 -97.84 0.53 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 14.8 m-20 -112.4 -7.48 13.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -1.122 . . . . 0.0 110.166 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.621 ' OD1' HG23 ' A' ' 63' ' ' THR . 12.0 m-20 -102.55 157.75 16.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.592 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 41.3 m-85 -138.55 139.5 38.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.218 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 58.6 t -117.19 104.19 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.737 HG11 ' H42' ' A' ' 131' ' ' JN3 . 57.6 t -104.16 128.32 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.685 HG23 ' OG1' ' A' ' 59' ' ' THR . 94.0 m -130.51 100.27 5.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.1 m -83.68 140.15 32.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 110.224 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 57' ' ' THR . 55.3 mttt -132.17 107.38 8.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.868 . . . . 0.0 110.204 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.97 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -94.0 168.15 12.25 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 110.211 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.781 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.6 Cg_endo -72.96 -29.93 11.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.016 1.535 . . . . 0.0 110.477 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -95.35 -22.05 18.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -162.45 169.58 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.211 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 52' ' ' LYS . 9.2 p -134.6 124.88 26.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.227 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 73' ' ' MET . 54.0 t -123.24 125.86 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.685 ' OG1' HG23 ' A' ' 50' ' ' THR . 64.3 m -112.94 148.16 35.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.213 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -143.87 147.52 34.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.279 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 t -138.92 140.12 38.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.621 ' CE1' HG11 ' A' ' 82' ' ' VAL . 34.5 p90 -151.89 166.19 32.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -0.904 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.621 HG23 ' OD1' ' A' ' 46' ' ' ASP . 88.7 m -116.26 152.26 34.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 3.9 tp -78.47 122.91 26.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.56 14.4 53.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -144.63 136.11 25.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -1.169 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.0 123.1 18.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.461 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.12 150.54 43.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.244 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -83.93 132.58 34.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 110.222 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.86 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 26.7 mm -121.85 146.31 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 m -123.62 136.97 54.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 0.0 110.21 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.674 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 57.9 p -90.92 162.68 14.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.291 -0.88 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.677 ' CE ' H122 ' A' ' 130' ' ' JN3 . 23.9 mtm -75.8 -10.62 59.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.506 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 4.5 p30 -88.76 -14.92 35.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.49 28.73 4.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.674 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 18.0 mttt -107.02 128.16 54.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -1.121 . . . . 0.0 110.233 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -107.06 139.36 41.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.208 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.518 HD11 H181 ' A' ' 131' ' ' JN3 . 0.5 OUTLIER -169.29 154.37 5.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.208 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.0 mtmm -98.6 153.05 18.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.419 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -157.82 133.66 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 m -95.2 102.58 14.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.186 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.838 HG13 HD21 ' A' ' 89' ' ' LEU . 47.5 t -73.81 142.99 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 6.5 p-80 -144.36 157.25 44.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.927 . . . . 0.0 110.246 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 84' ' ' LEU . 12.0 mt -99.86 134.26 43.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.875 . . . . 0.0 110.233 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -140.73 117.22 10.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.246 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.603 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 17.9 m120 61.93 27.59 16.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.53 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.61 40.58 26.75 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.53 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 61.3 mttt -151.4 130.32 12.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -1.14 . . . . 0.0 110.225 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.838 HD21 HG13 ' A' ' 82' ' ' VAL . 7.4 tt -76.58 129.94 37.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.742 HG13 ' HG2' ' A' ' 99' ' ' GLU . 70.3 t -138.46 125.92 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.932 . . . . 0.0 110.188 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.532 ' OG1' HG22 ' A' ' 82' ' ' VAL . 51.9 m -117.92 90.57 3.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 12.1 pttp -85.24 164.55 17.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 110.211 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 34.9 t -155.07 -158.37 0.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.405 ' N ' ' OG ' ' A' ' 93' ' ' SER . 35.0 mt-10 -108.1 35.41 3.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 110.239 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -177.58 1.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.0 110.149 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.896 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER 179.21 148.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.198 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -121.76 160.62 24.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.155 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 11.3 t60 -142.15 140.92 32.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.182 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.742 ' HG2' HG13 ' A' ' 90' ' ' VAL . 48.2 mt-10 -151.74 126.33 9.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.226 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.689 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 41.3 tt0 -125.95 156.32 39.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.161 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.689 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 7.8 mp0 -157.53 147.55 20.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.902 . . . . 0.0 110.261 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.0 p -116.12 139.26 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -130.33 99.48 5.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.925 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.37 -118.11 5.76 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -103.9 8.15 36.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.232 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -116.1 159.06 22.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.467 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -129.04 139.2 52.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.289 -0.882 . . . . 0.0 110.17 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 80.0 t -126.33 126.18 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.2 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 35.1 mt-10 -110.5 131.28 55.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 99' ' ' GLU . 12.2 p -122.17 117.62 26.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 97' ' ' SER . 53.8 mt -129.16 139.41 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.251 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 69.9 p -112.75 131.56 55.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.176 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 3.2 t80 -151.89 126.82 9.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.918 . . . . 0.0 110.231 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.451 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.42 36.51 92.72 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.89 11.42 66.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.497 HG11 ' HA ' ' A' ' 17' ' ' PHE . 69.2 t -114.36 138.06 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -1.117 . . . . 0.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 43.9 m -112.18 135.67 52.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 110.195 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.67 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 59.2 tp -115.0 144.36 43.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.1 mt -125.7 94.44 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 9.9 ttp180 -89.54 132.26 35.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 110.204 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.501 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 45.1 mtm180 -109.9 122.8 48.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 6' ' ' TRP . 59.2 m -119.73 152.96 36.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -116.98 155.48 29.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.212 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' THR . 39.5 ttp85 -81.38 135.2 35.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.221 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 1.09 H191 HD21 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.86 ' H8 ' HG21 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.225 0.536 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -77.27 -33.09 55.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.1 p -56.87 146.26 27.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.299 -0.875 . . . . 0.0 110.172 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.15 -174.06 17.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 89.0 m -107.64 131.11 54.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -1.141 . . . . 0.0 110.241 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.556 ' CD1' HD12 ' A' ' 40' ' ' ILE . 90.8 m95 -120.15 145.09 47.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -126.47 122.06 34.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.851 . . . . 0.0 110.177 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.5 126.02 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 39.1 p90 -126.81 -29.61 2.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.912 . . . . 0.0 110.19 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.78 129.57 40.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.86 . . . . 0.0 110.269 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.6 pt20 -143.11 119.61 11.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 110.203 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.535 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.6 tt0 -98.66 144.45 27.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 110.247 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.868 ' ND2' ' OE1' ' A' ' 16' ' ' GLU . 1.0 OUTLIER 60.25 14.21 4.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.154 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.861 ' CE1' HD11 ' A' ' 18' ' ' LEU . 74.0 t80 -51.59 -52.14 49.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -62.95 -48.5 78.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.868 ' OE1' ' ND2' ' A' ' 13' ' ' ASN . 65.3 mt-10 -55.73 -59.36 4.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.148 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.713 ' CD2' HD22 ' A' ' 118' ' ' LEU . 70.4 t80 -49.2 -55.49 12.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.074 HD21 H191 ' A' ' 130' ' ' JN3 . 12.7 mt -58.15 -42.25 85.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 3.5 tttm -49.14 -41.23 35.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.57 -27.75 66.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.902 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.1 tp -58.75 -20.27 47.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.61 28.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 110.268 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 21' ' ' LEU . 65.6 mt -74.73 165.86 50.2 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.134 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.554 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 45.6 Cg_endo -73.14 140.13 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.021 1.537 . . . . 0.0 110.382 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.7 -40.87 84.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.61 -26.58 56.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.229 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.674 HD22 ' OD1' ' A' ' 74' ' ' ASP . 43.3 tp -92.46 -19.41 22.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.747 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 94.0 mt -82.92 -40.93 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 0.0 110.172 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -75.36 -27.56 59.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.174 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 57.9 tpp -86.53 -27.64 23.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.237 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -103.03 4.92 37.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.747 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 6.3 ptt180 -71.57 2.07 5.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -152.33 48.66 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 110.24 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.1 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.9 mt -123.72 118.46 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.207 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.47 84.56 0.11 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.232 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.1 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.05 130.58 15.62 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.986 1.519 . . . . 0.0 110.433 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.8 mt -84.39 157.86 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.6 t -137.26 115.77 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -96.27 137.49 35.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.556 HD12 ' CD1' ' A' ' 6' ' ' TRP . 79.3 mt -123.95 129.72 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 55.8 tt0 -130.33 67.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 0.0 110.23 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.733 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 48.8 tt0 -62.39 171.37 1.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.143 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.733 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 17.9 mtmt -171.74 38.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.153 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.16 -104.54 0.87 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -108.52 0.64 21.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -1.149 . . . . 0.0 110.222 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.1 t0 -108.89 145.04 36.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.696 ' CE1' HD11 ' A' ' 64' ' ' LEU . 7.6 m-85 -127.18 139.43 52.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 110.276 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 59.4 t -120.01 104.61 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.719 HG11 ' H42' ' A' ' 131' ' ' JN3 . 91.9 t -106.29 122.44 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 110.146 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.674 HG23 ' OG1' ' A' ' 59' ' ' THR . 91.3 m -122.72 106.08 10.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 110.261 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 58' ' ' VAL . 51.1 m -92.61 134.58 34.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -127.11 119.6 26.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.961 . . . . 0.0 110.289 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.718 HG21 H213 ' A' ' 130' ' ' JN3 . 0.1 OUTLIER -103.25 169.86 6.92 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.174 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.07 -17.82 24.5 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.093 1.575 . . . . 0.0 110.404 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -104.88 -24.71 12.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.956 . . . . 0.0 110.213 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.653 ' O ' ' OG1' ' A' ' 53' ' ' THR . 3.8 pt20 -163.58 169.08 19.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.186 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.0 p -129.79 127.85 41.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.231 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' A' ' 73' ' ' MET . 19.4 m -124.96 127.02 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.177 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.674 ' OG1' HG23 ' A' ' 50' ' ' THR . 36.2 m -115.64 147.36 40.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -142.46 149.46 39.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.261 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.3 t -141.81 137.76 31.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.152 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.696 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 52.0 p90 -150.5 169.89 20.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 110.237 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.9 m -117.65 150.57 38.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.196 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.696 HD11 ' CE1' ' A' ' 47' ' ' PHE . 17.3 mt -79.53 123.81 27.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 110.212 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.48 9.66 52.56 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -145.72 143.7 29.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -1.131 . . . . 0.0 110.193 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -68.68 127.78 34.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.202 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.592 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.06 147.63 50.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -80.28 134.99 36.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.241 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.888 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 23.8 mm -124.26 144.81 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.151 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.1 m -121.78 136.06 54.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.21 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.659 HG21 ' O25' ' A' ' 131' ' ' JN3 . 66.4 p -87.88 161.14 17.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.672 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 1.5 ttp -73.89 -11.91 60.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.198 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.674 ' OD1' HD22 ' A' ' 27' ' ' LEU . 7.3 t0 -89.13 -14.04 37.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 110.213 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.67 50.77 0.83 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.613 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 7.7 tttt -128.61 129.65 46.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -1.155 . . . . 0.0 110.146 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -105.79 137.59 43.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.203 -0.936 . . . . 0.0 110.192 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.663 HD11 H181 ' A' ' 131' ' ' JN3 . 0.8 OUTLIER -166.1 155.08 11.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.232 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -101.45 145.47 28.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.537 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.3 m -153.08 133.78 13.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.307 -0.871 . . . . 0.0 110.156 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -94.97 100.04 11.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.788 HG13 HD21 ' A' ' 89' ' ' LEU . 49.4 t -70.36 142.26 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.66 ' CE1' ' HB ' ' A' ' 90' ' ' VAL . 24.5 p80 -146.04 151.41 37.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.15 132.03 40.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 110.262 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -140.87 131.49 25.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 97.3 m-20 56.69 17.43 3.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.2 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.56 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 83.8 40.88 8.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.56 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 97.4 mttt -155.57 131.84 10.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -1.121 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.788 HD21 HG13 ' A' ' 82' ' ' VAL . 6.7 tt -72.64 130.89 41.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.244 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.753 HG22 ' HG3' ' A' ' 99' ' ' GLU . 92.8 t -139.25 125.31 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.179 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.537 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 99.5 m -115.65 90.16 3.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -84.59 169.5 14.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.214 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 29.5 t -160.72 -157.58 0.54 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 110.196 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.445 ' N ' ' OG ' ' A' ' 93' ' ' SER . 18.7 tt0 -109.74 32.93 4.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.231 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.709 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -175.74 6.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 1.073 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.3 OUTLIER 171.87 141.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 110.26 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -114.72 174.75 5.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.545 ' ND1' H122 ' A' ' 131' ' ' JN3 . 10.0 t60 -156.31 137.84 14.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.148 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.753 ' HG3' HG22 ' A' ' 90' ' ' VAL . 69.5 tt0 -149.85 126.49 10.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.218 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 47.5 tt0 -125.54 161.16 27.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.923 . . . . 0.0 110.247 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.532 ' OE1' ' HG3' ' A' ' 103' ' ' LYS . 10.9 tm-20 -161.81 148.72 14.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.434 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 10.8 p -116.0 143.18 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 110.223 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.532 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 92.6 mttt -133.26 92.7 3.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.99 -109.81 2.98 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.678 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 24.5 p30 -112.1 11.23 20.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -1.152 . . . . 0.0 110.18 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.678 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 61.5 mt-10 -118.64 155.18 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.491 ' HG3' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -125.1 141.85 51.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.48 121.54 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.13 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 40.8 mt-10 -107.74 119.27 38.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.556 ' N ' ' O ' ' A' ' 99' ' ' GLU . 38.0 p -108.48 119.61 40.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 97' ' ' SER . 53.0 mt -130.39 131.73 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.357 -0.84 . . . . 0.0 110.209 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 6.3 t -110.55 141.27 43.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.175 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.704 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 10.7 t80 -161.26 128.34 4.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.15 33.95 74.85 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.9 12.78 75.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 112' ' ' THR . 73.1 t -116.48 139.47 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -1.155 . . . . 0.0 110.191 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 47.3 m -112.92 134.0 54.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.713 HD22 ' CD2' ' A' ' 17' ' ' PHE . 43.1 tp -114.07 150.55 33.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.0 mt -130.6 94.74 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 9.4 ttp180 -88.93 131.42 35.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 25.7 mtt-85 -110.41 124.71 52.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.915 . . . . 0.0 110.174 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.1 m -122.07 149.44 43.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -115.38 153.15 31.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.19 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.7 ttp85 -78.19 134.75 37.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 125' ' ' VAL . 62.4 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.192 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 1.074 H191 HD21 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.888 ' H8 ' HG21 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.232 0.539 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.45 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 49.3 m-85 -78.97 -29.43 43.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.251 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 p -57.65 144.93 35.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.97 -178.7 17.33 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 91.0 m -106.13 134.73 48.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -1.148 . . . . 0.0 110.242 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.476 ' CE3' ' HB2' ' A' ' 107' ' ' MET . 92.9 m95 -121.15 136.33 55.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -118.88 118.15 30.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.201 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.448 HG21 ' HD2' ' A' ' 120' ' ' ARG . 59.5 t -63.94 126.03 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.238 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 11.8 p90 -128.5 -19.59 3.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -141.74 131.6 24.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.207 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -143.06 166.47 24.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.226 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 56.0 tt0 -141.03 146.44 37.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.932 . . . . 0.0 110.21 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 79.4 m-20 56.19 20.72 4.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.499 ' CE1' HD21 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -54.18 -53.67 50.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.862 . . . . 0.0 110.215 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -59.36 -57.04 14.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -46.25 -52.93 11.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.603 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 69.6 t80 -52.56 -46.3 66.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.17 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 mt -59.3 -43.05 92.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.893 . . . . 0.0 110.172 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -54.58 -42.08 70.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.4 75.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.83 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 3.9 tp -64.42 -17.41 63.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.17 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.83 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 74.95 28.91 1.04 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.226 -0.922 . . . . 0.0 110.22 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.559 HD11 HD23 ' A' ' 21' ' ' LEU . 20.2 mt -75.39 165.03 56.98 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.75 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.3 Cg_endo -73.11 139.89 30.3 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.036 1.545 . . . . 0.0 110.473 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HG2' ' HG3' ' A' ' 29' ' ' LYS . 41.9 tt0 -58.56 -36.32 73.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.291 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -61.55 -28.89 69.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.893 . . . . 0.0 110.192 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.75 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 33.3 tp -92.11 -29.2 16.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.222 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.654 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 95.8 mt -74.48 -44.29 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 3.5 mmpt? -71.07 -23.96 62.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.207 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.0 ttp -89.68 -29.31 18.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.16 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -100.64 -0.29 37.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.236 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.654 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -65.97 -11.61 48.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HB2' ' NE ' ' A' ' 32' ' ' ARG . 6.5 t0 -138.08 45.56 2.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 0.0 110.16 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.034 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 1.7 mt -115.81 122.1 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.895 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.54 82.42 0.12 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.236 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.034 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.7 Cg_endo -73.0 136.64 25.22 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.008 1.53 . . . . 0.0 110.451 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.6 mt -89.24 154.67 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.218 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.4 t -131.58 111.48 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 73.6 tt0 -94.81 132.47 39.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.451 HD12 ' CD1' ' A' ' 6' ' ' TRP . 67.4 mt -118.77 128.51 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -133.63 74.81 1.57 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 110.181 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.519 ' OE1' ' CZ ' ' A' ' 47' ' ' PHE . 13.0 pt20 -78.41 162.72 26.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 110.208 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 86.3 mttt -156.47 49.12 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 0.0 110.19 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.04 -100.61 0.9 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 39.5 m-20 -110.48 -7.85 14.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -1.221 . . . . 0.0 110.198 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -98.58 152.96 19.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.211 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.688 ' CD1' HD11 ' A' ' 64' ' ' LEU . 1.6 m-85 -136.42 136.42 39.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 110.155 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.01 110.82 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.196 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 4.6 m -113.75 135.32 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 91.1 m -122.07 98.16 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.91 . . . . 0.0 110.203 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.2 m -78.63 138.54 38.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.198 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -132.83 114.74 14.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.255 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.933 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -99.31 168.33 9.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.772 ' HD2' HG22 ' A' ' 53' ' ' THR . 47.1 Cg_endo -73.07 -33.85 7.01 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.017 1.535 . . . . 0.0 110.529 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -93.07 -21.87 19.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.221 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.658 ' O ' ' OG1' ' A' ' 53' ' ' THR . 1.6 tt0 -161.4 162.12 30.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.448 ' N ' ' CG ' ' A' ' 56' ' ' GLN . 3.5 p -128.71 130.11 46.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 110.263 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 73' ' ' MET . 87.9 t -129.19 124.28 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.186 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 14.5 t -109.64 143.08 39.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.285 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -138.72 148.98 44.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 110.211 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.4 t -140.59 134.94 31.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 110.245 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.666 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 27.5 p90 -148.03 166.91 26.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.7 m -115.46 146.38 41.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 0.0 110.185 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.688 HD11 ' CD1' ' A' ' 47' ' ' PHE . 14.5 mt -78.51 122.83 26.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.226 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.1 4.63 41.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -145.51 151.92 38.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -1.159 . . . . 0.0 110.16 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -72.4 131.13 42.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.11 151.46 49.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 12.9 p-10 -88.01 134.86 33.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.706 HD12 ' H62' ' A' ' 131' ' ' JN3 . 8.3 mm -124.37 143.28 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.88 . . . . 0.0 110.208 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 m -117.76 134.09 55.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.579 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 1.4 p -88.86 158.96 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.727 ' CE ' H122 ' A' ' 130' ' ' JN3 . 72.7 mtm -74.27 -8.11 55.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.246 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.481 ' OD1' ' HB ' ' A' ' 72' ' ' THR . 46.0 p-10 -92.03 -15.47 27.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 74' ' ' ASP . . . 109.14 28.44 4.4 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.579 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 3.9 mttt -108.44 130.94 55.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -1.148 . . . . 0.0 110.201 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -111.2 136.55 50.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 110.187 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.721 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -160.55 161.82 32.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.154 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.19 157.56 18.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.3 p -169.17 140.39 2.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.227 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.0 m -98.14 102.67 14.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.626 HG13 HD21 ' A' ' 89' ' ' LEU . 46.5 t -72.22 140.76 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.252 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.437 ' CE1' ' HB ' ' A' ' 90' ' ' VAL . 31.6 p80 -145.23 153.78 41.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.511 HD12 HD13 ' A' ' 64' ' ' LEU . 14.2 mt -100.99 126.37 47.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 0.0 110.251 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.25 147.3 39.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 53.3 15.25 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.22 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.62 48.83 6.04 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 7.3 pttt -169.85 135.96 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.324 -1.104 . . . . 0.0 110.229 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.681 HD22 ' H22' ' A' ' 131' ' ' JN3 . 5.5 tt -68.88 144.62 54.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.855 . . . . 0.0 110.238 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.495 HG23 ' C ' ' A' ' 89' ' ' LEU . 73.4 t -152.03 114.28 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.315 -0.866 . . . . 0.0 110.215 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.553 HG21 H111 ' A' ' 131' ' ' JN3 . 86.9 m -105.7 98.74 8.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.275 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 17.2 pttt -94.58 155.14 17.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 17.3 t -145.96 -165.92 2.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.45 ' N ' ' OG ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -100.52 31.88 3.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 110.199 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.5 ptpt -175.38 4.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.203 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.894 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -179.31 145.5 0.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -122.5 159.75 27.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 110.264 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.515 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 11.9 t60 -144.72 141.42 29.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.303 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.69 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 10.1 pt-20 -157.17 125.18 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 110.207 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.551 ' OE1' ' CE ' ' A' ' 107' ' ' MET . 6.1 tt0 -128.36 162.62 26.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.893 . . . . 0.0 110.213 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.496 ' CG ' ' HB2' ' A' ' 88' ' ' LYS . 20.3 mt-10 -153.73 155.93 36.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.81 139.96 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 110.197 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -135.8 98.65 3.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.01 -110.47 3.04 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -115.67 12.17 15.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -1.192 . . . . 0.0 110.16 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -117.71 160.03 22.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.199 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.551 ' CE ' ' OE1' ' A' ' 100' ' ' GLN . 28.1 tpp -132.09 138.02 47.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.56 132.54 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.18 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 34.8 mt-10 -117.71 130.1 56.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.672 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 5.7 m -122.65 124.45 43.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 97' ' ' SER . 87.3 mt -130.78 136.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.248 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.445 HG22 ' OG1' ' A' ' 117' ' ' THR . 15.8 p -113.36 127.11 56.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.257 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.515 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 27.3 t80 -149.29 129.79 13.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 110.172 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 62.41 39.58 97.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.44 6.58 49.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 114' ' ' GLY . 58.2 t -109.72 141.94 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -1.127 . . . . 0.0 110.258 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.445 ' OG1' HG22 ' A' ' 112' ' ' THR . 58.5 m -118.36 130.18 55.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.865 . . . . 0.0 110.211 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.603 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 48.8 tp -108.76 145.92 34.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.922 . . . . 0.0 110.252 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.09 114.68 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 32.5 ttp180 -111.49 128.02 55.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.96 . . . . 0.0 110.169 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 67.9 mtt180 -104.72 127.05 52.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 110.173 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 66.3 m -123.51 154.45 39.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.845 . . . . 0.0 110.171 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -118.14 160.7 21.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.162 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 5' ' ' THR . 15.6 ttp180 -88.79 137.69 32.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 125' ' ' VAL . 35.2 m . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.208 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 0.727 H122 ' CE ' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.721 H181 HD11 ' A' ' 78' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.244 0.545 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -76.73 -33.83 58.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.223 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 p -57.33 144.87 34.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.94 . . . . 0.0 110.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.73 -173.75 18.7 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.7 m -111.7 129.52 56.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -1.149 . . . . 0.0 110.229 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.523 ' CD1' HD12 ' A' ' 40' ' ' ILE . 70.1 m95 -118.01 138.61 52.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -118.31 118.13 30.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.3 t -64.95 126.22 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 18.0 p90 -127.08 -21.79 3.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.502 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -136.28 131.73 34.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.159 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.482 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 26.3 pt20 -146.98 118.27 7.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.204 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.442 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.5 tt0 -94.03 152.89 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.885 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 m120 50.47 27.25 2.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.169 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -58.05 -52.2 66.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -64.62 -50.52 66.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 110.188 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 36.7 mm-40 -51.06 -61.49 2.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.178 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.7 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 63.5 t80 -49.22 -52.3 27.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.171 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.581 HD23 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -59.5 -44.79 93.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 110.221 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 14.5 mttm -46.7 -38.31 9.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.29 -27.23 63.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.9 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.5 tp -61.87 -23.51 66.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.73 30.5 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.581 HD12 HD23 ' A' ' 18' ' ' LEU . 15.1 mt -77.53 166.77 41.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.1 Cg_endo -73.08 143.2 35.63 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.04 1.547 . . . . 0.0 110.43 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -65.16 -41.25 94.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.166 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -55.24 -28.14 51.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.397 -0.815 . . . . 0.0 110.175 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.575 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 41.5 tp -89.43 -22.07 22.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 24' ' ' PRO . 92.5 mt -86.99 -40.01 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -72.58 -30.04 64.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 110.241 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.405 ' CE ' ' HD2' ' A' ' 55' ' ' ARG . 9.5 ttp -87.77 -24.03 23.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -101.66 6.58 42.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 110.175 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.684 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 16.6 ptt180 -68.12 4.17 1.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.337 -0.852 . . . . 0.0 110.195 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.684 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.9 m-20 -151.73 50.21 0.81 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.087 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.3 mt -122.48 119.37 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.215 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -91.19 83.25 0.11 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 110.301 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.087 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.9 Cg_endo -73.02 136.52 24.97 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.023 1.538 . . . . 0.0 110.475 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 38' ' ' VAL . 55.1 mt -100.45 171.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.185 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.55 ' N ' HG22 ' A' ' 37' ' ' ILE . 11.2 p -147.41 132.9 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.217 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -110.3 111.55 22.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 110.206 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' A' ' 6' ' ' TRP . 64.3 mt -99.93 138.46 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.244 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.541 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 56.7 tt0 -137.76 70.0 1.39 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.154 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.569 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 52.5 tt0 -67.0 159.75 27.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.206 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 53.9 mmtt -156.17 42.76 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.59 -100.59 0.77 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -109.94 -5.62 15.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -1.185 . . . . 0.0 110.261 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.405 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 7.1 t0 -102.12 152.32 21.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.484 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 39.1 m-85 -133.96 140.88 47.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.198 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -126.55 104.9 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.211 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.734 HG11 ' H42' ' A' ' 131' ' ' JN3 . 58.6 t -106.75 135.8 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 110.231 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.737 ' OG1' HG23 ' A' ' 59' ' ' THR . 99.8 m -133.81 104.67 6.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 m -87.3 136.91 32.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.858 . . . . 0.0 110.247 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -129.65 123.53 31.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 110.188 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.644 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -107.15 169.03 7.18 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.05 -18.78 23.7 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.06 1.558 . . . . 0.0 110.448 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.405 ' HD2' ' CE ' ' A' ' 30' ' ' MET . 26.8 ttt180 -103.41 -21.92 13.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.21 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.644 ' O ' ' OG1' ' A' ' 53' ' ' THR . 17.8 pt20 -164.13 165.11 22.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 110.142 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 p -129.41 130.47 46.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.151 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.36 127.88 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.737 HG23 ' OG1' ' A' ' 50' ' ' THR . 91.2 m -112.27 137.76 49.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 59' ' ' THR . 58.0 m-20 -133.51 151.86 51.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 t -147.12 128.75 15.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.723 ' CE1' ' H5 ' ' A' ' 131' ' ' JN3 . 37.1 p90 -141.87 169.19 18.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 110.184 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.6 m -114.78 142.45 46.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.178 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.574 HD11 ' CA ' ' A' ' 83' ' ' HIS . 3.0 tp -76.58 124.95 28.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.99 -2.75 41.05 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.59 149.96 45.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -1.13 . . . . 0.0 110.18 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' OE2' ' HD2' ' A' ' 79' ' ' LYS . 71.4 tt0 -70.76 123.81 22.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.62 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -122.83 148.0 45.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 110.271 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -80.23 135.01 36.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 110.146 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.818 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 17.2 mm -128.22 145.14 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 110.25 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 t -119.23 135.43 54.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.27 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.829 HG23 H161 ' A' ' 131' ' ' JN3 . 0.2 OUTLIER -84.15 156.28 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.655 ' CE ' H122 ' A' ' 130' ' ' JN3 . 0.2 OUTLIER -67.95 -17.18 64.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.715 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -83.11 -10.3 58.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.16 28.36 5.86 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.436 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 10.3 mtpt -106.24 133.76 50.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -1.129 . . . . 0.0 110.246 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.03 138.49 44.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.686 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -169.48 150.82 4.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.141 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.453 ' HD2' ' OE2' ' A' ' 67' ' ' GLU . 7.2 mtmm -95.15 155.95 16.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.916 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.28 131.76 5.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.195 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 m -93.37 99.39 11.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.226 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.898 ' CG1' HD21 ' A' ' 89' ' ' LEU . 40.7 t -73.99 143.86 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.662 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 2.9 p-80 -147.36 160.62 42.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 0.0 110.225 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 mp -101.06 133.87 44.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 0.0 110.186 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -139.03 115.52 10.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 53.2 t-20 62.79 24.19 14.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.656 ' O ' ' CG ' ' A' ' 88' ' ' LYS . . . 80.76 46.46 7.22 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.656 ' CG ' ' O ' ' A' ' 87' ' ' GLY . 28.7 mtmt -161.87 117.83 2.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -1.149 . . . . 0.0 110.219 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.898 HD21 ' CG1' ' A' ' 82' ' ' VAL . 1.7 tt -61.79 135.84 57.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 110.189 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.662 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 75.6 t -145.42 121.93 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.939 ' CG2' ' HB3' ' A' ' 98' ' ' HIS . 8.8 t -118.86 103.69 9.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.185 -0.947 . . . . 0.0 110.191 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 51.1 pttt -93.55 154.52 17.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 110.189 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 t -141.67 -158.24 0.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 36.8 mt-10 -109.52 31.82 5.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.22 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.57 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -176.88 6.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 110.198 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.835 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 178.28 147.5 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 111' ' ' ILE . 15.9 t -125.24 158.41 34.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 110.243 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.939 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 12.0 t60 -141.61 146.02 35.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.849 ' HB2' HG23 ' A' ' 110' ' ' THR . 24.5 mt-10 -157.68 126.04 5.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.266 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 10.3 tt0 -126.17 162.06 26.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.538 ' OE2' ' O ' ' A' ' 102' ' ' VAL . 11.0 tm-20 -160.4 150.91 18.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.538 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 8.4 p -116.72 142.75 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.206 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 50.6 mttt -134.56 91.2 2.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.07 -107.42 2.79 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -115.09 9.64 15.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -1.199 . . . . 0.0 110.243 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -117.97 161.13 20.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 110.19 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.48 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -131.85 140.68 49.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.216 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.5 t -126.92 125.02 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.224 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 28.0 mt-10 -110.73 126.99 55.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.849 HG23 ' HB2' ' A' ' 99' ' ' GLU . 4.8 t -117.93 119.46 34.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.216 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 97' ' ' SER . 71.6 mt -126.12 132.16 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 31.8 m -109.74 132.93 53.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.616 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 11.8 t80 -156.3 127.39 6.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.929 . . . . 0.0 110.223 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 67.28 36.54 89.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.34 7.3 60.15 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 17' ' ' PHE . 60.4 t -111.01 141.01 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -1.156 . . . . 0.0 110.223 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 78.5 m -117.48 130.44 56.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.226 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.7 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 54.7 tp -110.38 146.85 35.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.239 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.31 100.25 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.182 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.44 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 9.1 mtm180 -93.39 119.89 33.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.0 110.207 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 42.3 mtt180 -101.13 125.75 47.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 110.231 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.8 m -123.88 158.1 32.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.184 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 10.4 tttm -119.93 158.31 26.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.415 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 22.3 ttt180 -85.68 136.64 33.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 110.24 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.207 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 0.715 H151 ' HB3' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.867 H112 HG21 ' A' ' 91' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.282 0.563 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 75.2 m-85 -74.63 -31.03 61.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 110.224 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.8 m -56.89 144.43 33.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.209 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.27 -175.95 18.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.732 HG22 ' HG3' ' A' ' 39' ' ' GLU . 19.2 p -107.04 131.59 53.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -1.126 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.544 ' CD1' ' HE2' ' A' ' 107' ' ' MET . 93.2 m95 -119.6 137.02 54.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -119.28 113.7 21.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.239 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.424 HG11 ' OE1' ' A' ' 11' ' ' GLN . 39.9 t -61.04 135.99 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.165 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 10' ' ' ALA . 10.9 p90 -139.09 -15.82 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.206 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.532 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -138.7 130.97 28.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.435 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 15.7 mt-30 -144.87 160.64 40.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.902 . . . . 0.0 110.202 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.782 ' CD ' HD12 ' A' ' 119' ' ' ILE . 12.7 pt-20 -137.77 150.91 47.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.147 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.7 m120 54.35 33.79 19.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.44 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.6 t80 -62.83 -54.32 40.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -60.78 -53.72 53.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -50.0 -56.05 12.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.494 ' HD1' HD22 ' A' ' 18' ' ' LEU . 33.2 t80 -54.05 -47.0 72.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.895 ' CD1' HD12 ' A' ' 23' ' ' LEU . 2.3 mm? -60.74 -42.1 96.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.163 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -54.45 -37.52 65.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 110.159 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.91 -33.2 71.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 110.24 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.869 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.5 tp -63.86 -21.19 66.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 0.0 110.252 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.869 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 77.98 31.77 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 110.216 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.895 HD12 ' CD1' ' A' ' 18' ' ' LEU . 14.2 mt -80.13 166.18 42.02 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.183 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.484 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.09 142.35 34.19 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.103 1.581 . . . . 0.0 110.386 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.538 ' CD ' ' HE3' ' A' ' 29' ' ' LYS . 43.2 tt0 -64.79 -33.5 76.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -61.15 -26.88 68.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.484 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 40.0 tp -90.07 -27.81 19.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 110.158 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.5 mt -76.19 -45.23 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.287 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HE3' ' CD ' ' A' ' 25' ' ' GLU . 21.0 mttt -69.4 -26.82 64.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.4 mtt -85.95 -27.66 24.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.189 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -101.47 7.38 42.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.579 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 16.0 ptt180 -66.7 -1.28 3.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.202 -0.936 . . . . 0.0 110.195 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.579 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.1 m-20 -148.0 47.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.259 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.974 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 5.1 mt -121.51 115.49 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 110.242 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -92.54 88.76 0.33 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.974 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.9 Cg_endo -73.03 139.26 29.6 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.042 1.548 . . . . 0.0 110.467 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 38' ' ' VAL . 17.2 mt -89.89 162.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' N ' HG22 ' A' ' 37' ' ' ILE . 79.5 t -139.11 114.05 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 110.217 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.732 ' HG3' HG22 ' A' ' 5' ' ' THR . 13.4 tt0 -98.12 136.6 38.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 110.168 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.518 HD12 ' CD1' ' A' ' 6' ' ' TRP . 74.8 mt -124.68 129.29 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 54.6 tt0 -129.92 75.1 1.63 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 0.0 110.19 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.72 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 2.0 tm0? -72.39 162.06 29.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 43.1 mtmt -160.51 49.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.18 -104.19 1.31 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 64.4 m-20 -109.85 -0.37 18.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -1.148 . . . . 0.0 110.152 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.0 t0 -104.03 146.54 28.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.0 110.194 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.787 ' CE1' HD11 ' A' ' 64' ' ' LEU . 4.1 m-85 -128.36 135.42 49.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.4 t -123.7 108.29 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.212 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.817 HG11 ' H42' ' A' ' 131' ' ' JN3 . 85.3 t -110.23 128.98 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.8 m -129.13 108.03 10.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -92.04 138.25 31.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.25 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 1.1 pttt -131.85 126.09 33.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 110.166 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.865 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.89 170.41 5.46 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.926 . . . . 0.0 110.184 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.752 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.5 Cg_endo -73.03 -20.03 22.35 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.039 1.547 . . . . 0.0 110.497 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -105.04 -22.03 13.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 0.0 110.218 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' OE1' ' O25' ' A' ' 130' ' ' JN3 . 7.7 pt20 -161.83 159.6 27.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.4 p -130.51 131.0 44.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 110.239 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.402 ' CG1' HG23 ' A' ' 71' ' ' THR . 56.2 t -128.53 129.36 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.223 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.4 t -111.19 137.49 48.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.257 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.417 ' HB3' ' CD1' ' A' ' 70' ' ' ILE . 63.0 m-20 -132.3 149.62 52.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 110.161 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 t -144.67 128.97 17.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.898 . . . . 0.0 110.186 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.779 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 39.6 p90 -142.81 170.44 15.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.521 HG21 ' HE2' ' A' ' 66' ' ' LYS . 17.6 m -119.01 153.41 34.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.222 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.787 HD11 ' CE1' ' A' ' 47' ' ' PHE . 22.2 mt -81.4 125.34 30.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.22 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.28 12.39 54.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HE2' HG21 ' A' ' 63' ' ' THR . 46.7 mtmt -146.7 139.26 25.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.147 . . . . 0.0 110.218 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -66.04 127.22 31.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -127.94 149.06 50.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.57 138.53 33.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.177 -0.952 . . . . 0.0 110.254 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.795 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 5.0 mm -130.57 144.43 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.415 HG22 ' OD1' ' A' ' 60' ' ' ASN . 4.1 t -118.22 135.01 54.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.671 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 34.7 p -87.1 160.38 18.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.189 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.675 ' HE3' H122 ' A' ' 130' ' ' JN3 . 11.9 ttm -72.22 -11.53 60.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.964 ' HB3' H151 ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -89.51 -13.36 37.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.155 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.0 51.11 0.96 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 11.0 mttt -128.53 133.11 48.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -1.126 . . . . 0.0 110.169 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -110.0 135.87 50.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.563 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -164.02 159.71 20.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.224 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -105.86 155.32 19.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.197 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.1 p -164.13 136.62 4.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.23 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.4 m -95.29 97.67 10.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 110.225 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.827 HG13 HD21 ' A' ' 89' ' ' LEU . 47.6 t -69.23 142.18 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 110.248 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.471 ' CE1' ' HB ' ' A' ' 90' ' ' VAL . 26.7 p80 -147.54 150.09 33.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.43 HD12 HD13 ' A' ' 64' ' ' LEU . 18.5 mt -96.06 129.89 43.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.54 144.12 31.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 110.141 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.36 11.55 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.59 45.39 6.11 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 11.5 pttt -170.76 132.28 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -1.124 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.827 HD21 HG13 ' A' ' 82' ' ' VAL . 3.6 tt -61.16 149.19 38.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.896 HG22 ' HG3' ' A' ' 99' ' ' GLU . 87.3 t -155.51 109.3 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 87.2 m -103.01 103.78 13.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.183 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.433 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 5.6 ptmt -99.4 157.47 16.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.224 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 14.3 t -151.21 -171.13 3.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.202 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.54 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 54.3 tt0 -98.14 30.73 2.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.188 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.525 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 1.6 pttt -169.8 -2.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 0.0 110.205 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.854 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -176.31 147.49 0.7 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.92 . . . . 0.0 110.212 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.8 159.05 28.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.847 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.637 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 20.4 t60 -143.17 137.08 28.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.896 ' HG3' HG22 ' A' ' 90' ' ' VAL . 44.8 tt0 -151.19 126.91 10.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.163 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.576 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 9.1 tt0 -133.76 154.79 50.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 110.111 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.487 ' HA ' ' CE1' ' A' ' 2' ' ' PHE . 58.8 tt0 -149.37 159.86 43.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 110.269 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.41 138.06 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -0.897 . . . . 0.0 110.173 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -133.84 93.97 3.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.277 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.67 -106.75 2.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -118.78 12.61 13.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -1.135 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.04 155.27 31.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.159 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.544 ' HE2' ' CD1' ' A' ' 6' ' ' TRP . 25.8 tpp -128.41 140.31 51.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.1 t -125.97 126.69 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.183 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.576 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 29.5 mt-10 -114.58 136.13 53.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 p -124.73 123.93 41.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.233 -0.917 . . . . 0.0 110.22 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 72.7 mt -130.88 129.82 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 5.0 t -113.41 131.87 55.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 6.3 t80 -154.19 125.12 7.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.256 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.29 33.38 61.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.25 3.73 66.42 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 112' ' ' THR . 62.9 t -109.69 139.56 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -1.157 . . . . 0.0 110.199 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 55.3 m -113.98 135.22 54.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.224 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 12' ' ' GLU . 41.6 tp -113.95 139.13 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.172 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.782 HD12 ' CD ' ' A' ' 12' ' ' GLU . 96.8 mt -120.43 110.45 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -105.96 120.94 43.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.94 . . . . 0.0 110.186 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 52.4 mtt180 -102.17 127.05 49.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 0.0 110.19 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.9 m -122.81 163.41 20.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.207 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -128.15 158.56 37.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.902 . . . . 0.0 110.19 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -85.11 136.56 33.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.177 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 0.964 H151 ' HB3' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.817 ' H42' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.745 ' HB1' HG11 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.26 0.552 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.04 -33.74 59.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.208 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.3 p -56.81 145.71 28.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.44 -177.02 17.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.763 HG22 ' HG3' ' A' ' 39' ' ' GLU . 42.3 p -105.75 134.24 49.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -1.182 . . . . 0.0 110.18 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.497 ' CD1' ' HE2' ' A' ' 107' ' ' MET . 95.3 m95 -121.27 142.62 49.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -124.07 118.2 26.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.209 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.4 HG12 ' CD ' ' A' ' 11' ' ' GLN . 49.2 t -65.8 126.78 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 110.167 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 22.6 p90 -128.16 -23.07 3.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.719 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -135.13 133.61 39.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 110.223 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.719 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 2.0 mp0 -146.7 112.24 5.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.892 . . . . 0.0 110.216 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.484 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.1 tt0 -89.65 147.32 23.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.0 m120 55.02 24.07 5.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.655 ' CE1' HD11 ' A' ' 18' ' ' LEU . 27.5 t80 -56.57 -52.43 64.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 110.208 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -63.54 -48.61 76.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.23 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 66.8 mt-10 -53.79 -62.23 1.79 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 110.222 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.71 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 38.2 t80 -48.29 -57.83 5.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.66 HD23 HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -57.12 -46.66 82.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 110.183 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -42.79 -41.86 3.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.192 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.19 -28.25 66.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.866 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -58.13 -20.13 38.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.219 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 77.94 31.37 0.42 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.66 HD12 HD23 ' A' ' 18' ' ' LEU . 15.5 mt -77.03 165.99 48.1 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.188 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.615 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.08 140.59 31.46 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.969 1.51 . . . . 0.0 110.409 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.411 ' HG2' ' HE2' ' A' ' 29' ' ' LYS . 42.4 tt0 -61.52 -39.48 91.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.29 -26.54 63.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.309 -0.87 . . . . 0.0 110.191 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.615 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 14.8 tp -90.42 -23.26 21.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 95.2 mt -81.09 -43.18 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.978 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HE2' ' HG2' ' A' ' 25' ' ' GLU . 37.3 mtmt -72.52 -24.41 61.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 37.4 mtt -87.9 -32.91 18.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -97.99 5.44 48.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.632 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 31.3 ptt85 -65.53 -1.11 2.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.632 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.6 m-20 -149.91 47.57 0.93 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.942 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.9 mt -118.7 121.03 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -95.8 83.02 0.22 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.337 -0.852 . . . . 0.0 110.234 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.942 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.5 Cg_endo -73.05 137.49 26.55 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.031 1.543 . . . . 0.0 110.47 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.5 mt -90.01 157.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.155 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.3 t -134.93 112.72 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.763 ' HG3' HG22 ' A' ' 5' ' ' THR . 21.0 tt0 -94.05 138.24 32.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.234 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.469 HD12 ' CD1' ' A' ' 6' ' ' TRP . 71.3 mt -126.73 127.78 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.214 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -133.03 75.27 1.61 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.246 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.533 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 6.7 pt20 -78.57 163.53 25.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.218 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 31.0 mmtp -154.79 49.93 0.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.75 -99.21 0.8 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -110.05 -9.11 14.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.271 -1.135 . . . . 0.0 110.216 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 34.4 t0 -98.0 157.23 16.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 110.196 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.605 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.1 m-85 -139.89 133.55 30.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.232 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.9 t -114.24 100.75 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 110.242 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.97 HG21 ' H42' ' A' ' 131' ' ' JN3 . 4.2 p -100.85 135.49 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.187 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 59' ' ' THR . 36.0 m -138.59 105.56 5.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.4 m -88.4 138.2 31.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.244 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -130.35 119.16 22.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 110.282 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.854 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -106.89 167.44 9.48 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 110.223 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.767 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.8 Cg_endo -73.07 -20.68 21.47 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.057 1.556 . . . . 0.0 110.472 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -102.93 -20.6 14.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.439 ' HG2' ' O25' ' A' ' 130' ' ' JN3 . 5.0 pt20 -166.31 159.17 14.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.907 . . . . 0.0 110.191 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.3 p -129.05 131.29 47.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.224 -0.922 . . . . 0.0 110.205 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.26 128.26 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 110.19 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 50' ' ' THR . 46.2 m -110.59 136.83 49.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 110.19 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 49' ' ' VAL . 81.6 m-20 -135.02 153.91 51.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.245 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.2 t -143.17 128.17 18.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.221 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.706 ' CE1' HG21 ' A' ' 82' ' ' VAL . 52.4 p90 -139.7 168.59 19.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.162 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.5 m -120.07 142.48 48.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 84' ' ' LEU . 15.5 mt -74.21 126.03 29.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 110.258 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.89 58.23 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -137.47 142.23 41.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.263 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -68.01 126.25 28.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.207 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . . . -127.28 150.1 49.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 0.0 110.237 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -81.57 136.56 35.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 110.227 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.793 ' CD1' ' H62' ' A' ' 131' ' ' JN3 . 3.8 mm -129.43 144.77 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -116.77 134.42 54.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.253 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.717 HG23 H161 ' A' ' 131' ' ' JN3 . 0.3 OUTLIER -86.02 155.06 21.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.883 . . . . 0.0 110.128 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.787 ' SD ' H213 ' A' ' 130' ' ' JN3 . 16.4 ttm -67.13 -14.94 63.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.215 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.654 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -86.47 -13.07 47.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.54 29.72 4.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -104.99 135.39 46.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -1.156 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -112.02 132.59 54.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.227 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.691 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -161.14 162.95 31.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -107.86 158.69 17.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.194 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.498 ' HB2' HG23 ' A' ' 91' ' ' THR . 25.3 p -165.4 147.26 7.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.204 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.45 87.85 2.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.223 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 89' ' ' LEU . 16.1 t -53.3 154.96 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 110.18 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.537 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -152.17 147.46 26.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 0.0 110.224 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.633 HD12 HD13 ' A' ' 64' ' ' LEU . 13.9 mt -100.91 99.07 9.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 87' ' ' GLY . . . -114.37 152.59 31.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.178 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.496 ' HB3' ' CD ' ' A' ' 88' ' ' LYS . 3.3 t30 46.5 17.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 110.149 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 85' ' ' ALA . . . 77.97 48.96 7.31 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.754 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -167.21 127.69 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -1.159 . . . . 0.0 110.252 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.859 HD11 HG11 ' A' ' 82' ' ' VAL . 4.2 tt -59.22 147.67 34.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 110.179 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.824 HG12 ' HG3' ' A' ' 99' ' ' GLU . 22.2 m -154.67 109.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 97.5 m -103.55 100.11 9.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -98.11 161.0 13.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.47 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -152.33 -165.36 2.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 110.186 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 49.2 tt0 -101.16 31.29 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' CE2' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -173.3 4.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.933 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.67 141.69 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.303 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.617 ' O ' HG23 ' A' ' 111' ' ' ILE . 69.3 m -117.52 160.52 21.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.566 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 19.1 t60 -144.12 140.66 29.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.824 ' HG3' HG12 ' A' ' 90' ' ' VAL . 14.0 tt0 -155.17 123.59 5.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.231 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 12.0 tt0 -129.04 157.17 42.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -153.84 154.67 34.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.209 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.745 HG11 ' HB1' ' A' ' 1' ' ' ALA . 10.0 p -116.43 141.52 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -136.61 90.69 2.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.24 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.8 -105.59 2.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -119.19 11.42 12.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -1.145 . . . . 0.0 110.169 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -117.52 154.31 31.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.229 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.497 ' HE2' ' CD1' ' A' ' 6' ' ' TRP . 26.8 tpp -125.38 138.57 54.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 110.293 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.2 t -126.4 124.73 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.33 -0.857 . . . . 0.0 110.228 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 33.2 mt-10 -112.32 121.61 45.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 99' ' ' GLU . 85.4 m -110.19 119.09 38.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.231 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 97' ' ' SER . 68.1 mt -126.52 129.72 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 74.7 m -109.31 138.06 46.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.547 ' CE2' ' O ' ' A' ' 95' ' ' LYS . 21.1 t80 -160.81 127.65 4.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 110.196 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.23 34.45 75.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.75 8.55 68.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.3 t -112.4 141.42 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -1.168 . . . . 0.0 110.207 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.9 m -116.9 130.94 57.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 110.259 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.71 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 41.8 tp -110.34 152.68 25.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.5 mt -131.37 94.6 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -88.57 126.53 35.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.221 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 27.6 mtt180 -106.23 125.78 51.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 56.5 m -123.49 153.42 40.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.919 . . . . 0.0 110.218 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -119.81 159.01 25.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.87 . . . . 0.0 110.204 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -86.0 135.28 33.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.255 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 0.787 H213 ' SD ' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.97 ' H42' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.793 ' O ' ' HB2' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.264 0.554 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.793 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 29.7 m-85 68.93 -59.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 110.266 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 1' ' ' ALA . 2.9 p -51.91 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.36 -162.69 33.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.655 HG22 ' HG3' ' A' ' 39' ' ' GLU . 9.8 p -114.2 128.07 56.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -1.145 . . . . 0.0 110.22 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.532 ' CD1' HD12 ' A' ' 40' ' ' ILE . 92.0 m95 -117.11 137.82 52.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.254 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.37 123.19 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 110.257 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.52 133.03 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.544 ' CD1' ' HB2' ' A' ' 10' ' ' ALA . 34.2 p90 -133.75 -27.62 1.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.544 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -130.94 137.13 49.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.56 ' O ' ' HG2' ' A' ' 11' ' ' GLN . 3.7 pm0 -152.18 140.96 20.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.209 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.402 ' O ' HD12 ' A' ' 118' ' ' LEU . 30.9 tt0 -115.28 151.26 34.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 50.57 25.38 1.98 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -55.22 -47.13 75.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -0.92 . . . . 0.0 110.241 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.12 -51.82 54.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -49.03 -61.64 1.96 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.169 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.605 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 52.2 t80 -50.32 -44.94 54.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.142 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.632 HD21 H191 ' A' ' 130' ' ' JN3 . 49.5 mt -61.14 -46.72 89.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.245 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -50.98 -36.53 39.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.262 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.38 -32.21 72.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.849 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -61.14 -21.01 63.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.849 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 75.62 37.82 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.248 -0.907 . . . . 0.0 110.172 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.734 HD22 ' HD2' ' A' ' 24' ' ' PRO . 3.7 mt -79.19 165.32 49.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.734 ' HD2' HD22 ' A' ' 23' ' ' LEU . 46.2 Cg_endo -73.04 136.37 24.68 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.989 1.521 . . . . 0.0 110.508 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -54.09 -30.78 49.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.53 -41.55 96.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.902 . . . . 0.0 110.271 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.605 HD22 ' OD1' ' A' ' 74' ' ' ASP . 63.4 tp -80.09 -45.83 17.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.247 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.8 mt -53.48 -54.1 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 110.215 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 6.6 mmtp -59.35 -29.73 67.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.438 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 65.1 mtt -86.08 -20.53 28.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 0.0 110.168 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.66 ' HB1' ' C18' ' A' ' 130' ' ' JN3 . . . -103.67 4.56 35.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.245 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.767 ' HG3' ' OD2' ' A' ' 33' ' ' ASP . 20.3 ptt180 -75.21 -0.4 19.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.227 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.767 ' OD2' ' HG3' ' A' ' 32' ' ' ARG . 62.6 m-20 -152.36 42.03 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.964 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 27.5 mt -121.36 115.46 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.219 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.55 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -92.25 88.83 0.32 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.208 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.964 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.4 Cg_endo -73.12 138.6 28.25 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.026 1.54 . . . . 0.0 110.399 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -89.62 157.35 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.254 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -136.84 119.09 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.655 ' HG3' HG22 ' A' ' 5' ' ' THR . 28.5 tt0 -100.64 134.5 43.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 110.185 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.532 HD12 ' CD1' ' A' ' 6' ' ' TRP . 83.0 mt -121.9 129.48 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -131.89 74.9 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.807 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 24.3 tt0 -73.87 164.45 26.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.6 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 47.3 mttt -156.97 42.29 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 110.221 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.8 -97.69 0.62 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -112.88 -0.24 14.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -1.185 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -104.84 147.95 27.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.967 . . . . 0.0 110.243 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 1.178 ' CD2' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -128.57 133.95 48.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 110.224 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.5 t -122.37 107.73 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.248 -0.908 . . . . 0.0 110.191 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.885 HG11 ' H42' ' A' ' 131' ' ' JN3 . 82.3 t -110.18 133.99 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.2 m -132.69 107.46 8.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 0.0 110.203 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -92.0 137.45 32.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 110.234 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 1.6 pttm -131.5 127.83 38.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.104 HG21 H213 ' A' ' 130' ' ' JN3 . 0.1 OUTLIER -111.49 170.23 5.49 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 110.186 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.99 -16.54 25.64 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.054 1.555 . . . . 0.0 110.487 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.0 mtp-105 -106.32 -19.33 13.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.898 . . . . 0.0 110.191 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.58 ' O ' ' OG1' ' A' ' 53' ' ' THR . 19.5 pt20 -167.44 161.25 13.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 110.232 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.9 p -130.03 133.8 46.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.3 t -131.3 130.18 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.937 . . . . 0.0 110.176 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 59' ' ' THR . 13.9 t -112.04 134.8 53.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 110.143 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -129.69 151.91 49.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -0.88 . . . . 0.0 110.173 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -147.04 127.39 13.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.72 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 38.2 p90 -141.4 172.93 12.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 110.218 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.5 m -118.68 148.71 42.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.202 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.178 HD11 ' CD2' ' A' ' 47' ' ' PHE . 9.9 mt -79.57 123.34 27.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.269 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.93 5.41 47.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -143.94 145.3 32.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -1.139 . . . . 0.0 110.164 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.21 127.19 31.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -125.42 148.18 48.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -83.86 136.2 34.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.922 . . . . 0.0 110.224 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.775 ' CD1' ' H62' ' A' ' 131' ' ' JN3 . 6.0 mm -127.85 145.96 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.172 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 t -119.84 133.46 55.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.626 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -83.28 155.8 23.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.658 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -69.05 -17.04 63.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 110.228 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.605 ' OD1' HD22 ' A' ' 27' ' ' LEU . 8.1 t0 -84.89 -12.24 53.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.34 30.58 4.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.626 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 23.5 mttt -107.28 131.98 53.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -1.136 . . . . 0.0 110.15 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -111.69 138.19 48.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.218 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.594 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -167.65 159.37 11.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 57.3 mttt -103.75 167.5 9.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 110.202 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 27.0 p -178.22 137.36 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 110.245 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.9 m -93.93 104.9 16.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.31 -0.869 . . . . 0.0 110.213 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.695 HG13 HD21 ' A' ' 89' ' ' LEU . 55.3 t -75.78 140.28 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.257 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.563 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 9.0 p-80 -144.11 155.25 43.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 89' ' ' LEU . 4.3 tp -100.14 134.41 43.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.92 117.55 14.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 10.0 t-20 61.55 30.23 18.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 75.94 40.99 29.01 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 83.5 mttt -152.96 125.0 7.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 110.181 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.723 HD22 ' H22' ' A' ' 131' ' ' JN3 . 7.8 tt -71.44 134.47 46.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.197 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.757 HG13 ' HG2' ' A' ' 99' ' ' GLU . 77.2 t -140.64 120.26 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 110.286 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 53.6 m -113.24 92.4 3.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.211 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 14.3 ptmt -86.22 160.6 19.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.446 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -152.96 -169.77 3.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.145 -0.972 . . . . 0.0 110.211 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -99.29 36.93 1.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.19 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.489 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -179.15 -1.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.823 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -175.11 147.3 0.91 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.242 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 111' ' ' ILE . 39.1 m -124.53 152.49 43.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.497 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 18.2 t60 -137.47 142.91 41.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 110.261 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.757 ' HG2' HG13 ' A' ' 90' ' ' VAL . 47.5 mt-10 -153.24 128.65 9.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 12.5 tt0 -132.51 152.7 51.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.131 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.57 155.38 39.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 110.259 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.515 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.9 p -119.71 135.49 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -128.6 96.07 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 110.177 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.94 -101.67 1.72 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -120.67 10.78 11.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -1.142 . . . . 0.0 110.177 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -119.6 158.34 26.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.225 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.459 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -129.27 140.39 51.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 110.165 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.4 t -123.35 123.16 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 29.5 mt-10 -109.48 121.07 44.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 99' ' ' GLU . 20.8 m -111.95 117.02 31.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 97' ' ' SER . 67.6 mt -123.31 128.21 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 45.6 m -107.99 135.59 49.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.528 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 13.8 t80 -158.39 127.36 5.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 65.89 37.48 93.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.99 8.22 60.87 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 17' ' ' PHE . 60.5 t -111.03 139.08 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -1.116 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 62.0 m -117.78 132.09 56.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.605 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 67.5 tp -110.9 149.14 31.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.3 mt -128.33 98.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 16.3 mtm180 -96.11 128.52 43.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 25.3 mtt180 -104.31 128.26 52.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 107' ' ' MET . 75.4 m -124.09 155.99 37.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.202 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -119.41 151.01 39.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 110.203 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 5' ' ' THR . 45.4 ttt180 -75.71 138.31 41.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.188 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.7 ' OXT' HG22 ' A' ' 125' ' ' VAL . 9.3 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.268 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 1.104 H213 HG21 ' A' ' 53' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.885 ' H42' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.229 0.538 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -78.4 -32.24 48.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 110.18 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 76.6 p -56.64 145.32 28.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.27 -174.06 18.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.1 m -109.85 130.25 55.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -1.136 . . . . 0.0 110.218 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.479 ' CD1' HD12 ' A' ' 40' ' ' ILE . 90.5 m95 -118.61 145.66 45.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.853 . . . . 0.0 110.25 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -127.97 118.94 24.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.181 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.554 HG21 ' HD2' ' A' ' 120' ' ' ARG . 48.9 t -64.35 136.35 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.945 . . . . 0.0 110.23 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 11.1 p90 -137.61 -19.14 1.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 110.224 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.705 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -137.22 134.28 36.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -0.925 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.705 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 5.1 mt-30 -149.0 162.76 39.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 110.158 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.502 ' O ' HD12 ' A' ' 118' ' ' LEU . 59.4 tt0 -134.12 144.85 48.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.415 ' ND2' ' OE1' ' A' ' 16' ' ' GLU . 4.3 t30 54.98 35.7 25.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.266 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -65.08 -49.23 70.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 0.0 110.199 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -60.88 -48.08 83.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.166 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 55.2 mt-10 -55.32 -46.2 76.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.591 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 43.5 t80 -52.86 -60.31 3.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.887 . . . . 0.0 110.271 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.764 HD22 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -50.83 -39.94 54.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.199 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -58.77 -36.81 74.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.245 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.18 -38.2 60.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.973 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.9 tp -56.57 -25.24 51.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.925 . . . . 0.0 110.19 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.973 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 84.99 18.1 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.764 HD12 HD22 ' A' ' 18' ' ' LEU . 15.3 mt -66.1 166.86 14.11 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 47.2 Cg_endo -73.04 133.31 19.52 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.019 1.536 . . . . 0.0 110.446 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.986 ' HA ' HD12 ' A' ' 28' ' ' ILE . 61.1 mm-40 -51.23 -46.41 62.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.197 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.09 -37.27 20.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.569 HD11 H232 ' A' ' 130' ' ' JN3 . 35.3 tp -80.1 -37.36 33.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.898 . . . . 0.0 110.288 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.986 HD12 ' HA ' ' A' ' 25' ' ' GLU . 45.6 mt -58.82 -54.75 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -56.9 -24.45 52.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.575 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 56.6 mtt -93.62 -18.39 22.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.233 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -105.45 -10.59 16.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.224 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -1.71 3.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -150.83 47.03 0.86 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.169 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 13.1 mt -125.0 109.0 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -84.1 88.13 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.169 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.2 Cg_endo -73.11 138.42 27.98 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.04 1.548 . . . . 0.0 110.45 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 38' ' ' VAL . 46.1 mt -89.78 164.56 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 110.178 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.552 HG21 HH22 ' A' ' 120' ' ' ARG . 75.9 t -141.79 119.98 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 110.287 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -101.83 135.91 42.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.205 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.487 ' CD1' ' HE1' ' A' ' 107' ' ' MET . 75.5 mt -121.32 129.78 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.15 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 43.7 tt0 -132.33 66.51 1.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.943 . . . . 0.0 110.228 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.919 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 37.6 tt0 -71.47 162.26 29.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.573 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 18.5 pttm -159.11 48.01 0.32 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.296 -0.878 . . . . 0.0 110.175 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.4 -103.16 0.78 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 60.2 m-20 -111.52 0.57 16.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -1.132 . . . . 0.0 110.167 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.728 ' OD1' HG23 ' A' ' 63' ' ' THR . 43.6 m-20 -104.18 150.35 24.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 110.267 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 1.168 ' CD2' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -130.88 135.46 47.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.42 105.75 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 110.219 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.746 HG11 ' H42' ' A' ' 131' ' ' JN3 . 62.6 t -109.07 135.18 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.257 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.766 ' OG1' HG23 ' A' ' 59' ' ' THR . 98.3 m -132.17 108.49 9.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.902 . . . . 0.0 110.163 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -90.1 132.77 35.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.9 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -127.94 122.72 33.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.264 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.848 HG21 H213 ' A' ' 130' ' ' JN3 . 0.6 OUTLIER -106.16 170.19 6.08 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.178 -0.951 . . . . 0.0 110.225 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.12 -17.73 24.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.066 1.561 . . . . 0.0 110.382 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -104.11 -22.69 13.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 0.0 110.176 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.592 ' O ' ' OG1' ' A' ' 53' ' ' THR . 14.7 pt20 -162.82 164.69 26.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.7 p -130.29 130.41 44.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.915 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.47 HG21 ' HG3' ' A' ' 73' ' ' MET . 61.6 t -128.86 126.27 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.766 HG23 ' OG1' ' A' ' 50' ' ' THR . 85.6 m -108.83 141.18 41.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.233 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.534 ' OD1' ' O ' ' A' ' 59' ' ' THR . 73.2 m-20 -137.11 151.61 49.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.4 m -146.58 132.07 18.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.673 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 41.2 p90 -145.24 170.13 16.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.918 . . . . 0.0 110.185 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.728 HG23 ' OD1' ' A' ' 46' ' ' ASP . 86.5 m -116.26 148.53 40.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.168 HD11 ' CD2' ' A' ' 47' ' ' PHE . 10.4 mt -80.17 124.25 28.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.72 6.67 49.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -145.82 148.76 33.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -1.082 . . . . 0.0 110.217 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -71.68 125.2 26.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.204 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.602 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -122.24 150.43 42.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 110.221 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -84.53 133.16 34.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 110.102 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.706 ' CD1' ' H62' ' A' ' 131' ' ' JN3 . 5.1 mm -126.38 146.71 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.221 -0.924 . . . . 0.0 110.175 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -121.44 135.03 55.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 110.232 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.666 HG23 H161 ' A' ' 131' ' ' JN3 . 0.2 OUTLIER -84.81 154.77 22.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.852 ' HE2' H122 ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -67.63 -15.04 63.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.223 -0.923 . . . . 0.0 110.176 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.454 ' HB3' H151 ' A' ' 130' ' ' JN3 . 3.0 p30 -85.52 -10.37 56.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.938 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.2 31.97 4.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.509 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 26.4 mttt -108.77 132.63 53.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.13 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -108.38 136.69 47.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.872 . . . . 0.0 110.203 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.909 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -165.49 156.94 14.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -105.56 165.12 11.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 0.0 110.224 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -175.15 137.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.293 -0.88 . . . . 0.0 110.178 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 m -95.52 99.89 11.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -0.894 . . . . 0.0 110.195 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.781 HG11 HD11 ' A' ' 89' ' ' LEU . 53.1 t -72.99 141.24 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 14.6 p80 -146.55 160.33 42.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.77 130.83 48.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 110.212 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.426 ' O ' ' HE2' ' A' ' 88' ' ' LYS . . . -137.46 133.37 34.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.1 t30 57.63 13.44 1.94 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.04 53.54 2.81 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.818 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 3.6 pttt -174.74 125.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -1.182 . . . . 0.0 110.214 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.781 HD11 HG11 ' A' ' 82' ' ' VAL . 4.1 tt -57.31 147.46 25.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.18 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 89' ' ' LEU . 78.9 t -157.57 109.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.971 ' CG2' ' HB3' ' A' ' 98' ' ' HIS . 10.0 t -106.39 107.93 19.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 110.21 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -97.53 151.99 19.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.146 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 1.4 m -144.86 -174.1 4.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 110.162 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 61.1 tt0 -99.0 38.49 1.38 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 94' ' ' GLU . 2.6 pttt 179.22 2.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.206 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.825 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.82 143.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 0.0 110.197 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -125.06 157.31 36.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.971 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 46.5 t-80 -144.79 143.16 30.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.203 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.473 ' CG ' HG22 ' A' ' 90' ' ' VAL . 17.1 tt0 -153.9 125.05 7.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.509 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 42.6 tt0 -125.83 158.93 33.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.895 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -156.68 156.94 34.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 110.148 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.437 HG23 ' CH2' ' A' ' 6' ' ' TRP . 10.0 p -120.84 140.35 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -132.82 89.14 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.1 -104.67 2.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.606 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 44.2 p-10 -117.79 7.39 12.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -1.123 . . . . 0.0 110.274 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.606 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 43.4 mt-10 -115.16 167.75 10.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.247 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.487 ' HE1' ' CD1' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -138.98 139.88 38.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 110.226 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.1 t -125.78 129.36 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 24.0 mt-10 -116.67 135.61 53.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.6 m -124.79 120.93 33.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.203 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 97' ' ' SER . 81.4 mt -126.76 135.88 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.246 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.498 HG22 HG23 ' A' ' 117' ' ' THR . 73.5 p -117.5 125.06 50.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.255 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.51 ' HD2' ' CB ' ' A' ' 96' ' ' PHE . 56.0 t80 -148.11 128.06 13.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -0.877 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.3 35.92 88.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.12 6.0 59.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 112' ' ' THR . 76.9 t -111.08 135.65 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -1.132 . . . . 0.0 110.199 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.498 HG23 HG22 ' A' ' 112' ' ' THR . 57.4 m -113.37 135.89 53.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.591 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 18.9 tp -115.03 141.29 48.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.55 108.63 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.554 ' HD2' HG21 ' A' ' 8' ' ' VAL . 26.8 ttp180 -104.92 124.54 49.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.16 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 9.4 mtm180 -103.72 124.96 49.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.423 ' OG ' HG22 ' A' ' 8' ' ' VAL . 56.9 m -119.57 161.39 20.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.277 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 34.7 tttm -127.76 155.81 43.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 110.249 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.4 ttt180 -80.27 134.68 36.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.9 . . . . 0.0 110.217 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.204 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 0.852 H122 ' HE2' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.967 H112 HG21 ' A' ' 91' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.235 0.54 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 87.6 m-85 -76.92 -31.31 56.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 110.185 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.4 p -54.99 143.34 26.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.915 . . . . 0.0 110.149 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.05 -173.61 17.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.7 m -107.94 131.71 54.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -1.191 . . . . 0.0 110.23 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.513 ' NE1' ' HE3' ' A' ' 107' ' ' MET . 89.9 m95 -119.72 134.82 55.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 110.223 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -117.45 118.79 33.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.915 . . . . 0.0 110.171 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.422 HG11 ' CD ' ' A' ' 11' ' ' GLN . 60.2 t -66.75 128.42 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.0 110.226 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 46.6 p90 -126.38 -24.19 3.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.433 ' C ' ' HG3' ' A' ' 11' ' ' GLN . . . -136.43 132.03 34.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.433 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 29.9 mt-30 -141.37 120.81 13.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.442 ' HG2' HD21 ' A' ' 13' ' ' ASN . 52.3 tt0 -98.96 144.33 28.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.222 -0.924 . . . . 0.0 110.19 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.442 HD21 ' HG2' ' A' ' 12' ' ' GLU . 23.4 m-80 56.59 18.35 3.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.224 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.462 ' O ' HD23 ' A' ' 18' ' ' LEU . 61.9 t80 -55.04 -44.46 74.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.853 . . . . 0.0 110.239 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -67.87 -45.08 75.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 44.0 mt-10 -57.47 -59.95 4.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.809 ' HD1' HD22 ' A' ' 18' ' ' LEU . 51.4 t80 -51.14 -56.54 12.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.197 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.829 HD11 ' H8 ' ' A' ' 130' ' ' JN3 . 4.0 mm? -54.73 -42.82 72.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 1.1 tmtm? -54.7 -37.32 65.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -30.6 70.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.919 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -57.56 -20.83 34.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.208 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.919 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 82.1 28.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.267 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.521 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 65.2 mt -73.48 167.4 35.12 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.94 . . . . 0.0 110.24 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 46.1 Cg_endo -73.02 136.05 24.17 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.416 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.423 ' HA ' HD12 ' A' ' 28' ' ' ILE . 43.4 mt-10 -52.11 -44.93 64.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.183 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.82 -27.07 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.18 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 23.2 tp -88.54 -21.7 23.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.871 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 82.9 mt -78.6 -41.76 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -74.72 -21.53 59.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 110.225 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.6 mtt -90.54 -30.62 17.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.179 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -104.52 4.24 32.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 110.197 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.871 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.89 -6.71 23.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.217 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -147.36 49.78 1.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 0.0 110.22 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.072 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.5 mt -123.9 117.72 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.566 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 2.1 mptt -90.0 86.72 0.19 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.072 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.05 133.44 19.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.95 1.5 . . . . 0.0 110.432 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.8 mt -86.2 158.45 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 80.5 t -137.74 118.94 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.245 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -98.84 133.45 43.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.181 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.47 HD12 ' CD1' ' A' ' 6' ' ' TRP . 67.5 mt -118.53 133.04 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.173 -0.954 . . . . 0.0 110.145 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -138.09 68.01 1.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.875 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.587 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 15.8 pt20 -71.69 167.7 19.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.213 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 43.0 mttt -160.43 47.26 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.197 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.74 -98.74 0.72 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 23.1 m-20 -111.5 -6.79 14.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 110.206 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.44 155.52 17.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.239 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.804 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.3 m-85 -138.98 135.98 34.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.39 109.71 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.617 HG21 ' H3 ' ' A' ' 131' ' ' JN3 . 76.6 t -111.1 134.05 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.905 . . . . 0.0 110.164 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.623 HG23 ' OG1' ' A' ' 59' ' ' THR . 49.5 m -129.39 106.94 9.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.238 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.4 m -87.72 135.59 33.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.241 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -128.74 114.7 16.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.2 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.931 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -102.88 168.31 9.01 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.205 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.714 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.09 -22.01 19.88 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.946 1.498 . . . . 0.0 110.433 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.619 ' HD2' HD11 ' A' ' 34' ' ' ILE . 15.5 mtp-105 -99.66 -20.96 16.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.276 -0.89 . . . . 0.0 110.178 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.472 ' O ' ' OG1' ' A' ' 53' ' ' THR . 15.7 pt20 -168.24 160.25 11.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.7 p -128.98 134.76 48.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.21 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -132.45 130.04 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.204 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.623 ' OG1' HG23 ' A' ' 50' ' ' THR . 88.4 m -110.26 138.26 46.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.457 ' OD1' ' CG2' ' A' ' 71' ' ' THR . 67.8 m-20 -134.57 156.0 49.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -151.17 126.29 9.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.749 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 44.0 p90 -139.33 176.08 9.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.1 m -120.49 147.01 45.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 110.254 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.804 HD11 ' CD1' ' A' ' 47' ' ' PHE . 21.1 mt -81.04 123.59 28.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 110.271 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.54 2.59 40.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -145.6 148.79 33.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 110.238 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -70.91 131.03 43.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.248 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -132.36 144.06 50.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.185 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 14.1 p-10 -73.82 141.6 46.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.879 . . . . 0.0 110.225 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.774 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 2.4 mm -136.28 141.61 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 110.244 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.457 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 4.0 t -113.86 132.79 55.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.242 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.788 HG23 H161 ' A' ' 131' ' ' JN3 . 0.2 OUTLIER -83.97 160.0 21.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 110.256 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.826 ' HE3' H122 ' A' ' 130' ' ' JN3 . 13.3 ttm -68.49 -19.27 64.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -83.29 -12.88 56.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.75 28.11 5.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.447 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 5.4 mttm -101.38 133.73 45.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -1.146 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -109.71 132.71 53.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.249 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.813 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -163.59 160.25 22.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -104.94 160.92 14.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.282 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -170.86 138.91 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.154 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 m -96.95 99.4 10.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.885 . . . . 0.0 110.276 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.658 HG13 HD21 ' A' ' 89' ' ' LEU . 47.4 t -69.0 140.74 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.523 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 19.5 p80 -146.62 154.08 41.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.25 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.7 mt -98.13 129.6 44.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.185 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.37 143.71 34.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 110.166 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.74 13.18 0.98 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 110.186 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.22 48.04 5.25 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.752 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -172.17 134.15 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 110.22 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.658 HD21 HG13 ' A' ' 82' ' ' VAL . 1.9 tt -61.31 145.77 50.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.879 HG22 ' HG3' ' A' ' 99' ' ' GLU . 87.2 t -153.78 109.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 97.6 m -102.75 103.16 13.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 110.191 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -100.42 156.21 17.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.915 . . . . 0.0 110.208 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.587 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 2.9 t -147.36 -163.65 1.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.228 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.682 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 32.4 tt0 -101.85 33.85 2.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.328 -0.857 . . . . 0.0 110.113 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 8.6 ptmt -177.97 7.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.886 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -179.65 141.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.223 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 111' ' ' ILE . 47.9 m -118.99 156.96 28.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.618 ' CD2' H122 ' A' ' 131' ' ' JN3 . 54.2 t-80 -140.11 143.4 36.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 110.26 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.879 ' HG3' HG22 ' A' ' 90' ' ' VAL . 17.9 tt0 -158.28 119.16 3.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 110.271 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 9.5 tt0 -123.94 158.72 31.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 110.248 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.458 ' HA ' ' CE1' ' A' ' 2' ' ' PHE . 28.2 tt0 -157.95 152.69 25.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.24 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.439 ' HB ' ' HE2' ' A' ' 107' ' ' MET . 10.6 p -117.7 142.91 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -129.75 90.71 3.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.05 -113.34 3.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -105.73 3.83 29.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 110.191 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -112.22 160.55 17.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.513 ' HE3' ' NE1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -130.02 140.09 50.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.21 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.2 t -127.58 122.31 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 110.178 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 19.8 mt-10 -104.23 128.1 51.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.186 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' GLU . 50.6 m -120.4 114.38 21.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.872 . . . . 0.0 110.23 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' SER . 60.9 mt -126.12 136.59 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.229 -0.919 . . . . 0.0 110.237 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 88.2 m -112.34 134.55 53.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.209 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.613 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 15.9 t80 -157.56 128.44 6.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 0.0 110.167 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 65.43 36.65 92.88 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.88 13.44 66.42 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 112' ' ' THR . 72.8 t -116.94 136.92 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -1.163 . . . . 0.0 110.18 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.3 m -114.09 131.76 56.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.641 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 61.5 tp -109.91 146.45 35.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.0 mt -129.12 94.11 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 110.259 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.654 ' NH1' ' H12' ' A' ' 130' ' ' JN3 . 18.1 mtm180 -90.47 129.08 36.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 0.0 110.206 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 84.7 mtt180 -105.19 125.91 51.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.2 m -122.64 150.88 42.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -118.64 156.71 28.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 110.201 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -83.55 135.52 34.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.193 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 0.829 ' H8 ' HD11 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.813 H181 HD11 ' A' ' 78' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.245 0.545 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -75.82 -29.78 58.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.198 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.88 143.26 38.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.231 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.59 -172.71 19.36 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.7 m -110.65 131.77 54.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -1.093 . . . . 0.0 110.221 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.48 ' CE2' ' HE3' ' A' ' 107' ' ' MET . 92.3 m95 -119.28 143.28 47.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -125.73 117.79 24.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.239 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.432 HG22 ' OG ' ' A' ' 122' ' ' SER . 47.8 t -66.01 130.28 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.191 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 11.7 p90 -129.71 -18.98 3.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.494 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -139.37 134.87 33.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.498 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.8 pt20 -146.8 118.23 7.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -95.95 150.34 20.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 53.38 22.68 2.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.423 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 59.6 t80 -57.82 -45.07 86.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.201 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.28 -54.01 20.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -47.43 -64.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.586 ' HA ' HG11 ' A' ' 116' ' ' VAL . 45.5 t80 -48.06 -43.83 30.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.336 -0.852 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.49 HD21 H191 ' A' ' 130' ' ' JN3 . 17.0 mt -62.76 -45.15 94.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.945 . . . . 0.0 110.191 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -52.33 -33.31 42.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.69 -34.12 73.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.219 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.781 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -60.02 -21.16 60.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.264 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.781 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 73.06 45.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.014 HD22 ' HD2' ' A' ' 24' ' ' PRO . 5.7 mt -86.08 169.27 15.93 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.014 ' HD2' HD22 ' A' ' 23' ' ' LEU . 46.0 Cg_endo -73.11 135.4 22.86 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.031 1.542 . . . . 0.0 110.466 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -56.39 -26.55 53.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.92 . . . . 0.0 110.178 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.94 -38.07 82.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.93 . . . . 0.0 110.263 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.535 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 66.2 tp -83.87 -40.84 18.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 24' ' ' PRO . 63.1 mt -57.78 -51.36 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 33.1 mmtt -61.67 -29.61 70.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 60.1 ttm -84.75 -23.79 29.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 0.0 110.228 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.628 ' HB1' H183 ' A' ' 130' ' ' JN3 . . . -101.88 11.37 38.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.903 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 29' ' ' LYS . 30.1 ptt180 -79.0 -2.58 40.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.208 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -151.66 44.91 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.915 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 21.1 mt -123.34 113.12 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 89.41 0.43 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.207 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.915 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.08 143.21 35.65 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.016 1.535 . . . . 0.0 110.403 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 38' ' ' VAL . 21.3 mt -89.24 162.9 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.206 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.418 ' N ' HG22 ' A' ' 37' ' ' ILE . 98.3 t -141.28 119.44 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.159 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -100.05 138.94 36.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.9 . . . . 0.0 110.2 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.463 ' CD1' ' HE1' ' A' ' 107' ' ' MET . 60.2 mt -123.93 132.37 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 110.181 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -138.19 69.42 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.699 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 4.6 pt20 -75.03 173.63 10.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.699 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 71.4 mttt -165.53 48.64 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 110.189 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.23 -99.25 0.76 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 27.6 m-20 -111.69 -4.54 14.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 0.0 110.216 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -101.43 149.74 23.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.914 . . . . 0.0 110.232 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.748 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.1 m-85 -133.24 137.11 45.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.1 t -124.9 108.55 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.165 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.781 HG11 ' H42' ' A' ' 131' ' ' JN3 . 81.6 t -110.1 134.64 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.877 . . . . 0.0 110.212 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.0 m -132.57 107.37 8.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.902 . . . . 0.0 110.186 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.4 m -87.16 135.5 33.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 110.215 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -128.78 120.83 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.209 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.881 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -107.14 168.48 7.96 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.222 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.79 ' HD2' HG22 ' A' ' 53' ' ' THR . 45.8 Cg_endo -73.03 -19.73 22.68 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.949 1.499 . . . . 0.0 110.407 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -106.26 -20.06 13.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.85 . . . . 0.0 110.203 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.573 ' NE2' ' HG2' ' A' ' 73' ' ' MET . 13.6 pt20 -163.38 158.96 21.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.169 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 p -132.33 131.53 42.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.32 131.35 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 110.195 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 59' ' ' THR . 13.7 t -112.25 136.83 51.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 110.242 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -133.05 149.4 52.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -141.17 130.05 23.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.936 . . . . 0.0 110.248 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.72 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 37.6 p90 -143.93 169.46 17.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.7 m -118.34 146.76 44.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.748 HD11 ' CD1' ' A' ' 47' ' ' PHE . 17.8 mt -76.29 125.83 29.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 0.0 110.19 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.48 10.25 57.05 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -145.43 138.03 25.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -1.171 . . . . 0.0 110.218 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -67.39 122.81 18.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.166 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . . . -127.09 142.04 51.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -0.919 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -71.22 144.69 50.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.226 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.873 HD12 ' H62' ' A' ' 131' ' ' JN3 . 16.7 mm -134.88 142.79 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.225 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.3 m -115.56 132.22 56.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.227 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.726 HG23 H161 ' A' ' 131' ' ' JN3 . 0.2 OUTLIER -86.74 161.15 18.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.255 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.759 ' HE3' H122 ' A' ' 130' ' ' JN3 . 8.9 ttm -69.85 -20.84 63.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.721 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -79.34 -16.23 56.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.885 . . . . 0.0 110.186 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.87 23.01 6.98 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -96.58 138.47 34.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -1.136 . . . . 0.0 110.191 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -114.11 131.32 56.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.182 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.774 HD11 H181 ' A' ' 131' ' ' JN3 . 0.5 OUTLIER -163.27 156.51 19.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.232 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -100.61 150.98 22.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 110.254 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.0 133.42 8.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.3 m -95.25 101.01 12.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.801 HG13 HD21 ' A' ' 89' ' ' LEU . 45.1 t -72.21 139.8 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.646 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 8.1 p-80 -139.21 156.04 47.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mp -100.19 131.44 46.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.96 116.65 13.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.887 . . . . 0.0 110.195 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 65.8 t30 60.1 28.06 17.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.671 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.15 48.01 10.29 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.872 ' HD2' ' OE2' ' A' ' 101' ' ' GLU . 3.4 mtpt -159.44 119.27 3.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -1.141 . . . . 0.0 110.221 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.801 HD21 HG13 ' A' ' 82' ' ' VAL . 5.2 tt -66.8 140.67 57.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 110.215 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.746 HG13 ' HG2' ' A' ' 99' ' ' GLU . 45.5 t -149.34 120.76 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.548 HG21 H111 ' A' ' 131' ' ' JN3 . 68.8 m -112.87 95.52 5.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -90.18 165.35 14.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.265 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 7.3 t -157.61 -162.54 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.543 ' N ' ' OG ' ' A' ' 93' ' ' SER . 41.6 tt0 -105.28 31.56 4.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 110.309 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 8.8 ptpt -172.6 1.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.906 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER 179.22 144.29 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 110.258 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 111' ' ' ILE . 46.2 m -119.27 159.99 23.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.261 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.538 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 13.1 t60 -143.31 139.06 29.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.249 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.746 ' HG2' HG13 ' A' ' 90' ' ' VAL . 52.4 mt-10 -151.33 129.27 11.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.905 . . . . 0.0 110.161 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 28.4 tt0 -132.7 153.8 50.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.872 ' OE2' ' HD2' ' A' ' 88' ' ' LYS . 57.6 tt0 -153.49 156.86 38.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.274 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.418 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.4 p -121.09 137.72 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -127.93 92.74 3.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.4 -107.34 2.62 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -113.81 8.61 17.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -1.198 . . . . 0.0 110.227 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -117.24 158.7 23.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.48 ' HE3' ' CE2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -129.94 142.21 50.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.253 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 121' ' ' ARG . 91.1 t -128.19 125.7 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 0.0 110.223 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 31.4 mt-10 -108.4 126.96 53.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.211 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' GLU . 37.2 m -117.34 116.62 27.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' SER . 66.9 mt -125.71 129.58 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 50.7 m -106.52 139.68 40.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.169 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.606 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 11.7 t80 -161.48 126.36 3.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 66.63 38.2 93.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.2 8.46 58.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 17' ' ' PHE . 60.2 t -110.89 141.52 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -1.165 . . . . 0.0 110.217 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.2 m -117.73 130.75 56.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.893 . . . . 0.0 110.233 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.586 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 64.2 tp -110.01 148.33 31.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.208 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 92.0 mt -128.91 98.91 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.201 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.68 ' NH1' ' H12' ' A' ' 130' ' ' JN3 . 13.7 mtm180 -93.41 124.48 37.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 46.7 mtm-85 -102.66 127.83 49.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.432 ' OG ' HG22 ' A' ' 8' ' ' VAL . 75.5 m -125.54 160.18 30.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.912 . . . . 0.0 110.223 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -123.97 157.06 35.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.157 -0.964 . . . . 0.0 110.223 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' THR . 15.4 ttt85 -81.75 133.37 35.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.224 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.205 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 0.759 H122 ' HE3' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.873 ' H62' HD12 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.312 0.577 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 101' ' ' GLU . 90.3 m-85 -75.23 -30.96 60.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.1 m -56.5 145.59 27.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.22 -178.15 16.66 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 63.6 m -103.77 132.14 50.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -1.175 . . . . 0.0 110.195 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.584 ' NE1' ' HE1' ' A' ' 107' ' ' MET . 99.2 m95 -121.06 144.64 48.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -126.72 117.29 22.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.889 . . . . 0.0 110.116 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.427 HG11 ' CD ' ' A' ' 11' ' ' GLN . 48.8 t -64.6 126.06 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 13.3 p90 -125.98 -21.05 4.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.167 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -138.26 133.62 33.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' CD ' HG11 ' A' ' 8' ' ' VAL . 43.2 mt-30 -145.25 114.6 7.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.195 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.44 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.0 tt0 -92.04 144.01 25.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.937 . . . . 0.0 110.197 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 21.3 m120 57.44 17.51 3.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.922 . . . . 0.0 110.215 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.866 ' CE1' HD11 ' A' ' 18' ' ' LEU . 81.9 t80 -53.59 -47.75 69.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.197 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -66.28 -47.84 72.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 36.2 mt-10 -55.78 -62.3 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.717 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 62.7 t80 -47.24 -57.89 4.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.268 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.996 HD21 H191 ' A' ' 130' ' ' JN3 . 7.7 mt -57.14 -44.32 83.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.326 -0.859 . . . . 0.0 110.192 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 9.8 ttmm -46.93 -40.73 14.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.231 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.69 65.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.889 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.1 tp -56.81 -19.56 17.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.889 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.22 27.85 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.154 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.477 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 58.8 mt -74.21 166.67 42.7 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.221 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.13 138.87 28.68 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.026 1.54 . . . . 0.0 110.415 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -58.74 -41.02 85.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -56.19 -26.2 49.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.001 HD11 H232 ' A' ' 130' ' ' JN3 . 44.3 tp -93.12 -18.83 22.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.606 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 90.4 mt -82.68 -42.47 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.235 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.31 -32.67 66.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.56 -32.81 36.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.217 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -97.2 5.98 49.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.606 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.31 -5.3 13.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 110.204 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.403 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 7.4 p-10 -149.23 52.61 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.226 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.139 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.7 mt -122.86 114.86 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.28 83.62 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.189 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.139 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.5 Cg_endo -73.03 131.59 17.01 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.109 1.584 . . . . 0.0 110.411 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.5 mt -86.11 155.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.5 t -135.25 118.54 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 110.238 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.477 ' O ' HD13 ' A' ' 40' ' ' ILE . 22.5 tt0 -97.43 137.61 36.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.591 HD12 HG22 ' A' ' 49' ' ' VAL . 50.6 mm -124.75 129.02 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.224 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -129.28 74.18 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 110.184 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.668 ' OE1' ' CZ ' ' A' ' 47' ' ' PHE . 57.8 tt0 -69.86 166.3 19.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.193 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 36.8 mtmt -165.34 44.86 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.171 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.03 -105.25 1.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -107.63 -2.42 20.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -1.135 . . . . 0.0 110.224 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -102.28 148.72 25.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 110.189 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.775 ' CD1' HD11 ' A' ' 64' ' ' LEU . 1.9 m-85 -131.03 135.06 47.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.292 -0.88 . . . . 0.0 110.152 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.8 t -120.19 108.99 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.923 HG11 ' H42' ' A' ' 131' ' ' JN3 . 73.5 t -110.04 129.95 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.433 HG22 ' HE3' ' A' ' 52' ' ' LYS . 92.7 m -129.56 105.38 8.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 110.268 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 m -89.55 137.52 32.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.88 . . . . 0.0 110.222 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.433 ' HE3' HG22 ' A' ' 50' ' ' THR . 44.2 mttt -130.47 112.8 13.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.168 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.682 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -95.7 168.63 10.48 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.173 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.417 ' CD ' HG23 ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.12 -17.14 24.97 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.018 1.536 . . . . 0.0 110.434 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -106.55 -18.41 13.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.682 ' O ' ' OG1' ' A' ' 53' ' ' THR . 14.2 pt20 -167.84 161.63 13.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.1 p -128.53 135.82 49.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.99 126.9 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.209 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 t -109.92 139.56 44.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 110.147 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -136.2 147.93 47.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.254 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -139.49 130.54 26.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.242 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.912 ' CE1' HG21 ' A' ' 82' ' ' VAL . 34.2 p90 -144.42 173.15 12.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.228 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.0 m -120.19 143.35 48.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.298 -0.876 . . . . 0.0 110.126 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.775 HD11 ' CD1' ' A' ' 47' ' ' PHE . 30.8 mt -74.34 127.17 32.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.172 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.88 -1.4 57.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -136.34 145.11 45.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -1.135 . . . . 0.0 110.231 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -68.91 125.42 26.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.609 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -125.65 151.52 46.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -82.27 133.95 35.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.925 . . . . 0.0 110.187 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.881 HD12 ' H62' ' A' ' 131' ' ' JN3 . 18.9 mm -125.94 145.65 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 110.252 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -121.04 135.13 55.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.925 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.706 HG23 H161 ' A' ' 131' ' ' JN3 . 0.2 OUTLIER -85.28 157.46 20.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 0.0 110.238 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.759 ' HG2' H222 ' A' ' 130' ' ' JN3 . 0.2 OUTLIER -68.87 -16.98 63.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 110.25 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.596 ' OD1' HD22 ' A' ' 27' ' ' LEU . 15.9 t0 -84.13 -11.49 56.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.09 30.3 4.84 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.594 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 27.7 mttt -104.03 132.07 50.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -1.138 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -107.18 135.02 49.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.285 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.766 HD11 H181 ' A' ' 131' ' ' JN3 . 0.8 OUTLIER -166.01 158.9 15.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.163 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -104.88 147.16 28.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.467 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.2 m -151.04 139.19 20.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -103.25 88.64 3.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.182 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.042 HG11 HD11 ' A' ' 89' ' ' LEU . 16.9 t -52.73 157.03 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 110.271 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.68 144.51 19.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.252 -0.905 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.649 HD13 HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -99.85 105.09 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.243 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.93 150.91 44.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.153 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 52.57 15.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.242 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.84 40.17 12.48 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.673 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 9.2 ptpt -163.54 133.0 4.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -1.127 . . . . 0.0 110.169 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.042 HD11 HG11 ' A' ' 82' ' ' VAL . 5.5 tt -61.42 145.07 52.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.206 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.657 HG13 ' HG3' ' A' ' 99' ' ' GLU . 41.4 t -150.48 111.42 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 87.4 m -106.96 97.95 7.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.232 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 14.9 ptpt -95.45 162.78 13.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 110.193 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.5 t -152.42 -164.47 1.96 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -102.21 33.34 3.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 0.0 110.231 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.1 pttt -174.98 2.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.18 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.99 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER 178.56 143.14 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.643 ' O ' HG23 ' A' ' 111' ' ' ILE . 50.7 m -116.85 164.91 13.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 0.0 110.209 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.825 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 17.9 t60 -146.84 141.24 26.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.825 ' HG3' ' O ' ' A' ' 98' ' ' HIS . 4.3 mp0 -153.58 128.29 9.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 0.0 110.213 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 9.8 tt0 -131.89 157.4 44.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.443 ' HA ' ' CE2' ' A' ' 2' ' ' PHE . 36.7 tt0 -156.32 154.28 30.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.06 142.57 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.185 -0.947 . . . . 0.0 110.131 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -136.74 95.04 3.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 110.2 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.9 -110.76 3.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -114.62 12.62 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -1.149 . . . . 0.0 110.216 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -119.24 157.83 27.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.584 ' HE1' ' NE1' ' A' ' 6' ' ' TRP . 2.2 tpp -127.96 140.49 51.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.234 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.7 t -127.48 124.5 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 120' ' ' ARG . 23.5 mt-10 -109.35 118.26 36.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.567 ' N ' ' O ' ' A' ' 99' ' ' GLU . 41.3 m -108.76 118.65 37.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 110.253 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 97' ' ' SER . 53.6 mt -127.76 132.64 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.164 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 76.6 m -108.52 139.54 43.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.672 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 10.9 t80 -161.19 127.06 3.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 65.48 38.59 94.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 67.92 12.31 62.21 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 17' ' ' PHE . 63.4 t -114.57 138.27 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 110.168 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.6 m -115.02 131.49 56.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.263 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.717 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 63.8 tp -111.41 151.06 28.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 110.242 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.9 mt -129.39 94.1 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.484 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 64.8 mtp180 -87.27 124.09 32.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.192 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 65.3 mtt180 -104.72 125.15 50.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 74.3 m -124.29 152.93 42.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -115.39 156.12 26.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 110.215 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 5' ' ' THR . 32.3 ttt180 -82.61 136.04 34.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.196 -179.981 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 1.001 H232 HD11 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.923 ' H42' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.194 0.521 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -77.28 -35.07 55.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 110.248 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.89 144.38 44.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.16 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.59 176.19 14.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 42.3 p -103.48 134.05 47.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -1.108 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.467 ' CZ3' ' HG3' ' A' ' 107' ' ' MET . 86.0 m95 -122.46 142.96 50.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.226 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -123.31 118.51 27.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.488 HG13 ' HG2' ' A' ' 120' ' ' ARG . 51.0 t -64.61 127.74 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.285 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 47.6 p90 -128.41 -28.19 2.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.92 . . . . 0.0 110.25 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' HB2' ' CD2' ' A' ' 9' ' ' TYR . . . -132.84 133.76 43.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.175 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.593 ' NE2' ' CG ' ' A' ' 14' ' ' TYR . 15.4 pt20 -146.62 118.61 8.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -97.11 148.99 22.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.148 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 m120 53.08 21.89 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 110.218 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.943 ' CE1' HD11 ' A' ' 18' ' ' LEU . 86.6 t80 -60.12 -42.95 95.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 110.236 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.625 ' HG3' ' N ' ' A' ' 16' ' ' GLU . 14.2 pt-20 -69.55 -45.59 68.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 110.169 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.625 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 41.8 mt-10 -57.67 -60.37 3.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.713 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 52.2 t80 -51.65 -53.64 36.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.023 HD21 H191 ' A' ' 130' ' ' JN3 . 8.9 mt -59.38 -47.23 86.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 110.19 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -48.46 -38.74 20.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.917 . . . . 0.0 110.175 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.22 -25.07 65.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.946 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.5 tp -60.37 -18.74 52.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.232 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.946 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 82.61 26.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 23' ' ' LEU . 24.2 mt -72.91 163.14 70.61 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 110.231 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.493 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.9 Cg_endo -73.03 140.16 30.94 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.022 1.538 . . . . 0.0 110.442 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -56.02 -44.67 78.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -51.42 -36.53 44.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.16 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.493 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 20.8 tp -83.01 -23.34 33.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.685 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 35.0 mt -75.23 -40.98 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 9.3 mtmt -76.43 -22.84 54.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.214 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.6 mtt -87.92 -27.24 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.948 . . . . 0.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -104.73 4.72 32.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.174 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.859 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 21.1 ptt180 -70.69 1.53 5.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -0.914 . . . . 0.0 110.206 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.859 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 1.5 m-20 -153.82 42.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.254 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.907 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 7.1 mt -121.38 117.06 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -94.06 89.25 0.42 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.251 -0.905 . . . . 0.0 110.221 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.907 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.09 138.07 27.44 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.0 1.526 . . . . 0.0 110.408 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.1 mt -87.51 161.42 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.922 . . . . 0.0 110.182 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.87 120.98 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -101.6 138.27 38.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.507 HD12 ' HE3' ' A' ' 107' ' ' MET . 75.5 mt -124.95 132.79 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.888 . . . . 0.0 110.23 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -137.14 72.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.614 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 1.1 pt20 -76.42 169.65 17.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.211 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 75.7 mttt -161.26 46.71 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 110.239 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.18 -97.88 0.64 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -112.03 -6.84 14.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.153 . . . . 0.0 110.207 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.561 ' OD1' HG23 ' A' ' 63' ' ' THR . 49.4 m-20 -99.8 152.71 19.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.917 . . . . 0.0 110.157 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.652 ' CE1' HD11 ' A' ' 64' ' ' LEU . 2.1 m-85 -136.34 137.96 41.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.62 109.6 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.21 -0.931 . . . . 0.0 110.229 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.728 HG11 ' H42' ' A' ' 131' ' ' JN3 . 64.1 t -111.19 134.41 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.186 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.672 ' OG1' HG23 ' A' ' 59' ' ' THR . 91.3 m -131.14 109.91 10.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -90.42 135.11 33.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -127.51 122.11 32.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.208 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.815 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.58 168.87 7.19 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.239 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.757 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.05 -17.54 24.8 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.059 1.557 . . . . 0.0 110.466 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.464 ' HD3' ' HB3' ' A' ' 56' ' ' GLN . 1.8 tmt_? -105.57 -24.09 12.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.186 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.485 ' OE1' ' HG2' ' A' ' 73' ' ' MET . 2.5 pt20 -162.88 164.34 26.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.232 -0.918 . . . . 0.0 110.216 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.2 p -132.12 128.23 37.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 110.192 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.48 132.76 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.93 . . . . 0.0 110.222 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.672 HG23 ' OG1' ' A' ' 50' ' ' THR . 28.7 m -112.56 136.54 51.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 110.246 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -133.03 150.58 52.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.174 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.4 m -143.08 137.51 29.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.202 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.889 ' CD1' HG21 ' A' ' 82' ' ' VAL . 32.5 p90 -150.04 162.01 41.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.561 HG23 ' OD1' ' A' ' 46' ' ' ASP . 90.7 m -112.2 143.54 43.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.652 HD11 ' CE1' ' A' ' 47' ' ' PHE . 14.1 mt -69.16 124.79 24.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.54 19.03 53.74 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' C ' HG23 ' A' ' 81' ' ' THR . 91.2 mttt -150.89 138.9 20.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -1.191 . . . . 0.0 110.152 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -72.05 135.51 46.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 0.0 110.188 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.46 146.75 42.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.233 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 13.9 p-10 -76.27 141.4 41.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.168 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.95 HD13 H191 ' A' ' 131' ' ' JN3 . 74.7 mt -140.31 145.93 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 p -111.83 147.34 35.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.194 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.641 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -98.6 158.6 15.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.213 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.677 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 10.5 ttm -68.13 -17.16 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.564 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 3.1 p30 -87.5 -18.28 30.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.86 26.76 4.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.641 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 19.4 mttt -101.59 133.4 46.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -1.111 . . . . 0.0 110.226 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -110.67 134.99 51.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.757 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -165.44 161.38 18.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -104.55 151.51 23.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.2 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.495 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 0.9 OUTLIER -155.23 140.53 17.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.203 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.441 HG23 ' C ' ' A' ' 66' ' ' LYS . 6.1 m -102.4 86.37 2.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.209 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.889 HG21 ' CD1' ' A' ' 62' ' ' PHE . 11.5 t -52.75 152.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.885 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.14 148.25 32.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.512 HD12 HD13 ' A' ' 64' ' ' LEU . 1.6 mt -102.19 105.02 15.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.67 132.27 55.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.211 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.7 t30 45.68 39.53 5.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.887 . . . . 0.0 110.217 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.36 42.62 95.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.661 ' HD3' ' CD ' ' A' ' 101' ' ' GLU . 25.3 mttt -150.04 119.38 6.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -1.104 . . . . 0.0 110.189 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.801 HD21 HG13 ' A' ' 82' ' ' VAL . 1.5 tt -68.87 133.2 47.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.815 HG22 ' HG3' ' A' ' 99' ' ' GLU . 20.7 t -139.78 120.85 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.559 HG21 H111 ' A' ' 131' ' ' JN3 . 87.9 m -113.76 94.66 4.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.2 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 46.7 pttt -94.25 163.13 13.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.272 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 28.6 t -150.23 -154.66 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.206 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.49 ' N ' ' OG ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -107.04 22.55 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.17 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -165.41 6.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.201 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 1.018 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.86 139.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 111' ' ' ILE . 16.0 t -112.38 165.29 12.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.61 ' CD2' H122 ' A' ' 131' ' ' JN3 . 42.5 t-80 -149.5 136.46 19.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.815 ' HG3' HG22 ' A' ' 90' ' ' VAL . 33.3 tt0 -152.05 128.58 10.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.9 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.702 HE21 ' HG2' ' A' ' 109' ' ' GLU . 11.9 tt0 -132.43 160.52 36.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.179 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.661 ' CD ' ' HD3' ' A' ' 88' ' ' LYS . 82.3 tt0 -155.89 150.12 25.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.225 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.77 142.16 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 110.215 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -133.73 93.35 3.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 110.196 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.5 -108.39 2.78 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -114.26 8.73 16.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -1.119 . . . . 0.0 110.197 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -115.49 154.78 28.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.923 . . . . 0.0 110.164 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.507 ' HE3' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -125.5 141.91 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.19 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.1 t -128.68 122.16 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.702 ' HG2' HE21 ' A' ' 100' ' ' GLN . 27.1 mt-10 -105.42 121.75 44.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.223 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.665 ' N ' ' O ' ' A' ' 99' ' ' GLU . 19.6 m -112.61 116.04 29.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 97' ' ' SER . 52.2 mt -126.47 132.1 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 77.0 m -108.95 137.26 47.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.92 . . . . 0.0 110.225 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 11.6 t80 -159.56 126.52 4.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.94 32.79 77.92 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.46 9.65 78.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 17' ' ' PHE . 52.2 t -113.37 141.68 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -1.123 . . . . 0.0 110.246 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.3 m -115.85 134.26 55.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.192 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.713 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 16.9 tp -112.67 140.04 47.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 118' ' ' LEU . 58.1 mt -122.48 98.38 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.488 ' HG2' HG13 ' A' ' 8' ' ' VAL . 6.1 ttp180 -93.59 124.96 37.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 110.244 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 32.9 mtm180 -103.07 122.82 45.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 6' ' ' TRP . 73.6 m -120.44 150.42 40.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -114.91 151.63 33.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 110.19 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.1 ttt180 -74.87 133.31 41.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.189 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 1.023 H191 HD21 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.95 H191 HD13 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.227 0.537 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -76.03 -28.01 57.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.207 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 p -57.79 144.47 38.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.8 -176.05 18.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.5 m -108.14 134.24 51.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -1.093 . . . . 0.0 110.215 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.549 ' CH2' HG23 ' A' ' 102' ' ' VAL . 98.8 m95 -121.12 139.2 53.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.179 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -121.89 125.6 46.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.239 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.651 HG12 ' HD3' ' A' ' 120' ' ' ARG . 19.4 m -62.34 123.35 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.212 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -134.27 2.77 3.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 110.223 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 121' ' ' ARG . . . -163.03 120.79 1.97 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -147.08 164.85 31.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 110.206 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' O ' HD12 ' A' ' 118' ' ' LEU . 39.8 tt0 -135.97 153.58 51.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 48.27 38.08 9.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -67.06 -49.31 65.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.188 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -61.8 -46.4 89.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 61.3 mt-10 -55.15 -42.93 73.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.195 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 55.2 t80 -55.41 -57.67 10.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 110.278 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.725 HD22 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -50.78 -38.89 50.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 110.195 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 33.2 mttp -60.33 -38.8 84.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.262 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.63 -40.94 69.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.981 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.0 tp -54.68 -26.22 32.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.893 . . . . 0.0 110.23 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.981 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 86.64 18.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.725 HD12 HD22 ' A' ' 18' ' ' LEU . 16.5 mt -66.69 170.31 6.17 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.175 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 46.8 Cg_endo -73.09 132.96 18.86 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.123 1.591 . . . . 0.0 110.41 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.675 ' HA ' HD12 ' A' ' 28' ' ' ILE . 25.6 tp10 -51.94 -47.91 64.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.225 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -48.42 -35.62 13.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 110.241 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.529 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 41.6 tp -79.54 -33.4 41.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.17 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.675 HD12 ' HA ' ' A' ' 25' ' ' GLU . 85.6 mt -61.95 -52.22 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.193 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.408 ' HE2' ' HG3' ' A' ' 25' ' ' GLU . 17.5 mttm -59.08 -26.1 64.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -0.913 . . . . 0.0 110.179 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.462 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 12.1 ttm -91.8 -23.12 19.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.629 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -101.29 -5.94 24.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -3.72 16.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -147.62 43.43 1.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.049 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 18.0 mt -120.49 109.93 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 110.206 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HA ' HG21 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -90.48 86.59 0.2 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 0.0 110.198 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.049 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.6 Cg_endo -73.14 146.42 40.95 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.069 1.562 . . . . 0.0 110.443 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 38' ' ' VAL . 12.2 mt -91.17 162.29 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.227 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' N ' HG22 ' A' ' 37' ' ' ILE . 79.4 t -138.36 120.75 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -103.45 134.58 46.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.533 HD12 ' CD1' ' A' ' 6' ' ' TRP . 68.8 mt -120.67 131.7 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 37.0 tt0 -135.95 73.09 1.45 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 110.215 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.532 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -76.12 164.1 26.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.201 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 59.6 mttt -158.71 49.84 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.42 -101.85 1.01 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -110.91 1.11 17.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -1.131 . . . . 0.0 110.174 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 42.2 t0 -108.23 144.02 36.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 110.265 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.692 ' CD1' HD11 ' A' ' 64' ' ' LEU . 3.6 m-85 -127.29 143.51 51.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.897 . . . . 0.0 110.248 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.6 t -132.35 106.92 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.178 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.538 HG21 ' C3 ' ' A' ' 131' ' ' JN3 . 92.4 t -108.82 134.88 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.243 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.765 ' OG1' HG23 ' A' ' 59' ' ' THR . 87.1 m -131.91 109.51 10.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.217 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.0 m -92.1 132.72 36.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.257 -0.902 . . . . 0.0 110.093 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -126.17 128.32 47.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.28 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.806 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -111.11 169.76 5.97 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.0 110.273 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.13 -8.87 22.74 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.005 1.529 . . . . 0.0 110.403 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -117.39 -20.84 8.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.607 ' O ' ' OG1' ' A' ' 53' ' ' THR . 16.2 pt20 -162.43 160.5 26.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.883 . . . . 0.0 110.17 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 p -131.09 131.15 43.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 73' ' ' MET . 57.4 t -127.7 129.35 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.194 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.765 HG23 ' OG1' ' A' ' 50' ' ' THR . 62.3 m -112.26 139.75 47.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -135.09 152.06 51.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.903 . . . . 0.0 110.19 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.4 t -148.38 131.15 16.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.225 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.773 ' CE1' ' H5 ' ' A' ' 131' ' ' JN3 . 50.5 p90 -143.51 171.55 13.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.929 . . . . 0.0 110.151 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.2 m -119.8 140.88 50.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.692 HD11 ' CD1' ' A' ' 47' ' ' PHE . 17.5 mt -74.41 127.67 33.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 110.202 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.42 4.4 56.18 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -145.05 145.07 31.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -1.154 . . . . 0.0 110.205 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.44 123.96 22.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.221 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.591 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.89 150.74 44.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 12.0 p-10 -86.39 140.65 29.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.761 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 12.1 mm -130.15 144.42 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -116.56 131.77 56.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.194 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.663 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 73.0 p -86.04 158.16 19.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.907 ' HE2' H122 ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -70.01 -13.76 62.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.729 ' HB3' H151 ' A' ' 130' ' ' JN3 . 3.6 p30 -86.28 -16.92 36.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 110.22 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.53 27.7 4.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.663 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 22.1 mttt -105.06 131.36 52.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -107.84 135.83 48.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.26 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.622 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -164.22 159.38 20.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 110.195 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 83.4 mttt -105.93 171.01 7.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 110.256 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 27.6 p -179.88 136.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 m -95.34 103.43 15.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.197 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.707 HG13 HD21 ' A' ' 89' ' ' LEU . 43.2 t -76.77 140.54 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 110.244 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.647 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 35.0 p-80 -139.44 156.6 46.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.209 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 84' ' ' LEU . 53.8 mt -101.41 132.15 47.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.164 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -135.77 117.97 15.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.22 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 57.84 31.39 20.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 110.231 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.634 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 72.24 49.78 19.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.675 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 51.1 mtpt -158.57 117.21 3.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.8 HD22 ' H22' ' A' ' 131' ' ' JN3 . 4.5 tt -65.77 140.28 58.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.193 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.906 HG22 ' CG ' ' A' ' 99' ' ' GLU . 97.8 t -146.69 117.0 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 99.8 m -110.97 94.8 5.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 110.223 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -88.45 161.7 16.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.231 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 96' ' ' PHE . 30.2 t -157.47 -177.13 6.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.918 . . . . 0.0 110.237 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 84.1 tt0 -95.26 33.46 1.56 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.902 . . . . 0.0 110.184 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.541 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 10.8 ptpt -173.5 -2.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.837 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -176.96 146.62 0.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.2 m -123.13 156.87 34.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.154 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.696 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 17.6 t60 -140.23 134.56 31.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.906 ' CG ' HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -149.07 125.14 10.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.857 . . . . 0.0 110.21 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.745 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 10.0 tt0 -131.94 156.47 46.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.675 ' OE1' ' HE3' ' A' ' 88' ' ' LYS . 76.8 tt0 -151.65 159.55 43.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.549 HG23 ' CH2' ' A' ' 6' ' ' TRP . 10.9 p -122.65 137.23 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -132.16 93.3 3.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.53 -106.77 2.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -117.67 10.79 13.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -1.147 . . . . 0.0 110.165 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -118.43 160.79 21.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.195 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.536 ' SD ' ' OE1' ' A' ' 100' ' ' GLN . 28.5 ttm -134.58 142.08 46.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.221 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 74.2 t -125.62 128.65 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 110.24 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.745 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 15.7 mt-10 -115.87 136.17 53.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.211 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 99' ' ' GLU . 3.1 t -126.27 122.61 36.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.183 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.29 133.01 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 89.6 m -113.27 133.87 54.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.157 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 21' ' ' LEU . 26.1 t80 -154.82 122.58 5.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 110.227 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.94 35.5 65.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.39 5.39 63.0 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 112' ' ' THR . 70.2 t -111.05 135.76 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -1.162 . . . . 0.0 110.23 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.2 m -112.93 135.43 53.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.577 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 23.5 tp -115.76 139.57 50.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.04 120.18 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.651 ' HD3' HG12 ' A' ' 8' ' ' VAL . 5.5 ttm105 -115.39 119.18 35.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 110.219 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 84.4 mtt180 -99.94 125.15 45.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.428 ' HB3' ' HB3' ' A' ' 6' ' ' TRP . 11.4 m -120.54 152.03 38.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.22 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -113.58 152.51 30.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 5' ' ' THR . 31.8 ttt180 -78.96 136.91 37.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.196 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.146 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 0.907 H122 ' HE2' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.8 ' H22' HD22 ' A' ' 89' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.616 ' O ' HG11 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.211 0.529 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.56 ' HA ' HG21 ' A' ' 102' ' ' VAL . 64.4 m-85 -84.02 -38.47 20.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 110.251 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.4 p -58.78 145.26 41.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.275 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.06 -178.99 16.78 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 85.0 m -104.05 132.04 50.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -1.154 . . . . 0.0 110.193 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.691 ' CD1' HD12 ' A' ' 40' ' ' ILE . 88.4 m95 -121.73 142.7 49.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.895 . . . . 0.0 110.164 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.01 122.32 38.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 110.212 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.55 124.16 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.204 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 38.1 p90 -124.94 -32.43 3.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.194 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.01 127.16 41.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.261 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 23.0 pt20 -141.48 117.72 10.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.589 ' O ' HD12 ' A' ' 118' ' ' LEU . 41.4 tt0 -96.19 144.25 26.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.219 -0.926 . . . . 0.0 110.279 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' GLU . 12.9 t30 60.79 14.63 5.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.841 ' CE1' HD11 ' A' ' 18' ' ' LEU . 60.5 t80 -50.98 -53.75 30.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 110.315 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.8 -49.1 76.27 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 34.1 mt-10 -55.05 -58.98 5.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 110.236 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.73 ' CD2' HD22 ' A' ' 118' ' ' LEU . 63.9 t80 -50.56 -54.73 20.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.027 HD21 H191 ' A' ' 130' ' ' JN3 . 4.4 mt -59.18 -41.18 87.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -50.09 -39.54 42.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.51 -27.53 65.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.909 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -59.71 -19.69 51.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.99 27.57 0.31 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 23' ' ' LEU . 37.4 mt -74.32 164.2 62.92 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.335 -0.853 . . . . 0.0 110.186 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.554 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -73.13 140.8 31.63 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.066 1.561 . . . . 0.0 110.391 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.89 -41.11 90.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.156 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.6 -27.39 49.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.554 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 42.2 tp -91.74 -18.91 23.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.188 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.7 mt -85.01 -40.93 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -73.83 -30.87 62.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.181 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 51.6 ttm -82.57 -30.83 29.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.838 . . . . 0.0 110.234 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -99.17 3.97 46.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 110.206 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.679 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -64.5 -10.19 23.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.232 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.679 ' OD2' ' HD2' ' A' ' 32' ' ' ARG . 69.2 m-20 -143.93 55.96 1.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.21 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 1.8 mt -126.32 114.41 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -86.32 83.06 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 110.232 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.21 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.7 Cg_endo -73.07 131.52 16.85 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.029 1.542 . . . . 0.0 110.389 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -87.52 153.59 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 110.246 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.48 118.44 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.215 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -96.78 131.9 43.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.229 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.691 HD12 ' CD1' ' A' ' 6' ' ' TRP . 74.0 mt -117.36 135.49 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.193 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -138.01 68.01 1.41 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.503 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -71.04 163.28 27.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 110.221 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 86.4 mttt -158.3 45.99 0.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.18 -97.85 0.67 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 52.3 m-20 -112.18 -3.7 14.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -1.181 . . . . 0.0 110.202 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.809 ' OD1' HG23 ' A' ' 63' ' ' THR . 38.3 m-20 -106.85 148.96 27.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 34.3 m-85 -131.88 148.79 52.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -127.27 99.74 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 110.164 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.668 HG11 ' H42' ' A' ' 131' ' ' JN3 . 59.7 t -102.13 132.65 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.865 . . . . 0.0 110.206 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 58.7 m -134.03 108.78 8.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.214 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 m -93.65 134.3 36.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 110.244 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -127.03 127.08 44.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.663 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 62.3 p -109.29 170.03 5.82 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.945 . . . . 0.0 110.204 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.652 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 46.7 Cg_endo -73.06 -5.57 17.43 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -120.7 -23.85 5.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.663 ' O ' ' OG1' ' A' ' 53' ' ' THR . 4.5 pt20 -161.43 165.89 28.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.175 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.2 p -132.6 130.8 40.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.161 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.652 HG21 ' HA ' ' A' ' 73' ' ' MET . 48.9 t -127.37 126.21 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 14.7 t -111.06 146.39 36.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.894 ' OD1' HG22 ' A' ' 71' ' ' THR . 10.8 m-80 -139.63 142.91 37.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.85 . . . . 0.0 110.15 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -139.58 135.05 32.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.19 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.742 ' CE1' HG11 ' A' ' 82' ' ' VAL . 54.1 p90 -148.06 170.78 17.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.809 HG23 ' OD1' ' A' ' 46' ' ' ASP . 91.3 m -116.78 151.05 37.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.236 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.504 HD11 ' CA ' ' A' ' 83' ' ' HIS . 3.5 tp -82.66 120.07 25.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.244 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.85 9.61 34.44 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -148.53 147.08 28.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -1.154 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -68.76 126.72 30.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -126.14 148.01 49.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.313 -0.867 . . . . 0.0 110.173 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -84.3 138.36 32.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.787 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 11.4 mm -128.21 145.07 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 110.185 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.894 HG22 ' OD1' ' A' ' 60' ' ' ASN . 5.1 t -119.72 131.32 55.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 73.1 p -84.22 160.89 20.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.652 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -74.15 -12.52 60.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.117 -0.989 . . . . 0.0 110.226 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.667 ' HB3' H151 ' A' ' 130' ' ' JN3 . 4.9 p-10 -89.35 -9.54 50.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.52 51.39 1.21 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.584 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 9.3 tttt -129.63 128.46 42.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -1.132 . . . . 0.0 110.197 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -104.53 141.04 37.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.656 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -168.72 156.32 7.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 110.248 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 13.7 mttm -105.41 165.86 10.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.217 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.9 p -178.05 139.95 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 p -94.46 107.95 19.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 0.0 110.22 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.809 HG13 HD21 ' A' ' 89' ' ' LEU . 48.1 t -79.47 140.38 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.568 ' CE1' ' HB ' ' A' ' 90' ' ' VAL . 30.9 p80 -145.03 161.54 39.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.426 HD11 ' HZ ' ' A' ' 47' ' ' PHE . 16.5 mt -103.61 134.35 47.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -136.91 120.44 17.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 110.235 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 86.7 m-20 58.72 31.7 21.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.578 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 72.83 44.07 39.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.788 ' HD3' ' OE2' ' A' ' 101' ' ' GLU . 10.0 mtmt -156.39 121.66 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -1.164 . . . . 0.0 110.152 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.812 HD22 ' H22' ' A' ' 131' ' ' JN3 . 4.2 tt -66.73 136.04 54.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.897 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.683 HG13 ' HG2' ' A' ' 99' ' ' GLU . 69.2 t -142.34 117.27 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 75.0 m -109.99 95.3 5.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 110.244 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -91.55 154.43 19.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.215 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.4 t -145.84 -163.95 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.158 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -102.69 33.08 3.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.2 OUTLIER -175.52 2.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.919 . . . . 0.0 110.187 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.823 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -178.73 148.42 0.42 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 0.0 110.184 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.605 ' O ' HG23 ' A' ' 111' ' ' ILE . 41.8 m -123.75 159.89 28.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 19.8 t60 -142.21 142.92 32.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.915 . . . . 0.0 110.251 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.683 ' HG2' HG13 ' A' ' 90' ' ' VAL . 47.6 mt-10 -155.73 123.2 5.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.143 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.425 ' CG ' ' HG2' ' A' ' 109' ' ' GLU . 11.6 tt0 -129.23 159.07 37.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.202 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.788 ' OE2' ' HD3' ' A' ' 88' ' ' LYS . 57.6 tt0 -157.09 156.83 33.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 110.208 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.616 HG11 ' O ' ' A' ' 1' ' ' ALA . 39.8 t -118.98 139.18 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -134.96 89.78 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.216 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.83 -102.59 2.48 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -123.09 10.72 9.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -1.122 . . . . 0.0 110.22 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -115.84 151.68 34.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.543 ' HG2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -121.74 137.01 54.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.4 t -125.29 120.56 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.425 ' HG2' ' CG ' ' A' ' 100' ' ' GLN . 35.4 mt-10 -109.01 118.71 37.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.567 ' N ' ' O ' ' A' ' 99' ' ' GLU . 63.4 m -107.97 116.61 32.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.266 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 97' ' ' SER . 54.0 mt -125.4 131.46 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.226 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 32.7 m -109.69 134.47 51.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.59 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 12.8 t80 -157.42 128.16 6.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.21 33.83 74.32 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.08 11.73 70.77 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 112' ' ' THR . 78.0 t -116.26 138.36 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -1.135 . . . . 0.0 110.202 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 63.2 m -113.27 132.48 55.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.73 HD22 ' CD2' ' A' ' 17' ' ' PHE . 29.5 tp -113.02 152.09 29.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.89 . . . . 0.0 110.244 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.9 mt -129.65 94.98 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.172 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -87.76 126.61 35.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 91.0 mtt180 -106.88 124.96 50.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.214 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.2 m -122.66 149.4 44.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -115.55 150.76 36.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 110.177 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' THR . 23.2 ttt85 -74.99 132.95 41.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.445 HG13 ' OXT' ' A' ' 125' ' ' VAL . 7.9 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.191 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 1.027 H191 HD21 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.812 ' H22' HD22 ' A' ' 89' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.188 0.518 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -77.06 -27.85 54.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 57.2 m -59.17 148.52 31.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 110.266 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.63 163.83 13.93 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.434 ' OG1' ' HB ' ' A' ' 125' ' ' VAL . 20.5 p -78.3 155.52 30.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -1.159 . . . . 0.0 110.16 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.598 ' CH2' HG23 ' A' ' 102' ' ' VAL . 96.7 m95 -141.93 127.64 19.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.983 ' HB3' ' HG2' ' A' ' 123' ' ' LYS . 6.1 tt0 -94.63 146.34 24.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.187 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 36' ' ' PRO . 38.6 t -67.37 112.32 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.259 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 1.355 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 2.1 m-85 -72.86 -69.52 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.895 . . . . 0.0 110.252 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.961 ' H ' ' HG3' ' A' ' 121' ' ' ARG . . . -149.07 170.76 17.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.26 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.703 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 3.1 mp0 -148.43 112.25 5.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.238 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 54.6 tt0 -91.8 150.93 20.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.19 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 14' ' ' TYR . 23.6 m-20 52.49 19.12 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 7.4 t80 -42.85 -65.31 0.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.135 -0.978 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' GLU . 47.2 mt-10 -47.88 -57.33 5.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.212 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 5.7 mm-40 -41.83 -49.88 4.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.469 ' CD2' HD22 ' A' ' 118' ' ' LEU . 12.6 t80 -52.04 -63.3 1.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.791 ' CD2' HD12 ' A' ' 23' ' ' LEU . 7.6 mt -44.49 -44.46 8.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.275 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 22.8 mttm -52.72 -37.93 59.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.03 -40.08 63.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.22 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.883 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -57.51 -25.22 59.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 110.231 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.883 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.6 23.22 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 110.162 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.791 HD12 ' CD2' ' A' ' 18' ' ' LEU . 15.5 mt -71.54 170.12 13.11 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.209 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.3 Cg_endo -73.11 139.32 29.46 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.067 1.562 . . . . 0.0 110.374 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 5.6 pt-20 -59.93 -46.74 88.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 110.238 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' A' ' 24' ' ' PRO . 2.6 p30 -47.34 -34.67 7.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.194 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 18.4 tp -88.97 -32.25 17.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.228 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.669 HG12 HD13 ' A' ' 18' ' ' LEU . 72.8 mt -70.61 -49.16 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 110.177 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -63.63 -32.07 73.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 110.164 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.1 ttp -84.33 -11.77 55.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 110.159 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.502 ' HB1' H183 ' A' ' 130' ' ' JN3 . . . -111.2 3.81 18.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.258 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.568 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 9.4 ptt180 -68.29 -3.21 10.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.182 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 81.0 m-20 -146.91 51.46 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.897 . . . . 0.0 110.178 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.817 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 11.6 mt -126.54 113.49 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.224 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -98.49 85.27 0.4 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.172 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.0 ' HB3' HG23 ' A' ' 53' ' ' THR . 46.6 Cg_endo -73.05 154.69 52.72 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.983 1.517 . . . . 0.0 110.44 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.536 HG22 ' N ' ' A' ' 38' ' ' VAL . 6.3 mt -95.32 169.31 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.193 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.536 ' N ' HG22 ' A' ' 37' ' ' ILE . 75.1 t -145.64 118.24 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.248 -0.907 . . . . 0.0 110.225 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -98.31 147.19 24.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 3' ' ' SER . 65.4 mt -133.96 125.23 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -127.15 80.07 1.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.868 . . . . 0.0 110.177 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.752 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 41.1 tt0 -78.77 162.62 26.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.187 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 34.3 mmtt -159.22 46.28 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.248 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.15 -96.73 0.66 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -116.59 3.11 13.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -1.137 . . . . 0.0 110.157 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 40.5 t0 -107.98 139.28 42.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.93 . . . . 0.0 110.249 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.929 ' CE2' HD11 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -120.61 135.61 55.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.38 103.16 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 110.154 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.754 HG11 ' H42' ' A' ' 131' ' ' JN3 . 60.0 t -106.08 129.03 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.157 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.922 ' OG1' HG23 ' A' ' 59' ' ' THR . 57.5 m -130.23 107.9 9.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.5 m -89.57 128.08 35.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.158 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.459 ' CA ' HG22 ' A' ' 57' ' ' THR . 52.2 mtmt -120.75 124.09 44.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.16 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.0 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.56 169.07 6.93 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.223 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.881 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.7 Cg_endo -73.04 -16.81 25.4 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.997 1.525 . . . . 0.0 110.483 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -111.95 -20.79 11.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.58 ' O ' ' OG1' ' A' ' 53' ' ' THR . 2.0 tt0 -160.95 155.32 23.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.459 HG22 ' CA ' ' A' ' 52' ' ' LYS . 4.3 p -131.46 137.54 48.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.167 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.8 t -133.65 132.04 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.908 . . . . 0.0 110.243 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.922 HG23 ' OG1' ' A' ' 50' ' ' THR . 17.1 m -111.79 137.31 49.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 110.205 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.473 ' HB3' ' CD1' ' A' ' 70' ' ' ILE . 31.2 m-20 -132.38 155.77 47.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.932 . . . . 0.0 110.214 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 t -152.32 127.42 9.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.2 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.771 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 34.5 p90 -141.99 174.02 10.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.314 -0.867 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 27.7 m -118.38 150.71 39.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.929 HD11 ' CE2' ' A' ' 47' ' ' PHE . 5.6 mt -78.58 125.2 29.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.74 10.1 58.06 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -142.36 141.12 32.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -1.165 . . . . 0.0 110.173 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.8 124.87 25.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 0.0 110.22 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.479 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -125.35 149.29 48.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 0.0 110.27 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -82.15 139.08 34.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 110.138 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.774 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 4.4 mm -132.78 144.74 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 0.0 110.218 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -116.74 137.6 52.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.247 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.723 HG23 H161 ' A' ' 131' ' ' JN3 . 0.2 OUTLIER -87.15 156.98 19.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.189 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.904 ' HE3' H122 ' A' ' 130' ' ' JN3 . 13.7 ttm -66.89 -16.36 64.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 110.256 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.67 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -86.56 -9.66 55.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.229 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.96 33.74 4.55 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.568 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 28.3 mttt -107.27 133.31 52.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -109.45 136.53 48.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.668 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -169.04 157.97 8.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.152 -0.968 . . . . 0.0 110.22 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 9.7 mtmt -102.29 172.06 7.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 110.227 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.3 p -178.65 137.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 110.154 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.0 m -97.04 99.75 11.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.683 HG13 HD21 ' A' ' 89' ' ' LEU . 46.1 t -72.84 139.03 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.235 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.64 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 11.4 p-80 -138.58 161.26 37.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 84' ' ' LEU . 26.4 mt -105.63 132.12 52.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.262 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.62 115.61 13.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.218 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 59.8 t30 59.38 31.82 21.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.426 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 73.77 43.91 33.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.426 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 85.9 mttt -152.58 120.78 6.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -1.133 . . . . 0.0 110.177 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.713 HD22 ' H22' ' A' ' 131' ' ' JN3 . 7.4 tt -72.54 133.11 44.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.698 HG22 ' HG3' ' A' ' 99' ' ' GLU . 99.0 t -141.55 122.83 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.918 . . . . 0.0 110.198 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 54.6 m -113.85 92.48 3.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 62.1 pttt -87.46 162.35 17.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 110.208 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 28.3 t -155.8 -164.44 1.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 110.181 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' N ' ' OG ' ' A' ' 93' ' ' SER . 40.7 tt0 -103.99 31.56 4.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.92 . . . . 0.0 110.183 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -172.65 -2.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.144 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.804 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -173.7 147.99 1.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.185 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 111' ' ' ILE . 70.9 m -124.82 154.33 41.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.515 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 20.3 t60 -141.6 140.36 33.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.698 ' HG3' HG22 ' A' ' 90' ' ' VAL . 29.5 tt0 -152.15 127.52 9.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 110.186 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 13.8 tt0 -130.2 150.43 51.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.229 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -148.2 154.08 39.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 110.253 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.598 HG23 ' CH2' ' A' ' 6' ' ' TRP . 13.2 p -119.69 131.86 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -126.76 93.09 3.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.882 . . . . 0.0 110.201 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.76 -95.74 1.26 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -126.52 15.74 7.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -1.162 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -123.73 150.75 44.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 110.206 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 121' ' ' ARG . 8.2 tpp -125.79 140.14 52.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.885 . . . . 0.0 110.172 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.02 124.46 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 110.256 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 33.6 mt-10 -115.25 123.7 49.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.9 m -111.99 123.16 49.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 97' ' ' SER . 73.7 mt -129.09 128.43 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.904 . . . . 0.0 110.197 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 90.1 m -111.93 133.49 54.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 110.223 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 5.8 t80 -156.0 122.38 5.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.245 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.07 32.54 58.42 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.41 1.43 65.03 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.1 t -108.5 141.31 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -1.131 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.5 m -119.57 130.99 55.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.249 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.469 HD22 ' CD2' ' A' ' 17' ' ' PHE . 59.0 tp -110.43 140.84 44.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 85.4 mt -114.61 105.29 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -106.26 119.03 38.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -0.962 . . . . 0.0 110.196 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.961 ' HG3' ' H ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -102.49 136.87 41.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 1.4 m -123.71 140.1 53.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.278 -0.889 . . . . 0.0 110.205 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 1.355 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 15.4 ptmt -99.81 146.35 26.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.511 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 68.7 ttt180 -77.43 135.95 38.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.434 ' HB ' ' OG1' ' A' ' 5' ' ' THR . 64.7 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.21 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 0.904 H122 ' HE3' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.774 ' H8 ' HG21 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.25 0.547 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.433 ' HA ' ' CE ' ' A' ' 107' ' ' MET . 85.0 m-85 -77.67 -31.19 52.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -57.12 147.22 25.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.63 163.93 13.06 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 25.2 m -80.79 150.93 29.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 110.193 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.701 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 97.5 m95 -136.61 130.96 33.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.206 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.967 ' O ' ' HA ' ' A' ' 122' ' ' SER . 32.4 tt0 -95.73 144.59 26.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.201 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 36' ' ' PRO . 21.7 t -66.61 119.96 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.905 . . . . 0.0 110.181 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 1.154 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.9 OUTLIER -80.94 -68.68 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 110.256 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.921 ' H ' ' HG3' ' A' ' 121' ' ' ARG . . . -150.33 169.6 21.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 110.236 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -146.44 110.59 5.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.487 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 9.5 mm-40 -88.55 155.07 19.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.716 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 68.3 m-20 47.38 21.35 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 110.165 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 4.4 t80 -46.19 -61.86 1.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' GLU . 67.0 mt-10 -51.27 -57.77 7.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.716 ' OE1' ' HA ' ' A' ' 13' ' ' ASN . 6.7 mp0 -41.7 -49.59 4.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -50.28 -62.8 1.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.247 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.619 HD13 HG12 ' A' ' 28' ' ' ILE . 9.2 mt -44.98 -47.35 11.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 90.4 mttt -49.4 -39.09 31.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.133 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.14 -38.4 63.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.174 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.917 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.3 tp -58.98 -24.81 63.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.239 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.917 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 80.25 22.49 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.713 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 6.6 mt -71.39 170.91 10.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 110.194 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.713 ' HD2' ' CD2' ' A' ' 23' ' ' LEU . 46.1 Cg_endo -72.99 138.07 27.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.004 1.528 . . . . 0.0 110.446 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -59.47 -40.76 87.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.212 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -53.24 -33.49 53.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.9 HD11 H232 ' A' ' 130' ' ' JN3 . 52.1 tp -85.65 -35.41 20.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.619 HG12 HD13 ' A' ' 18' ' ' LEU . 96.2 mt -63.26 -52.09 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -59.52 -29.61 68.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.192 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 96.2 mtp -86.37 -12.8 48.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.235 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.711 ' HB1' H183 ' A' ' 130' ' ' JN3 . . . -111.51 -3.62 15.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.888 . . . . 0.0 110.242 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -63.64 -6.61 5.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -147.2 55.21 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.82 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 16.5 mt -130.46 114.2 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -98.24 85.79 0.42 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.984 ' HB3' HG23 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.07 149.34 46.33 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.996 1.524 . . . . 0.0 110.426 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.621 HG22 ' N ' ' A' ' 38' ' ' VAL . 19.8 mt -89.51 175.25 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.235 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.621 ' N ' HG22 ' A' ' 37' ' ' ILE . 61.0 t -152.92 119.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -101.13 152.0 21.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 110.249 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.488 HD12 ' HE3' ' A' ' 107' ' ' MET . 58.2 mt -139.46 130.3 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.42 ' HB3' ' HB ' ' A' ' 48' ' ' VAL . 59.7 tt0 -130.1 72.36 1.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 110.207 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.697 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 56.4 tt0 -66.45 173.64 3.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.245 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.697 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 8.3 mtmt -171.49 35.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.234 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.1 -100.25 0.57 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -111.47 -0.86 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -1.151 . . . . 0.0 110.21 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 39.5 t0 -107.32 146.76 31.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.182 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.767 ' CE1' HD11 ' A' ' 64' ' ' LEU . 4.5 m-85 -127.53 139.52 52.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 65.7 t -120.91 101.99 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.208 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.898 HG11 ' H42' ' A' ' 131' ' ' JN3 . 68.8 t -103.93 130.75 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.193 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 85.5 m -133.31 105.42 6.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.89 . . . . 0.0 110.207 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -86.03 132.0 34.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HA ' HG22 ' A' ' 57' ' ' THR . 57.4 mttt -124.72 122.98 39.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.984 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -109.53 168.09 8.19 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.735 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.06 -5.99 18.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.966 1.508 . . . . 0.0 110.412 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -122.45 -18.41 6.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.19 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.445 ' O ' ' OG1' ' A' ' 53' ' ' THR . 5.8 pt20 -164.6 158.69 18.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 52' ' ' LYS . 11.6 p -133.94 133.52 41.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.895 . . . . 0.0 110.21 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.53 132.84 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.214 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 13.5 t -115.28 138.71 50.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -0.912 . . . . 0.0 110.163 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -135.35 151.93 50.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 110.277 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.2 t -141.37 132.42 26.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.167 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.796 ' CE1' HG21 ' A' ' 82' ' ' VAL . 33.6 p90 -146.64 169.98 17.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 58.1 m -117.81 153.85 32.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -0.929 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.767 HD11 ' CE1' ' A' ' 47' ' ' PHE . 8.0 mt -82.71 122.84 28.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.91 -3.16 55.7 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -132.98 148.63 52.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -1.148 . . . . 0.0 110.197 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.46 ' OE2' ' HB3' ' A' ' 79' ' ' LYS . 5.4 tm-20 -73.68 133.18 43.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.247 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -133.33 148.63 51.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.168 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 15.2 p-10 -78.14 135.1 37.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.898 . . . . 0.0 110.246 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.906 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 17.1 mm -127.92 143.53 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.172 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p -118.47 139.86 50.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.206 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.724 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 29.3 p -93.54 158.0 15.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.233 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.622 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 0.7 OUTLIER -68.54 -11.44 59.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.2 -0.937 . . . . 0.0 110.226 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.822 ' HB3' H151 ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -87.54 -17.78 31.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 110.256 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.86 29.48 4.07 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.724 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 28.5 mttt -105.07 136.03 45.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 8.4 ptpp? -111.57 133.25 53.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.629 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -163.29 162.26 25.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 110.238 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 35.4 mttt -105.28 151.03 24.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.42 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.2 m -152.88 139.3 18.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.229 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.01 90.56 3.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.881 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.847 HG13 HD21 ' A' ' 89' ' ' LEU . 39.3 t -58.71 152.23 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.276 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -146.59 152.25 38.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.546 HD12 HD13 ' A' ' 64' ' ' LEU . 1.3 mt -105.58 102.31 11.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.87 132.44 54.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.1 t30 45.61 38.18 3.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.411 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 66.73 41.03 93.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.411 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 89.8 mttt -147.68 125.68 12.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -1.149 . . . . 0.0 110.212 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.847 HD21 HG13 ' A' ' 82' ' ' VAL . 6.2 tt -75.23 132.55 41.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.782 HG13 ' HG2' ' A' ' 99' ' ' GLU . 43.4 t -137.84 123.76 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.898 . . . . 0.0 110.241 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.543 HG21 H111 ' A' ' 131' ' ' JN3 . 55.3 m -119.7 88.69 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.448 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 16.1 ptmt -85.65 171.52 11.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.183 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 15.1 t -160.03 -161.24 0.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.177 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.491 ' N ' ' OG ' ' A' ' 93' ' ' SER . 23.1 mt-10 -106.15 34.49 3.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 110.202 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.449 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 7.4 ptpt -177.49 -0.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.892 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -175.76 146.85 0.76 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -120.74 157.89 28.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 22.2 t60 -142.58 138.51 30.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.285 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.782 ' HG2' HG13 ' A' ' 90' ' ' VAL . 44.2 mt-10 -149.59 128.2 12.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.917 . . . . 0.0 110.208 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.609 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 53.6 tt0 -128.67 155.31 45.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 9.5 mp0 -154.82 148.91 25.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 102' ' ' VAL . 12.1 p -116.18 137.04 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 110.299 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -131.65 95.54 3.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.22 -98.02 1.46 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -126.25 12.08 7.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.254 -1.145 . . . . 0.0 110.196 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -118.71 156.05 29.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -0.914 . . . . 0.0 110.151 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.488 ' HE3' HD12 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -129.02 140.84 51.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.201 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.3 t -127.66 125.66 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.22 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.406 ' HG3' ' HG3' ' A' ' 100' ' ' GLN . 27.9 mt-10 -114.84 132.64 56.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.0 m -121.37 122.75 40.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.216 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 97' ' ' SER . 56.8 mt -129.75 133.92 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 75.1 p -113.93 136.47 52.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 0.0 110.203 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 4.6 t80 -157.36 122.75 4.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.875 . . . . 0.0 110.217 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.61 36.11 62.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.74 1.86 55.2 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 112' ' ' THR . 53.0 t -106.7 143.47 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -1.155 . . . . 0.0 110.174 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.447 HG23 HG22 ' A' ' 112' ' ' THR . 85.8 m -121.46 129.39 52.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.487 ' CD1' ' O ' ' A' ' 12' ' ' GLU . 63.0 tp -108.37 145.02 35.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.3 mt -119.03 103.31 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.214 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -102.61 114.18 28.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.921 ' HG3' ' H ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -102.09 137.94 39.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.967 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 5.9 m -125.5 161.88 26.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 110.223 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 1.154 ' HB2' ' CE2' ' A' ' 9' ' ' TYR . 51.8 tttt -128.57 157.55 40.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 110.225 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 5' ' ' THR . 45.2 ttt180 -89.95 135.52 33.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.209 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.565 HG11 ' OE1' ' A' ' 7' ' ' GLN . 33.8 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 0.9 H232 HD11 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.906 ' H8 ' HG21 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.258 0.551 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.432 ' CE2' ' HA ' ' A' ' 101' ' ' GLU . 80.5 m-85 -81.09 -30.89 34.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.179 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.1 p -57.82 148.5 25.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.68 164.79 13.03 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 21.6 m -82.58 145.95 29.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -1.151 . . . . 0.0 110.202 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.645 ' CH2' HG23 ' A' ' 102' ' ' VAL . 98.1 m95 -129.88 130.36 45.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.851 ' HB2' ' HG2' ' A' ' 123' ' ' LYS . 65.1 mt-30 -103.26 117.72 35.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.897 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 36' ' ' PRO . 16.9 t -35.95 134.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.236 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 1.476 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -99.46 -57.47 2.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 110.192 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 1.324 ' HB3' ' NE ' ' A' ' 121' ' ' ARG . . . -158.52 163.97 36.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 110.255 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.599 ' HB2' ' CG ' ' A' ' 14' ' ' TYR . 1.8 pt20 -137.26 106.17 5.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.77 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 39.4 tt0 -94.87 126.48 40.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.801 ' OD1' ' OE1' ' A' ' 16' ' ' GLU . 12.1 t30 77.91 -4.02 2.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.867 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.75 ' CE1' HD21 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -29.9 -72.72 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 110.222 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 14' ' ' TYR . 46.4 mt-10 -39.52 -61.15 0.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.801 ' OE1' ' OD1' ' A' ' 13' ' ' ASN . 28.6 mt-10 -42.93 -55.86 3.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.215 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.625 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 77.1 t80 -52.82 -46.6 67.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.85 -44.33 86.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.234 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -52.33 -42.18 63.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 110.154 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.99 -31.16 69.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 110.235 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.844 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.7 tp -65.3 -17.14 64.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 75.48 27.54 1.03 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.157 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.725 HD11 HD23 ' A' ' 21' ' ' LEU . 41.6 mt -76.57 163.66 64.54 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.172 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -73.09 138.62 28.37 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.999 1.526 . . . . 0.0 110.39 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -55.38 -38.3 68.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 110.25 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 30' ' ' MET . 44.5 t0 -59.24 -27.61 65.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.229 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.994 HD11 H232 ' A' ' 130' ' ' JN3 . 52.5 tp -90.7 -32.59 16.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 110.171 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.629 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.7 mt -69.74 -45.62 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 110.195 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -70.31 -19.9 63.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.416 ' HE2' ' NH2' ' A' ' 55' ' ' ARG . 90.1 mmm -91.47 -29.17 17.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 110.154 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.637 ' HB1' H183 ' A' ' 130' ' ' JN3 . . . -102.31 -1.59 30.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.211 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.629 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 2.4 ppt_? -65.51 -10.55 35.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.175 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 10.3 t0 -141.65 47.7 1.65 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.12 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mt -121.22 113.13 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.78 81.28 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.25 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.12 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.9 Cg_endo -73.06 142.39 34.39 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.921 1.485 . . . . 0.0 110.371 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 38' ' ' VAL . 6.6 mt -88.64 164.62 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.261 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.445 ' N ' HG22 ' A' ' 37' ' ' ILE . 55.5 t -141.52 109.93 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.236 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -89.25 137.66 32.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.276 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.442 HD12 ' CD1' ' A' ' 6' ' ' TRP . 82.1 mt -125.04 127.36 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.198 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -127.43 70.48 1.32 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.6 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 57.0 tt0 -68.57 164.41 21.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.231 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 37.3 mttt -162.73 46.11 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.95 -101.06 0.89 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 29.3 m-20 -111.04 -3.86 15.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -1.146 . . . . 0.0 110.179 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -99.64 151.39 21.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.768 ' CE1' HD11 ' A' ' 64' ' ' LEU . 2.3 m-85 -133.42 131.03 39.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.225 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.3 109.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.186 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.521 HG11 ' H42' ' A' ' 131' ' ' JN3 . 98.5 t -111.81 129.27 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.169 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 88.4 m -123.81 103.31 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.17 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.3 m -83.63 137.94 33.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 0.0 110.164 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -131.74 117.05 18.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 110.16 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.973 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -103.68 168.17 9.06 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 110.239 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.84 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.3 Cg_endo -73.08 -27.81 13.54 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.016 1.535 . . . . 0.0 110.4 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.416 ' NH2' ' HE2' ' A' ' 30' ' ' MET . 3.6 ttm180 -97.28 -23.83 15.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.249 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.554 ' NE2' H221 ' A' ' 130' ' ' JN3 . 1.1 pm0 -161.13 161.98 31.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.224 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 p -129.74 128.06 41.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 110.226 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 73' ' ' MET . 59.4 t -126.77 127.83 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 110.16 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 14.1 t -111.65 140.85 45.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.195 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -138.1 131.72 30.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.175 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -123.12 136.18 54.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.214 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.908 ' CE1' HG21 ' A' ' 82' ' ' VAL . 45.7 p90 -149.06 167.32 26.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.216 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.1 m -116.37 148.69 40.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 110.247 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.772 HD13 HD12 ' A' ' 84' ' ' LEU . 37.2 mt -76.49 126.37 30.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.56 13.23 58.57 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' C ' HG23 ' A' ' 81' ' ' THR . 56.7 mttm -144.22 138.67 28.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -1.136 . . . . 0.0 110.225 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -70.68 124.48 24.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.187 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.65 149.36 49.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.254 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -77.37 137.15 38.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.885 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 25.5 mm -128.16 145.22 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -0.888 . . . . 0.0 110.226 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.0 p -121.73 134.78 54.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.92 . . . . 0.0 110.213 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.684 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 36.5 p -86.96 156.51 19.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.91 . . . . 0.0 110.176 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.782 ' HB3' H222 ' A' ' 130' ' ' JN3 . 10.7 mtm -68.42 -15.6 63.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 110.181 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.654 ' OD1' HD22 ' A' ' 27' ' ' LEU . 11.2 t0 -82.32 -22.59 35.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.208 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.09 19.62 5.11 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.684 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 22.3 mttt -96.38 137.81 34.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -1.142 . . . . 0.0 110.236 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -113.96 133.22 55.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.712 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -161.55 162.07 30.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -106.01 143.99 33.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -0.894 . . . . 0.0 110.2 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.453 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -148.46 139.17 22.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.44 HG23 ' C ' ' A' ' 66' ' ' LYS . 17.8 m -104.4 93.07 4.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 110.192 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.957 HG11 HD11 ' A' ' 89' ' ' LEU . 16.2 t -57.36 152.4 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.907 . . . . 0.0 110.217 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.54 147.28 30.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.253 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.772 HD12 HD13 ' A' ' 64' ' ' LEU . 6.0 mt -102.99 98.83 8.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.214 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 86' ' ' ASN . . . -110.11 138.03 47.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.159 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 85' ' ' ALA . 29.7 m120 42.98 39.35 1.75 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.47 52.09 53.56 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.782 ' HE2' ' OE1' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -161.61 112.98 1.72 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -1.18 . . . . 0.0 110.164 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.957 HD11 HG11 ' A' ' 82' ' ' VAL . 3.9 tt -58.95 144.06 46.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.775 HG13 ' CG ' ' A' ' 99' ' ' GLU . 48.1 t -151.01 114.62 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 85.5 m -109.73 94.2 4.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -91.43 165.14 13.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.859 . . . . 0.0 110.173 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.461 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 1.6 m -155.99 -158.44 0.81 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.572 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 53.1 tt0 -107.9 29.13 7.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.529 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 7.8 ptpt -171.1 1.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.247 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.863 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -178.65 148.04 0.41 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.181 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.737 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -122.72 157.83 31.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.64 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 16.0 t60 -139.82 138.39 35.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 110.234 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.775 ' CG ' HG13 ' A' ' 90' ' ' VAL . 78.1 mt-10 -152.66 126.15 8.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.455 ' CG ' ' HG2' ' A' ' 109' ' ' GLU . 9.3 tt0 -133.92 155.65 49.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.782 ' OE1' ' HE2' ' A' ' 88' ' ' LYS . 47.5 tt0 -149.51 163.61 37.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.143 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.645 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.0 p -127.2 129.49 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.182 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.6 pttt -126.94 96.9 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 110.202 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.57 -111.29 3.26 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.542 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 45.9 p-10 -115.2 14.42 16.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -1.132 . . . . 0.0 110.25 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.542 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 20.0 mt-10 -119.66 157.72 27.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.178 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.529 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 26.4 ttm -132.56 140.92 48.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 110.226 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 121' ' ' ARG . 65.1 t -127.42 133.65 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.206 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 70.9 mt-10 -117.5 123.99 47.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 110.227 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.2 m -114.02 123.13 48.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.18 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 97' ' ' SER . 82.2 mt -131.86 132.77 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 63.5 p -109.02 136.25 48.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 0.0 110.188 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 8.7 t80 -156.99 124.94 5.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.94 . . . . 0.0 110.19 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 67.68 38.45 89.96 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.53 2.67 44.46 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.9 t -105.66 147.1 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -1.165 . . . . 0.0 110.18 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.7 m -122.28 127.77 50.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.189 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.75 HD21 ' CE1' ' A' ' 14' ' ' TYR . 62.9 tp -105.98 153.07 22.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 91.4 mt -132.15 101.12 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 110.184 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 3.9 ttt180 -104.33 122.28 45.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 1.324 ' NE ' ' HB3' ' A' ' 10' ' ' ALA . 4.4 ptt180 -103.89 142.42 34.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.753 ' C ' ' CD2' ' A' ' 9' ' ' TYR . 0.7 OUTLIER -129.69 147.78 51.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.85 . . . . 0.0 110.248 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 1.476 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -106.57 149.15 27.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.185 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 5' ' ' THR . 76.1 ttt180 -82.18 139.89 34.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.171 179.943 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 0.994 H232 HD11 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.885 ' H8 ' HG21 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.312 0.577 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -77.29 -33.75 55.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.223 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.1 p -57.22 146.79 27.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.202 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.81 -177.91 17.31 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.6 m -105.3 132.69 51.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -1.149 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.53 ' CE3' ' HB2' ' A' ' 107' ' ' MET . 98.5 m95 -121.13 147.08 46.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.862 . . . . 0.0 110.198 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -128.82 115.38 17.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 110.175 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.629 HG22 ' HD3' ' A' ' 120' ' ' ARG . 40.1 t -61.67 133.88 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.301 -0.874 . . . . 0.0 110.257 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.503 ' OH ' ' HB3' ' A' ' 121' ' ' ARG . 16.4 p90 -135.88 -19.4 1.56 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -139.05 133.81 32.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 110.277 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -146.1 116.77 7.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.237 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.594 ' O ' HD12 ' A' ' 118' ' ' LEU . 63.5 mm-40 -88.44 142.12 27.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.9 . . . . 0.0 110.281 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.5 t30 55.66 26.31 9.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.23 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.618 ' CE1' HD11 ' A' ' 18' ' ' LEU . 35.1 t80 -54.8 -50.39 68.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -65.99 -45.94 79.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -0.934 . . . . 0.0 110.166 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.86 -60.35 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.194 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.66 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 41.8 t80 -48.56 -60.42 2.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.192 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.723 HD23 HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -53.92 -54.39 39.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.503 ' C ' ' O ' ' A' ' 18' ' ' LEU . 56.7 mttt -36.53 -44.99 0.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.14 -27.35 68.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.907 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -60.65 -19.58 58.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.263 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.907 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 80.15 30.79 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 110.186 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.723 HD12 HD23 ' A' ' 18' ' ' LEU . 15.0 mt -78.03 164.52 56.53 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.925 . . . . 0.0 110.197 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.598 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.4 Cg_endo -73.13 141.19 32.21 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.019 1.536 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -62.25 -39.37 92.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.159 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -57.11 -29.36 63.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.211 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.801 HD11 H232 ' A' ' 130' ' ' JN3 . 44.7 tp -89.42 -23.14 22.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.206 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.9 mt -82.29 -40.22 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.199 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -73.49 -29.09 62.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.239 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.7 ttm -88.11 -25.95 22.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.208 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -101.74 2.72 38.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.621 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 18.0 ptt180 -67.33 -1.12 4.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.234 -0.916 . . . . 0.0 110.212 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.549 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.5 m-20 -146.74 49.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.915 . . . . 0.0 110.181 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.906 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.2 mt -122.41 123.07 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.75 83.0 0.23 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.211 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.906 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -72.98 138.94 29.21 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.061 1.558 . . . . 0.0 110.454 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.7 mt -93.16 153.93 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.886 . . . . 0.0 110.208 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.3 t -132.09 119.78 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 110.199 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -98.49 134.92 40.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 110.212 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.509 HD12 ' CD1' ' A' ' 6' ' ' TRP . 67.9 mt -121.52 131.13 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -135.72 74.53 1.51 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.248 -0.908 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.624 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 1.6 pt20 -76.64 164.88 25.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 57.0 mmtt -159.02 51.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 110.213 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.15 -103.66 1.26 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -107.82 -3.38 19.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -1.187 . . . . 0.0 110.125 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.7 t0 -103.33 148.12 26.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.875 . . . . 0.0 110.185 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.694 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.9 m-85 -132.14 139.35 48.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.9 108.96 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.165 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.811 HG11 ' H42' ' A' ' 131' ' ' JN3 . 92.4 t -110.08 130.03 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.238 -0.914 . . . . 0.0 110.186 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.759 ' OG1' HG23 ' A' ' 59' ' ' THR . 94.2 m -130.07 110.59 11.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -92.93 132.91 36.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.162 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -125.46 121.55 34.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.191 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.797 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.4 168.64 7.54 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.193 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.685 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.2 Cg_endo -73.12 -18.69 23.58 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.055 1.555 . . . . 0.0 110.395 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 19.9 mtp-105 -104.57 -20.83 13.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.414 ' O ' ' OG1' ' A' ' 53' ' ' THR . 19.0 pt20 -166.81 160.75 14.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.194 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 p -129.78 133.47 47.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.195 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.17 128.79 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 110.265 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.759 HG23 ' OG1' ' A' ' 50' ' ' THR . 25.1 m -111.86 138.4 48.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.256 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 59' ' ' THR . 67.0 m-20 -134.75 153.35 52.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 t -146.51 128.4 15.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.212 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.774 ' CE1' ' H5 ' ' A' ' 131' ' ' JN3 . 33.9 p90 -140.8 173.64 11.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -123.38 141.95 51.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.694 HD11 ' CD1' ' A' ' 47' ' ' PHE . 18.1 mt -74.28 126.21 30.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.02 -1.91 55.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.0 143.32 40.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -1.19 . . . . 0.0 110.17 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -66.61 122.4 17.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.286 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.57 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.54 146.87 47.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.176 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -81.94 137.28 35.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.779 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 4.9 mm -128.43 145.24 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -116.29 134.47 54.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.777 HG23 H161 ' A' ' 131' ' ' JN3 . 0.3 OUTLIER -87.15 154.76 20.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.905 . . . . 0.0 110.186 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.886 ' HE3' H122 ' A' ' 130' ' ' JN3 . 12.5 ttm -65.91 -16.54 63.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.257 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.747 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -85.26 -11.35 55.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 110.186 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.25 33.2 4.65 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -107.32 133.24 52.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -1.191 . . . . 0.0 110.198 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -108.1 135.86 48.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.95 . . . . 0.0 110.199 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.634 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -167.43 156.18 9.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -103.49 166.85 10.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.23 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p -175.22 139.78 0.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.3 m -98.84 100.52 11.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.176 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.62 ' O ' HD23 ' A' ' 64' ' ' LEU . 44.0 t -72.83 139.35 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 110.186 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 25.6 p-80 -136.55 161.08 36.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 110.207 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.5 mt -106.56 130.52 54.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -135.1 116.08 14.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 93.1 m-20 59.02 28.13 17.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.8 37.68 29.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -141.44 122.2 14.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -1.159 . . . . 0.0 110.248 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.698 HD22 ' H22' ' A' ' 131' ' ' JN3 . 7.8 tt -77.56 126.36 30.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.265 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.841 HG22 ' HG3' ' A' ' 99' ' ' GLU . 92.2 t -135.47 127.17 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.189 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.614 ' OG1' HG22 ' A' ' 82' ' ' VAL . 56.0 m -117.97 85.87 2.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.235 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -79.58 166.78 21.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.235 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.448 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -158.61 -167.2 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.204 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.748 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 43.4 mt-10 -100.84 43.82 1.04 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.181 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.748 ' HB3' ' O ' ' A' ' 94' ' ' GLU . 7.0 ptmt 170.1 3.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.239 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.843 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -176.95 144.65 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 111' ' ' ILE . 70.4 m -123.53 153.91 39.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.482 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 17.5 t60 -138.56 145.89 41.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.841 ' HG3' HG22 ' A' ' 90' ' ' VAL . 2.4 tt0 -157.78 121.08 3.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.232 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.615 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 26.0 tt0 -122.8 159.81 27.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 27.5 mt-10 -157.61 144.76 18.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.442 HG23 ' CH2' ' A' ' 6' ' ' TRP . 11.3 p -111.07 140.84 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.23 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -137.11 96.22 3.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.877 . . . . 0.0 110.227 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.04 -108.98 2.77 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -116.39 10.83 14.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -1.163 . . . . 0.0 110.18 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.53 156.51 28.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.188 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.53 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 27.5 ttm -128.69 141.12 51.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.338 -0.851 . . . . 0.0 110.192 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 121' ' ' ARG . 94.7 t -126.37 123.97 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.867 . . . . 0.0 110.194 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 23.3 mt-10 -110.66 115.28 29.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.1 m -105.6 122.8 46.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 110.207 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 97' ' ' SER . 61.6 mt -129.82 129.73 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 45.8 m -109.6 135.73 50.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.165 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.591 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 15.9 t80 -159.17 127.05 4.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.07 32.88 65.53 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.48 5.47 67.88 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 112' ' ' THR . 61.6 t -110.16 143.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.334 -1.097 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.0 m -118.6 130.18 55.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.9 . . . . 0.0 110.126 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.66 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 42.7 tp -111.24 147.36 35.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.196 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 87.0 mt -122.35 95.97 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 110.275 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.629 ' HD3' HG22 ' A' ' 8' ' ' VAL . 3.0 ttm180 -88.94 117.52 28.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 110.213 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.503 ' HB3' ' OH ' ' A' ' 9' ' ' TYR . 29.2 mtt180 -101.69 128.82 47.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.925 . . . . 0.0 110.17 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.2 m -126.8 151.81 47.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.197 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -112.09 156.22 22.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.194 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -83.31 135.53 34.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.202 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 0.886 H122 ' HE3' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.811 ' H42' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.251 0.548 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -78.34 -29.62 47.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.203 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.66 148.04 30.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -0.915 . . . . 0.0 110.218 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.6 163.77 13.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.8 m -80.38 152.23 28.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -1.173 . . . . 0.0 110.178 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.719 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 89.9 m95 -139.21 132.89 30.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.728 ' N ' ' O ' ' A' ' 123' ' ' LYS . 24.8 tt0 -98.71 124.66 43.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 36' ' ' PRO . 10.9 t -44.33 126.2 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 1.267 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -88.51 -65.93 0.97 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 1.014 ' HB3' ' HD2' ' A' ' 121' ' ' ARG . . . -155.07 163.13 40.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 11' ' ' GLN . 13.6 pt20 -136.65 101.7 4.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.6 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 56.8 tt0 -87.05 137.46 32.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.133 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.6 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 32.2 m-20 65.36 -1.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 1.183 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 77.8 t80 -32.22 -64.35 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.577 ' HG3' ' N ' ' A' ' 16' ' ' GLU . 13.6 pt-20 -48.26 -51.04 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.235 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.577 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 68.0 mt-10 -54.74 -61.17 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.648 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 49.0 t80 -49.61 -56.27 10.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.183 HD11 ' CZ ' ' A' ' 14' ' ' TYR . 21.0 mt -54.58 -46.81 73.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 65.2 mttt -46.83 -41.29 15.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 -26.16 66.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 110.221 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.861 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -63.22 -20.16 65.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.861 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 78.86 30.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.246 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 37.3 mt -77.32 167.3 37.56 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.259 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.0 Cg_endo -73.1 140.32 30.98 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.065 1.56 . . . . 0.0 110.41 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -61.49 -36.57 80.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.168 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -59.22 -30.06 67.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.181 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.658 HD22 ' OD1' ' A' ' 74' ' ' ASP . 44.9 tp -89.46 -21.21 23.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 110.153 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.747 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 78.0 mt -78.71 -41.26 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 0.0 110.198 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HA ' ' HD2' ' A' ' 32' ' ' ARG . 18.0 mtmt -75.22 -24.1 57.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.27 -0.894 . . . . 0.0 110.251 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.5 tpp -87.87 -29.8 20.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.454 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -105.52 8.4 33.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 110.23 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.747 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.0 ptm85 -67.88 -7.67 30.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 110.176 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -146.74 59.86 1.2 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.192 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.5 mt -129.64 110.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.583 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -88.57 80.41 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.954 . . . . 0.0 110.274 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.192 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.05 140.78 31.83 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.005 1.529 . . . . 0.0 110.459 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 38' ' ' VAL . 5.2 mt -87.9 165.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.459 ' N ' HG22 ' A' ' 37' ' ' ILE . 69.0 t -142.67 116.59 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.239 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -92.17 140.74 29.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.2 mt -126.92 129.25 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 110.18 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -129.67 66.37 1.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.619 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 52.6 tt0 -63.95 168.96 4.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.619 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 33.5 mtmt -167.78 44.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 0.0 110.22 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.97 -103.97 1.04 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 25.8 m-20 -108.23 -3.11 18.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -1.187 . . . . 0.0 110.172 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.36 150.3 23.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.684 ' CE1' HD11 ' A' ' 64' ' ' LEU . 2.9 m-85 -133.25 134.37 43.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.08 109.45 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 0.0 110.18 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.733 HG11 ' H42' ' A' ' 131' ' ' JN3 . 91.0 t -111.41 129.85 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.259 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.7 ' OG1' HG23 ' A' ' 59' ' ' THR . 84.7 m -126.04 106.86 9.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 110.195 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.8 m -88.64 136.55 32.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.202 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -129.69 117.52 20.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.884 HG22 ' HD2' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -102.39 168.11 9.42 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.884 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.1 Cg_endo -73.05 -28.01 13.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.028 1.541 . . . . 0.0 110.394 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.14 -19.43 17.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.245 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.508 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.4 OUTLIER -164.05 160.36 21.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.244 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 p -128.94 127.85 42.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.265 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' A' ' 73' ' ' MET . 58.2 t -125.78 124.42 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.149 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.7 HG23 ' OG1' ' A' ' 50' ' ' THR . 36.7 m -110.17 144.57 38.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -141.24 147.73 38.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.893 . . . . 0.0 110.25 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.7 m -139.07 135.08 33.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.923 . . . . 0.0 110.264 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 1.035 ' CE1' HG21 ' A' ' 82' ' ' VAL . 51.7 p90 -147.69 170.99 16.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 110.229 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.2 m -118.52 145.37 45.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 110.228 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.684 HD11 ' CE1' ' A' ' 47' ' ' PHE . 51.0 mt -77.1 124.44 27.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.27 -3.75 54.8 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -134.31 148.62 50.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 0.0 110.185 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.463 ' HA ' ' CG2' ' A' ' 81' ' ' THR . 75.7 tt0 -72.45 128.54 35.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.224 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.96 150.74 50.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -82.05 133.71 35.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.882 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 22.9 mm -123.45 145.06 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 96.3 m -122.8 135.07 54.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.697 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 43.1 p -89.78 157.92 17.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.722 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -68.3 -12.53 61.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.268 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.658 ' OD1' HD22 ' A' ' 27' ' ' LEU . 5.3 t0 -85.31 -21.5 28.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.06 23.23 4.99 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.697 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 27.1 mttt -98.62 135.32 40.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -1.118 . . . . 0.0 110.161 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -113.01 135.22 54.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 110.21 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.609 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -164.47 160.69 20.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.152 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' HD3' ' OE2' ' A' ' 67' ' ' GLU . 25.8 mttp -104.05 146.33 28.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.279 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.56 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -148.58 141.8 25.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.463 ' CG2' ' HA ' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -106.43 89.39 3.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.211 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.035 HG21 ' CE1' ' A' ' 62' ' ' PHE . 12.2 t -57.71 152.54 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.161 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.19 146.12 28.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.564 ' CD1' HD13 ' A' ' 64' ' ' LEU . 14.9 mt -98.41 101.02 12.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.843 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 86' ' ' ASN . . . -117.33 148.91 41.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.222 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' ALA . 3.4 t-20 44.53 27.51 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.159 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.424 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 70.45 40.17 68.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.792 ' HD3' ' CD ' ' A' ' 101' ' ' GLU . 11.1 mttt -152.95 132.09 12.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.208 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.872 HD11 HG11 ' A' ' 82' ' ' VAL . 8.3 tt -72.19 135.9 46.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.664 HG12 ' CG ' ' A' ' 99' ' ' GLU . 11.6 m -143.72 123.26 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.235 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.56 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 95.2 m -114.56 91.87 3.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 5.9 ptmt -88.49 163.78 15.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.238 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 29.3 t -152.65 -158.03 0.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.196 -0.94 . . . . 0.0 110.197 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.459 ' N ' ' OG ' ' A' ' 93' ' ' SER . 44.6 mt-10 -106.59 26.15 10.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.505 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 7.8 ptpt -167.03 0.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.94 ' CD1' ' O ' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -177.67 146.21 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 111' ' ' ILE . 29.3 t -117.72 160.03 22.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 15.3 t60 -143.99 139.25 28.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.664 ' CG ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -152.18 127.77 10.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.544 ' NE2' ' SD ' ' A' ' 107' ' ' MET . 46.0 tt0 -131.66 155.04 48.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.188 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.792 ' CD ' ' HD3' ' A' ' 88' ' ' LYS . 45.1 tt0 -151.64 155.09 37.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.461 HG23 ' CH2' ' A' ' 6' ' ' TRP . 11.2 p -119.33 134.4 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.219 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.18 94.67 3.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.172 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.38 -111.84 3.37 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -116.23 18.31 15.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.17 . . . . 0.0 110.253 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -123.66 148.51 46.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.218 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.548 ' HB3' ' HB2' ' A' ' 122' ' ' SER . 34.0 ttm -123.58 139.06 54.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 0.0 110.247 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.62 129.33 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 33.4 mt-10 -115.6 109.81 18.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 110.199 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 99' ' ' GLU . 25.8 m -99.01 123.21 43.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.133 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 97' ' ' SER . 52.7 mt -132.29 129.28 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.223 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 21.8 m -104.63 142.92 33.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.887 . . . . 0.0 110.267 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.633 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 5.6 t80 -163.16 124.83 2.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 68.9 37.44 83.67 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.34 9.38 60.91 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 112' ' ' THR . 65.2 t -112.32 140.2 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -1.13 . . . . 0.0 110.194 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.7 m -113.72 129.31 56.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 110.221 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.648 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 48.4 tp -108.66 153.65 23.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.259 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.8 mt -130.97 94.55 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 0.9 OUTLIER -95.97 128.65 43.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 110.272 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 1.014 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 1.3 ptp180 -109.85 136.9 48.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.226 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.588 ' C ' ' HD2' ' A' ' 9' ' ' TYR . 39.8 m -125.57 135.46 52.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 1.267 ' HB2' ' CE2' ' A' ' 9' ' ' TYR . 71.7 tttt -92.94 153.89 18.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.246 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 27.5 ttp85 -89.52 134.83 33.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.456 HG21 ' OE1' ' A' ' 7' ' ' GLN . 53.0 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.221 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 0.931 H191 HD21 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.882 ' H8 ' HG21 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.281 0.563 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -76.33 -33.16 58.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 110.224 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.1 p -56.08 146.55 22.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 110.159 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.7 -172.49 19.47 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.726 HG22 ' HG3' ' A' ' 39' ' ' GLU . 5.8 p -110.69 128.04 55.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -1.133 . . . . 0.0 110.233 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.536 ' CH2' HG23 ' A' ' 102' ' ' VAL . 94.3 m95 -115.92 143.51 45.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.171 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -128.71 116.67 19.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.179 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.08 144.88 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.253 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 9' ' ' TYR . 8.0 p90 -147.09 -14.23 0.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.251 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -139.61 141.86 37.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.14 164.7 37.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -140.33 158.8 43.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.19 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 46.51 38.03 5.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 110.233 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 7.8 t80 -69.84 -55.33 10.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -53.19 -57.88 8.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.271 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -48.38 -45.44 35.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.222 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.651 ' CD2' HD22 ' A' ' 118' ' ' LEU . 10.0 t80 -55.59 -57.25 12.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 110.228 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.721 HD13 HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -51.07 -43.32 61.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.167 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -54.78 -35.49 63.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.39 -41.91 62.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -0.97 . . . . 0.0 110.162 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.9 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.7 tp -55.26 -25.58 34.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 80.56 24.13 0.35 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.708 HD12 HD22 ' A' ' 18' ' ' LEU . 14.5 mt -69.13 166.52 27.99 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.145 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.0 Cg_endo -73.14 132.13 17.61 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.058 1.557 . . . . 0.0 110.407 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.66 ' HA ' HD12 ' A' ' 28' ' ' ILE . 44.8 mt-10 -49.7 -46.04 49.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.972 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -50.33 -35.81 29.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.191 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 41.7 tp -84.45 -33.61 23.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.721 HG12 HD13 ' A' ' 18' ' ' LEU . 96.9 mt -61.22 -56.09 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.149 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' A' ' 30' ' ' MET . 13.4 pttp -56.01 -24.43 39.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.688 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 85.6 mtp -94.17 -9.74 35.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.245 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.676 ' HB1' H183 ' A' ' 130' ' ' JN3 . . . -113.34 -5.84 13.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.218 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.707 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -71.86 0.82 8.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 110.286 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.707 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.5 m-20 -150.18 41.69 0.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.688 ' CD1' ' O ' ' A' ' 30' ' ' MET . 23.8 mt -122.84 115.47 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.267 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -100.82 90.19 1.45 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.978 ' HB3' HG23 ' A' ' 53' ' ' THR . 46.5 Cg_endo -73.09 146.04 40.49 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.918 1.483 . . . . 0.0 110.4 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 38' ' ' VAL . 6.4 mt -86.45 173.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.61 ' N ' HG22 ' A' ' 37' ' ' ILE . 70.0 t -150.19 119.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.177 -0.952 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.726 ' HG3' HG22 ' A' ' 5' ' ' THR . 20.1 tt0 -103.45 148.04 26.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.225 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.56 HD11 HE22 ' A' ' 100' ' ' GLN . 55.8 mt -136.4 132.14 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 110.23 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 55.9 tt0 -132.28 73.82 1.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.793 ' OE1' ' N ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -68.73 170.53 9.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.244 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 14.2 mtmt -168.55 43.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.793 ' N ' ' OE1' ' A' ' 42' ' ' GLN . . . 120.04 -102.49 0.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 26.8 m-20 -110.36 -2.0 16.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -1.135 . . . . 0.0 110.154 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.1 t0 -104.2 150.39 24.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.789 ' CE1' HD11 ' A' ' 64' ' ' LEU . 3.0 m-85 -131.37 137.27 48.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.21 108.08 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.141 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.956 HG11 ' H42' ' A' ' 131' ' ' JN3 . 62.8 t -108.37 130.92 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.65 HG23 ' OG1' ' A' ' 59' ' ' THR . 77.6 m -133.22 106.07 7.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.3 m -89.04 137.68 32.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.887 . . . . 0.0 110.223 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -130.97 124.11 30.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 110.258 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.978 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.08 169.25 6.81 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.78 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.4 Cg_endo -73.0 -20.53 21.82 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.992 1.522 . . . . 0.0 110.414 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -105.67 -22.46 12.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.417 ' HG3' ' HG1' ' A' ' 53' ' ' THR . 4.5 pt20 -159.74 161.76 34.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 p -132.4 128.15 36.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 110.233 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.55 127.42 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.91 . . . . 0.0 110.233 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.65 ' OG1' HG23 ' A' ' 50' ' ' THR . 91.5 m -111.28 142.09 43.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 49' ' ' VAL . 83.6 m-20 -139.41 151.05 45.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.162 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 m -141.58 135.14 29.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.191 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.61 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 35.0 p90 -148.26 166.65 27.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.8 m -116.02 150.4 37.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.789 HD11 ' CE1' ' A' ' 47' ' ' PHE . 31.4 mt -78.45 125.66 29.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.928 . . . . 0.0 110.198 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.47 5.93 60.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -139.95 139.46 36.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -1.135 . . . . 0.0 110.222 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -65.91 124.8 23.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.541 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -124.76 148.16 48.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.154 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 14.8 p-10 -81.18 136.89 35.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.161 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.841 HD12 ' H62' ' A' ' 131' ' ' JN3 . 23.7 mm -128.85 142.43 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 110.161 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 m -113.55 139.88 48.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 110.233 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.685 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 68.3 p -93.97 158.39 15.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.781 ' HE3' H122 ' A' ' 130' ' ' JN3 . 15.8 ttm -70.67 -13.28 62.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.206 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.93 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.3 p30 -86.54 -12.87 47.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.02 25.42 7.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.685 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 12.0 mttt -102.89 136.89 41.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -1.114 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -110.67 135.37 51.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.162 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.573 HD11 H181 ' A' ' 131' ' ' JN3 . 0.5 OUTLIER -166.21 153.67 9.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.277 -0.89 . . . . 0.0 110.208 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -99.23 155.98 17.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.3 m -157.92 134.26 9.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.167 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -96.55 96.38 8.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.196 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.907 HG13 HD21 ' A' ' 89' ' ' LEU . 48.4 t -69.92 142.53 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.669 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 13.9 p-80 -140.84 155.49 46.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.177 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.409 ' CD1' HD13 ' A' ' 64' ' ' LEU . 51.5 mt -100.12 132.34 45.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -138.75 111.51 7.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.22 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.676 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 86.2 m-20 64.35 27.59 13.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.214 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.532 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.34 43.5 20.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.623 ' HD2' ' OE2' ' A' ' 101' ' ' GLU . 49.4 mtpt -153.37 118.86 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -1.167 . . . . 0.0 110.203 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.907 HD21 HG13 ' A' ' 82' ' ' VAL . 4.8 tt -68.69 142.94 54.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.233 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.772 HG13 ' HG2' ' A' ' 99' ' ' GLU . 55.3 t -150.69 120.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.787 ' OG1' HG22 ' A' ' 82' ' ' VAL . 5.4 m -114.04 95.73 5.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.434 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -89.0 167.48 13.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.24 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 3.3 m -158.55 -168.08 2.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 110.236 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 27.0 tp10 -101.74 33.68 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.502 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 8.6 ptpt -174.75 0.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.226 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.895 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -179.01 144.71 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 0.0 110.184 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.9 m -119.4 158.37 26.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.4 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 16.4 t60 -143.42 136.52 27.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.207 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.772 ' HG2' HG13 ' A' ' 90' ' ' VAL . 92.2 mt-10 -148.32 131.38 16.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.219 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.56 HE22 HD11 ' A' ' 40' ' ' ILE . 40.5 tt0 -134.7 152.9 52.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.227 -0.921 . . . . 0.0 110.186 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.623 ' OE2' ' HD2' ' A' ' 88' ' ' LYS . 58.1 tt0 -150.72 159.11 44.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.536 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.7 p -123.52 136.89 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 110.18 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -130.65 96.97 4.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.246 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.53 -98.08 1.75 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.502 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 30.7 p-10 -126.87 11.6 7.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -1.137 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.502 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 48.4 mt-10 -118.38 164.99 14.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.213 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.519 ' CE ' ' NE1' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -137.27 143.04 41.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.17 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 121' ' ' ARG . 76.4 t -127.21 127.31 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.375 -0.828 . . . . 0.0 110.238 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 33.9 mt-10 -114.42 134.74 54.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.0 m -124.09 122.38 37.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.179 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 74.8 mt -127.76 131.82 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 110.2 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 80.5 m -112.75 135.58 53.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.512 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 4.9 t80 -156.81 123.95 5.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.17 -0.956 . . . . 0.0 110.274 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 70.03 37.75 73.67 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.49 4.68 52.89 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 112' ' ' THR . 60.2 t -108.65 139.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -1.17 . . . . 0.0 110.178 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 63.6 m -115.13 130.86 57.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.651 HD22 ' CD2' ' A' ' 17' ' ' PHE . 36.9 tp -110.19 141.93 42.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.182 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.6 mt -120.34 121.36 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.463 ' NH1' ' H12' ' A' ' 130' ' ' JN3 . 22.3 mtm180 -117.75 117.57 29.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.156 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 12.2 mtt180 -98.24 129.01 44.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.169 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.5 p -125.74 166.33 16.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 110.263 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 35.4 tttm -129.62 158.83 38.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 110.155 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.405 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 73.8 ttt180 -81.35 134.58 35.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.22 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 130' ' ' JN3 . . . . . 0.93 H151 ' HB3' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' JN3 . . . . . 0.956 ' H42' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.23 0.538 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 m -56.56 145.16 29.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.888 . . . . 0.0 110.182 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.6 -176.48 17.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.4 m -106.35 131.28 53.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -1.137 . . . . 0.0 110.251 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.467 ' CZ3' ' HG3' ' A' ' 107' ' ' MET . 93.0 m95 -119.62 142.84 48.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -124.22 122.12 36.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 110.257 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.15 127.21 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 121' ' ' ARG . 34.3 p90 -133.08 2.37 3.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.251 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.82 127.99 2.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -143.96 120.77 11.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.243 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 55.7 tt0 -99.82 144.65 28.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.941 . . . . 0.0 110.197 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 22.3 m120 58.32 16.33 3.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.277 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.961 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 90.4 t80 -52.98 -47.64 68.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 110.164 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.09 -47.51 76.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 37.0 mt-10 -56.47 -60.23 3.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.67 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 45.0 t80 -49.74 -54.99 15.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.961 HD11 ' CZ ' ' A' ' 14' ' ' TYR . 22.2 mt -52.68 -49.51 65.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 63.1 mttt -42.47 -40.19 2.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.915 . . . . 0.0 110.156 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.451 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -68.84 -25.54 64.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.864 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -59.04 -19.09 40.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.181 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.864 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 76.36 25.43 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.903 . . . . 0.0 110.166 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 20.3 mt -75.17 168.24 29.35 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 23' ' ' LEU . 46.4 Cg_endo -73.05 138.06 27.52 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.01 1.531 . . . . 0.0 110.444 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 28' ' ' ILE . 69.4 mm-40 -54.32 -44.44 72.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.925 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -53.75 -25.3 18.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.524 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 44.9 tp -90.36 -23.95 20.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.901 . . . . 0.0 110.243 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.854 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 81.2 mt -74.81 -42.3 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.233 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -74.97 -20.6 59.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.9 mmm -93.0 -27.12 17.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.212 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.513 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -105.71 4.44 30.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 110.273 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.854 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 23.4 ptt180 -72.43 3.63 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 10.4 t0 -154.45 47.19 0.58 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.081 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 4.2 mt -121.12 117.29 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 110.168 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -91.3 82.48 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.186 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.081 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.09 132.89 18.77 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.034 1.544 . . . . 0.0 110.428 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 38' ' ' VAL . 8.2 mt -83.2 162.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.414 ' N ' HG22 ' A' ' 37' ' ' ILE . 73.0 t -140.67 116.48 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 40' ' ' ILE . 36.0 tt0 -97.21 136.01 38.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.855 . . . . 0.0 110.224 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 39' ' ' GLU . 51.5 mm -123.63 132.78 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.198 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 48' ' ' VAL . 37.2 tt0 -132.56 63.21 1.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 110.2 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.646 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 51.6 tt0 -59.3 165.8 2.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 110.218 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 38.3 mtmt -163.77 37.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.28 -97.84 0.53 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 14.8 m-20 -112.4 -7.48 13.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -1.122 . . . . 0.0 110.166 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.621 ' OD1' HG23 ' A' ' 63' ' ' THR . 12.0 m-20 -102.55 157.75 16.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.592 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 41.3 m-85 -138.55 139.5 38.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.218 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 58.6 t -117.19 104.19 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.439 HG22 ' CD1' ' A' ' 40' ' ' ILE . 57.6 t -104.16 128.32 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.685 HG23 ' OG1' ' A' ' 59' ' ' THR . 94.0 m -130.51 100.27 5.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.1 m -83.68 140.15 32.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 110.224 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 57' ' ' THR . 55.3 mttt -132.17 107.38 8.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.868 . . . . 0.0 110.204 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.97 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -94.0 168.15 12.25 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 110.211 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.781 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.6 Cg_endo -72.96 -29.93 11.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.016 1.535 . . . . 0.0 110.477 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -95.35 -22.05 18.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -162.45 169.58 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.211 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 52' ' ' LYS . 9.2 p -134.6 124.88 26.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.227 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 73' ' ' MET . 54.0 t -123.24 125.86 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.685 ' OG1' HG23 ' A' ' 50' ' ' THR . 64.3 m -112.94 148.16 35.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.213 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 59' ' ' THR . 27.2 m120 -143.87 147.52 34.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.279 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 t -138.92 140.12 38.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.621 ' CE1' HG11 ' A' ' 82' ' ' VAL . 34.5 p90 -151.89 166.19 32.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -0.904 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.621 HG23 ' OD1' ' A' ' 46' ' ' ASP . 88.7 m -116.26 152.26 34.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 3.9 tp -78.47 122.91 26.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.56 14.4 53.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -144.63 136.11 25.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -1.169 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.0 123.1 18.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.461 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.12 150.54 43.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.244 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -83.93 132.58 34.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 110.222 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 70' ' ' ILE . 26.7 mm -121.85 146.31 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 m -123.62 136.97 54.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 0.0 110.21 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.674 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 57.9 p -90.92 162.68 14.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.291 -0.88 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.487 ' HA ' HG21 ' A' ' 58' ' ' VAL . 23.9 mtm -75.8 -10.62 59.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.506 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 4.5 p30 -88.76 -14.92 35.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.49 28.73 4.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.674 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 18.0 mttt -107.02 128.16 54.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -1.121 . . . . 0.0 110.233 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -107.06 139.36 41.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.208 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.29 154.37 5.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.208 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.0 mtmm -98.6 153.05 18.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.419 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -157.82 133.66 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 m -95.2 102.58 14.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.186 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.838 HG13 HD21 ' A' ' 89' ' ' LEU . 47.5 t -73.81 142.99 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 6.5 p-80 -144.36 157.25 44.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.927 . . . . 0.0 110.246 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 84' ' ' LEU . 12.0 mt -99.86 134.26 43.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.875 . . . . 0.0 110.233 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -140.73 117.22 10.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.246 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.603 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 17.9 m120 61.93 27.59 16.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.53 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.61 40.58 26.75 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.53 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 61.3 mttt -151.4 130.32 12.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -1.14 . . . . 0.0 110.225 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.838 HD21 HG13 ' A' ' 82' ' ' VAL . 7.4 tt -76.58 129.94 37.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.742 HG13 ' HG2' ' A' ' 99' ' ' GLU . 70.3 t -138.46 125.92 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.932 . . . . 0.0 110.188 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.532 ' OG1' HG22 ' A' ' 82' ' ' VAL . 51.9 m -117.92 90.57 3.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 12.1 pttp -85.24 164.55 17.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 110.211 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 34.9 t -155.07 -158.37 0.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.405 ' N ' ' OG ' ' A' ' 93' ' ' SER . 35.0 mt-10 -108.1 35.41 3.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 110.239 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -177.58 1.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.0 110.149 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.896 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER 179.21 148.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.198 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -121.76 160.62 24.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.155 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 52.1 t-80 -142.15 140.92 32.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.182 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.742 ' HG2' HG13 ' A' ' 90' ' ' VAL . 48.2 mt-10 -151.74 126.33 9.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.226 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.689 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 41.3 tt0 -125.95 156.32 39.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.161 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.689 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 7.8 mp0 -157.53 147.55 20.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.902 . . . . 0.0 110.261 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.0 p -116.12 139.26 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -130.33 99.48 5.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.925 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.37 -118.11 5.76 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -103.9 8.15 36.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.232 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -116.1 159.06 22.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.467 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -129.04 139.2 52.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.289 -0.882 . . . . 0.0 110.17 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 80.0 t -126.33 126.18 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.2 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 35.1 mt-10 -110.5 131.28 55.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 99' ' ' GLU . 12.2 p -122.17 117.62 26.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 97' ' ' SER . 53.8 mt -129.16 139.41 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.251 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 69.9 p -112.75 131.56 55.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.176 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 3.2 t80 -151.89 126.82 9.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.918 . . . . 0.0 110.231 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.451 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.42 36.51 92.72 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.89 11.42 66.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.497 HG11 ' HA ' ' A' ' 17' ' ' PHE . 69.2 t -114.36 138.06 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -1.117 . . . . 0.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 43.9 m -112.18 135.67 52.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 110.195 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.67 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 59.2 tp -115.0 144.36 43.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.1 mt -125.7 94.44 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 9.9 ttp180 -89.54 132.26 35.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 110.204 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.501 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 45.1 mtm180 -109.9 122.8 48.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 6' ' ' TRP . 59.2 m -119.73 152.96 36.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -116.98 155.48 29.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.212 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' THR . 39.5 ttp85 -81.38 135.2 35.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.221 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.244 0.545 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.1 p -56.87 146.26 27.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.299 -0.875 . . . . 0.0 110.172 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.15 -174.06 17.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 89.0 m -107.64 131.11 54.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -1.141 . . . . 0.0 110.241 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.556 ' CD1' HD12 ' A' ' 40' ' ' ILE . 90.8 m95 -120.15 145.09 47.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -126.47 122.06 34.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.851 . . . . 0.0 110.177 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.5 126.02 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 39.1 p90 -126.81 -29.61 2.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.912 . . . . 0.0 110.19 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.78 129.57 40.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.86 . . . . 0.0 110.269 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.6 pt20 -143.11 119.61 11.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 110.203 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.535 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.6 tt0 -98.66 144.45 27.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 110.247 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.718 ' OD1' ' OE1' ' A' ' 16' ' ' GLU . 1.9 t30 60.25 14.21 4.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.861 ' CE1' HD11 ' A' ' 18' ' ' LEU . 74.0 t80 -51.59 -52.14 49.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -62.95 -48.5 78.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.718 ' OE1' ' OD1' ' A' ' 13' ' ' ASN . 65.3 mt-10 -55.73 -59.36 4.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.148 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.713 ' CD2' HD22 ' A' ' 118' ' ' LEU . 70.4 t80 -49.2 -55.49 12.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.861 HD11 ' CE1' ' A' ' 14' ' ' TYR . 12.7 mt -58.15 -42.25 85.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 3.5 tttm -49.14 -41.23 35.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.57 -27.75 66.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.902 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.1 tp -58.75 -20.27 47.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.61 28.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 110.268 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 21' ' ' LEU . 65.6 mt -74.73 165.86 50.2 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.134 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.554 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 45.6 Cg_endo -73.14 140.13 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.021 1.537 . . . . 0.0 110.382 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.7 -40.87 84.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.61 -26.58 56.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.229 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.674 HD22 ' OD1' ' A' ' 74' ' ' ASP . 43.3 tp -92.46 -19.41 22.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.747 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 94.0 mt -82.92 -40.93 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 0.0 110.172 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -75.36 -27.56 59.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.174 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 57.9 tpp -86.53 -27.64 23.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.237 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -103.03 4.92 37.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.747 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 6.3 ptt180 -71.57 2.07 5.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -152.33 48.66 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 110.24 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.1 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.9 mt -123.72 118.46 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.207 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.47 84.56 0.11 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.232 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.1 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.05 130.58 15.62 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.986 1.519 . . . . 0.0 110.433 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.8 mt -84.39 157.86 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.6 t -137.26 115.77 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -96.27 137.49 35.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.556 HD12 ' CD1' ' A' ' 6' ' ' TRP . 79.3 mt -123.95 129.72 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 55.8 tt0 -130.33 67.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 0.0 110.23 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.733 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 9.3 tt0 -62.39 171.37 1.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.143 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.733 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 17.9 mtmt -171.74 38.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.153 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.16 -104.54 0.87 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -108.52 0.64 21.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -1.149 . . . . 0.0 110.222 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.1 t0 -108.89 145.04 36.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.696 ' CE1' HD11 ' A' ' 64' ' ' LEU . 7.6 m-85 -127.18 139.43 52.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 110.276 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 59.4 t -120.01 104.61 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.29 122.44 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 110.146 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.674 HG23 ' OG1' ' A' ' 59' ' ' THR . 91.3 m -122.72 106.08 10.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 110.261 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 58' ' ' VAL . 51.1 m -92.61 134.58 34.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -127.11 119.6 26.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.961 . . . . 0.0 110.289 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.653 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -103.25 169.86 6.92 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.174 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.07 -17.82 24.5 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.093 1.575 . . . . 0.0 110.404 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -104.88 -24.71 12.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.956 . . . . 0.0 110.213 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.653 ' O ' ' OG1' ' A' ' 53' ' ' THR . 3.8 pt20 -163.58 169.08 19.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.186 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.0 p -129.79 127.85 41.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.231 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' A' ' 73' ' ' MET . 19.4 m -124.96 127.02 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.177 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.674 ' OG1' HG23 ' A' ' 50' ' ' THR . 36.2 m -115.64 147.36 40.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -142.46 149.46 39.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.261 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.3 t -141.81 137.76 31.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.152 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.62 ' CE1' HG21 ' A' ' 82' ' ' VAL . 52.0 p90 -150.5 169.89 20.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 110.237 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.9 m -117.65 150.57 38.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.196 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.696 HD11 ' CE1' ' A' ' 47' ' ' PHE . 17.3 mt -79.53 123.81 27.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 110.212 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.48 9.66 52.56 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -145.72 143.7 29.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -1.131 . . . . 0.0 110.193 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -68.68 127.78 34.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.202 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.592 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.06 147.63 50.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -80.28 134.99 36.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.241 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 70' ' ' ILE . 23.8 mm -124.26 144.81 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.151 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.1 m -121.78 136.06 54.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.21 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.613 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 66.4 p -87.88 161.14 17.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.605 ' HA ' HG11 ' A' ' 58' ' ' VAL . 1.5 ttp -73.89 -11.91 60.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.198 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.674 ' OD1' HD22 ' A' ' 27' ' ' LEU . 7.3 t0 -89.13 -14.04 37.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 110.213 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.67 50.77 0.83 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.613 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 7.7 tttt -128.61 129.65 46.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -1.155 . . . . 0.0 110.146 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -105.79 137.59 43.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.203 -0.936 . . . . 0.0 110.192 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.1 155.08 11.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.232 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -101.45 145.47 28.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.537 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.3 m -153.08 133.78 13.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.307 -0.871 . . . . 0.0 110.156 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -94.97 100.04 11.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.788 HG13 HD21 ' A' ' 89' ' ' LEU . 49.4 t -70.36 142.26 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 8.5 p-80 -146.04 151.41 37.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.15 132.03 40.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 110.262 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -140.87 131.49 25.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 97.3 m-20 56.69 17.43 3.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.2 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.56 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 83.8 40.88 8.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.56 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 97.4 mttt -155.57 131.84 10.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -1.121 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.788 HD21 HG13 ' A' ' 82' ' ' VAL . 6.7 tt -72.64 130.89 41.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.244 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.753 HG22 ' HG3' ' A' ' 99' ' ' GLU . 92.8 t -139.25 125.31 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.179 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.537 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 99.5 m -115.65 90.16 3.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -84.59 169.5 14.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.214 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 29.5 t -160.72 -157.58 0.54 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 110.196 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.445 ' N ' ' OG ' ' A' ' 93' ' ' SER . 18.7 tt0 -109.74 32.93 4.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.231 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.709 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -175.74 6.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 1.073 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.3 OUTLIER 171.87 141.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 110.26 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -114.72 174.75 5.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.423 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 47.6 t-80 -156.31 137.84 14.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.148 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.753 ' HG3' HG22 ' A' ' 90' ' ' VAL . 69.5 tt0 -149.85 126.49 10.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.218 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 47.5 tt0 -125.54 161.16 27.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.923 . . . . 0.0 110.247 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.532 ' OE1' ' HG3' ' A' ' 103' ' ' LYS . 10.9 tm-20 -161.81 148.72 14.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.434 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 10.8 p -116.0 143.18 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 110.223 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.532 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 92.6 mttt -133.26 92.7 3.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.99 -109.81 2.98 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.678 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 24.5 p30 -112.1 11.23 20.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -1.152 . . . . 0.0 110.18 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.678 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 61.5 mt-10 -118.64 155.18 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.491 ' HG3' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -125.1 141.85 51.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.48 121.54 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.13 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 40.8 mt-10 -107.74 119.27 38.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.556 ' N ' ' O ' ' A' ' 99' ' ' GLU . 38.0 p -108.48 119.61 40.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 97' ' ' SER . 53.0 mt -130.39 131.73 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.357 -0.84 . . . . 0.0 110.209 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 6.3 t -110.55 141.27 43.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.175 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.704 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 10.7 t80 -161.26 128.34 4.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.15 33.95 74.85 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.9 12.78 75.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 112' ' ' THR . 73.1 t -116.48 139.47 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -1.155 . . . . 0.0 110.191 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 47.3 m -112.92 134.0 54.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.713 HD22 ' CD2' ' A' ' 17' ' ' PHE . 43.1 tp -114.07 150.55 33.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.0 mt -130.6 94.74 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 9.4 ttp180 -88.93 131.42 35.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 25.7 mtt-85 -110.41 124.71 52.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.915 . . . . 0.0 110.174 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.1 m -122.07 149.44 43.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -115.38 153.15 31.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.19 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.7 ttp85 -78.19 134.75 37.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 125' ' ' VAL . 62.4 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.192 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.45 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 49.3 m-85 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.319 0.581 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 p -57.65 144.93 35.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.97 -178.7 17.33 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 91.0 m -106.13 134.73 48.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -1.148 . . . . 0.0 110.242 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.476 ' CE3' ' HB2' ' A' ' 107' ' ' MET . 92.9 m95 -121.15 136.33 55.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -118.88 118.15 30.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.201 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.448 HG21 ' HD2' ' A' ' 120' ' ' ARG . 59.5 t -63.94 126.03 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.238 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 11.8 p90 -128.5 -19.59 3.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -141.74 131.6 24.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.207 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -143.06 166.47 24.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.226 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 56.0 tt0 -141.03 146.44 37.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.932 . . . . 0.0 110.21 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 79.4 m-20 56.19 20.72 4.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.499 ' CE1' HD21 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -54.18 -53.67 50.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.862 . . . . 0.0 110.215 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -59.36 -57.04 14.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -46.25 -52.93 11.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.603 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 69.6 t80 -52.56 -46.3 66.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.17 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 mt -59.3 -43.05 92.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.893 . . . . 0.0 110.172 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -54.58 -42.08 70.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.4 75.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.83 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 3.9 tp -64.42 -17.41 63.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.17 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.83 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 74.95 28.91 1.04 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.226 -0.922 . . . . 0.0 110.22 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.559 HD11 HD23 ' A' ' 21' ' ' LEU . 20.2 mt -75.39 165.03 56.98 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.75 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.3 Cg_endo -73.11 139.89 30.3 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.036 1.545 . . . . 0.0 110.473 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HG2' ' HG3' ' A' ' 29' ' ' LYS . 41.9 tt0 -58.56 -36.32 73.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.291 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -61.55 -28.89 69.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.893 . . . . 0.0 110.192 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.75 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 33.3 tp -92.11 -29.2 16.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.222 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.654 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 95.8 mt -74.48 -44.29 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 3.5 mmpt? -71.07 -23.96 62.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.207 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.0 ttp -89.68 -29.31 18.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.16 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -100.64 -0.29 37.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.236 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.654 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -65.97 -11.61 48.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HB2' ' NE ' ' A' ' 32' ' ' ARG . 6.5 t0 -138.08 45.56 2.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 0.0 110.16 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.034 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 1.7 mt -115.81 122.1 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.895 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.54 82.42 0.12 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.236 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.034 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.7 Cg_endo -73.0 136.64 25.22 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.008 1.53 . . . . 0.0 110.451 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.6 mt -89.24 154.67 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.218 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.4 t -131.58 111.48 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 73.6 tt0 -94.81 132.47 39.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.451 HD12 ' CD1' ' A' ' 6' ' ' TRP . 67.4 mt -118.77 128.51 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -133.63 74.81 1.57 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 110.181 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.519 ' OE1' ' CZ ' ' A' ' 47' ' ' PHE . 13.0 pt20 -78.41 162.72 26.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 110.208 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 86.3 mttt -156.47 49.12 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 0.0 110.19 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.04 -100.61 0.9 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 39.5 m-20 -110.48 -7.85 14.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -1.221 . . . . 0.0 110.198 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -98.58 152.96 19.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.211 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.688 ' CD1' HD11 ' A' ' 64' ' ' LEU . 1.6 m-85 -136.42 136.42 39.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 110.155 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.01 110.82 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.196 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 4.6 m -113.75 135.32 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 91.1 m -122.07 98.16 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.91 . . . . 0.0 110.203 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.2 m -78.63 138.54 38.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.198 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -132.83 114.74 14.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.255 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.933 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -99.31 168.33 9.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.772 ' HD2' HG22 ' A' ' 53' ' ' THR . 47.1 Cg_endo -73.07 -33.85 7.01 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.017 1.535 . . . . 0.0 110.529 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -93.07 -21.87 19.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.221 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.658 ' O ' ' OG1' ' A' ' 53' ' ' THR . 1.6 tt0 -161.4 162.12 30.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.448 ' N ' ' CG ' ' A' ' 56' ' ' GLN . 3.5 p -128.71 130.11 46.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 110.263 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 73' ' ' MET . 87.9 t -129.19 124.28 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.186 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 14.5 t -109.64 143.08 39.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.285 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 59' ' ' THR . 23.7 m120 -138.72 148.98 44.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 110.211 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.4 t -140.59 134.94 31.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 110.245 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.666 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 27.5 p90 -148.03 166.91 26.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.7 m -115.46 146.38 41.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 0.0 110.185 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.688 HD11 ' CD1' ' A' ' 47' ' ' PHE . 14.5 mt -78.51 122.83 26.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.226 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.1 4.63 41.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -145.51 151.92 38.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -1.159 . . . . 0.0 110.16 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -72.4 131.13 42.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.11 151.46 49.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 12.9 p-10 -88.01 134.86 33.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 70' ' ' ILE . 8.3 mm -124.37 143.28 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.88 . . . . 0.0 110.208 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 m -117.76 134.09 55.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.579 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 1.4 p -88.86 158.96 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.601 ' HA ' HG21 ' A' ' 58' ' ' VAL . 72.7 mtm -74.27 -8.11 55.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.246 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.481 ' OD1' ' HB ' ' A' ' 72' ' ' THR . 46.0 p-10 -92.03 -15.47 27.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 74' ' ' ASP . . . 109.14 28.44 4.4 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.579 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 3.9 mttt -108.44 130.94 55.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -1.148 . . . . 0.0 110.201 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -111.2 136.55 50.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 110.187 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.526 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -160.55 161.82 32.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.154 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.19 157.56 18.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.3 p -169.17 140.39 2.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.227 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.0 m -98.14 102.67 14.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.626 HG13 HD21 ' A' ' 89' ' ' LEU . 46.5 t -72.22 140.76 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.252 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.547 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 14.4 p-80 -145.23 153.78 41.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.511 HD12 HD13 ' A' ' 64' ' ' LEU . 14.2 mt -100.99 126.37 47.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 0.0 110.251 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.25 147.3 39.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 53.3 15.25 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.22 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.62 48.83 6.04 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 7.3 pttt -169.85 135.96 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.324 -1.104 . . . . 0.0 110.229 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.626 HD21 HG13 ' A' ' 82' ' ' VAL . 5.5 tt -68.88 144.62 54.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.855 . . . . 0.0 110.238 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.547 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 73.4 t -152.03 114.28 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.315 -0.866 . . . . 0.0 110.215 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 86.9 m -105.7 98.74 8.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.275 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 17.2 pttt -94.58 155.14 17.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 17.3 t -145.96 -165.92 2.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.45 ' N ' ' OG ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -100.52 31.88 3.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 110.199 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.5 ptpt -175.38 4.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.203 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.894 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -179.31 145.5 0.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -122.5 159.75 27.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 110.264 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.515 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 54.0 t-80 -144.72 141.42 29.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.303 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.69 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 10.1 pt-20 -157.17 125.18 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 110.207 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.551 ' OE1' ' CE ' ' A' ' 107' ' ' MET . 6.1 tt0 -128.36 162.62 26.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.893 . . . . 0.0 110.213 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.496 ' CG ' ' HB2' ' A' ' 88' ' ' LYS . 20.3 mt-10 -153.73 155.93 36.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.81 139.96 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 110.197 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -135.8 98.65 3.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.01 -110.47 3.04 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -115.67 12.17 15.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -1.192 . . . . 0.0 110.16 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -117.71 160.03 22.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.199 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.551 ' CE ' ' OE1' ' A' ' 100' ' ' GLN . 28.1 tpp -132.09 138.02 47.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.56 132.54 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.18 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 34.8 mt-10 -117.71 130.1 56.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.672 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 5.7 m -122.65 124.45 43.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 97' ' ' SER . 87.3 mt -130.78 136.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.248 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.445 HG22 ' OG1' ' A' ' 117' ' ' THR . 15.8 p -113.36 127.11 56.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.257 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.515 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 27.3 t80 -149.29 129.79 13.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 110.172 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 62.41 39.58 97.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.44 6.58 49.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 114' ' ' GLY . 58.2 t -109.72 141.94 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -1.127 . . . . 0.0 110.258 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.445 ' OG1' HG22 ' A' ' 112' ' ' THR . 58.5 m -118.36 130.18 55.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.865 . . . . 0.0 110.211 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.603 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 48.8 tp -108.76 145.92 34.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.922 . . . . 0.0 110.252 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.09 114.68 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 32.5 ttp180 -111.49 128.02 55.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.96 . . . . 0.0 110.169 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 67.9 mtt180 -104.72 127.05 52.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 110.173 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 66.3 m -123.51 154.45 39.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.845 . . . . 0.0 110.171 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -118.14 160.7 21.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.162 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 5' ' ' THR . 15.6 ttp180 -88.79 137.69 32.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 125' ' ' VAL . 35.2 m . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.208 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.278 0.561 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 p -57.33 144.87 34.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.94 . . . . 0.0 110.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.73 -173.75 18.7 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.7 m -111.7 129.52 56.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -1.149 . . . . 0.0 110.229 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.523 ' CD1' HD12 ' A' ' 40' ' ' ILE . 70.1 m95 -118.01 138.61 52.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -118.31 118.13 30.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.3 t -64.95 126.22 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 18.0 p90 -127.08 -21.79 3.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.502 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -136.28 131.73 34.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.159 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.482 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 26.3 pt20 -146.98 118.27 7.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.204 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.442 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.5 tt0 -94.03 152.89 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.885 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 m120 50.47 27.25 2.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.169 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -58.05 -52.2 66.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -64.62 -50.52 66.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 110.188 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 36.7 mm-40 -51.06 -61.49 2.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.178 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.7 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 63.5 t80 -49.22 -52.3 27.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.171 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.581 HD23 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -59.5 -44.79 93.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 110.221 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 14.5 mttm -46.7 -38.31 9.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.29 -27.23 63.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.9 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.5 tp -61.87 -23.51 66.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.73 30.5 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.581 HD12 HD23 ' A' ' 18' ' ' LEU . 15.1 mt -77.53 166.77 41.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.1 Cg_endo -73.08 143.2 35.63 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.04 1.547 . . . . 0.0 110.43 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -65.16 -41.25 94.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.166 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -55.24 -28.14 51.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.397 -0.815 . . . . 0.0 110.175 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.575 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 41.5 tp -89.43 -22.07 22.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 24' ' ' PRO . 92.5 mt -86.99 -40.01 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -72.58 -30.04 64.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 110.241 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.405 ' CE ' ' HD2' ' A' ' 55' ' ' ARG . 9.5 ttp -87.77 -24.03 23.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -101.66 6.58 42.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 110.175 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.684 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 16.6 ptt180 -68.12 4.17 1.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.337 -0.852 . . . . 0.0 110.195 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.684 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.9 m-20 -151.73 50.21 0.81 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.087 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.3 mt -122.48 119.37 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.215 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -91.19 83.25 0.11 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 110.301 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.087 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.9 Cg_endo -73.02 136.52 24.97 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.023 1.538 . . . . 0.0 110.475 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 38' ' ' VAL . 55.1 mt -100.45 171.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.185 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.55 ' N ' HG22 ' A' ' 37' ' ' ILE . 11.2 p -147.41 132.9 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.217 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -110.3 111.55 22.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 110.206 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' A' ' 6' ' ' TRP . 64.3 mt -99.93 138.46 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.244 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.541 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 56.7 tt0 -137.76 70.0 1.39 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.154 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.569 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 52.5 tt0 -67.0 159.75 27.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.206 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 53.9 mmtt -156.17 42.76 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.59 -100.59 0.77 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -109.94 -5.62 15.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -1.185 . . . . 0.0 110.261 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.405 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 7.1 t0 -102.12 152.32 21.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.484 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 39.1 m-85 -133.96 140.88 47.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.198 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -126.55 104.9 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.211 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.75 135.8 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 110.231 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.737 ' OG1' HG23 ' A' ' 59' ' ' THR . 99.8 m -133.81 104.67 6.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 m -87.3 136.91 32.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.858 . . . . 0.0 110.247 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -129.65 123.53 31.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 110.188 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.644 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -107.15 169.03 7.18 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.05 -18.78 23.7 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.06 1.558 . . . . 0.0 110.448 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.405 ' HD2' ' CE ' ' A' ' 30' ' ' MET . 26.8 ttt180 -103.41 -21.92 13.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.21 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.644 ' O ' ' OG1' ' A' ' 53' ' ' THR . 17.8 pt20 -164.13 165.11 22.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 110.142 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 p -129.41 130.47 46.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.151 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.36 127.88 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.737 HG23 ' OG1' ' A' ' 50' ' ' THR . 91.2 m -112.27 137.76 49.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 59' ' ' THR . 58.0 m-20 -133.51 151.86 51.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 t -147.12 128.75 15.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.62 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 37.1 p90 -141.87 169.19 18.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 110.184 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.6 m -114.78 142.45 46.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.178 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.574 HD11 ' CA ' ' A' ' 83' ' ' HIS . 3.0 tp -76.58 124.95 28.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.99 -2.75 41.05 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.59 149.96 45.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -1.13 . . . . 0.0 110.18 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' OE2' ' HD2' ' A' ' 79' ' ' LYS . 71.4 tt0 -70.76 123.81 22.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.62 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -122.83 148.0 45.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 110.271 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -80.23 135.01 36.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 110.146 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.462 HD13 ' HA ' ' A' ' 70' ' ' ILE . 17.2 mm -128.22 145.14 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 110.25 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 t -119.23 135.43 54.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.27 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.436 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -84.15 156.28 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -17.18 64.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.407 ' OD1' ' HB2' ' A' ' 76' ' ' LYS . 2.9 p30 -83.11 -10.3 58.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.16 28.36 5.86 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.436 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 10.3 mtpt -106.24 133.76 50.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -1.129 . . . . 0.0 110.246 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.03 138.49 44.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.473 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -169.48 150.82 4.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.141 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.453 ' HD2' ' OE2' ' A' ' 67' ' ' GLU . 7.2 mtmm -95.15 155.95 16.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.916 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.28 131.76 5.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.195 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 m -93.37 99.39 11.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.226 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.898 ' CG1' HD21 ' A' ' 89' ' ' LEU . 40.7 t -73.99 143.86 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.662 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 2.9 p-80 -147.36 160.62 42.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 0.0 110.225 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 mp -101.06 133.87 44.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 0.0 110.186 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -139.03 115.52 10.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 53.2 t-20 62.79 24.19 14.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.656 ' O ' ' CG ' ' A' ' 88' ' ' LYS . . . 80.76 46.46 7.22 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.656 ' CG ' ' O ' ' A' ' 87' ' ' GLY . 28.7 mtmt -161.87 117.83 2.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -1.149 . . . . 0.0 110.219 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.898 HD21 ' CG1' ' A' ' 82' ' ' VAL . 1.7 tt -61.79 135.84 57.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 110.189 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.662 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 75.6 t -145.42 121.93 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.939 ' CG2' ' HB3' ' A' ' 98' ' ' HIS . 8.8 t -118.86 103.69 9.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.185 -0.947 . . . . 0.0 110.191 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 51.1 pttt -93.55 154.52 17.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 110.189 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 t -141.67 -158.24 0.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 36.8 mt-10 -109.52 31.82 5.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.22 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.57 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -176.88 6.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 110.198 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.835 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 178.28 147.5 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 111' ' ' ILE . 15.9 t -125.24 158.41 34.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 110.243 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.939 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 59.0 t-80 -141.61 146.02 35.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.849 ' HB2' HG23 ' A' ' 110' ' ' THR . 24.5 mt-10 -157.68 126.04 5.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.266 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 61.1 tt0 -126.17 162.06 26.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.538 ' OE2' ' O ' ' A' ' 102' ' ' VAL . 11.0 tm-20 -160.4 150.91 18.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.538 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 8.4 p -116.72 142.75 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.206 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 50.6 mttt -134.56 91.2 2.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.07 -107.42 2.79 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -115.09 9.64 15.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -1.199 . . . . 0.0 110.243 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -117.97 161.13 20.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 110.19 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.48 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -131.85 140.68 49.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.216 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.5 t -126.92 125.02 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.224 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 28.0 mt-10 -110.73 126.99 55.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.849 HG23 ' HB2' ' A' ' 99' ' ' GLU . 4.8 t -117.93 119.46 34.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.216 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 97' ' ' SER . 71.6 mt -126.12 132.16 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 31.8 m -109.74 132.93 53.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.616 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 11.8 t80 -156.3 127.39 6.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.929 . . . . 0.0 110.223 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 67.28 36.54 89.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.34 7.3 60.15 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 17' ' ' PHE . 60.4 t -111.01 141.01 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -1.156 . . . . 0.0 110.223 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 78.5 m -117.48 130.44 56.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.226 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.7 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 54.7 tp -110.38 146.85 35.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.239 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.31 100.25 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.182 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.44 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 9.1 mtm180 -93.39 119.89 33.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.0 110.207 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 42.3 mtt180 -101.13 125.75 47.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 110.231 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.8 m -123.88 158.1 32.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.184 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 10.4 tttm -119.93 158.31 26.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.415 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 22.3 ttt180 -85.68 136.64 33.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 110.24 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.207 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 75.2 m-85 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.249 0.547 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.8 m -56.89 144.43 33.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.209 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.27 -175.95 18.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.732 HG22 ' HG3' ' A' ' 39' ' ' GLU . 19.2 p -107.04 131.59 53.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -1.126 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.544 ' CD1' ' HE2' ' A' ' 107' ' ' MET . 93.2 m95 -119.6 137.02 54.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -119.28 113.7 21.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.239 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.424 HG11 ' OE1' ' A' ' 11' ' ' GLN . 39.9 t -61.04 135.99 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.165 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 10' ' ' ALA . 10.9 p90 -139.09 -15.82 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.206 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.532 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -138.7 130.97 28.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.435 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 15.7 mt-30 -144.87 160.64 40.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.902 . . . . 0.0 110.202 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.782 ' CD ' HD12 ' A' ' 119' ' ' ILE . 12.7 pt-20 -137.77 150.91 47.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.147 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.7 m120 54.35 33.79 19.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.44 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.6 t80 -62.83 -54.32 40.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -60.78 -53.72 53.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -50.0 -56.05 12.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.494 ' HD1' HD22 ' A' ' 18' ' ' LEU . 33.2 t80 -54.05 -47.0 72.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.895 ' CD1' HD12 ' A' ' 23' ' ' LEU . 2.3 mm? -60.74 -42.1 96.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.163 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -54.45 -37.52 65.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 110.159 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.91 -33.2 71.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 110.24 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.869 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.5 tp -63.86 -21.19 66.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 0.0 110.252 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.869 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 77.98 31.77 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 110.216 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.895 HD12 ' CD1' ' A' ' 18' ' ' LEU . 14.2 mt -80.13 166.18 42.02 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.183 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.484 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.09 142.35 34.19 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.103 1.581 . . . . 0.0 110.386 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.538 ' CD ' ' HE3' ' A' ' 29' ' ' LYS . 43.2 tt0 -64.79 -33.5 76.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -61.15 -26.88 68.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.484 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 40.0 tp -90.07 -27.81 19.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 110.158 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.5 mt -76.19 -45.23 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.287 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HE3' ' CD ' ' A' ' 25' ' ' GLU . 21.0 mttt -69.4 -26.82 64.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.4 mtt -85.95 -27.66 24.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.189 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -101.47 7.38 42.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.579 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 16.0 ptt180 -66.7 -1.28 3.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.202 -0.936 . . . . 0.0 110.195 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.579 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.1 m-20 -148.0 47.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.259 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.974 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 5.1 mt -121.51 115.49 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 110.242 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -92.54 88.76 0.33 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.974 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.9 Cg_endo -73.03 139.26 29.6 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.042 1.548 . . . . 0.0 110.467 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 38' ' ' VAL . 17.2 mt -89.89 162.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' N ' HG22 ' A' ' 37' ' ' ILE . 79.5 t -139.11 114.05 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 110.217 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.732 ' HG3' HG22 ' A' ' 5' ' ' THR . 13.4 tt0 -98.12 136.6 38.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 110.168 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.518 HD12 ' CD1' ' A' ' 6' ' ' TRP . 74.8 mt -124.68 129.29 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 54.6 tt0 -129.92 75.1 1.63 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 0.0 110.19 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.72 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 2.0 tm0? -72.39 162.06 29.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 43.1 mtmt -160.51 49.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.18 -104.19 1.31 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 64.4 m-20 -109.85 -0.37 18.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -1.148 . . . . 0.0 110.152 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.0 t0 -104.03 146.54 28.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.0 110.194 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.787 ' CE1' HD11 ' A' ' 64' ' ' LEU . 4.1 m-85 -128.36 135.42 49.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.4 t -123.7 108.29 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.212 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.3 t -110.23 128.98 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.8 m -129.13 108.03 10.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -92.04 138.25 31.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.25 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 1.1 pttt -131.85 126.09 33.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 110.166 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.865 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.89 170.41 5.46 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.926 . . . . 0.0 110.184 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.752 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.5 Cg_endo -73.03 -20.03 22.35 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.039 1.547 . . . . 0.0 110.497 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -105.04 -22.03 13.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 0.0 110.218 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -161.83 159.6 27.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.241 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.4 p -130.51 131.0 44.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 110.239 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.402 ' CG1' HG23 ' A' ' 71' ' ' THR . 56.2 t -128.53 129.36 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.223 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.4 t -111.19 137.49 48.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.257 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.417 ' HB3' ' CD1' ' A' ' 70' ' ' ILE . 63.0 m-20 -132.3 149.62 52.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 110.161 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 t -144.67 128.97 17.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.898 . . . . 0.0 110.186 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.442 ' CB ' ' CB ' ' A' ' 68' ' ' ALA . 39.6 p90 -142.81 170.44 15.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.521 HG21 ' HE2' ' A' ' 66' ' ' LYS . 17.6 m -119.01 153.41 34.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.222 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.787 HD11 ' CE1' ' A' ' 47' ' ' PHE . 22.2 mt -81.4 125.34 30.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.22 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.28 12.39 54.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HE2' HG21 ' A' ' 63' ' ' THR . 46.7 mtmt -146.7 139.26 25.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.147 . . . . 0.0 110.218 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -66.04 127.22 31.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -127.94 149.06 50.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.57 138.53 33.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.177 -0.952 . . . . 0.0 110.254 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 70' ' ' ILE . 5.0 mm -130.57 144.43 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.415 HG22 ' OD1' ' A' ' 60' ' ' ASN . 4.1 t -118.22 135.01 54.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.671 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 34.7 p -87.1 160.38 18.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.189 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.517 ' SD ' HG21 ' A' ' 53' ' ' THR . 11.9 ttm -72.22 -11.53 60.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -89.51 -13.36 37.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.155 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.0 51.11 0.96 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 11.0 mttt -128.53 133.11 48.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -1.126 . . . . 0.0 110.169 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -110.0 135.87 50.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.499 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -164.02 159.71 20.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.224 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -105.86 155.32 19.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.197 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.1 p -164.13 136.62 4.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.23 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.4 m -95.29 97.67 10.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 110.225 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.827 HG13 HD21 ' A' ' 89' ' ' LEU . 47.6 t -69.23 142.18 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 110.248 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.62 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 9.6 p-80 -147.54 150.09 33.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.43 HD12 HD13 ' A' ' 64' ' ' LEU . 18.5 mt -96.06 129.89 43.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.54 144.12 31.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 110.141 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.36 11.55 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.59 45.39 6.11 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 11.5 pttt -170.76 132.28 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -1.124 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.827 HD21 HG13 ' A' ' 82' ' ' VAL . 3.6 tt -61.16 149.19 38.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.896 HG22 ' HG3' ' A' ' 99' ' ' GLU . 87.3 t -155.51 109.3 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 87.2 m -103.01 103.78 13.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.183 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.433 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 5.6 ptmt -99.4 157.47 16.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.224 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 14.3 t -151.21 -171.13 3.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.202 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.54 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 54.3 tt0 -98.14 30.73 2.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.188 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.525 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 1.6 pttt -169.8 -2.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 0.0 110.205 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.854 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -176.31 147.49 0.7 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.92 . . . . 0.0 110.212 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.8 159.05 28.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.847 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.637 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 64.6 t-80 -143.17 137.08 28.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.896 ' HG3' HG22 ' A' ' 90' ' ' VAL . 44.8 tt0 -151.19 126.91 10.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.163 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.576 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 9.1 tt0 -133.76 154.79 50.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 110.111 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.487 ' HA ' ' CE1' ' A' ' 2' ' ' PHE . 58.8 tt0 -149.37 159.86 43.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 110.269 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.41 138.06 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -0.897 . . . . 0.0 110.173 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -133.84 93.97 3.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.277 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.67 -106.75 2.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -118.78 12.61 13.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -1.135 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.04 155.27 31.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.159 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.544 ' HE2' ' CD1' ' A' ' 6' ' ' TRP . 25.8 tpp -128.41 140.31 51.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.1 t -125.97 126.69 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.183 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.576 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 29.5 mt-10 -114.58 136.13 53.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 p -124.73 123.93 41.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.233 -0.917 . . . . 0.0 110.22 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 72.7 mt -130.88 129.82 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 5.0 t -113.41 131.87 55.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 6.3 t80 -154.19 125.12 7.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.256 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.29 33.38 61.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.25 3.73 66.42 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 112' ' ' THR . 62.9 t -109.69 139.56 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -1.157 . . . . 0.0 110.199 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 55.3 m -113.98 135.22 54.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.224 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 12' ' ' GLU . 41.6 tp -113.95 139.13 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.172 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.782 HD12 ' CD ' ' A' ' 12' ' ' GLU . 96.8 mt -120.43 110.45 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -105.96 120.94 43.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.94 . . . . 0.0 110.186 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 52.4 mtt180 -102.17 127.05 49.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 0.0 110.19 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.9 m -122.81 163.41 20.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.207 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -128.15 158.56 37.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.902 . . . . 0.0 110.19 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -85.11 136.56 33.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.177 -179.955 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.32 0.581 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.3 p -56.81 145.71 28.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.44 -177.02 17.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.763 HG22 ' HG3' ' A' ' 39' ' ' GLU . 42.3 p -105.75 134.24 49.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -1.182 . . . . 0.0 110.18 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.497 ' CD1' ' HE2' ' A' ' 107' ' ' MET . 95.3 m95 -121.27 142.62 49.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -124.07 118.2 26.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.209 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.4 HG12 ' CD ' ' A' ' 11' ' ' GLN . 49.2 t -65.8 126.78 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 110.167 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 22.6 p90 -128.16 -23.07 3.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.719 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -135.13 133.61 39.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 110.223 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.719 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 2.0 mp0 -146.7 112.24 5.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.892 . . . . 0.0 110.216 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.484 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.1 tt0 -89.65 147.32 23.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.442 ' ND2' ' HG2' ' A' ' 12' ' ' GLU . 75.6 m-20 55.02 24.07 5.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.655 ' CE1' HD11 ' A' ' 18' ' ' LEU . 27.5 t80 -56.57 -52.43 64.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 110.208 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -63.54 -48.61 76.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.23 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 66.8 mt-10 -53.79 -62.23 1.79 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 110.222 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.71 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 38.2 t80 -48.29 -57.83 5.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.66 HD23 HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -57.12 -46.66 82.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 110.183 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -42.79 -41.86 3.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.192 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.19 -28.25 66.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.866 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -58.13 -20.13 38.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.219 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 77.94 31.37 0.42 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.66 HD12 HD23 ' A' ' 18' ' ' LEU . 15.5 mt -77.03 165.99 48.1 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.188 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.615 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.08 140.59 31.46 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.969 1.51 . . . . 0.0 110.409 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.411 ' HG2' ' HE2' ' A' ' 29' ' ' LYS . 42.4 tt0 -61.52 -39.48 91.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.29 -26.54 63.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.309 -0.87 . . . . 0.0 110.191 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.615 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 14.8 tp -90.42 -23.26 21.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 95.2 mt -81.09 -43.18 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.978 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HE2' ' HG2' ' A' ' 25' ' ' GLU . 37.3 mtmt -72.52 -24.41 61.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 37.4 mtt -87.9 -32.91 18.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -97.99 5.44 48.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.632 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 31.3 ptt85 -65.53 -1.11 2.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.632 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.6 m-20 -149.91 47.57 0.93 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.942 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.9 mt -118.7 121.03 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -95.8 83.02 0.22 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.337 -0.852 . . . . 0.0 110.234 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.942 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.5 Cg_endo -73.05 137.49 26.55 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.031 1.543 . . . . 0.0 110.47 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.5 mt -90.01 157.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.155 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.3 t -134.93 112.72 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.763 ' HG3' HG22 ' A' ' 5' ' ' THR . 21.0 tt0 -94.05 138.24 32.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.234 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.469 HD12 ' CD1' ' A' ' 6' ' ' TRP . 71.3 mt -126.73 127.78 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.214 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -133.03 75.27 1.61 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.246 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.533 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 6.7 pt20 -78.57 163.53 25.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.218 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 31.0 mmtp -154.79 49.93 0.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.75 -99.21 0.8 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -110.05 -9.11 14.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.271 -1.135 . . . . 0.0 110.216 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 34.4 t0 -98.0 157.23 16.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 110.196 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.605 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.1 m-85 -139.89 133.55 30.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.232 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.9 t -114.24 100.75 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 110.242 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 60' ' ' ASN . 4.2 p -100.85 135.49 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.187 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 59' ' ' THR . 36.0 m -138.59 105.56 5.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.4 m -88.4 138.2 31.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.244 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -130.35 119.16 22.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 110.282 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.854 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -106.89 167.44 9.48 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 110.223 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.767 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.8 Cg_endo -73.07 -20.68 21.47 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.057 1.556 . . . . 0.0 110.472 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -102.93 -20.6 14.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -166.31 159.17 14.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.907 . . . . 0.0 110.191 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.3 p -129.05 131.29 47.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.224 -0.922 . . . . 0.0 110.205 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.26 128.26 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 110.19 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 50' ' ' THR . 46.2 m -110.59 136.83 49.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 110.19 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 49' ' ' VAL . 81.6 m-20 -135.02 153.91 51.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.245 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.2 t -143.17 128.17 18.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.221 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.706 ' CE1' HG21 ' A' ' 82' ' ' VAL . 52.4 p90 -139.7 168.59 19.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.162 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.5 m -120.07 142.48 48.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 84' ' ' LEU . 15.5 mt -74.21 126.03 29.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 110.258 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.89 58.23 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -137.47 142.23 41.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.263 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -68.01 126.25 28.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.207 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . . . -127.28 150.1 49.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 0.0 110.237 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -81.57 136.56 35.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 110.227 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.47 HD13 ' HA ' ' A' ' 70' ' ' ILE . 3.8 mm -129.43 144.77 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -116.77 134.42 54.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.253 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.02 155.06 21.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.883 . . . . 0.0 110.128 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 53' ' ' THR . 16.4 ttm -67.13 -14.94 63.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.215 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.47 -13.07 47.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.54 29.72 4.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -104.99 135.39 46.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -1.156 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -112.02 132.59 54.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.227 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -161.14 162.95 31.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -107.86 158.69 17.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.194 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.498 ' HB2' HG23 ' A' ' 91' ' ' THR . 25.3 p -165.4 147.26 7.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.204 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.45 87.85 2.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.223 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 89' ' ' LEU . 16.1 t -53.3 154.96 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 110.18 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.537 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -152.17 147.46 26.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 0.0 110.224 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.633 HD12 HD13 ' A' ' 64' ' ' LEU . 13.9 mt -100.91 99.07 9.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 87' ' ' GLY . . . -114.37 152.59 31.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.178 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.496 ' HB3' ' CD ' ' A' ' 88' ' ' LYS . 3.3 t30 46.5 17.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 110.149 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 85' ' ' ALA . . . 77.97 48.96 7.31 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.754 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -167.21 127.69 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -1.159 . . . . 0.0 110.252 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.859 HD11 HG11 ' A' ' 82' ' ' VAL . 4.2 tt -59.22 147.67 34.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 110.179 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.824 HG12 ' HG3' ' A' ' 99' ' ' GLU . 22.2 m -154.67 109.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 97.5 m -103.55 100.11 9.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -98.11 161.0 13.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.47 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -152.33 -165.36 2.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 110.186 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 49.2 tt0 -101.16 31.29 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' CE2' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -173.3 4.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.933 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.67 141.69 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.303 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.617 ' O ' HG23 ' A' ' 111' ' ' ILE . 69.3 m -117.52 160.52 21.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.566 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.9 t-80 -144.12 140.66 29.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.824 ' HG3' HG12 ' A' ' 90' ' ' VAL . 14.0 tt0 -155.17 123.59 5.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.231 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 12.0 tt0 -129.04 157.17 42.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -153.84 154.67 34.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.209 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.43 141.52 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.226 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -136.61 90.69 2.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.24 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.8 -105.59 2.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -119.19 11.42 12.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -1.145 . . . . 0.0 110.169 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -117.52 154.31 31.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.229 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.497 ' HE2' ' CD1' ' A' ' 6' ' ' TRP . 26.8 tpp -125.38 138.57 54.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 110.293 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.2 t -126.4 124.73 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.33 -0.857 . . . . 0.0 110.228 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 33.2 mt-10 -112.32 121.61 45.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 99' ' ' GLU . 85.4 m -110.19 119.09 38.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.231 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 97' ' ' SER . 68.1 mt -126.52 129.72 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 74.7 m -109.31 138.06 46.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.547 ' CE2' ' O ' ' A' ' 95' ' ' LYS . 21.1 t80 -160.81 127.65 4.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 110.196 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.23 34.45 75.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.75 8.55 68.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.3 t -112.4 141.42 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -1.168 . . . . 0.0 110.207 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.9 m -116.9 130.94 57.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 110.259 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.71 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 41.8 tp -110.34 152.68 25.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.5 mt -131.37 94.6 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -88.57 126.53 35.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.221 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 27.6 mtt180 -106.23 125.78 51.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 56.5 m -123.49 153.42 40.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.919 . . . . 0.0 110.218 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -119.81 159.01 25.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.87 . . . . 0.0 110.204 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -86.0 135.28 33.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.255 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.434 ' CE2' HG12 ' A' ' 102' ' ' VAL . 29.7 m-85 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.283 0.563 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -51.91 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.36 -162.69 33.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.655 HG22 ' HG3' ' A' ' 39' ' ' GLU . 9.8 p -114.2 128.07 56.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -1.145 . . . . 0.0 110.22 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.532 ' CD1' HD12 ' A' ' 40' ' ' ILE . 92.0 m95 -117.11 137.82 52.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.254 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.37 123.19 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 110.257 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.52 133.03 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.544 ' CD1' ' HB2' ' A' ' 10' ' ' ALA . 34.2 p90 -133.75 -27.62 1.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.544 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -130.94 137.13 49.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.56 ' O ' ' HG2' ' A' ' 11' ' ' GLN . 3.7 pm0 -152.18 140.96 20.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.209 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.402 ' O ' HD12 ' A' ' 118' ' ' LEU . 30.9 tt0 -115.28 151.26 34.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 50.57 25.38 1.98 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -55.22 -47.13 75.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -0.92 . . . . 0.0 110.241 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.12 -51.82 54.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -49.03 -61.64 1.96 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.169 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.605 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 52.2 t80 -50.32 -44.94 54.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.142 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 18' ' ' LEU . 49.5 mt -61.14 -46.72 89.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.245 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -50.98 -36.53 39.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.262 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.38 -32.21 72.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.849 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -61.14 -21.01 63.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.849 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 75.62 37.82 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.248 -0.907 . . . . 0.0 110.172 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.734 HD22 ' HD2' ' A' ' 24' ' ' PRO . 3.7 mt -79.19 165.32 49.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.734 ' HD2' HD22 ' A' ' 23' ' ' LEU . 46.2 Cg_endo -73.04 136.37 24.68 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.989 1.521 . . . . 0.0 110.508 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -54.09 -30.78 49.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.53 -41.55 96.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.902 . . . . 0.0 110.271 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.605 HD22 ' OD1' ' A' ' 74' ' ' ASP . 63.4 tp -80.09 -45.83 17.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.247 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.8 mt -53.48 -54.1 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 110.215 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 6.6 mmtp -59.35 -29.73 67.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.438 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 65.1 mtt -86.08 -20.53 28.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 0.0 110.168 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.555 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -103.67 4.56 35.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.245 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.767 ' HG3' ' OD2' ' A' ' 33' ' ' ASP . 20.3 ptt180 -75.21 -0.4 19.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.227 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.767 ' OD2' ' HG3' ' A' ' 32' ' ' ARG . 62.6 m-20 -152.36 42.03 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.964 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 27.5 mt -121.36 115.46 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.219 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.55 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -92.25 88.83 0.32 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.208 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.964 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.4 Cg_endo -73.12 138.6 28.25 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.026 1.54 . . . . 0.0 110.399 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -89.62 157.35 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.254 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -136.84 119.09 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.655 ' HG3' HG22 ' A' ' 5' ' ' THR . 28.5 tt0 -100.64 134.5 43.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 110.185 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.532 HD12 ' CD1' ' A' ' 6' ' ' TRP . 83.0 mt -121.9 129.48 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -131.89 74.9 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.807 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 4.0 tt0 -73.87 164.45 26.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.6 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 47.3 mttt -156.97 42.29 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 110.221 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.8 -97.69 0.62 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -112.88 -0.24 14.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -1.185 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -104.84 147.95 27.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.967 . . . . 0.0 110.243 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 1.178 ' CD2' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -128.57 133.95 48.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 110.224 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.5 t -122.37 107.73 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.248 -0.908 . . . . 0.0 110.191 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.18 133.99 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.2 m -132.69 107.46 8.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 0.0 110.203 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -92.0 137.45 32.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 110.234 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 1.6 pttm -131.5 127.83 38.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.58 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -111.49 170.23 5.49 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 110.186 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.99 -16.54 25.64 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.054 1.555 . . . . 0.0 110.487 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.0 mtp-105 -106.32 -19.33 13.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.898 . . . . 0.0 110.191 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.58 ' O ' ' OG1' ' A' ' 53' ' ' THR . 19.5 pt20 -167.44 161.25 13.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 110.232 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.9 p -130.03 133.8 46.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.3 t -131.3 130.18 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.937 . . . . 0.0 110.176 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 59' ' ' THR . 13.9 t -112.04 134.8 53.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 110.143 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -129.69 151.91 49.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -0.88 . . . . 0.0 110.173 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -147.04 127.39 13.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.649 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 38.2 p90 -141.4 172.93 12.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 110.218 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.5 m -118.68 148.71 42.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.202 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.178 HD11 ' CD2' ' A' ' 47' ' ' PHE . 9.9 mt -79.57 123.34 27.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.269 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.93 5.41 47.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -143.94 145.3 32.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -1.139 . . . . 0.0 110.164 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.21 127.19 31.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -125.42 148.18 48.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -83.86 136.2 34.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.922 . . . . 0.0 110.224 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 70' ' ' ILE . 6.0 mm -127.85 145.96 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.172 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 t -119.84 133.46 55.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.626 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -83.28 155.8 23.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -17.04 63.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 110.228 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.605 ' OD1' HD22 ' A' ' 27' ' ' LEU . 8.1 t0 -84.89 -12.24 53.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.34 30.58 4.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.626 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 23.5 mttt -107.28 131.98 53.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -1.136 . . . . 0.0 110.15 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -111.69 138.19 48.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.218 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.55 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -167.65 159.37 11.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 57.3 mttt -103.75 167.5 9.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 110.202 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 27.0 p -178.22 137.36 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 110.245 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.9 m -93.93 104.9 16.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.31 -0.869 . . . . 0.0 110.213 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.695 HG13 HD21 ' A' ' 89' ' ' LEU . 55.3 t -75.78 140.28 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.257 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.563 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 9.0 p-80 -144.11 155.25 43.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 89' ' ' LEU . 4.3 tp -100.14 134.41 43.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.92 117.55 14.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 10.0 t-20 61.55 30.23 18.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 75.94 40.99 29.01 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 83.5 mttt -152.96 125.0 7.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 110.181 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.695 HD21 HG13 ' A' ' 82' ' ' VAL . 7.8 tt -71.44 134.47 46.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.197 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.757 HG13 ' HG2' ' A' ' 99' ' ' GLU . 77.2 t -140.64 120.26 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 110.286 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 53.6 m -113.24 92.4 3.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.211 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 14.3 ptmt -86.22 160.6 19.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.446 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -152.96 -169.77 3.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.145 -0.972 . . . . 0.0 110.211 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -99.29 36.93 1.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.19 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.489 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -179.15 -1.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.823 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -175.11 147.3 0.91 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.242 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 111' ' ' ILE . 39.1 m -124.53 152.49 43.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.497 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 62.3 t-80 -137.47 142.91 41.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 110.261 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.757 ' HG2' HG13 ' A' ' 90' ' ' VAL . 47.5 mt-10 -153.24 128.65 9.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 12.5 tt0 -132.51 152.7 51.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.131 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.57 155.38 39.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 110.259 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.515 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.9 p -119.71 135.49 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -128.6 96.07 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 110.177 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.94 -101.67 1.72 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -120.67 10.78 11.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -1.142 . . . . 0.0 110.177 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -119.6 158.34 26.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.225 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.459 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -129.27 140.39 51.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 110.165 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.4 t -123.35 123.16 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 29.5 mt-10 -109.48 121.07 44.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 99' ' ' GLU . 20.8 m -111.95 117.02 31.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 97' ' ' SER . 67.6 mt -123.31 128.21 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 45.6 m -107.99 135.59 49.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.528 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 13.8 t80 -158.39 127.36 5.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 65.89 37.48 93.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.99 8.22 60.87 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 17' ' ' PHE . 60.5 t -111.03 139.08 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -1.116 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 62.0 m -117.78 132.09 56.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.605 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 67.5 tp -110.9 149.14 31.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.3 mt -128.33 98.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 16.3 mtm180 -96.11 128.52 43.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 25.3 mtt180 -104.31 128.26 52.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 107' ' ' MET . 75.4 m -124.09 155.99 37.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.202 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -119.41 151.01 39.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 110.203 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 5' ' ' THR . 45.4 ttt180 -75.71 138.31 41.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.188 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.7 ' OXT' HG22 ' A' ' 125' ' ' VAL . 9.3 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.268 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.235 0.54 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 76.6 p -56.64 145.32 28.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.27 -174.06 18.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.1 m -109.85 130.25 55.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -1.136 . . . . 0.0 110.218 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.479 ' CD1' HD12 ' A' ' 40' ' ' ILE . 90.5 m95 -118.61 145.66 45.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.853 . . . . 0.0 110.25 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -127.97 118.94 24.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.181 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.554 HG21 ' HD2' ' A' ' 120' ' ' ARG . 48.9 t -64.35 136.35 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.945 . . . . 0.0 110.23 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 11.1 p90 -137.61 -19.14 1.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 110.224 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.705 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -137.22 134.28 36.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -0.925 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.705 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 5.1 mt-30 -149.0 162.76 39.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 110.158 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.502 ' O ' HD12 ' A' ' 118' ' ' LEU . 59.4 tt0 -134.12 144.85 48.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.415 ' ND2' ' OE1' ' A' ' 16' ' ' GLU . 4.3 t30 54.98 35.7 25.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.266 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -65.08 -49.23 70.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 0.0 110.199 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -60.88 -48.08 83.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.166 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 55.2 mt-10 -55.32 -46.2 76.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.591 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 43.5 t80 -52.86 -60.31 3.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.887 . . . . 0.0 110.271 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.764 HD22 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -50.83 -39.94 54.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.199 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -58.77 -36.81 74.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.245 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.18 -38.2 60.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.973 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.9 tp -56.57 -25.24 51.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.925 . . . . 0.0 110.19 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.973 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 84.99 18.1 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.764 HD12 HD22 ' A' ' 18' ' ' LEU . 15.3 mt -66.1 166.86 14.11 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 47.2 Cg_endo -73.04 133.31 19.52 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.019 1.536 . . . . 0.0 110.446 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.986 ' HA ' HD12 ' A' ' 28' ' ' ILE . 61.1 mm-40 -51.23 -46.41 62.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.197 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.09 -37.27 20.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.516 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 35.3 tp -80.1 -37.36 33.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.898 . . . . 0.0 110.288 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.986 HD12 ' HA ' ' A' ' 25' ' ' GLU . 45.6 mt -58.82 -54.75 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -56.9 -24.45 52.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.575 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 56.6 mtt -93.62 -18.39 22.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.233 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -105.45 -10.59 16.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.224 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -1.71 3.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -150.83 47.03 0.86 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.169 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 13.1 mt -125.0 109.0 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -84.1 88.13 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.169 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.2 Cg_endo -73.11 138.42 27.98 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.04 1.548 . . . . 0.0 110.45 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 38' ' ' VAL . 46.1 mt -89.78 164.56 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 110.178 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.552 HG21 HH22 ' A' ' 120' ' ' ARG . 75.9 t -141.79 119.98 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 110.287 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -101.83 135.91 42.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.205 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.487 ' CD1' ' HE1' ' A' ' 107' ' ' MET . 75.5 mt -121.32 129.78 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.15 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 43.7 tt0 -132.33 66.51 1.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.943 . . . . 0.0 110.228 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.919 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 37.6 tt0 -71.47 162.26 29.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.573 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 18.5 pttm -159.11 48.01 0.32 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.296 -0.878 . . . . 0.0 110.175 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.4 -103.16 0.78 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 60.2 m-20 -111.52 0.57 16.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -1.132 . . . . 0.0 110.167 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.728 ' OD1' HG23 ' A' ' 63' ' ' THR . 43.6 m-20 -104.18 150.35 24.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 110.267 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 1.168 ' CD2' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -130.88 135.46 47.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.42 105.75 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 110.219 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.6 t -109.07 135.18 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.257 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.766 ' OG1' HG23 ' A' ' 59' ' ' THR . 98.3 m -132.17 108.49 9.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.902 . . . . 0.0 110.163 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -90.1 132.77 35.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.9 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -127.94 122.72 33.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.264 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.631 ' CG2' ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -106.16 170.19 6.08 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.178 -0.951 . . . . 0.0 110.225 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.12 -17.73 24.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.066 1.561 . . . . 0.0 110.382 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -104.11 -22.69 13.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 0.0 110.176 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.592 ' O ' ' OG1' ' A' ' 53' ' ' THR . 14.7 pt20 -162.82 164.69 26.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.7 p -130.29 130.41 44.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.915 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.47 HG21 ' HG3' ' A' ' 73' ' ' MET . 61.6 t -128.86 126.27 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.766 HG23 ' OG1' ' A' ' 50' ' ' THR . 85.6 m -108.83 141.18 41.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.233 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.534 ' OD1' ' O ' ' A' ' 59' ' ' THR . 73.2 m-20 -137.11 151.61 49.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.4 m -146.58 132.07 18.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.602 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 41.2 p90 -145.24 170.13 16.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.918 . . . . 0.0 110.185 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.728 HG23 ' OD1' ' A' ' 46' ' ' ASP . 86.5 m -116.26 148.53 40.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.168 HD11 ' CD2' ' A' ' 47' ' ' PHE . 10.4 mt -80.17 124.25 28.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.72 6.67 49.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -145.82 148.76 33.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -1.082 . . . . 0.0 110.217 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -71.68 125.2 26.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.204 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.602 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -122.24 150.43 42.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 110.221 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -84.53 133.16 34.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 110.102 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 70' ' ' ILE . 5.1 mm -126.38 146.71 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.221 -0.924 . . . . 0.0 110.175 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -121.44 135.03 55.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 110.232 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.509 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -84.81 154.77 22.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.47 ' HG3' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -67.63 -15.04 63.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.223 -0.923 . . . . 0.0 110.176 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 76' ' ' LYS . 3.0 p30 -85.52 -10.37 56.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.938 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.2 31.97 4.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.509 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 26.4 mttt -108.77 132.63 53.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.13 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -108.38 136.69 47.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.872 . . . . 0.0 110.203 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.447 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -165.49 156.94 14.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -105.56 165.12 11.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 0.0 110.224 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -175.15 137.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.293 -0.88 . . . . 0.0 110.178 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 m -95.52 99.89 11.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -0.894 . . . . 0.0 110.195 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.781 HG11 HD11 ' A' ' 89' ' ' LEU . 53.1 t -72.99 141.24 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 5.3 p-80 -146.55 160.33 42.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.77 130.83 48.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 110.212 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.426 ' O ' ' HE2' ' A' ' 88' ' ' LYS . . . -137.46 133.37 34.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.1 t30 57.63 13.44 1.94 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.04 53.54 2.81 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.818 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 3.6 pttt -174.74 125.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -1.182 . . . . 0.0 110.214 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.781 HD11 HG11 ' A' ' 82' ' ' VAL . 4.1 tt -57.31 147.46 25.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.18 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 89' ' ' LEU . 78.9 t -157.57 109.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.971 ' CG2' ' HB3' ' A' ' 98' ' ' HIS . 10.0 t -106.39 107.93 19.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 110.21 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -97.53 151.99 19.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.146 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 1.4 m -144.86 -174.1 4.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 110.162 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 61.1 tt0 -99.0 38.49 1.38 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 94' ' ' GLU . 2.6 pttt 179.22 2.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.206 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.825 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.82 143.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 0.0 110.197 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -125.06 157.31 36.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.971 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 46.5 t-80 -144.79 143.16 30.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.203 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.473 ' CG ' HG22 ' A' ' 90' ' ' VAL . 17.1 tt0 -153.9 125.05 7.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.509 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 42.6 tt0 -125.83 158.93 33.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.895 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -156.68 156.94 34.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 110.148 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.437 HG23 ' CH2' ' A' ' 6' ' ' TRP . 10.0 p -120.84 140.35 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -132.82 89.14 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.1 -104.67 2.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.606 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 44.2 p-10 -117.79 7.39 12.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -1.123 . . . . 0.0 110.274 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.606 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 43.4 mt-10 -115.16 167.75 10.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.247 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.487 ' HE1' ' CD1' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -138.98 139.88 38.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 110.226 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.1 t -125.78 129.36 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 24.0 mt-10 -116.67 135.61 53.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.6 m -124.79 120.93 33.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.203 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 97' ' ' SER . 81.4 mt -126.76 135.88 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.246 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.498 HG22 HG23 ' A' ' 117' ' ' THR . 73.5 p -117.5 125.06 50.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.255 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.51 ' HD2' ' CB ' ' A' ' 96' ' ' PHE . 56.0 t80 -148.11 128.06 13.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -0.877 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.3 35.92 88.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.12 6.0 59.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 112' ' ' THR . 76.9 t -111.08 135.65 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -1.132 . . . . 0.0 110.199 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.498 HG23 HG22 ' A' ' 112' ' ' THR . 57.4 m -113.37 135.89 53.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.591 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 18.9 tp -115.03 141.29 48.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.55 108.63 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.554 ' HD2' HG21 ' A' ' 8' ' ' VAL . 26.8 ttp180 -104.92 124.54 49.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.16 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 9.4 mtm180 -103.72 124.96 49.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.423 ' OG ' HG22 ' A' ' 8' ' ' VAL . 56.9 m -119.57 161.39 20.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.277 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 34.7 tttm -127.76 155.81 43.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 110.249 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.4 ttt180 -80.27 134.68 36.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.9 . . . . 0.0 110.217 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.204 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 87.6 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.212 0.53 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.4 p -54.99 143.34 26.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.915 . . . . 0.0 110.149 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.05 -173.61 17.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.7 m -107.94 131.71 54.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -1.191 . . . . 0.0 110.23 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.513 ' NE1' ' HE3' ' A' ' 107' ' ' MET . 89.9 m95 -119.72 134.82 55.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 110.223 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -117.45 118.79 33.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.915 . . . . 0.0 110.171 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.422 HG11 ' CD ' ' A' ' 11' ' ' GLN . 60.2 t -66.75 128.42 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.0 110.226 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 46.6 p90 -126.38 -24.19 3.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.433 ' C ' ' HG3' ' A' ' 11' ' ' GLN . . . -136.43 132.03 34.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.433 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 29.9 mt-30 -141.37 120.81 13.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 52.3 tt0 -98.96 144.33 28.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.222 -0.924 . . . . 0.0 110.19 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.496 HD22 ' CD ' ' A' ' 16' ' ' GLU . 6.9 m120 56.59 18.35 3.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.224 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.462 ' O ' HD23 ' A' ' 18' ' ' LEU . 61.9 t80 -55.04 -44.46 74.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.853 . . . . 0.0 110.239 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -67.87 -45.08 75.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.496 ' CD ' HD22 ' A' ' 13' ' ' ASN . 44.0 mt-10 -57.47 -59.95 4.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.809 ' HD1' HD22 ' A' ' 18' ' ' LEU . 51.4 t80 -51.14 -56.54 12.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.197 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.809 HD22 ' HD1' ' A' ' 17' ' ' PHE . 4.0 mm? -54.73 -42.82 72.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 1.1 tmtm? -54.7 -37.32 65.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -30.6 70.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.919 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -57.56 -20.83 34.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.208 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.919 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 82.1 28.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.267 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.521 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 65.2 mt -73.48 167.4 35.12 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.94 . . . . 0.0 110.24 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 46.1 Cg_endo -73.02 136.05 24.17 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.416 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.423 ' HA ' HD12 ' A' ' 28' ' ' ILE . 43.4 mt-10 -52.11 -44.93 64.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.183 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.82 -27.07 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.18 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 23.2 tp -88.54 -21.7 23.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.871 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 82.9 mt -78.6 -41.76 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -74.72 -21.53 59.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 110.225 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.6 mtt -90.54 -30.62 17.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.179 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -104.52 4.24 32.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 110.197 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.871 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.89 -6.71 23.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.217 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -147.36 49.78 1.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 0.0 110.22 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.072 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.5 mt -123.9 117.72 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.566 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 2.1 mptt -90.0 86.72 0.19 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.072 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.05 133.44 19.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.95 1.5 . . . . 0.0 110.432 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.8 mt -86.2 158.45 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 80.5 t -137.74 118.94 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.245 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -98.84 133.45 43.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.181 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.47 HD12 ' CD1' ' A' ' 6' ' ' TRP . 67.5 mt -118.53 133.04 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.173 -0.954 . . . . 0.0 110.145 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -138.09 68.01 1.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.875 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.587 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 15.8 pt20 -71.69 167.7 19.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.213 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 43.0 mttt -160.43 47.26 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.197 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.74 -98.74 0.72 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 23.1 m-20 -111.5 -6.79 14.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 110.206 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.44 155.52 17.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.239 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.804 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.3 m-85 -138.98 135.98 34.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.39 109.71 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -111.1 134.05 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.905 . . . . 0.0 110.164 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.623 HG23 ' OG1' ' A' ' 59' ' ' THR . 49.5 m -129.39 106.94 9.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.238 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.4 m -87.72 135.59 33.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.241 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -128.74 114.7 16.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.2 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.931 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -102.88 168.31 9.01 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.205 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.714 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.09 -22.01 19.88 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.946 1.498 . . . . 0.0 110.433 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.619 ' HD2' HD11 ' A' ' 34' ' ' ILE . 15.5 mtp-105 -99.66 -20.96 16.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.276 -0.89 . . . . 0.0 110.178 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.472 ' O ' ' OG1' ' A' ' 53' ' ' THR . 15.7 pt20 -168.24 160.25 11.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.7 p -128.98 134.76 48.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.21 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -132.45 130.04 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.204 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.623 ' OG1' HG23 ' A' ' 50' ' ' THR . 88.4 m -110.26 138.26 46.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.457 ' OD1' ' CG2' ' A' ' 71' ' ' THR . 67.8 m-20 -134.57 156.0 49.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -151.17 126.29 9.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.529 ' CE1' HG21 ' A' ' 82' ' ' VAL . 44.0 p90 -139.33 176.08 9.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.1 m -120.49 147.01 45.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 110.254 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.804 HD11 ' CD1' ' A' ' 47' ' ' PHE . 21.1 mt -81.04 123.59 28.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 110.271 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.54 2.59 40.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -145.6 148.79 33.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 110.238 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -70.91 131.03 43.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.248 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -132.36 144.06 50.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.185 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 14.1 p-10 -73.82 141.6 46.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.879 . . . . 0.0 110.225 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 70' ' ' ILE . 2.4 mm -136.28 141.61 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 110.244 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.457 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 4.0 t -113.86 132.79 55.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.242 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.447 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -83.97 160.0 21.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 110.256 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.511 ' SD ' HG21 ' A' ' 53' ' ' THR . 13.3 ttm -68.49 -19.27 64.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -83.29 -12.88 56.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.75 28.11 5.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.447 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 5.4 mttm -101.38 133.73 45.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -1.146 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -109.71 132.71 53.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.249 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.59 160.25 22.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -104.94 160.92 14.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.282 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -170.86 138.91 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.154 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 m -96.95 99.4 10.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.885 . . . . 0.0 110.276 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.658 HG13 HD21 ' A' ' 89' ' ' LEU . 47.4 t -69.0 140.74 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.599 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 6.8 p-80 -146.62 154.08 41.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.25 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.7 mt -98.13 129.6 44.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.185 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.37 143.71 34.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 110.166 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.74 13.18 0.98 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 110.186 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.22 48.04 5.25 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.752 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -172.17 134.15 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 110.22 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.658 HD21 HG13 ' A' ' 82' ' ' VAL . 1.9 tt -61.31 145.77 50.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.879 HG22 ' HG3' ' A' ' 99' ' ' GLU . 87.2 t -153.78 109.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 97.6 m -102.75 103.16 13.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 110.191 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -100.42 156.21 17.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.915 . . . . 0.0 110.208 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.587 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 2.9 t -147.36 -163.65 1.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.228 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.682 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 32.4 tt0 -101.85 33.85 2.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.328 -0.857 . . . . 0.0 110.113 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 8.6 ptmt -177.97 7.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.886 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -179.65 141.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.223 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 111' ' ' ILE . 47.9 m -118.99 156.96 28.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.556 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 54.2 t-80 -140.11 143.4 36.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 110.26 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.879 ' HG3' HG22 ' A' ' 90' ' ' VAL . 17.9 tt0 -158.28 119.16 3.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 110.271 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 9.5 tt0 -123.94 158.72 31.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 110.248 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.458 ' HA ' ' CE1' ' A' ' 2' ' ' PHE . 28.2 tt0 -157.95 152.69 25.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.24 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.439 ' HB ' ' HE2' ' A' ' 107' ' ' MET . 10.6 p -117.7 142.91 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -129.75 90.71 3.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.05 -113.34 3.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -105.73 3.83 29.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 110.191 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -112.22 160.55 17.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.513 ' HE3' ' NE1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -130.02 140.09 50.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.21 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.2 t -127.58 122.31 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 110.178 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 19.8 mt-10 -104.23 128.1 51.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.186 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' GLU . 50.6 m -120.4 114.38 21.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.872 . . . . 0.0 110.23 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' SER . 60.9 mt -126.12 136.59 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.229 -0.919 . . . . 0.0 110.237 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 88.2 m -112.34 134.55 53.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.209 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.613 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 15.9 t80 -157.56 128.44 6.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 0.0 110.167 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 65.43 36.65 92.88 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.88 13.44 66.42 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 112' ' ' THR . 72.8 t -116.94 136.92 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -1.163 . . . . 0.0 110.18 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.3 m -114.09 131.76 56.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.641 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 61.5 tp -109.91 146.45 35.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.0 mt -129.12 94.11 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 110.259 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 18.1 mtm180 -90.47 129.08 36.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 0.0 110.206 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 84.7 mtt180 -105.19 125.91 51.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.2 m -122.64 150.88 42.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -118.64 156.71 28.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 110.201 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -83.55 135.52 34.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.193 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.261 0.553 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.88 143.26 38.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.231 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.59 -172.71 19.36 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.7 m -110.65 131.77 54.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -1.093 . . . . 0.0 110.221 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.48 ' CE2' ' HE3' ' A' ' 107' ' ' MET . 92.3 m95 -119.28 143.28 47.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -125.73 117.79 24.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.239 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.432 HG22 ' OG ' ' A' ' 122' ' ' SER . 47.8 t -66.01 130.28 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.191 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 11.7 p90 -129.71 -18.98 3.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.494 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -139.37 134.87 33.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.498 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.8 pt20 -146.8 118.23 7.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -95.95 150.34 20.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 53.38 22.68 2.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.423 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 59.6 t80 -57.82 -45.07 86.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.201 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.28 -54.01 20.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -47.43 -64.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.586 ' HA ' HG11 ' A' ' 116' ' ' VAL . 45.5 t80 -48.06 -43.83 30.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.336 -0.852 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.423 HD11 ' CZ ' ' A' ' 14' ' ' TYR . 17.0 mt -62.76 -45.15 94.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.945 . . . . 0.0 110.191 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -52.33 -33.31 42.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.69 -34.12 73.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.219 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.781 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -60.02 -21.16 60.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.264 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.781 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 73.06 45.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.014 HD22 ' HD2' ' A' ' 24' ' ' PRO . 5.7 mt -86.08 169.27 15.93 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.014 ' HD2' HD22 ' A' ' 23' ' ' LEU . 46.0 Cg_endo -73.11 135.4 22.86 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.031 1.542 . . . . 0.0 110.466 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -56.39 -26.55 53.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.92 . . . . 0.0 110.178 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.94 -38.07 82.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.93 . . . . 0.0 110.263 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.535 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 66.2 tp -83.87 -40.84 18.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 24' ' ' PRO . 63.1 mt -57.78 -51.36 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 33.1 mmtt -61.67 -29.61 70.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 60.1 ttm -84.75 -23.79 29.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 0.0 110.228 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.509 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -101.88 11.37 38.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.903 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 29' ' ' LYS . 30.1 ptt180 -79.0 -2.58 40.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.208 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -151.66 44.91 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.915 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 21.1 mt -123.34 113.12 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 89.41 0.43 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.207 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.915 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.08 143.21 35.65 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.016 1.535 . . . . 0.0 110.403 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 38' ' ' VAL . 21.3 mt -89.24 162.9 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.206 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.418 ' N ' HG22 ' A' ' 37' ' ' ILE . 98.3 t -141.28 119.44 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.159 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -100.05 138.94 36.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.9 . . . . 0.0 110.2 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.463 ' CD1' ' HE1' ' A' ' 107' ' ' MET . 60.2 mt -123.93 132.37 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 110.181 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -138.19 69.42 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.699 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 4.6 pt20 -75.03 173.63 10.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.699 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 71.4 mttt -165.53 48.64 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 110.189 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.23 -99.25 0.76 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 27.6 m-20 -111.69 -4.54 14.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 0.0 110.216 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -101.43 149.74 23.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.914 . . . . 0.0 110.232 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.748 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.1 m-85 -133.24 137.11 45.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.1 t -124.9 108.55 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.165 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.6 t -110.1 134.64 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.877 . . . . 0.0 110.212 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.0 m -132.57 107.37 8.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.902 . . . . 0.0 110.186 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.4 m -87.16 135.5 33.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 110.215 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -128.78 120.83 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.209 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.881 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -107.14 168.48 7.96 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.222 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.79 ' HD2' HG22 ' A' ' 53' ' ' THR . 45.8 Cg_endo -73.03 -19.73 22.68 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.949 1.499 . . . . 0.0 110.407 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -106.26 -20.06 13.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.85 . . . . 0.0 110.203 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.573 ' NE2' ' HG2' ' A' ' 73' ' ' MET . 13.6 pt20 -163.38 158.96 21.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.169 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 p -132.33 131.53 42.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.32 131.35 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 110.195 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 59' ' ' THR . 13.7 t -112.25 136.83 51.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 110.242 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -133.05 149.4 52.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -141.17 130.05 23.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.936 . . . . 0.0 110.248 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.451 ' CE1' HG21 ' A' ' 82' ' ' VAL . 37.6 p90 -143.93 169.46 17.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.7 m -118.34 146.76 44.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.748 HD11 ' CD1' ' A' ' 47' ' ' PHE . 17.8 mt -76.29 125.83 29.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 0.0 110.19 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.48 10.25 57.05 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -145.43 138.03 25.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -1.171 . . . . 0.0 110.218 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -67.39 122.81 18.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.166 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . . . -127.09 142.04 51.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -0.919 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -71.22 144.69 50.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.226 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.7 mm -134.88 142.79 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.225 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.3 m -115.56 132.22 56.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.227 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.452 ' HB ' ' OD2' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -86.74 161.15 18.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.255 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.573 ' HG2' ' NE2' ' A' ' 56' ' ' GLN . 8.9 ttm -69.85 -20.84 63.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.452 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 2.9 p30 -79.34 -16.23 56.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.885 . . . . 0.0 110.186 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.87 23.01 6.98 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -96.58 138.47 34.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -1.136 . . . . 0.0 110.191 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -114.11 131.32 56.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.182 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.27 156.51 19.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.232 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -100.61 150.98 22.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 110.254 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.0 133.42 8.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.3 m -95.25 101.01 12.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.801 HG13 HD21 ' A' ' 89' ' ' LEU . 45.1 t -72.21 139.8 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.646 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 8.1 p-80 -139.21 156.04 47.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mp -100.19 131.44 46.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.96 116.65 13.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.887 . . . . 0.0 110.195 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 65.8 t30 60.1 28.06 17.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.671 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.15 48.01 10.29 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.872 ' HD2' ' OE2' ' A' ' 101' ' ' GLU . 3.4 mtpt -159.44 119.27 3.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -1.141 . . . . 0.0 110.221 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.801 HD21 HG13 ' A' ' 82' ' ' VAL . 5.2 tt -66.8 140.67 57.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 110.215 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.746 HG13 ' HG2' ' A' ' 99' ' ' GLU . 45.5 t -149.34 120.76 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 68.8 m -112.87 95.52 5.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -90.18 165.35 14.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.265 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 7.3 t -157.61 -162.54 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.543 ' N ' ' OG ' ' A' ' 93' ' ' SER . 41.6 tt0 -105.28 31.56 4.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 110.309 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 8.8 ptpt -172.6 1.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.906 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER 179.22 144.29 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 110.258 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 111' ' ' ILE . 46.2 m -119.27 159.99 23.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.261 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.538 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 56.1 t-80 -143.31 139.06 29.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.249 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.746 ' HG2' HG13 ' A' ' 90' ' ' VAL . 52.4 mt-10 -151.33 129.27 11.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.905 . . . . 0.0 110.161 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 28.4 tt0 -132.7 153.8 50.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.872 ' OE2' ' HD2' ' A' ' 88' ' ' LYS . 57.6 tt0 -153.49 156.86 38.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.274 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.418 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.4 p -121.09 137.72 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -127.93 92.74 3.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.4 -107.34 2.62 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -113.81 8.61 17.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -1.198 . . . . 0.0 110.227 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -117.24 158.7 23.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.48 ' HE3' ' CE2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -129.94 142.21 50.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.253 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 121' ' ' ARG . 91.1 t -128.19 125.7 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 0.0 110.223 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 31.4 mt-10 -108.4 126.96 53.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.211 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' GLU . 37.2 m -117.34 116.62 27.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' SER . 66.9 mt -125.71 129.58 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 50.7 m -106.52 139.68 40.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.169 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.606 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 11.7 t80 -161.48 126.36 3.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 66.63 38.2 93.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.2 8.46 58.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 17' ' ' PHE . 60.2 t -110.89 141.52 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -1.165 . . . . 0.0 110.217 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.2 m -117.73 130.75 56.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.893 . . . . 0.0 110.233 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.586 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 64.2 tp -110.01 148.33 31.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.208 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 92.0 mt -128.91 98.91 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.201 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.474 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 13.7 mtm180 -93.41 124.48 37.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 46.7 mtm-85 -102.66 127.83 49.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.432 ' OG ' HG22 ' A' ' 8' ' ' VAL . 75.5 m -125.54 160.18 30.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.912 . . . . 0.0 110.223 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -123.97 157.06 35.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.157 -0.964 . . . . 0.0 110.223 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' THR . 15.4 ttt85 -81.75 133.37 35.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.224 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.205 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 101' ' ' GLU . 90.3 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.278 0.561 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.1 m -56.5 145.59 27.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.22 -178.15 16.66 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 63.6 m -103.77 132.14 50.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -1.175 . . . . 0.0 110.195 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.596 ' NE1' ' HE1' ' A' ' 107' ' ' MET . 99.2 m95 -121.06 144.64 48.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -126.72 117.29 22.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.889 . . . . 0.0 110.116 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.427 HG11 ' CD ' ' A' ' 11' ' ' GLN . 48.8 t -64.6 126.06 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 13.3 p90 -125.98 -21.05 4.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.167 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.52 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -138.26 133.62 33.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.427 ' CD ' HG11 ' A' ' 8' ' ' VAL . 43.2 mt-30 -145.25 114.6 7.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.195 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.44 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.0 tt0 -92.04 144.01 25.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.937 . . . . 0.0 110.197 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 21.3 m120 57.44 17.51 3.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.922 . . . . 0.0 110.215 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.866 ' CE1' HD11 ' A' ' 18' ' ' LEU . 81.9 t80 -53.59 -47.75 69.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.197 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -66.28 -47.84 72.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 36.2 mt-10 -55.78 -62.3 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.717 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 62.7 t80 -47.24 -57.89 4.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.268 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.866 HD11 ' CE1' ' A' ' 14' ' ' TYR . 7.7 mt -57.14 -44.32 83.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.326 -0.859 . . . . 0.0 110.192 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 9.8 ttmm -46.93 -40.73 14.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.231 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.69 65.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.889 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.1 tp -56.81 -19.56 17.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.889 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.22 27.85 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.154 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.477 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 58.8 mt -74.21 166.67 42.7 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.221 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.13 138.87 28.68 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.026 1.54 . . . . 0.0 110.415 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -58.74 -41.02 85.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -56.19 -26.2 49.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.596 HD22 ' OD1' ' A' ' 74' ' ' ASP . 44.3 tp -93.12 -18.83 22.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.606 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 90.4 mt -82.68 -42.47 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.235 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.31 -32.67 66.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.56 -32.81 36.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.217 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -97.2 5.98 49.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.606 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.31 -5.3 13.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 110.204 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.403 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 7.4 p-10 -149.23 52.61 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.226 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.139 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.7 mt -122.86 114.86 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.28 83.62 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.189 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.139 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.5 Cg_endo -73.03 131.59 17.01 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.109 1.584 . . . . 0.0 110.411 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.5 mt -86.11 155.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.5 t -135.25 118.54 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 110.238 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.477 ' O ' HD13 ' A' ' 40' ' ' ILE . 22.5 tt0 -97.43 137.61 36.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.591 HD12 HG22 ' A' ' 49' ' ' VAL . 50.6 mm -124.75 129.02 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.224 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -129.28 74.18 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 110.184 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.668 ' OE1' ' CZ ' ' A' ' 47' ' ' PHE . 57.8 tt0 -69.86 166.3 19.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.193 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 36.8 mtmt -165.34 44.86 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.171 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.03 -105.25 1.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -107.63 -2.42 20.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -1.135 . . . . 0.0 110.224 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -102.28 148.72 25.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 110.189 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.775 ' CD1' HD11 ' A' ' 64' ' ' LEU . 1.9 m-85 -131.03 135.06 47.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.292 -0.88 . . . . 0.0 110.152 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.8 t -120.19 108.99 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.591 HG22 HD12 ' A' ' 40' ' ' ILE . 73.5 t -110.04 129.95 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.433 HG22 ' HE3' ' A' ' 52' ' ' LYS . 92.7 m -129.56 105.38 8.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 110.268 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 m -89.55 137.52 32.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.88 . . . . 0.0 110.222 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.433 ' HE3' HG22 ' A' ' 50' ' ' THR . 44.2 mttt -130.47 112.8 13.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.168 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.682 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -95.7 168.63 10.48 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.173 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.417 ' CD ' HG23 ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.12 -17.14 24.97 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.018 1.536 . . . . 0.0 110.434 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -106.55 -18.41 13.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.682 ' O ' ' OG1' ' A' ' 53' ' ' THR . 14.2 pt20 -167.84 161.63 13.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.1 p -128.53 135.82 49.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.99 126.9 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.209 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 t -109.92 139.56 44.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 110.147 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -136.2 147.93 47.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.254 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -139.49 130.54 26.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.242 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.912 ' CE1' HG21 ' A' ' 82' ' ' VAL . 34.2 p90 -144.42 173.15 12.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.228 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.0 m -120.19 143.35 48.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.298 -0.876 . . . . 0.0 110.126 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.775 HD11 ' CD1' ' A' ' 47' ' ' PHE . 30.8 mt -74.34 127.17 32.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.172 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.88 -1.4 57.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -136.34 145.11 45.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -1.135 . . . . 0.0 110.231 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -68.91 125.42 26.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.609 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -125.65 151.52 46.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -82.27 133.95 35.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.925 . . . . 0.0 110.187 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.415 HG23 HD12 ' A' ' 70' ' ' ILE . 18.9 mm -125.94 145.65 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 110.252 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -121.04 135.13 55.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.925 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.594 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -85.28 157.46 20.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 0.0 110.238 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.87 -16.98 63.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 110.25 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.596 ' OD1' HD22 ' A' ' 27' ' ' LEU . 15.9 t0 -84.13 -11.49 56.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.09 30.3 4.84 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.594 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 27.7 mttt -104.03 132.07 50.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -1.138 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -107.18 135.02 49.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.285 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.01 158.9 15.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.163 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -104.88 147.16 28.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.467 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.2 m -151.04 139.19 20.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -103.25 88.64 3.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.182 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.042 HG11 HD11 ' A' ' 89' ' ' LEU . 16.9 t -52.73 157.03 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 110.271 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.68 144.51 19.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.252 -0.905 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.649 HD13 HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -99.85 105.09 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.243 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.93 150.91 44.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.153 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 52.57 15.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.242 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.84 40.17 12.48 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.673 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 9.2 ptpt -163.54 133.0 4.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -1.127 . . . . 0.0 110.169 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.042 HD11 HG11 ' A' ' 82' ' ' VAL . 5.5 tt -61.42 145.07 52.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.206 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.657 HG13 ' HG3' ' A' ' 99' ' ' GLU . 41.4 t -150.48 111.42 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 87.4 m -106.96 97.95 7.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.232 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.43 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 14.9 ptpt -95.45 162.78 13.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 110.193 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.5 t -152.42 -164.47 1.96 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -102.21 33.34 3.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 0.0 110.231 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.1 pttt -174.98 2.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.18 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.99 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER 178.56 143.14 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.643 ' O ' HG23 ' A' ' 111' ' ' ILE . 50.7 m -116.85 164.91 13.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 0.0 110.209 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.825 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 60.5 t-80 -146.84 141.24 26.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.825 ' HG3' ' O ' ' A' ' 98' ' ' HIS . 4.3 mp0 -153.58 128.29 9.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 0.0 110.213 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 58.8 tt0 -131.89 157.4 44.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.443 ' HA ' ' CE2' ' A' ' 2' ' ' PHE . 36.7 tt0 -156.32 154.28 30.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.06 142.57 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.185 -0.947 . . . . 0.0 110.131 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -136.74 95.04 3.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 110.2 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.9 -110.76 3.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -114.62 12.62 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -1.149 . . . . 0.0 110.216 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -119.24 157.83 27.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.596 ' HE1' ' NE1' ' A' ' 6' ' ' TRP . 2.2 tpp -127.96 140.49 51.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.234 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.7 t -127.48 124.5 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 120' ' ' ARG . 23.5 mt-10 -109.35 118.26 36.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.567 ' N ' ' O ' ' A' ' 99' ' ' GLU . 41.3 m -108.76 118.65 37.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 110.253 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 97' ' ' SER . 53.6 mt -127.76 132.64 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.164 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 76.6 m -108.52 139.54 43.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.672 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 10.9 t80 -161.19 127.06 3.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 65.48 38.59 94.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 67.92 12.31 62.21 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 17' ' ' PHE . 63.4 t -114.57 138.27 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 110.168 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.6 m -115.02 131.49 56.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.263 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.717 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 63.8 tp -111.41 151.06 28.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 110.242 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.9 mt -129.39 94.1 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.484 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 64.8 mtp180 -87.27 124.09 32.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.192 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 65.3 mtt180 -104.72 125.15 50.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 74.3 m -124.29 152.93 42.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -115.39 156.12 26.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 110.215 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 5' ' ' THR . 32.3 ttt180 -82.61 136.04 34.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.196 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.246 0.546 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.89 144.38 44.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.16 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.59 176.19 14.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 42.3 p -103.48 134.05 47.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -1.108 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.642 ' NE1' ' HE3' ' A' ' 107' ' ' MET . 86.0 m95 -122.46 142.96 50.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.226 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -123.31 118.51 27.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.488 HG13 ' HG2' ' A' ' 120' ' ' ARG . 51.0 t -64.61 127.74 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.285 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 47.6 p90 -128.41 -28.19 2.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.92 . . . . 0.0 110.25 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.415 ' HB2' ' CD2' ' A' ' 9' ' ' TYR . . . -132.84 133.76 43.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.175 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 14' ' ' TYR . 5.4 pt20 -146.62 118.61 8.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -97.11 148.99 22.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.148 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 m120 53.08 21.89 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 110.218 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.943 ' CE1' HD11 ' A' ' 18' ' ' LEU . 86.6 t80 -60.12 -42.95 95.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 110.236 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.625 ' HG3' ' N ' ' A' ' 16' ' ' GLU . 14.2 pt-20 -69.55 -45.59 68.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 110.169 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.625 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 41.8 mt-10 -57.67 -60.37 3.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.713 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 52.2 t80 -51.65 -53.64 36.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.943 HD11 ' CE1' ' A' ' 14' ' ' TYR . 8.9 mt -59.38 -47.23 86.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 110.19 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -48.46 -38.74 20.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.917 . . . . 0.0 110.175 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.22 -25.07 65.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.946 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.5 tp -60.37 -18.74 52.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.232 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.946 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 82.61 26.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 23' ' ' LEU . 24.2 mt -72.91 163.14 70.61 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 110.231 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.493 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.9 Cg_endo -73.03 140.16 30.94 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.022 1.538 . . . . 0.0 110.442 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -56.02 -44.67 78.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -51.42 -36.53 44.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.16 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.493 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 20.8 tp -83.01 -23.34 33.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.685 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 35.0 mt -75.23 -40.98 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 9.3 mtmt -76.43 -22.84 54.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.214 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.6 mtt -87.92 -27.24 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.948 . . . . 0.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -104.73 4.72 32.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.174 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.859 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 21.1 ptt180 -70.69 1.53 5.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -0.914 . . . . 0.0 110.206 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.859 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 1.5 m-20 -153.82 42.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.254 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.907 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 7.1 mt -121.38 117.06 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -94.06 89.25 0.42 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.251 -0.905 . . . . 0.0 110.221 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.907 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.09 138.07 27.44 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.0 1.526 . . . . 0.0 110.408 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.1 mt -87.51 161.42 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.922 . . . . 0.0 110.182 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.87 120.98 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -101.6 138.27 38.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.5 mt -124.95 132.79 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.888 . . . . 0.0 110.23 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -137.14 72.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.614 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 6.5 pt20 -76.42 169.65 17.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.211 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 75.7 mttt -161.26 46.71 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 110.239 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.18 -97.88 0.64 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -112.03 -6.84 14.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.153 . . . . 0.0 110.207 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.561 ' OD1' HG23 ' A' ' 63' ' ' THR . 49.4 m-20 -99.8 152.71 19.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.917 . . . . 0.0 110.157 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.652 ' CE1' HD11 ' A' ' 64' ' ' LEU . 2.1 m-85 -136.34 137.96 41.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.62 109.6 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.21 -0.931 . . . . 0.0 110.229 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.1 t -111.19 134.41 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.186 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.672 ' OG1' HG23 ' A' ' 59' ' ' THR . 91.3 m -131.14 109.91 10.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -90.42 135.11 33.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -127.51 122.11 32.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.208 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.815 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.58 168.87 7.19 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.239 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.757 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.05 -17.54 24.8 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.059 1.557 . . . . 0.0 110.466 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.464 ' HD3' ' HB3' ' A' ' 56' ' ' GLN . 1.8 tmt_? -105.57 -24.09 12.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.186 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.485 ' OE1' ' HG2' ' A' ' 73' ' ' MET . 2.5 pt20 -162.88 164.34 26.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.232 -0.918 . . . . 0.0 110.216 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.2 p -132.12 128.23 37.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 110.192 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.48 132.76 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.93 . . . . 0.0 110.222 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.672 HG23 ' OG1' ' A' ' 50' ' ' THR . 28.7 m -112.56 136.54 51.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 110.246 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.473 ' ND2' ' OG1' ' A' ' 71' ' ' THR . 14.5 m120 -133.03 150.58 52.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.174 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.4 m -143.08 137.51 29.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.202 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.889 ' CD1' HG21 ' A' ' 82' ' ' VAL . 32.5 p90 -150.04 162.01 41.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.561 HG23 ' OD1' ' A' ' 46' ' ' ASP . 90.7 m -112.2 143.54 43.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.652 HD11 ' CE1' ' A' ' 47' ' ' PHE . 14.1 mt -69.16 124.79 24.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.54 19.03 53.74 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.441 ' C ' HG23 ' A' ' 81' ' ' THR . 91.2 mttt -150.89 138.9 20.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -1.191 . . . . 0.0 110.152 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -72.05 135.51 46.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 0.0 110.188 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.46 146.75 42.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.233 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 13.9 p-10 -76.27 141.4 41.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.168 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 74.7 mt -140.31 145.93 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.473 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 1.6 p -111.83 147.34 35.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.194 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.641 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -98.6 158.6 15.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.213 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.626 ' SD ' HG21 ' A' ' 53' ' ' THR . 10.5 ttm -68.13 -17.16 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.564 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 3.1 p30 -87.5 -18.28 30.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.86 26.76 4.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.641 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 19.4 mttt -101.59 133.4 46.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -1.111 . . . . 0.0 110.226 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -110.67 134.99 51.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -165.44 161.38 18.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -104.55 151.51 23.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.2 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.495 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 0.9 OUTLIER -155.23 140.53 17.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.203 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.441 HG23 ' C ' ' A' ' 66' ' ' LYS . 6.1 m -102.4 86.37 2.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.209 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.889 HG21 ' CD1' ' A' ' 62' ' ' PHE . 11.5 t -52.75 152.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.885 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.14 148.25 32.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.512 HD12 HD13 ' A' ' 64' ' ' LEU . 1.6 mt -102.19 105.02 15.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.67 132.27 55.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.211 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.7 t30 45.68 39.53 5.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.887 . . . . 0.0 110.217 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.36 42.62 95.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.661 ' HD3' ' CD ' ' A' ' 101' ' ' GLU . 25.3 mttt -150.04 119.38 6.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -1.104 . . . . 0.0 110.189 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.801 HD21 HG13 ' A' ' 82' ' ' VAL . 1.5 tt -68.87 133.2 47.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.815 HG22 ' HG3' ' A' ' 99' ' ' GLU . 20.7 t -139.78 120.85 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.495 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 87.9 m -113.76 94.66 4.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.2 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 46.7 pttt -94.25 163.13 13.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.272 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 28.6 t -150.23 -154.66 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.206 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.49 ' N ' ' OG ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -107.04 22.55 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.17 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -165.41 6.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.201 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 1.018 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.86 139.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 111' ' ' ILE . 16.0 t -112.38 165.29 12.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.412 ' O ' HG13 ' A' ' 90' ' ' VAL . 42.5 t-80 -149.5 136.46 19.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.815 ' HG3' HG22 ' A' ' 90' ' ' VAL . 33.3 tt0 -152.05 128.58 10.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.9 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.538 ' OE1' ' HG2' ' A' ' 109' ' ' GLU . 39.1 tt0 -132.43 160.52 36.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.179 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.661 ' CD ' ' HD3' ' A' ' 88' ' ' LYS . 82.3 tt0 -155.89 150.12 25.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.225 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.77 142.16 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 110.215 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -133.73 93.35 3.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 110.196 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.5 -108.39 2.78 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -114.26 8.73 16.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -1.119 . . . . 0.0 110.197 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -115.49 154.78 28.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.923 . . . . 0.0 110.164 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.642 ' HE3' ' NE1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -125.5 141.91 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.19 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.1 t -128.68 122.16 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.538 ' HG2' ' OE1' ' A' ' 100' ' ' GLN . 27.1 mt-10 -105.42 121.75 44.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.223 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.665 ' N ' ' O ' ' A' ' 99' ' ' GLU . 19.6 m -112.61 116.04 29.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 97' ' ' SER . 52.2 mt -126.47 132.1 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 77.0 m -108.95 137.26 47.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.92 . . . . 0.0 110.225 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 11.6 t80 -159.56 126.52 4.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.94 32.79 77.92 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.46 9.65 78.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 17' ' ' PHE . 52.2 t -113.37 141.68 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -1.123 . . . . 0.0 110.246 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.3 m -115.85 134.26 55.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.192 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.713 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 16.9 tp -112.67 140.04 47.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 118' ' ' LEU . 58.1 mt -122.48 98.38 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.488 ' HG2' HG13 ' A' ' 8' ' ' VAL . 6.1 ttp180 -93.59 124.96 37.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 110.244 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 32.9 mtm180 -103.07 122.82 45.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 6' ' ' TRP . 73.6 m -120.44 150.42 40.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -114.91 151.63 33.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 110.19 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.1 ttt180 -74.87 133.31 41.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.189 179.977 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.231 0.539 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 p -57.79 144.47 38.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.8 -176.05 18.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.5 m -108.14 134.24 51.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -1.093 . . . . 0.0 110.215 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.549 ' CH2' HG23 ' A' ' 102' ' ' VAL . 98.8 m95 -121.12 139.2 53.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.179 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -121.89 125.6 46.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.239 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.651 HG12 ' HD3' ' A' ' 120' ' ' ARG . 19.4 m -62.34 123.35 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.212 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -134.27 2.77 3.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 110.223 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 121' ' ' ARG . . . -163.03 120.79 1.97 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -147.08 164.85 31.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 110.206 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.454 ' O ' HD12 ' A' ' 118' ' ' LEU . 39.8 tt0 -135.97 153.58 51.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 48.27 38.08 9.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -67.06 -49.31 65.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.188 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -61.8 -46.4 89.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 61.3 mt-10 -55.15 -42.93 73.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.195 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 55.2 t80 -55.41 -57.67 10.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 110.278 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.725 HD22 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -50.78 -38.89 50.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 110.195 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 33.2 mttp -60.33 -38.8 84.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.262 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.63 -40.94 69.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.981 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.0 tp -54.68 -26.22 32.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.893 . . . . 0.0 110.23 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.981 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 86.64 18.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.725 HD12 HD22 ' A' ' 18' ' ' LEU . 16.5 mt -66.69 170.31 6.17 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.175 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 46.8 Cg_endo -73.09 132.96 18.86 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.123 1.591 . . . . 0.0 110.41 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.675 ' HA ' HD12 ' A' ' 28' ' ' ILE . 25.6 tp10 -51.94 -47.91 64.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.225 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -48.42 -35.62 13.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 110.241 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.529 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 41.6 tp -79.54 -33.4 41.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.17 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.675 HD12 ' HA ' ' A' ' 25' ' ' GLU . 85.6 mt -61.95 -52.22 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.193 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.408 ' HE2' ' HG3' ' A' ' 25' ' ' GLU . 17.5 mttm -59.08 -26.1 64.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -0.913 . . . . 0.0 110.179 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.462 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 12.1 ttm -91.8 -23.12 19.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.629 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -101.29 -5.94 24.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -3.72 16.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -147.62 43.43 1.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.049 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 18.0 mt -120.49 109.93 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 110.206 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HA ' HG21 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -90.48 86.59 0.2 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 0.0 110.198 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.049 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.6 Cg_endo -73.14 146.42 40.95 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.069 1.562 . . . . 0.0 110.443 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 38' ' ' VAL . 12.2 mt -91.17 162.29 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.227 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' N ' HG22 ' A' ' 37' ' ' ILE . 79.4 t -138.36 120.75 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -103.45 134.58 46.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.533 HD12 ' CD1' ' A' ' 6' ' ' TRP . 68.8 mt -120.67 131.7 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 37.0 tt0 -135.95 73.09 1.45 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 110.215 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.532 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -76.12 164.1 26.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.201 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 59.6 mttt -158.71 49.84 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.42 -101.85 1.01 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -110.91 1.11 17.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -1.131 . . . . 0.0 110.174 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 42.2 t0 -108.23 144.02 36.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 110.265 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.692 ' CD1' HD11 ' A' ' 64' ' ' LEU . 3.6 m-85 -127.29 143.51 51.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.897 . . . . 0.0 110.248 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.6 t -132.35 106.92 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.178 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.4 t -108.82 134.88 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.243 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.765 ' OG1' HG23 ' A' ' 59' ' ' THR . 87.1 m -131.91 109.51 10.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.217 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.0 m -92.1 132.72 36.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.257 -0.902 . . . . 0.0 110.093 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -126.17 128.32 47.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.28 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.806 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -111.11 169.76 5.97 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.0 110.273 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.13 -8.87 22.74 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.005 1.529 . . . . 0.0 110.403 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -117.39 -20.84 8.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.607 ' O ' ' OG1' ' A' ' 53' ' ' THR . 16.2 pt20 -162.43 160.5 26.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.883 . . . . 0.0 110.17 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 p -131.09 131.15 43.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 73' ' ' MET . 57.4 t -127.7 129.35 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.194 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.765 HG23 ' OG1' ' A' ' 50' ' ' THR . 62.3 m -112.26 139.75 47.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -135.09 152.06 51.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.903 . . . . 0.0 110.19 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.4 t -148.38 131.15 16.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.225 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.591 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 50.5 p90 -143.51 171.55 13.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.929 . . . . 0.0 110.151 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.2 m -119.8 140.88 50.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.692 HD11 ' CD1' ' A' ' 47' ' ' PHE . 17.5 mt -74.41 127.67 33.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 110.202 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.42 4.4 56.18 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -145.05 145.07 31.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -1.154 . . . . 0.0 110.205 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.44 123.96 22.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.221 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.591 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.89 150.74 44.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 12.0 p-10 -86.39 140.65 29.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 70' ' ' ILE . 12.1 mm -130.15 144.42 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -116.56 131.77 56.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.194 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.663 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 73.0 p -86.04 158.16 19.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.484 ' HG3' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -70.01 -13.76 62.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.515 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 3.6 p30 -86.28 -16.92 36.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 110.22 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.53 27.7 4.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.663 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 22.1 mttt -105.06 131.36 52.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -107.84 135.83 48.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.26 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.541 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -164.22 159.38 20.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 110.195 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 83.4 mttt -105.93 171.01 7.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 110.256 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 27.6 p -179.88 136.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 m -95.34 103.43 15.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.197 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.707 HG13 HD21 ' A' ' 89' ' ' LEU . 43.2 t -76.77 140.54 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 110.244 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.647 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 35.0 p-80 -139.44 156.6 46.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.209 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 84' ' ' LEU . 53.8 mt -101.41 132.15 47.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.164 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -135.77 117.97 15.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.22 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 57.84 31.39 20.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 110.231 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.634 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 72.24 49.78 19.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.675 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 51.1 mtpt -158.57 117.21 3.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.707 HD21 HG13 ' A' ' 82' ' ' VAL . 4.5 tt -65.77 140.28 58.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.193 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.906 HG22 ' CG ' ' A' ' 99' ' ' GLU . 97.8 t -146.69 117.0 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 99.8 m -110.97 94.8 5.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 110.223 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -88.45 161.7 16.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.231 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 96' ' ' PHE . 30.2 t -157.47 -177.13 6.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.918 . . . . 0.0 110.237 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 84.1 tt0 -95.26 33.46 1.56 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.902 . . . . 0.0 110.184 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.541 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 10.8 ptpt -173.5 -2.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.837 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -176.96 146.62 0.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.2 m -123.13 156.87 34.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.154 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.696 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.5 t-80 -140.23 134.56 31.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.906 ' CG ' HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -149.07 125.14 10.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.857 . . . . 0.0 110.21 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.745 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 10.0 tt0 -131.94 156.47 46.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.675 ' OE1' ' HE3' ' A' ' 88' ' ' LYS . 76.8 tt0 -151.65 159.55 43.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.549 HG23 ' CH2' ' A' ' 6' ' ' TRP . 10.9 p -122.65 137.23 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -132.16 93.3 3.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.53 -106.77 2.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.427 ' ND2' ' HG3' ' A' ' 106' ' ' GLU . 3.4 p-10 -117.67 10.79 13.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -1.147 . . . . 0.0 110.165 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.427 ' HG3' ' ND2' ' A' ' 105' ' ' ASN . 70.0 mt-10 -118.43 160.79 21.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.195 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.536 ' SD ' ' OE1' ' A' ' 100' ' ' GLN . 28.5 ttm -134.58 142.08 46.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.221 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 74.2 t -125.62 128.65 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 110.24 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.745 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 15.7 mt-10 -115.87 136.17 53.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.211 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 99' ' ' GLU . 3.1 t -126.27 122.61 36.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.183 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.29 133.01 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 89.6 m -113.27 133.87 54.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.157 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 21' ' ' LEU . 26.1 t80 -154.82 122.58 5.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 110.227 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.94 35.5 65.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.39 5.39 63.0 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 112' ' ' THR . 70.2 t -111.05 135.76 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -1.162 . . . . 0.0 110.23 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.2 m -112.93 135.43 53.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.577 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 23.5 tp -115.76 139.57 50.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.04 120.18 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.651 ' HD3' HG12 ' A' ' 8' ' ' VAL . 5.5 ttm105 -115.39 119.18 35.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 110.219 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 84.4 mtt180 -99.94 125.15 45.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.428 ' HB3' ' HB3' ' A' ' 6' ' ' TRP . 11.4 m -120.54 152.03 38.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.22 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -113.58 152.51 30.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 5' ' ' THR . 31.8 ttt180 -78.96 136.91 37.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.196 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.146 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.56 ' HA ' HG21 ' A' ' 102' ' ' VAL . 64.4 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.269 0.557 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.4 p -58.78 145.26 41.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.275 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.06 -178.99 16.78 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 85.0 m -104.05 132.04 50.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -1.154 . . . . 0.0 110.193 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.691 ' CD1' HD12 ' A' ' 40' ' ' ILE . 88.4 m95 -121.73 142.7 49.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.895 . . . . 0.0 110.164 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.01 122.32 38.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 110.212 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.55 124.16 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.204 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 38.1 p90 -124.94 -32.43 3.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.194 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.01 127.16 41.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.261 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 23.0 pt20 -141.48 117.72 10.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.589 ' O ' HD12 ' A' ' 118' ' ' LEU . 41.4 tt0 -96.19 144.25 26.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.219 -0.926 . . . . 0.0 110.279 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' GLU . 6.8 t-20 60.79 14.63 5.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.841 ' CE1' HD11 ' A' ' 18' ' ' LEU . 60.5 t80 -50.98 -53.75 30.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 110.315 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.8 -49.1 76.27 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 34.1 mt-10 -55.05 -58.98 5.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 110.236 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.73 ' CD2' HD22 ' A' ' 118' ' ' LEU . 63.9 t80 -50.56 -54.73 20.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.841 HD11 ' CE1' ' A' ' 14' ' ' TYR . 4.4 mt -59.18 -41.18 87.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -50.09 -39.54 42.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.51 -27.53 65.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.909 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -59.71 -19.69 51.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.99 27.57 0.31 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 23' ' ' LEU . 37.4 mt -74.32 164.2 62.92 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.335 -0.853 . . . . 0.0 110.186 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.554 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -73.13 140.8 31.63 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.066 1.561 . . . . 0.0 110.391 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.89 -41.11 90.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.156 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.6 -27.39 49.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.554 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 42.2 tp -91.74 -18.91 23.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.188 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.7 mt -85.01 -40.93 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -73.83 -30.87 62.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.181 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 51.6 ttm -82.57 -30.83 29.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.838 . . . . 0.0 110.234 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -99.17 3.97 46.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 110.206 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.679 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -64.5 -10.19 23.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.232 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.679 ' OD2' ' HD2' ' A' ' 32' ' ' ARG . 69.2 m-20 -143.93 55.96 1.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.21 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 1.8 mt -126.32 114.41 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -86.32 83.06 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 110.232 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.21 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.7 Cg_endo -73.07 131.52 16.85 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.029 1.542 . . . . 0.0 110.389 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -87.52 153.59 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 110.246 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.48 118.44 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.215 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -96.78 131.9 43.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.229 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.691 HD12 ' CD1' ' A' ' 6' ' ' TRP . 74.0 mt -117.36 135.49 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.193 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -138.01 68.01 1.41 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.503 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -71.04 163.28 27.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 110.221 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 86.4 mttt -158.3 45.99 0.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.18 -97.85 0.67 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 52.3 m-20 -112.18 -3.7 14.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -1.181 . . . . 0.0 110.202 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.809 ' OD1' HG23 ' A' ' 63' ' ' THR . 38.3 m-20 -106.85 148.96 27.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 34.3 m-85 -131.88 148.79 52.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -127.27 99.74 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 110.164 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.13 132.65 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.865 . . . . 0.0 110.206 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 58.7 m -134.03 108.78 8.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.214 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 m -93.65 134.3 36.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 110.244 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -127.03 127.08 44.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.663 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 62.3 p -109.29 170.03 5.82 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.945 . . . . 0.0 110.204 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.652 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 46.7 Cg_endo -73.06 -5.57 17.43 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -120.7 -23.85 5.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.663 ' O ' ' OG1' ' A' ' 53' ' ' THR . 4.5 pt20 -161.43 165.89 28.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.175 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.2 p -132.6 130.8 40.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.161 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.652 HG21 ' HA ' ' A' ' 73' ' ' MET . 48.9 t -127.37 126.21 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 14.7 t -111.06 146.39 36.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.894 ' OD1' HG22 ' A' ' 71' ' ' THR . 10.8 m-80 -139.63 142.91 37.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.85 . . . . 0.0 110.15 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -139.58 135.05 32.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.19 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.742 ' CE1' HG11 ' A' ' 82' ' ' VAL . 54.1 p90 -148.06 170.78 17.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.809 HG23 ' OD1' ' A' ' 46' ' ' ASP . 91.3 m -116.78 151.05 37.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.236 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.504 HD11 ' CA ' ' A' ' 83' ' ' HIS . 3.5 tp -82.66 120.07 25.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.244 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.85 9.61 34.44 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -148.53 147.08 28.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -1.154 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -68.76 126.72 30.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -126.14 148.01 49.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.313 -0.867 . . . . 0.0 110.173 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -84.3 138.36 32.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 70' ' ' ILE . 11.4 mm -128.21 145.07 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 110.185 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.894 HG22 ' OD1' ' A' ' 60' ' ' ASN . 5.1 t -119.72 131.32 55.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 73.1 p -84.22 160.89 20.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.652 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -74.15 -12.52 60.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.117 -0.989 . . . . 0.0 110.226 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.507 ' OD1' ' HB ' ' A' ' 72' ' ' THR . 4.9 p-10 -89.35 -9.54 50.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.52 51.39 1.21 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.584 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 9.3 tttt -129.63 128.46 42.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -1.132 . . . . 0.0 110.197 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -104.53 141.04 37.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.656 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -168.72 156.32 7.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 110.248 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 13.7 mttm -105.41 165.86 10.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.217 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.9 p -178.05 139.95 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 p -94.46 107.95 19.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 0.0 110.22 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.809 HG13 HD21 ' A' ' 89' ' ' LEU . 48.1 t -79.47 140.38 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.622 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 15.3 p-80 -145.03 161.54 39.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.426 HD11 ' HZ ' ' A' ' 47' ' ' PHE . 16.5 mt -103.61 134.35 47.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -136.91 120.44 17.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 110.235 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 86.7 m-20 58.72 31.7 21.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.578 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 72.83 44.07 39.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.788 ' HD3' ' OE2' ' A' ' 101' ' ' GLU . 10.0 mtmt -156.39 121.66 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -1.164 . . . . 0.0 110.152 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.809 HD21 HG13 ' A' ' 82' ' ' VAL . 4.2 tt -66.73 136.04 54.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.897 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.683 HG13 ' HG2' ' A' ' 99' ' ' GLU . 69.2 t -142.34 117.27 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 75.0 m -109.99 95.3 5.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 110.244 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -91.55 154.43 19.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.215 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.4 t -145.84 -163.95 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.158 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -102.69 33.08 3.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.2 OUTLIER -175.52 2.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.919 . . . . 0.0 110.187 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.823 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -178.73 148.42 0.42 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 0.0 110.184 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.605 ' O ' HG23 ' A' ' 111' ' ' ILE . 41.8 m -123.75 159.89 28.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.8 t-80 -142.21 142.92 32.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.915 . . . . 0.0 110.251 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.683 ' HG2' HG13 ' A' ' 90' ' ' VAL . 47.6 mt-10 -155.73 123.2 5.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.143 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.425 ' CG ' ' HG2' ' A' ' 109' ' ' GLU . 11.6 tt0 -129.23 159.07 37.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.202 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.788 ' OE2' ' HD3' ' A' ' 88' ' ' LYS . 57.6 tt0 -157.09 156.83 33.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 110.208 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.56 HG21 ' HA ' ' A' ' 2' ' ' PHE . 39.8 t -118.98 139.18 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -134.96 89.78 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.216 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.83 -102.59 2.48 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -123.09 10.72 9.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -1.122 . . . . 0.0 110.22 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -115.84 151.68 34.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.543 ' HG2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -121.74 137.01 54.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.4 t -125.29 120.56 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.425 ' HG2' ' CG ' ' A' ' 100' ' ' GLN . 35.4 mt-10 -109.01 118.71 37.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.567 ' N ' ' O ' ' A' ' 99' ' ' GLU . 63.4 m -107.97 116.61 32.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.266 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 97' ' ' SER . 54.0 mt -125.4 131.46 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.226 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 32.7 m -109.69 134.47 51.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.59 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 12.8 t80 -157.42 128.16 6.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.21 33.83 74.32 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.08 11.73 70.77 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 112' ' ' THR . 78.0 t -116.26 138.36 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -1.135 . . . . 0.0 110.202 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 63.2 m -113.27 132.48 55.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.73 HD22 ' CD2' ' A' ' 17' ' ' PHE . 29.5 tp -113.02 152.09 29.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.89 . . . . 0.0 110.244 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.9 mt -129.65 94.98 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.172 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -87.76 126.61 35.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 91.0 mtt180 -106.88 124.96 50.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.214 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.2 m -122.66 149.4 44.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -115.55 150.76 36.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 110.177 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' THR . 23.2 ttt85 -74.99 132.95 41.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.445 HG13 ' OXT' ' A' ' 125' ' ' VAL . 7.9 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.191 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.23 0.538 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 57.2 m -59.17 148.52 31.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 110.266 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.63 163.83 13.93 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.434 ' OG1' ' HB ' ' A' ' 125' ' ' VAL . 20.5 p -78.3 155.52 30.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -1.159 . . . . 0.0 110.16 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.598 ' CH2' HG23 ' A' ' 102' ' ' VAL . 96.7 m95 -141.93 127.64 19.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.983 ' HB3' ' HG2' ' A' ' 123' ' ' LYS . 6.1 tt0 -94.63 146.34 24.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.187 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 36' ' ' PRO . 38.6 t -67.37 112.32 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.259 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 1.355 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 2.1 m-85 -72.86 -69.52 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.895 . . . . 0.0 110.252 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.961 ' H ' ' HG3' ' A' ' 121' ' ' ARG . . . -149.07 170.76 17.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.26 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.703 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 3.1 mp0 -148.43 112.25 5.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.238 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 54.6 tt0 -91.8 150.93 20.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.19 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 14' ' ' TYR . 23.6 m-20 52.49 19.12 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 7.4 t80 -42.85 -65.31 0.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.135 -0.978 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' GLU . 47.2 mt-10 -47.88 -57.33 5.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.212 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 5.7 mm-40 -41.83 -49.88 4.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.469 ' CD2' HD22 ' A' ' 118' ' ' LEU . 12.6 t80 -52.04 -63.3 1.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.791 ' CD2' HD12 ' A' ' 23' ' ' LEU . 7.6 mt -44.49 -44.46 8.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.275 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 22.8 mttm -52.72 -37.93 59.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.03 -40.08 63.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.22 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.883 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -57.51 -25.22 59.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 110.231 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.883 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.6 23.22 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 110.162 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.791 HD12 ' CD2' ' A' ' 18' ' ' LEU . 15.5 mt -71.54 170.12 13.11 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.209 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.3 Cg_endo -73.11 139.32 29.46 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.067 1.562 . . . . 0.0 110.374 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 5.6 pt-20 -59.93 -46.74 88.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 110.238 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' A' ' 24' ' ' PRO . 2.6 p30 -47.34 -34.67 7.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.194 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 18.4 tp -88.97 -32.25 17.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.228 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.669 HG12 HD13 ' A' ' 18' ' ' LEU . 72.8 mt -70.61 -49.16 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 110.177 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -63.63 -32.07 73.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 110.164 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.1 ttp -84.33 -11.77 55.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 110.159 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -111.2 3.81 18.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.258 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.568 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 9.4 ptt180 -68.29 -3.21 10.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.182 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 81.0 m-20 -146.91 51.46 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.897 . . . . 0.0 110.178 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.817 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 11.6 mt -126.54 113.49 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.224 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -98.49 85.27 0.4 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.172 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.0 ' HB3' HG23 ' A' ' 53' ' ' THR . 46.6 Cg_endo -73.05 154.69 52.72 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.983 1.517 . . . . 0.0 110.44 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.536 HG22 ' N ' ' A' ' 38' ' ' VAL . 6.3 mt -95.32 169.31 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.193 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.536 ' N ' HG22 ' A' ' 37' ' ' ILE . 75.1 t -145.64 118.24 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.248 -0.907 . . . . 0.0 110.225 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -98.31 147.19 24.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 3' ' ' SER . 65.4 mt -133.96 125.23 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -127.15 80.07 1.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.868 . . . . 0.0 110.177 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.752 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 41.1 tt0 -78.77 162.62 26.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.187 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 34.3 mmtt -159.22 46.28 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.248 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.15 -96.73 0.66 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -116.59 3.11 13.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -1.137 . . . . 0.0 110.157 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 40.5 t0 -107.98 139.28 42.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.93 . . . . 0.0 110.249 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.929 ' CE2' HD11 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -120.61 135.61 55.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.38 103.16 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 110.154 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.08 129.03 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.157 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.922 ' OG1' HG23 ' A' ' 59' ' ' THR . 57.5 m -130.23 107.9 9.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.5 m -89.57 128.08 35.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.158 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.459 ' CA ' HG22 ' A' ' 57' ' ' THR . 52.2 mtmt -120.75 124.09 44.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.16 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.0 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.56 169.07 6.93 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.223 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.881 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.7 Cg_endo -73.04 -16.81 25.4 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.997 1.525 . . . . 0.0 110.483 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -111.95 -20.79 11.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.58 ' O ' ' OG1' ' A' ' 53' ' ' THR . 2.0 tt0 -160.95 155.32 23.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.459 HG22 ' CA ' ' A' ' 52' ' ' LYS . 4.3 p -131.46 137.54 48.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.167 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.549 HG12 HD21 ' A' ' 60' ' ' ASN . 56.8 t -133.65 132.04 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.908 . . . . 0.0 110.243 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.922 HG23 ' OG1' ' A' ' 50' ' ' THR . 17.1 m -111.79 137.31 49.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 110.205 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.549 HD21 HG12 ' A' ' 58' ' ' VAL . 7.5 m120 -132.38 155.77 47.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.932 . . . . 0.0 110.214 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 t -152.32 127.42 9.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.2 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.479 ' CB ' ' CB ' ' A' ' 68' ' ' ALA . 34.5 p90 -141.99 174.02 10.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.314 -0.867 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 27.7 m -118.38 150.71 39.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.929 HD11 ' CE2' ' A' ' 47' ' ' PHE . 5.6 mt -78.58 125.2 29.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.74 10.1 58.06 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -142.36 141.12 32.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -1.165 . . . . 0.0 110.173 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.8 124.87 25.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 0.0 110.22 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.479 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -125.35 149.29 48.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 0.0 110.27 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -82.15 139.08 34.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 110.138 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 4.4 mm -132.78 144.74 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 0.0 110.218 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -116.74 137.6 52.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.247 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.568 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -87.15 156.98 19.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.189 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.7 ttm -66.89 -16.36 64.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 110.256 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.56 -9.66 55.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.229 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.96 33.74 4.55 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.568 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 28.3 mttt -107.27 133.31 52.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -109.45 136.53 48.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.422 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -169.04 157.97 8.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.152 -0.968 . . . . 0.0 110.22 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 9.7 mtmt -102.29 172.06 7.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 110.227 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.3 p -178.65 137.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 110.154 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.0 m -97.04 99.75 11.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.683 HG13 HD21 ' A' ' 89' ' ' LEU . 46.1 t -72.84 139.03 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.235 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.64 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 11.4 p-80 -138.58 161.26 37.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 84' ' ' LEU . 26.4 mt -105.63 132.12 52.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.262 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.62 115.61 13.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.218 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 59.8 t30 59.38 31.82 21.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.426 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 73.77 43.91 33.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.426 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 85.9 mttt -152.58 120.78 6.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -1.133 . . . . 0.0 110.177 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.683 HD21 HG13 ' A' ' 82' ' ' VAL . 7.4 tt -72.54 133.11 44.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.698 HG22 ' HG3' ' A' ' 99' ' ' GLU . 99.0 t -141.55 122.83 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.918 . . . . 0.0 110.198 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 54.6 m -113.85 92.48 3.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 62.1 pttt -87.46 162.35 17.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 110.208 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 28.3 t -155.8 -164.44 1.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 110.181 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.423 ' N ' ' OG ' ' A' ' 93' ' ' SER . 40.7 tt0 -103.99 31.56 4.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.92 . . . . 0.0 110.183 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -172.65 -2.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.144 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.804 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -173.7 147.99 1.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.185 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 111' ' ' ILE . 70.9 m -124.82 154.33 41.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.515 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 64.1 t-80 -141.6 140.36 33.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.698 ' HG3' HG22 ' A' ' 90' ' ' VAL . 29.5 tt0 -152.15 127.52 9.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 110.186 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 13.8 tt0 -130.2 150.43 51.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.229 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -148.2 154.08 39.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 110.253 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.598 HG23 ' CH2' ' A' ' 6' ' ' TRP . 13.2 p -119.69 131.86 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -126.76 93.09 3.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.882 . . . . 0.0 110.201 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.76 -95.74 1.26 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -126.52 15.74 7.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -1.162 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -123.73 150.75 44.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 110.206 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 121' ' ' ARG . 8.2 tpp -125.79 140.14 52.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.885 . . . . 0.0 110.172 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.02 124.46 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 110.256 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 33.6 mt-10 -115.25 123.7 49.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.9 m -111.99 123.16 49.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 97' ' ' SER . 73.7 mt -129.09 128.43 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.904 . . . . 0.0 110.197 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 90.1 m -111.93 133.49 54.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 110.223 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 5.8 t80 -156.0 122.38 5.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.245 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.07 32.54 58.42 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.41 1.43 65.03 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.1 t -108.5 141.31 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -1.131 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.5 m -119.57 130.99 55.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.249 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.469 HD22 ' CD2' ' A' ' 17' ' ' PHE . 59.0 tp -110.43 140.84 44.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 85.4 mt -114.61 105.29 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -106.26 119.03 38.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -0.962 . . . . 0.0 110.196 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.961 ' HG3' ' H ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -102.49 136.87 41.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 1.4 m -123.71 140.1 53.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.278 -0.889 . . . . 0.0 110.205 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 1.355 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 15.4 ptmt -99.81 146.35 26.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.511 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 68.7 ttt180 -77.43 135.95 38.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.434 ' HB ' ' OG1' ' A' ' 5' ' ' THR . 64.7 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.21 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.433 ' HA ' ' CE ' ' A' ' 107' ' ' MET . 85.0 m-85 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.239 0.543 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -57.12 147.22 25.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.63 163.93 13.06 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 25.2 m -80.79 150.93 29.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 110.193 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.701 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 97.5 m95 -136.61 130.96 33.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.206 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.967 ' O ' ' HA ' ' A' ' 122' ' ' SER . 32.4 tt0 -95.73 144.59 26.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.201 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 36' ' ' PRO . 21.7 t -66.61 119.96 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.905 . . . . 0.0 110.181 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 1.154 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.9 OUTLIER -80.94 -68.68 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 110.256 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.921 ' H ' ' HG3' ' A' ' 121' ' ' ARG . . . -150.33 169.6 21.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 110.236 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -146.44 110.59 5.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.487 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 9.5 mm-40 -88.55 155.07 19.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.716 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 68.3 m-20 47.38 21.35 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 110.165 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 4.4 t80 -46.19 -61.86 1.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' GLU . 67.0 mt-10 -51.27 -57.77 7.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.716 ' OE1' ' HA ' ' A' ' 13' ' ' ASN . 6.7 mp0 -41.7 -49.59 4.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -50.28 -62.8 1.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.247 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.619 HD13 HG12 ' A' ' 28' ' ' ILE . 9.2 mt -44.98 -47.35 11.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 90.4 mttt -49.4 -39.09 31.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.133 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.14 -38.4 63.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.174 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.917 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.3 tp -58.98 -24.81 63.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.239 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.917 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 80.25 22.49 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.713 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 6.6 mt -71.39 170.91 10.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 110.194 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.713 ' HD2' ' CD2' ' A' ' 23' ' ' LEU . 46.1 Cg_endo -72.99 138.07 27.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.004 1.528 . . . . 0.0 110.446 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -59.47 -40.76 87.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.212 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -53.24 -33.49 53.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.635 HD23 HD22 ' A' ' 23' ' ' LEU . 52.1 tp -85.65 -35.41 20.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.619 HG12 HD13 ' A' ' 18' ' ' LEU . 96.2 mt -63.26 -52.09 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -59.52 -29.61 68.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.192 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 96.2 mtp -86.37 -12.8 48.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.235 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.602 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -111.51 -3.62 15.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.888 . . . . 0.0 110.242 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -63.64 -6.61 5.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -147.2 55.21 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.82 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 16.5 mt -130.46 114.2 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -98.24 85.79 0.42 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.984 ' HB3' HG23 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.07 149.34 46.33 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.996 1.524 . . . . 0.0 110.426 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.621 HG22 ' N ' ' A' ' 38' ' ' VAL . 19.8 mt -89.51 175.25 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.235 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.621 ' N ' HG22 ' A' ' 37' ' ' ILE . 61.0 t -152.92 119.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -101.13 152.0 21.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 110.249 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.488 HD12 ' HE3' ' A' ' 107' ' ' MET . 58.2 mt -139.46 130.3 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.42 ' HB3' ' HB ' ' A' ' 48' ' ' VAL . 59.7 tt0 -130.1 72.36 1.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 110.207 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.697 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 56.4 tt0 -66.45 173.64 3.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.245 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.697 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 8.3 mtmt -171.49 35.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.234 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.1 -100.25 0.57 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -111.47 -0.86 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -1.151 . . . . 0.0 110.21 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 39.5 t0 -107.32 146.76 31.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.182 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.767 ' CE1' HD11 ' A' ' 64' ' ' LEU . 4.5 m-85 -127.53 139.52 52.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 65.7 t -120.91 101.99 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.208 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.8 t -103.93 130.75 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.193 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 85.5 m -133.31 105.42 6.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.89 . . . . 0.0 110.207 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -86.03 132.0 34.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HA ' HG22 ' A' ' 57' ' ' THR . 57.4 mttt -124.72 122.98 39.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.984 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -109.53 168.09 8.19 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.735 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.06 -5.99 18.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.966 1.508 . . . . 0.0 110.412 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -122.45 -18.41 6.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.19 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.445 ' O ' ' OG1' ' A' ' 53' ' ' THR . 5.8 pt20 -164.6 158.69 18.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 52' ' ' LYS . 11.6 p -133.94 133.52 41.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.895 . . . . 0.0 110.21 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.53 132.84 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.214 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 13.5 t -115.28 138.71 50.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -0.912 . . . . 0.0 110.163 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -135.35 151.93 50.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 110.277 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.2 t -141.37 132.42 26.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.167 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.796 ' CE1' HG21 ' A' ' 82' ' ' VAL . 33.6 p90 -146.64 169.98 17.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 58.1 m -117.81 153.85 32.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -0.929 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.767 HD11 ' CE1' ' A' ' 47' ' ' PHE . 8.0 mt -82.71 122.84 28.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.91 -3.16 55.7 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -132.98 148.63 52.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -1.148 . . . . 0.0 110.197 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.46 ' OE2' ' HB3' ' A' ' 79' ' ' LYS . 5.4 tm-20 -73.68 133.18 43.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.247 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -133.33 148.63 51.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.168 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 15.2 p-10 -78.14 135.1 37.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.898 . . . . 0.0 110.246 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 70' ' ' ILE . 17.1 mm -127.92 143.53 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.172 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p -118.47 139.86 50.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.206 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.724 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 29.3 p -93.54 158.0 15.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.233 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -11.44 59.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.2 -0.937 . . . . 0.0 110.226 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.454 ' OD2' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -87.54 -17.78 31.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 110.256 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.86 29.48 4.07 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.724 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 28.5 mttt -105.07 136.03 45.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 8.4 ptpp? -111.57 133.25 53.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.29 162.26 25.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 110.238 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 35.4 mttt -105.28 151.03 24.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.42 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.2 m -152.88 139.3 18.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.229 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.01 90.56 3.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.881 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.847 HG13 HD21 ' A' ' 89' ' ' LEU . 39.3 t -58.71 152.23 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.276 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -146.59 152.25 38.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.546 HD12 HD13 ' A' ' 64' ' ' LEU . 1.3 mt -105.58 102.31 11.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.87 132.44 54.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.1 t30 45.61 38.18 3.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.411 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 66.73 41.03 93.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.411 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 89.8 mttt -147.68 125.68 12.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -1.149 . . . . 0.0 110.212 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.847 HD21 HG13 ' A' ' 82' ' ' VAL . 6.2 tt -75.23 132.55 41.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.782 HG13 ' HG2' ' A' ' 99' ' ' GLU . 43.4 t -137.84 123.76 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.898 . . . . 0.0 110.241 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 55.3 m -119.7 88.69 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.448 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 16.1 ptmt -85.65 171.52 11.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.183 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 15.1 t -160.03 -161.24 0.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.177 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.491 ' N ' ' OG ' ' A' ' 93' ' ' SER . 23.1 mt-10 -106.15 34.49 3.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 110.202 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.449 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 7.4 ptpt -177.49 -0.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.892 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -175.76 146.85 0.76 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -120.74 157.89 28.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 63.4 t-80 -142.58 138.51 30.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.285 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.782 ' HG2' HG13 ' A' ' 90' ' ' VAL . 44.2 mt-10 -149.59 128.2 12.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.917 . . . . 0.0 110.208 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.609 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 53.6 tt0 -128.67 155.31 45.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 9.5 mp0 -154.82 148.91 25.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 102' ' ' VAL . 12.1 p -116.18 137.04 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 110.299 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -131.65 95.54 3.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.22 -98.02 1.46 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -126.25 12.08 7.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.254 -1.145 . . . . 0.0 110.196 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -118.71 156.05 29.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -0.914 . . . . 0.0 110.151 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.488 ' HE3' HD12 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -129.02 140.84 51.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.201 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.3 t -127.66 125.66 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.22 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.406 ' HG3' ' HG3' ' A' ' 100' ' ' GLN . 27.9 mt-10 -114.84 132.64 56.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.0 m -121.37 122.75 40.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.216 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 97' ' ' SER . 56.8 mt -129.75 133.92 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 75.1 p -113.93 136.47 52.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 0.0 110.203 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 4.6 t80 -157.36 122.75 4.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.875 . . . . 0.0 110.217 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.61 36.11 62.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.74 1.86 55.2 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 112' ' ' THR . 53.0 t -106.7 143.47 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -1.155 . . . . 0.0 110.174 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.447 HG23 HG22 ' A' ' 112' ' ' THR . 85.8 m -121.46 129.39 52.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.487 ' CD1' ' O ' ' A' ' 12' ' ' GLU . 63.0 tp -108.37 145.02 35.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.3 mt -119.03 103.31 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.214 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -102.61 114.18 28.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.921 ' HG3' ' H ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -102.09 137.94 39.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.967 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 5.9 m -125.5 161.88 26.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 110.223 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 1.154 ' HB2' ' CE2' ' A' ' 9' ' ' TYR . 51.8 tttt -128.57 157.55 40.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 110.225 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 5' ' ' THR . 45.2 ttt180 -89.95 135.52 33.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.209 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.565 HG11 ' OE1' ' A' ' 7' ' ' GLN . 33.8 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.432 ' CE2' ' HA ' ' A' ' 101' ' ' GLU . 80.5 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.155 0.503 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.1 p -57.82 148.5 25.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.68 164.79 13.03 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 21.6 m -82.58 145.95 29.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -1.151 . . . . 0.0 110.202 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.645 ' CH2' HG23 ' A' ' 102' ' ' VAL . 98.1 m95 -129.88 130.36 45.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.851 ' HB2' ' HG2' ' A' ' 123' ' ' LYS . 65.1 mt-30 -103.26 117.72 35.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.897 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 36' ' ' PRO . 16.9 t -35.95 134.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.236 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 1.476 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -99.46 -57.47 2.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 110.192 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 1.324 ' HB3' ' NE ' ' A' ' 121' ' ' ARG . . . -158.52 163.97 36.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 110.255 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.599 ' HB2' ' CG ' ' A' ' 14' ' ' TYR . 1.8 pt20 -137.26 106.17 5.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.77 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 39.4 tt0 -94.87 126.48 40.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.951 ' ND2' ' OE1' ' A' ' 16' ' ' GLU . 18.1 t-20 77.91 -4.02 2.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.867 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.75 ' CE1' HD21 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -29.9 -72.72 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 110.222 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 14' ' ' TYR . 46.4 mt-10 -39.52 -61.15 0.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.951 ' OE1' ' ND2' ' A' ' 13' ' ' ASN . 28.6 mt-10 -42.93 -55.86 3.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.215 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.625 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 77.1 t80 -52.82 -46.6 67.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.85 -44.33 86.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.234 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -52.33 -42.18 63.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 110.154 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.99 -31.16 69.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 110.235 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.844 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.7 tp -65.3 -17.14 64.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 75.48 27.54 1.03 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.157 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.725 HD11 HD23 ' A' ' 21' ' ' LEU . 41.6 mt -76.57 163.66 64.54 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.172 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -73.09 138.62 28.37 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.999 1.526 . . . . 0.0 110.39 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -55.38 -38.3 68.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 110.25 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 30' ' ' MET . 44.5 t0 -59.24 -27.61 65.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.229 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.654 HD22 ' OD1' ' A' ' 74' ' ' ASP . 52.5 tp -90.7 -32.59 16.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 110.171 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.629 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.7 mt -69.74 -45.62 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 110.195 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -70.31 -19.9 63.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.416 ' HE2' ' NH2' ' A' ' 55' ' ' ARG . 90.1 mmm -91.47 -29.17 17.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 110.154 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.503 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -102.31 -1.59 30.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.211 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.629 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 2.4 ppt_? -65.51 -10.55 35.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.175 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 10.3 t0 -141.65 47.7 1.65 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.12 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mt -121.22 113.13 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.78 81.28 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.25 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.12 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.9 Cg_endo -73.06 142.39 34.39 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.921 1.485 . . . . 0.0 110.371 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 38' ' ' VAL . 6.6 mt -88.64 164.62 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.261 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.445 ' N ' HG22 ' A' ' 37' ' ' ILE . 55.5 t -141.52 109.93 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.236 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -89.25 137.66 32.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.276 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.442 HD12 ' CD1' ' A' ' 6' ' ' TRP . 82.1 mt -125.04 127.36 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.198 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -127.43 70.48 1.32 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.6 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 57.0 tt0 -68.57 164.41 21.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.231 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 37.3 mttt -162.73 46.11 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.95 -101.06 0.89 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 29.3 m-20 -111.04 -3.86 15.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -1.146 . . . . 0.0 110.179 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -99.64 151.39 21.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.768 ' CE1' HD11 ' A' ' 64' ' ' LEU . 2.3 m-85 -133.42 131.03 39.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.225 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.3 109.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.186 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.5 t -111.81 129.27 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.169 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 88.4 m -123.81 103.31 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.17 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.3 m -83.63 137.94 33.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 0.0 110.164 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -131.74 117.05 18.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 110.16 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.973 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -103.68 168.17 9.06 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 110.239 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.84 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.3 Cg_endo -73.08 -27.81 13.54 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.016 1.535 . . . . 0.0 110.4 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.416 ' NH2' ' HE2' ' A' ' 30' ' ' MET . 3.6 ttm180 -97.28 -23.83 15.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.249 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.486 ' O ' ' OG1' ' A' ' 53' ' ' THR . 1.1 pm0 -161.13 161.98 31.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.224 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 p -129.74 128.06 41.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 110.226 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 73' ' ' MET . 59.4 t -126.77 127.83 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 110.16 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 14.1 t -111.65 140.85 45.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.195 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.452 ' ND2' ' OG1' ' A' ' 71' ' ' THR . 23.6 m120 -138.1 131.72 30.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.175 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -123.12 136.18 54.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.214 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.908 ' CE1' HG21 ' A' ' 82' ' ' VAL . 45.7 p90 -149.06 167.32 26.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.216 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.1 m -116.37 148.69 40.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 110.247 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.772 HD13 HD12 ' A' ' 84' ' ' LEU . 37.2 mt -76.49 126.37 30.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.56 13.23 58.57 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' C ' HG23 ' A' ' 81' ' ' THR . 56.7 mttm -144.22 138.67 28.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -1.136 . . . . 0.0 110.225 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -70.68 124.48 24.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.187 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.65 149.36 49.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.254 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -77.37 137.15 38.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 70' ' ' ILE . 25.5 mm -128.16 145.22 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -0.888 . . . . 0.0 110.226 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.452 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 2.0 p -121.73 134.78 54.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.92 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.684 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 36.5 p -86.96 156.51 19.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.91 . . . . 0.0 110.176 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.444 ' HA ' HG21 ' A' ' 58' ' ' VAL . 10.7 mtm -68.42 -15.6 63.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 110.181 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.654 ' OD1' HD22 ' A' ' 27' ' ' LEU . 11.2 t0 -82.32 -22.59 35.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.208 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.09 19.62 5.11 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.684 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 22.3 mttt -96.38 137.81 34.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -1.142 . . . . 0.0 110.236 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -113.96 133.22 55.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.55 162.07 30.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -106.01 143.99 33.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -0.894 . . . . 0.0 110.2 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.453 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -148.46 139.17 22.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.44 HG23 ' C ' ' A' ' 66' ' ' LYS . 17.8 m -104.4 93.07 4.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 110.192 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.957 HG11 HD11 ' A' ' 89' ' ' LEU . 16.2 t -57.36 152.4 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.907 . . . . 0.0 110.217 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.54 147.28 30.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.253 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.772 HD12 HD13 ' A' ' 64' ' ' LEU . 6.0 mt -102.99 98.83 8.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.214 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 86' ' ' ASN . . . -110.11 138.03 47.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.159 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 85' ' ' ALA . 29.7 m120 42.98 39.35 1.75 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.47 52.09 53.56 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.782 ' HE2' ' OE1' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -161.61 112.98 1.72 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -1.18 . . . . 0.0 110.164 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.957 HD11 HG11 ' A' ' 82' ' ' VAL . 3.9 tt -58.95 144.06 46.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.775 HG13 ' CG ' ' A' ' 99' ' ' GLU . 48.1 t -151.01 114.62 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 85.5 m -109.73 94.2 4.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -91.43 165.14 13.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.859 . . . . 0.0 110.173 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.461 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 1.6 m -155.99 -158.44 0.81 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.572 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 53.1 tt0 -107.9 29.13 7.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.529 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 7.8 ptpt -171.1 1.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.247 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.863 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -178.65 148.04 0.41 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.181 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.737 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -122.72 157.83 31.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.64 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.2 t-80 -139.82 138.39 35.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 110.234 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.775 ' CG ' HG13 ' A' ' 90' ' ' VAL . 78.1 mt-10 -152.66 126.15 8.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.489 ' NE2' ' SD ' ' A' ' 107' ' ' MET . 50.3 tt0 -133.92 155.65 49.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.782 ' OE1' ' HE2' ' A' ' 88' ' ' LYS . 47.5 tt0 -149.51 163.61 37.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.143 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.645 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.0 p -127.2 129.49 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.182 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.6 pttt -126.94 96.9 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 110.202 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.57 -111.29 3.26 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.542 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 45.9 p-10 -115.2 14.42 16.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -1.132 . . . . 0.0 110.25 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.542 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 20.0 mt-10 -119.66 157.72 27.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.178 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.529 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 26.4 ttm -132.56 140.92 48.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 110.226 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 121' ' ' ARG . 65.1 t -127.42 133.65 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.206 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 70.9 mt-10 -117.5 123.99 47.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 110.227 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.2 m -114.02 123.13 48.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.18 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 97' ' ' SER . 82.2 mt -131.86 132.77 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 63.5 p -109.02 136.25 48.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 0.0 110.188 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 8.7 t80 -156.99 124.94 5.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.94 . . . . 0.0 110.19 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 67.68 38.45 89.96 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.53 2.67 44.46 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.9 t -105.66 147.1 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -1.165 . . . . 0.0 110.18 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.7 m -122.28 127.77 50.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.189 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.75 HD21 ' CE1' ' A' ' 14' ' ' TYR . 62.9 tp -105.98 153.07 22.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 91.4 mt -132.15 101.12 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 110.184 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 3.9 ttt180 -104.33 122.28 45.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 1.324 ' NE ' ' HB3' ' A' ' 10' ' ' ALA . 4.4 ptt180 -103.89 142.42 34.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.753 ' C ' ' CD2' ' A' ' 9' ' ' TYR . 0.7 OUTLIER -129.69 147.78 51.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.85 . . . . 0.0 110.248 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 1.476 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -106.57 149.15 27.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.185 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 5' ' ' THR . 76.1 ttt180 -82.18 139.89 34.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.171 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.248 0.547 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.1 p -57.22 146.79 27.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.202 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.81 -177.91 17.31 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.6 m -105.3 132.69 51.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -1.149 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.53 ' CE3' ' HB2' ' A' ' 107' ' ' MET . 98.5 m95 -121.13 147.08 46.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.862 . . . . 0.0 110.198 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -128.82 115.38 17.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 110.175 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.629 HG22 ' HD3' ' A' ' 120' ' ' ARG . 40.1 t -61.67 133.88 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.301 -0.874 . . . . 0.0 110.257 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.503 ' OH ' ' HB3' ' A' ' 121' ' ' ARG . 16.4 p90 -135.88 -19.4 1.56 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -139.05 133.81 32.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 110.277 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -146.1 116.77 7.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.237 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.594 ' O ' HD12 ' A' ' 118' ' ' LEU . 63.5 mm-40 -88.44 142.12 27.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.9 . . . . 0.0 110.281 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.5 t30 55.66 26.31 9.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.23 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.618 ' CE1' HD11 ' A' ' 18' ' ' LEU . 35.1 t80 -54.8 -50.39 68.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -65.99 -45.94 79.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -0.934 . . . . 0.0 110.166 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.86 -60.35 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.194 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.66 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 41.8 t80 -48.56 -60.42 2.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.192 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.723 HD23 HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -53.92 -54.39 39.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.503 ' C ' ' O ' ' A' ' 18' ' ' LEU . 56.7 mttt -36.53 -44.99 0.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.14 -27.35 68.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.907 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -60.65 -19.58 58.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.263 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.907 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 80.15 30.79 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 110.186 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.723 HD12 HD23 ' A' ' 18' ' ' LEU . 15.0 mt -78.03 164.52 56.53 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.925 . . . . 0.0 110.197 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.598 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.4 Cg_endo -73.13 141.19 32.21 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.019 1.536 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -62.25 -39.37 92.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.159 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -57.11 -29.36 63.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.211 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.598 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 44.7 tp -89.42 -23.14 22.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.206 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.9 mt -82.29 -40.22 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.199 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -73.49 -29.09 62.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.239 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.7 ttm -88.11 -25.95 22.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.208 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -101.74 2.72 38.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.621 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 18.0 ptt180 -67.33 -1.12 4.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.234 -0.916 . . . . 0.0 110.212 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.549 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.5 m-20 -146.74 49.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.915 . . . . 0.0 110.181 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.906 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.2 mt -122.41 123.07 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.75 83.0 0.23 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.211 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.906 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -72.98 138.94 29.21 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.061 1.558 . . . . 0.0 110.454 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.7 mt -93.16 153.93 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.886 . . . . 0.0 110.208 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.3 t -132.09 119.78 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 110.199 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -98.49 134.92 40.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 110.212 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.509 HD12 ' CD1' ' A' ' 6' ' ' TRP . 67.9 mt -121.52 131.13 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -135.72 74.53 1.51 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.248 -0.908 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.624 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 1.6 pt20 -76.64 164.88 25.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 57.0 mmtt -159.02 51.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 110.213 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.15 -103.66 1.26 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -107.82 -3.38 19.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -1.187 . . . . 0.0 110.125 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.7 t0 -103.33 148.12 26.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.875 . . . . 0.0 110.185 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.694 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.9 m-85 -132.14 139.35 48.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.9 108.96 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.165 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.4 t -110.08 130.03 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.238 -0.914 . . . . 0.0 110.186 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.759 ' OG1' HG23 ' A' ' 59' ' ' THR . 94.2 m -130.07 110.59 11.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -92.93 132.91 36.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.162 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -125.46 121.55 34.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.191 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.797 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.4 168.64 7.54 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.193 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.685 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.2 Cg_endo -73.12 -18.69 23.58 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.055 1.555 . . . . 0.0 110.395 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 19.9 mtp-105 -104.57 -20.83 13.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.414 ' O ' ' OG1' ' A' ' 53' ' ' THR . 19.0 pt20 -166.81 160.75 14.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.194 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 p -129.78 133.47 47.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.195 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.17 128.79 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 110.265 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.759 HG23 ' OG1' ' A' ' 50' ' ' THR . 25.1 m -111.86 138.4 48.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.256 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 59' ' ' THR . 67.0 m-20 -134.75 153.35 52.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 t -146.51 128.4 15.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.212 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.57 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 33.9 p90 -140.8 173.64 11.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -123.38 141.95 51.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.694 HD11 ' CD1' ' A' ' 47' ' ' PHE . 18.1 mt -74.28 126.21 30.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.02 -1.91 55.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.0 143.32 40.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -1.19 . . . . 0.0 110.17 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -66.61 122.4 17.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.286 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.57 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.54 146.87 47.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.176 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -81.94 137.28 35.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 70' ' ' ILE . 4.9 mm -128.43 145.24 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -116.29 134.47 54.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.15 154.76 20.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.905 . . . . 0.0 110.186 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.44 ' SD ' HG21 ' A' ' 53' ' ' THR . 12.5 ttm -65.91 -16.54 63.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.257 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -85.26 -11.35 55.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 110.186 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.25 33.2 4.65 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -107.32 133.24 52.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -1.191 . . . . 0.0 110.198 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -108.1 135.86 48.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.95 . . . . 0.0 110.199 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.544 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -167.43 156.18 9.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -103.49 166.85 10.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.23 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p -175.22 139.78 0.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.3 m -98.84 100.52 11.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.176 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.62 ' O ' HD23 ' A' ' 64' ' ' LEU . 44.0 t -72.83 139.35 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 110.186 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 25.6 p-80 -136.55 161.08 36.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 110.207 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.5 mt -106.56 130.52 54.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -135.1 116.08 14.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 93.1 m-20 59.02 28.13 17.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.8 37.68 29.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -141.44 122.2 14.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -1.159 . . . . 0.0 110.248 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.498 HD21 HG13 ' A' ' 82' ' ' VAL . 7.8 tt -77.56 126.36 30.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.265 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.841 HG22 ' HG3' ' A' ' 99' ' ' GLU . 92.2 t -135.47 127.17 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.189 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.614 ' OG1' HG22 ' A' ' 82' ' ' VAL . 56.0 m -117.97 85.87 2.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.235 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -79.58 166.78 21.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.235 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.448 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -158.61 -167.2 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.204 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.748 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 43.4 mt-10 -100.84 43.82 1.04 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.181 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.748 ' HB3' ' O ' ' A' ' 94' ' ' GLU . 7.0 ptmt 170.1 3.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.239 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.843 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -176.95 144.65 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 111' ' ' ILE . 70.4 m -123.53 153.91 39.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.482 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 64.4 t-80 -138.56 145.89 41.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.841 ' HG3' HG22 ' A' ' 90' ' ' VAL . 2.4 tt0 -157.78 121.08 3.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.232 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.615 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 26.0 tt0 -122.8 159.81 27.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 27.5 mt-10 -157.61 144.76 18.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.442 HG23 ' CH2' ' A' ' 6' ' ' TRP . 11.3 p -111.07 140.84 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.23 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -137.11 96.22 3.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.877 . . . . 0.0 110.227 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.04 -108.98 2.77 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -116.39 10.83 14.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -1.163 . . . . 0.0 110.18 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.53 156.51 28.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.188 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.53 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 27.5 ttm -128.69 141.12 51.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.338 -0.851 . . . . 0.0 110.192 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 121' ' ' ARG . 94.7 t -126.37 123.97 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.867 . . . . 0.0 110.194 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 23.3 mt-10 -110.66 115.28 29.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.1 m -105.6 122.8 46.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 110.207 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 97' ' ' SER . 61.6 mt -129.82 129.73 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 45.8 m -109.6 135.73 50.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.165 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.591 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 15.9 t80 -159.17 127.05 4.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.07 32.88 65.53 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.48 5.47 67.88 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 112' ' ' THR . 61.6 t -110.16 143.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.334 -1.097 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.0 m -118.6 130.18 55.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.9 . . . . 0.0 110.126 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.66 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 42.7 tp -111.24 147.36 35.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.196 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 87.0 mt -122.35 95.97 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 110.275 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.629 ' HD3' HG22 ' A' ' 8' ' ' VAL . 3.0 ttm180 -88.94 117.52 28.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 110.213 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.503 ' HB3' ' OH ' ' A' ' 9' ' ' TYR . 29.2 mtt180 -101.69 128.82 47.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.925 . . . . 0.0 110.17 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.2 m -126.8 151.81 47.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.197 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -112.09 156.22 22.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.194 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -83.31 135.53 34.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.202 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.236 0.541 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.66 148.04 30.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -0.915 . . . . 0.0 110.218 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.6 163.77 13.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.8 m -80.38 152.23 28.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -1.173 . . . . 0.0 110.178 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.719 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 89.9 m95 -139.21 132.89 30.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.728 ' N ' ' O ' ' A' ' 123' ' ' LYS . 24.8 tt0 -98.71 124.66 43.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 36' ' ' PRO . 10.9 t -44.33 126.2 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 1.267 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -88.51 -65.93 0.97 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 1.014 ' HB3' ' HD2' ' A' ' 121' ' ' ARG . . . -155.07 163.13 40.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.6 pt20 -136.65 101.7 4.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.6 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 56.8 tt0 -87.05 137.46 32.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.133 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.6 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 32.2 m-20 65.36 -1.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 1.183 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 77.8 t80 -32.22 -64.35 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.577 ' HG3' ' N ' ' A' ' 16' ' ' GLU . 13.6 pt-20 -48.26 -51.04 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.235 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.577 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 68.0 mt-10 -54.74 -61.17 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.648 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 49.0 t80 -49.61 -56.27 10.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.183 HD11 ' CZ ' ' A' ' 14' ' ' TYR . 21.0 mt -54.58 -46.81 73.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 65.2 mttt -46.83 -41.29 15.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 -26.16 66.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 110.221 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.861 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -63.22 -20.16 65.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.861 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 78.86 30.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.246 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 37.3 mt -77.32 167.3 37.56 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.259 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.0 Cg_endo -73.1 140.32 30.98 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.065 1.56 . . . . 0.0 110.41 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -61.49 -36.57 80.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.168 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -59.22 -30.06 67.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.181 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.658 HD22 ' OD1' ' A' ' 74' ' ' ASP . 44.9 tp -89.46 -21.21 23.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 110.153 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.747 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 78.0 mt -78.71 -41.26 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 0.0 110.198 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HA ' ' HD2' ' A' ' 32' ' ' ARG . 18.0 mtmt -75.22 -24.1 57.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.27 -0.894 . . . . 0.0 110.251 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.5 tpp -87.87 -29.8 20.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.454 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -105.52 8.4 33.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 110.23 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.747 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.0 ptm85 -67.88 -7.67 30.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 110.176 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -146.74 59.86 1.2 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.192 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.5 mt -129.64 110.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.583 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -88.57 80.41 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.954 . . . . 0.0 110.274 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.192 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.05 140.78 31.83 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.005 1.529 . . . . 0.0 110.459 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 38' ' ' VAL . 5.2 mt -87.9 165.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.459 ' N ' HG22 ' A' ' 37' ' ' ILE . 69.0 t -142.67 116.59 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.239 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -92.17 140.74 29.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.2 mt -126.92 129.25 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 110.18 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -129.67 66.37 1.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.619 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 52.6 tt0 -63.95 168.96 4.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.619 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 33.5 mtmt -167.78 44.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 0.0 110.22 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.97 -103.97 1.04 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 25.8 m-20 -108.23 -3.11 18.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -1.187 . . . . 0.0 110.172 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.36 150.3 23.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.684 ' CE1' HD11 ' A' ' 64' ' ' LEU . 2.9 m-85 -133.25 134.37 43.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.08 109.45 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 0.0 110.18 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.0 t -111.41 129.85 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.259 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.7 ' OG1' HG23 ' A' ' 59' ' ' THR . 84.7 m -126.04 106.86 9.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 110.195 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.8 m -88.64 136.55 32.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.202 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -129.69 117.52 20.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.884 HG22 ' HD2' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -102.39 168.11 9.42 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.884 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.1 Cg_endo -73.05 -28.01 13.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.028 1.541 . . . . 0.0 110.394 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.14 -19.43 17.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.245 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.508 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.4 OUTLIER -164.05 160.36 21.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.244 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 p -128.94 127.85 42.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.265 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' A' ' 73' ' ' MET . 58.2 t -125.78 124.42 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.149 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.7 HG23 ' OG1' ' A' ' 50' ' ' THR . 36.7 m -110.17 144.57 38.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -141.24 147.73 38.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.893 . . . . 0.0 110.25 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.7 m -139.07 135.08 33.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.923 . . . . 0.0 110.264 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 1.035 ' CE1' HG21 ' A' ' 82' ' ' VAL . 51.7 p90 -147.69 170.99 16.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 110.229 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.2 m -118.52 145.37 45.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 110.228 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.684 HD11 ' CE1' ' A' ' 47' ' ' PHE . 51.0 mt -77.1 124.44 27.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.27 -3.75 54.8 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -134.31 148.62 50.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 0.0 110.185 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.463 ' HA ' ' CG2' ' A' ' 81' ' ' THR . 75.7 tt0 -72.45 128.54 35.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.224 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.96 150.74 50.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -82.05 133.71 35.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 70' ' ' ILE . 22.9 mm -123.45 145.06 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 96.3 m -122.8 135.07 54.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.697 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 43.1 p -89.78 157.92 17.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.722 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -68.3 -12.53 61.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.268 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.658 ' OD1' HD22 ' A' ' 27' ' ' LEU . 5.3 t0 -85.31 -21.5 28.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.06 23.23 4.99 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.697 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 27.1 mttt -98.62 135.32 40.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -1.118 . . . . 0.0 110.161 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -113.01 135.22 54.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 110.21 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -164.47 160.69 20.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.152 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' HD3' ' OE2' ' A' ' 67' ' ' GLU . 25.8 mttp -104.05 146.33 28.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.279 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.56 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -148.58 141.8 25.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.463 ' CG2' ' HA ' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -106.43 89.39 3.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.211 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.035 HG21 ' CE1' ' A' ' 62' ' ' PHE . 12.2 t -57.71 152.54 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.161 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.19 146.12 28.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.564 ' CD1' HD13 ' A' ' 64' ' ' LEU . 14.9 mt -98.41 101.02 12.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.843 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 86' ' ' ASN . . . -117.33 148.91 41.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.222 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' ALA . 3.4 t-20 44.53 27.51 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.159 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.424 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 70.45 40.17 68.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.792 ' HD3' ' CD ' ' A' ' 101' ' ' GLU . 11.1 mttt -152.95 132.09 12.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.208 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.872 HD11 HG11 ' A' ' 82' ' ' VAL . 8.3 tt -72.19 135.9 46.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.664 HG12 ' CG ' ' A' ' 99' ' ' GLU . 11.6 m -143.72 123.26 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.235 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.56 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 95.2 m -114.56 91.87 3.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 5.9 ptmt -88.49 163.78 15.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.238 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 29.3 t -152.65 -158.03 0.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.196 -0.94 . . . . 0.0 110.197 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.459 ' N ' ' OG ' ' A' ' 93' ' ' SER . 44.6 mt-10 -106.59 26.15 10.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.505 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 7.8 ptpt -167.03 0.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.94 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -177.67 146.21 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 111' ' ' ILE . 29.3 t -117.72 160.03 22.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 58.6 t-80 -143.99 139.25 28.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.664 ' CG ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -152.18 127.77 10.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.544 ' NE2' ' SD ' ' A' ' 107' ' ' MET . 46.0 tt0 -131.66 155.04 48.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.188 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.792 ' CD ' ' HD3' ' A' ' 88' ' ' LYS . 45.1 tt0 -151.64 155.09 37.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.461 HG23 ' CH2' ' A' ' 6' ' ' TRP . 11.2 p -119.33 134.4 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.219 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.18 94.67 3.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.172 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.38 -111.84 3.37 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -116.23 18.31 15.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.17 . . . . 0.0 110.253 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -123.66 148.51 46.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.218 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.548 ' HB3' ' HB2' ' A' ' 122' ' ' SER . 34.0 ttm -123.58 139.06 54.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 0.0 110.247 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.62 129.33 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 33.4 mt-10 -115.6 109.81 18.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 110.199 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 99' ' ' GLU . 25.8 m -99.01 123.21 43.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.133 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 97' ' ' SER . 52.7 mt -132.29 129.28 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.223 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 21.8 m -104.63 142.92 33.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.887 . . . . 0.0 110.267 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.633 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 5.6 t80 -163.16 124.83 2.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 68.9 37.44 83.67 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.34 9.38 60.91 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 112' ' ' THR . 65.2 t -112.32 140.2 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -1.13 . . . . 0.0 110.194 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.7 m -113.72 129.31 56.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 110.221 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.648 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 48.4 tp -108.66 153.65 23.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.259 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.8 mt -130.97 94.55 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 0.9 OUTLIER -95.97 128.65 43.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 110.272 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 1.014 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 1.3 ptp180 -109.85 136.9 48.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.226 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.588 ' C ' ' HD2' ' A' ' 9' ' ' TYR . 39.8 m -125.57 135.46 52.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 1.267 ' HB2' ' CE2' ' A' ' 9' ' ' TYR . 71.7 tttt -92.94 153.89 18.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.246 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 27.5 ttp85 -89.52 134.83 33.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.456 HG21 ' OE1' ' A' ' 7' ' ' GLN . 53.0 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.221 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.252 0.549 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.1 p -56.08 146.55 22.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 110.159 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.7 -172.49 19.47 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.726 HG22 ' HG3' ' A' ' 39' ' ' GLU . 5.8 p -110.69 128.04 55.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -1.133 . . . . 0.0 110.233 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.536 ' CH2' HG23 ' A' ' 102' ' ' VAL . 94.3 m95 -115.92 143.51 45.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.171 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -128.71 116.67 19.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.179 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.08 144.88 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.253 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 9' ' ' TYR . 8.0 p90 -147.09 -14.23 0.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.251 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -139.61 141.86 37.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.14 164.7 37.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -140.33 158.8 43.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.19 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 46.51 38.03 5.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 110.233 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 7.8 t80 -69.84 -55.33 10.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -53.19 -57.88 8.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.271 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -48.38 -45.44 35.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.222 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.651 ' CD2' HD22 ' A' ' 118' ' ' LEU . 10.0 t80 -55.59 -57.25 12.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 110.228 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.721 HD13 HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -51.07 -43.32 61.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.167 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -54.78 -35.49 63.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.39 -41.91 62.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -0.97 . . . . 0.0 110.162 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.9 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.7 tp -55.26 -25.58 34.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 80.56 24.13 0.35 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.708 HD12 HD22 ' A' ' 18' ' ' LEU . 14.5 mt -69.13 166.52 27.99 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.145 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.0 Cg_endo -73.14 132.13 17.61 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.058 1.557 . . . . 0.0 110.407 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.66 ' HA ' HD12 ' A' ' 28' ' ' ILE . 44.8 mt-10 -49.7 -46.04 49.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.972 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -50.33 -35.81 29.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.191 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 41.7 tp -84.45 -33.61 23.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.721 HG12 HD13 ' A' ' 18' ' ' LEU . 96.9 mt -61.22 -56.09 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.149 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' A' ' 30' ' ' MET . 13.4 pttp -56.01 -24.43 39.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.688 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 85.6 mtp -94.17 -9.74 35.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.245 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -113.34 -5.84 13.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.218 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.707 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -71.86 0.82 8.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 110.286 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.707 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.5 m-20 -150.18 41.69 0.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.688 ' CD1' ' O ' ' A' ' 30' ' ' MET . 23.8 mt -122.84 115.47 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.267 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -100.82 90.19 1.45 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.978 ' HB3' HG23 ' A' ' 53' ' ' THR . 46.5 Cg_endo -73.09 146.04 40.49 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.918 1.483 . . . . 0.0 110.4 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 38' ' ' VAL . 6.4 mt -86.45 173.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.61 ' N ' HG22 ' A' ' 37' ' ' ILE . 70.0 t -150.19 119.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.177 -0.952 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.726 ' HG3' HG22 ' A' ' 5' ' ' THR . 20.1 tt0 -103.45 148.04 26.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.225 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.56 HD11 HE22 ' A' ' 100' ' ' GLN . 55.8 mt -136.4 132.14 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 110.23 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 55.9 tt0 -132.28 73.82 1.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.793 ' OE1' ' N ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -68.73 170.53 9.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.244 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 14.2 mtmt -168.55 43.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.793 ' N ' ' OE1' ' A' ' 42' ' ' GLN . . . 120.04 -102.49 0.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 26.8 m-20 -110.36 -2.0 16.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -1.135 . . . . 0.0 110.154 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.1 t0 -104.2 150.39 24.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.789 ' CE1' HD11 ' A' ' 64' ' ' LEU . 3.0 m-85 -131.37 137.27 48.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.21 108.08 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.141 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' ASN . 62.8 t -108.37 130.92 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.65 HG23 ' OG1' ' A' ' 59' ' ' THR . 77.6 m -133.22 106.07 7.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.3 m -89.04 137.68 32.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.887 . . . . 0.0 110.223 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -130.97 124.11 30.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 110.258 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.978 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.08 169.25 6.81 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.78 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.4 Cg_endo -73.0 -20.53 21.82 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.992 1.522 . . . . 0.0 110.414 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -105.67 -22.46 12.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.417 ' HG3' ' HG1' ' A' ' 53' ' ' THR . 4.5 pt20 -159.74 161.76 34.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 p -132.4 128.15 36.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 110.233 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.55 127.42 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.91 . . . . 0.0 110.233 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.65 ' OG1' HG23 ' A' ' 50' ' ' THR . 91.5 m -111.28 142.09 43.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 49' ' ' VAL . 28.1 m120 -139.41 151.05 45.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.162 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 m -141.58 135.14 29.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.191 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.541 ' CB ' ' CB ' ' A' ' 68' ' ' ALA . 35.0 p90 -148.26 166.65 27.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.8 m -116.02 150.4 37.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.789 HD11 ' CE1' ' A' ' 47' ' ' PHE . 31.4 mt -78.45 125.66 29.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.928 . . . . 0.0 110.198 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.47 5.93 60.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -139.95 139.46 36.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -1.135 . . . . 0.0 110.222 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -65.91 124.8 23.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.541 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -124.76 148.16 48.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.154 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 14.8 p-10 -81.18 136.89 35.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.161 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 70' ' ' ILE . 23.7 mm -128.85 142.43 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 110.161 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 m -113.55 139.88 48.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 110.233 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.685 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 68.3 p -93.97 158.39 15.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.8 ttm -70.67 -13.28 62.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.206 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.54 -12.87 47.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.02 25.42 7.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.685 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 12.0 mttt -102.89 136.89 41.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -1.114 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -110.67 135.37 51.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.162 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.404 HD21 HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -166.21 153.67 9.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.277 -0.89 . . . . 0.0 110.208 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -99.23 155.98 17.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.3 m -157.92 134.26 9.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.167 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -96.55 96.38 8.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.196 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.907 HG13 HD21 ' A' ' 89' ' ' LEU . 48.4 t -69.92 142.53 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.669 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 13.9 p-80 -140.84 155.49 46.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.177 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.409 ' CD1' HD13 ' A' ' 64' ' ' LEU . 51.5 mt -100.12 132.34 45.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -138.75 111.51 7.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.22 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.676 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 86.2 m-20 64.35 27.59 13.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.214 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.532 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.34 43.5 20.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.623 ' HD2' ' OE2' ' A' ' 101' ' ' GLU . 49.4 mtpt -153.37 118.86 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -1.167 . . . . 0.0 110.203 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.907 HD21 HG13 ' A' ' 82' ' ' VAL . 4.8 tt -68.69 142.94 54.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.233 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.772 HG13 ' HG2' ' A' ' 99' ' ' GLU . 55.3 t -150.69 120.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.787 ' OG1' HG22 ' A' ' 82' ' ' VAL . 5.4 m -114.04 95.73 5.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.434 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -89.0 167.48 13.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.24 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 3.3 m -158.55 -168.08 2.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 110.236 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 27.0 tp10 -101.74 33.68 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.502 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 8.6 ptpt -174.75 0.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.226 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.895 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -179.01 144.71 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 0.0 110.184 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.9 m -119.4 158.37 26.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.4 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 56.8 t-80 -143.42 136.52 27.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.207 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.772 ' HG2' HG13 ' A' ' 90' ' ' VAL . 92.2 mt-10 -148.32 131.38 16.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.219 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.56 HE22 HD11 ' A' ' 40' ' ' ILE . 40.5 tt0 -134.7 152.9 52.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.227 -0.921 . . . . 0.0 110.186 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.623 ' OE2' ' HD2' ' A' ' 88' ' ' LYS . 58.1 tt0 -150.72 159.11 44.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.536 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.7 p -123.52 136.89 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 110.18 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -130.65 96.97 4.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.246 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.53 -98.08 1.75 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.502 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 30.7 p-10 -126.87 11.6 7.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -1.137 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.502 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 48.4 mt-10 -118.38 164.99 14.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.213 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.519 ' CE ' ' NE1' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -137.27 143.04 41.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.17 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 121' ' ' ARG . 76.4 t -127.21 127.31 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.375 -0.828 . . . . 0.0 110.238 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 33.9 mt-10 -114.42 134.74 54.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.0 m -124.09 122.38 37.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.179 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 74.8 mt -127.76 131.82 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 110.2 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 80.5 m -112.75 135.58 53.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.512 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 4.9 t80 -156.81 123.95 5.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.17 -0.956 . . . . 0.0 110.274 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 70.03 37.75 73.67 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.49 4.68 52.89 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 112' ' ' THR . 60.2 t -108.65 139.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -1.17 . . . . 0.0 110.178 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 63.6 m -115.13 130.86 57.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.651 HD22 ' CD2' ' A' ' 17' ' ' PHE . 36.9 tp -110.19 141.93 42.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.182 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.6 mt -120.34 121.36 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -117.75 117.57 29.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.156 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 12.2 mtt180 -98.24 129.01 44.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.169 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.5 p -125.74 166.33 16.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 110.263 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 35.4 tttm -129.62 158.83 38.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 110.155 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.405 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 73.8 ttt180 -81.35 134.58 35.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.22 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.247 0.546 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -76.48 -31.68 57.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.301 -0.874 . . . . 0.0 110.22 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 m -56.56 145.16 29.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.888 . . . . 0.0 110.182 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.6 -176.48 17.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.4 m -106.35 131.28 53.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -1.137 . . . . 0.0 110.251 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.467 ' CZ3' ' HG3' ' A' ' 107' ' ' MET . 93.0 m95 -119.62 142.84 48.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -124.22 122.12 36.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 110.257 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.15 127.21 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 121' ' ' ARG . 34.3 p90 -133.08 2.37 3.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.251 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.82 127.99 2.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -143.96 120.77 11.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.243 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 55.7 tt0 -99.82 144.65 28.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.941 . . . . 0.0 110.197 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 22.3 m120 58.32 16.33 3.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.277 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.961 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 90.4 t80 -52.98 -47.64 68.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 110.164 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.09 -47.51 76.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 37.0 mt-10 -56.47 -60.23 3.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.67 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 45.0 t80 -49.74 -54.99 15.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.09 HD21 H191 ' A' ' 130' ' ' JN3 . 22.2 mt -52.68 -49.51 65.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 63.1 mttt -42.47 -40.19 2.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.915 . . . . 0.0 110.156 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.451 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -68.84 -25.54 64.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.864 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -59.04 -19.09 40.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.181 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.864 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 76.36 25.43 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.903 . . . . 0.0 110.166 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 20.3 mt -75.17 168.24 29.35 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 23' ' ' LEU . 46.4 Cg_endo -73.05 138.06 27.52 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.01 1.531 . . . . 0.0 110.444 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 28' ' ' ILE . 69.4 mm-40 -54.32 -44.44 72.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.925 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -53.75 -25.3 18.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.524 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 44.9 tp -90.36 -23.95 20.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.901 . . . . 0.0 110.243 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.854 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 81.2 mt -74.81 -42.3 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.233 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -74.97 -20.6 59.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.9 mmm -93.0 -27.12 17.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.212 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.513 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -105.71 4.44 30.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 110.273 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.854 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 23.4 ptt180 -72.43 3.63 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 10.4 t0 -154.45 47.19 0.58 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.081 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 4.2 mt -121.12 117.29 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 110.168 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -91.3 82.48 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.186 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.081 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.09 132.89 18.77 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.034 1.544 . . . . 0.0 110.428 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 38' ' ' VAL . 8.2 mt -83.2 162.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.414 ' N ' HG22 ' A' ' 37' ' ' ILE . 73.0 t -140.67 116.48 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 40' ' ' ILE . 36.0 tt0 -97.21 136.01 38.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.855 . . . . 0.0 110.224 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 39' ' ' GLU . 51.5 mm -123.63 132.78 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.198 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 48' ' ' VAL . 37.2 tt0 -132.56 63.21 1.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 110.2 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.646 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 51.6 tt0 -59.3 165.8 2.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 110.218 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 38.3 mtmt -163.77 37.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.28 -97.84 0.53 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 14.8 m-20 -112.4 -7.48 13.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -1.122 . . . . 0.0 110.166 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.621 ' OD1' HG23 ' A' ' 63' ' ' THR . 12.0 m-20 -102.55 157.75 16.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.592 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 41.3 m-85 -138.55 139.5 38.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.218 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 58.6 t -117.19 104.19 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.737 HG11 ' H42' ' A' ' 131' ' ' JN3 . 57.6 t -104.16 128.32 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.685 HG23 ' OG1' ' A' ' 59' ' ' THR . 94.0 m -130.51 100.27 5.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.1 m -83.68 140.15 32.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 110.224 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 57' ' ' THR . 55.3 mttt -132.17 107.38 8.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.868 . . . . 0.0 110.204 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.97 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -94.0 168.15 12.25 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 110.211 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.781 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.6 Cg_endo -72.96 -29.93 11.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.016 1.535 . . . . 0.0 110.477 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -95.35 -22.05 18.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -162.45 169.58 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.211 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 52' ' ' LYS . 9.2 p -134.6 124.88 26.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.227 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 73' ' ' MET . 54.0 t -123.24 125.86 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.685 ' OG1' HG23 ' A' ' 50' ' ' THR . 64.3 m -112.94 148.16 35.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.213 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 59' ' ' THR . 27.2 m120 -143.87 147.52 34.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.279 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 t -138.92 140.12 38.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.621 ' CE1' HG11 ' A' ' 82' ' ' VAL . 34.5 p90 -151.89 166.19 32.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -0.904 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.621 HG23 ' OD1' ' A' ' 46' ' ' ASP . 88.7 m -116.26 152.26 34.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 3.9 tp -78.47 122.91 26.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.56 14.4 53.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -144.63 136.11 25.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -1.169 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.0 123.1 18.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.461 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.12 150.54 43.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.244 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -83.93 132.58 34.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 110.222 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.86 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 26.7 mm -121.85 146.31 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 m -123.62 136.97 54.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 0.0 110.21 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.674 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 57.9 p -90.92 162.68 14.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.291 -0.88 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.677 ' CE ' H122 ' A' ' 130' ' ' JN3 . 23.9 mtm -75.8 -10.62 59.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.506 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 4.5 p30 -88.76 -14.92 35.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.49 28.73 4.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.674 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 18.0 mttt -107.02 128.16 54.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -1.121 . . . . 0.0 110.233 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -107.06 139.36 41.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.208 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.518 HD11 H181 ' A' ' 131' ' ' JN3 . 0.5 OUTLIER -169.29 154.37 5.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.208 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.0 mtmm -98.6 153.05 18.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.419 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -157.82 133.66 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 m -95.2 102.58 14.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.186 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.838 HG13 HD21 ' A' ' 89' ' ' LEU . 47.5 t -73.81 142.99 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 6.5 p-80 -144.36 157.25 44.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.927 . . . . 0.0 110.246 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 84' ' ' LEU . 12.0 mt -99.86 134.26 43.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.875 . . . . 0.0 110.233 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -140.73 117.22 10.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.246 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.603 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 17.9 m120 61.93 27.59 16.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.53 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.61 40.58 26.75 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.53 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 61.3 mttt -151.4 130.32 12.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -1.14 . . . . 0.0 110.225 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.838 HD21 HG13 ' A' ' 82' ' ' VAL . 7.4 tt -76.58 129.94 37.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.742 HG13 ' HG2' ' A' ' 99' ' ' GLU . 70.3 t -138.46 125.92 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.932 . . . . 0.0 110.188 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.532 ' OG1' HG22 ' A' ' 82' ' ' VAL . 51.9 m -117.92 90.57 3.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 12.1 pttp -85.24 164.55 17.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 110.211 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 34.9 t -155.07 -158.37 0.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.405 ' N ' ' OG ' ' A' ' 93' ' ' SER . 35.0 mt-10 -108.1 35.41 3.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 110.239 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -177.58 1.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.0 110.149 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.896 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER 179.21 148.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.198 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -121.76 160.62 24.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.155 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.688 ' CD2' H122 ' A' ' 131' ' ' JN3 . 52.1 t-80 -142.15 140.92 32.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.182 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.742 ' HG2' HG13 ' A' ' 90' ' ' VAL . 48.2 mt-10 -151.74 126.33 9.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.226 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.689 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 41.3 tt0 -125.95 156.32 39.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.161 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.689 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 7.8 mp0 -157.53 147.55 20.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.902 . . . . 0.0 110.261 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.0 p -116.12 139.26 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -130.33 99.48 5.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.925 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.37 -118.11 5.76 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -103.9 8.15 36.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.232 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -116.1 159.06 22.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.467 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -129.04 139.2 52.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.289 -0.882 . . . . 0.0 110.17 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 80.0 t -126.33 126.18 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.2 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 35.1 mt-10 -110.5 131.28 55.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 99' ' ' GLU . 12.2 p -122.17 117.62 26.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 97' ' ' SER . 53.8 mt -129.16 139.41 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.251 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 69.9 p -112.75 131.56 55.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.176 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 3.2 t80 -151.89 126.82 9.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.918 . . . . 0.0 110.231 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.451 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.42 36.51 92.72 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.89 11.42 66.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.497 HG11 ' HA ' ' A' ' 17' ' ' PHE . 69.2 t -114.36 138.06 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -1.117 . . . . 0.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 43.9 m -112.18 135.67 52.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 110.195 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.67 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 59.2 tp -115.0 144.36 43.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.1 mt -125.7 94.44 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.187 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 9.9 ttp180 -89.54 132.26 35.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 110.204 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.501 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 45.1 mtm180 -109.9 122.8 48.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 6' ' ' TRP . 59.2 m -119.73 152.96 36.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -116.98 155.48 29.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.212 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' THR . 39.5 ttp85 -81.38 135.2 35.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.221 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 1.09 H191 HD21 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.86 ' H8 ' HG21 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.225 0.536 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -77.27 -33.09 55.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.1 p -56.87 146.26 27.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.299 -0.875 . . . . 0.0 110.172 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.15 -174.06 17.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 89.0 m -107.64 131.11 54.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -1.141 . . . . 0.0 110.241 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.556 ' CD1' HD12 ' A' ' 40' ' ' ILE . 90.8 m95 -120.15 145.09 47.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -126.47 122.06 34.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.851 . . . . 0.0 110.177 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.5 126.02 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 39.1 p90 -126.81 -29.61 2.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.912 . . . . 0.0 110.19 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.78 129.57 40.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.86 . . . . 0.0 110.269 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.6 pt20 -143.11 119.61 11.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 110.203 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.535 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.6 tt0 -98.66 144.45 27.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 110.247 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.718 ' OD1' ' OE1' ' A' ' 16' ' ' GLU . 1.9 t30 60.25 14.21 4.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.861 ' CE1' HD11 ' A' ' 18' ' ' LEU . 74.0 t80 -51.59 -52.14 49.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -62.95 -48.5 78.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.718 ' OE1' ' OD1' ' A' ' 13' ' ' ASN . 65.3 mt-10 -55.73 -59.36 4.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.148 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.713 ' CD2' HD22 ' A' ' 118' ' ' LEU . 70.4 t80 -49.2 -55.49 12.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.074 HD21 H191 ' A' ' 130' ' ' JN3 . 12.7 mt -58.15 -42.25 85.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 3.5 tttm -49.14 -41.23 35.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.57 -27.75 66.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.902 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.1 tp -58.75 -20.27 47.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.61 28.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 110.268 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 21' ' ' LEU . 65.6 mt -74.73 165.86 50.2 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.134 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.554 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 45.6 Cg_endo -73.14 140.13 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.021 1.537 . . . . 0.0 110.382 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.7 -40.87 84.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.61 -26.58 56.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.229 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.674 HD22 ' OD1' ' A' ' 74' ' ' ASP . 43.3 tp -92.46 -19.41 22.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.747 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 94.0 mt -82.92 -40.93 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 0.0 110.172 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -75.36 -27.56 59.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.174 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 57.9 tpp -86.53 -27.64 23.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.237 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -103.03 4.92 37.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.747 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 6.3 ptt180 -71.57 2.07 5.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -152.33 48.66 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 110.24 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.1 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.9 mt -123.72 118.46 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.207 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.47 84.56 0.11 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.232 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.1 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.05 130.58 15.62 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.986 1.519 . . . . 0.0 110.433 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.8 mt -84.39 157.86 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.6 t -137.26 115.77 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -96.27 137.49 35.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.556 HD12 ' CD1' ' A' ' 6' ' ' TRP . 79.3 mt -123.95 129.72 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 55.8 tt0 -130.33 67.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 0.0 110.23 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.733 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 9.3 tt0 -62.39 171.37 1.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.143 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.733 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 17.9 mtmt -171.74 38.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.153 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.16 -104.54 0.87 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -108.52 0.64 21.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -1.149 . . . . 0.0 110.222 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.1 t0 -108.89 145.04 36.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.696 ' CE1' HD11 ' A' ' 64' ' ' LEU . 7.6 m-85 -127.18 139.43 52.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 110.276 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 59.4 t -120.01 104.61 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.719 HG11 ' H42' ' A' ' 131' ' ' JN3 . 91.9 t -106.29 122.44 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 110.146 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.674 HG23 ' OG1' ' A' ' 59' ' ' THR . 91.3 m -122.72 106.08 10.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 110.261 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 58' ' ' VAL . 51.1 m -92.61 134.58 34.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -127.11 119.6 26.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.961 . . . . 0.0 110.289 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.718 HG21 H213 ' A' ' 130' ' ' JN3 . 0.1 OUTLIER -103.25 169.86 6.92 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.174 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.07 -17.82 24.5 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.093 1.575 . . . . 0.0 110.404 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -104.88 -24.71 12.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.956 . . . . 0.0 110.213 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.653 ' O ' ' OG1' ' A' ' 53' ' ' THR . 3.8 pt20 -163.58 169.08 19.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.186 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.0 p -129.79 127.85 41.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.231 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' A' ' 73' ' ' MET . 19.4 m -124.96 127.02 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.177 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.674 ' OG1' HG23 ' A' ' 50' ' ' THR . 36.2 m -115.64 147.36 40.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -142.46 149.46 39.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.261 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.3 t -141.81 137.76 31.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.152 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.696 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 52.0 p90 -150.5 169.89 20.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 110.237 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.9 m -117.65 150.57 38.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.196 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.696 HD11 ' CE1' ' A' ' 47' ' ' PHE . 17.3 mt -79.53 123.81 27.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 110.212 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.48 9.66 52.56 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -145.72 143.7 29.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -1.131 . . . . 0.0 110.193 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -68.68 127.78 34.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.202 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.592 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.06 147.63 50.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -80.28 134.99 36.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.241 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.888 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 23.8 mm -124.26 144.81 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.151 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.1 m -121.78 136.06 54.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 110.21 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.659 HG21 ' O25' ' A' ' 131' ' ' JN3 . 66.4 p -87.88 161.14 17.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.672 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 1.5 ttp -73.89 -11.91 60.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.198 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.674 ' OD1' HD22 ' A' ' 27' ' ' LEU . 7.3 t0 -89.13 -14.04 37.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 110.213 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.67 50.77 0.83 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.613 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 7.7 tttt -128.61 129.65 46.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -1.155 . . . . 0.0 110.146 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -105.79 137.59 43.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.203 -0.936 . . . . 0.0 110.192 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.663 HD11 H181 ' A' ' 131' ' ' JN3 . 0.8 OUTLIER -166.1 155.08 11.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.232 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -101.45 145.47 28.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.537 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.3 m -153.08 133.78 13.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.307 -0.871 . . . . 0.0 110.156 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -94.97 100.04 11.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.788 HG13 HD21 ' A' ' 89' ' ' LEU . 49.4 t -70.36 142.26 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 8.5 p-80 -146.04 151.41 37.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.15 132.03 40.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 110.262 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -140.87 131.49 25.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 97.3 m-20 56.69 17.43 3.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.2 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.56 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 83.8 40.88 8.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.56 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 97.4 mttt -155.57 131.84 10.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -1.121 . . . . 0.0 110.221 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.788 HD21 HG13 ' A' ' 82' ' ' VAL . 6.7 tt -72.64 130.89 41.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.244 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.753 HG22 ' HG3' ' A' ' 99' ' ' GLU . 92.8 t -139.25 125.31 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.179 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.537 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 99.5 m -115.65 90.16 3.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -84.59 169.5 14.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.214 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 29.5 t -160.72 -157.58 0.54 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 110.196 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.445 ' N ' ' OG ' ' A' ' 93' ' ' SER . 18.7 tt0 -109.74 32.93 4.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.231 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.709 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -175.74 6.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 1.073 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.3 OUTLIER 171.87 141.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 110.26 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -114.72 174.75 5.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.738 ' CD2' H122 ' A' ' 131' ' ' JN3 . 47.6 t-80 -156.31 137.84 14.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.148 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.753 ' HG3' HG22 ' A' ' 90' ' ' VAL . 69.5 tt0 -149.85 126.49 10.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.218 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 47.5 tt0 -125.54 161.16 27.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.923 . . . . 0.0 110.247 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.532 ' OE1' ' HG3' ' A' ' 103' ' ' LYS . 10.9 tm-20 -161.81 148.72 14.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.434 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 10.8 p -116.0 143.18 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 110.223 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.532 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 92.6 mttt -133.26 92.7 3.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.99 -109.81 2.98 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.678 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 24.5 p30 -112.1 11.23 20.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -1.152 . . . . 0.0 110.18 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.678 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 61.5 mt-10 -118.64 155.18 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.491 ' HG3' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -125.1 141.85 51.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.48 121.54 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.13 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 40.8 mt-10 -107.74 119.27 38.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.556 ' N ' ' O ' ' A' ' 99' ' ' GLU . 38.0 p -108.48 119.61 40.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 97' ' ' SER . 53.0 mt -130.39 131.73 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.357 -0.84 . . . . 0.0 110.209 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 6.3 t -110.55 141.27 43.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.175 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.704 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 10.7 t80 -161.26 128.34 4.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.15 33.95 74.85 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.9 12.78 75.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 112' ' ' THR . 73.1 t -116.48 139.47 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -1.155 . . . . 0.0 110.191 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 47.3 m -112.92 134.0 54.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.713 HD22 ' CD2' ' A' ' 17' ' ' PHE . 43.1 tp -114.07 150.55 33.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.0 mt -130.6 94.74 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 9.4 ttp180 -88.93 131.42 35.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 25.7 mtt-85 -110.41 124.71 52.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.915 . . . . 0.0 110.174 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.1 m -122.07 149.44 43.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -115.38 153.15 31.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.19 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.7 ttp85 -78.19 134.75 37.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 125' ' ' VAL . 62.4 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.192 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 1.074 H191 HD21 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.888 ' H8 ' HG21 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.232 0.539 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.45 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 49.3 m-85 -78.97 -29.43 43.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.251 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 p -57.65 144.93 35.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.97 -178.7 17.33 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 91.0 m -106.13 134.73 48.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -1.148 . . . . 0.0 110.242 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.476 ' CE3' ' HB2' ' A' ' 107' ' ' MET . 92.9 m95 -121.15 136.33 55.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -118.88 118.15 30.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.201 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.448 HG21 ' HD2' ' A' ' 120' ' ' ARG . 59.5 t -63.94 126.03 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.238 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 11.8 p90 -128.5 -19.59 3.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -141.74 131.6 24.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.207 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -143.06 166.47 24.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.226 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 56.0 tt0 -141.03 146.44 37.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.932 . . . . 0.0 110.21 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 79.4 m-20 56.19 20.72 4.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.499 ' CE1' HD21 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -54.18 -53.67 50.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.862 . . . . 0.0 110.215 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -59.36 -57.04 14.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -46.25 -52.93 11.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.603 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 69.6 t80 -52.56 -46.3 66.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.17 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 mt -59.3 -43.05 92.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.893 . . . . 0.0 110.172 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -54.58 -42.08 70.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.4 75.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.83 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 3.9 tp -64.42 -17.41 63.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.17 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.83 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 74.95 28.91 1.04 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.226 -0.922 . . . . 0.0 110.22 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.559 HD11 HD23 ' A' ' 21' ' ' LEU . 20.2 mt -75.39 165.03 56.98 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.75 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.3 Cg_endo -73.11 139.89 30.3 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.036 1.545 . . . . 0.0 110.473 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HG2' ' HG3' ' A' ' 29' ' ' LYS . 41.9 tt0 -58.56 -36.32 73.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.291 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -61.55 -28.89 69.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.893 . . . . 0.0 110.192 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.75 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 33.3 tp -92.11 -29.2 16.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.222 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.654 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 95.8 mt -74.48 -44.29 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 3.5 mmpt? -71.07 -23.96 62.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.207 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.0 ttp -89.68 -29.31 18.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.16 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -100.64 -0.29 37.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.236 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.654 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -65.97 -11.61 48.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HB2' ' NE ' ' A' ' 32' ' ' ARG . 6.5 t0 -138.08 45.56 2.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 0.0 110.16 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.034 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 1.7 mt -115.81 122.1 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.895 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.54 82.42 0.12 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.236 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.034 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.7 Cg_endo -73.0 136.64 25.22 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.008 1.53 . . . . 0.0 110.451 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.6 mt -89.24 154.67 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.218 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.4 t -131.58 111.48 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 73.6 tt0 -94.81 132.47 39.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.451 HD12 ' CD1' ' A' ' 6' ' ' TRP . 67.4 mt -118.77 128.51 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -133.63 74.81 1.57 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 110.181 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.519 ' OE1' ' CZ ' ' A' ' 47' ' ' PHE . 13.0 pt20 -78.41 162.72 26.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 110.208 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 86.3 mttt -156.47 49.12 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 0.0 110.19 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.04 -100.61 0.9 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 39.5 m-20 -110.48 -7.85 14.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -1.221 . . . . 0.0 110.198 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -98.58 152.96 19.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.211 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.688 ' CD1' HD11 ' A' ' 64' ' ' LEU . 1.6 m-85 -136.42 136.42 39.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 110.155 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.01 110.82 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.196 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 4.6 m -113.75 135.32 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 91.1 m -122.07 98.16 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.91 . . . . 0.0 110.203 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.2 m -78.63 138.54 38.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.198 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -132.83 114.74 14.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.255 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.933 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -99.31 168.33 9.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.772 ' HD2' HG22 ' A' ' 53' ' ' THR . 47.1 Cg_endo -73.07 -33.85 7.01 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.017 1.535 . . . . 0.0 110.529 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -93.07 -21.87 19.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.221 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.658 ' O ' ' OG1' ' A' ' 53' ' ' THR . 1.6 tt0 -161.4 162.12 30.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.448 ' N ' ' CG ' ' A' ' 56' ' ' GLN . 3.5 p -128.71 130.11 46.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 110.263 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 73' ' ' MET . 87.9 t -129.19 124.28 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.186 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 14.5 t -109.64 143.08 39.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.285 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 59' ' ' THR . 23.7 m120 -138.72 148.98 44.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 110.211 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.4 t -140.59 134.94 31.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 110.245 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.666 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 27.5 p90 -148.03 166.91 26.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.7 m -115.46 146.38 41.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 0.0 110.185 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.688 HD11 ' CD1' ' A' ' 47' ' ' PHE . 14.5 mt -78.51 122.83 26.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.226 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.1 4.63 41.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -145.51 151.92 38.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -1.159 . . . . 0.0 110.16 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -72.4 131.13 42.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.11 151.46 49.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 12.9 p-10 -88.01 134.86 33.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.706 HD12 ' H62' ' A' ' 131' ' ' JN3 . 8.3 mm -124.37 143.28 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.88 . . . . 0.0 110.208 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 m -117.76 134.09 55.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.579 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 1.4 p -88.86 158.96 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.727 ' CE ' H122 ' A' ' 130' ' ' JN3 . 72.7 mtm -74.27 -8.11 55.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.246 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.481 ' OD1' ' HB ' ' A' ' 72' ' ' THR . 46.0 p-10 -92.03 -15.47 27.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 74' ' ' ASP . . . 109.14 28.44 4.4 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.579 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 3.9 mttt -108.44 130.94 55.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -1.148 . . . . 0.0 110.201 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -111.2 136.55 50.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 110.187 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.721 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -160.55 161.82 32.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.154 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.19 157.56 18.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.3 p -169.17 140.39 2.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.227 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.0 m -98.14 102.67 14.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.626 HG13 HD21 ' A' ' 89' ' ' LEU . 46.5 t -72.22 140.76 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.252 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.547 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 14.4 p-80 -145.23 153.78 41.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.511 HD12 HD13 ' A' ' 64' ' ' LEU . 14.2 mt -100.99 126.37 47.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 0.0 110.251 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.25 147.3 39.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 53.3 15.25 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.22 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.62 48.83 6.04 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 7.3 pttt -169.85 135.96 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.324 -1.104 . . . . 0.0 110.229 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.681 HD22 ' H22' ' A' ' 131' ' ' JN3 . 5.5 tt -68.88 144.62 54.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.855 . . . . 0.0 110.238 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.547 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 73.4 t -152.03 114.28 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.315 -0.866 . . . . 0.0 110.215 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.553 HG21 H111 ' A' ' 131' ' ' JN3 . 86.9 m -105.7 98.74 8.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.275 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 17.2 pttt -94.58 155.14 17.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 17.3 t -145.96 -165.92 2.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.45 ' N ' ' OG ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -100.52 31.88 3.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 110.199 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.5 ptpt -175.38 4.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.203 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.894 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -179.31 145.5 0.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -122.5 159.75 27.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 110.264 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.515 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 54.0 t-80 -144.72 141.42 29.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.303 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.69 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 10.1 pt-20 -157.17 125.18 5.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 110.207 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.551 ' OE1' ' CE ' ' A' ' 107' ' ' MET . 6.1 tt0 -128.36 162.62 26.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.893 . . . . 0.0 110.213 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.496 ' CG ' ' HB2' ' A' ' 88' ' ' LYS . 20.3 mt-10 -153.73 155.93 36.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.81 139.96 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 110.197 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -135.8 98.65 3.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.01 -110.47 3.04 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -115.67 12.17 15.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -1.192 . . . . 0.0 110.16 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -117.71 160.03 22.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.199 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.551 ' CE ' ' OE1' ' A' ' 100' ' ' GLN . 28.1 tpp -132.09 138.02 47.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.56 132.54 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.18 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 34.8 mt-10 -117.71 130.1 56.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.672 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 5.7 m -122.65 124.45 43.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 97' ' ' SER . 87.3 mt -130.78 136.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.248 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.445 HG22 ' OG1' ' A' ' 117' ' ' THR . 15.8 p -113.36 127.11 56.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.257 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.515 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 27.3 t80 -149.29 129.79 13.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 110.172 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 62.41 39.58 97.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.44 6.58 49.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 114' ' ' GLY . 58.2 t -109.72 141.94 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -1.127 . . . . 0.0 110.258 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.445 ' OG1' HG22 ' A' ' 112' ' ' THR . 58.5 m -118.36 130.18 55.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.865 . . . . 0.0 110.211 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.603 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 48.8 tp -108.76 145.92 34.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.922 . . . . 0.0 110.252 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.09 114.68 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 32.5 ttp180 -111.49 128.02 55.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.96 . . . . 0.0 110.169 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 67.9 mtt180 -104.72 127.05 52.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 110.173 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 66.3 m -123.51 154.45 39.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.845 . . . . 0.0 110.171 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -118.14 160.7 21.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.162 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 5' ' ' THR . 15.6 ttp180 -88.79 137.69 32.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 125' ' ' VAL . 35.2 m . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.208 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 0.727 H122 ' CE ' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.721 H181 HD11 ' A' ' 78' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.244 0.545 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -76.73 -33.83 58.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.223 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 p -57.33 144.87 34.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.94 . . . . 0.0 110.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.73 -173.75 18.7 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.7 m -111.7 129.52 56.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -1.149 . . . . 0.0 110.229 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.523 ' CD1' HD12 ' A' ' 40' ' ' ILE . 70.1 m95 -118.01 138.61 52.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -118.31 118.13 30.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.3 t -64.95 126.22 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 18.0 p90 -127.08 -21.79 3.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.502 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -136.28 131.73 34.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.159 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.482 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 26.3 pt20 -146.98 118.27 7.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.204 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.442 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.5 tt0 -94.03 152.89 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.885 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 m120 50.47 27.25 2.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.169 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -58.05 -52.2 66.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -64.62 -50.52 66.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 110.188 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 36.7 mm-40 -51.06 -61.49 2.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.178 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.7 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 63.5 t80 -49.22 -52.3 27.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.171 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.581 HD23 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -59.5 -44.79 93.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 110.221 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 14.5 mttm -46.7 -38.31 9.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.29 -27.23 63.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.9 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.5 tp -61.87 -23.51 66.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.73 30.5 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.581 HD12 HD23 ' A' ' 18' ' ' LEU . 15.1 mt -77.53 166.77 41.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.1 Cg_endo -73.08 143.2 35.63 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.04 1.547 . . . . 0.0 110.43 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -65.16 -41.25 94.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.166 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -55.24 -28.14 51.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.397 -0.815 . . . . 0.0 110.175 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.575 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 41.5 tp -89.43 -22.07 22.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 24' ' ' PRO . 92.5 mt -86.99 -40.01 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -72.58 -30.04 64.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.908 . . . . 0.0 110.241 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.405 ' CE ' ' HD2' ' A' ' 55' ' ' ARG . 9.5 ttp -87.77 -24.03 23.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -101.66 6.58 42.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 110.175 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.684 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 16.6 ptt180 -68.12 4.17 1.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.337 -0.852 . . . . 0.0 110.195 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.684 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.9 m-20 -151.73 50.21 0.81 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.087 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.3 mt -122.48 119.37 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.215 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -91.19 83.25 0.11 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 110.301 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.087 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.9 Cg_endo -73.02 136.52 24.97 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.023 1.538 . . . . 0.0 110.475 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 38' ' ' VAL . 55.1 mt -100.45 171.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.185 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.55 ' N ' HG22 ' A' ' 37' ' ' ILE . 11.2 p -147.41 132.9 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.217 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -110.3 111.55 22.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 110.206 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' A' ' 6' ' ' TRP . 64.3 mt -99.93 138.46 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.244 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.541 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 56.7 tt0 -137.76 70.0 1.39 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.154 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.569 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 52.5 tt0 -67.0 159.75 27.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.206 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 53.9 mmtt -156.17 42.76 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.59 -100.59 0.77 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -109.94 -5.62 15.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -1.185 . . . . 0.0 110.261 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.405 ' C ' ' CD1' ' A' ' 47' ' ' PHE . 7.1 t0 -102.12 152.32 21.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.484 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 39.1 m-85 -133.96 140.88 47.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.198 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -126.55 104.9 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.211 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.734 HG11 ' H42' ' A' ' 131' ' ' JN3 . 58.6 t -106.75 135.8 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 110.231 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.737 ' OG1' HG23 ' A' ' 59' ' ' THR . 99.8 m -133.81 104.67 6.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 m -87.3 136.91 32.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.858 . . . . 0.0 110.247 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -129.65 123.53 31.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 110.188 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.644 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -107.15 169.03 7.18 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.05 -18.78 23.7 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.06 1.558 . . . . 0.0 110.448 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.405 ' HD2' ' CE ' ' A' ' 30' ' ' MET . 26.8 ttt180 -103.41 -21.92 13.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.21 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.644 ' O ' ' OG1' ' A' ' 53' ' ' THR . 17.8 pt20 -164.13 165.11 22.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 110.142 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 p -129.41 130.47 46.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.151 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.36 127.88 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.737 HG23 ' OG1' ' A' ' 50' ' ' THR . 91.2 m -112.27 137.76 49.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 59' ' ' THR . 58.0 m-20 -133.51 151.86 51.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 t -147.12 128.75 15.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.723 ' CE1' ' H5 ' ' A' ' 131' ' ' JN3 . 37.1 p90 -141.87 169.19 18.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 110.184 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.6 m -114.78 142.45 46.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.178 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.574 HD11 ' CA ' ' A' ' 83' ' ' HIS . 3.0 tp -76.58 124.95 28.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.99 -2.75 41.05 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.59 149.96 45.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -1.13 . . . . 0.0 110.18 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' OE2' ' HD2' ' A' ' 79' ' ' LYS . 71.4 tt0 -70.76 123.81 22.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.62 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -122.83 148.0 45.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 110.271 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -80.23 135.01 36.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 110.146 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.818 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 17.2 mm -128.22 145.14 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 110.25 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 t -119.23 135.43 54.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.27 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.829 HG23 H161 ' A' ' 131' ' ' JN3 . 0.2 OUTLIER -84.15 156.28 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.655 ' CE ' H122 ' A' ' 130' ' ' JN3 . 0.2 OUTLIER -67.95 -17.18 64.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.715 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -83.11 -10.3 58.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.197 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.16 28.36 5.86 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.436 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 10.3 mtpt -106.24 133.76 50.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -1.129 . . . . 0.0 110.246 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.03 138.49 44.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.686 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -169.48 150.82 4.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.141 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.453 ' HD2' ' OE2' ' A' ' 67' ' ' GLU . 7.2 mtmm -95.15 155.95 16.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.916 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.28 131.76 5.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.195 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 m -93.37 99.39 11.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.226 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.898 ' CG1' HD21 ' A' ' 89' ' ' LEU . 40.7 t -73.99 143.86 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.662 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 2.9 p-80 -147.36 160.62 42.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 0.0 110.225 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 mp -101.06 133.87 44.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 0.0 110.186 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -139.03 115.52 10.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 53.2 t-20 62.79 24.19 14.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.656 ' O ' ' CG ' ' A' ' 88' ' ' LYS . . . 80.76 46.46 7.22 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.656 ' CG ' ' O ' ' A' ' 87' ' ' GLY . 28.7 mtmt -161.87 117.83 2.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -1.149 . . . . 0.0 110.219 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.898 HD21 ' CG1' ' A' ' 82' ' ' VAL . 1.7 tt -61.79 135.84 57.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 110.189 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.662 ' O ' ' CE1' ' A' ' 83' ' ' HIS . 75.6 t -145.42 121.93 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.939 ' CG2' ' HB3' ' A' ' 98' ' ' HIS . 8.8 t -118.86 103.69 9.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.185 -0.947 . . . . 0.0 110.191 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 51.1 pttt -93.55 154.52 17.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 110.189 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 t -141.67 -158.24 0.84 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 36.8 mt-10 -109.52 31.82 5.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.22 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.57 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -176.88 6.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 110.198 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.835 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 178.28 147.5 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 111' ' ' ILE . 15.9 t -125.24 158.41 34.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 110.243 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.939 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 59.0 t-80 -141.61 146.02 35.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.893 . . . . 0.0 110.196 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.849 ' HB2' HG23 ' A' ' 110' ' ' THR . 24.5 mt-10 -157.68 126.04 5.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.266 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 61.1 tt0 -126.17 162.06 26.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.538 ' OE2' ' O ' ' A' ' 102' ' ' VAL . 11.0 tm-20 -160.4 150.91 18.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.538 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 8.4 p -116.72 142.75 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.206 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HG3' ' OE1' ' A' ' 101' ' ' GLU . 50.6 mttt -134.56 91.2 2.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.21 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.07 -107.42 2.79 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -115.09 9.64 15.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -1.199 . . . . 0.0 110.243 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -117.97 161.13 20.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 110.19 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.48 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -131.85 140.68 49.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.216 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.5 t -126.92 125.02 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.224 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 28.0 mt-10 -110.73 126.99 55.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.849 HG23 ' HB2' ' A' ' 99' ' ' GLU . 4.8 t -117.93 119.46 34.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.216 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 97' ' ' SER . 71.6 mt -126.12 132.16 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 31.8 m -109.74 132.93 53.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.616 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 11.8 t80 -156.3 127.39 6.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.929 . . . . 0.0 110.223 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 67.28 36.54 89.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.34 7.3 60.15 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 17' ' ' PHE . 60.4 t -111.01 141.01 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -1.156 . . . . 0.0 110.223 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 78.5 m -117.48 130.44 56.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.226 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.7 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 54.7 tp -110.38 146.85 35.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.239 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.31 100.25 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.182 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.44 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 9.1 mtm180 -93.39 119.89 33.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.0 110.207 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 42.3 mtt180 -101.13 125.75 47.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 110.231 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.8 m -123.88 158.1 32.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.184 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 10.4 tttm -119.93 158.31 26.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.415 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 22.3 ttt180 -85.68 136.64 33.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 110.24 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.207 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 0.715 H151 ' HB3' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.867 H112 HG21 ' A' ' 91' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.282 0.563 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 75.2 m-85 -74.63 -31.03 61.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 110.224 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.8 m -56.89 144.43 33.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.209 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.27 -175.95 18.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.732 HG22 ' HG3' ' A' ' 39' ' ' GLU . 19.2 p -107.04 131.59 53.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -1.126 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.544 ' CD1' ' HE2' ' A' ' 107' ' ' MET . 93.2 m95 -119.6 137.02 54.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -119.28 113.7 21.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.239 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.424 HG11 ' OE1' ' A' ' 11' ' ' GLN . 39.9 t -61.04 135.99 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.165 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 10' ' ' ALA . 10.9 p90 -139.09 -15.82 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.206 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.532 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -138.7 130.97 28.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.435 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 15.7 mt-30 -144.87 160.64 40.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.902 . . . . 0.0 110.202 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.782 ' CD ' HD12 ' A' ' 119' ' ' ILE . 12.7 pt-20 -137.77 150.91 47.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.147 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.7 m120 54.35 33.79 19.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.44 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.6 t80 -62.83 -54.32 40.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -60.78 -53.72 53.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -50.0 -56.05 12.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.494 ' HD1' HD22 ' A' ' 18' ' ' LEU . 33.2 t80 -54.05 -47.0 72.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.895 ' CD1' HD12 ' A' ' 23' ' ' LEU . 2.3 mm? -60.74 -42.1 96.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.163 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -54.45 -37.52 65.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 110.159 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.91 -33.2 71.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 110.24 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.869 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.5 tp -63.86 -21.19 66.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 0.0 110.252 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.869 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 77.98 31.77 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 110.216 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.895 HD12 ' CD1' ' A' ' 18' ' ' LEU . 14.2 mt -80.13 166.18 42.02 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.183 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.484 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.09 142.35 34.19 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.103 1.581 . . . . 0.0 110.386 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.538 ' CD ' ' HE3' ' A' ' 29' ' ' LYS . 43.2 tt0 -64.79 -33.5 76.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -61.15 -26.88 68.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.484 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 40.0 tp -90.07 -27.81 19.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 110.158 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 95.5 mt -76.19 -45.23 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.287 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HE3' ' CD ' ' A' ' 25' ' ' GLU . 21.0 mttt -69.4 -26.82 64.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.4 mtt -85.95 -27.66 24.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.189 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -101.47 7.38 42.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.579 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 16.0 ptt180 -66.7 -1.28 3.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.202 -0.936 . . . . 0.0 110.195 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.579 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.1 m-20 -148.0 47.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.259 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.974 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 5.1 mt -121.51 115.49 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 110.242 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -92.54 88.76 0.33 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.974 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.9 Cg_endo -73.03 139.26 29.6 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.042 1.548 . . . . 0.0 110.467 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 38' ' ' VAL . 17.2 mt -89.89 162.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' N ' HG22 ' A' ' 37' ' ' ILE . 79.5 t -139.11 114.05 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 110.217 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.732 ' HG3' HG22 ' A' ' 5' ' ' THR . 13.4 tt0 -98.12 136.6 38.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 110.168 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.518 HD12 ' CD1' ' A' ' 6' ' ' TRP . 74.8 mt -124.68 129.29 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 54.6 tt0 -129.92 75.1 1.63 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 0.0 110.19 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.72 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 2.0 tm0? -72.39 162.06 29.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 43.1 mtmt -160.51 49.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.18 -104.19 1.31 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 64.4 m-20 -109.85 -0.37 18.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -1.148 . . . . 0.0 110.152 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.0 t0 -104.03 146.54 28.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.0 110.194 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.787 ' CE1' HD11 ' A' ' 64' ' ' LEU . 4.1 m-85 -128.36 135.42 49.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.4 t -123.7 108.29 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.212 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.817 HG11 ' H42' ' A' ' 131' ' ' JN3 . 85.3 t -110.23 128.98 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.8 m -129.13 108.03 10.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -92.04 138.25 31.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.25 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 1.1 pttt -131.85 126.09 33.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 110.166 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.865 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.89 170.41 5.46 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.926 . . . . 0.0 110.184 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.752 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.5 Cg_endo -73.03 -20.03 22.35 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.039 1.547 . . . . 0.0 110.497 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -105.04 -22.03 13.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 0.0 110.218 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' OE1' ' O25' ' A' ' 130' ' ' JN3 . 7.7 pt20 -161.83 159.6 27.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.4 p -130.51 131.0 44.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 110.239 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.402 ' CG1' HG23 ' A' ' 71' ' ' THR . 56.2 t -128.53 129.36 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.223 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.4 t -111.19 137.49 48.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.257 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.417 ' HB3' ' CD1' ' A' ' 70' ' ' ILE . 63.0 m-20 -132.3 149.62 52.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 110.161 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 t -144.67 128.97 17.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.898 . . . . 0.0 110.186 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.779 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 39.6 p90 -142.81 170.44 15.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.521 HG21 ' HE2' ' A' ' 66' ' ' LYS . 17.6 m -119.01 153.41 34.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.222 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.787 HD11 ' CE1' ' A' ' 47' ' ' PHE . 22.2 mt -81.4 125.34 30.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.22 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.28 12.39 54.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HE2' HG21 ' A' ' 63' ' ' THR . 46.7 mtmt -146.7 139.26 25.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.147 . . . . 0.0 110.218 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -66.04 127.22 31.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -127.94 149.06 50.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.57 138.53 33.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.177 -0.952 . . . . 0.0 110.254 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.795 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 5.0 mm -130.57 144.43 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.415 HG22 ' OD1' ' A' ' 60' ' ' ASN . 4.1 t -118.22 135.01 54.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.671 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 34.7 p -87.1 160.38 18.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.189 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.675 ' HE3' H122 ' A' ' 130' ' ' JN3 . 11.9 ttm -72.22 -11.53 60.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.964 ' HB3' H151 ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -89.51 -13.36 37.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.155 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.0 51.11 0.96 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 11.0 mttt -128.53 133.11 48.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -1.126 . . . . 0.0 110.169 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -110.0 135.87 50.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.563 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -164.02 159.71 20.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 110.224 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -105.86 155.32 19.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.197 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.1 p -164.13 136.62 4.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.23 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.4 m -95.29 97.67 10.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 110.225 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.827 HG13 HD21 ' A' ' 89' ' ' LEU . 47.6 t -69.23 142.18 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 110.248 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.62 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 9.6 p-80 -147.54 150.09 33.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.43 HD12 HD13 ' A' ' 64' ' ' LEU . 18.5 mt -96.06 129.89 43.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.54 144.12 31.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 110.141 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.36 11.55 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.59 45.39 6.11 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 11.5 pttt -170.76 132.28 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -1.124 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.827 HD21 HG13 ' A' ' 82' ' ' VAL . 3.6 tt -61.16 149.19 38.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.896 HG22 ' HG3' ' A' ' 99' ' ' GLU . 87.3 t -155.51 109.3 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 87.2 m -103.01 103.78 13.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.183 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.433 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 5.6 ptmt -99.4 157.47 16.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.224 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 14.3 t -151.21 -171.13 3.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.202 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.54 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 54.3 tt0 -98.14 30.73 2.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.188 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.525 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 1.6 pttt -169.8 -2.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 0.0 110.205 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.854 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -176.31 147.49 0.7 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.92 . . . . 0.0 110.212 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.8 159.05 28.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.847 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.637 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 64.6 t-80 -143.17 137.08 28.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.896 ' HG3' HG22 ' A' ' 90' ' ' VAL . 44.8 tt0 -151.19 126.91 10.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.163 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.576 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 9.1 tt0 -133.76 154.79 50.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 110.111 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.487 ' HA ' ' CE1' ' A' ' 2' ' ' PHE . 58.8 tt0 -149.37 159.86 43.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 110.269 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.41 138.06 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -0.897 . . . . 0.0 110.173 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -133.84 93.97 3.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.277 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.67 -106.75 2.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -118.78 12.61 13.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -1.135 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.04 155.27 31.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.159 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.544 ' HE2' ' CD1' ' A' ' 6' ' ' TRP . 25.8 tpp -128.41 140.31 51.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.1 t -125.97 126.69 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.183 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.576 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 29.5 mt-10 -114.58 136.13 53.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 p -124.73 123.93 41.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.233 -0.917 . . . . 0.0 110.22 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 72.7 mt -130.88 129.82 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 5.0 t -113.41 131.87 55.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 6.3 t80 -154.19 125.12 7.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.256 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.29 33.38 61.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.25 3.73 66.42 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 112' ' ' THR . 62.9 t -109.69 139.56 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -1.157 . . . . 0.0 110.199 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 55.3 m -113.98 135.22 54.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.224 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 12' ' ' GLU . 41.6 tp -113.95 139.13 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.172 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.782 HD12 ' CD ' ' A' ' 12' ' ' GLU . 96.8 mt -120.43 110.45 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -105.96 120.94 43.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.94 . . . . 0.0 110.186 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 52.4 mtt180 -102.17 127.05 49.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 0.0 110.19 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.9 m -122.81 163.41 20.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.207 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -128.15 158.56 37.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.902 . . . . 0.0 110.19 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -85.11 136.56 33.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.177 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 0.964 H151 ' HB3' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.817 ' H42' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.745 ' HB1' HG11 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.26 0.552 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.04 -33.74 59.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.208 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.3 p -56.81 145.71 28.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.44 -177.02 17.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.763 HG22 ' HG3' ' A' ' 39' ' ' GLU . 42.3 p -105.75 134.24 49.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -1.182 . . . . 0.0 110.18 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.497 ' CD1' ' HE2' ' A' ' 107' ' ' MET . 95.3 m95 -121.27 142.62 49.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -124.07 118.2 26.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.209 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.4 HG12 ' CD ' ' A' ' 11' ' ' GLN . 49.2 t -65.8 126.78 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 110.167 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 22.6 p90 -128.16 -23.07 3.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.719 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -135.13 133.61 39.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 110.223 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.719 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 2.0 mp0 -146.7 112.24 5.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.892 . . . . 0.0 110.216 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.484 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.1 tt0 -89.65 147.32 23.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.241 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.442 ' ND2' ' HG2' ' A' ' 12' ' ' GLU . 75.6 m-20 55.02 24.07 5.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.655 ' CE1' HD11 ' A' ' 18' ' ' LEU . 27.5 t80 -56.57 -52.43 64.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 110.208 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -63.54 -48.61 76.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.23 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 66.8 mt-10 -53.79 -62.23 1.79 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 110.222 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.71 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 38.2 t80 -48.29 -57.83 5.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.66 HD23 HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -57.12 -46.66 82.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 110.183 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -42.79 -41.86 3.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.192 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.19 -28.25 66.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.866 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -58.13 -20.13 38.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.219 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 77.94 31.37 0.42 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.66 HD12 HD23 ' A' ' 18' ' ' LEU . 15.5 mt -77.03 165.99 48.1 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.188 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.615 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.08 140.59 31.46 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.969 1.51 . . . . 0.0 110.409 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.411 ' HG2' ' HE2' ' A' ' 29' ' ' LYS . 42.4 tt0 -61.52 -39.48 91.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.29 -26.54 63.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.309 -0.87 . . . . 0.0 110.191 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.615 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 14.8 tp -90.42 -23.26 21.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 95.2 mt -81.09 -43.18 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.978 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HE2' ' HG2' ' A' ' 25' ' ' GLU . 37.3 mtmt -72.52 -24.41 61.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 37.4 mtt -87.9 -32.91 18.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -97.99 5.44 48.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.632 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 31.3 ptt85 -65.53 -1.11 2.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.632 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.6 m-20 -149.91 47.57 0.93 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.942 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.9 mt -118.7 121.03 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -95.8 83.02 0.22 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.337 -0.852 . . . . 0.0 110.234 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.942 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.5 Cg_endo -73.05 137.49 26.55 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.031 1.543 . . . . 0.0 110.47 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.5 mt -90.01 157.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.155 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.3 t -134.93 112.72 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.763 ' HG3' HG22 ' A' ' 5' ' ' THR . 21.0 tt0 -94.05 138.24 32.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.234 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.469 HD12 ' CD1' ' A' ' 6' ' ' TRP . 71.3 mt -126.73 127.78 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.214 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -133.03 75.27 1.61 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.246 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.533 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 6.7 pt20 -78.57 163.53 25.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.218 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 31.0 mmtp -154.79 49.93 0.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.75 -99.21 0.8 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -110.05 -9.11 14.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.271 -1.135 . . . . 0.0 110.216 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 34.4 t0 -98.0 157.23 16.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 110.196 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.605 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.1 m-85 -139.89 133.55 30.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.232 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.9 t -114.24 100.75 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 110.242 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.97 HG21 ' H42' ' A' ' 131' ' ' JN3 . 4.2 p -100.85 135.49 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.187 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 59' ' ' THR . 36.0 m -138.59 105.56 5.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.4 m -88.4 138.2 31.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.244 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -130.35 119.16 22.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 110.282 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.854 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -106.89 167.44 9.48 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 110.223 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.767 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.8 Cg_endo -73.07 -20.68 21.47 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.057 1.556 . . . . 0.0 110.472 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -102.93 -20.6 14.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.439 ' HG2' ' O25' ' A' ' 130' ' ' JN3 . 5.0 pt20 -166.31 159.17 14.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.907 . . . . 0.0 110.191 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.3 p -129.05 131.29 47.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.224 -0.922 . . . . 0.0 110.205 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.26 128.26 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 110.19 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 50' ' ' THR . 46.2 m -110.59 136.83 49.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 110.19 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 49' ' ' VAL . 81.6 m-20 -135.02 153.91 51.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.245 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.2 t -143.17 128.17 18.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.221 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.706 ' CE1' HG21 ' A' ' 82' ' ' VAL . 52.4 p90 -139.7 168.59 19.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.162 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.5 m -120.07 142.48 48.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.861 . . . . 0.0 110.237 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 84' ' ' LEU . 15.5 mt -74.21 126.03 29.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 110.258 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.89 58.23 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -137.47 142.23 41.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.263 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -68.01 126.25 28.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.207 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . . . -127.28 150.1 49.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 0.0 110.237 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -81.57 136.56 35.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 110.227 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.793 ' CD1' ' H62' ' A' ' 131' ' ' JN3 . 3.8 mm -129.43 144.77 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -116.77 134.42 54.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.253 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.717 HG23 H161 ' A' ' 131' ' ' JN3 . 0.3 OUTLIER -86.02 155.06 21.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.883 . . . . 0.0 110.128 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.787 ' SD ' H213 ' A' ' 130' ' ' JN3 . 16.4 ttm -67.13 -14.94 63.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.215 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.654 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -86.47 -13.07 47.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.54 29.72 4.93 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -104.99 135.39 46.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -1.156 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -112.02 132.59 54.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.227 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.691 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -161.14 162.95 31.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -107.86 158.69 17.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.194 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.498 ' HB2' HG23 ' A' ' 91' ' ' THR . 25.3 p -165.4 147.26 7.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.204 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.45 87.85 2.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.223 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 89' ' ' LEU . 16.1 t -53.3 154.96 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 110.18 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.537 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -152.17 147.46 26.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 0.0 110.224 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.633 HD12 HD13 ' A' ' 64' ' ' LEU . 13.9 mt -100.91 99.07 9.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 87' ' ' GLY . . . -114.37 152.59 31.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.178 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.496 ' HB3' ' CD ' ' A' ' 88' ' ' LYS . 3.3 t30 46.5 17.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 110.149 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 85' ' ' ALA . . . 77.97 48.96 7.31 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.754 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -167.21 127.69 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -1.159 . . . . 0.0 110.252 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.859 HD11 HG11 ' A' ' 82' ' ' VAL . 4.2 tt -59.22 147.67 34.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 110.179 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.824 HG12 ' HG3' ' A' ' 99' ' ' GLU . 22.2 m -154.67 109.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 97.5 m -103.55 100.11 9.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -98.11 161.0 13.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.47 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -152.33 -165.36 2.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.0 110.186 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 49.2 tt0 -101.16 31.29 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' CE2' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -173.3 4.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.933 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.67 141.69 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.303 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.617 ' O ' HG23 ' A' ' 111' ' ' ILE . 69.3 m -117.52 160.52 21.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.566 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.9 t-80 -144.12 140.66 29.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.824 ' HG3' HG12 ' A' ' 90' ' ' VAL . 14.0 tt0 -155.17 123.59 5.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.231 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 12.0 tt0 -129.04 157.17 42.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -153.84 154.67 34.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.209 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.745 HG11 ' HB1' ' A' ' 1' ' ' ALA . 10.0 p -116.43 141.52 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -136.61 90.69 2.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.24 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.8 -105.59 2.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -119.19 11.42 12.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -1.145 . . . . 0.0 110.169 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -117.52 154.31 31.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.229 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.497 ' HE2' ' CD1' ' A' ' 6' ' ' TRP . 26.8 tpp -125.38 138.57 54.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 110.293 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.2 t -126.4 124.73 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.33 -0.857 . . . . 0.0 110.228 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 33.2 mt-10 -112.32 121.61 45.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 99' ' ' GLU . 85.4 m -110.19 119.09 38.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.231 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 97' ' ' SER . 68.1 mt -126.52 129.72 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 74.7 m -109.31 138.06 46.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.547 ' CE2' ' O ' ' A' ' 95' ' ' LYS . 21.1 t80 -160.81 127.65 4.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 110.196 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.23 34.45 75.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.75 8.55 68.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.3 t -112.4 141.42 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -1.168 . . . . 0.0 110.207 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.9 m -116.9 130.94 57.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 110.259 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.71 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 41.8 tp -110.34 152.68 25.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.5 mt -131.37 94.6 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -88.57 126.53 35.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.221 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 27.6 mtt180 -106.23 125.78 51.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 56.5 m -123.49 153.42 40.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.919 . . . . 0.0 110.218 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -119.81 159.01 25.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.87 . . . . 0.0 110.204 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -86.0 135.28 33.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.255 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 0.787 H213 ' SD ' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.97 ' H42' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.793 ' O ' ' HB2' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.264 0.554 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.793 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 29.7 m-85 68.93 -59.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 110.266 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 1' ' ' ALA . 2.9 p -51.91 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.36 -162.69 33.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.655 HG22 ' HG3' ' A' ' 39' ' ' GLU . 9.8 p -114.2 128.07 56.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -1.145 . . . . 0.0 110.22 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.532 ' CD1' HD12 ' A' ' 40' ' ' ILE . 92.0 m95 -117.11 137.82 52.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.254 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.37 123.19 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 110.257 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.52 133.03 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.544 ' CD1' ' HB2' ' A' ' 10' ' ' ALA . 34.2 p90 -133.75 -27.62 1.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.544 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -130.94 137.13 49.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.56 ' O ' ' HG2' ' A' ' 11' ' ' GLN . 3.7 pm0 -152.18 140.96 20.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.209 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.402 ' O ' HD12 ' A' ' 118' ' ' LEU . 30.9 tt0 -115.28 151.26 34.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 50.57 25.38 1.98 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -55.22 -47.13 75.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -0.92 . . . . 0.0 110.241 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.12 -51.82 54.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -49.03 -61.64 1.96 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.169 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.605 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 52.2 t80 -50.32 -44.94 54.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.142 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.632 HD21 H191 ' A' ' 130' ' ' JN3 . 49.5 mt -61.14 -46.72 89.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.245 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -50.98 -36.53 39.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.262 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.38 -32.21 72.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.849 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -61.14 -21.01 63.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.849 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 75.62 37.82 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.248 -0.907 . . . . 0.0 110.172 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.734 HD22 ' HD2' ' A' ' 24' ' ' PRO . 3.7 mt -79.19 165.32 49.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.734 ' HD2' HD22 ' A' ' 23' ' ' LEU . 46.2 Cg_endo -73.04 136.37 24.68 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.989 1.521 . . . . 0.0 110.508 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -54.09 -30.78 49.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -64.53 -41.55 96.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.902 . . . . 0.0 110.271 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.605 HD22 ' OD1' ' A' ' 74' ' ' ASP . 63.4 tp -80.09 -45.83 17.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.247 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.8 mt -53.48 -54.1 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 110.215 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 6.6 mmtp -59.35 -29.73 67.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.438 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 65.1 mtt -86.08 -20.53 28.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 0.0 110.168 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.66 ' HB1' ' C18' ' A' ' 130' ' ' JN3 . . . -103.67 4.56 35.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.245 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.767 ' HG3' ' OD2' ' A' ' 33' ' ' ASP . 20.3 ptt180 -75.21 -0.4 19.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.227 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.767 ' OD2' ' HG3' ' A' ' 32' ' ' ARG . 62.6 m-20 -152.36 42.03 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.257 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.964 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 27.5 mt -121.36 115.46 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.219 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.55 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -92.25 88.83 0.32 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.208 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.964 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.4 Cg_endo -73.12 138.6 28.25 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.026 1.54 . . . . 0.0 110.399 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -89.62 157.35 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.254 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -136.84 119.09 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.655 ' HG3' HG22 ' A' ' 5' ' ' THR . 28.5 tt0 -100.64 134.5 43.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 110.185 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.532 HD12 ' CD1' ' A' ' 6' ' ' TRP . 83.0 mt -121.9 129.48 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -131.89 74.9 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.807 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 4.0 tt0 -73.87 164.45 26.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.6 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 47.3 mttt -156.97 42.29 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 110.221 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.8 -97.69 0.62 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -112.88 -0.24 14.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -1.185 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -104.84 147.95 27.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.967 . . . . 0.0 110.243 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 1.178 ' CD2' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -128.57 133.95 48.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 110.224 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.5 t -122.37 107.73 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.248 -0.908 . . . . 0.0 110.191 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.885 HG11 ' H42' ' A' ' 131' ' ' JN3 . 82.3 t -110.18 133.99 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.2 m -132.69 107.46 8.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 0.0 110.203 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -92.0 137.45 32.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 110.234 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 1.6 pttm -131.5 127.83 38.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.104 HG21 H213 ' A' ' 130' ' ' JN3 . 0.1 OUTLIER -111.49 170.23 5.49 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 110.186 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.99 -16.54 25.64 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.054 1.555 . . . . 0.0 110.487 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.0 mtp-105 -106.32 -19.33 13.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.898 . . . . 0.0 110.191 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.58 ' O ' ' OG1' ' A' ' 53' ' ' THR . 19.5 pt20 -167.44 161.25 13.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 110.232 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.9 p -130.03 133.8 46.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.3 t -131.3 130.18 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.937 . . . . 0.0 110.176 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 59' ' ' THR . 13.9 t -112.04 134.8 53.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 110.143 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -129.69 151.91 49.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -0.88 . . . . 0.0 110.173 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -147.04 127.39 13.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.72 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 38.2 p90 -141.4 172.93 12.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 110.218 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.5 m -118.68 148.71 42.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.202 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.178 HD11 ' CD2' ' A' ' 47' ' ' PHE . 9.9 mt -79.57 123.34 27.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.269 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.93 5.41 47.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -143.94 145.3 32.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -1.139 . . . . 0.0 110.164 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.21 127.19 31.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -125.42 148.18 48.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -83.86 136.2 34.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.922 . . . . 0.0 110.224 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.775 ' CD1' ' H62' ' A' ' 131' ' ' JN3 . 6.0 mm -127.85 145.96 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.172 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 t -119.84 133.46 55.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.626 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -83.28 155.8 23.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.658 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -69.05 -17.04 63.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 110.228 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.605 ' OD1' HD22 ' A' ' 27' ' ' LEU . 8.1 t0 -84.89 -12.24 53.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.34 30.58 4.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.626 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 23.5 mttt -107.28 131.98 53.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -1.136 . . . . 0.0 110.15 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -111.69 138.19 48.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.218 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.594 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -167.65 159.37 11.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 57.3 mttt -103.75 167.5 9.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 110.202 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 27.0 p -178.22 137.36 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 110.245 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.9 m -93.93 104.9 16.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.31 -0.869 . . . . 0.0 110.213 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.695 HG13 HD21 ' A' ' 89' ' ' LEU . 55.3 t -75.78 140.28 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.257 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.563 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 9.0 p-80 -144.11 155.25 43.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 89' ' ' LEU . 4.3 tp -100.14 134.41 43.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.92 117.55 14.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 10.0 t-20 61.55 30.23 18.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 75.94 40.99 29.01 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 83.5 mttt -152.96 125.0 7.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 110.181 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.723 HD22 ' H22' ' A' ' 131' ' ' JN3 . 7.8 tt -71.44 134.47 46.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.197 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.757 HG13 ' HG2' ' A' ' 99' ' ' GLU . 77.2 t -140.64 120.26 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 110.286 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 53.6 m -113.24 92.4 3.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.211 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 14.3 ptmt -86.22 160.6 19.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.446 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -152.96 -169.77 3.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.145 -0.972 . . . . 0.0 110.211 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -99.29 36.93 1.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.19 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.489 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -179.15 -1.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.823 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -175.11 147.3 0.91 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.242 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 111' ' ' ILE . 39.1 m -124.53 152.49 43.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.497 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 62.3 t-80 -137.47 142.91 41.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 110.261 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.757 ' HG2' HG13 ' A' ' 90' ' ' VAL . 47.5 mt-10 -153.24 128.65 9.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 12.5 tt0 -132.51 152.7 51.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.131 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.57 155.38 39.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 110.259 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.515 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.9 p -119.71 135.49 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 110.205 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -128.6 96.07 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 110.177 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.94 -101.67 1.72 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -120.67 10.78 11.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -1.142 . . . . 0.0 110.177 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -119.6 158.34 26.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.225 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.459 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -129.27 140.39 51.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 110.165 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.4 t -123.35 123.16 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 29.5 mt-10 -109.48 121.07 44.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 99' ' ' GLU . 20.8 m -111.95 117.02 31.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 97' ' ' SER . 67.6 mt -123.31 128.21 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 45.6 m -107.99 135.59 49.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.528 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 13.8 t80 -158.39 127.36 5.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 65.89 37.48 93.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.99 8.22 60.87 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 17' ' ' PHE . 60.5 t -111.03 139.08 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -1.116 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 62.0 m -117.78 132.09 56.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.605 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 67.5 tp -110.9 149.14 31.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.3 mt -128.33 98.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 16.3 mtm180 -96.11 128.52 43.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 25.3 mtt180 -104.31 128.26 52.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 107' ' ' MET . 75.4 m -124.09 155.99 37.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.202 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -119.41 151.01 39.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 110.203 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 5' ' ' THR . 45.4 ttt180 -75.71 138.31 41.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.188 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.7 ' OXT' HG22 ' A' ' 125' ' ' VAL . 9.3 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.268 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 1.104 H213 HG21 ' A' ' 53' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.885 ' H42' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.229 0.538 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -78.4 -32.24 48.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 110.18 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 76.6 p -56.64 145.32 28.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.27 -174.06 18.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.1 m -109.85 130.25 55.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -1.136 . . . . 0.0 110.218 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.479 ' CD1' HD12 ' A' ' 40' ' ' ILE . 90.5 m95 -118.61 145.66 45.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.853 . . . . 0.0 110.25 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -127.97 118.94 24.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.181 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.554 HG21 ' HD2' ' A' ' 120' ' ' ARG . 48.9 t -64.35 136.35 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.945 . . . . 0.0 110.23 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 11.1 p90 -137.61 -19.14 1.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 110.224 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.705 ' O ' ' HG3' ' A' ' 11' ' ' GLN . . . -137.22 134.28 36.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -0.925 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.705 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 5.1 mt-30 -149.0 162.76 39.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 110.158 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.502 ' O ' HD12 ' A' ' 118' ' ' LEU . 59.4 tt0 -134.12 144.85 48.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.415 ' ND2' ' OE1' ' A' ' 16' ' ' GLU . 4.3 t30 54.98 35.7 25.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.266 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -65.08 -49.23 70.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 0.0 110.199 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -60.88 -48.08 83.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.166 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 55.2 mt-10 -55.32 -46.2 76.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.591 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 43.5 t80 -52.86 -60.31 3.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.887 . . . . 0.0 110.271 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.764 HD22 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -50.83 -39.94 54.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.199 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -58.77 -36.81 74.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.245 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.18 -38.2 60.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.973 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.9 tp -56.57 -25.24 51.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.925 . . . . 0.0 110.19 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.973 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 84.99 18.1 0.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.764 HD12 HD22 ' A' ' 18' ' ' LEU . 15.3 mt -66.1 166.86 14.11 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 47.2 Cg_endo -73.04 133.31 19.52 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.019 1.536 . . . . 0.0 110.446 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.986 ' HA ' HD12 ' A' ' 28' ' ' ILE . 61.1 mm-40 -51.23 -46.41 62.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.197 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.09 -37.27 20.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.569 HD11 H232 ' A' ' 130' ' ' JN3 . 35.3 tp -80.1 -37.36 33.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.898 . . . . 0.0 110.288 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.986 HD12 ' HA ' ' A' ' 25' ' ' GLU . 45.6 mt -58.82 -54.75 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -56.9 -24.45 52.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.575 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 56.6 mtt -93.62 -18.39 22.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.233 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.56 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -105.45 -10.59 16.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.224 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -1.71 3.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -150.83 47.03 0.86 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.217 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.169 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 13.1 mt -125.0 109.0 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -84.1 88.13 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.169 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.2 Cg_endo -73.11 138.42 27.98 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.04 1.548 . . . . 0.0 110.45 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 38' ' ' VAL . 46.1 mt -89.78 164.56 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 110.178 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.552 HG21 HH22 ' A' ' 120' ' ' ARG . 75.9 t -141.79 119.98 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 110.287 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -101.83 135.91 42.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.205 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.487 ' CD1' ' HE1' ' A' ' 107' ' ' MET . 75.5 mt -121.32 129.78 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.15 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 43.7 tt0 -132.33 66.51 1.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.943 . . . . 0.0 110.228 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.919 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 37.6 tt0 -71.47 162.26 29.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.573 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 18.5 pttm -159.11 48.01 0.32 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.296 -0.878 . . . . 0.0 110.175 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.4 -103.16 0.78 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 60.2 m-20 -111.52 0.57 16.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -1.132 . . . . 0.0 110.167 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.728 ' OD1' HG23 ' A' ' 63' ' ' THR . 43.6 m-20 -104.18 150.35 24.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 110.267 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 1.168 ' CD2' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -130.88 135.46 47.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.42 105.75 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 110.219 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.746 HG11 ' H42' ' A' ' 131' ' ' JN3 . 62.6 t -109.07 135.18 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 110.257 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.766 ' OG1' HG23 ' A' ' 59' ' ' THR . 98.3 m -132.17 108.49 9.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.902 . . . . 0.0 110.163 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -90.1 132.77 35.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.9 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -127.94 122.72 33.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.264 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.848 HG21 H213 ' A' ' 130' ' ' JN3 . 0.6 OUTLIER -106.16 170.19 6.08 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.178 -0.951 . . . . 0.0 110.225 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.12 -17.73 24.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.066 1.561 . . . . 0.0 110.382 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -104.11 -22.69 13.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 0.0 110.176 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.592 ' O ' ' OG1' ' A' ' 53' ' ' THR . 14.7 pt20 -162.82 164.69 26.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.7 p -130.29 130.41 44.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.915 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.47 HG21 ' HG3' ' A' ' 73' ' ' MET . 61.6 t -128.86 126.27 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.156 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.766 HG23 ' OG1' ' A' ' 50' ' ' THR . 85.6 m -108.83 141.18 41.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.233 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.534 ' OD1' ' O ' ' A' ' 59' ' ' THR . 73.2 m-20 -137.11 151.61 49.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.4 m -146.58 132.07 18.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.673 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 41.2 p90 -145.24 170.13 16.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.918 . . . . 0.0 110.185 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.728 HG23 ' OD1' ' A' ' 46' ' ' ASP . 86.5 m -116.26 148.53 40.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.168 HD11 ' CD2' ' A' ' 47' ' ' PHE . 10.4 mt -80.17 124.25 28.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.72 6.67 49.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -145.82 148.76 33.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -1.082 . . . . 0.0 110.217 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -71.68 125.2 26.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.204 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.602 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -122.24 150.43 42.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 110.221 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -84.53 133.16 34.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 110.102 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.706 ' CD1' ' H62' ' A' ' 131' ' ' JN3 . 5.1 mm -126.38 146.71 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.221 -0.924 . . . . 0.0 110.175 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -121.44 135.03 55.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 110.232 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.666 HG23 H161 ' A' ' 131' ' ' JN3 . 0.2 OUTLIER -84.81 154.77 22.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.852 ' HE2' H122 ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -67.63 -15.04 63.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.223 -0.923 . . . . 0.0 110.176 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.454 ' HB3' H151 ' A' ' 130' ' ' JN3 . 3.0 p30 -85.52 -10.37 56.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.938 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.2 31.97 4.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.509 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 26.4 mttt -108.77 132.63 53.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.13 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -108.38 136.69 47.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.872 . . . . 0.0 110.203 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.909 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -165.49 156.94 14.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -105.56 165.12 11.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 0.0 110.224 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -175.15 137.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.293 -0.88 . . . . 0.0 110.178 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 m -95.52 99.89 11.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -0.894 . . . . 0.0 110.195 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.781 HG11 HD11 ' A' ' 89' ' ' LEU . 53.1 t -72.99 141.24 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 5.3 p-80 -146.55 160.33 42.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.77 130.83 48.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 110.212 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.426 ' O ' ' HE2' ' A' ' 88' ' ' LYS . . . -137.46 133.37 34.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.1 t30 57.63 13.44 1.94 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.04 53.54 2.81 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.818 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 3.6 pttt -174.74 125.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -1.182 . . . . 0.0 110.214 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.781 HD11 HG11 ' A' ' 82' ' ' VAL . 4.1 tt -57.31 147.46 25.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.18 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 89' ' ' LEU . 78.9 t -157.57 109.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.971 ' CG2' ' HB3' ' A' ' 98' ' ' HIS . 10.0 t -106.39 107.93 19.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 110.21 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -97.53 151.99 19.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 110.146 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 1.4 m -144.86 -174.1 4.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 110.162 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 61.1 tt0 -99.0 38.49 1.38 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 94' ' ' GLU . 2.6 pttt 179.22 2.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.206 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.825 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.82 143.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 0.0 110.197 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -125.06 157.31 36.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.971 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 46.5 t-80 -144.79 143.16 30.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.203 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.473 ' CG ' HG22 ' A' ' 90' ' ' VAL . 17.1 tt0 -153.9 125.05 7.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.509 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 42.6 tt0 -125.83 158.93 33.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.895 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -156.68 156.94 34.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 110.148 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.437 HG23 ' CH2' ' A' ' 6' ' ' TRP . 10.0 p -120.84 140.35 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -132.82 89.14 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.1 -104.67 2.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.606 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 44.2 p-10 -117.79 7.39 12.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -1.123 . . . . 0.0 110.274 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.606 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 43.4 mt-10 -115.16 167.75 10.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.247 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.487 ' HE1' ' CD1' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -138.98 139.88 38.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 110.226 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 65.1 t -125.78 129.36 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 24.0 mt-10 -116.67 135.61 53.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.6 m -124.79 120.93 33.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.203 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 97' ' ' SER . 81.4 mt -126.76 135.88 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.246 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.498 HG22 HG23 ' A' ' 117' ' ' THR . 73.5 p -117.5 125.06 50.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.255 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.51 ' HD2' ' CB ' ' A' ' 96' ' ' PHE . 56.0 t80 -148.11 128.06 13.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -0.877 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.3 35.92 88.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.12 6.0 59.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 112' ' ' THR . 76.9 t -111.08 135.65 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -1.132 . . . . 0.0 110.199 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.498 HG23 HG22 ' A' ' 112' ' ' THR . 57.4 m -113.37 135.89 53.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.591 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 18.9 tp -115.03 141.29 48.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.55 108.63 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.554 ' HD2' HG21 ' A' ' 8' ' ' VAL . 26.8 ttp180 -104.92 124.54 49.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.16 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 9.4 mtm180 -103.72 124.96 49.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.423 ' OG ' HG22 ' A' ' 8' ' ' VAL . 56.9 m -119.57 161.39 20.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.277 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 34.7 tttm -127.76 155.81 43.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 110.249 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.4 ttt180 -80.27 134.68 36.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.9 . . . . 0.0 110.217 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.204 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 0.852 H122 ' HE2' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.967 H112 HG21 ' A' ' 91' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.235 0.54 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' A' ' 101' ' ' GLU . 87.6 m-85 -76.92 -31.31 56.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 110.185 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.4 p -54.99 143.34 26.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.915 . . . . 0.0 110.149 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.05 -173.61 17.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.7 m -107.94 131.71 54.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -1.191 . . . . 0.0 110.23 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.513 ' NE1' ' HE3' ' A' ' 107' ' ' MET . 89.9 m95 -119.72 134.82 55.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 110.223 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -117.45 118.79 33.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.915 . . . . 0.0 110.171 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.422 HG11 ' CD ' ' A' ' 11' ' ' GLN . 60.2 t -66.75 128.42 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.0 110.226 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 46.6 p90 -126.38 -24.19 3.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.433 ' C ' ' HG3' ' A' ' 11' ' ' GLN . . . -136.43 132.03 34.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.433 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 29.9 mt-30 -141.37 120.81 13.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 52.3 tt0 -98.96 144.33 28.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.222 -0.924 . . . . 0.0 110.19 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.496 HD22 ' CD ' ' A' ' 16' ' ' GLU . 6.9 m120 56.59 18.35 3.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.224 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.462 ' O ' HD23 ' A' ' 18' ' ' LEU . 61.9 t80 -55.04 -44.46 74.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.853 . . . . 0.0 110.239 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -67.87 -45.08 75.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.496 ' CD ' HD22 ' A' ' 13' ' ' ASN . 44.0 mt-10 -57.47 -59.95 4.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.809 ' HD1' HD22 ' A' ' 18' ' ' LEU . 51.4 t80 -51.14 -56.54 12.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.197 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.829 HD11 ' H8 ' ' A' ' 130' ' ' JN3 . 4.0 mm? -54.73 -42.82 72.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 1.1 tmtm? -54.7 -37.32 65.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -30.6 70.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.919 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -57.56 -20.83 34.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.208 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.919 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 82.1 28.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.267 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.521 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 65.2 mt -73.48 167.4 35.12 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.94 . . . . 0.0 110.24 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 46.1 Cg_endo -73.02 136.05 24.17 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.416 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.423 ' HA ' HD12 ' A' ' 28' ' ' ILE . 43.4 mt-10 -52.11 -44.93 64.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.183 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.82 -27.07 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.18 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 23.2 tp -88.54 -21.7 23.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.871 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 82.9 mt -78.6 -41.76 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -74.72 -21.53 59.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 110.225 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.6 mtt -90.54 -30.62 17.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.179 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -104.52 4.24 32.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 110.197 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.871 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.89 -6.71 23.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.217 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -147.36 49.78 1.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 0.0 110.22 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.072 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.5 mt -123.9 117.72 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.566 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 2.1 mptt -90.0 86.72 0.19 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.072 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.05 133.44 19.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.95 1.5 . . . . 0.0 110.432 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.8 mt -86.2 158.45 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 80.5 t -137.74 118.94 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.245 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -98.84 133.45 43.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.181 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.47 HD12 ' CD1' ' A' ' 6' ' ' TRP . 67.5 mt -118.53 133.04 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.173 -0.954 . . . . 0.0 110.145 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -138.09 68.01 1.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.875 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.587 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 15.8 pt20 -71.69 167.7 19.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.213 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 43.0 mttt -160.43 47.26 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.197 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.74 -98.74 0.72 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 23.1 m-20 -111.5 -6.79 14.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 110.206 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.44 155.52 17.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.239 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.804 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.3 m-85 -138.98 135.98 34.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.39 109.71 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.617 HG21 ' H3 ' ' A' ' 131' ' ' JN3 . 76.6 t -111.1 134.05 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.905 . . . . 0.0 110.164 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.623 HG23 ' OG1' ' A' ' 59' ' ' THR . 49.5 m -129.39 106.94 9.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.238 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.4 m -87.72 135.59 33.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.241 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -128.74 114.7 16.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.2 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.931 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -102.88 168.31 9.01 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.205 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.714 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.09 -22.01 19.88 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.946 1.498 . . . . 0.0 110.433 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.619 ' HD2' HD11 ' A' ' 34' ' ' ILE . 15.5 mtp-105 -99.66 -20.96 16.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.276 -0.89 . . . . 0.0 110.178 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.472 ' O ' ' OG1' ' A' ' 53' ' ' THR . 15.7 pt20 -168.24 160.25 11.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.7 p -128.98 134.76 48.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.21 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -132.45 130.04 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.204 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.623 ' OG1' HG23 ' A' ' 50' ' ' THR . 88.4 m -110.26 138.26 46.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.457 ' OD1' ' CG2' ' A' ' 71' ' ' THR . 67.8 m-20 -134.57 156.0 49.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -151.17 126.29 9.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.749 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 44.0 p90 -139.33 176.08 9.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.1 m -120.49 147.01 45.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 110.254 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.804 HD11 ' CD1' ' A' ' 47' ' ' PHE . 21.1 mt -81.04 123.59 28.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 110.271 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.54 2.59 40.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -145.6 148.79 33.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -1.141 . . . . 0.0 110.238 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -70.91 131.03 43.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.248 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -132.36 144.06 50.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.185 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 14.1 p-10 -73.82 141.6 46.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.879 . . . . 0.0 110.225 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.774 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 2.4 mm -136.28 141.61 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 110.244 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.457 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 4.0 t -113.86 132.79 55.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.242 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.788 HG23 H161 ' A' ' 131' ' ' JN3 . 0.2 OUTLIER -83.97 160.0 21.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 110.256 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.826 ' HE3' H122 ' A' ' 130' ' ' JN3 . 13.3 ttm -68.49 -19.27 64.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -83.29 -12.88 56.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.75 28.11 5.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.447 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 5.4 mttm -101.38 133.73 45.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -1.146 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -109.71 132.71 53.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.249 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.813 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -163.59 160.25 22.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 110.206 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -104.94 160.92 14.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.282 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -170.86 138.91 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.154 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.7 m -96.95 99.4 10.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.885 . . . . 0.0 110.276 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.658 HG13 HD21 ' A' ' 89' ' ' LEU . 47.4 t -69.0 140.74 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.599 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 6.8 p-80 -146.62 154.08 41.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.25 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.7 mt -98.13 129.6 44.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.185 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.37 143.71 34.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -0.87 . . . . 0.0 110.166 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.74 13.18 0.98 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 110.186 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.22 48.04 5.25 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.752 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -172.17 134.15 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 110.22 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.658 HD21 HG13 ' A' ' 82' ' ' VAL . 1.9 tt -61.31 145.77 50.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.879 HG22 ' HG3' ' A' ' 99' ' ' GLU . 87.2 t -153.78 109.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 97.6 m -102.75 103.16 13.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 110.191 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -100.42 156.21 17.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.915 . . . . 0.0 110.208 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.587 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 2.9 t -147.36 -163.65 1.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.228 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.682 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 32.4 tt0 -101.85 33.85 2.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.328 -0.857 . . . . 0.0 110.113 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 8.6 ptmt -177.97 7.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.886 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -179.65 141.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.223 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 111' ' ' ILE . 47.9 m -118.99 156.96 28.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.618 ' CD2' H122 ' A' ' 131' ' ' JN3 . 54.2 t-80 -140.11 143.4 36.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 110.26 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.879 ' HG3' HG22 ' A' ' 90' ' ' VAL . 17.9 tt0 -158.28 119.16 3.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 110.271 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 9.5 tt0 -123.94 158.72 31.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 110.248 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.458 ' HA ' ' CE1' ' A' ' 2' ' ' PHE . 28.2 tt0 -157.95 152.69 25.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.24 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.439 ' HB ' ' HE2' ' A' ' 107' ' ' MET . 10.6 p -117.7 142.91 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -129.75 90.71 3.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.05 -113.34 3.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -105.73 3.83 29.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 110.191 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -112.22 160.55 17.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.513 ' HE3' ' NE1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -130.02 140.09 50.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.21 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.2 t -127.58 122.31 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 110.178 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 19.8 mt-10 -104.23 128.1 51.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.186 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' GLU . 50.6 m -120.4 114.38 21.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.872 . . . . 0.0 110.23 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' SER . 60.9 mt -126.12 136.59 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.229 -0.919 . . . . 0.0 110.237 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 88.2 m -112.34 134.55 53.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.209 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.613 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 15.9 t80 -157.56 128.44 6.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 0.0 110.167 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 65.43 36.65 92.88 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.88 13.44 66.42 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 112' ' ' THR . 72.8 t -116.94 136.92 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -1.163 . . . . 0.0 110.18 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.3 m -114.09 131.76 56.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.641 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 61.5 tp -109.91 146.45 35.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.0 mt -129.12 94.11 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 110.259 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.654 ' NH1' ' H12' ' A' ' 130' ' ' JN3 . 18.1 mtm180 -90.47 129.08 36.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 0.0 110.206 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 84.7 mtt180 -105.19 125.91 51.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.2 m -122.64 150.88 42.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -118.64 156.71 28.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 110.201 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -83.55 135.52 34.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.193 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 0.829 ' H8 ' HD11 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.813 H181 HD11 ' A' ' 78' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.245 0.545 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -75.82 -29.78 58.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.198 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.88 143.26 38.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.231 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.59 -172.71 19.36 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.7 m -110.65 131.77 54.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -1.093 . . . . 0.0 110.221 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.48 ' CE2' ' HE3' ' A' ' 107' ' ' MET . 92.3 m95 -119.28 143.28 47.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -125.73 117.79 24.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.239 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.432 HG22 ' OG ' ' A' ' 122' ' ' SER . 47.8 t -66.01 130.28 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.191 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 11.7 p90 -129.71 -18.98 3.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.494 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -139.37 134.87 33.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.498 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 13.8 pt20 -146.8 118.23 7.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -95.95 150.34 20.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 53.38 22.68 2.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.423 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 59.6 t80 -57.82 -45.07 86.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.201 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.28 -54.01 20.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -47.43 -64.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.586 ' HA ' HG11 ' A' ' 116' ' ' VAL . 45.5 t80 -48.06 -43.83 30.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.336 -0.852 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.49 HD21 H191 ' A' ' 130' ' ' JN3 . 17.0 mt -62.76 -45.15 94.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.945 . . . . 0.0 110.191 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -52.33 -33.31 42.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.69 -34.12 73.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.219 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.781 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -60.02 -21.16 60.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.264 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.781 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 73.06 45.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.014 HD22 ' HD2' ' A' ' 24' ' ' PRO . 5.7 mt -86.08 169.27 15.93 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.014 ' HD2' HD22 ' A' ' 23' ' ' LEU . 46.0 Cg_endo -73.11 135.4 22.86 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.031 1.542 . . . . 0.0 110.466 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -56.39 -26.55 53.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.92 . . . . 0.0 110.178 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.94 -38.07 82.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.93 . . . . 0.0 110.263 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.535 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 66.2 tp -83.87 -40.84 18.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 24' ' ' PRO . 63.1 mt -57.78 -51.36 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 33.1 mmtt -61.67 -29.61 70.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 60.1 ttm -84.75 -23.79 29.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 0.0 110.228 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.628 ' HB1' H183 ' A' ' 130' ' ' JN3 . . . -101.88 11.37 38.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.903 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 29' ' ' LYS . 30.1 ptt180 -79.0 -2.58 40.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.208 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -151.66 44.91 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.915 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 21.1 mt -123.34 113.12 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 89.41 0.43 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.207 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.915 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.08 143.21 35.65 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.016 1.535 . . . . 0.0 110.403 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 38' ' ' VAL . 21.3 mt -89.24 162.9 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.206 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.418 ' N ' HG22 ' A' ' 37' ' ' ILE . 98.3 t -141.28 119.44 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.159 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -100.05 138.94 36.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.9 . . . . 0.0 110.2 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.463 ' CD1' ' HE1' ' A' ' 107' ' ' MET . 60.2 mt -123.93 132.37 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 110.181 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -138.19 69.42 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.699 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 4.6 pt20 -75.03 173.63 10.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.699 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 71.4 mttt -165.53 48.64 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 110.189 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.23 -99.25 0.76 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 27.6 m-20 -111.69 -4.54 14.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 0.0 110.216 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -101.43 149.74 23.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.914 . . . . 0.0 110.232 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.748 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.1 m-85 -133.24 137.11 45.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.1 t -124.9 108.55 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.165 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.781 HG11 ' H42' ' A' ' 131' ' ' JN3 . 81.6 t -110.1 134.64 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.877 . . . . 0.0 110.212 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.0 m -132.57 107.37 8.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.902 . . . . 0.0 110.186 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.4 m -87.16 135.5 33.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 110.215 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -128.78 120.83 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.209 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.881 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -107.14 168.48 7.96 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.222 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.79 ' HD2' HG22 ' A' ' 53' ' ' THR . 45.8 Cg_endo -73.03 -19.73 22.68 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.949 1.499 . . . . 0.0 110.407 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 -106.26 -20.06 13.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.85 . . . . 0.0 110.203 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.573 ' NE2' ' HG2' ' A' ' 73' ' ' MET . 13.6 pt20 -163.38 158.96 21.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.169 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 p -132.33 131.53 42.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.32 131.35 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 110.195 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 59' ' ' THR . 13.7 t -112.25 136.83 51.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 110.242 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -133.05 149.4 52.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.132 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -141.17 130.05 23.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.936 . . . . 0.0 110.248 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.72 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 37.6 p90 -143.93 169.46 17.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.7 m -118.34 146.76 44.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.748 HD11 ' CD1' ' A' ' 47' ' ' PHE . 17.8 mt -76.29 125.83 29.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 0.0 110.19 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.48 10.25 57.05 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -145.43 138.03 25.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -1.171 . . . . 0.0 110.218 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -67.39 122.81 18.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.166 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . . . -127.09 142.04 51.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -0.919 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -71.22 144.69 50.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.226 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.873 HD12 ' H62' ' A' ' 131' ' ' JN3 . 16.7 mm -134.88 142.79 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.225 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.3 m -115.56 132.22 56.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.227 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.726 HG23 H161 ' A' ' 131' ' ' JN3 . 0.2 OUTLIER -86.74 161.15 18.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.255 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.759 ' HE3' H122 ' A' ' 130' ' ' JN3 . 8.9 ttm -69.85 -20.84 63.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.721 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -79.34 -16.23 56.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.885 . . . . 0.0 110.186 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.87 23.01 6.98 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -96.58 138.47 34.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -1.136 . . . . 0.0 110.191 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -114.11 131.32 56.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.182 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.774 HD11 H181 ' A' ' 131' ' ' JN3 . 0.5 OUTLIER -163.27 156.51 19.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.232 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -100.61 150.98 22.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 110.254 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.0 133.42 8.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.3 m -95.25 101.01 12.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.801 HG13 HD21 ' A' ' 89' ' ' LEU . 45.1 t -72.21 139.8 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.646 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 8.1 p-80 -139.21 156.04 47.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mp -100.19 131.44 46.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.96 116.65 13.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.887 . . . . 0.0 110.195 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 65.8 t30 60.1 28.06 17.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.671 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.15 48.01 10.29 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.872 ' HD2' ' OE2' ' A' ' 101' ' ' GLU . 3.4 mtpt -159.44 119.27 3.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -1.141 . . . . 0.0 110.221 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.801 HD21 HG13 ' A' ' 82' ' ' VAL . 5.2 tt -66.8 140.67 57.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 110.215 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.746 HG13 ' HG2' ' A' ' 99' ' ' GLU . 45.5 t -149.34 120.76 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.548 HG21 H111 ' A' ' 131' ' ' JN3 . 68.8 m -112.87 95.52 5.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -90.18 165.35 14.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.265 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 7.3 t -157.61 -162.54 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.543 ' N ' ' OG ' ' A' ' 93' ' ' SER . 41.6 tt0 -105.28 31.56 4.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 110.309 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 8.8 ptpt -172.6 1.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.906 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER 179.22 144.29 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 110.258 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 111' ' ' ILE . 46.2 m -119.27 159.99 23.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.261 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.557 ' CD2' H122 ' A' ' 131' ' ' JN3 . 56.1 t-80 -143.31 139.06 29.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.249 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.746 ' HG2' HG13 ' A' ' 90' ' ' VAL . 52.4 mt-10 -151.33 129.27 11.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.905 . . . . 0.0 110.161 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 28.4 tt0 -132.7 153.8 50.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.872 ' OE2' ' HD2' ' A' ' 88' ' ' LYS . 57.6 tt0 -153.49 156.86 38.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.274 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.418 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.4 p -121.09 137.72 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -127.93 92.74 3.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.4 -107.34 2.62 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -113.81 8.61 17.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -1.198 . . . . 0.0 110.227 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -117.24 158.7 23.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.48 ' HE3' ' CE2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -129.94 142.21 50.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.253 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 121' ' ' ARG . 91.1 t -128.19 125.7 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 0.0 110.223 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 31.4 mt-10 -108.4 126.96 53.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.211 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' GLU . 37.2 m -117.34 116.62 27.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 97' ' ' SER . 66.9 mt -125.71 129.58 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.22 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 50.7 m -106.52 139.68 40.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.169 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.606 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 11.7 t80 -161.48 126.36 3.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 66.63 38.2 93.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.2 8.46 58.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 17' ' ' PHE . 60.2 t -110.89 141.52 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -1.165 . . . . 0.0 110.217 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.2 m -117.73 130.75 56.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.893 . . . . 0.0 110.233 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.586 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 64.2 tp -110.01 148.33 31.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.208 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 92.0 mt -128.91 98.91 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.201 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.68 ' NH1' ' H12' ' A' ' 130' ' ' JN3 . 13.7 mtm180 -93.41 124.48 37.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 46.7 mtm-85 -102.66 127.83 49.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.432 ' OG ' HG22 ' A' ' 8' ' ' VAL . 75.5 m -125.54 160.18 30.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.912 . . . . 0.0 110.223 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -123.97 157.06 35.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.157 -0.964 . . . . 0.0 110.223 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' THR . 15.4 ttt85 -81.75 133.37 35.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.224 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.205 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 0.759 H122 ' HE3' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.873 ' H62' HD12 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.312 0.577 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 101' ' ' GLU . 90.3 m-85 -75.23 -30.96 60.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.1 m -56.5 145.59 27.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.22 -178.15 16.66 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 63.6 m -103.77 132.14 50.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -1.175 . . . . 0.0 110.195 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.596 ' NE1' ' HE1' ' A' ' 107' ' ' MET . 99.2 m95 -121.06 144.64 48.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -126.72 117.29 22.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.889 . . . . 0.0 110.116 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.427 HG11 ' CD ' ' A' ' 11' ' ' GLN . 48.8 t -64.6 126.06 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 13.3 p90 -125.98 -21.05 4.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.167 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' N ' ' CD1' ' A' ' 9' ' ' TYR . . . -138.26 133.62 33.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' CD ' HG11 ' A' ' 8' ' ' VAL . 43.2 mt-30 -145.25 114.6 7.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.195 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.44 ' O ' HD12 ' A' ' 118' ' ' LEU . 56.0 tt0 -92.04 144.01 25.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.937 . . . . 0.0 110.197 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 21.3 m120 57.44 17.51 3.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.922 . . . . 0.0 110.215 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.866 ' CE1' HD11 ' A' ' 18' ' ' LEU . 81.9 t80 -53.59 -47.75 69.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.197 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -66.28 -47.84 72.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 36.2 mt-10 -55.78 -62.3 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.717 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 62.7 t80 -47.24 -57.89 4.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.268 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.996 HD21 H191 ' A' ' 130' ' ' JN3 . 7.7 mt -57.14 -44.32 83.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.326 -0.859 . . . . 0.0 110.192 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 9.8 ttmm -46.93 -40.73 14.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.231 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.69 65.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.889 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.1 tp -56.81 -19.56 17.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.889 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.22 27.85 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.154 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.477 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 58.8 mt -74.21 166.67 42.7 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.221 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.8 Cg_endo -73.13 138.87 28.68 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.026 1.54 . . . . 0.0 110.415 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -58.74 -41.02 85.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -56.19 -26.2 49.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.001 HD11 H232 ' A' ' 130' ' ' JN3 . 44.3 tp -93.12 -18.83 22.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.606 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 90.4 mt -82.68 -42.47 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.235 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.31 -32.67 66.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 48.6 ttm -80.56 -32.81 36.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.217 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -97.2 5.98 49.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.606 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.31 -5.3 13.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 110.204 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.403 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 7.4 p-10 -149.23 52.61 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.226 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.139 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.7 mt -122.86 114.86 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.28 83.62 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.189 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.139 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.5 Cg_endo -73.03 131.59 17.01 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.109 1.584 . . . . 0.0 110.411 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.5 mt -86.11 155.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.5 t -135.25 118.54 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 110.238 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.477 ' O ' HD13 ' A' ' 40' ' ' ILE . 22.5 tt0 -97.43 137.61 36.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.591 HD12 HG22 ' A' ' 49' ' ' VAL . 50.6 mm -124.75 129.02 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.224 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -129.28 74.18 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 110.184 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.668 ' OE1' ' CZ ' ' A' ' 47' ' ' PHE . 57.8 tt0 -69.86 166.3 19.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.193 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 36.8 mtmt -165.34 44.86 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.171 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.03 -105.25 1.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -107.63 -2.42 20.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -1.135 . . . . 0.0 110.224 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -102.28 148.72 25.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 110.189 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.775 ' CD1' HD11 ' A' ' 64' ' ' LEU . 1.9 m-85 -131.03 135.06 47.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.292 -0.88 . . . . 0.0 110.152 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.8 t -120.19 108.99 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.923 HG11 ' H42' ' A' ' 131' ' ' JN3 . 73.5 t -110.04 129.95 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.433 HG22 ' HE3' ' A' ' 52' ' ' LYS . 92.7 m -129.56 105.38 8.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 110.268 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 m -89.55 137.52 32.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.88 . . . . 0.0 110.222 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.433 ' HE3' HG22 ' A' ' 50' ' ' THR . 44.2 mttt -130.47 112.8 13.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.168 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.682 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -95.7 168.63 10.48 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.173 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.417 ' CD ' HG23 ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.12 -17.14 24.97 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.018 1.536 . . . . 0.0 110.434 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -106.55 -18.41 13.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.682 ' O ' ' OG1' ' A' ' 53' ' ' THR . 14.2 pt20 -167.84 161.63 13.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.1 p -128.53 135.82 49.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.99 126.9 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.209 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 t -109.92 139.56 44.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 110.147 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -136.2 147.93 47.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.254 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -139.49 130.54 26.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.242 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.912 ' CE1' HG21 ' A' ' 82' ' ' VAL . 34.2 p90 -144.42 173.15 12.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.228 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.0 m -120.19 143.35 48.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.298 -0.876 . . . . 0.0 110.126 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.775 HD11 ' CD1' ' A' ' 47' ' ' PHE . 30.8 mt -74.34 127.17 32.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.172 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.88 -1.4 57.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -136.34 145.11 45.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -1.135 . . . . 0.0 110.231 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -68.91 125.42 26.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.609 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -125.65 151.52 46.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -82.27 133.95 35.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.925 . . . . 0.0 110.187 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.881 HD12 ' H62' ' A' ' 131' ' ' JN3 . 18.9 mm -125.94 145.65 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 110.252 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -121.04 135.13 55.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.925 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.706 HG23 H161 ' A' ' 131' ' ' JN3 . 0.2 OUTLIER -85.28 157.46 20.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 0.0 110.238 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.759 ' HG2' H222 ' A' ' 130' ' ' JN3 . 0.2 OUTLIER -68.87 -16.98 63.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 110.25 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.596 ' OD1' HD22 ' A' ' 27' ' ' LEU . 15.9 t0 -84.13 -11.49 56.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.09 30.3 4.84 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.594 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 27.7 mttt -104.03 132.07 50.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -1.138 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -107.18 135.02 49.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.285 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.766 HD11 H181 ' A' ' 131' ' ' JN3 . 0.8 OUTLIER -166.01 158.9 15.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.163 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -104.88 147.16 28.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.467 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.2 m -151.04 139.19 20.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -103.25 88.64 3.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.182 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.042 HG11 HD11 ' A' ' 89' ' ' LEU . 16.9 t -52.73 157.03 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 110.271 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.68 144.51 19.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.252 -0.905 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.649 HD13 HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -99.85 105.09 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.243 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.93 150.91 44.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.153 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 52.57 15.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.242 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.84 40.17 12.48 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.673 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 9.2 ptpt -163.54 133.0 4.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -1.127 . . . . 0.0 110.169 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.042 HD11 HG11 ' A' ' 82' ' ' VAL . 5.5 tt -61.42 145.07 52.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.206 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.657 HG13 ' HG3' ' A' ' 99' ' ' GLU . 41.4 t -150.48 111.42 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 87.4 m -106.96 97.95 7.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.232 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 14.9 ptpt -95.45 162.78 13.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 110.193 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.5 t -152.42 -164.47 1.96 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -102.21 33.34 3.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 0.0 110.231 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 1.1 pttt -174.98 2.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.18 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.99 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER 178.56 143.14 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.643 ' O ' HG23 ' A' ' 111' ' ' ILE . 50.7 m -116.85 164.91 13.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 0.0 110.209 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.825 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 60.5 t-80 -146.84 141.24 26.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.825 ' HG3' ' O ' ' A' ' 98' ' ' HIS . 4.3 mp0 -153.58 128.29 9.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 0.0 110.213 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 58.8 tt0 -131.89 157.4 44.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.443 ' HA ' ' CE2' ' A' ' 2' ' ' PHE . 36.7 tt0 -156.32 154.28 30.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.06 142.57 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.185 -0.947 . . . . 0.0 110.131 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -136.74 95.04 3.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 110.2 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.9 -110.76 3.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -114.62 12.62 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -1.149 . . . . 0.0 110.216 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -119.24 157.83 27.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.596 ' HE1' ' NE1' ' A' ' 6' ' ' TRP . 2.2 tpp -127.96 140.49 51.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.234 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.7 t -127.48 124.5 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 120' ' ' ARG . 23.5 mt-10 -109.35 118.26 36.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.876 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.567 ' N ' ' O ' ' A' ' 99' ' ' GLU . 41.3 m -108.76 118.65 37.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 110.253 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 97' ' ' SER . 53.6 mt -127.76 132.64 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.164 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 76.6 m -108.52 139.54 43.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.672 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 10.9 t80 -161.19 127.06 3.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 65.48 38.59 94.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 67.92 12.31 62.21 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 17' ' ' PHE . 63.4 t -114.57 138.27 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 110.168 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.6 m -115.02 131.49 56.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.263 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.717 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 63.8 tp -111.41 151.06 28.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 110.242 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.9 mt -129.39 94.1 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.484 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 64.8 mtp180 -87.27 124.09 32.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.192 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 65.3 mtt180 -104.72 125.15 50.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 107' ' ' MET . 74.3 m -124.29 152.93 42.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -115.39 156.12 26.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 110.215 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 5' ' ' THR . 32.3 ttt180 -82.61 136.04 34.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.196 -179.981 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 1.001 H232 HD11 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.923 ' H42' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.194 0.521 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -77.28 -35.07 55.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 110.248 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.89 144.38 44.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.16 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.59 176.19 14.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 42.3 p -103.48 134.05 47.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -1.108 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.642 ' NE1' ' HE3' ' A' ' 107' ' ' MET . 86.0 m95 -122.46 142.96 50.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.226 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -123.31 118.51 27.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.488 HG13 ' HG2' ' A' ' 120' ' ' ARG . 51.0 t -64.61 127.74 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.285 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 47.6 p90 -128.41 -28.19 2.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.92 . . . . 0.0 110.25 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' HB2' ' CD2' ' A' ' 9' ' ' TYR . . . -132.84 133.76 43.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.175 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 14' ' ' TYR . 5.4 pt20 -146.62 118.61 8.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -97.11 148.99 22.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.148 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 m120 53.08 21.89 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 110.218 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.943 ' CE1' HD11 ' A' ' 18' ' ' LEU . 86.6 t80 -60.12 -42.95 95.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 110.236 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.625 ' HG3' ' N ' ' A' ' 16' ' ' GLU . 14.2 pt-20 -69.55 -45.59 68.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 110.169 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.625 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 41.8 mt-10 -57.67 -60.37 3.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.713 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 52.2 t80 -51.65 -53.64 36.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.023 HD21 H191 ' A' ' 130' ' ' JN3 . 8.9 mt -59.38 -47.23 86.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 110.19 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -48.46 -38.74 20.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.917 . . . . 0.0 110.175 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.22 -25.07 65.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.946 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.5 tp -60.37 -18.74 52.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.232 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.946 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 82.61 26.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 23' ' ' LEU . 24.2 mt -72.91 163.14 70.61 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 110.231 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.493 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.9 Cg_endo -73.03 140.16 30.94 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.022 1.538 . . . . 0.0 110.442 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -56.02 -44.67 78.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -51.42 -36.53 44.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.16 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.493 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 20.8 tp -83.01 -23.34 33.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.685 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 35.0 mt -75.23 -40.98 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 9.3 mtmt -76.43 -22.84 54.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.214 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.6 mtt -87.92 -27.24 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.948 . . . . 0.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -104.73 4.72 32.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.174 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.859 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 21.1 ptt180 -70.69 1.53 5.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -0.914 . . . . 0.0 110.206 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.859 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 1.5 m-20 -153.82 42.02 0.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.254 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.907 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 7.1 mt -121.38 117.06 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -94.06 89.25 0.42 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.251 -0.905 . . . . 0.0 110.221 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.907 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.1 Cg_endo -73.09 138.07 27.44 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.0 1.526 . . . . 0.0 110.408 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.1 mt -87.51 161.42 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.922 . . . . 0.0 110.182 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.6 t -139.87 120.98 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -101.6 138.27 38.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.5 mt -124.95 132.79 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.888 . . . . 0.0 110.23 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -137.14 72.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.614 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 6.5 pt20 -76.42 169.65 17.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.211 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 75.7 mttt -161.26 46.71 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 110.239 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.18 -97.88 0.64 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -112.03 -6.84 14.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.153 . . . . 0.0 110.207 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.561 ' OD1' HG23 ' A' ' 63' ' ' THR . 49.4 m-20 -99.8 152.71 19.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.917 . . . . 0.0 110.157 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.652 ' CE1' HD11 ' A' ' 64' ' ' LEU . 2.1 m-85 -136.34 137.96 41.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.62 109.6 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.21 -0.931 . . . . 0.0 110.229 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.728 HG11 ' H42' ' A' ' 131' ' ' JN3 . 64.1 t -111.19 134.41 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.186 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.672 ' OG1' HG23 ' A' ' 59' ' ' THR . 91.3 m -131.14 109.91 10.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -90.42 135.11 33.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -127.51 122.11 32.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.208 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.815 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.58 168.87 7.19 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.239 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.757 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.05 -17.54 24.8 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.059 1.557 . . . . 0.0 110.466 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.464 ' HD3' ' HB3' ' A' ' 56' ' ' GLN . 1.8 tmt_? -105.57 -24.09 12.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.186 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.485 ' OE1' ' HG2' ' A' ' 73' ' ' MET . 2.5 pt20 -162.88 164.34 26.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.232 -0.918 . . . . 0.0 110.216 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.2 p -132.12 128.23 37.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 110.192 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.48 132.76 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.93 . . . . 0.0 110.222 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.672 HG23 ' OG1' ' A' ' 50' ' ' THR . 28.7 m -112.56 136.54 51.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 110.246 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.473 ' ND2' ' OG1' ' A' ' 71' ' ' THR . 14.5 m120 -133.03 150.58 52.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.174 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.4 m -143.08 137.51 29.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.202 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.889 ' CD1' HG21 ' A' ' 82' ' ' VAL . 32.5 p90 -150.04 162.01 41.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.561 HG23 ' OD1' ' A' ' 46' ' ' ASP . 90.7 m -112.2 143.54 43.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.652 HD11 ' CE1' ' A' ' 47' ' ' PHE . 14.1 mt -69.16 124.79 24.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.54 19.03 53.74 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' C ' HG23 ' A' ' 81' ' ' THR . 91.2 mttt -150.89 138.9 20.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -1.191 . . . . 0.0 110.152 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -72.05 135.51 46.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 0.0 110.188 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.46 146.75 42.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.233 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 13.9 p-10 -76.27 141.4 41.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.168 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.95 HD13 H191 ' A' ' 131' ' ' JN3 . 74.7 mt -140.31 145.93 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.473 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 1.6 p -111.83 147.34 35.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.194 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.641 ' OG1' ' CB ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -98.6 158.6 15.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.213 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.677 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 10.5 ttm -68.13 -17.16 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.564 ' OD2' ' HB ' ' A' ' 72' ' ' THR . 3.1 p30 -87.5 -18.28 30.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.86 26.76 4.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.641 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 19.4 mttt -101.59 133.4 46.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -1.111 . . . . 0.0 110.226 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -110.67 134.99 51.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.757 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -165.44 161.38 18.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -104.55 151.51 23.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.2 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.495 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 0.9 OUTLIER -155.23 140.53 17.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.203 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.441 HG23 ' C ' ' A' ' 66' ' ' LYS . 6.1 m -102.4 86.37 2.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.209 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.889 HG21 ' CD1' ' A' ' 62' ' ' PHE . 11.5 t -52.75 152.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.885 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.14 148.25 32.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.512 HD12 HD13 ' A' ' 64' ' ' LEU . 1.6 mt -102.19 105.02 15.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.67 132.27 55.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.211 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.7 t30 45.68 39.53 5.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.887 . . . . 0.0 110.217 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.36 42.62 95.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.661 ' HD3' ' CD ' ' A' ' 101' ' ' GLU . 25.3 mttt -150.04 119.38 6.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -1.104 . . . . 0.0 110.189 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.801 HD21 HG13 ' A' ' 82' ' ' VAL . 1.5 tt -68.87 133.2 47.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.815 HG22 ' HG3' ' A' ' 99' ' ' GLU . 20.7 t -139.78 120.85 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.559 HG21 H111 ' A' ' 131' ' ' JN3 . 87.9 m -113.76 94.66 4.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.2 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 46.7 pttt -94.25 163.13 13.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.272 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 28.6 t -150.23 -154.66 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.206 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.49 ' N ' ' OG ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -107.04 22.55 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.17 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -165.41 6.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.201 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 1.018 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER 179.86 139.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 111' ' ' ILE . 16.0 t -112.38 165.29 12.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.61 ' CD2' H122 ' A' ' 131' ' ' JN3 . 42.5 t-80 -149.5 136.46 19.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.815 ' HG3' HG22 ' A' ' 90' ' ' VAL . 33.3 tt0 -152.05 128.58 10.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.9 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.538 ' OE1' ' HG2' ' A' ' 109' ' ' GLU . 39.1 tt0 -132.43 160.52 36.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.179 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.661 ' CD ' ' HD3' ' A' ' 88' ' ' LYS . 82.3 tt0 -155.89 150.12 25.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.225 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.77 142.16 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 110.215 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -133.73 93.35 3.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 110.196 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.5 -108.39 2.78 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -114.26 8.73 16.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -1.119 . . . . 0.0 110.197 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -115.49 154.78 28.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.923 . . . . 0.0 110.164 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.642 ' HE3' ' NE1' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -125.5 141.91 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.19 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.1 t -128.68 122.16 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.538 ' HG2' ' OE1' ' A' ' 100' ' ' GLN . 27.1 mt-10 -105.42 121.75 44.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.223 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.665 ' N ' ' O ' ' A' ' 99' ' ' GLU . 19.6 m -112.61 116.04 29.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 97' ' ' SER . 52.2 mt -126.47 132.1 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 77.0 m -108.95 137.26 47.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.92 . . . . 0.0 110.225 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 11.6 t80 -159.56 126.52 4.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.94 32.79 77.92 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.46 9.65 78.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 17' ' ' PHE . 52.2 t -113.37 141.68 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -1.123 . . . . 0.0 110.246 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.3 m -115.85 134.26 55.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.192 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.713 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 16.9 tp -112.67 140.04 47.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 118' ' ' LEU . 58.1 mt -122.48 98.38 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.488 ' HG2' HG13 ' A' ' 8' ' ' VAL . 6.1 ttp180 -93.59 124.96 37.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 110.244 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 32.9 mtm180 -103.07 122.82 45.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 6' ' ' TRP . 73.6 m -120.44 150.42 40.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -114.91 151.63 33.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 110.19 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' THR . 21.1 ttt180 -74.87 133.31 41.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.189 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 1.023 H191 HD21 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.95 H191 HD13 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.227 0.537 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -76.03 -28.01 57.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.207 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 p -57.79 144.47 38.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.8 -176.05 18.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 86.5 m -108.14 134.24 51.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -1.093 . . . . 0.0 110.215 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.549 ' CH2' HG23 ' A' ' 102' ' ' VAL . 98.8 m95 -121.12 139.2 53.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.179 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -121.89 125.6 46.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.239 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.651 HG12 ' HD3' ' A' ' 120' ' ' ARG . 19.4 m -62.34 123.35 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.212 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -134.27 2.77 3.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 110.223 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 121' ' ' ARG . . . -163.03 120.79 1.97 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -147.08 164.85 31.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 110.206 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' O ' HD12 ' A' ' 118' ' ' LEU . 39.8 tt0 -135.97 153.58 51.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 48.27 38.08 9.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -67.06 -49.31 65.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.188 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -61.8 -46.4 89.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 61.3 mt-10 -55.15 -42.93 73.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.195 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 55.2 t80 -55.41 -57.67 10.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 110.278 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.725 HD22 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -50.78 -38.89 50.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.37 -0.831 . . . . 0.0 110.195 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 33.2 mttp -60.33 -38.8 84.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.262 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.63 -40.94 69.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.981 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.0 tp -54.68 -26.22 32.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.893 . . . . 0.0 110.23 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.981 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 86.64 18.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.725 HD12 HD22 ' A' ' 18' ' ' LEU . 16.5 mt -66.69 170.31 6.17 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.175 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 46.8 Cg_endo -73.09 132.96 18.86 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.123 1.591 . . . . 0.0 110.41 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.675 ' HA ' HD12 ' A' ' 28' ' ' ILE . 25.6 tp10 -51.94 -47.91 64.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 110.225 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -48.42 -35.62 13.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 110.241 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.529 ' CB ' ' HG2' ' A' ' 24' ' ' PRO . 41.6 tp -79.54 -33.4 41.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.17 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.675 HD12 ' HA ' ' A' ' 25' ' ' GLU . 85.6 mt -61.95 -52.22 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.193 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.408 ' HE2' ' HG3' ' A' ' 25' ' ' GLU . 17.5 mttm -59.08 -26.1 64.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -0.913 . . . . 0.0 110.179 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.462 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 12.1 ttm -91.8 -23.12 19.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.629 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -101.29 -5.94 24.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -3.72 16.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -147.62 43.43 1.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.049 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 18.0 mt -120.49 109.93 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 110.206 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HA ' HG21 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -90.48 86.59 0.2 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.18 -0.95 . . . . 0.0 110.198 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.049 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.6 Cg_endo -73.14 146.42 40.95 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.069 1.562 . . . . 0.0 110.443 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 38' ' ' VAL . 12.2 mt -91.17 162.29 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.227 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' N ' HG22 ' A' ' 37' ' ' ILE . 79.4 t -138.36 120.75 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -103.45 134.58 46.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.533 HD12 ' CD1' ' A' ' 6' ' ' TRP . 68.8 mt -120.67 131.7 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 37.0 tt0 -135.95 73.09 1.45 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 110.215 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.532 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -76.12 164.1 26.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.201 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 59.6 mttt -158.71 49.84 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.42 -101.85 1.01 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -110.91 1.11 17.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -1.131 . . . . 0.0 110.174 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 42.2 t0 -108.23 144.02 36.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 110.265 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.692 ' CD1' HD11 ' A' ' 64' ' ' LEU . 3.6 m-85 -127.29 143.51 51.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.897 . . . . 0.0 110.248 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.6 t -132.35 106.92 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.178 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.538 HG21 ' C3 ' ' A' ' 131' ' ' JN3 . 92.4 t -108.82 134.88 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.243 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.765 ' OG1' HG23 ' A' ' 59' ' ' THR . 87.1 m -131.91 109.51 10.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.217 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.0 m -92.1 132.72 36.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.257 -0.902 . . . . 0.0 110.093 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -126.17 128.32 47.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.28 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.806 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -111.11 169.76 5.97 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.0 110.273 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.13 -8.87 22.74 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.005 1.529 . . . . 0.0 110.403 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -117.39 -20.84 8.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.607 ' O ' ' OG1' ' A' ' 53' ' ' THR . 16.2 pt20 -162.43 160.5 26.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.883 . . . . 0.0 110.17 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 p -131.09 131.15 43.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 73' ' ' MET . 57.4 t -127.7 129.35 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.194 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.765 HG23 ' OG1' ' A' ' 50' ' ' THR . 62.3 m -112.26 139.75 47.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -135.09 152.06 51.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.903 . . . . 0.0 110.19 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.4 t -148.38 131.15 16.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.225 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.773 ' CE1' ' H5 ' ' A' ' 131' ' ' JN3 . 50.5 p90 -143.51 171.55 13.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.929 . . . . 0.0 110.151 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.2 m -119.8 140.88 50.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.692 HD11 ' CD1' ' A' ' 47' ' ' PHE . 17.5 mt -74.41 127.67 33.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 110.202 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.42 4.4 56.18 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -145.05 145.07 31.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -1.154 . . . . 0.0 110.205 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.44 123.96 22.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.221 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.591 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.89 150.74 44.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 12.0 p-10 -86.39 140.65 29.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.761 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 12.1 mm -130.15 144.42 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -116.56 131.77 56.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.194 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.663 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 73.0 p -86.04 158.16 19.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.907 ' HE2' H122 ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -70.01 -13.76 62.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.729 ' HB3' H151 ' A' ' 130' ' ' JN3 . 3.6 p30 -86.28 -16.92 36.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 110.22 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.53 27.7 4.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.663 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 22.1 mttt -105.06 131.36 52.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -107.84 135.83 48.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.26 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.622 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -164.22 159.38 20.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 110.195 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 83.4 mttt -105.93 171.01 7.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 110.256 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 27.6 p -179.88 136.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 m -95.34 103.43 15.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.197 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.707 HG13 HD21 ' A' ' 89' ' ' LEU . 43.2 t -76.77 140.54 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 110.244 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.647 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 35.0 p-80 -139.44 156.6 46.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.209 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 84' ' ' LEU . 53.8 mt -101.41 132.15 47.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.164 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -135.77 117.97 15.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.22 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 57.84 31.39 20.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 110.231 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.634 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 72.24 49.78 19.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.675 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 51.1 mtpt -158.57 117.21 3.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.8 HD22 ' H22' ' A' ' 131' ' ' JN3 . 4.5 tt -65.77 140.28 58.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.193 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.906 HG22 ' CG ' ' A' ' 99' ' ' GLU . 97.8 t -146.69 117.0 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 99.8 m -110.97 94.8 5.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 110.223 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -88.45 161.7 16.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.231 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 96' ' ' PHE . 30.2 t -157.47 -177.13 6.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.918 . . . . 0.0 110.237 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 84.1 tt0 -95.26 33.46 1.56 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.902 . . . . 0.0 110.184 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.541 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 10.8 ptpt -173.5 -2.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.837 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -176.96 146.62 0.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.2 m -123.13 156.87 34.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.154 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.696 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.5 t-80 -140.23 134.56 31.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.906 ' CG ' HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -149.07 125.14 10.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.857 . . . . 0.0 110.21 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.745 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . 10.0 tt0 -131.94 156.47 46.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.675 ' OE1' ' HE3' ' A' ' 88' ' ' LYS . 76.8 tt0 -151.65 159.55 43.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.549 HG23 ' CH2' ' A' ' 6' ' ' TRP . 10.9 p -122.65 137.23 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -132.16 93.3 3.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.53 -106.77 2.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.427 ' ND2' ' HG3' ' A' ' 106' ' ' GLU . 3.4 p-10 -117.67 10.79 13.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -1.147 . . . . 0.0 110.165 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.427 ' HG3' ' ND2' ' A' ' 105' ' ' ASN . 70.0 mt-10 -118.43 160.79 21.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.195 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.536 ' SD ' ' OE1' ' A' ' 100' ' ' GLN . 28.5 ttm -134.58 142.08 46.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.221 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 74.2 t -125.62 128.65 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 110.24 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.745 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 15.7 mt-10 -115.87 136.17 53.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.211 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 99' ' ' GLU . 3.1 t -126.27 122.61 36.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.183 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.29 133.01 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 89.6 m -113.27 133.87 54.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.157 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 21' ' ' LEU . 26.1 t80 -154.82 122.58 5.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 110.227 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.94 35.5 65.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.39 5.39 63.0 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 112' ' ' THR . 70.2 t -111.05 135.76 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -1.162 . . . . 0.0 110.23 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.2 m -112.93 135.43 53.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.577 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 23.5 tp -115.76 139.57 50.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.04 120.18 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.651 ' HD3' HG12 ' A' ' 8' ' ' VAL . 5.5 ttm105 -115.39 119.18 35.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 110.219 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 84.4 mtt180 -99.94 125.15 45.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.428 ' HB3' ' HB3' ' A' ' 6' ' ' TRP . 11.4 m -120.54 152.03 38.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.22 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -113.58 152.51 30.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 5' ' ' THR . 31.8 ttt180 -78.96 136.91 37.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.196 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.146 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 0.907 H122 ' HE2' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.8 ' H22' HD22 ' A' ' 89' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.616 ' O ' HG11 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.211 0.529 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.56 ' HA ' HG21 ' A' ' 102' ' ' VAL . 64.4 m-85 -84.02 -38.47 20.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 110.251 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.4 p -58.78 145.26 41.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.275 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.06 -178.99 16.78 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 85.0 m -104.05 132.04 50.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -1.154 . . . . 0.0 110.193 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.691 ' CD1' HD12 ' A' ' 40' ' ' ILE . 88.4 m95 -121.73 142.7 49.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.895 . . . . 0.0 110.164 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.01 122.32 38.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 110.212 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.55 124.16 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.204 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 38.1 p90 -124.94 -32.43 3.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.194 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.01 127.16 41.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.261 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 23.0 pt20 -141.48 117.72 10.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.589 ' O ' HD12 ' A' ' 118' ' ' LEU . 41.4 tt0 -96.19 144.25 26.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.219 -0.926 . . . . 0.0 110.279 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' GLU . 6.8 t-20 60.79 14.63 5.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.841 ' CE1' HD11 ' A' ' 18' ' ' LEU . 60.5 t80 -50.98 -53.75 30.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 110.315 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.8 -49.1 76.27 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 34.1 mt-10 -55.05 -58.98 5.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 110.236 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.73 ' CD2' HD22 ' A' ' 118' ' ' LEU . 63.9 t80 -50.56 -54.73 20.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.027 HD21 H191 ' A' ' 130' ' ' JN3 . 4.4 mt -59.18 -41.18 87.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -50.09 -39.54 42.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.51 -27.53 65.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.909 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -59.71 -19.69 51.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.99 27.57 0.31 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 23' ' ' LEU . 37.4 mt -74.32 164.2 62.92 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.335 -0.853 . . . . 0.0 110.186 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.554 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -73.13 140.8 31.63 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.066 1.561 . . . . 0.0 110.391 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.89 -41.11 90.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.156 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.6 -27.39 49.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.554 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 42.2 tp -91.74 -18.91 23.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.188 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.7 mt -85.01 -40.93 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -73.83 -30.87 62.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.181 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 51.6 ttm -82.57 -30.83 29.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.838 . . . . 0.0 110.234 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -99.17 3.97 46.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 110.206 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.679 ' HD2' ' OD2' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -64.5 -10.19 23.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.232 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.679 ' OD2' ' HD2' ' A' ' 32' ' ' ARG . 69.2 m-20 -143.93 55.96 1.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.21 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 1.8 mt -126.32 114.41 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 110.216 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -86.32 83.06 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 110.232 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.21 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.7 Cg_endo -73.07 131.52 16.85 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.029 1.542 . . . . 0.0 110.389 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -87.52 153.59 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 110.246 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.48 118.44 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.215 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -96.78 131.9 43.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.229 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.691 HD12 ' CD1' ' A' ' 6' ' ' TRP . 74.0 mt -117.36 135.49 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.193 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -138.01 68.01 1.41 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.503 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -71.04 163.28 27.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 110.221 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 86.4 mttt -158.3 45.99 0.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.18 -97.85 0.67 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 52.3 m-20 -112.18 -3.7 14.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -1.181 . . . . 0.0 110.202 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.809 ' OD1' HG23 ' A' ' 63' ' ' THR . 38.3 m-20 -106.85 148.96 27.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 34.3 m-85 -131.88 148.79 52.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -127.27 99.74 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 110.164 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.668 HG11 ' H42' ' A' ' 131' ' ' JN3 . 59.7 t -102.13 132.65 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.865 . . . . 0.0 110.206 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 58.7 m -134.03 108.78 8.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.214 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 m -93.65 134.3 36.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 110.244 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -127.03 127.08 44.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.663 ' OG1' ' O ' ' A' ' 56' ' ' GLN . 62.3 p -109.29 170.03 5.82 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.945 . . . . 0.0 110.204 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.652 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 46.7 Cg_endo -73.06 -5.57 17.43 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -120.7 -23.85 5.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.663 ' O ' ' OG1' ' A' ' 53' ' ' THR . 4.5 pt20 -161.43 165.89 28.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.175 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.2 p -132.6 130.8 40.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.161 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.652 HG21 ' HA ' ' A' ' 73' ' ' MET . 48.9 t -127.37 126.21 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 14.7 t -111.06 146.39 36.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.894 ' OD1' HG22 ' A' ' 71' ' ' THR . 10.8 m-80 -139.63 142.91 37.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.85 . . . . 0.0 110.15 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -139.58 135.05 32.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.19 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.742 ' CE1' HG11 ' A' ' 82' ' ' VAL . 54.1 p90 -148.06 170.78 17.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.809 HG23 ' OD1' ' A' ' 46' ' ' ASP . 91.3 m -116.78 151.05 37.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.236 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.504 HD11 ' CA ' ' A' ' 83' ' ' HIS . 3.5 tp -82.66 120.07 25.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.244 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.85 9.61 34.44 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -148.53 147.08 28.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -1.154 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -68.76 126.72 30.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -126.14 148.01 49.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.313 -0.867 . . . . 0.0 110.173 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -84.3 138.36 32.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.787 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 11.4 mm -128.21 145.07 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 110.185 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.894 HG22 ' OD1' ' A' ' 60' ' ' ASN . 5.1 t -119.72 131.32 55.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 73.1 p -84.22 160.89 20.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.652 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -74.15 -12.52 60.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.117 -0.989 . . . . 0.0 110.226 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.667 ' HB3' H151 ' A' ' 130' ' ' JN3 . 4.9 p-10 -89.35 -9.54 50.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.209 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.52 51.39 1.21 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.584 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 9.3 tttt -129.63 128.46 42.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -1.132 . . . . 0.0 110.197 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -104.53 141.04 37.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.656 HD13 ' CE2' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -168.72 156.32 7.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 110.248 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 13.7 mttm -105.41 165.86 10.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.217 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.9 p -178.05 139.95 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 p -94.46 107.95 19.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 0.0 110.22 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.809 HG13 HD21 ' A' ' 89' ' ' LEU . 48.1 t -79.47 140.38 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.622 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 15.3 p-80 -145.03 161.54 39.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.426 HD11 ' HZ ' ' A' ' 47' ' ' PHE . 16.5 mt -103.61 134.35 47.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -136.91 120.44 17.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 110.235 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 86.7 m-20 58.72 31.7 21.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.578 ' O ' ' HG3' ' A' ' 88' ' ' LYS . . . 72.83 44.07 39.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.788 ' HD3' ' OE2' ' A' ' 101' ' ' GLU . 10.0 mtmt -156.39 121.66 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -1.164 . . . . 0.0 110.152 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.812 HD22 ' H22' ' A' ' 131' ' ' JN3 . 4.2 tt -66.73 136.04 54.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.897 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.683 HG13 ' HG2' ' A' ' 99' ' ' GLU . 69.2 t -142.34 117.27 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 75.0 m -109.99 95.3 5.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 110.244 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -91.55 154.43 19.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.215 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.4 t -145.84 -163.95 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.158 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -102.69 33.08 3.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 0.2 OUTLIER -175.52 2.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.919 . . . . 0.0 110.187 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.823 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -178.73 148.42 0.42 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 0.0 110.184 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.605 ' O ' HG23 ' A' ' 111' ' ' ILE . 41.8 m -123.75 159.89 28.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.617 ' CD2' H122 ' A' ' 131' ' ' JN3 . 65.8 t-80 -142.21 142.92 32.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.915 . . . . 0.0 110.251 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.683 ' HG2' HG13 ' A' ' 90' ' ' VAL . 47.6 mt-10 -155.73 123.2 5.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.143 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.425 ' CG ' ' HG2' ' A' ' 109' ' ' GLU . 11.6 tt0 -129.23 159.07 37.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.202 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.788 ' OE2' ' HD3' ' A' ' 88' ' ' LYS . 57.6 tt0 -157.09 156.83 33.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 110.208 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.616 HG11 ' O ' ' A' ' 1' ' ' ALA . 39.8 t -118.98 139.18 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -134.96 89.78 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.216 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.83 -102.59 2.48 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -123.09 10.72 9.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -1.122 . . . . 0.0 110.22 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -115.84 151.68 34.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.543 ' HG2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -121.74 137.01 54.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.4 t -125.29 120.56 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.425 ' HG2' ' CG ' ' A' ' 100' ' ' GLN . 35.4 mt-10 -109.01 118.71 37.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.567 ' N ' ' O ' ' A' ' 99' ' ' GLU . 63.4 m -107.97 116.61 32.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.266 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 97' ' ' SER . 54.0 mt -125.4 131.46 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.226 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 32.7 m -109.69 134.47 51.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.59 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 12.8 t80 -157.42 128.16 6.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.21 33.83 74.32 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.08 11.73 70.77 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 112' ' ' THR . 78.0 t -116.26 138.36 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -1.135 . . . . 0.0 110.202 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 63.2 m -113.27 132.48 55.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.73 HD22 ' CD2' ' A' ' 17' ' ' PHE . 29.5 tp -113.02 152.09 29.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.89 . . . . 0.0 110.244 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.9 mt -129.65 94.98 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.172 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -87.76 126.61 35.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 91.0 mtt180 -106.88 124.96 50.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.214 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.2 m -122.66 149.4 44.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -115.55 150.76 36.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 110.177 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' THR . 23.2 ttt85 -74.99 132.95 41.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.249 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.445 HG13 ' OXT' ' A' ' 125' ' ' VAL . 7.9 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.191 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 1.027 H191 HD21 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.812 ' H22' HD22 ' A' ' 89' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.188 0.518 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -77.06 -27.85 54.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 57.2 m -59.17 148.52 31.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 110.266 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.63 163.83 13.93 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.434 ' OG1' ' HB ' ' A' ' 125' ' ' VAL . 20.5 p -78.3 155.52 30.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -1.159 . . . . 0.0 110.16 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.598 ' CH2' HG23 ' A' ' 102' ' ' VAL . 96.7 m95 -141.93 127.64 19.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.168 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.983 ' HB3' ' HG2' ' A' ' 123' ' ' LYS . 6.1 tt0 -94.63 146.34 24.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.187 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 36' ' ' PRO . 38.6 t -67.37 112.32 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.259 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 1.355 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 2.1 m-85 -72.86 -69.52 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.895 . . . . 0.0 110.252 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.961 ' H ' ' HG3' ' A' ' 121' ' ' ARG . . . -149.07 170.76 17.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.26 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.703 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 3.1 mp0 -148.43 112.25 5.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.238 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 54.6 tt0 -91.8 150.93 20.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.19 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 14' ' ' TYR . 23.6 m-20 52.49 19.12 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 7.4 t80 -42.85 -65.31 0.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.135 -0.978 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' GLU . 47.2 mt-10 -47.88 -57.33 5.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.212 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 5.7 mm-40 -41.83 -49.88 4.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.469 ' CD2' HD22 ' A' ' 118' ' ' LEU . 12.6 t80 -52.04 -63.3 1.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.791 ' CD2' HD12 ' A' ' 23' ' ' LEU . 7.6 mt -44.49 -44.46 8.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.275 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 22.8 mttm -52.72 -37.93 59.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.03 -40.08 63.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.22 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.883 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -57.51 -25.22 59.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 110.231 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.883 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 79.6 23.22 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 110.162 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.791 HD12 ' CD2' ' A' ' 18' ' ' LEU . 15.5 mt -71.54 170.12 13.11 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.209 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.3 Cg_endo -73.11 139.32 29.46 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.067 1.562 . . . . 0.0 110.374 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 5.6 pt-20 -59.93 -46.74 88.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 110.238 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' A' ' 24' ' ' PRO . 2.6 p30 -47.34 -34.67 7.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.194 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 18.4 tp -88.97 -32.25 17.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.228 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.669 HG12 HD13 ' A' ' 18' ' ' LEU . 72.8 mt -70.61 -49.16 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 110.177 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -63.63 -32.07 73.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 110.164 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.1 ttp -84.33 -11.77 55.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 110.159 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.502 ' HB1' H183 ' A' ' 130' ' ' JN3 . . . -111.2 3.81 18.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.258 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.568 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 9.4 ptt180 -68.29 -3.21 10.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.182 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 81.0 m-20 -146.91 51.46 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.897 . . . . 0.0 110.178 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.817 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 11.6 mt -126.54 113.49 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.224 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -98.49 85.27 0.4 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.172 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.0 ' HB3' HG23 ' A' ' 53' ' ' THR . 46.6 Cg_endo -73.05 154.69 52.72 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.983 1.517 . . . . 0.0 110.44 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.536 HG22 ' N ' ' A' ' 38' ' ' VAL . 6.3 mt -95.32 169.31 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.193 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.536 ' N ' HG22 ' A' ' 37' ' ' ILE . 75.1 t -145.64 118.24 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.248 -0.907 . . . . 0.0 110.225 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -98.31 147.19 24.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 3' ' ' SER . 65.4 mt -133.96 125.23 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -127.15 80.07 1.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.868 . . . . 0.0 110.177 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.752 ' HB2' ' CE1' ' A' ' 47' ' ' PHE . 41.1 tt0 -78.77 162.62 26.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.187 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 34.3 mmtt -159.22 46.28 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.248 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.15 -96.73 0.66 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -116.59 3.11 13.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -1.137 . . . . 0.0 110.157 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 40.5 t0 -107.98 139.28 42.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.93 . . . . 0.0 110.249 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.929 ' CE2' HD11 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -120.61 135.61 55.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.38 103.16 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 110.154 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.754 HG11 ' H42' ' A' ' 131' ' ' JN3 . 60.0 t -106.08 129.03 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.157 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.922 ' OG1' HG23 ' A' ' 59' ' ' THR . 57.5 m -130.23 107.9 9.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.5 m -89.57 128.08 35.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.158 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.459 ' CA ' HG22 ' A' ' 57' ' ' THR . 52.2 mtmt -120.75 124.09 44.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.16 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.0 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.56 169.07 6.93 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.223 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.881 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.7 Cg_endo -73.04 -16.81 25.4 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.997 1.525 . . . . 0.0 110.483 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -111.95 -20.79 11.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.207 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.58 ' O ' ' OG1' ' A' ' 53' ' ' THR . 2.0 tt0 -160.95 155.32 23.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.459 HG22 ' CA ' ' A' ' 52' ' ' LYS . 4.3 p -131.46 137.54 48.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.167 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.549 HG12 HD21 ' A' ' 60' ' ' ASN . 56.8 t -133.65 132.04 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.908 . . . . 0.0 110.243 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.922 HG23 ' OG1' ' A' ' 50' ' ' THR . 17.1 m -111.79 137.31 49.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 110.205 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.549 HD21 HG12 ' A' ' 58' ' ' VAL . 7.5 m120 -132.38 155.77 47.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.932 . . . . 0.0 110.214 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 t -152.32 127.42 9.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.2 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.771 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 34.5 p90 -141.99 174.02 10.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.314 -0.867 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 27.7 m -118.38 150.71 39.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.929 HD11 ' CE2' ' A' ' 47' ' ' PHE . 5.6 mt -78.58 125.2 29.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.74 10.1 58.06 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -142.36 141.12 32.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -1.165 . . . . 0.0 110.173 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.8 124.87 25.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 0.0 110.22 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.479 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -125.35 149.29 48.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.932 . . . . 0.0 110.27 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -82.15 139.08 34.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 110.138 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.774 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 4.4 mm -132.78 144.74 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 0.0 110.218 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 t -116.74 137.6 52.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.247 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.723 HG23 H161 ' A' ' 131' ' ' JN3 . 0.2 OUTLIER -87.15 156.98 19.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.189 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.904 ' HE3' H122 ' A' ' 130' ' ' JN3 . 13.7 ttm -66.89 -16.36 64.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 110.256 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.67 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -86.56 -9.66 55.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.229 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.96 33.74 4.55 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.568 ' CB ' ' OG1' ' A' ' 72' ' ' THR . 28.3 mttt -107.27 133.31 52.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.189 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -109.45 136.53 48.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.668 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -169.04 157.97 8.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.152 -0.968 . . . . 0.0 110.22 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 9.7 mtmt -102.29 172.06 7.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 110.227 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.3 p -178.65 137.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 110.154 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.0 m -97.04 99.75 11.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.683 HG13 HD21 ' A' ' 89' ' ' LEU . 46.1 t -72.84 139.03 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.235 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.64 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 11.4 p-80 -138.58 161.26 37.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 84' ' ' LEU . 26.4 mt -105.63 132.12 52.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.262 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.62 115.61 13.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.218 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 59.8 t30 59.38 31.82 21.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.426 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 73.77 43.91 33.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.426 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 85.9 mttt -152.58 120.78 6.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -1.133 . . . . 0.0 110.177 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.713 HD22 ' H22' ' A' ' 131' ' ' JN3 . 7.4 tt -72.54 133.11 44.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.698 HG22 ' HG3' ' A' ' 99' ' ' GLU . 99.0 t -141.55 122.83 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.918 . . . . 0.0 110.198 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 54.6 m -113.85 92.48 3.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 62.1 pttt -87.46 162.35 17.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 110.208 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 28.3 t -155.8 -164.44 1.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 110.181 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' N ' ' OG ' ' A' ' 93' ' ' SER . 40.7 tt0 -103.99 31.56 4.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.92 . . . . 0.0 110.183 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -172.65 -2.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.144 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.804 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -173.7 147.99 1.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.185 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 111' ' ' ILE . 70.9 m -124.82 154.33 41.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.515 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 64.1 t-80 -141.6 140.36 33.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.698 ' HG3' HG22 ' A' ' 90' ' ' VAL . 29.5 tt0 -152.15 127.52 9.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 110.186 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 13.8 tt0 -130.2 150.43 51.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.229 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -148.2 154.08 39.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 110.253 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.598 HG23 ' CH2' ' A' ' 6' ' ' TRP . 13.2 p -119.69 131.86 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -126.76 93.09 3.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.882 . . . . 0.0 110.201 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.76 -95.74 1.26 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -126.52 15.74 7.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -1.162 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -123.73 150.75 44.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 110.206 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 121' ' ' ARG . 8.2 tpp -125.79 140.14 52.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.885 . . . . 0.0 110.172 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.02 124.46 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 110.256 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 33.6 mt-10 -115.25 123.7 49.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.9 m -111.99 123.16 49.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 110.176 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 97' ' ' SER . 73.7 mt -129.09 128.43 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.904 . . . . 0.0 110.197 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 90.1 m -111.93 133.49 54.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 110.223 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 5.8 t80 -156.0 122.38 5.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.245 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.07 32.54 58.42 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.41 1.43 65.03 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.1 t -108.5 141.31 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -1.131 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.5 m -119.57 130.99 55.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 110.249 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.469 HD22 ' CD2' ' A' ' 17' ' ' PHE . 59.0 tp -110.43 140.84 44.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 85.4 mt -114.61 105.29 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -106.26 119.03 38.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -0.962 . . . . 0.0 110.196 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.961 ' HG3' ' H ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -102.49 136.87 41.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 1.4 m -123.71 140.1 53.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.278 -0.889 . . . . 0.0 110.205 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 1.355 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 15.4 ptmt -99.81 146.35 26.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.511 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 68.7 ttt180 -77.43 135.95 38.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.434 ' HB ' ' OG1' ' A' ' 5' ' ' THR . 64.7 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.21 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 0.904 H122 ' HE3' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.774 ' H8 ' HG21 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.25 0.547 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.433 ' HA ' ' CE ' ' A' ' 107' ' ' MET . 85.0 m-85 -77.67 -31.19 52.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -57.12 147.22 25.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.63 163.93 13.06 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 25.2 m -80.79 150.93 29.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 110.193 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.701 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 97.5 m95 -136.61 130.96 33.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.206 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.967 ' O ' ' HA ' ' A' ' 122' ' ' SER . 32.4 tt0 -95.73 144.59 26.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.201 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 36' ' ' PRO . 21.7 t -66.61 119.96 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.905 . . . . 0.0 110.181 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 1.154 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.9 OUTLIER -80.94 -68.68 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 110.256 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.921 ' H ' ' HG3' ' A' ' 121' ' ' ARG . . . -150.33 169.6 21.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 110.236 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -146.44 110.59 5.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.487 ' O ' ' CD1' ' A' ' 118' ' ' LEU . 9.5 mm-40 -88.55 155.07 19.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.716 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 68.3 m-20 47.38 21.35 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 110.165 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 4.4 t80 -46.19 -61.86 1.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' GLU . 67.0 mt-10 -51.27 -57.77 7.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.716 ' OE1' ' HA ' ' A' ' 13' ' ' ASN . 6.7 mp0 -41.7 -49.59 4.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -50.28 -62.8 1.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.247 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.619 HD13 HG12 ' A' ' 28' ' ' ILE . 9.2 mt -44.98 -47.35 11.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 90.4 mttt -49.4 -39.09 31.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.133 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.14 -38.4 63.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.174 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.917 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.3 tp -58.98 -24.81 63.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.239 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.917 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 80.25 22.49 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.713 ' CD2' ' HD2' ' A' ' 24' ' ' PRO . 6.6 mt -71.39 170.91 10.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 110.194 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.713 ' HD2' ' CD2' ' A' ' 23' ' ' LEU . 46.1 Cg_endo -72.99 138.07 27.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.004 1.528 . . . . 0.0 110.446 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -59.47 -40.76 87.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.212 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -53.24 -33.49 53.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.9 HD11 H232 ' A' ' 130' ' ' JN3 . 52.1 tp -85.65 -35.41 20.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.619 HG12 HD13 ' A' ' 18' ' ' LEU . 96.2 mt -63.26 -52.09 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -59.52 -29.61 68.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.192 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 96.2 mtp -86.37 -12.8 48.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.235 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.711 ' HB1' H183 ' A' ' 130' ' ' JN3 . . . -111.51 -3.62 15.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.888 . . . . 0.0 110.242 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -63.64 -6.61 5.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -147.2 55.21 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.82 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 16.5 mt -130.46 114.2 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -98.24 85.79 0.42 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.984 ' HB3' HG23 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.07 149.34 46.33 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.996 1.524 . . . . 0.0 110.426 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.621 HG22 ' N ' ' A' ' 38' ' ' VAL . 19.8 mt -89.51 175.25 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.235 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.621 ' N ' HG22 ' A' ' 37' ' ' ILE . 61.0 t -152.92 119.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -101.13 152.0 21.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.0 110.249 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.488 HD12 ' HE3' ' A' ' 107' ' ' MET . 58.2 mt -139.46 130.3 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.42 ' HB3' ' HB ' ' A' ' 48' ' ' VAL . 59.7 tt0 -130.1 72.36 1.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 110.207 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.697 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 56.4 tt0 -66.45 173.64 3.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.245 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.697 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 8.3 mtmt -171.49 35.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.234 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.1 -100.25 0.57 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -111.47 -0.86 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -1.151 . . . . 0.0 110.21 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 39.5 t0 -107.32 146.76 31.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.182 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.767 ' CE1' HD11 ' A' ' 64' ' ' LEU . 4.5 m-85 -127.53 139.52 52.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 41' ' ' GLN . 65.7 t -120.91 101.99 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.208 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.898 HG11 ' H42' ' A' ' 131' ' ' JN3 . 68.8 t -103.93 130.75 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.193 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 85.5 m -133.31 105.42 6.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.89 . . . . 0.0 110.207 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -86.03 132.0 34.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 110.257 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HA ' HG22 ' A' ' 57' ' ' THR . 57.4 mttt -124.72 122.98 39.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.984 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -109.53 168.09 8.19 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 110.228 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.735 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.0 Cg_endo -73.06 -5.99 18.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.966 1.508 . . . . 0.0 110.412 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -122.45 -18.41 6.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.19 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.445 ' O ' ' OG1' ' A' ' 53' ' ' THR . 5.8 pt20 -164.6 158.69 18.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 52' ' ' LYS . 11.6 p -133.94 133.52 41.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.895 . . . . 0.0 110.21 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.53 132.84 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.214 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 13.5 t -115.28 138.71 50.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -0.912 . . . . 0.0 110.163 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -135.35 151.93 50.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 110.277 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.2 t -141.37 132.42 26.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.167 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.796 ' CE1' HG21 ' A' ' 82' ' ' VAL . 33.6 p90 -146.64 169.98 17.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 58.1 m -117.81 153.85 32.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -0.929 . . . . 0.0 110.192 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.767 HD11 ' CE1' ' A' ' 47' ' ' PHE . 8.0 mt -82.71 122.84 28.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.91 -3.16 55.7 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -132.98 148.63 52.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -1.148 . . . . 0.0 110.197 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.46 ' OE2' ' HB3' ' A' ' 79' ' ' LYS . 5.4 tm-20 -73.68 133.18 43.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.247 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -133.33 148.63 51.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.168 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 15.2 p-10 -78.14 135.1 37.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.898 . . . . 0.0 110.246 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.906 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 17.1 mm -127.92 143.53 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.172 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p -118.47 139.86 50.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.206 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.724 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 29.3 p -93.54 158.0 15.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.233 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.622 ' HB3' ' H17' ' A' ' 130' ' ' JN3 . 0.7 OUTLIER -68.54 -11.44 59.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.2 -0.937 . . . . 0.0 110.226 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.822 ' HB3' H151 ' A' ' 130' ' ' JN3 . 0.0 OUTLIER -87.54 -17.78 31.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 110.256 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.86 29.48 4.07 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.724 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 28.5 mttt -105.07 136.03 45.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 8.4 ptpp? -111.57 133.25 53.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.629 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -163.29 162.26 25.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 110.238 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 35.4 mttt -105.28 151.03 24.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.42 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.2 m -152.88 139.3 18.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.229 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.01 90.56 3.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.881 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.847 HG13 HD21 ' A' ' 89' ' ' LEU . 39.3 t -58.71 152.23 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.276 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -146.59 152.25 38.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.546 HD12 HD13 ' A' ' 64' ' ' LEU . 1.3 mt -105.58 102.31 11.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.87 132.44 54.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.1 t30 45.61 38.18 3.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.411 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 66.73 41.03 93.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.411 ' HG3' ' C ' ' A' ' 87' ' ' GLY . 89.8 mttt -147.68 125.68 12.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -1.149 . . . . 0.0 110.212 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.847 HD21 HG13 ' A' ' 82' ' ' VAL . 6.2 tt -75.23 132.55 41.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.782 HG13 ' HG2' ' A' ' 99' ' ' GLU . 43.4 t -137.84 123.76 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.898 . . . . 0.0 110.241 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.543 HG21 H111 ' A' ' 131' ' ' JN3 . 55.3 m -119.7 88.69 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.448 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 16.1 ptmt -85.65 171.52 11.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.183 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 15.1 t -160.03 -161.24 0.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.177 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.491 ' N ' ' OG ' ' A' ' 93' ' ' SER . 23.1 mt-10 -106.15 34.49 3.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 110.202 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.449 ' HG3' ' CD2' ' A' ' 96' ' ' PHE . 7.4 ptpt -177.49 -0.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.892 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -175.76 146.85 0.76 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -120.74 157.89 28.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.65 ' CE1' ' H21' ' A' ' 131' ' ' JN3 . 63.4 t-80 -142.58 138.51 30.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.285 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.782 ' HG2' HG13 ' A' ' 90' ' ' VAL . 44.2 mt-10 -149.59 128.2 12.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.917 . . . . 0.0 110.208 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.609 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 53.6 tt0 -128.67 155.31 45.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 9.5 mp0 -154.82 148.91 25.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 102' ' ' VAL . 12.1 p -116.18 137.04 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 110.299 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -131.65 95.54 3.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.22 -98.02 1.46 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -126.25 12.08 7.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.254 -1.145 . . . . 0.0 110.196 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -118.71 156.05 29.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -0.914 . . . . 0.0 110.151 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.488 ' HE3' HD12 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -129.02 140.84 51.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.201 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.3 t -127.66 125.66 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.22 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.406 ' HG3' ' HG3' ' A' ' 100' ' ' GLN . 27.9 mt-10 -114.84 132.64 56.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.0 m -121.37 122.75 40.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.216 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 97' ' ' SER . 56.8 mt -129.75 133.92 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 75.1 p -113.93 136.47 52.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 0.0 110.203 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 4.6 t80 -157.36 122.75 4.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.875 . . . . 0.0 110.217 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.61 36.11 62.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.74 1.86 55.2 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 112' ' ' THR . 53.0 t -106.7 143.47 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -1.155 . . . . 0.0 110.174 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.447 HG23 HG22 ' A' ' 112' ' ' THR . 85.8 m -121.46 129.39 52.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.487 ' CD1' ' O ' ' A' ' 12' ' ' GLU . 63.0 tp -108.37 145.02 35.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.3 mt -119.03 103.31 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.214 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -102.61 114.18 28.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.921 ' HG3' ' H ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -102.09 137.94 39.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.967 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 5.9 m -125.5 161.88 26.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 110.223 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 1.154 ' HB2' ' CE2' ' A' ' 9' ' ' TYR . 51.8 tttt -128.57 157.55 40.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 110.225 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 5' ' ' THR . 45.2 ttt180 -89.95 135.52 33.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.209 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.565 HG11 ' OE1' ' A' ' 7' ' ' GLN . 33.8 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 0.9 H232 HD11 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.906 ' H8 ' HG21 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.258 0.551 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.432 ' CE2' ' HA ' ' A' ' 101' ' ' GLU . 80.5 m-85 -81.09 -30.89 34.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.179 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.1 p -57.82 148.5 25.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.208 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.68 164.79 13.03 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 21.6 m -82.58 145.95 29.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -1.151 . . . . 0.0 110.202 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.645 ' CH2' HG23 ' A' ' 102' ' ' VAL . 98.1 m95 -129.88 130.36 45.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.851 ' HB2' ' HG2' ' A' ' 123' ' ' LYS . 65.1 mt-30 -103.26 117.72 35.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.897 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 36' ' ' PRO . 16.9 t -35.95 134.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.236 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 1.476 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -99.46 -57.47 2.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 110.192 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 1.324 ' HB3' ' NE ' ' A' ' 121' ' ' ARG . . . -158.52 163.97 36.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 110.255 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.599 ' HB2' ' CG ' ' A' ' 14' ' ' TYR . 1.8 pt20 -137.26 106.17 5.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.77 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 39.4 tt0 -94.87 126.48 40.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.951 ' ND2' ' OE1' ' A' ' 16' ' ' GLU . 18.1 t-20 77.91 -4.02 2.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.867 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.75 ' CE1' HD21 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -29.9 -72.72 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 110.222 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 14' ' ' TYR . 46.4 mt-10 -39.52 -61.15 0.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.951 ' OE1' ' ND2' ' A' ' 13' ' ' ASN . 28.6 mt-10 -42.93 -55.86 3.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.215 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.625 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 77.1 t80 -52.82 -46.6 67.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.85 -44.33 86.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.234 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -52.33 -42.18 63.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 110.154 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.99 -31.16 69.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 110.235 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.844 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.7 tp -65.3 -17.14 64.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 75.48 27.54 1.03 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.157 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.725 HD11 HD23 ' A' ' 21' ' ' LEU . 41.6 mt -76.57 163.66 64.54 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.172 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HG2' ' CB ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -73.09 138.62 28.37 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.999 1.526 . . . . 0.0 110.39 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -55.38 -38.3 68.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 110.25 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 30' ' ' MET . 44.5 t0 -59.24 -27.61 65.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.229 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.994 HD11 H232 ' A' ' 130' ' ' JN3 . 52.5 tp -90.7 -32.59 16.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 110.171 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.629 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.7 mt -69.74 -45.62 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 110.195 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -70.31 -19.9 63.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.416 ' HE2' ' NH2' ' A' ' 55' ' ' ARG . 90.1 mmm -91.47 -29.17 17.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 110.154 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.637 ' HB1' H183 ' A' ' 130' ' ' JN3 . . . -102.31 -1.59 30.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.211 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.629 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 2.4 ppt_? -65.51 -10.55 35.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.175 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 10.3 t0 -141.65 47.7 1.65 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.12 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mt -121.22 113.13 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.78 81.28 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.25 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.12 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 45.9 Cg_endo -73.06 142.39 34.39 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.921 1.485 . . . . 0.0 110.371 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 38' ' ' VAL . 6.6 mt -88.64 164.62 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.261 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.445 ' N ' HG22 ' A' ' 37' ' ' ILE . 55.5 t -141.52 109.93 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.236 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -89.25 137.66 32.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.276 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.442 HD12 ' CD1' ' A' ' 6' ' ' TRP . 82.1 mt -125.04 127.36 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.198 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -127.43 70.48 1.32 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.6 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 57.0 tt0 -68.57 164.41 21.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.231 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 37.3 mttt -162.73 46.11 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.95 -101.06 0.89 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 29.3 m-20 -111.04 -3.86 15.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -1.146 . . . . 0.0 110.179 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -99.64 151.39 21.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.768 ' CE1' HD11 ' A' ' 64' ' ' LEU . 2.3 m-85 -133.42 131.03 39.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.225 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.3 109.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.186 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.521 HG11 ' H42' ' A' ' 131' ' ' JN3 . 98.5 t -111.81 129.27 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.169 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 88.4 m -123.81 103.31 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.17 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.3 m -83.63 137.94 33.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.304 -0.873 . . . . 0.0 110.164 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -131.74 117.05 18.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 110.16 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.973 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -103.68 168.17 9.06 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 110.239 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.84 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.3 Cg_endo -73.08 -27.81 13.54 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.016 1.535 . . . . 0.0 110.4 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.416 ' NH2' ' HE2' ' A' ' 30' ' ' MET . 3.6 ttm180 -97.28 -23.83 15.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.249 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.554 ' NE2' H221 ' A' ' 130' ' ' JN3 . 1.1 pm0 -161.13 161.98 31.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.224 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 p -129.74 128.06 41.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 110.226 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 73' ' ' MET . 59.4 t -126.77 127.83 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 110.16 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 14.1 t -111.65 140.85 45.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.195 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.452 ' ND2' ' OG1' ' A' ' 71' ' ' THR . 23.6 m120 -138.1 131.72 30.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.175 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -123.12 136.18 54.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.214 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.908 ' CE1' HG21 ' A' ' 82' ' ' VAL . 45.7 p90 -149.06 167.32 26.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.216 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.1 m -116.37 148.69 40.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 110.247 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.772 HD13 HD12 ' A' ' 84' ' ' LEU . 37.2 mt -76.49 126.37 30.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.56 13.23 58.57 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' C ' HG23 ' A' ' 81' ' ' THR . 56.7 mttm -144.22 138.67 28.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -1.136 . . . . 0.0 110.225 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -70.68 124.48 24.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.187 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.65 149.36 49.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.254 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -77.37 137.15 38.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.885 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 25.5 mm -128.16 145.22 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -0.888 . . . . 0.0 110.226 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.452 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 2.0 p -121.73 134.78 54.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.92 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.684 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 36.5 p -86.96 156.51 19.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.91 . . . . 0.0 110.176 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.782 ' HB3' H222 ' A' ' 130' ' ' JN3 . 10.7 mtm -68.42 -15.6 63.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 110.181 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.654 ' OD1' HD22 ' A' ' 27' ' ' LEU . 11.2 t0 -82.32 -22.59 35.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.208 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.09 19.62 5.11 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.684 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 22.3 mttt -96.38 137.81 34.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -1.142 . . . . 0.0 110.236 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -113.96 133.22 55.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.712 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -161.55 162.07 30.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -106.01 143.99 33.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -0.894 . . . . 0.0 110.2 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.453 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -148.46 139.17 22.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.44 HG23 ' C ' ' A' ' 66' ' ' LYS . 17.8 m -104.4 93.07 4.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 110.192 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.957 HG11 HD11 ' A' ' 89' ' ' LEU . 16.2 t -57.36 152.4 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.907 . . . . 0.0 110.217 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.54 147.28 30.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.253 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.772 HD12 HD13 ' A' ' 64' ' ' LEU . 6.0 mt -102.99 98.83 8.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.214 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 86' ' ' ASN . . . -110.11 138.03 47.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.159 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 85' ' ' ALA . 29.7 m120 42.98 39.35 1.75 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.47 52.09 53.56 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.782 ' HE2' ' OE1' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -161.61 112.98 1.72 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -1.18 . . . . 0.0 110.164 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.957 HD11 HG11 ' A' ' 82' ' ' VAL . 3.9 tt -58.95 144.06 46.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.775 HG13 ' CG ' ' A' ' 99' ' ' GLU . 48.1 t -151.01 114.62 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 85.5 m -109.73 94.2 4.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -91.43 165.14 13.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.859 . . . . 0.0 110.173 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.461 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 1.6 m -155.99 -158.44 0.81 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 53.1 tt0 -107.9 29.13 7.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.529 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 7.8 ptpt -171.1 1.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.247 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.863 ' CD1' ' O ' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -178.65 148.04 0.41 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 110.181 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.737 ' O ' HG23 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -122.72 157.83 31.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.64 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 65.2 t-80 -139.82 138.39 35.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 110.234 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.775 ' CG ' HG13 ' A' ' 90' ' ' VAL . 78.1 mt-10 -152.66 126.15 8.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.489 ' NE2' ' SD ' ' A' ' 107' ' ' MET . 50.3 tt0 -133.92 155.65 49.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.782 ' OE1' ' HE2' ' A' ' 88' ' ' LYS . 47.5 tt0 -149.51 163.61 37.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.143 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.645 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.0 p -127.2 129.49 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.182 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.6 pttt -126.94 96.9 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 110.202 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.57 -111.29 3.26 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.542 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 45.9 p-10 -115.2 14.42 16.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -1.132 . . . . 0.0 110.25 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.542 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 20.0 mt-10 -119.66 157.72 27.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.178 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.529 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 26.4 ttm -132.56 140.92 48.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 110.226 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 121' ' ' ARG . 65.1 t -127.42 133.65 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.206 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 70.9 mt-10 -117.5 123.99 47.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 110.227 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.2 m -114.02 123.13 48.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.18 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 97' ' ' SER . 82.2 mt -131.86 132.77 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 63.5 p -109.02 136.25 48.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 0.0 110.188 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 8.7 t80 -156.99 124.94 5.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.94 . . . . 0.0 110.19 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 67.68 38.45 89.96 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.53 2.67 44.46 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 112' ' ' THR . 57.9 t -105.66 147.1 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -1.165 . . . . 0.0 110.18 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.7 m -122.28 127.77 50.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.189 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.75 HD21 ' CE1' ' A' ' 14' ' ' TYR . 62.9 tp -105.98 153.07 22.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 91.4 mt -132.15 101.12 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 110.184 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 3.9 ttt180 -104.33 122.28 45.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 1.324 ' NE ' ' HB3' ' A' ' 10' ' ' ALA . 4.4 ptt180 -103.89 142.42 34.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.753 ' C ' ' CD2' ' A' ' 9' ' ' TYR . 0.7 OUTLIER -129.69 147.78 51.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.85 . . . . 0.0 110.248 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 1.476 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -106.57 149.15 27.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.185 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 5' ' ' THR . 76.1 ttt180 -82.18 139.89 34.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 110.196 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.171 179.943 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 0.994 H232 HD11 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.885 ' H8 ' HG21 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.312 0.577 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -77.29 -33.75 55.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.223 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.1 p -57.22 146.79 27.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.202 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.81 -177.91 17.31 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.6 m -105.3 132.69 51.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -1.149 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.53 ' CE3' ' HB2' ' A' ' 107' ' ' MET . 98.5 m95 -121.13 147.08 46.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.862 . . . . 0.0 110.198 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -128.82 115.38 17.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 110.175 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.629 HG22 ' HD3' ' A' ' 120' ' ' ARG . 40.1 t -61.67 133.88 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.301 -0.874 . . . . 0.0 110.257 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.503 ' OH ' ' HB3' ' A' ' 121' ' ' ARG . 16.4 p90 -135.88 -19.4 1.56 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -139.05 133.81 32.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 110.277 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -146.1 116.77 7.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.237 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.594 ' O ' HD12 ' A' ' 118' ' ' LEU . 63.5 mm-40 -88.44 142.12 27.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.9 . . . . 0.0 110.281 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.5 t30 55.66 26.31 9.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.23 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.618 ' CE1' HD11 ' A' ' 18' ' ' LEU . 35.1 t80 -54.8 -50.39 68.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -65.99 -45.94 79.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -0.934 . . . . 0.0 110.166 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.86 -60.35 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.194 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.66 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 41.8 t80 -48.56 -60.42 2.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.192 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.723 HD23 HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -53.92 -54.39 39.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.503 ' C ' ' O ' ' A' ' 18' ' ' LEU . 56.7 mttt -36.53 -44.99 0.47 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.14 -27.35 68.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.907 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -60.65 -19.58 58.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.263 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.907 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 80.15 30.79 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 110.186 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.723 HD12 HD23 ' A' ' 18' ' ' LEU . 15.0 mt -78.03 164.52 56.53 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.925 . . . . 0.0 110.197 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.598 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 45.4 Cg_endo -73.13 141.19 32.21 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.019 1.536 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -62.25 -39.37 92.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.159 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -57.11 -29.36 63.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.211 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.801 HD11 H232 ' A' ' 130' ' ' JN3 . 44.7 tp -89.42 -23.14 22.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.206 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 96.9 mt -82.29 -40.22 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.199 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -73.49 -29.09 62.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.239 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.7 ttm -88.11 -25.95 22.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.208 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -101.74 2.72 38.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.621 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 18.0 ptt180 -67.33 -1.12 4.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.234 -0.916 . . . . 0.0 110.212 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.549 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.5 m-20 -146.74 49.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.915 . . . . 0.0 110.181 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.906 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.2 mt -122.41 123.07 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.75 83.0 0.23 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.211 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.906 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -72.98 138.94 29.21 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.061 1.558 . . . . 0.0 110.454 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.7 mt -93.16 153.93 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.886 . . . . 0.0 110.208 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.3 t -132.09 119.78 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 110.199 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -98.49 134.92 40.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 110.212 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.509 HD12 ' CD1' ' A' ' 6' ' ' TRP . 67.9 mt -121.52 131.13 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -135.72 74.53 1.51 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.248 -0.908 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.624 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 1.6 pt20 -76.64 164.88 25.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 57.0 mmtt -159.02 51.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 110.213 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.15 -103.66 1.26 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -107.82 -3.38 19.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -1.187 . . . . 0.0 110.125 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.7 t0 -103.33 148.12 26.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.875 . . . . 0.0 110.185 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.694 ' CD1' HD11 ' A' ' 64' ' ' LEU . 2.9 m-85 -132.14 139.35 48.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.9 108.96 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.165 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.811 HG11 ' H42' ' A' ' 131' ' ' JN3 . 92.4 t -110.08 130.03 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.238 -0.914 . . . . 0.0 110.186 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.759 ' OG1' HG23 ' A' ' 59' ' ' THR . 94.2 m -130.07 110.59 11.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -92.93 132.91 36.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.162 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -125.46 121.55 34.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.191 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.797 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.4 168.64 7.54 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.193 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.685 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.2 Cg_endo -73.12 -18.69 23.58 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.055 1.555 . . . . 0.0 110.395 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 19.9 mtp-105 -104.57 -20.83 13.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.414 ' O ' ' OG1' ' A' ' 53' ' ' THR . 19.0 pt20 -166.81 160.75 14.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.194 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 p -129.78 133.47 47.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.195 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.17 128.79 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 110.265 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.759 HG23 ' OG1' ' A' ' 50' ' ' THR . 25.1 m -111.86 138.4 48.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.256 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 59' ' ' THR . 67.0 m-20 -134.75 153.35 52.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 t -146.51 128.4 15.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.212 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.774 ' CE1' ' H5 ' ' A' ' 131' ' ' JN3 . 33.9 p90 -140.8 173.64 11.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -123.38 141.95 51.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.694 HD11 ' CD1' ' A' ' 47' ' ' PHE . 18.1 mt -74.28 126.21 30.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.02 -1.91 55.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.0 143.32 40.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -1.19 . . . . 0.0 110.17 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -66.61 122.4 17.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.286 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.57 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -123.54 146.87 47.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.176 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -81.94 137.28 35.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.779 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 4.9 mm -128.43 145.24 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -116.29 134.47 54.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.777 HG23 H161 ' A' ' 131' ' ' JN3 . 0.3 OUTLIER -87.15 154.76 20.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.905 . . . . 0.0 110.186 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.886 ' HE3' H122 ' A' ' 130' ' ' JN3 . 12.5 ttm -65.91 -16.54 63.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.257 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.747 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.9 p30 -85.26 -11.35 55.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 110.186 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.25 33.2 4.65 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -107.32 133.24 52.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -1.191 . . . . 0.0 110.198 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -108.1 135.86 48.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.95 . . . . 0.0 110.199 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.634 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -167.43 156.18 9.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -103.49 166.85 10.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.23 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p -175.22 139.78 0.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.3 m -98.84 100.52 11.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.176 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.62 ' O ' HD23 ' A' ' 64' ' ' LEU . 44.0 t -72.83 139.35 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 110.186 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 25.6 p-80 -136.55 161.08 36.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 110.207 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.5 mt -106.56 130.52 54.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -135.1 116.08 14.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 93.1 m-20 59.02 28.13 17.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.8 37.68 29.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -141.44 122.2 14.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -1.159 . . . . 0.0 110.248 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.698 HD22 ' H22' ' A' ' 131' ' ' JN3 . 7.8 tt -77.56 126.36 30.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.265 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.841 HG22 ' HG3' ' A' ' 99' ' ' GLU . 92.2 t -135.47 127.17 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.189 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.614 ' OG1' HG22 ' A' ' 82' ' ' VAL . 56.0 m -117.97 85.87 2.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.235 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -79.58 166.78 21.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.235 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.448 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -158.61 -167.2 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.204 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.748 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 43.4 mt-10 -100.84 43.82 1.04 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.181 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.748 ' HB3' ' O ' ' A' ' 94' ' ' GLU . 7.0 ptmt 170.1 3.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.239 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.843 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.6 OUTLIER -176.95 144.65 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 111' ' ' ILE . 70.4 m -123.53 153.91 39.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.513 ' CD2' H122 ' A' ' 131' ' ' JN3 . 64.4 t-80 -138.56 145.89 41.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.922 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.841 ' HG3' HG22 ' A' ' 90' ' ' VAL . 2.4 tt0 -157.78 121.08 3.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.232 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.615 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 26.0 tt0 -122.8 159.81 27.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 27.5 mt-10 -157.61 144.76 18.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.442 HG23 ' CH2' ' A' ' 6' ' ' TRP . 11.3 p -111.07 140.84 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.23 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -137.11 96.22 3.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.877 . . . . 0.0 110.227 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.04 -108.98 2.77 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -116.39 10.83 14.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -1.163 . . . . 0.0 110.18 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.53 156.51 28.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.188 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.53 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 27.5 ttm -128.69 141.12 51.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.338 -0.851 . . . . 0.0 110.192 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 121' ' ' ARG . 94.7 t -126.37 123.97 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.867 . . . . 0.0 110.194 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 23.3 mt-10 -110.66 115.28 29.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.1 m -105.6 122.8 46.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 110.207 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 97' ' ' SER . 61.6 mt -129.82 129.73 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 45.8 m -109.6 135.73 50.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.165 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.591 ' HD2' ' HB2' ' A' ' 96' ' ' PHE . 15.9 t80 -159.17 127.05 4.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.07 32.88 65.53 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.48 5.47 67.88 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 112' ' ' THR . 61.6 t -110.16 143.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.334 -1.097 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.0 m -118.6 130.18 55.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.9 . . . . 0.0 110.126 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.66 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 42.7 tp -111.24 147.36 35.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.196 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 87.0 mt -122.35 95.97 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 110.275 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.629 ' HD3' HG22 ' A' ' 8' ' ' VAL . 3.0 ttm180 -88.94 117.52 28.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 110.213 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.503 ' HB3' ' OH ' ' A' ' 9' ' ' TYR . 29.2 mtt180 -101.69 128.82 47.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.925 . . . . 0.0 110.17 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.2 m -126.8 151.81 47.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.197 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -112.09 156.22 22.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.194 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -83.31 135.53 34.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.202 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 0.886 H122 ' HE3' ' A' ' 73' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.811 ' H42' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.251 0.548 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -78.34 -29.62 47.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.203 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.66 148.04 30.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -0.915 . . . . 0.0 110.218 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.6 163.77 13.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.8 m -80.38 152.23 28.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -1.173 . . . . 0.0 110.178 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.719 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 89.9 m95 -139.21 132.89 30.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.728 ' N ' ' O ' ' A' ' 123' ' ' LYS . 24.8 tt0 -98.71 124.66 43.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 36' ' ' PRO . 10.9 t -44.33 126.2 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 1.267 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -88.51 -65.93 0.97 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 1.014 ' HB3' ' HD2' ' A' ' 121' ' ' ARG . . . -155.07 163.13 40.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 11' ' ' GLN . 13.6 pt20 -136.65 101.7 4.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.6 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 56.8 tt0 -87.05 137.46 32.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.133 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.6 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 32.2 m-20 65.36 -1.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 1.183 ' CZ ' HD11 ' A' ' 18' ' ' LEU . 77.8 t80 -32.22 -64.35 0.17 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.577 ' HG3' ' N ' ' A' ' 16' ' ' GLU . 13.6 pt-20 -48.26 -51.04 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.235 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.577 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 68.0 mt-10 -54.74 -61.17 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.648 ' CG ' ' HB2' ' A' ' 118' ' ' LEU . 49.0 t80 -49.61 -56.27 10.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.183 HD11 ' CZ ' ' A' ' 14' ' ' TYR . 21.0 mt -54.58 -46.81 73.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 65.2 mttt -46.83 -41.29 15.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 -26.16 66.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 110.221 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.861 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -63.22 -20.16 65.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.861 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 78.86 30.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.246 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 37.3 mt -77.32 167.3 37.56 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.259 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.0 Cg_endo -73.1 140.32 30.98 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.065 1.56 . . . . 0.0 110.41 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -61.49 -36.57 80.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.168 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -59.22 -30.06 67.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.181 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.658 HD22 ' OD1' ' A' ' 74' ' ' ASP . 44.9 tp -89.46 -21.21 23.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 110.153 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.747 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 78.0 mt -78.71 -41.26 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 0.0 110.198 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HA ' ' HD2' ' A' ' 32' ' ' ARG . 18.0 mtmt -75.22 -24.1 57.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.27 -0.894 . . . . 0.0 110.251 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.5 tpp -87.87 -29.8 20.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.454 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -105.52 8.4 33.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 110.23 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.747 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 4.0 ptm85 -67.88 -7.67 30.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 110.176 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -146.74 59.86 1.2 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.192 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 3.5 mt -129.64 110.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.583 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -88.57 80.41 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.954 . . . . 0.0 110.274 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.192 ' HD3' ' O ' ' A' ' 34' ' ' ILE . 46.0 Cg_endo -73.05 140.78 31.83 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.005 1.529 . . . . 0.0 110.459 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 38' ' ' VAL . 5.2 mt -87.9 165.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.459 ' N ' HG22 ' A' ' 37' ' ' ILE . 69.0 t -142.67 116.59 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.239 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -92.17 140.74 29.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 75.2 mt -126.92 129.25 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 110.18 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -129.67 66.37 1.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.619 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 52.6 tt0 -63.95 168.96 4.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.619 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 33.5 mtmt -167.78 44.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 0.0 110.22 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.97 -103.97 1.04 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 25.8 m-20 -108.23 -3.11 18.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -1.187 . . . . 0.0 110.172 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.36 150.3 23.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.684 ' CE1' HD11 ' A' ' 64' ' ' LEU . 2.9 m-85 -133.25 134.37 43.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.08 109.45 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 0.0 110.18 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.733 HG11 ' H42' ' A' ' 131' ' ' JN3 . 91.0 t -111.41 129.85 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.259 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.7 ' OG1' HG23 ' A' ' 59' ' ' THR . 84.7 m -126.04 106.86 9.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 110.195 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.8 m -88.64 136.55 32.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.202 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -129.69 117.52 20.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.884 HG22 ' HD2' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -102.39 168.11 9.42 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.884 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.1 Cg_endo -73.05 -28.01 13.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.028 1.541 . . . . 0.0 110.394 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.14 -19.43 17.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.245 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.508 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.4 OUTLIER -164.05 160.36 21.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.244 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 p -128.94 127.85 42.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.265 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' A' ' 73' ' ' MET . 58.2 t -125.78 124.42 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.149 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.7 HG23 ' OG1' ' A' ' 50' ' ' THR . 36.7 m -110.17 144.57 38.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -141.24 147.73 38.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.893 . . . . 0.0 110.25 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.7 m -139.07 135.08 33.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.923 . . . . 0.0 110.264 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 1.035 ' CE1' HG21 ' A' ' 82' ' ' VAL . 51.7 p90 -147.69 170.99 16.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 110.229 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.2 m -118.52 145.37 45.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 110.228 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.684 HD11 ' CE1' ' A' ' 47' ' ' PHE . 51.0 mt -77.1 124.44 27.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 110.202 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.27 -3.75 54.8 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -134.31 148.62 50.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 0.0 110.185 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.463 ' HA ' ' CG2' ' A' ' 81' ' ' THR . 75.7 tt0 -72.45 128.54 35.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.224 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . . . -128.96 150.74 50.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -82.05 133.71 35.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.882 HG21 ' H8 ' ' A' ' 131' ' ' JN3 . 22.9 mm -123.45 145.06 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 96.3 m -122.8 135.07 54.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.697 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 43.1 p -89.78 157.92 17.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.722 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -68.3 -12.53 61.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.268 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.658 ' OD1' HD22 ' A' ' 27' ' ' LEU . 5.3 t0 -85.31 -21.5 28.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.06 23.23 4.99 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.697 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 27.1 mttt -98.62 135.32 40.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -1.118 . . . . 0.0 110.161 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -113.01 135.22 54.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.215 -0.928 . . . . 0.0 110.21 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.609 HD11 H181 ' A' ' 131' ' ' JN3 . 0.6 OUTLIER -164.47 160.69 20.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.152 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' HD3' ' OE2' ' A' ' 67' ' ' GLU . 25.8 mttp -104.05 146.33 28.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.279 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.56 ' HB3' ' CG2' ' A' ' 91' ' ' THR . 1.0 OUTLIER -148.58 141.8 25.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.463 ' CG2' ' HA ' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -106.43 89.39 3.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.211 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.035 HG21 ' CE1' ' A' ' 62' ' ' PHE . 12.2 t -57.71 152.54 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.161 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.19 146.12 28.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.564 ' CD1' HD13 ' A' ' 64' ' ' LEU . 14.9 mt -98.41 101.02 12.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.843 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 86' ' ' ASN . . . -117.33 148.91 41.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.222 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' ALA . 3.4 t-20 44.53 27.51 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.159 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.424 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 70.45 40.17 68.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.792 ' HD3' ' CD ' ' A' ' 101' ' ' GLU . 11.1 mttt -152.95 132.09 12.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.208 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.872 HD11 HG11 ' A' ' 82' ' ' VAL . 8.3 tt -72.19 135.9 46.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.664 HG12 ' CG ' ' A' ' 99' ' ' GLU . 11.6 m -143.72 123.26 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.235 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.56 ' CG2' ' HB3' ' A' ' 80' ' ' CYS . 95.2 m -114.56 91.87 3.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 5.9 ptmt -88.49 163.78 15.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.238 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 94' ' ' GLU . 29.3 t -152.65 -158.03 0.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.196 -0.94 . . . . 0.0 110.197 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.459 ' N ' ' OG ' ' A' ' 93' ' ' SER . 44.6 mt-10 -106.59 26.15 10.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.505 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 7.8 ptpt -167.03 0.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.94 ' CD1' ' O ' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -177.67 146.21 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 111' ' ' ILE . 29.3 t -117.72 160.03 22.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.573 ' CD2' H122 ' A' ' 131' ' ' JN3 . 58.6 t-80 -143.99 139.25 28.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.664 ' CG ' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -152.18 127.77 10.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.196 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.544 ' NE2' ' SD ' ' A' ' 107' ' ' MET . 46.0 tt0 -131.66 155.04 48.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.188 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.792 ' CD ' ' HD3' ' A' ' 88' ' ' LYS . 45.1 tt0 -151.64 155.09 37.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.461 HG23 ' CH2' ' A' ' 6' ' ' TRP . 11.2 p -119.33 134.4 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.219 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.18 94.67 3.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.172 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.38 -111.84 3.37 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -116.23 18.31 15.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.17 . . . . 0.0 110.253 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -123.66 148.51 46.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.218 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.548 ' HB3' ' HB2' ' A' ' 122' ' ' SER . 34.0 ttm -123.58 139.06 54.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 0.0 110.247 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.62 129.33 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 120' ' ' ARG . 33.4 mt-10 -115.6 109.81 18.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 110.199 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 99' ' ' GLU . 25.8 m -99.01 123.21 43.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.133 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 97' ' ' SER . 52.7 mt -132.29 129.28 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.223 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 21.8 m -104.63 142.92 33.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.887 . . . . 0.0 110.267 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.633 ' CE2' ' HB3' ' A' ' 96' ' ' PHE . 5.6 t80 -163.16 124.83 2.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 68.9 37.44 83.67 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.34 9.38 60.91 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 112' ' ' THR . 65.2 t -112.32 140.2 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -1.13 . . . . 0.0 110.194 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.7 m -113.72 129.31 56.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 110.221 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.648 ' HB2' ' CG ' ' A' ' 17' ' ' PHE . 48.4 tp -108.66 153.65 23.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.259 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 94.8 mt -130.97 94.55 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 0.9 OUTLIER -95.97 128.65 43.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 110.272 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 1.014 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 1.3 ptp180 -109.85 136.9 48.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.226 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.588 ' C ' ' HD2' ' A' ' 9' ' ' TYR . 39.8 m -125.57 135.46 52.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 1.267 ' HB2' ' CE2' ' A' ' 9' ' ' TYR . 71.7 tttt -92.94 153.89 18.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.246 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 27.5 ttp85 -89.52 134.83 33.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.233 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.456 HG21 ' OE1' ' A' ' 7' ' ' GLN . 53.0 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.221 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 0.931 H191 HD21 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.882 ' H8 ' HG21 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.281 0.563 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -76.33 -33.16 58.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 110.224 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.1 p -56.08 146.55 22.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 110.159 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.7 -172.49 19.47 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.726 HG22 ' HG3' ' A' ' 39' ' ' GLU . 5.8 p -110.69 128.04 55.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -1.133 . . . . 0.0 110.233 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.536 ' CH2' HG23 ' A' ' 102' ' ' VAL . 94.3 m95 -115.92 143.51 45.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.171 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -128.71 116.67 19.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.179 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.08 144.88 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.253 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 9' ' ' TYR . 8.0 p90 -147.09 -14.23 0.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.251 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . . . -139.61 141.86 37.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.14 164.7 37.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -140.33 158.8 43.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.19 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 46.51 38.03 5.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 110.233 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 7.8 t80 -69.84 -55.33 10.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -53.19 -57.88 8.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.271 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -48.38 -45.44 35.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.222 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.651 ' CD2' HD22 ' A' ' 118' ' ' LEU . 10.0 t80 -55.59 -57.25 12.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 110.228 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.721 HD13 HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -51.07 -43.32 61.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.167 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -54.78 -35.49 63.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.39 -41.91 62.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -0.97 . . . . 0.0 110.162 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.9 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.7 tp -55.26 -25.58 34.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . 80.56 24.13 0.35 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.708 HD12 HD22 ' A' ' 18' ' ' LEU . 14.5 mt -69.13 166.52 27.99 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.145 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 27' ' ' LEU . 46.0 Cg_endo -73.14 132.13 17.61 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.058 1.557 . . . . 0.0 110.407 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.66 ' HA ' HD12 ' A' ' 28' ' ' ILE . 44.8 mt-10 -49.7 -46.04 49.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.972 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -50.33 -35.81 29.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.191 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 41.7 tp -84.45 -33.61 23.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.721 HG12 HD13 ' A' ' 18' ' ' LEU . 96.9 mt -61.22 -56.09 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.149 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' A' ' 30' ' ' MET . 13.4 pttp -56.01 -24.43 39.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.688 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 85.6 mtp -94.17 -9.74 35.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.245 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.676 ' HB1' H183 ' A' ' 130' ' ' JN3 . . . -113.34 -5.84 13.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.218 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.707 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -71.86 0.82 8.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 110.286 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.707 ' OD1' ' O ' ' A' ' 32' ' ' ARG . 82.5 m-20 -150.18 41.69 0.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.688 ' CD1' ' O ' ' A' ' 30' ' ' MET . 23.8 mt -122.84 115.47 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.267 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -100.82 90.19 1.45 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.978 ' HB3' HG23 ' A' ' 53' ' ' THR . 46.5 Cg_endo -73.09 146.04 40.49 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.918 1.483 . . . . 0.0 110.4 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 38' ' ' VAL . 6.4 mt -86.45 173.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.61 ' N ' HG22 ' A' ' 37' ' ' ILE . 70.0 t -150.19 119.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.177 -0.952 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.726 ' HG3' HG22 ' A' ' 5' ' ' THR . 20.1 tt0 -103.45 148.04 26.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.225 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.56 HD11 HE22 ' A' ' 100' ' ' GLN . 55.8 mt -136.4 132.14 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 110.23 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 55.9 tt0 -132.28 73.82 1.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.793 ' OE1' ' N ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -68.73 170.53 9.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.244 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 14.2 mtmt -168.55 43.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.793 ' N ' ' OE1' ' A' ' 42' ' ' GLN . . . 120.04 -102.49 0.89 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 26.8 m-20 -110.36 -2.0 16.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -1.135 . . . . 0.0 110.154 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 47' ' ' PHE . 41.1 t0 -104.2 150.39 24.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.789 ' CE1' HD11 ' A' ' 64' ' ' LEU . 3.0 m-85 -131.37 137.27 48.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.21 108.08 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.141 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.956 HG11 ' H42' ' A' ' 131' ' ' JN3 . 62.8 t -108.37 130.92 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.943 . . . . 0.0 110.179 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.65 HG23 ' OG1' ' A' ' 59' ' ' THR . 77.6 m -133.22 106.07 7.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.3 m -89.04 137.68 32.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.887 . . . . 0.0 110.223 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -130.97 124.11 30.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 110.258 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.978 HG23 ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -108.08 169.25 6.81 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.78 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.4 Cg_endo -73.0 -20.53 21.82 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.992 1.522 . . . . 0.0 110.414 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -105.67 -22.46 12.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.417 ' HG3' ' HG1' ' A' ' 53' ' ' THR . 4.5 pt20 -159.74 161.76 34.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 p -132.4 128.15 36.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 110.233 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.55 127.42 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.91 . . . . 0.0 110.233 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.65 ' OG1' HG23 ' A' ' 50' ' ' THR . 91.5 m -111.28 142.09 43.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 49' ' ' VAL . 28.1 m120 -139.41 151.05 45.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.162 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 m -141.58 135.14 29.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.191 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.61 ' CE2' ' H5 ' ' A' ' 131' ' ' JN3 . 35.0 p90 -148.26 166.65 27.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.136 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.8 m -116.02 150.4 37.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.789 HD11 ' CE1' ' A' ' 47' ' ' PHE . 31.4 mt -78.45 125.66 29.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.928 . . . . 0.0 110.198 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.47 5.93 60.05 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -139.95 139.46 36.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -1.135 . . . . 0.0 110.222 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -65.91 124.8 23.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.541 ' CB ' ' CB ' ' A' ' 62' ' ' PHE . . . -124.76 148.16 48.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.154 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 14.8 p-10 -81.18 136.89 35.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.161 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.841 HD12 ' H62' ' A' ' 131' ' ' JN3 . 23.7 mm -128.85 142.43 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 110.161 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 m -113.55 139.88 48.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 110.233 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.685 ' OG1' ' HB2' ' A' ' 76' ' ' LYS . 68.3 p -93.97 158.39 15.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.781 ' HE3' H122 ' A' ' 130' ' ' JN3 . 15.8 ttm -70.67 -13.28 62.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.206 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.93 ' HB3' H151 ' A' ' 130' ' ' JN3 . 2.3 p30 -86.54 -12.87 47.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.02 25.42 7.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.685 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 12.0 mttt -102.89 136.89 41.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -1.114 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -110.67 135.37 51.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.162 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.573 HD11 H181 ' A' ' 131' ' ' JN3 . 0.5 OUTLIER -166.21 153.67 9.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.277 -0.89 . . . . 0.0 110.208 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -99.23 155.98 17.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.3 m -157.92 134.26 9.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.167 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -96.55 96.38 8.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.196 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.907 HG13 HD21 ' A' ' 89' ' ' LEU . 48.4 t -69.92 142.53 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.669 ' CE1' ' O ' ' A' ' 90' ' ' VAL . 13.9 p-80 -140.84 155.49 46.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.177 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.409 ' CD1' HD13 ' A' ' 64' ' ' LEU . 51.5 mt -100.12 132.34 45.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . -138.75 111.51 7.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.22 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.676 ' HB2' ' O ' ' A' ' 85' ' ' ALA . 86.2 m-20 64.35 27.59 13.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.214 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.532 ' C ' ' HG3' ' A' ' 88' ' ' LYS . . . 76.34 43.5 20.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.623 ' HD2' ' OE2' ' A' ' 101' ' ' GLU . 49.4 mtpt -153.37 118.86 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -1.167 . . . . 0.0 110.203 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.907 HD21 HG13 ' A' ' 82' ' ' VAL . 4.8 tt -68.69 142.94 54.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.233 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.772 HG13 ' HG2' ' A' ' 99' ' ' GLU . 55.3 t -150.69 120.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.787 ' OG1' HG22 ' A' ' 82' ' ' VAL . 5.4 m -114.04 95.73 5.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.434 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -89.0 167.48 13.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.24 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 96' ' ' PHE . 3.3 m -158.55 -168.08 2.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 110.236 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 27.0 tp10 -101.74 33.68 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.502 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 8.6 ptpt -174.75 0.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.226 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.895 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -179.01 144.71 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 0.0 110.184 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.9 m -119.4 158.37 26.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.598 ' CD2' H122 ' A' ' 131' ' ' JN3 . 56.8 t-80 -143.42 136.52 27.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.207 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.772 ' HG2' HG13 ' A' ' 90' ' ' VAL . 92.2 mt-10 -148.32 131.38 16.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.219 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.56 HE22 HD11 ' A' ' 40' ' ' ILE . 40.5 tt0 -134.7 152.9 52.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.227 -0.921 . . . . 0.0 110.186 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.623 ' OE2' ' HD2' ' A' ' 88' ' ' LYS . 58.1 tt0 -150.72 159.11 44.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.536 HG23 ' CH2' ' A' ' 6' ' ' TRP . 12.7 p -123.52 136.89 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 110.18 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -130.65 96.97 4.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.246 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.53 -98.08 1.75 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.502 ' OD1' ' HG3' ' A' ' 106' ' ' GLU . 30.7 p-10 -126.87 11.6 7.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -1.137 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.502 ' HG3' ' OD1' ' A' ' 105' ' ' ASN . 48.4 mt-10 -118.38 164.99 14.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.213 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.519 ' CE ' ' NE1' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -137.27 143.04 41.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.17 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 121' ' ' ARG . 76.4 t -127.21 127.31 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.375 -0.828 . . . . 0.0 110.238 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 33.9 mt-10 -114.42 134.74 54.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.0 m -124.09 122.38 37.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.179 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 74.8 mt -127.76 131.82 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 110.2 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 80.5 m -112.75 135.58 53.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.512 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 4.9 t80 -156.81 123.95 5.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.17 -0.956 . . . . 0.0 110.274 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 70.03 37.75 73.67 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.49 4.68 52.89 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 112' ' ' THR . 60.2 t -108.65 139.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -1.17 . . . . 0.0 110.178 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 63.6 m -115.13 130.86 57.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.651 HD22 ' CD2' ' A' ' 17' ' ' PHE . 36.9 tp -110.19 141.93 42.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.182 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 95.6 mt -120.34 121.36 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.463 ' NH1' ' H12' ' A' ' 130' ' ' JN3 . 22.3 mtm180 -117.75 117.57 29.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.156 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 9' ' ' TYR . 12.2 mtt180 -98.24 129.01 44.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.169 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.5 p -125.74 166.33 16.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 110.263 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' TRP . 35.4 tttm -129.62 158.83 38.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 110.155 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.405 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 73.8 ttt180 -81.35 134.58 35.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.22 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' JN3 . . . . . 0.93 H151 ' HB3' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' JN3 . . . . . 0.956 ' H42' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_